What this is: FAERS is a spontaneous, voluntary, unverified adverse-event
reporting system. Disproportionality measures (PRR, ROR) flag reporting patterns worth
investigating — they are not incidence rates and do not establish causation.
Reporting is shaped by drug age on market, media attention, litigation, and indication
severity, independent of true risk. Values are precomputed on a batch schedule; see
"last recalculated" below.
Total FAERS reports
Reaction terms tracked
Drugs with signals
Last recalculated
Top reactions by report volume
| Reaction | Reports | Co-occurring drugs | Top signal | |
|---|---|---|---|---|
| 1 | Drug Ineffective | 1,299,281 | 1,139 | Gold (PRR 9.7) |
| 2 | Off Label Use | 856,387 | 1,129 | Infliximab-Dyyb (PRR 12.8) |
| 3 | Death | 849,879 | 1,124 | Sucroferric Oxyhydroxide (PRR 9.3) |
| 4 | Nausea | 778,532 | 1,125 | Trisodium Citrate Dihydrate (PRR 11.9) |
| 5 | Fatigue | 766,588 | 1,121 | Desoximetasone (PRR 12.9) |
| 6 | Diarrhoea | 634,721 | 1,121 | Trofinetide (PRR 17.8) |
| 7 | Headache | 617,862 | 1,137 | Caffeine Citrate (PRR 10.5) |
| 8 | Pain | 607,158 | 1,158 | Protamine Sulfate (PRR 19.2) |
| 9 | Dyspnoea | 558,127 | 1,128 | Isopropyl Alcohol Spray (PRR 13.6) |
| 10 | Dizziness | 491,285 | 1,145 | Trisodium Citrate Dihydrate (PRR 18.3) |
| 11 | Vomiting | 462,654 | 1,121 | Sodium Sulfate, Magnesium Sulfate, And Potassium Chloride (PRR 23.4) |
| 12 | Malaise | 433,763 | 1,127 | Coal Tar (PRR 18.3) |
| 13 | Rash | 427,881 | 1,114 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 30.1) |
| 14 | Arthralgia | 408,883 | 1,159 | Escherichia Coli (PRR 28.0) |
| 15 | Pruritus | 372,949 | 1,152 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 35.2) |
| 16 | Asthenia | 371,081 | 1,116 | Escherichia Coli (PRR 27.0) |
| 17 | Pyrexia | 341,650 | 1,141 | Isopropyl Alcohol Spray (PRR 19.6) |
| 18 | Fall | 328,076 | 1,162 | Escherichia Coli (PRR 35.8) |
| 19 | Pneumonia | 318,973 | 1,120 | Coal Tar (PRR 17.7) |
| 20 | Injection Site Pain | 299,523 | 1,161 | Kit For The Preparation Of Gallium Ga 68 Gozetotide Injection (PRR 46.1) |
| 21 | Condition Aggravated | 297,981 | 1,153 | Infliximab-Dyyb (PRR 26.5) |
| 22 | Pain In Extremity | 291,273 | 1,173 | Triclosan (PRR 20.6) |
| 23 | Anxiety | 281,523 | 1,181 | Talc (PRR 38.9) |
| 24 | Product Dose Omission Issue | 280,971 | 1,194 | Pexidartinib Hydrochloride (PRR 27.5) |
| 25 | Cough | 276,106 | 1,145 | Escherichia Coli (PRR 36.4) |
| 26 | Weight Decreased | 275,349 | 1,145 | Triclosan (PRR 24.6) |
| 27 | Insomnia | 263,241 | 1,173 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 46.8) |
| 28 | Product Use In Unapproved Indication | 241,070 | 1,167 | Ibuprofen, Acetaminophen (PRR 53.4) |
| 29 | Feeling Abnormal | 237,380 | 1,163 | Estriol0.2% (PRR 20.1) |
| 30 | Abdominal Pain | 229,419 | 1,132 | Escherichia Coli (PRR 44.6) |
| 31 | Back Pain | 229,409 | 1,133 | Perflutren (PRR 38.8) |
| 32 | Decreased Appetite | 228,553 | 1,128 | Escherichia Coli (PRR 43.1) |
| 33 | Depression | 225,508 | 1,171 | Atazanavir Sulfate (PRR 24.5) |
| 34 | Incorrect Dose Administered | 221,929 | 1,170 | Tirzepatide (PRR 19.7) |
| 35 | Weight Increased | 219,845 | 1,176 | Triprolidine Hydrochloride (PRR 59.3) |
| 36 | Overdose | 213,770 | 1,184 | Hydrocodone Polistirex And Chlorpheniramine Polistirex (PRR 46.0) |
| 37 | Constipation | 213,553 | 1,156 | Phosphoric Acid (PRR 55.4) |
| 38 | Hypertension | 209,236 | 1,132 | Triclosan (PRR 36.0) |
| 39 | Abdominal Pain Upper | 202,724 | 1,165 | Escherichia Coli (PRR 45.0) |
| 40 | Erythema | 202,577 | 1,137 | Fluocinolone Acetonide, Hydroquinone, And Tretinoin (PRR 30.3) |
| 41 | Wrong Technique In Product Usage Process | 199,314 | 1,145 | Scopolamine Transdermal System (PRR 20.9) |
| 42 | Somnolence | 198,390 | 1,174 | Medicinal Massage Oil (PRR 66.0) |
| 43 | Hypotension | 197,646 | 1,140 | Acebutolol Hydrochloride (PRR 47.5) |
| 44 | Alopecia | 194,180 | 1,168 | Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride (PRR 54.9) |
| 45 | Drug Hypersensitivity | 191,655 | 1,185 | Nickel (PRR 69.4) |
| 46 | Gait Disturbance | 189,407 | 1,167 | Triprolidine Hydrochloride (PRR 67.0) |
| 47 | Anaemia | 188,336 | 1,139 | Citric Acid (PRR 29.5) |
| 48 | Blood Glucose Increased | 186,672 | 1,155 | Insulin Lispro (PRR 39.4) |
| 49 | Product Use Issue | 184,493 | 1,149 | Potassium Phosphate, Dibasic (PRR 47.7) |
| 50 | Chest Pain | 183,140 | 1,141 | Estriol0.2% (PRR 25.5) |
| 51 | Hypersensitivity | 182,912 | 1,156 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 57.6) |
| 52 | Nasopharyngitis | 182,295 | 1,195 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 57.0) |
| 53 | Muscle Spasms | 181,136 | 1,166 | Gadoxetate Disodium (PRR 39.8) |
| 54 | No Adverse Event | 175,026 | 1,177 | Menthol And Lidocaine (PRR 113.2) |
| 55 | Covid-19 | 174,599 | 1,162 | Nirmatrelvir And Ritonavir (PRR 57.6) |
| 56 | Inappropriate Schedule Of Product Administration | 174,471 | 1,167 | Tetrahydrozoline Hydrochloride (PRR 38.9) |
| 57 | Myocardial Infarction | 173,520 | 1,118 | Eptifibatide (PRR 32.4) |
| 58 | Urinary Tract Infection | 167,830 | 1,118 | Nitrofurantoin Monohydrate/Macrocrystalline (PRR 17.2) |
| 59 | Cerebrovascular Accident | 167,800 | 1,114 | Diphenhydramine Hydrochloride, Brompheniramine Maleate, And Dextromethorphan Hydrobromide (PRR 48.0) |
| 60 | Myalgia | 167,738 | 1,138 | Escherichia Coli (PRR 59.1) |
| 61 | Toxicity To Various Agents | 165,620 | 1,169 | Acebutolol Hydrochloride (PRR 47.8) |
| 62 | Drug Dose Omission | 165,472 | 1,085 | Cinacalcet Hydrochloride (PRR 24.8) |
| 63 | Abdominal Discomfort | 164,952 | 1,184 | Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride (PRR 68.4) |
| 64 | Urticaria | 164,230 | 1,176 | Triprolidine Hydrochloride (PRR 81.5) |
| 65 | Tremor | 164,054 | 1,158 | Efinaconazole (PRR 10.1) |
| 66 | Drug Dependence | 160,534 | 1,026 | Oxycodone Hydrochloride (PRR 158.4) |
| 67 | Confusional State | 159,773 | 1,160 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 64.2) |
| 68 | Drug Interaction | 156,580 | 1,160 | Serotonin (PRR 43.9) |
| 69 | Paraesthesia | 155,629 | 1,168 | Trisodium Citrate Dihydrate (PRR 114.5) |
| 70 | Peripheral Swelling | 151,425 | 1,169 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 81.8) |
| 71 | Blood Pressure Increased | 151,199 | 1,154 | Escherichia Coli (PRR 66.2) |
| 72 | Hospitalisation | 150,365 | 1,151 | Ivacaftor (PRR 23.9) |
| 73 | Acute Kidney Injury | 150,299 | 1,156 | Omepraole, Sodium Bicarbonate (PRR 51.5) |
| 74 | Hypoaesthesia | 147,881 | 1,181 | Triclosan (PRR 49.3) |
| 75 | Infection | 142,285 | 1,156 | Sodium Borate (PRR 90.4) |
| 76 | Memory Impairment | 135,741 | 1,174 | Triclosan (PRR 37.4) |
| 77 | Vision Blurred | 134,806 | 1,171 | Escherichia Coli (PRR 61.4) |
| 78 | Neutropenia | 133,702 | 1,168 | Clozapine (PRR 27.1) |
| 79 | Product Quality Issue | 133,032 | 1,145 | Magnesium Salicylate (PRR 98.7) |
| 80 | Renal Failure | 132,013 | 1,140 | Protamine Sulfate (PRR 86.6) |
| 81 | Dehydration | 131,636 | 1,126 | Estriol0.2% (PRR 33.7) |
| 82 | Dry Skin | 129,814 | 1,155 | Adapalene (PRR 61.0) |
| 83 | Psoriasis | 129,020 | 1,133 | Coal Tar (PRR 87.2) |
| 84 | Hyperhidrosis | 127,257 | 1,161 | Almotriptan Malate (PRR 107.2) |
| 85 | Loss Of Consciousness | 126,533 | 1,123 | Fluorescein Sodium (PRR 13.3) |
| 86 | Injection Site Erythema | 121,816 | 1,078 | Rilonacept (PRR 20.0) |
| 87 | Visual Impairment | 121,404 | 1,157 | Aceclidine (PRR 59.9) |
| 88 | Oedema Peripheral | 120,711 | 1,151 | Triclosan (PRR 48.5) |
| 89 | Emotional Distress | 119,903 | 1,157 | Protamine Sulfate (PRR 66.9) |
| 90 | Joint Swelling | 118,884 | 1,178 | Triprolidine Hydrochloride (PRR 116.5) |
| 91 | Disease Progression | 116,374 | 1,169 | Tislelizumab-Jsgr (PRR 64.3) |
| 92 | Chills | 115,872 | 1,146 | Escherichia Coli (PRR 100.2) |
| 93 | Palpitations | 115,461 | 1,165 | Tetrahydrozoline Hydrochloride (PRR 53.6) |
| 94 | General Physical Health Deterioration | 113,372 | 1,165 | Bismuth Subnitrate (PRR 118.6) |
| 95 | Seizure | 113,255 | 1,143 | Fenfluramine (PRR 81.4) |
| 96 | Muscular Weakness | 112,150 | 1,151 | Triclosan (PRR 45.7) |
| 97 | Rheumatoid Arthritis | 111,585 | 1,132 | Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride (PRR 98.8) |
| 98 | Asthma | 110,622 | 1,193 | Pyrilamine Maleate (PRR 149.7) |
| 99 | Influenza | 110,352 | 1,148 | Coal Tar (PRR 51.8) |
| 100 | Sepsis | 110,128 | 1,153 | Medicinal Massage Oil (PRR 120.7) |
| 101 | Thrombocytopenia | 110,039 | 1,154 | Ibritumomab Tiuxetan (PRR 21.5) |
| 102 | White Blood Cell Count Decreased | 107,081 | 1,144 | Dyclonine Hydrochloride (PRR 91.6) |
| 103 | Platelet Count Decreased | 105,116 | 1,165 | Rilzabrutinib (PRR 53.7) |
| 104 | Haemorrhage | 103,170 | 1,104 | Antihemophilic Factor (Recombinant), Fc-Vwf-Xten Fusion Protein-Ehtl (PRR 81.2) |
| 105 | Abdominal Distension | 102,603 | 1,148 | Medicinal Massage Oil (PRR 118.1) |
| 106 | Haemoglobin Decreased | 101,549 | 1,134 | Mitapivat (PRR 42.4) |
| 107 | Sinusitis | 101,430 | 1,202 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 142.6) |
| 108 | Flushing | 100,775 | 1,171 | Flutemetamol F-18 (PRR 107.6) |
| 109 | Chest Discomfort | 100,644 | 1,154 | Coal Tar (PRR 49.1) |
| 110 | Malignant Neoplasm Progression | 100,523 | 1,100 | Streptozocin (PRR 54.4) |
| 111 | Illness | 99,156 | 1,151 | Bremelanotide (PRR 15.0) |
| 112 | Syncope | 98,791 | 1,124 | Escherichia Coli (PRR 99.3) |
| 113 | Accidental Exposure To Product | 98,588 | 1,049 | Adalimumab-Aqvh (PRR 73.6) |
| 114 | Heart Rate Increased | 97,724 | 1,150 | Estriol0.2% (PRR 46.0) |
| 115 | Dyspepsia | 96,814 | 1,161 | Triprolidine Hydrochloride (PRR 120.6) |
| 116 | Atrial Fibrillation | 96,251 | 1,127 | Dronedarone (PRR 30.6) |
| 117 | Drug Intolerance | 94,981 | 1,180 | Bismuth Subnitrate (PRR 125.3) |
| 118 | Contusion | 94,872 | 1,168 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 87.8) |
| 119 | Pulmonary Embolism | 94,211 | 1,130 | Titanium (PRR 125.2) |
| 120 | Migraine | 93,625 | 1,180 | Triprolidine Hydrochloride (PRR 116.1) |
| 121 | Dysphagia | 93,408 | 1,138 | Coal Tar (PRR 56.9) |
| 122 | Neuropathy Peripheral | 93,291 | 1,134 | Enfortumab Vedotin (PRR 26.4) |
| 123 | Breast Cancer | 92,816 | 1,062 | Acetylcholine Chloride, (PRR 92.6) |
| 124 | Cardiac Disorder | 92,679 | 1,135 | Colesevelam Hydrochloride (PRR 24.9) |
| 125 | Swelling | 92,156 | 1,168 | Titanium (PRR 133.7) |
| 126 | Oropharyngeal Pain | 91,377 | 1,152 | Cefprozil (PRR 11.3) |
| 127 | Adverse Event | 90,941 | 1,152 | Triprolidine Hydrochloride (PRR 50.3) |
| 128 | Suicidal Ideation | 90,448 | 1,135 | Esketamine Hydrochloride (PRR 17.7) |
| 129 | Adverse Drug Reaction | 88,287 | 1,151 | Minoxidil Foam 5% (Womens) (PRR 67.7) |
| 130 | Tachycardia | 87,680 | 1,159 | Escherichia Coli (PRR 136.1) |
| 131 | Drug Withdrawal Syndrome | 87,538 | 1,019 | Oxycodone Hydrochloride (PRR 69.3) |
| 132 | Gastrointestinal Disorder | 87,232 | 1,141 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 112.9) |
| 133 | Maternal Exposure During Pregnancy | 87,044 | 1,112 | Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride (PRR 117.8) |
| 134 | Intentional Product Use Issue | 86,792 | 1,166 | Diatrizoate Meglumine (PRR 91.9) |
| 135 | Musculoskeletal Stiffness | 86,515 | 1,186 | Pyrilamine Maleate (PRR 191.4) |
| 136 | Device Issue | 86,107 | 1,043 | Alcohol Pad (PRR 85.8) |
| 137 | Intentional Product Misuse | 85,716 | 1,131 | Titanium (PRR 140.6) |
| 138 | Balance Disorder | 85,439 | 1,164 | Phosphoric Acid (PRR 132.5) |
| 139 | Product Storage Error | 85,392 | 1,036 | Rituximab-Arrx (PRR 105.7) |
| 140 | Completed Suicide | 83,036 | 1,043 | Conium Maculatum (PRR 166.2) |
| 141 | Gastrointestinal Haemorrhage | 82,984 | 1,122 | Rivaroxaban (PRR 34.9) |
| 142 | Renal Impairment | 82,573 | 1,138 | Protamine Sulfate (PRR 81.4) |
| 143 | Drug Abuse | 82,552 | 1,011 | Tobacco Leaf (PRR 181.9) |
| 144 | Skin Exfoliation | 82,006 | 1,130 | Coal Tar (PRR 73.3) |
| 145 | Cardiac Arrest | 81,770 | 1,139 | Cocaine Hydrochloride (PRR 61.8) |
| 146 | Influenza Like Illness | 81,554 | 1,142 | Coal Tar (PRR 64.9) |
| 147 | Treatment Failure | 81,001 | 1,197 | Sodium Borate (PRR 154.1) |
| 148 | Foetal Exposure During Pregnancy | 80,176 | 1,046 | Lamivudine And Tenofovir Disoproxil Fumarate (PRR 73.8) |
| 149 | Prostate Cancer | 80,145 | 1,013 | Edetate Calcium Disodium (PRR 187.3) |
| 150 | Cardiac Failure Congestive | 80,029 | 1,146 | Hydralazine Hydrochloride And Isosorbide Dinitrate (PRR 25.4) |
| 151 | Dry Mouth | 79,923 | 1,182 | Titanium (PRR 157.4) |
| 152 | Thrombosis | 79,623 | 1,115 | Titanium (PRR 151.4) |
| 153 | Cardiac Failure | 79,291 | 1,135 | Tafamidis Meglumine (PRR 29.7) |
| 154 | Gastrooesophageal Reflux Disease | 79,134 | 1,167 | Pyrilamine Maleate (PRR 205.0) |
| 155 | Injection Site Haemorrhage | 78,298 | 1,023 | Testosterone Enanthate (PRR 22.2) |
| 156 | Injection Site Bruising | 77,817 | 1,044 | Camphor (PRR 21.2) |
| 157 | Arthritis | 77,752 | 1,180 | Triamcinolone Hexacetonide (PRR 123.1) |
| 158 | Chronic Kidney Disease | 75,643 | 1,174 | Cimetidine Hydrochloride (PRR 191.9) |
| 159 | Drug Dose Omission By Device | 75,594 | 801 | Somatropin (PRR 90.1) |
| 160 | Diabetes Mellitus | 75,570 | 1,130 | Titanium (PRR 163.0) |
| 161 | Acne | 75,180 | 1,124 | Adapalene (PRR 125.0) |
| 162 | Injection Site Swelling | 74,774 | 1,031 | Betamethasone Sodium Phosphate And Betamethasone Acetate (PRR 57.9) |
| 163 | Unevaluable Event | 74,672 | 1,151 | Protamine Sulfate (PRR 142.4) |
| 164 | Hot Flush | 74,392 | 1,136 | Relugolix (PRR 97.9) |
| 165 | Hallucination | 73,973 | 1,163 | Pimavanserin Tartrate (PRR 77.8) |
| 166 | Epistaxis | 73,966 | 1,131 | Sotatercept-Csrk (PRR 24.9) |
| 167 | Dysgeusia | 73,702 | 1,155 | Tetrahydrozoline Hydrochloride (PRR 85.0) |
| 168 | Bronchitis | 73,426 | 1,165 | Zingiber Officinale (PRR 175.0) |
| 169 | Agitation | 72,685 | 1,156 | Dexmedetomidine (PRR 13.0) |
| 170 | Underdose | 72,108 | 1,117 | Chloroprocaine Hydrochloride Ophthalmic Gel (PRR 149.1) |
| 171 | Respiratory Failure | 72,022 | 1,131 | Potassium Phosphate, Monobasic (PRR 32.8) |
| 172 | Inappropriate Schedule Of Drug Administration | 71,213 | 1,058 | Canakinumab (PRR 34.1) |
| 173 | Stress | 70,979 | 1,147 | Bismuth Subnitrate (PRR 187.3) |
| 174 | Mobility Decreased | 70,677 | 1,168 | Triprolidine Hydrochloride (PRR 186.3) |
| 175 | Skin Burning Sensation | 70,201 | 1,064 | Adapalene (PRR 167.8) |
| 176 | Therapeutic Product Effect Incomplete | 69,782 | 1,176 | Sodium Borate (PRR 204.8) |
| 177 | Injury | 69,734 | 1,173 | Triprolidine Hydrochloride (PRR 188.8) |
| 178 | Burning Sensation | 69,200 | 1,155 | Gadoxetate Disodium (PRR 104.2) |
| 179 | Sleep Disorder | 69,051 | 1,175 | Triprolidine Hydrochloride (PRR 185.7) |
| 180 | Multiple Sclerosis Relapse | 68,219 | 1,024 | Teriflunomide (PRR 38.1) |
| 181 | Therapy Interrupted | 68,083 | 1,106 | Relugolix, Estradiol Hemihydrate, And Norethindrone Acetate (PRR 96.2) |
| 182 | Injection Site Reaction | 67,720 | 1,048 | Diatrizoate Meglumine (PRR 128.1) |
| 183 | Hepatic Enzyme Increased | 67,066 | 1,161 | Caffeine Citrate (PRR 131.9) |
| 184 | Device Malfunction | 66,312 | 1,031 | Pegfilgrastim-Cbqv (PRR 195.4) |
| 185 | Neoplasm Malignant | 65,823 | 1,093 | Sodium Borate (PRR 197.5) |
| 186 | Injection Site Pruritus | 65,676 | 1,032 | Methyl Salicylate 10% (PRR 33.3) |
| 187 | Blood Pressure Decreased | 65,449 | 1,148 | Iopromide (PRR 29.4) |
| 188 | Product Dose Omission | 65,353 | 1,057 | Bacillus Calmette-Guerin (PRR 31.8) |
| 189 | Febrile Neutropenia | 65,352 | 1,126 | Dyclonine Hydrochloride (PRR 133.4) |
| 190 | Device Difficult To Use | 65,213 | 933 | Evolocumab (PRR 129.9) |
| 191 | Infusion Related Reaction | 65,186 | 1,130 | Isopropyl Alcohol Spray (PRR 137.1) |
| 192 | Blood Creatinine Increased | 64,561 | 1,138 | Pyrilamine Maleate (PRR 235.2) |
| 193 | Amnesia | 64,472 | 1,160 | Estriol0.2% (PRR 69.1) |
| 194 | Deep Vein Thrombosis | 64,456 | 1,130 | Tetrahydrozoline Hydrochloride (PRR 97.2) |
| 195 | Device Expulsion | 64,356 | 515 | Levonorgestrel (PRR 247.6) |
| 196 | Swelling Face | 64,176 | 1,130 | Frovatriptan Succinate (PRR 85.1) |
| 197 | Rhinorrhoea | 63,602 | 1,153 | Acetylcholine Chloride, (PRR 135.2) |
| 198 | Intentional Overdose | 62,912 | 1,031 | Serotonin (PRR 100.7) |
| 199 | Exposure During Pregnancy | 61,367 | 1,085 | Hetastarch (PRR 86.9) |
| 200 | Alanine Aminotransferase Increased | 60,624 | 1,135 | Vorasidenib (PRR 49.0) |
| 201 | Feeling Hot | 60,569 | 1,150 | Trisodium Citrate Dihydrate (PRR 151.4) |
| 202 | Vertigo | 60,181 | 1,132 | Tetrahydrozoline Hydrochloride (PRR 106.6) |
| 203 | Pleural Effusion | 60,113 | 1,131 | Pyrilamine Maleate (PRR 269.9) |
| 204 | Ill-Defined Disorder | 59,995 | 1,131 | Hamamelis Virginiana (PRR 168.3) |
| 205 | Suicide Attempt | 59,966 | 1,038 | Trifluoperazine Hydrochloride (PRR 127.4) |
| 206 | Stomatitis | 59,870 | 1,178 | Triprolidine Hydrochloride (PRR 198.9) |
| 207 | Discomfort | 59,825 | 1,158 | Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride (PRR 142.2) |
| 208 | Therapeutic Response Decreased | 59,514 | 1,129 | Incobotulinumtoxina (PRR 45.8) |
| 209 | Irritability | 59,437 | 1,144 | Trifluoperazine Hydrochloride (PRR 108.5) |
| 210 | Bladder Cancer | 58,798 | 979 | Pioglitazone (PRR 83.9) |
| 211 | Cataract | 58,529 | 1,161 | Carboxymethylcellulose Sodium, Glycerin And Polysorbate 80 (PRR 82.4) |
| 212 | Wheezing | 58,383 | 1,186 | Pyrilamine Maleate (PRR 254.2) |
| 213 | Crohn^S Disease | 57,974 | 0 | (PRR —) |
| 214 | Bone Pain | 57,867 | 1,141 | Adefovir Dipivoxil (PRR 33.3) |
| 215 | Nasal Congestion | 57,763 | 1,154 | Acetylcholine Chloride, (PRR 148.9) |
| 216 | Dysphonia | 57,651 | 1,147 | Frovatriptan Succinate (PRR 93.3) |
| 217 | Convulsion | 57,239 | 1,066 | Extended Phenytoin Sodium (PRR 49.0) |
| 218 | Surgery | 57,199 | 1,104 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 53.4) |
| 219 | Herpes Zoster | 56,803 | 1,119 | Dyclonine Hydrochloride (PRR 103.6) |
| 220 | Product Substitution Issue | 56,796 | 1,051 | Lidocaine Patch 4% (PRR 72.9) |
| 221 | Lethargy | 56,759 | 1,130 | Fenfluramine (PRR 12.5) |
| 222 | Flatulence | 55,856 | 1,129 | Telotristat Ethyl (PRR 25.8) |
| 223 | Hyponatraemia | 55,469 | 1,142 | Medicinal Massage Oil (PRR 239.9) |
| 224 | Blister | 55,292 | 1,162 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 187.0) |
| 225 | Neck Pain | 55,226 | 1,163 | Phosphorus (PRR 58.9) |
| 226 | Oxygen Saturation Decreased | 55,074 | 1,140 | Pentobarbital Sodium (PRR 190.0) |
| 227 | Arthropathy | 55,051 | 1,156 | Sodium Borate (PRR 194.1) |
| 228 | Eye Irritation | 55,017 | 1,116 | Acoltremon (PRR 210.2) |
| 229 | Drug Ineffective For Unapproved Indication | 55,009 | 1,150 | Frovatriptan Succinate (PRR 103.7) |
| 230 | Pancytopenia | 54,996 | 1,122 | Foscarnet Sodium (PRR 26.9) |
| 231 | Dependence | 54,825 | 626 | Promethazine Hydrochloride And Codeine Phosphate (PRR 395.8) |
| 232 | Medication Error | 54,774 | 1,122 | Tetrahydrozoline Hydrochloride (PRR 113.1) |
| 233 | Eye Pain | 54,501 | 1,189 | Homatropine Hydrobromide (PRR 232.1) |
| 234 | Haematochezia | 54,382 | 1,144 | Tetrahydrozoline Hydrochloride (PRR 115.3) |
| 235 | Anaphylactic Reaction | 54,207 | 1,143 | Cat Hair (PRR 110.2) |
| 236 | Drug Effect Decreased | 53,928 | 1,038 | Mebrofenin (PRR 141.9) |
| 237 | Treatment Noncompliance | 53,620 | 1,117 | Nicotine Transdermal System Patch (PRR 75.9) |
| 238 | Oedema | 53,422 | 1,151 | Triprolidine Hydrochloride (PRR 259.5) |
| 239 | Disturbance In Attention | 53,371 | 1,154 | Estriol0.2% (PRR 85.3) |
| 240 | Rash Pruritic | 53,239 | 1,109 | Teplizumab-Mzwv (PRR 27.5) |
| 241 | Bradycardia | 52,434 | 1,148 | Hetastarch (PRR 82.4) |
| 242 | Aspartate Aminotransferase Increased | 52,399 | 1,149 | Onasemnogene Abeparvovec-Xioi (PRR 61.9) |
| 243 | Pancreatitis | 52,224 | 1,134 | Hyaluronidase (PRR 44.6) |
| 244 | Musculoskeletal Pain | 52,126 | 1,162 | Sodium Borate (PRR 249.5) |
| 245 | Depressed Mood | 51,943 | 1,122 | Calamine (PRR 19.1) |
| 246 | Nervousness | 51,825 | 1,119 | Camphor (PRR 45.4) |
| 247 | Speech Disorder | 51,710 | 1,132 | Apomorphine Hydrochloride (PRR 23.9) |
| 248 | Chronic Obstructive Pulmonary Disease | 51,452 | 1,126 | Bismuth Subnitrate (PRR 231.4) |
| 249 | Inflammation | 50,660 | 1,180 | Gadoxetate Disodium (PRR 139.7) |
| 250 | Therapy Cessation | 50,422 | 1,089 | Lomitapide Mesylate (PRR 87.8) |
| 251 | Fluid Retention | 50,173 | 1,136 | Calcium Sennosides (PRR 72.1) |
| 252 | Cellulitis | 49,783 | 1,120 | Ishancare Hemorrhoid Cream (PRR 27.7) |
| 253 | Eczema | 49,642 | 1,131 | Tetrahydrozoline Hydrochloride (PRR 123.3) |
| 254 | Aggression | 49,497 | 1,097 | Tobacco Leaf (PRR 31.3) |
| 255 | Dermatitis Atopic | 49,300 | 1,004 | Dupilumab (PRR 444.6) |
| 256 | Leukopenia | 49,235 | 1,120 | Trifluoperazine Hydrochloride (PRR 141.4) |
| 257 | Lung Disorder | 48,320 | 1,150 | Calcium Sennosides (PRR 140.7) |
| 258 | Hypoglycaemia | 47,901 | 1,130 | Streptozocin (PRR 66.7) |
| 259 | Dry Eye | 47,814 | 1,140 | Mineral Oil And White Petrolatum (PRR 102.7) |
| 260 | Colorectal Cancer | 47,716 | 513 | Ranitidine (PRR 61.0) |
| 261 | Interstitial Lung Disease | 47,680 | 1,092 | Fam-Trastuzumab Deruxtecan-Nxki (PRR 45.1) |
| 262 | Renal Cancer | 47,603 | 893 | Ranitidine (PRR 53.9) |
| 263 | Blood Glucose Decreased | 47,566 | 1,087 | Exenatide (PRR 51.8) |
| 264 | Multiple Sclerosis | 47,437 | 1,022 | Glatiramer Acetate Injection (PRR 56.3) |
| 265 | Disease Recurrence | 47,088 | 1,119 | Nirmatrelvir And Ritonavir (PRR 285.7) |
| 266 | Coma | 47,047 | 1,140 | Escherichia Coli (PRR 240.6) |
| 267 | Arrhythmia | 46,935 | 1,119 | Propafenone Hydrochloride (PRR 17.2) |
| 268 | Loss Of Personal Independence In Daily Activities | 46,930 | 1,133 | Acetylcholine Chloride, (PRR 169.7) |
| 269 | Productive Cough | 46,715 | 1,166 | Edetate Calcium Disodium (PRR 321.3) |
| 270 | Rash Erythematous | 46,233 | 1,114 | Calcium Sennosides (PRR 61.6) |
| 271 | Ocular Hyperaemia | 46,105 | 1,139 | Aceclidine (PRR 202.0) |
| 272 | Renal Disorder | 46,076 | 1,128 | Edetate Calcium Disodium (PRR 325.8) |
| 273 | Blood Cholesterol Increased | 46,026 | 1,144 | Titanium (PRR 239.2) |
| 274 | Cognitive Disorder | 45,908 | 1,175 | Acebutolol Hydrochloride (PRR 230.7) |
| 275 | Upper Respiratory Tract Infection | 45,546 | 1,167 | Pyrilamine Maleate (PRR 356.3) |
| 276 | Tinnitus | 45,412 | 1,143 | Escherichia Coli (PRR 217.7) |
| 277 | Skin Discolouration | 45,347 | 1,143 | Setmelanotide (PRR 59.2) |
| 278 | Hypokalaemia | 45,292 | 1,142 | Triamcinolone Hexacetonide (PRR 92.5) |
| 279 | Skin Irritation | 45,290 | 1,035 | Adapalene (PRR 159.6) |
| 280 | Nephrolithiasis | 45,138 | 1,134 | Almotriptan Malate (PRR 259.1) |
| 281 | Wrong Technique In Device Usage Process | 45,123 | 926 | Budesonide, Glycopyrrolate, And Formoterol Fumarate (PRR 52.8) |
| 282 | Lower Respiratory Tract Infection | 44,722 | 1,153 | Pyrilamine Maleate (PRR 355.1) |
| 283 | Therapeutic Response Unexpected | 44,429 | 1,079 | Fluciclovine F-18 (PRR 83.9) |
| 284 | Pulmonary Oedema | 44,238 | 1,108 | Meprobamate (PRR 19.9) |
| 285 | Throat Irritation | 44,119 | 1,115 | Cat Hair (PRR 77.7) |
| 286 | Colitis Ulcerative | 44,014 | 1,078 | Tetrahydrozoline Hydrochloride (PRR 142.5) |
| 287 | Therapy Non-Responder | 43,989 | 1,154 | Sodium Borate (PRR 287.0) |
| 288 | Therapeutic Product Effect Decreased | 43,799 | 1,097 | Diatrizoate Meglumine (PRR 201.4) |
| 289 | Liver Disorder | 43,716 | 1,145 | Bismuth Subnitrate (PRR 109.6) |
| 290 | Angioedema | 43,561 | 1,111 | Frovatriptan Succinate (PRR 124.2) |
| 291 | Mental Disorder | 43,020 | 1,125 | Acetylcholine Chloride, (PRR 199.9) |
| 292 | Device Dislocation | 42,830 | 1,009 | Copper (PRR 98.3) |
| 293 | Septic Shock | 42,652 | 1,131 | Triamcinolone Hexacetonide (PRR 258.2) |
| 294 | Rectal Haemorrhage | 42,548 | 1,129 | Tetrahydrozoline Hydrochloride (PRR 149.1) |
| 295 | Renal Failure Acute | 42,477 | 1,060 | Protamine Sulfate (PRR 48.0) |
| 296 | Hypoacusis | 42,394 | 1,090 | Teprotumumab (PRR 41.5) |
| 297 | Vaginal Haemorrhage | 42,018 | 1,038 | Ulipristal Acetate (PRR 72.4) |
| 298 | Osteoarthritis | 41,916 | 1,138 | Triclosan (PRR 173.6) |
| 299 | Device Leakage | 41,779 | 1,002 | Somatropin (PRR 95.4) |
| 300 | Withdrawal Syndrome | 41,668 | 1,031 | Rosemary Oil (PRR 68.2) |
| 301 | Cardio-Respiratory Arrest | 41,536 | 1,112 | Escherichia Coli (PRR 268.8) |
| 302 | Road Traffic Accident | 41,310 | 1,094 | Triclosan (PRR 143.1) |
| 303 | Pollakiuria | 41,095 | 1,118 | Gemcitabine Intravesical (PRR 98.1) |
| 304 | Rhabdomyolysis | 41,077 | 1,082 | Triheptanoin (PRR 52.5) |
| 305 | Lung Neoplasm Malignant | 40,770 | 1,035 | Brigatinib (PRR 31.6) |
| 306 | Osteoporosis | 40,642 | 1,146 | Triclosan (PRR 146.4) |
| 307 | Blindness | 40,179 | 1,110 | Escherichia Coli (PRR 287.2) |
| 308 | Dyskinesia | 40,027 | 1,134 | Ziprasidone Hydrochloride (PRR 142.0) |
| 309 | Neutrophil Count Decreased | 39,979 | 1,089 | Phosphoric Acid (PRR 65.3) |
| 310 | Abortion Spontaneous | 39,706 | 1,014 | Doxylamine Succinate And Pyridoxine Hydrochloride, Delayed Release Tablets 10 Mg/10 Mg (PRR 126.4) |
| 311 | Psoriatic Arthropathy | 39,690 | 1,027 | Triprolidine Hydrochloride (PRR 352.5) |
| 312 | Extra Dose Administered | 39,373 | 1,021 | Tirzepatide (PRR 41.3) |
| 313 | Abnormal Behaviour | 39,358 | 1,090 | Zanamivir (PRR 84.0) |
| 314 | Disorientation | 39,202 | 1,122 | Glycerine (PRR 32.6) |
| 315 | Depressed Level Of Consciousness | 38,957 | 1,134 | Phosphoric Acid (PRR 228.2) |
| 316 | Device Breakage | 38,771 | 1,000 | Copper (PRR 194.4) |
| 317 | Plasma Cell Myeloma | 38,582 | 1,025 | Belantamab Mafodotin (PRR 80.3) |
| 318 | White Blood Cell Count Increased | 37,999 | 1,124 | Hyaluronidase (PRR 64.2) |
| 319 | Colitis | 37,172 | 1,125 | Sodium Borate (PRR 110.7) |
| 320 | Dysarthria | 37,128 | 1,135 | Coal Tar (PRR 137.9) |
| 321 | Dyspnoea Exertional | 37,040 | 1,120 | Colesevelam Hydrochloride (PRR 63.6) |
| 322 | Intestinal Obstruction | 36,973 | 1,124 | Teduglutide (PRR 17.7) |
| 323 | Hepatic Function Abnormal | 36,579 | 1,106 | Echinacea (Angustifolia), Tabebuia Impetiginosa, Hydrastis Canadensis, Glandula Suprarenalis Suis, Thymus (Suis), Thyroidinum (Suis), Arsenicum Album, Bryonia (Alba), Cocculus Indicus, Colchicum Autumnale, Ledum Palustre, Mercurius Cyanatus, Natrum Sulphuricum, Pulsatilla (Pratensis), Sepia, Silicea, Aflatoxin (B1) (PRR 54.5) |
| 324 | Eye Swelling | 36,487 | 1,125 | Polymyxin B Sulfate And Trimethoprim (PRR 69.0) |
| 325 | Injection Site Mass | 36,379 | 1,003 | Lenacapavir Sodium (PRR 44.4) |
| 326 | Dysuria | 36,367 | 1,126 | Gemcitabine Intravesical (PRR 117.4) |
| 327 | Wrong Technique In Drug Usage Process | 36,366 | 1,004 | Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose (PRR 67.4) |
| 328 | Drug Effect Incomplete | 36,362 | 1,022 | Glucarpidase (PRR 52.5) |
| 329 | Restlessness | 36,168 | 1,113 | Trisodium Citrate Dihydrate (PRR 48.5) |
| 330 | Accidental Overdose | 36,070 | 1,075 | Tetrahydrozoline Hydrochloride (PRR 171.9) |
| 331 | Panic Attack | 36,003 | 1,089 | Coal Tar (PRR 35.2) |
| 332 | Crying | 35,996 | 1,077 | Prucalopride Succinate (PRR 27.1) |
| 333 | C-Reactive Protein Increased | 35,891 | 1,150 | Zingiber Officinale (PRR 358.4) |
| 334 | Hyperglycaemia | 35,847 | 1,121 | Inavolisib (PRR 146.2) |
| 335 | Incorrect Route Of Drug Administration | 35,780 | 999 | Iothalamate Meglumine (PRR 289.2) |
| 336 | Electrocardiogram Qt Prolonged | 35,519 | 1,092 | Aluminum Hydroxide (PRR 133.7) |
| 337 | Cerebral Haemorrhage | 35,292 | 1,099 | Tirofiban Hydrochloride (PRR 66.7) |
| 338 | Product Adhesion Issue | 34,988 | 789 | Lidocaine 4% Maximum Strength 24 Hr (PRR 385.8) |
| 339 | Lymphadenopathy | 34,970 | 1,127 | Dyclonine Hydrochloride (PRR 180.8) |
| 340 | Systemic Lupus Erythematosus | 34,912 | 1,052 | Cortisone Acetate (PRR 369.3) |
| 341 | Heart Rate Decreased | 34,825 | 1,124 | Fingolimod Lauryl Sulfate (PRR 78.2) |
| 342 | Neoplasm Progression | 34,644 | 1,024 | Palbociclib (PRR 96.0) |
| 343 | Hypoxia | 34,609 | 1,145 | Pyrilamine Maleate (PRR 449.0) |
| 344 | Hyperkalaemia | 34,443 | 1,087 | Finerenone (PRR 53.4) |
| 345 | Rash Macular | 34,366 | 1,108 | Octocrylene, Avobenzone (PRR 25.5) |
| 346 | Gastric Disorder | 34,365 | 1,062 | Dimethyl Fumarate (PRR 32.4) |
| 347 | Nightmare | 34,305 | 1,059 | Almotriptan Malate (PRR 382.0) |
| 348 | Delirium | 34,123 | 1,151 | Triclosan (PRR 117.3) |
| 349 | Drug Exposure During Pregnancy | 34,045 | 1,000 | Chamomilla, Passiflora Incarnata, Valeriana Officinalis, Allium Sativum, Argentum Nitricum, Avena Sativa, Caladium Seguinum, Kali Bichromicum, Lobelia Inflata, Lycopodium Clavatum, Serotonin (Hydrochloride), Tabacum, Adrenalinum, Ammoniacum Gummi, Balsamum Peruvianum, Cactus Cacti, Selenium Metallicum (PRR 164.7) |
| 350 | Haematuria | 33,851 | 1,113 | Edetate Calcium Disodium (PRR 443.6) |
| 351 | Device Use Error | 33,630 | 719 | Pegfilgrastim (PRR 46.0) |
| 352 | Myelosuppression | 33,574 | 1,001 | Penpulimab (PRR 114.5) |
| 353 | Anger | 33,517 | 1,067 | Tafenoquine (PRR 139.5) |
| 354 | Transient Ischaemic Attack | 33,442 | 1,083 | Bismuth Subnitrate (PRR 152.5) |
| 355 | Type 2 Diabetes Mellitus | 33,331 | 1,114 | Triprolidine Hydrochloride (PRR 426.9) |
| 356 | Circumstance Or Information Capable Of Leading To Medication Error | 33,110 | 1,016 | Rituximab-Arrx (PRR 192.0) |
| 357 | Visual Acuity Reduced | 33,051 | 1,068 | Homatropine Hydrobromide (PRR 333.0) |
| 358 | Fungal Infection | 32,860 | 1,113 | Daunorubicin Hydrochloride (PRR 34.8) |
| 359 | Urinary Retention | 32,846 | 1,127 | Sofpironium Bromide (PRR 52.8) |
| 360 | Skin Disorder | 32,840 | 1,115 | Asian Ginseng (PRR 36.8) |
| 361 | Viral Infection | 32,807 | 1,122 | Edetate Calcium Disodium (PRR 457.7) |
| 362 | Lip Swelling | 32,794 | 1,089 | Estriol0.2% (PRR 144.0) |
| 363 | Expired Product Administered | 32,744 | 1,030 | Acetaminophen-Aspirin-Caffeine (PRR 300.1) |
| 364 | Osteonecrosis | 32,712 | 1,031 | Tenofovir Disoproxil Fumarate (PRR 179.6) |
| 365 | Staphylococcal Infection | 32,670 | 1,123 | Diclofenac Sodium/Misoprostol (PRR 62.5) |
| 366 | Gait Inability | 32,667 | 1,136 | Hamamelis Virginiana (PRR 247.3) |
| 367 | Eye Pruritus | 32,536 | 1,055 | Estriol0.2% (PRR 134.3) |
| 368 | Impaired Healing | 32,407 | 1,124 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 330.4) |
| 369 | Cholelithiasis | 32,370 | 1,134 | Drospirenone And Ethinyl Estradiol (PRR 68.2) |
| 370 | Eye Disorder | 32,347 | 1,112 | Tetracaine (PRR 27.6) |
| 371 | Movement Disorder | 31,840 | 1,122 | Gadoxetate Disodium (PRR 108.1) |
| 372 | Night Sweats | 31,776 | 1,115 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 254.1) |
| 373 | Hip Fracture | 31,680 | 1,073 | Alendronate Sodium And Cholecalciferol (PRR 29.4) |
| 374 | Lactic Acidosis | 31,670 | 1,040 | Phenylalanine (PRR 108.9) |
| 375 | Cystitis | 31,543 | 1,113 | Coal Tar (PRR 170.1) |
| 376 | Mood Swings | 31,482 | 1,047 | Tafenoquine (PRR 95.4) |
| 377 | Hypothyroidism | 31,426 | 1,125 | Sodium Iodide I 123 (PRR 272.9) |
| 378 | Therapeutic Response Shortened | 31,408 | 1,006 | Serdexmethylphenidate And Dexmethylphenidate (PRR 55.7) |
| 379 | Bone Density Decreased | 31,262 | 1,014 | Emtricitabine And Tenofovir Disoproxil Fumarate (PRR 516.1) |
| 380 | Metabolic Acidosis | 31,240 | 1,093 | Serotonin (PRR 205.5) |
| 381 | Head Injury | 31,162 | 1,100 | L Dopa (PRR 35.5) |
| 382 | Nervous System Disorder | 30,902 | 1,110 | Metoclopramide (PRR 114.4) |
| 383 | Gynaecomastia | 30,895 | 872 | Risperidone (PRR 614.0) |
| 384 | Swollen Tongue | 30,853 | 1,089 | Tetrahydrozoline Hydrochloride (PRR 196.2) |
| 385 | Drug Administration Error | 30,716 | 1,018 | Glycerin, Lidocaine (PRR 91.3) |
| 386 | Femur Fracture | 30,644 | 1,059 | Alendronate Sodium And Cholecalciferol (PRR 360.1) |
| 387 | Emotional Disorder | 30,613 | 1,073 | Risperidone (PRR 37.6) |
| 388 | Limb Discomfort | 30,544 | 1,095 | Gold (PRR 16.7) |
| 389 | Drug-Induced Liver Injury | 30,439 | 1,088 | Triclosan (PRR 125.2) |
| 390 | Epilepsy | 30,116 | 1,096 | Phosphorus (PRR 150.8) |
| 391 | Coronary Artery Disease | 30,113 | 1,086 | Bismuth Subnitrate (PRR 184.8) |
| 392 | Injection Site Rash | 29,949 | 1,002 | Rilonacept (PRR 40.1) |
| 393 | Aphasia | 29,887 | 1,131 | Coal Tar (PRR 171.5) |
| 394 | Hepatic Failure | 29,826 | 1,100 | Nitisinone (PRR 33.0) |
| 395 | Premature Baby | 29,797 | 1,010 | Methyldopa (PRR 135.2) |
| 396 | Contraindicated Product Administered | 29,768 | 1,072 | Cortisone Acetate (PRR 303.4) |
| 397 | Blood Potassium Decreased | 29,693 | 1,124 | Mifepristone (PRR 68.3) |
| 398 | Oesophageal Carcinoma | 29,632 | 658 | Ranitidine (PRR 50.0) |
| 399 | Renal Injury | 29,626 | 1,062 | Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Disoproxil Fumarate (PRR 341.9) |
| 400 | Respiratory Disorder | 29,606 | 1,124 | Acetylcholine Chloride, (PRR 290.6) |
| 401 | Lacrimation Increased | 29,486 | 1,107 | Edetate Calcium Disodium (PRR 509.3) |
| 402 | Urinary Incontinence | 29,226 | 1,125 | Alendronate Sodium And Cholecalciferol (PRR 20.5) |
| 403 | Acute Myocardial Infarction | 29,220 | 1,091 | Andexanet Alfa (PRR 37.1) |
| 404 | Psychotic Disorder | 29,151 | 1,045 | Aesculus Hippocastanum Whole (PRR 75.7) |
| 405 | Laboratory Test Abnormal | 29,092 | 1,083 | Cinacalcet Hydrochloride (PRR 75.7) |
| 406 | Ascites | 29,030 | 1,113 | Titanium (PRR 442.9) |
| 407 | Dysstasia | 28,911 | 1,104 | Asian Ginseng (PRR 41.8) |
| 408 | Liver Function Test Abnormal | 28,883 | 1,092 | Dyclonine Hydrochloride (PRR 203.8) |
| 409 | Blood Creatine Phosphokinase Increased | 28,867 | 1,072 | Delandistrogene Moxeparvovec-Rokl (PRR 52.4) |
| 410 | Drug Effective For Unapproved Indication | 28,834 | 1,002 | Ibuprofen, Acetaminophen (PRR 434.6) |
| 411 | Pancreatic Carcinoma | 28,679 | 1,002 | Ranitidine (PRR 32.5) |
| 412 | Angina Pectoris | 28,469 | 1,092 | Coal Tar (PRR 173.6) |
| 413 | International Normalised Ratio Increased | 28,416 | 1,062 | Warfarin Sodium (PRR 97.7) |
| 414 | Red Blood Cell Count Decreased | 28,255 | 1,107 | Niraparib (PRR 47.1) |
| 415 | Hypersomnia | 28,252 | 1,104 | Levoketoconazole (PRR 21.1) |
| 416 | Needle Issue | 28,227 | 1,002 | Aripiprazole Lauroxil (PRR 105.4) |
| 417 | Incorrect Drug Administration Duration | 28,154 | 1,000 | Alka-Seltzer Gold (PRR 56.5) |
| 418 | Tardive Dyskinesia | 28,115 | 999 | Metoclopramide Hydrochloride (PRR 366.3) |
| 419 | Pain In Jaw | 27,982 | 1,097 | Epoprostenol (PRR 112.8) |
| 420 | Haemoptysis | 27,589 | 1,114 | Pyrilamine Maleate (PRR 550.9) |
| 421 | Multiple Organ Dysfunction Syndrome | 27,539 | 1,079 | Bismuth Subnitrate (PRR 489.4) |
| 422 | Feeling Cold | 27,528 | 1,085 | Oritavancin Diphosphate (PRR 43.1) |
| 423 | Dementia | 27,481 | 1,061 | L Dopa (PRR 66.2) |
| 424 | Respiratory Arrest | 27,447 | 1,057 | Cocaine Hydrochloride (PRR 174.4) |
| 425 | Wound | 27,439 | 1,102 | Pseudoephedrine Hydrochloride (PRR 406.3) |
| 426 | Abnormal Dreams | 27,435 | 1,031 | Varenicline Tartrate (PRR 103.4) |
| 427 | Mental Status Changes | 27,430 | 1,111 | Gadoxetate Disodium (PRR 127.2) |
| 428 | Procedural Pain | 27,294 | 1,037 | Cupric Oxide (PRR 191.2) |
| 429 | Diverticulitis | 27,271 | 1,080 | Zingiber Officinale (PRR 489.4) |
| 430 | Respiratory Distress | 27,254 | 1,112 | Trihexyphenidyl Hydrochloride (PRR 31.3) |
| 431 | Intentional Dose Omission | 26,988 | 1,038 | Eteplirsen (PRR 90.4) |
| 432 | Pallor | 26,921 | 1,098 | Trisodium Citrate Dihydrate (PRR 330.2) |
| 433 | Skin Lesion | 26,869 | 1,109 | Potassium Phosphate, Dibasic (PRR 56.7) |
| 434 | Mood Altered | 26,822 | 1,048 | Nabilone (PRR 30.8) |
| 435 | Fear | 26,747 | 1,060 | Protamine Sulfate (PRR 364.1) |
| 436 | Limb Injury | 26,732 | 1,072 | Asian Ginseng (PRR 47.2) |
| 437 | Blood Bilirubin Increased | 26,730 | 1,102 | Fosamprenavir Calcium (PRR 149.0) |
| 438 | Pneumonitis | 26,683 | 1,052 | Mirvetuximab Soravtansine (PRR 41.5) |
| 439 | Throat Tightness | 26,659 | 1,069 | Cat Hair (PRR 61.9) |
| 440 | Pain Of Skin | 26,648 | 1,038 | Estriol0.2% (PRR 166.2) |
| 441 | Jaundice | 26,633 | 1,078 | Maralixibat Chloride (PRR 34.4) |
| 442 | Frequent Bowel Movements | 26,552 | 1,071 | Tetrahydrozoline Hydrochloride (PRR 244.9) |
| 443 | Breast Cancer Female | 26,546 | 856 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 245.7) |
| 444 | Product Dose Omission In Error | 26,505 | 1,028 | Pexidartinib Hydrochloride (PRR 75.7) |
| 445 | Ear Infection | 26,195 | 1,091 | Triclosan (PRR 139.6) |
| 446 | Menstruation Irregular | 26,190 | 858 | Levonorgestrel (PRR 137.6) |
| 447 | Anhedonia | 26,140 | 1,039 | Protamine Sulfate (PRR 276.1) |
| 448 | Pharmaceutical Product Complaint | 25,992 | 883 | Calcium Chloride, Magnesium Chloride, Potassium Chloride And Sodium Chloride (PRR 217.1) |
| 449 | Application Site Erythema | 25,971 | 1,000 | Cool And Heat Pain Relief (PRR 278.9) |
| 450 | Gastritis | 25,945 | 1,108 | Alendronate Sodium And Cholecalciferol (PRR 26.0) |
| 451 | Rash Generalised | 25,918 | 1,038 | Amifostine (PRR 50.6) |
| 452 | Joint Stiffness | 25,897 | 1,092 | Sodium Borate (PRR 408.3) |
| 453 | Deafness | 25,852 | 1,086 | Teprotumumab (PRR 40.2) |
| 454 | Device Delivery System Issue | 25,791 | 671 | Testosterone Gel, 1% (PRR 333.4) |
| 455 | Sedation | 25,728 | 1,011 | Almotriptan Malate (PRR 510.9) |
| 456 | Mucosal Inflammation | 25,720 | 1,039 | Palifermin (PRR 116.1) |
| 457 | Haematoma | 25,671 | 1,097 | Camphor (PRR 64.2) |
| 458 | Diplopia | 25,635 | 1,106 | Escherichia Coli (PRR 382.7) |
| 459 | Respiratory Tract Infection | 25,626 | 1,122 | Edetate Calcium Disodium (PRR 586.1) |
| 460 | Skin Ulcer | 25,481 | 1,109 | Gold (PRR 40.7) |
| 461 | Erectile Dysfunction | 25,414 | 1,030 | Gallium Ga-68 Gozetotide (PRR 102.4) |
| 462 | Unresponsive To Stimuli | 25,387 | 1,080 | Ferumoxytol (PRR 59.9) |
| 463 | Drug Resistance | 25,348 | 1,014 | Adefovir Dipivoxil (PRR 178.6) |
| 464 | Anaphylactic Shock | 25,291 | 1,054 | Remimazolam Besylate (PRR 216.4) |
| 465 | Gastric Cancer | 25,287 | 950 | Ranitidine (PRR 44.0) |
| 466 | Hepatitis | 25,260 | 1,083 | Tetracycline Hydrochloride (PRR 92.2) |
| 467 | Cardiovascular Disorder | 25,244 | 1,048 | Bismuth Subnitrate (PRR 189.9) |
| 468 | Drug Reaction With Eosinophilia And Systemic Symptoms | 25,217 | 1,016 | Iomeprol Injection (PRR 103.9) |
| 469 | Haematemesis | 25,089 | 1,098 | Escherichia Coli (PRR 463.6) |
| 470 | Incorrect Dose Administered By Device | 25,064 | 768 | Testosterone Gel, 1% (PRR 115.2) |
| 471 | Hypophagia | 25,037 | 1,095 | Trimipramine (PRR 26.0) |
| 472 | Abdominal Pain Lower | 25,027 | 1,077 | Levonorgestrel (PRR 60.5) |
| 473 | Glycosylated Haemoglobin Increased | 24,861 | 1,012 | Empagliflozin, Linagliptin, Metformin Hydrochloride (PRR 35.3) |
| 474 | Extrapyramidal Disorder | 24,755 | 999 | Metoclopramide (PRR 335.5) |
| 475 | Abasia | 24,735 | 1,021 | Gadodiamide (PRR 17.8) |
| 476 | Ageusia | 24,680 | 1,060 | Galphimia Glauca Flowering Top, Luffa Operculata Fruit, And Schoenocaulon Officinale Seed (PRR 441.9) |
| 477 | Product Complaint | 24,630 | 931 | Perphenazine And Amitriptyline Hydrochloride (PRR 112.0) |
| 478 | Osteonecrosis Of Jaw | 24,596 | 1,003 | Pamidronate Disodium (PRR 110.0) |
| 479 | Pneumonia Aspiration | 24,595 | 1,129 | Horse Chestnut (PRR 140.1) |
| 480 | Blood Alkaline Phosphatase Increased | 24,552 | 1,091 | Seladelpar Lysine (PRR 73.7) |
| 481 | Encephalopathy | 24,173 | 1,094 | Tiagabine Hydrochloride (PRR 163.2) |
| 482 | Cerebral Infarction | 24,135 | 1,054 | Andexanet Alfa (PRR 65.5) |
| 483 | Fibromyalgia | 23,969 | 1,061 | Hamamelis Virginiana (PRR 316.0) |
| 484 | Hepatic Cancer | 23,959 | 768 | Ranitidine (PRR 48.1) |
| 485 | Mental Impairment | 23,951 | 1,065 | Acetylcholine Chloride, (PRR 359.3) |
| 486 | Injection Site Urticaria | 23,939 | 998 | Dermatophagoides Pteronyssinus (PRR 32.9) |
| 487 | Neuralgia | 23,935 | 1,138 | Titanium (PRR 504.4) |
| 488 | Localised Infection | 23,883 | 1,055 | Diclofenac Sodium/Misoprostol (PRR 29.8) |
| 489 | Presyncope | 23,881 | 1,082 | Escherichia Coli (PRR 411.1) |
| 490 | Liver Injury | 23,865 | 1,079 | Triprolidine Hydrochloride (PRR 505.2) |
| 491 | Blood Pressure Fluctuation | 23,753 | 1,076 | Infliximab-Dyyb (PRR 63.6) |
| 492 | Diabetic Ketoacidosis | 23,654 | 1,014 | Canagliflozin (PRR 118.0) |
| 493 | Product Prescribing Error | 23,366 | 1,030 | Methyltestosterone (PRR 65.9) |
| 494 | Palmar-Plantar Erythrodysaesthesia Syndrome | 23,083 | 1,000 | Regorafenib (PRR 119.1) |
| 495 | Muscle Twitching | 22,811 | 1,087 | Dyclonine Hydrochloride (PRR 382.6) |
| 496 | Pericardial Effusion | 22,712 | 1,068 | Sotatercept-Csrk (PRR 27.3) |
| 497 | Shock | 22,519 | 1,066 | Activated Charcoal (PRR 47.2) |
| 498 | Heart Rate Irregular | 22,428 | 1,057 | Methazolamide (PRR 38.1) |
| 499 | Application Site Pruritus | 22,400 | 888 | Clonidine Transdermal System (PRR 155.4) |
| 500 | Exposure Via Skin Contact | 22,317 | 807 | Dupilumab (PRR 70.1) |
| 501 | Chromaturia | 22,293 | 1,082 | Secnidazole (PRR 36.4) |
| 502 | Oral Pain | 22,172 | 1,068 | Dyclonine Hydrochloride (PRR 216.3) |
| 503 | Rash Papular | 22,167 | 1,054 | Estriol0.2% (PRR 144.9) |
| 504 | Product Availability Issue | 22,124 | 1,015 | Bacillus Calmette-Guerin (PRR 126.3) |
| 505 | Sneezing | 22,070 | 1,040 | Coal Tar (PRR 254.8) |
| 506 | Glossodynia | 22,064 | 1,040 | Desoximetasone (PRR 591.4) |
| 507 | Tooth Disorder | 22,057 | 1,055 | Alendronate Sodium And Cholecalciferol (PRR 88.6) |
| 508 | Pancreatitis Acute | 22,019 | 1,062 | Olezarsen Sodium (PRR 36.2) |
| 509 | Stevens-Johnson Syndrome | 21,989 | 1,051 | Hetastarch (PRR 80.9) |
| 510 | Transaminases Increased | 21,924 | 1,049 | Pyrilamine Maleate (PRR 693.5) |
| 511 | Gamma-Glutamyltransferase Increased | 21,891 | 1,043 | Delandistrogene Moxeparvovec-Rokl (PRR 119.1) |
| 512 | Hepatotoxicity | 21,876 | 1,037 | Sodium Borate (PRR 596.1) |
| 513 | Rash Maculo-Papular | 21,867 | 1,051 | Iomeprol Injection (PRR 156.9) |
| 514 | Melaena | 21,773 | 1,036 | Sevelamer Hydrochloride (PRR 26.6) |
| 515 | Application Site Pain | 21,728 | 1,000 | Acne Clear Body Cleanser (PRR 714.4) |
| 516 | Pruritus Generalised | 21,653 | 1,029 | Oritavancin (PRR 13.6) |
| 517 | Intervertebral Disc Protrusion | 21,633 | 1,079 | Quinidine Sulfate Tablet (PRR 87.0) |
| 518 | Product Dispensing Error | 21,462 | 1,010 | Piflufolastat F-18 (PRR 166.7) |
| 519 | Faeces Discoloured | 21,393 | 1,078 | Bismuth Subcitrate Potassium, Metronidazole, And Tetracycline Hydrochloride (PRR 69.7) |
| 520 | Clostridium Difficile Infection | 21,387 | 1,077 | Dyclonine Hydrochloride (PRR 408.1) |
| 521 | Altered State Of Consciousness | 21,268 | 1,055 | Escherichia Coli (PRR 545.3) |
| 522 | Skin Cancer | 21,265 | 1,016 | Avobenzone, Homosalate, Octisalate, And Octocrylene (PRR 219.4) |
| 523 | Impaired Work Ability | 21,165 | 1,034 | Tetrahydrozoline Hydrochloride (PRR 282.9) |
| 524 | Poor Quality Sleep | 21,118 | 1,071 | Mexiletine Hydrochloride (PRR 56.1) |
| 525 | Joint Injury | 21,104 | 1,071 | Sodium Borate (PRR 599.6) |
| 526 | Eating Disorder | 21,095 | 1,073 | Coal Tar (PRR 238.6) |
| 527 | Irritable Bowel Syndrome | 21,087 | 1,063 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 495.8) |
| 528 | Liver Function Test Increased | 21,048 | 1,096 | Pyrilamine Maleate (PRR 722.5) |
| 529 | Retching | 20,990 | 1,065 | Trofinetide (PRR 41.6) |
| 530 | Intentional Drug Misuse | 20,931 | 847 | Indium In -111 Pentetreotide (PRR 239.8) |
| 531 | Mouth Ulceration | 20,758 | 1,088 | Phosphoric Acid (PRR 138.4) |
| 532 | Hallucination, Visual | 20,708 | 1,044 | Selegiline Hydrochloride (PRR 49.1) |
| 533 | Pulmonary Hypertension | 20,636 | 1,076 | Epoprostenol (PRR 45.2) |
| 534 | Tooth Loss | 20,607 | 1,015 | Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Disoproxil Fumarate (PRR 331.2) |
| 535 | Knee Arthroplasty | 20,577 | 1,018 | Hamamelis Virginiana (PRR 294.5) |
| 536 | Dermatitis | 20,449 | 1,071 | Delgocitinib (PRR 86.9) |
| 537 | Peritonitis | 20,439 | 1,009 | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 195.5) |
| 538 | Product Preparation Error | 20,438 | 999 | Trace Elements 5 (PRR 633.3) |
| 539 | Injection Site Warmth | 20,327 | 903 | Bacillus Subtilis (PRR 62.3) |
| 540 | Rib Fracture | 20,258 | 1,077 | Alendronate Sodium And Cholecalciferol (PRR 59.6) |
| 541 | Body Temperature Increased | 20,204 | 1,105 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 348.8) |
| 542 | Bone Marrow Failure | 20,191 | 1,009 | Doxorubicin Hydrochloride Liposome (PRR 205.1) |
| 543 | Product Prescribing Issue | 20,084 | 1,019 | Rezafungin (PRR 142.2) |
| 544 | Incorrect Product Administration Duration | 20,027 | 1,007 | Instalax Polyethylene Glycol 3350 (PRR 113.2) |
| 545 | Pregnancy | 19,963 | 1,004 | Lactic Acid, L-, Citric Acid Monohydrate, And Potassium Bitartrate (PRR 350.5) |
| 546 | Intentional Self-Injury | 19,912 | 904 | Lisdexamfetamine Dimesylate Capsules (PRR 226.7) |
| 547 | Full Blood Count Decreased | 19,899 | 1,024 | Revumenib (PRR 49.8) |
| 548 | Injury Associated With Device | 19,852 | 698 | Copper (PRR 73.8) |
| 549 | Activities Of Daily Living Impaired | 19,823 | 1,013 | Metoclopramide (PRR 61.1) |
| 550 | Taste Disorder | 19,777 | 1,049 | Phosphorus (PRR 242.2) |
| 551 | Upper Limb Fracture | 19,751 | 1,024 | Alendronate Sodium And Cholecalciferol (PRR 26.6) |
| 552 | Haematocrit Decreased | 19,701 | 1,086 | Tisagenlecleucel (PRR 63.1) |
| 553 | Product Administration Error | 19,697 | 1,039 | Ranibizumab-Eqrn (PRR 84.9) |
| 554 | Prescribed Underdose | 19,685 | 1,015 | Triclosan (PRR 359.6) |
| 555 | Spinal Fracture | 19,675 | 1,032 | L Dopa (PRR 48.2) |
| 556 | Feeding Disorder | 19,674 | 1,066 | Trimipramine (PRR 33.1) |
| 557 | Product Physical Issue | 19,670 | 1,010 | Estradiol And Levonorgestrel (PRR 174.2) |
| 558 | Menorrhagia | 19,662 | 898 | Norethindrone Acetate, Ethinyl Estradiol And Ferrous Fumarate (PRR 81.9) |
| 559 | Sinus Disorder | 19,572 | 1,057 | Acetylcholine Chloride, (PRR 439.8) |
| 560 | Blood Pressure Abnormal | 19,549 | 1,057 | Amlodipine Valsartan And Hydrochlorothiazide (PRR 17.2) |
| 561 | Disability | 19,527 | 1,024 | Hamamelis Virginiana (PRR 336.2) |
| 562 | Kidney Infection | 19,357 | 1,053 | Nabilone (PRR 29.9) |
| 563 | Blood Pressure Systolic Increased | 19,336 | 1,061 | Dibucaine (PRR 131.5) |
| 564 | Haemorrhoids | 19,288 | 1,082 | Olmesartan Medoxomil-Hydrochlorothiazide (PRR 148.6) |
| 565 | Drug Prescribing Error | 19,229 | 1,001 | Methylphenidate (PRR 42.7) |
| 566 | Dystonia | 19,209 | 999 | Ziprasidone Hydrochloride (PRR 298.0) |
| 567 | Oral Herpes | 19,191 | 1,054 | Glycerin, Lidocaine (PRR 214.5) |
| 568 | Ear Pain | 19,190 | 1,101 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 392.7) |
| 569 | Choking | 19,165 | 1,051 | Aspirin/Caffeine Oral Powder (PRR 864.1) |
| 570 | Prescribed Overdose | 19,099 | 1,024 | Trifluoperazine Hydrochloride (PRR 329.2) |
| 571 | Glaucoma | 19,016 | 1,049 | Zingiber Officinale (PRR 677.3) |
| 572 | Hernia | 18,995 | 1,019 | Methazolamide (PRR 41.8) |
| 573 | Post Procedural Complication | 18,990 | 1,070 | Carbon Dioxide (PRR 86.1) |
| 574 | Acute Respiratory Failure | 18,896 | 1,100 | Tirofiban (PRR 38.5) |
| 575 | Musculoskeletal Disorder | 18,887 | 1,016 | Gold (PRR 50.6) |
| 576 | Serotonin Syndrome | 18,878 | 999 | Serotonin (PRR 340.7) |
| 577 | Sleep Apnoea Syndrome | 18,876 | 1,073 | Bupropion Hydrobromide (PRR 105.5) |
| 578 | Pulmonary Fibrosis | 18,862 | 1,051 | Pyrilamine Maleate (PRR 879.9) |
| 579 | Cholestasis | 18,848 | 1,016 | Isoleucine, Leucine, Lysine Acetate, Methionine, Phenylalanine, Threonine, Tryptophan, Valine, Cysteine Hydrochloride, Histidine, Tyrosine, N-Acetyl-Tyrosine, Alanine, Arginine, Proline, Serine, Glycine, Aspartic Acid, Glutamic Acid, And Taurine (PRR 353.1) |
| 580 | Feeling Jittery | 18,846 | 1,021 | Sodium Borate (PRR 81.9) |
| 581 | Lower Limb Fracture | 18,846 | 1,048 | Triclosan (PRR 256.6) |
| 582 | Cytokine Release Syndrome | 18,804 | 1,002 | Axicabtagene Ciloleucel (PRR 663.0) |
| 583 | Blood Urine Present | 18,803 | 1,065 | Dimenhydrinate (PRR 22.8) |
| 584 | Gastric Ulcer | 18,787 | 1,058 | Bayer Genuine Aspirin (PRR 29.1) |
| 585 | Eructation | 18,770 | 1,025 | Icosapent Ethyl (PRR 36.9) |
| 586 | Foot Fracture | 18,765 | 1,052 | Alendronate Sodium And Cholecalciferol (PRR 93.7) |
| 587 | Fracture | 18,689 | 1,043 | Dibucaine (PRR 58.3) |
| 588 | Skin Fissures | 18,634 | 1,024 | Baby Petroleum Jelly (PRR 56.1) |
| 589 | Hypocalcaemia | 18,630 | 1,046 | Triamcinolone Hexacetonide (PRR 225.3) |
| 590 | Proteinuria | 18,608 | 1,032 | Penicillamine (PRR 78.6) |
| 591 | Blood Sodium Decreased | 18,560 | 1,087 | Phosphorus (PRR 52.1) |
| 592 | Increased Appetite | 18,550 | 1,027 | Trifluoperazine Hydrochloride (PRR 366.5) |
| 593 | Thinking Abnormal | 18,487 | 1,025 | Fluphenazine Hydrochloride (PRR 90.0) |
| 594 | Tubulointerstitial Nephritis | 18,485 | 1,041 | Tetrahydrozoline Hydrochloride (PRR 320.1) |
| 595 | Hepatic Cirrhosis | 18,445 | 1,070 | Triclosan (PRR 219.7) |
| 596 | Photophobia | 18,426 | 1,084 | Escherichia Coli (PRR 458.3) |
| 597 | Hepatic Steatosis | 18,363 | 1,109 | Floxuridine (PRR 88.8) |
| 598 | Middle Insomnia | 18,358 | 1,015 | Tasimelteon (PRR 82.7) |
| 599 | Bacterial Infection | 18,329 | 1,112 | Bismuth Subnitrate (PRR 600.5) |
| 600 | Complication Of Device Insertion | 18,301 | 453 | Copper (PRR 404.4) |
| 601 | Blood Glucose Abnormal | 18,274 | 1,016 | Insulin Glulisine (PRR 30.9) |
| 602 | Agranulocytosis | 18,244 | 1,013 | Apis Mellifera (PRR 472.7) |
| 603 | End Stage Renal Disease | 18,178 | 1,059 | Bismuth Subnitrate (PRR 477.2) |
| 604 | Bone Disorder | 18,135 | 1,054 | Alendronate Sodium And Cholecalciferol (PRR 89.8) |
| 605 | Conjunctivitis | 18,134 | 1,077 | Sodium Borate (PRR 92.2) |
| 606 | Restless Legs Syndrome | 17,967 | 1,044 | Burosumab (PRR 51.1) |
| 607 | Pelvic Pain | 17,953 | 1,007 | Norethindrone Acetate (PRR 89.1) |
| 608 | Product Administered At Inappropriate Site | 17,922 | 747 | Clotrimazole Topical Solution Usp, 1% (PRR 216.5) |
| 609 | Gastroenteritis Viral | 17,870 | 1,066 | Triamcinolone Hexacetonide (PRR 234.9) |
| 610 | Osteomyelitis | 17,857 | 1,056 | Canagliflozin And Metformin Hydrochloride (PRR 128.8) |
| 611 | Toothache | 17,854 | 1,049 | Potassium Nitrate And Sodium Fluoride (PRR 80.0) |
| 612 | Leukocytosis | 17,845 | 1,075 | Dinutuximab (PRR 37.7) |
| 613 | Synovitis | 17,812 | 983 | Zingiber Officinale (PRR 723.3) |
| 614 | Gout | 17,730 | 1,069 | Bismuth Subnitrate (PRR 498.1) |
| 615 | Gallbladder Disorder | 17,671 | 1,056 | Drospirenone And Ethinyl Estradiol (PRR 139.8) |
| 616 | Ischaemic Stroke | 17,638 | 1,018 | Andexanet Alfa (PRR 59.8) |
| 617 | Thirst | 17,595 | 1,040 | Trisodium Citrate Dihydrate (PRR 248.6) |
| 618 | Blood Triglycerides Increased | 17,495 | 1,049 | Givinostat (PRR 112.3) |
| 619 | Diabetes Mellitus Inadequate Control | 17,478 | 1,015 | Acebutolol Hydrochloride (PRR 51.0) |
| 620 | Acute Respiratory Distress Syndrome | 17,460 | 1,044 | Beractant (PRR 45.2) |
| 621 | Local Swelling | 17,458 | 1,008 | Dextromethorphan Hbr, Guaifenesin, Doxylamine Succinate (PRR 13.6) |
| 622 | Lymphocyte Count Decreased | 17,455 | 1,048 | Tisagenlecleucel (PRR 98.9) |
| 623 | Cold Sweat | 17,417 | 1,048 | Fluorescein Sodium (PRR 40.4) |
| 624 | Drug Eruption | 17,395 | 1,039 | Mogamulizumab-Kpkc (PRR 69.9) |
| 625 | Head Discomfort | 17,384 | 1,050 | Escherichia Coli (PRR 668.7) |
| 626 | Multi-Organ Failure | 17,315 | 1,012 | Protamine Sulfate (PRR 294.5) |
| 627 | Metastases To Liver | 17,305 | 1,016 | Dextran 40 (PRR 132.9) |
| 628 | Syringe Issue | 17,297 | 708 | Leuprolide Acetate (PRR 224.8) |
| 629 | Eosinophilia | 17,243 | 1,019 | Limonene (PRR 654.8) |
| 630 | Orthostatic Hypotension | 17,222 | 1,067 | Phosphoric Acid (PRR 579.3) |
| 631 | Neurotoxicity | 17,148 | 1,001 | Axicabtagene Ciloleucel (PRR 183.8) |
| 632 | Paranoia | 17,094 | 1,014 | Tafenoquine (PRR 195.4) |
| 633 | Device Use Issue | 17,085 | 740 | Budesonide, Glycopyrrolate, And Formoterol Fumarate (PRR 135.6) |
| 634 | Metrorrhagia | 17,069 | 700 | Levonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol Tablets (PRR 134.8) |
| 635 | Musculoskeletal Discomfort | 16,978 | 1,053 | Methyltestosterone (PRR 90.6) |
| 636 | Scar | 16,930 | 1,044 | Gadoteridol (PRR 109.3) |
| 637 | Circulatory Collapse | 16,880 | 1,057 | Tetracaine Hydrochloride (PRR 79.8) |
| 638 | Hemiparesis | 16,823 | 1,048 | Coal Tar (PRR 303.1) |
| 639 | Complication Of Device Removal | 16,741 | 423 | Copper (PRR 714.8) |
| 640 | Face Oedema | 16,721 | 1,037 | Palifermin (PRR 44.6) |
| 641 | Upper Gastrointestinal Haemorrhage | 16,656 | 1,022 | Colloidal Silver (PRR 224.7) |
| 642 | Blood Urea Increased | 16,615 | 1,090 | Phentolamine Mesylate (PRR 110.4) |
| 643 | Incorrect Route Of Product Administration | 16,585 | 1,043 | Bismuth Subnitrate (PRR 682.7) |
| 644 | Amenorrhoea | 16,474 | 926 | Drospirenone (PRR 211.4) |
| 645 | Candida Infection | 16,466 | 1,084 | Phosphoric Acid (PRR 100.4) |
| 646 | Psychomotor Hyperactivity | 16,452 | 1,011 | Atomoxetine Hydrochloride (PRR 28.5) |
| 647 | Pericarditis | 16,447 | 1,016 | Triprolidine Hydrochloride (PRR 847.3) |
| 648 | Parkinson^S Disease | 16,426 | 0 | (PRR —) |
| 649 | Cytomegalovirus Infection | 16,416 | 1,002 | Ganciclovir Sodium (PRR 164.3) |
| 650 | Coagulopathy | 16,398 | 1,053 | Fomepizole (PRR 66.8) |
| 651 | Multiple Fractures | 16,356 | 1,002 | Emtricitabine And Tenofovir Disoproxil Fumarate (PRR 456.1) |
| 652 | Ventricular Tachycardia | 16,355 | 1,040 | Estriol0.2% (PRR 272.4) |
| 653 | Drug Level Increased | 16,348 | 1,014 | Aluminum Hydroxide (PRR 276.4) |
| 654 | Photosensitivity Reaction | 16,240 | 1,043 | Quinidine Sulfate Tablet (PRR 107.0) |
| 655 | Mania | 16,218 | 1,002 | Hypericum Perforatum (PRR 55.8) |
| 656 | Generalised Tonic-Clonic Seizure | 16,149 | 1,027 | Cetrorelix Acetate For Injection (PRR 398.1) |
| 657 | Metastases To Bone | 16,145 | 1,008 | Dextran 40 (PRR 142.5) |
| 658 | Back Disorder | 16,114 | 1,024 | Hamamelis Virginiana (PRR 438.9) |
| 659 | Blood Potassium Increased | 16,013 | 1,070 | Antifungal Liquid Spray (PRR 83.9) |
| 660 | Device Defective | 15,971 | 692 | Marstacimab-Hncq (PRR 92.6) |
| 661 | Muscle Tightness | 15,966 | 1,035 | Prucalopride Succinate (PRR 38.3) |
| 662 | Sleep Disorder Due To A General Medical Condition | 15,960 | 1,004 | Acetylcholine Chloride, (PRR 559.5) |
| 663 | Sensory Disturbance | 15,916 | 1,047 | Methazolamide (PRR 49.9) |
| 664 | Premature Delivery | 15,789 | 999 | Doconexent, Niacinamide, .Alpha.-Tocopherol Acetate, Dl-, Cholecalciferol, .Beta.-Carotene, Ascorbic Acid, Thiamine Mononitrate, Riboflavin, Pyridoxine Hydrochloride, Cyanocobalamin, Iron, Zinc Oxide, Cupric Oxide, Potassium Iodide, Magnesium Oxide, Folic Acid, And Levomefolate Calcium (PRR 408.7) |
| 665 | Obesity | 15,747 | 1,056 | Edetate Calcium Disodium (PRR 954.5) |
| 666 | Blood Lactate Dehydrogenase Increased | 15,738 | 1,034 | Polatuzumab Vedotin (PRR 58.2) |
| 667 | Abscess | 15,736 | 1,057 | Infliximab-Dyyb (PRR 34.1) |
| 668 | Ulcer | 15,724 | 1,063 | Bismuth Subnitrate (PRR 561.8) |
| 669 | Hallucination, Auditory | 15,707 | 1,006 | Ziconotide Acetate (PRR 72.7) |
| 670 | Respiratory Tract Congestion | 15,698 | 1,023 | Coal Tar (PRR 338.9) |
| 671 | Sciatica | 15,653 | 1,070 | Triclosan (PRR 387.5) |
| 672 | Pneumothorax | 15,643 | 1,078 | Colesevelam Hydrochloride (PRR 124.9) |
| 673 | Sickle Cell Anaemia With Crisis | 15,592 | 539 | Voxelotor (PRR 2,377.3) |
| 674 | Cyanosis | 15,555 | 1,033 | Primaquine Phosphate (PRR 128.3) |
| 675 | Lung Infection | 15,551 | 1,010 | Terlipressin (PRR 25.5) |
| 676 | Basal Cell Carcinoma | 15,412 | 1,034 | Avobenzone, Homosalate, Octisalate, Octocrylene, And Oxybenzone (PRR 121.4) |
| 677 | Pharyngeal Oedema | 15,391 | 1,009 | Icatibant Acetate (PRR 29.7) |
| 678 | Acute Myeloid Leukaemia | 15,367 | 1,006 | Avobenzone,Homosalate,Octisalate,Octocrylene (PRR 182.0) |
| 679 | Ejection Fraction Decreased | 15,366 | 1,028 | Digitalis (PRR 61.1) |
| 680 | Tendonitis | 15,351 | 1,026 | Octinoxate (PRR 1,011.4) |
| 681 | Ankle Fracture | 15,299 | 1,045 | Alendronate Sodium And Cholecalciferol (PRR 38.3) |
| 682 | Product Use Complaint | 15,297 | 1,011 | Clascoterone (PRR 278.0) |
| 683 | Drug Dispensing Error | 15,293 | 993 | Lysine, Leucine, Phenylalanine, Valine, Histidine, Isoleucine, Methionine, Threonine, Tryptophan, Alanine, Arginine, Glycine, Proline, Glutamic Acid, Serine, Aspartic Acid, Tyrosine (PRR 238.8) |
| 684 | Lymphoma | 15,293 | 1,011 | Tafasitamab-Cxix (PRR 252.9) |
| 685 | Musculoskeletal Chest Pain | 15,288 | 1,056 | Terbutaline Sulfate (PRR 29.8) |
| 686 | Delusion | 15,284 | 1,017 | Pimavanserin Tartrate (PRR 83.1) |
| 687 | Device Related Infection | 15,229 | 1,050 | Cerliponase Alfa (PRR 77.6) |
| 688 | Thyroid Disorder | 15,213 | 1,025 | Zingiber Officinale (PRR 564.2) |
| 689 | Economic Problem | 15,210 | 1,016 | Ferrous Asparto Glycinate, Ferrous Fumarate, Ascorbic Acid, Folic Acid, Levomefolate Glucosamine, Cyanocobalamin, Zinc, And Intrinsic Factor (PRR 125.0) |
| 690 | Blood Count Abnormal | 15,175 | 1,002 | Ciclesonide (PRR 68.6) |
| 691 | Osteopenia | 15,057 | 1,053 | Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Alafenamide (PRR 214.4) |
| 692 | Device Adhesion Issue | 15,010 | 288 | Pegfilgrastim (PRR 751.9) |
| 693 | Hip Arthroplasty | 14,987 | 1,013 | Hamamelis Virginiana (PRR 404.4) |
| 694 | Bone Loss | 14,984 | 940 | Emtricitabine And Tenofovir Disoproxil Fumarate (PRR 705.6) |
| 695 | Device Failure | 14,972 | 916 | Vaginal Cream (PRR 293.3) |
| 696 | Toxic Epidermal Necrolysis | 14,883 | 1,003 | Anhydrous Citric Acid (PRR 916.2) |
| 697 | Therapy Partial Responder | 14,864 | 1,019 | Betamethasone Dipropionate Usp, 0.05% (PRR 417.8) |
| 698 | Hypoaesthesia Oral | 14,863 | 1,038 | Articaine Hydrochloride And Epinephrine (PRR 105.7) |
| 699 | Haemorrhage Intracranial | 14,808 | 1,009 | Tenecteplase (PRR 103.8) |
| 700 | Drug Withdrawal Syndrome Neonatal | 14,762 | 374 | Methadone Hydrochloride (PRR 206.4) |
| 701 | Colon Cancer | 14,737 | 1,011 | Fruquintinib (PRR 141.7) |
| 702 | Pulmonary Mass | 14,676 | 1,057 | Pyrilamine Maleate (PRR 1,131.7) |
| 703 | Insurance Issue | 14,661 | 1,014 | Garadacimab (PRR 86.5) |
| 704 | Cardiomyopathy | 14,603 | 1,061 | Digitalis (PRR 50.5) |
| 705 | Fluid Overload | 14,568 | 1,011 | Arsenic (PRR 96.4) |
| 706 | Immunodeficiency | 14,537 | 1,040 | Triamcinolone Hexacetonide (PRR 289.0) |
| 707 | Meningioma | 14,531 | 697 | Medroxyprogesterone Acetate (PRR 1,443.2) |
| 708 | Injection Site Haematoma | 14,463 | 753 | Tetradecyl Hydrogen Sulfate (Ester) (PRR 168.4) |
| 709 | Brain Fog | 14,398 | 1,031 | Pexidartinib Hydrochloride (PRR 52.5) |
| 710 | Gastroenteritis | 14,382 | 1,070 | Olmesartan Medoxomil-Hydrochlorothiazide (PRR 21.9) |
| 711 | Pulmonary Arterial Hypertension | 14,375 | 1,000 | Epoprostenol (PRR 132.3) |
| 712 | Accidental Underdose | 14,371 | 464 | Insulin Glargine-Aglr (PRR 275.5) |
| 713 | Hypokinesia | 14,340 | 1,037 | Opicapone (PRR 50.7) |
| 714 | Apathy | 14,338 | 1,023 | Nilutamide (PRR 97.5) |
| 715 | Anosmia | 14,313 | 1,009 | Allium Cepa 5X, Zincum Aceticum 2X, Zincum Gluconium 1X (PRR 958.3) |
| 716 | Myelodysplastic Syndrome | 14,284 | 1,004 | Carmustine (PRR 94.9) |
| 717 | Hyperthyroidism | 14,277 | 1,023 | Octinoxate (PRR 1,087.5) |
| 718 | Skin Haemorrhage | 14,241 | 1,014 | Coal Tar (PRR 402.7) |
| 719 | Impaired Quality Of Life | 14,201 | 1,018 | Tetrahydrozoline Hydrochloride (PRR 380.5) |
| 720 | Paraesthesia Oral | 14,184 | 1,037 | Cupric Oxide (PRR 376.0) |
| 721 | Paralysis | 14,182 | 1,041 | Phosphorus (PRR 64.3) |
| 722 | Subdural Haematoma | 14,177 | 1,020 | Andexanet Alfa (PRR 39.2) |
| 723 | Bronchospasm | 14,128 | 1,023 | Naxitamab (PRR 103.4) |
| 724 | Cardiogenic Shock | 14,083 | 1,019 | Titanium (PRR 858.4) |
| 725 | Dialysis | 14,037 | 1,015 | Ascorbic Acid, Tocopheryl Acid Succinate, Thiamine, Riboflavin, Niacinamide, Pyridoxine, Folic Acid, Cobalamin, Biotin, Pantothenic Acid, Zinc, Selenium (PRR 136.5) |
| 726 | Hepatocellular Injury | 14,032 | 1,000 | Echinacea Purpurea (PRR 72.0) |
| 727 | Sinus Tachycardia | 13,987 | 1,045 | Belinostat (PRR 46.9) |
| 728 | Disseminated Intravascular Coagulation | 13,936 | 1,011 | Probenecid And Colchicine (PRR 116.5) |
| 729 | Seasonal Allergy | 13,932 | 1,062 | Trastuzumab-Qyyp (PRR 50.7) |
| 730 | Drug Effect Less Than Expected | 13,914 | 1,005 | Letibotulinumtoxina-Wlbg (PRR 456.9) |
| 731 | Blindness Unilateral | 13,899 | 1,007 | Echothiophate Iodide For Ophthalmic Solution (PRR 81.6) |
| 732 | Skin Reaction | 13,886 | 1,018 | Zingiber Officinale (PRR 618.2) |
| 733 | Lymphopenia | 13,885 | 1,007 | Edetate Calcium Disodium (PRR 1,082.7) |
| 734 | Coordination Abnormal | 13,864 | 1,031 | Coal Tar (PRR 372.6) |
| 735 | Carpal Tunnel Syndrome | 13,858 | 1,029 | Bupropion Hydrobromide (PRR 146.5) |
| 736 | Blood Test Abnormal | 13,856 | 1,035 | Pyrilamine Maleate (PRR 1,098.7) |
| 737 | Mass | 13,830 | 1,035 | Gadoxetate Disodium (PRR 505.2) |
| 738 | Aphonia | 13,765 | 1,027 | Amikacin (PRR 46.6) |
| 739 | Oral Discomfort | 13,735 | 1,014 | Stannous Fluoride (PRR 213.5) |
| 740 | Device Occlusion | 13,727 | 1,005 | Alcohol Gel (PRR 1,507.8) |
| 741 | Hypomagnesaemia | 13,692 | 1,033 | Phosphoric Acid (PRR 216.4) |
| 742 | Prostatic Specific Antigen Increased | 13,672 | 963 | Nilutamide (PRR 245.6) |
| 743 | Central Nervous System Lesion | 13,649 | 1,006 | Dextran 40 (PRR 210.7) |
| 744 | Drug Toxicity | 13,633 | 999 | Acetaminophen, Diphenhydramine (PRR 493.6) |
| 745 | Application Site Rash | 13,618 | 671 | Zinc Oxide 24.08% (PRR 434.3) |
| 746 | Coronary Artery Occlusion | 13,603 | 1,003 | Candesartan Cilexetil And Hydrochlorothiazide (PRR 36.5) |
| 747 | Peripheral Coldness | 13,601 | 1,043 | Ergotamine Tartrate And Caffeine (PRR 39.5) |
| 748 | Gingival Bleeding | 13,496 | 1,023 | Alteplase (PRR 114.3) |
| 749 | Akathisia | 13,470 | 824 | Trifluoperazine Hydrochloride (PRR 517.8) |
| 750 | Acute Hepatic Failure | 13,421 | 1,016 | Acetaminophen Tablet (PRR 268.2) |
| 751 | Tachypnoea | 13,370 | 1,014 | Chloroquine Phosphate (PRR 56.9) |
| 752 | Sinus Congestion | 13,355 | 1,019 | Coal Tar (PRR 419.6) |
| 753 | Uveitis | 13,331 | 1,001 | Homatropine Hydrobromide (PRR 814.1) |
| 754 | Hair Texture Abnormal | 13,316 | 996 | Aconitum Napellus, Allium Cepa, Gelsemium Semp., Zincum Gluconicum (PRR 423.9) |
| 755 | Product Taste Abnormal | 13,273 | 983 | Aspirin, Acetaminophen, Caffeine (PRR 141.8) |
| 756 | Hunger | 13,271 | 1,005 | Setmelanotide (PRR 98.3) |
| 757 | Quality Of Life Decreased | 13,259 | 1,034 | Talc (PRR 321.6) |
| 758 | Malignant Melanoma | 13,240 | 1,002 | Avobenzone, Homosalate, Octisalate, Octocrylene, And Oxybenzone (PRR 121.1) |
| 759 | Eye Haemorrhage | 13,196 | 1,008 | Ranibizumab (PRR 67.3) |
| 760 | Joint Range Of Motion Decreased | 13,192 | 1,022 | Triclosan (PRR 554.2) |
| 761 | Sopor | 13,192 | 566 | Anacardium Orientale, Aqua Marina, Argentum Nitricum, Asarum Canadense, Blatta Orientalis, Bufo Rana, Cerebrum Suis, Clematis Erecta, Cuprum Aceticum, Hypothalamus Suis, Ignatia Amara, Kali Phosphoricum, Lachesis Mutus, Mercurius Solubilis, Natrum Sulphuricum, Placenta Totalis Suis, Rhus Tox, Thuja Occidentalis, Thymolum, Valeriana Officinalis (PRR 298.9) |
| 762 | Sars-Cov-2 Test Positive | 13,181 | 1,007 | Viltolarsen (PRR 47.6) |
| 763 | Incorrect Product Storage | 13,154 | 674 | Diluent (PRR 281.0) |
| 764 | Adverse Reaction | 13,094 | 1,009 | Azathioprine Sodium (PRR 132.3) |
| 765 | Pulmonary Congestion | 13,065 | 1,054 | Coal Tar (PRR 68.9) |
| 766 | Complication Associated With Device | 13,049 | 1,003 | Etonogestrel (PRR 298.0) |
| 767 | Tooth Infection | 13,018 | 1,022 | Coal Tar (PRR 24.4) |
| 768 | Immune System Disorder | 12,985 | 1,028 | Taurine (PRR 15.1) |
| 769 | Bedridden | 12,957 | 1,034 | Prednisolone Sodium Phosphate (PRR 21.6) |
| 770 | Hand Deformity | 12,913 | 801 | Desoximetasone (PRR 1,311.2) |
| 771 | Dysmenorrhoea | 12,906 | 769 | Drospirenone (PRR 116.3) |
| 772 | Anorexia | 12,900 | 999 | Exenatide (PRR 29.4) |
| 773 | Platelet Count Increased | 12,894 | 1,019 | Diclofenac Sodium/Misoprostol (PRR 158.8) |
| 774 | Nodule | 12,881 | 1,014 | Edetate Calcium Disodium (PRR 1,167.3) |
| 775 | Ankylosing Spondylitis | 12,861 | 857 | Diclofenac Sodium/Misoprostol (PRR 59.1) |
| 776 | Oral Candidiasis | 12,840 | 1,063 | Sodium Borate (PRR 321.1) |
| 777 | Hiatus Hernia | 12,804 | 1,053 | Olmesartan Medoxomil-Hydrochlorothiazide (PRR 153.8) |
| 778 | Injection Site Induration | 12,792 | 846 | Deoxycholic Acid (PRR 60.3) |
| 779 | Genital Haemorrhage | 12,770 | 501 | Levonorgestrel (PRR 693.6) |
| 780 | Device Mechanical Issue | 12,736 | 350 | Somatropin (PRR 429.5) |
| 781 | Rotator Cuff Syndrome | 12,722 | 1,013 | Octinoxate (PRR 1,220.5) |
| 782 | Tuberculosis | 12,692 | 961 | Streptomycin (PRR 77.2) |
| 783 | Intraocular Pressure Increased | 12,672 | 1,001 | Homatropine Hydrobromide (PRR 856.6) |
| 784 | Mydriasis | 12,651 | 1,004 | Pheniramine Maleate And Naphazoline Hydrochloride (PRR 572.2) |
| 785 | Metastases To Central Nervous System | 12,642 | 1,002 | Dextran 40 (PRR 182.0) |
| 786 | Infusion Site Pain | 12,603 | 1,015 | Furosemide Injection 80 Mg/ 10 Ml (PRR 509.6) |
| 787 | Impaired Gastric Emptying | 12,585 | 1,033 | Oral Semaglutide (PRR 111.3) |
| 788 | Injection Site Irritation | 12,486 | 813 | Apomorphine Hydrochloride (PRR 70.5) |
| 789 | Brain Oedema | 12,462 | 1,027 | Fomepizole (PRR 140.7) |
| 790 | Poisoning | 12,453 | 999 | Amoxapine (PRR 140.7) |
| 791 | Hair Colour Changes | 12,414 | 954 | Pexidartinib Hydrochloride (PRR 560.0) |
| 792 | Muscle Atrophy | 12,410 | 1,027 | Dimeticone (PRR 71.0) |
| 793 | Injection Site Extravasation | 12,318 | 844 | Regadenoson (PRR 131.4) |
| 794 | Abnormal Weight Gain | 12,316 | 612 | Risperidone (PRR 513.3) |
| 795 | Dermatitis Allergic | 12,301 | 1,026 | Amcinonide (PRR 99.0) |
| 796 | Pharyngitis | 12,297 | 1,037 | Diclofenac Sodium/Misoprostol (PRR 65.7) |
| 797 | Tooth Extraction | 12,289 | 1,010 | Pamidronate Disodium (PRR 84.7) |
| 798 | Application Site Irritation | 12,281 | 635 | Berdazimer (PRR 166.2) |
| 799 | Pemphigus | 12,270 | 729 | Desoximetasone (PRR 2,047.0) |
| 800 | Cyst | 12,265 | 1,021 | Amcinonide (PRR 99.3) |
| 801 | Cardiomegaly | 12,243 | 1,048 | Methyltestosterone (PRR 125.7) |
| 802 | Muscle Spasticity | 12,240 | 1,000 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 589.1) |
| 803 | Injection Site Discolouration | 12,237 | 839 | Tetradecyl Hydrogen Sulfate (Ester) (PRR 179.2) |
| 804 | Libido Decreased | 12,230 | 981 | Pycnogenol 6X (PRR 59.0) |
| 805 | Tendon Rupture | 12,216 | 1,003 | Bempedoic Acid And Ezetimibe (PRR 42.0) |
| 806 | No Therapeutic Response | 12,211 | 1,003 | Mechlorethamine Hydrochloride (PRR 25.7) |
| 807 | Secretion Discharge | 12,194 | 1,024 | Camphor (PRR 193.2) |
| 808 | Hypercalcaemia | 12,172 | 1,025 | Palopegteriparatide (PRR 194.7) |
| 809 | Generalised Oedema | 12,153 | 1,059 | Escherichia Coli (PRR 863.1) |
| 810 | Ileus | 12,144 | 1,037 | Phenylalanine (PRR 284.3) |
| 811 | Small Intestinal Obstruction | 12,111 | 1,028 | Prochlorperazine Edisylate (PRR 21.5) |
| 812 | Respiratory Depression | 12,102 | 982 | Propylhexedrine (PRR 265.5) |
| 813 | Hepatic Cytolysis | 12,060 | 988 | Dexbrompheniramine Maleate (PRR 572.1) |
| 814 | Hepatitis C | 12,055 | 958 | Sofosbuvir (PRR 177.3) |
| 815 | Intercepted Product Preparation Error | 12,019 | 138 | Leuprolide Acetate (PRR 881.5) |
| 816 | Schizophrenia | 12,003 | 896 | Ziprasidone Hydrochloride (PRR 229.8) |
| 817 | Glomerular Filtration Rate Decreased | 11,956 | 1,027 | Finerenone (PRR 184.8) |
| 818 | Thyroid Cancer | 11,954 | 784 | Pazopanib (PRR 33.5) |
| 819 | Nocturia | 11,952 | 1,025 | Doxepn Hydrochloride (PRR 73.3) |
| 820 | Spinal Operation | 11,947 | 1,002 | Promethazine Hydrochloride And Codeine Phosphate (PRR 37.7) |
| 821 | Bursitis | 11,908 | 1,025 | Hyaluronidase (PRR 354.9) |
| 822 | Device Deployment Issue | 11,846 | 318 | Etonogestrel (PRR 173.5) |
| 823 | Wrist Fracture | 11,833 | 1,013 | Prucalopride Succinate (PRR 77.5) |
| 824 | Hyperlipidaemia | 11,829 | 1,060 | Bismuth Subnitrate (PRR 721.4) |
| 825 | Adrenal Insufficiency | 11,815 | 1,033 | Triamcinolone Hexacetonide (PRR 960.8) |
| 826 | Muscle Rigidity | 11,795 | 1,004 | Silver Nitrate (PRR 125.0) |
| 827 | Cytopenia | 11,794 | 1,002 | Cedazuridine And Decitabine (PRR 212.4) |
| 828 | Myoclonus | 11,767 | 1,006 | Lidocaine And Glycerin (PRR 479.8) |
| 829 | Ataxia | 11,761 | 1,015 | Potassium Bromide (PRR 83.4) |
| 830 | Macular Degeneration | 11,761 | 1,005 | Cupric Oxide (PRR 1,555.9) |
| 831 | Accident | 11,750 | 1,006 | Lanolin (PRR 121.6) |
| 832 | Polyneuropathy | 11,740 | 1,003 | L Dopa (PRR 101.0) |
| 833 | Neuroleptic Malignant Syndrome | 11,736 | 773 | Dantrolene (PRR 271.4) |
| 834 | Covid-19 Pneumonia | 11,733 | 1,019 | Ertugliflozin And Sitagliptin (PRR 179.5) |
| 835 | Cholecystitis | 11,728 | 1,042 | Drospirenone And Ethinyl Estradiol (PRR 68.3) |
| 836 | Blood Iron Decreased | 11,636 | 1,029 | Diclofenac Sodium/Misoprostol (PRR 73.5) |
| 837 | Bacteraemia | 11,616 | 1,053 | (Daunorubicin And Cytarabine) Liposome (PRR 43.7) |
| 838 | Caesarean Section | 11,607 | 876 | Dinoprostone (PRR 139.1) |
| 839 | Spinal Pain | 11,556 | 1,009 | Mefenamic Acid (PRR 36.2) |
| 840 | Madarosis | 11,555 | 904 | Docetaxel Anhydrous (PRR 427.4) |
| 841 | Splenomegaly | 11,555 | 1,015 | Momelotinib (PRR 65.8) |
| 842 | Eyelid Oedema | 11,551 | 1,006 | Alcaftadine (PRR 83.7) |
| 843 | Unintentional Medical Device Removal | 11,534 | 360 | Pegfilgrastim (PRR 742.6) |
| 844 | Sexual Dysfunction | 11,524 | 832 | Ziprasidone Hydrochloride (PRR 510.4) |
| 845 | Post Procedural Haemorrhage | 11,523 | 1,001 | Thrombin Human And Fibrinogen (PRR 59.2) |
| 846 | Vasculitis | 11,506 | 1,005 | Calcium Sennosides (PRR 583.5) |
| 847 | Gastric Haemorrhage | 11,434 | 1,007 | Bayer Genuine Aspirin (PRR 54.4) |
| 848 | Metastases To Lung | 11,392 | 999 | Regorafenib (PRR 53.3) |
| 849 | Neoplasm | 11,371 | 1,005 | Ceritinib (PRR 42.3) |
| 850 | Electrolyte Imbalance | 11,353 | 1,050 | Miltefosine (PRR 43.3) |
| 851 | Myocardial Ischaemia | 11,325 | 1,014 | Sennosides A And B (PRR 32.3) |
| 852 | Internal Haemorrhage | 11,297 | 1,003 | Rivaroxaban (PRR 47.3) |
| 853 | Impaired Driving Ability | 11,233 | 1,002 | Gaba (Gamma-Aminobutyric Acid) (PRR 52.2) |
| 854 | Cholecystectomy | 11,213 | 1,005 | Drospirenone And Ethinyl Estradiol (PRR 89.0) |
| 855 | Dermatitis Contact | 11,207 | 1,037 | Xerophyllum Asphodeloides, Aconitum Nap., Anacardium Orientale, Apis Mel., Bryonia, Cantharis, Croton, Graphites, Grindelia, Mezereum, Nux Vom., Ranunc. Bulb., Rhus Toxicodendron, Sarsaparilla, Sulphur, Echinacea, Rumex Crisp.,Taraxacum, Urtica Ur. (PRR 486.3) |
| 856 | Rebound Effect | 11,193 | 978 | Glucarpidase (PRR 160.5) |
| 857 | Micturition Urgency | 11,189 | 1,037 | Bismuth Subnitrate (PRR 456.8) |
| 858 | Scab | 11,188 | 1,013 | Imiquimod (PRR 61.7) |
| 859 | Myocarditis | 11,176 | 1,002 | Asenapine (PRR 113.0) |
| 860 | Mitral Valve Incompetence | 11,170 | 1,029 | Fenfluramine (PRR 148.9) |
| 861 | Status Epilepticus | 11,168 | 1,001 | Potassium Bromide (PRR 170.8) |
| 862 | Blood Calcium Decreased | 11,135 | 1,045 | Phosphoric Acid (PRR 827.7) |
| 863 | Fistula | 11,120 | 999 | Infliximab-Dyyb (PRR 63.5) |
| 864 | Intestinal Perforation | 11,089 | 1,006 | Enalaprilat (PRR 104.6) |
| 865 | Eye Infection | 11,068 | 1,018 | Aconitum Nap., Allium Cepa, Arsenicum Alb., Bryonia, Calendula, Chelidonium Majus, Cineraria, Euphrasia, Graphites, Lycopodium, Merc. Corros., Nux Vom., Phosphorus, Phytolacca, Picricum Ac., Pulsatilla, Rhus Toxicodendron, Sulphur, Echinacea (PRR 1,039.1) |
| 866 | Hypertensive Crisis | 11,018 | 1,006 | Tranylcypromine Sulfate (PRR 140.5) |
| 867 | Obstructive Airways Disorder | 11,016 | 1,006 | Pyrilamine Maleate (PRR 1,414.6) |
| 868 | Skin Infection | 11,015 | 1,036 | Lanolin (PRR 142.7) |
| 869 | Nerve Injury | 11,005 | 1,024 | Deoxycholic Acid (PRR 94.0) |
| 870 | Nephropathy Toxic | 10,992 | 1,001 | Streptozocin (PRR 141.2) |
| 871 | Ventricular Fibrillation | 10,992 | 1,010 | Titanium (PRR 1,172.9) |
| 872 | Malnutrition | 10,965 | 1,058 | Esomeprazole Sodium (PRR 52.1) |
| 873 | Foot Deformity | 10,953 | 1,009 | Triclosan (PRR 357.0) |
| 874 | Red Blood Cell Sedimentation Rate Increased | 10,946 | 999 | Triamcinolone Hexacetonide (PRR 978.8) |
| 875 | Dental Caries | 10,904 | 1,019 | Alendronate Sodium And Cholecalciferol (PRR 109.3) |
| 876 | Tooth Fracture | 10,879 | 1,008 | Alendronate Sodium And Cholecalciferol (PRR 86.3) |
| 877 | Blood Glucose Fluctuation | 10,849 | 921 | Insulin Human (PRR 41.2) |
| 878 | Injection Site Nodule | 10,841 | 763 | Lenacapavir Sodium (PRR 463.3) |
| 879 | Gastrointestinal Pain | 10,811 | 1,019 | Trimipramine (PRR 56.8) |
| 880 | Bipolar Disorder | 10,806 | 1,008 | Tafenoquine (PRR 123.6) |
| 881 | Oesophagitis | 10,794 | 1,018 | Capsicum Annuum, Cetraria Islandica, Fucus Vesiculosus, Glandula Suprarenalis Suis, Thyroidinum (Suis), Cadmium Iodatum, Hydrangea Arborescens, Phosphoricum Acidum, Phosphorus, Pulsatilla (Pratensis), Strontium Carbonicum, Uranium Nitricum, X-Ray (PRR 69.5) |
| 882 | Pulmonary Thrombosis | 10,780 | 1,005 | Alcohol Gel (PRR 1,920.1) |
| 883 | Product Packaging Quantity Issue | 10,772 | 889 | Bromfenac Ophthalmic Solution 0.09% (PRR 480.5) |
| 884 | Wound Infection | 10,727 | 1,019 | Triclosan (PRR 713.7) |
| 885 | Ocular Discomfort | 10,718 | 1,008 | Escherichia Coli (PRR 1,103.4) |
| 886 | Laryngitis | 10,715 | 1,018 | Triclosan (PRR 468.5) |
| 887 | Aspiration | 10,692 | 1,053 | Pyrilamine Maleate (PRR 1,522.7) |
| 888 | Back Injury | 10,686 | 1,013 | Diatrizoate Meglumine (PRR 314.7) |
| 889 | Pharyngitis Streptococcal | 10,684 | 1,003 | Formaldehyde (PRR 254.2) |
| 890 | Body Height Decreased | 10,670 | 1,004 | Asian Ginseng (PRR 113.5) |
| 891 | Skin Laceration | 10,659 | 1,025 | Glycine (PRR 85.0) |
| 892 | Breast Cancer Metastatic | 10,588 | 829 | Convallaria Majalis (PRR 1,303.6) |
| 893 | Decreased Activity | 10,574 | 1,023 | Imipramine Hydrochloride (PRR 56.0) |
| 894 | Drug Administered At Inappropriate Site | 10,556 | 563 | Calcipotriene Cream, 0.005% (PRR 57.1) |
| 895 | Sudden Death | 10,552 | 1,004 | Tetracaine Hydrochloride (PRR 191.5) |
| 896 | Breast Pain | 10,521 | 1,002 | Amcinonide (PRR 92.6) |
| 897 | Clostridium Difficile Colitis | 10,480 | 1,041 | Daunorubicin Hydrochloride (PRR 138.9) |
| 898 | Incontinence | 10,453 | 1,041 | Phosphorus (PRR 87.3) |
| 899 | Renal Pain | 10,426 | 1,009 | Tiopronin (PRR 32.5) |
| 900 | Full Blood Count Abnormal | 10,406 | 1,007 | Acetylcholine Chloride, (PRR 735.9) |
| 901 | Joint Dislocation | 10,392 | 1,020 | Triclosan (PRR 702.3) |
| 902 | Transfusion | 10,378 | 1,004 | Cedazuridine And Decitabine (PRR 158.3) |
| 903 | Hereditary Angioedema | 10,364 | 815 | Garadacimab (PRR 1,401.2) |
| 904 | Skeletal Injury | 10,329 | 665 | Tenofovir Disoproxil Fumarate (PRR 2,623.1) |
| 905 | Unintended Pregnancy | 10,325 | 334 | Ulipristal Acetate (PRR 601.2) |
| 906 | Tenderness | 10,305 | 1,031 | Dyclonine Hydrochloride (PRR 402.3) |
| 907 | Weight Fluctuation | 10,283 | 1,018 | Hyaluronidase (PRR 100.8) |
| 908 | Petechiae | 10,266 | 1,021 | Remibrutinib (PRR 305.0) |
| 909 | Ventricular Extrasystoles | 10,265 | 1,018 | Quinidine Gluconate (PRR 465.9) |
| 910 | Menstruation Delayed | 10,253 | 459 | Causticum (PRR 1,514.1) |
| 911 | Product Odour Abnormal | 10,246 | 818 | Icosapent Ethyl (PRR 273.4) |
| 912 | Scratch | 10,218 | 1,002 | Camphor (PRR 230.6) |
| 913 | Folliculitis | 10,195 | 1,004 | Chlorhexidine Gluconate And Isopropyl Alcohol (PRR 1,047.4) |
| 914 | Injection Site Discomfort | 10,189 | 732 | Kit For The Preparation Of Gallium Ga 68 Gozetotide Injection (PRR 84.7) |
| 915 | Poor Venous Access | 10,187 | 999 | Golodirsen (PRR 296.0) |
| 916 | Euphoric Mood | 10,169 | 974 | Trifluoperazine Hydrochloride (PRR 753.9) |
| 917 | Hyperbilirubinaemia | 10,168 | 1,005 | Esmolol Hydrochloride In Sodium Chloride (PRR 107.2) |
| 918 | Neutrophil Count Increased | 10,144 | 1,013 | Phentolamine Mesylate (PRR 168.1) |
| 919 | Ear Discomfort | 10,102 | 1,011 | Swim-Ear (PRR 745.5) |
| 920 | Drug Level Decreased | 10,094 | 955 | Cetrorelix Acetate For Injection (PRR 601.9) |
| 921 | Poor Quality Product Administered | 10,089 | 823 | Tuberculin Purified Protein Derivative (PRR 467.2) |
| 922 | Tooth Abscess | 10,085 | 1,015 | Diclofenac Sodium/Misoprostol (PRR 70.7) |
| 923 | Eye Discharge | 10,083 | 1,007 | Mineral Oil And White Petrolatum (PRR 218.0) |
| 924 | Subarachnoid Haemorrhage | 10,082 | 1,007 | Estriol0.2% (PRR 455.9) |
| 925 | Temperature Intolerance | 10,077 | 1,011 | Methyltestosterone (PRR 152.8) |
| 926 | Initial Insomnia | 10,064 | 1,007 | Nilutamide (PRR 139.0) |
| 927 | Helicobacter Infection | 10,062 | 999 | Desoximetasone (PRR 1,027.4) |
| 928 | Inappropriate Antidiuretic Hormone Secretion | 10,046 | 1,001 | Demeclocycline (PRR 90.4) |
| 929 | Eyelid Ptosis | 10,038 | 1,010 | Aesculus Hippocastanum Whole (PRR 220.1) |
| 930 | Sluggishness | 10,021 | 1,005 | Silver Nitrate (PRR 43.2) |
| 931 | Dry Throat | 10,020 | 1,007 | Trastuzumab-Qyyp (PRR 59.7) |
| 932 | Hypothermia | 10,010 | 1,003 | Anemone Patens (PRR 689.4) |
| 933 | Emphysema | 9,990 | 1,013 | Formoterol Fumarate (PRR 85.4) |
| 934 | Motor Dysfunction | 9,984 | 1,022 | Coal Tar (PRR 517.5) |
| 935 | Toxic Skin Eruption | 9,973 | 1,000 | Iomeprol Injection (PRR 153.0) |
| 936 | Peritonitis Bacterial | 9,934 | 612 | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 246.1) |
| 937 | Ovarian Cyst | 9,926 | 1,000 | Methyl Salicylate 10% (PRR 105.3) |
| 938 | Vaginal Discharge | 9,914 | 964 | Sodium Borate (PRR 416.2) |
| 939 | Brain Injury | 9,905 | 1,003 | Tafenoquine (PRR 303.5) |
| 940 | Hypotonia | 9,896 | 1,008 | Baclofen Injection (PRR 53.9) |
| 941 | Pneumocystis Jirovecii Pneumonia | 9,865 | 1,000 | Primaquine Phosphate (PRR 75.8) |
| 942 | Salivary Hypersecretion | 9,860 | 1,001 | Palifermin (PRR 70.2) |
| 943 | Bladder Disorder | 9,820 | 1,009 | Phosphoric Acid (PRR 204.1) |
| 944 | Body Temperature Decreased | 9,799 | 1,008 | Dibucaine (PRR 259.7) |
| 945 | Hepatomegaly | 9,745 | 1,026 | Crotamiton (PRR 41.8) |
| 946 | Ligament Sprain | 9,738 | 1,020 | Alendronate Sodium And Cholecalciferol (PRR 68.2) |
| 947 | Hospice Care | 9,721 | 1,003 | Dordaviprone (PRR 110.6) |
| 948 | Embedded Device | 9,719 | 394 | Copper (PRR 440.9) |
| 949 | Inflammatory Bowel Disease | 9,710 | 794 | Isotretinoin (PRR 494.6) |
| 950 | Renal Tubular Necrosis | 9,705 | 1,007 | Sodium Phosphate, Dibasic And Sodium Phosphate, Monobasic (PRR 158.0) |
| 951 | Inability To Afford Medication | 9,704 | 902 | Lisdexamfetamine Dimesylate Capsules (PRR 176.2) |
| 952 | Coeliac Disease | 9,688 | 999 | Calcium Sennosides (PRR 306.0) |
| 953 | Decreased Immune Responsiveness | 9,644 | 921 | Viscum Album Fruiting Top (PRR 118.0) |
| 954 | Parkinsonism | 9,624 | 866 | Salvia Officinalis (PRR 496.3) |
| 955 | Vitamin D Deficiency | 9,620 | 1,031 | Alendronate Sodium And Cholecalciferol (PRR 207.9) |
| 956 | Vitreous Floaters | 9,611 | 1,007 | Brolucizumab (PRR 352.1) |
| 957 | Knee Operation | 9,583 | 921 | Elosulfase Alfa (PRR 29.9) |
| 958 | Atelectasis | 9,570 | 1,060 | Sodium Borate (PRR 161.4) |
| 959 | Thrombotic Microangiopathy | 9,560 | 861 | Narsoplimab (PRR 515.6) |
| 960 | Sinus Bradycardia | 9,558 | 1,007 | Apraclonidine (PRR 103.1) |
| 961 | Affect Lability | 9,543 | 955 | Coal Tar (PRR 544.8) |
| 962 | Therapy Change | 9,516 | 1,002 | Efgartigimod Alfa And Hyaluronidase (Human Recombinant) (PRR 102.1) |
| 963 | Dizziness Postural | 9,478 | 1,012 | Camphor (PRR 261.1) |
| 964 | Pharyngeal Swelling | 9,448 | 1,004 | C1 Esterase Inhibitor Recombinant (PRR 131.4) |
| 965 | Autoimmune Disorder | 9,447 | 1,014 | Hyaluronidase (PRR 482.9) |
| 966 | Hypercholesterolaemia | 9,443 | 1,015 | Hamamelis Virginiana (PRR 910.2) |
| 967 | Supraventricular Tachycardia | 9,438 | 1,033 | Adenosine (PRR 135.7) |
| 968 | Laceration | 9,413 | 999 | Glycine (PRR 48.1) |
| 969 | Posterior Reversible Encephalopathy Syndrome | 9,394 | 1,002 | Amlodipine, Valsartan And Hydrochlorothiazide (PRR 132.2) |
| 970 | Spinal Disorder | 9,366 | 1,005 | Hydrocortisone Valerate (PRR 90.9) |
| 971 | Sputum Discoloured | 9,329 | 1,006 | Pyrilamine Maleate (PRR 1,634.3) |
| 972 | Eye Inflammation | 9,310 | 980 | Avanafil (PRR 387.0) |
| 973 | Leukaemia | 9,307 | 969 | Trifluoperazine Hydrochloride (PRR 347.0) |
| 974 | Arteriosclerosis | 9,304 | 1,022 | Calcium Sennosides (PRR 555.9) |
| 975 | Abortion Induced | 9,303 | 712 | Magnesium Sulfate (Heptahydrate) (PRR 147.2) |
| 976 | Squamous Cell Carcinoma | 9,301 | 1,000 | Flurbiprofen Sodium (PRR 198.7) |
| 977 | Breast Cancer Stage I | 9,268 | 393 | Triclosan (PRR 75.4) |
| 978 | Nephropathy | 9,262 | 1,008 | Asian Ginseng (PRR 130.7) |
| 979 | Deformity | 9,251 | 895 | Talc (PRR 418.9) |
| 980 | Grand Mal Convulsion | 9,244 | 948 | Extended Phenytoin Sodium (PRR 45.7) |
| 981 | Diarrhoea Haemorrhagic | 9,243 | 1,006 | Balsalazide Disodium (PRR 31.1) |
| 982 | Flank Pain | 9,235 | 1,027 | Sodium Borate (PRR 167.2) |
| 983 | Personality Change | 9,228 | 984 | Ziprasidone Hydrochloride (PRR 489.7) |
| 984 | Hepatic Encephalopathy | 9,218 | 1,005 | Terlipressin (PRR 114.9) |
| 985 | Erythema Multiforme | 9,201 | 1,003 | Cysteine Hydrochloride (PRR 281.2) |
| 986 | Intervertebral Disc Degeneration | 9,185 | 1,018 | Alendronate Sodium And Cholecalciferol (PRR 178.5) |
| 987 | Poisoning Deliberate | 9,183 | 500 | Cocaine Hydrochloride (PRR 230.5) |
| 988 | Appendicitis | 9,174 | 1,018 | Titanium (PRR 1,406.5) |
| 989 | Product Packaging Issue | 9,157 | 903 | Thrombin Topical Recombinant (PRR 101.2) |
| 990 | Haematotoxicity | 9,150 | 678 | Thioguanine (PRR 150.9) |
| 991 | Ovarian Cancer | 9,141 | 727 | Niraparib (PRR 68.0) |
| 992 | Blood Thyroid Stimulating Hormone Increased | 9,113 | 981 | Sodium Iodide I-131 (PRR 55.1) |
| 993 | Urosepsis | 9,099 | 1,009 | Methyl Salicylate 10% (PRR 419.1) |
| 994 | Increased Tendency To Bruise | 9,098 | 1,004 | Alendronate Sodium And Cholecalciferol (PRR 44.7) |
| 995 | Nerve Compression | 9,093 | 1,006 | Dinutuximab (PRR 68.6) |
| 996 | Retinal Detachment | 9,076 | 1,005 | Verteporfin For Injection (PRR 102.4) |
| 997 | Brain Neoplasm | 9,071 | 979 | Dyclonine Hydrochloride (PRR 72.1) |
| 998 | Iron Deficiency Anaemia | 9,067 | 1,036 | Titanium (PRR 202.4) |
| 999 | Gastrointestinal Carcinoma | 9,058 | 458 | Tranylcypromine (PRR 40.2) |
| 1000 | Pneumonia Bacterial | 9,014 | 593 | Remdesivir (PRR 21.8) |
| 1001 | Exostosis | 9,008 | 573 | Diclofenac Potassium, Film Coated (PRR 173.3) |
| 1002 | Optic Neuritis | 9,001 | 194 | Interferon Beta-1A (PRR 24.5) |
| 1003 | Pathogen Resistance | 8,983 | 170 | Tenofovir Disoproxil Fumarate Tablets (PRR 218.9) |
| 1004 | Developmental Delay | 8,980 | 99 | Hydrocodone Bitartrate And Acetaminophen (PRR 122.4) |
| 1005 | Wrong Drug Administered | 8,921 | 112 | Insulin Glulisine (PRR 40.5) |
| 1006 | Pregnancy With Contraceptive Device | 8,911 | 13 | Levonorgestrel (PRR 205.3) |
| 1007 | Lupus-Like Syndrome | 8,902 | 235 | Diclofenac Potassium, Film Coated (PRR 172.0) |
| 1008 | Haemolytic Anaemia | 8,874 | 354 | Daspone (PRR 40.2) |
| 1009 | Loss Of Libido | 8,864 | 134 | Finasteride (PRR 80.2) |
| 1010 | Myositis | 8,854 | 537 | Pseudoephedrine Hydrochloride (PRR 32.5) |
| 1011 | Lip Dry | 8,844 | 321 | Diclofenac Potassium, Film Coated (PRR 459.5) |
| 1012 | Oropharyngeal Discomfort | 8,819 | 417 | Ciclesonide (PRR 13.6) |
| 1013 | Gastrointestinal Infection | 8,813 | 554 | Human Immunoglobulin G (PRR 14.4) |
| 1014 | Labelled Drug-Drug Interaction Medication Error | 8,808 | 371 | Bupivacaine (PRR 64.8) |
| 1015 | Facial Pain | 8,805 | 574 | Felodipine Extended-Release Tablets (PRR 87.2) |
| 1016 | Haemarthrosis | 8,803 | 55 | Emicizumab (PRR 178.5) |
| 1017 | Lung Infiltration | 8,788 | 623 | Bleomycin Sulfate (PRR 13.8) |
| 1018 | Respiratory Rate Increased | 8,786 | 556 | Ciclesonide (PRR 27.2) |
| 1019 | Anal Incontinence | 8,785 | 641 | Vedolizumab (PRR 16.3) |
| 1020 | Cardiotoxicity | 8,750 | 254 | Trastuzumab (PRR 48.1) |
| 1021 | Product Distribution Issue | 8,746 | 309 | Teduglutide (PRR 27.9) |
| 1022 | Foreign Body In Reproductive Tract | 8,740 | 17 | Copper (PRR 89,124.5) |
| 1023 | Purpura | 8,728 | 461 | Rifampicin (PRR 20.9) |
| 1024 | Spinal Osteoarthritis | 8,716 | 731 | Alendronate Sodium (PRR 38.6) |
| 1025 | Groin Pain | 8,699 | 552 | Octreotide Acetate (PRR 11.3) |
| 1026 | Recalled Product Administered | 8,692 | 69 | Quinapril Hydrochloride (PRR 63.7) |
| 1027 | Poor Quality Device Used | 8,670 | 22 | Mometasone Furoate And Formoterol Fumarate Dihydrate (PRR 192.8) |
| 1028 | Blood Calcium Increased | 8,665 | 427 | Teriparatide (PRR 56.6) |
| 1029 | Urine Output Decreased | 8,647 | 627 | Basiliximab (PRR 21.7) |
| 1030 | Grip Strength Decreased | 8,635 | 351 | Diclofenac Potassium, Film Coated (PRR 295.6) |
| 1031 | Psychological Trauma | 8,628 | 281 | Trastuzumab (PRR 51.8) |
| 1032 | Tumour Lysis Syndrome | 8,622 | 322 | Venetoclax (PRR 51.6) |
| 1033 | Cardiac Murmur | 8,586 | 629 | Felodipine Extended-Release Tablets (PRR 37.3) |
| 1034 | Hidradenitis | 8,579 | 118 | Bimekizumab (PRR 221.6) |
| 1035 | Nail Disorder | 8,577 | 390 | Pseudoephedrine Hydrochloride (PRR 148.2) |
| 1036 | Immunosuppression | 8,565 | 392 | Ocrelizumab (PRR 10.0) |
| 1037 | Myopathy | 8,552 | 425 | Colchicine (PRR 20.8) |
| 1038 | Respiratory Syncytial Virus Infection | 8,544 | 408 | Palivizumab (PRR 442.6) |
| 1039 | Anuria | 8,538 | 466 | Basiliximab (PRR 22.7) |
| 1040 | Muscle Strain | 8,524 | 521 | Alendronate Sodium (PRR 12.8) |
| 1041 | Blood Magnesium Decreased | 8,520 | 697 | Niraparib (PRR 28.4) |
| 1042 | Hysterectomy | 8,517 | 300 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 24.9) |
| 1043 | Pyelonephritis | 8,500 | 596 | Basiliximab (PRR 14.5) |
| 1044 | Inadequate Analgesia | 8,466 | 78 | Buprenorphine (PRR 126.1) |
| 1045 | Skin Hyperpigmentation | 8,460 | 198 | Adapalene (PRR 54.3) |
| 1046 | Vitamin D Decreased | 8,454 | 516 | Asfotase Alfa (PRR 23.1) |
| 1047 | Uterine Perforation | 8,442 | 43 | Levonorgestrel (PRR 759.1) |
| 1048 | Product Communication Issue | 8,409 | 67 | Evolocumab (PRR 61.0) |
| 1049 | Skin Swelling | 8,397 | 161 | Adapalene (PRR 43.0) |
| 1050 | Cardiac Operation | 8,382 | 203 | Ranolazine (PRR 47.5) |
| 1051 | Haemodialysis | 8,381 | 364 | Darbepoetin Alfa (PRR 51.5) |
| 1052 | Facial Paralysis | 8,372 | 452 | Botulinum Toxin Type A (PRR 22.9) |
| 1053 | Pseudomonas Infection | 8,354 | 516 | Tobramycin (PRR 60.7) |
| 1054 | Skin Plaque | 8,319 | 203 | Secukinumab (PRR 43.2) |
| 1055 | Product Container Issue | 8,318 | 75 | Mometasone Furoate And Formoterol Fumarate Dihydrate (PRR 70.4) |
| 1056 | Atrial Septal Defect | 8,292 | 241 | Paroxetine Hydrochloride (PRR 42.3) |
| 1057 | Spinal Compression Fracture | 8,288 | 548 | Romosozumab-Aqqg (PRR 31.3) |
| 1058 | Breast Cancer Stage Ii | 8,286 | 176 | Diclofenac Potassium, Film Coated (PRR 102.9) |
| 1059 | Sensation Of Foreign Body | 8,275 | 281 | Copper (PRR 80.3) |
| 1060 | Embolism | 8,245 | 337 | Erlotinib (PRR 14.9) |
| 1061 | Hemiplegia | 8,239 | 346 | Methylprednisolone Acetate (PRR 51.5) |
| 1062 | Acute Coronary Syndrome | 8,233 | 428 | Ticagrelor (PRR 16.6) |
| 1063 | Hair Disorder | 8,227 | 237 | Docetaxel Anhydrous (PRR 665.5) |
| 1064 | Live Birth | 8,218 | 361 | Cortisone Acetate (PRR 253.0) |
| 1065 | Second Primary Malignancy | 8,205 | 177 | Bleomycin Sulfate (PRR 60.9) |
| 1066 | Eosinophil Count Increased | 8,199 | 371 | Ciclesonide (PRR 70.5) |
| 1067 | Infusion Site Erythema | 8,182 | 426 | Treprostinil (PRR 110.7) |
| 1068 | Drug Use Disorder | 8,171 | 116 | Oxazepam (PRR 49.4) |
| 1069 | Hyperaesthesia | 8,163 | 369 | Bupivacaine (PRR 21.8) |
| 1070 | Progressive Multifocal Leukoencephalopathy | 8,144 | 225 | Bendamustine Hcl (PRR 55.0) |
| 1071 | Muscle Injury | 8,101 | 258 | Desoximetasone (PRR 777.1) |
| 1072 | Abnormal Faeces | 8,091 | 342 | Teduglutide (PRR 39.3) |
| 1073 | Upper-Airway Cough Syndrome | 8,086 | 490 | Ciclesonide (PRR 44.9) |
| 1074 | Polyuria | 8,086 | 496 | Tolvaptan (PRR 83.9) |
| 1075 | Menstrual Disorder | 8,083 | 137 | Etonogestrel (PRR 34.3) |
| 1076 | Escherichia Infection | 8,071 | 540 | Valganciclovir Hydrochloride Powder, (PRR 29.9) |
| 1077 | Asphyxia | 8,068 | 252 | Oxazepam (PRR 41.1) |
| 1078 | Hiccups | 8,050 | 375 | Nicotine Polacrilex (PRR 44.9) |
| 1079 | Substance Abuse | 8,049 | 151 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 123.4) |
| 1080 | Decubitus Ulcer | 8,042 | 610 | Baclofen (PRR 11.2) |
| 1081 | Muscle Disorder | 8,028 | 290 | Ezetimibe And Simvastatin (PRR 9.6) |
| 1082 | Shock Haemorrhagic | 8,021 | 395 | Fondaparinux Sodium (PRR 57.0) |
| 1083 | Post Procedural Infection | 8,004 | 366 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 11.8) |
| 1084 | Uterine Cancer | 7,997 | 49 | Ranitidine (PRR 26.8) |
| 1085 | Sensory Loss | 7,970 | 434 | Methylprednisolone Acetate (PRR 61.1) |
| 1086 | Obsessive-Compulsive Disorder | 7,965 | 262 | Asenapine Maleate (PRR 55.8) |
| 1087 | Rhinitis | 7,957 | 568 | Ciclesonide (PRR 63.6) |
| 1088 | Stent Placement | 7,954 | 220 | Ranolazine (PRR 157.4) |
| 1089 | Frustration Tolerance Decreased | 7,938 | 339 | Ciclesonide (PRR 15.2) |
| 1090 | Blood Disorder | 7,911 | 368 | Quinine (PRR 17.3) |
| 1091 | Atrial Flutter | 7,908 | 569 | Dronedarone (PRR 27.4) |
| 1092 | Transplant Rejection | 7,904 | 172 | Tacrolimus (PRR 230.7) |
| 1093 | Nasal Discomfort | 7,863 | 190 | Acetaminophen, Chlorpheniramine Maleate, Phenylephrine Hcl (PRR 21.3) |
| 1094 | Miosis | 7,862 | 191 | Oxazepam (PRR 42.2) |
| 1095 | Gingival Pain | 7,860 | 463 | Felodipine Extended-Release Tablets (PRR 38.4) |
| 1096 | Renal Cyst | 7,855 | 669 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate (PRR 13.9) |
| 1097 | Heavy Menstrual Bleeding | 7,846 | 108 | Copper (PRR 111.2) |
| 1098 | Low Birth Weight Baby | 7,844 | 276 | Labetalol (PRR 85.9) |
| 1099 | Furuncle | 7,810 | 267 | Nitrofurantoin (PRR 8.1) |
| 1100 | Blood Albumin Decreased | 7,804 | 668 | Basiliximab (PRR 11.4) |
| 1101 | Tricuspid Valve Incompetence | 7,802 | 648 | Digoxin (PRR 22.1) |
| 1102 | Arterial Occlusive Disease | 7,797 | 290 | Methylprednisolone Acetate (PRR 61.7) |
| 1103 | Electrocardiogram Abnormal | 7,779 | 496 | Torsemide (PRR 14.9) |
| 1104 | Drug Screen Positive | 7,778 | 181 | Dronabinol (PRR 71.4) |
| 1105 | Myasthenia Gravis | 7,772 | 316 | Ravulizumab (PRR 100.0) |
| 1106 | Nicotine Dependence | 7,765 | 31 | Nicotine Polacrilex (PRR 624.9) |
| 1107 | Torsade De Pointes | 7,759 | 320 | Dofetilide (PRR 42.8) |
| 1108 | Haemorrhagic Stroke | 7,758 | 292 | Dutasteride (PRR 82.7) |
| 1109 | Multiple Allergies | 7,744 | 461 | Human Immunoglobulin G (PRR 61.9) |
| 1110 | Affective Disorder | 7,739 | 346 | Lithium (PRR 17.5) |
| 1111 | Apnoea | 7,733 | 334 | Palivizumab (PRR 51.2) |
| 1112 | Pulmonary Haemorrhage | 7,719 | 358 | Busulfan (PRR 21.4) |
| 1113 | Congenital Anomaly | 7,696 | 242 | Cortisone Acetate (PRR 72.9) |
| 1114 | Renal Failure Chronic | 7,696 | 431 | Epoetin Alfa (PRR 37.3) |
| 1115 | Gastrointestinal Inflammation | 7,679 | 230 | Vedolizumab (PRR 21.5) |
| 1116 | Pelvic Fracture | 7,667 | 400 | Raloxifene Hydrochloride (PRR 14.8) |
| 1117 | Maternal Drugs Affecting Foetus | 7,658 | 157 | Zidovudine (PRR 52.1) |
| 1118 | Atrioventricular Block | 7,652 | 362 | Lacosamide (PRR 12.2) |
| 1119 | Concussion | 7,640 | 488 | Dimenhydrinate (PRR 14.4) |
| 1120 | Haemolysis | 7,637 | 270 | Eculizumab (PRR 123.6) |
| 1121 | Acute Generalised Exanthematous Pustulosis | 7,636 | 273 | Terbinafine Hydrochloride (PRR 48.5) |
| 1122 | Bronchopulmonary Aspergillosis | 7,623 | 304 | Voriconazole Injection (PRR 125.3) |
| 1123 | Intercepted Product Administration Error | 7,619 | 21 | Epoetin Alfa (PRR 67.7) |
| 1124 | Procedural Complication | 7,614 | 181 | Sevoflurane (PRR 22.2) |
| 1125 | Low Density Lipoprotein Increased | 7,597 | 247 | Inclisiran (PRR 184.0) |
| 1126 | Aphthous Ulcer | 7,573 | 410 | Infliximab-Dyyb (PRR 78.5) |
| 1127 | Product Administration Interrupted | 7,570 | 459 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 610.9) |
| 1128 | Aortic Aneurysm | 7,560 | 315 | Tobramycin Solution (PRR 6.7) |
| 1129 | Acidosis | 7,555 | 513 | Norepinephrine (PRR 26.1) |
| 1130 | Hypoalbuminaemia | 7,548 | 493 | Axicabtagene Ciloleucel (PRR 32.3) |
| 1131 | Diffuse Large B-Cell Lymphoma | 7,531 | 193 | Polatuzumab Vedotin (PRR 121.5) |
| 1132 | Hepatocellular Carcinoma | 7,531 | 85 | Sorafenib (PRR 337.6) |
| 1133 | Lipase Increased | 7,527 | 369 | Nilotinib (PRR 25.0) |
| 1134 | Bowel Movement Irregularity | 7,523 | 389 | Linaclotide (PRR 18.7) |
| 1135 | Tendon Pain | 7,476 | 128 | Ciprofloxacin Tablets (PRR 81.5) |
| 1136 | Breast Tenderness | 7,467 | 71 | Levonorgestrel (PRR 49.1) |
| 1137 | Hyperthermia | 7,464 | 354 | Sevoflurane (PRR 31.2) |
| 1138 | Food Allergy | 7,456 | 357 | Methylprednisolone Acetate (PRR 178.8) |
| 1139 | Troponin Increased | 7,448 | 529 | Norepinephrine Bitartrate (PRR 34.2) |
| 1140 | General Symptom | 7,445 | 175 | Natalizumab (PRR 47.4) |
| 1141 | Dissociation | 7,441 | 126 | Esketamine Hydrochloride (PRR 1,174.1) |
| 1142 | Parosmia | 7,436 | 360 | Felodipine Extended-Release Tablets (PRR 37.6) |
| 1143 | Medical Device Complication | 7,402 | 56 | Etonogestrel (PRR 48.6) |
| 1144 | Haemodynamic Instability | 7,399 | 404 | Norepinephrine (PRR 49.1) |
| 1145 | Device Physical Property Issue | 7,386 | 73 | Somatropin (PRR 182.7) |
| 1146 | Ketoacidosis | 7,378 | 78 | Empagliflozin (PRR 79.4) |
| 1147 | Hydronephrosis | 7,366 | 512 | Basiliximab (PRR 27.8) |
| 1148 | Feeling Drunk | 7,363 | 293 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 39.3) |
| 1149 | Sunburn | 7,357 | 108 | Vemurafenib (PRR 92.4) |
| 1150 | Lower Gastrointestinal Haemorrhage | 7,325 | 405 | Dabigatran Etexilate Mesylate (PRR 52.6) |
| 1151 | Blood Pressure Diastolic Decreased | 7,319 | 453 | Octreotide Acetate (PRR 93.0) |
| 1152 | Pemphigoid | 7,314 | 219 | Linagliptin (PRR 40.0) |
| 1153 | Psychiatric Symptom | 7,289 | 242 | Paliperidone (PRR 9.3) |
| 1154 | Cerebral Disorder | 7,282 | 311 | Ado-Trastuzumab Emtansine (PRR 7.5) |
| 1155 | Peritoneal Dialysis Complication | 7,266 | 21 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 171.1) |
| 1156 | Blindness Transient | 7,264 | 184 | Aflibercept (PRR 111.3) |
| 1157 | Arthropod Bite | 7,254 | 388 | Human Immunoglobulin G (PRR 12.7) |
| 1158 | Oral Disorder | 7,252 | 415 | Chlorhexidine Gluconate (PRR 12.9) |
| 1159 | Hypophosphataemia | 7,250 | 495 | Phytonadione (PRR 61.0) |
| 1160 | Duodenal Ulcer Perforation | 7,246 | 228 | Desoximetasone (PRR 2,326.2) |
| 1161 | Uterine Leiomyoma | 7,241 | 211 | Copper (PRR 27.4) |
| 1162 | Mouth Haemorrhage | 7,240 | 344 | Emicizumab (PRR 54.2) |
| 1163 | Major Depression | 7,230 | 399 | Tofacitinib Citrate (PRR 37.7) |
| 1164 | Rash Pustular | 7,226 | 226 | Panitumumab (PRR 62.7) |
| 1165 | Device Information Output Issue | 7,213 | 15 | Somatropin (PRR 2,690.2) |
| 1166 | Tongue Disorder | 7,192 | 287 | Febuxostat Tablets 40 Mg (PRR 54.6) |
| 1167 | Intentional Underdose | 7,192 | 99 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 143.6) |
| 1168 | Drug Administered To Patient Of Inappropriate Age | 7,173 | 105 | Fexofenadine (PRR 36.5) |
| 1169 | Sensitive Skin | 7,147 | 170 | Adapalene (PRR 74.0) |
| 1170 | Faeces Soft | 7,142 | 324 | Vedolizumab (PRR 35.4) |
| 1171 | Graft Versus Host Disease | 7,140 | 217 | Busulfan (PRR 194.0) |
| 1172 | Haemophagocytic Lymphohistiocytosis | 7,131 | 280 | Anakinra (PRR 121.7) |
| 1173 | Visual Field Defect | 7,121 | 203 | Vigabatrin (PRR 28.8) |
| 1174 | Panic Reaction | 7,114 | 222 | Ziprasidone Mesylate (PRR 9.5) |
| 1175 | Diverticulum | 7,110 | 529 | Olmesartan Medoxomil (PRR 72.9) |
| 1176 | Dermatitis Bullous | 7,099 | 304 | Linagliptin (PRR 37.8) |
| 1177 | Metastasis | 7,082 | 150 | Ribociclib (PRR 43.4) |
| 1178 | Neutropenic Sepsis | 7,063 | 348 | Filgrastim (PRR 33.4) |
| 1179 | Retinal Haemorrhage | 7,017 | 186 | Ranibizumab (PRR 100.3) |
| 1180 | Anti-Cyclic Citrullinated Peptide Antibody Positive | 7,015 | 213 | Desoximetasone (PRR 3,739.1) |
| 1181 | Thermal Burn | 7,008 | 255 | Quetiapine Fumarate (PRR 13.0) |
| 1182 | Application Site Reaction | 7,003 | 42 | Nicotine (PRR 76.0) |
| 1183 | Hand Fracture | 6,994 | 370 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate (PRR 45.8) |
| 1184 | Liquid Product Physical Issue | 6,972 | 79 | Testosterone Cypionate (PRR 84.5) |
| 1185 | Right Ventricular Failure | 6,972 | 238 | Epoprostenol (PRR 138.8) |
| 1186 | Product Supply Issue | 6,964 | 139 | Cannabidiol (PRR 40.4) |
| 1187 | Duodenal Ulcer | 6,963 | 379 | Quinine (PRR 15.1) |
| 1188 | Pulmonary Toxicity | 6,928 | 248 | Bleomycin Sulfate (PRR 128.3) |
| 1189 | Extrasystoles | 6,920 | 285 | Sevoflurane (PRR 17.5) |
| 1190 | Fear Of Injection | 6,888 | 114 | Dimenhydrinate (PRR 27.3) |
| 1191 | Defaecation Urgency | 6,882 | 206 | Vedolizumab (PRR 68.3) |
| 1192 | Formication | 6,882 | 227 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 8.7) |
| 1193 | Crohn'S Disease | 6,861 | 91 | Isotretinoin (PRR 83.7) |
| 1194 | Papule | 6,859 | 266 | Iohexol (PRR 14.0) |
| 1195 | Large Intestine Perforation | 6,857 | 315 | Bevacizumab (PRR 17.5) |
| 1196 | Large Intestine Polyp | 6,840 | 362 | Olmesartan Medoxomil (PRR 82.8) |
| 1197 | Hair Growth Abnormal | 6,834 | 150 | Minoxidil (PRR 49.1) |
| 1198 | Autoimmune Hepatitis | 6,831 | 229 | Ipilimumab (PRR 29.4) |
| 1199 | Joint Effusion | 6,829 | 362 | Methylprednisolone Acetate (PRR 55.2) |
| 1200 | Infarction | 6,817 | 125 | Paricalcitol (PRR 57.9) |
| 1201 | Blood Testosterone Decreased | 6,816 | 128 | Testosterone (PRR 61.7) |
| 1202 | Lymphoedema | 6,812 | 488 | Dimenhydrinate (PRR 50.9) |
| 1203 | Encephalitis | 6,808 | 311 | Atezolizumab (PRR 22.3) |
| 1204 | Ecchymosis | 6,781 | 447 | Romiplostim (PRR 18.0) |
| 1205 | Drooling | 6,781 | 183 | Valbenazine (PRR 127.9) |
| 1206 | Onychoclasis | 6,780 | 255 | Ibrutinib (PRR 26.7) |
| 1207 | Nephrotic Syndrome | 6,763 | 245 | Mycophenolate Mofetil Hydrochloride (PRR 13.3) |
| 1208 | Eye Movement Disorder | 6,763 | 246 | Vigabatrin (PRR 13.4) |
| 1209 | Respiration Abnormal | 6,744 | 299 | Lumacaftor And Ivacaftor (PRR 70.8) |
| 1210 | Accidental Exposure To Product By Child | 6,735 | 89 | Loratadine Tablet (PRR 35.5) |
| 1211 | Hypertransaminasaemia | 6,725 | 411 | Pyrazinamide (PRR 22.6) |
| 1212 | Maternal Exposure Before Pregnancy | 6,706 | 139 | Etonogestrel And Ethinyl Estradiol (PRR 64.7) |
| 1213 | General Physical Condition Abnormal | 6,702 | 212 | Hydrocodone Bitartrate And Acetaminophen (PRR 13.7) |
| 1214 | Cholecystitis Chronic | 6,697 | 216 | Drospirenone And Ethinyl Estradiol (PRR 2,233.9) |
| 1215 | Ulcer Haemorrhage | 6,679 | 307 | Diclofenac Potassium, Film Coated (PRR 84.6) |
| 1216 | Abnormal Loss Of Weight | 6,678 | 272 | Nintedanib (PRR 24.7) |
| 1217 | Postoperative Wound Infection | 6,652 | 389 | Chlorhexidine Gluconate (PRR 12.0) |
| 1218 | Breast Mass | 6,641 | 292 | Ribociclib (PRR 20.7) |
| 1219 | Colitis Ischaemic | 6,633 | 359 | Sumatriptan Succinate (PRR 15.9) |
| 1220 | Post-Traumatic Stress Disorder | 6,628 | 395 | Hydrocodone Bitartrate And Acetaminophen (PRR 31.2) |
| 1221 | Terminal State | 6,622 | 129 | Canakinumab (PRR 44.9) |
| 1222 | Metastases To Lymph Nodes | 6,618 | 202 | Ado-Trastuzumab Emtansine (PRR 59.6) |
| 1223 | Product Label Issue | 6,617 | 92 | Guselkumab (PRR 20.0) |
| 1224 | Meningitis | 6,595 | 280 | Methylprednisolone Acetate (PRR 19.4) |
| 1225 | Atrioventricular Block Complete | 6,590 | 336 | Diltiazem Hydrochloride Extended-Release Tablets (PRR 17.1) |
| 1226 | Coronavirus Infection | 6,584 | 248 | Niraparib (PRR 26.8) |
| 1227 | Left Ventricular Dysfunction | 6,578 | 522 | Pertuzumab (PRR 29.1) |
| 1228 | Bronchiectasis | 6,574 | 476 | Ciclesonide (PRR 149.5) |
| 1229 | Cardiac Failure Acute | 6,560 | 410 | Eplerenone (PRR 28.7) |
| 1230 | Skin Mass | 6,556 | 239 | Vemurafenib (PRR 20.3) |
| 1231 | Wrong Product Administered | 6,553 | 177 | Tranexamic Acid (PRR 31.1) |
| 1232 | Walking Aid User | 6,535 | 439 | Diclofenac Potassium, Film Coated (PRR 131.5) |
| 1233 | Dysgraphia | 6,535 | 200 | Axicabtagene Ciloleucel (PRR 28.4) |
| 1234 | Product Formulation Issue | 6,522 | 62 | Minoxidil (PRR 64.3) |
| 1235 | Arteriosclerosis Coronary Artery | 6,521 | 526 | Dutasteride (PRR 95.7) |
| 1236 | Somnambulism | 6,503 | 263 | Sodium Oxybate (PRR 62.9) |
| 1237 | Bradyphrenia | 6,484 | 201 | Paroxetine Hydrochloride Hemihydrate (PRR 13.5) |
| 1238 | Poor Quality Drug Administered | 6,481 | 70 | Ibuprofen Tablets, Coated (PRR 28.5) |
| 1239 | Angina Unstable | 6,473 | 281 | Ticagrelor (PRR 27.0) |
| 1240 | Polyp | 6,466 | 335 | Olmesartan Medoxomil (PRR 22.8) |
| 1241 | Refusal Of Treatment By Patient | 6,457 | 219 | Paliperidone Palmitate (PRR 36.7) |
| 1242 | Tendon Disorder | 6,444 | 185 | Ciprofloxacin (PRR 46.5) |
| 1243 | Application Site Vesicles | 6,432 | 48 | Buprenorphine (PRR 42.4) |
| 1244 | Appetite Disorder | 6,427 | 460 | Quinapril Hydrochloride (PRR 26.1) |
| 1245 | Hyperprolactinaemia | 6,417 | 79 | Risperidone (PRR 360.6) |
| 1246 | Incoherent | 6,410 | 258 | Rivastigmine (PRR 10.3) |
| 1247 | Drug Specific Antibody Present | 6,402 | 92 | Infliximab-Dyyb (PRR 82.4) |
| 1248 | Aspergillus Infection | 6,400 | 268 | Voriconazole Injection (PRR 142.9) |
| 1249 | Herpes Simplex | 6,398 | 262 | Glycerin, Lidocaine (PRR 184.3) |
| 1250 | Galactorrhoea | 6,398 | 68 | Risperidone (PRR 222.9) |
| 1251 | Cardiac Flutter | 6,391 | 273 | Abaloparatide (PRR 9.3) |
| 1252 | Hepatitis Acute | 6,387 | 303 | Amoxicillin And Clavulanate Potassium (PRR 11.7) |
| 1253 | Occupational Exposure To Product | 6,382 | 29 | Pegfilgrastim (PRR 59.6) |
| 1254 | Sleep Disorder Due To General Medical Condition, Insomnia Type | 6,355 | 234 | Desoximetasone (PRR 714.4) |
| 1255 | Breast Cancer Stage Iii | 6,351 | 202 | Diclofenac Potassium, Film Coated (PRR 441.4) |
| 1256 | Proctalgia | 6,337 | 297 | Peginterferon Alfa-2A (PRR 30.2) |
| 1257 | Hypogammaglobulinaemia | 6,328 | 236 | Fludarabine Phosphate (PRR 75.4) |
| 1258 | C-Reactive Protein Abnormal | 6,324 | 273 | Diclofenac Potassium, Film Coated (PRR 556.6) |
| 1259 | Screaming | 6,317 | 172 | Oseltamivir Phosphate (PRR 16.2) |
| 1260 | Haemoglobin Abnormal | 6,315 | 236 | Eculizumab (PRR 33.6) |
| 1261 | Oral Mucosal Blistering | 6,314 | 233 | Cabozantinib (PRR 14.1) |
| 1262 | Multiple Injuries | 6,293 | 212 | Metoclopramide (PRR 193.1) |
| 1263 | White Blood Cell Count Abnormal | 6,288 | 189 | Acalabrutinib (PRR 23.8) |
| 1264 | Enteritis | 6,270 | 302 | Pegaspargase (PRR 39.7) |
| 1265 | Pre-Existing Condition Improved | 6,228 | 386 | Sodium Oxybate (PRR 174.1) |
| 1266 | Photopsia | 6,227 | 175 | Crizotinib (PRR 36.3) |
| 1267 | Nasal Dryness | 6,187 | 235 | Isotretinoin (PRR 16.8) |
| 1268 | Foreign Body Sensation In Eyes | 6,161 | 110 | Cenegermin-Bkbj (PRR 148.6) |
| 1269 | Drug Abuser | 6,147 | 77 | Oxycodone Hydrochloride (PRR 55.2) |
| 1270 | Epstein-Barr Virus Infection | 6,142 | 182 | Anti-Thymocyte Globulin (Rabbit) (PRR 92.7) |
| 1271 | Therapeutic Response Changed | 6,141 | 46 | Tirzepatide (PRR 72.9) |
| 1272 | Infusion Site Extravasation | 6,139 | 261 | Infliximab-Dyyb (PRR 41.0) |
| 1273 | Scoliosis | 6,129 | 383 | Alendronate Sodium (PRR 26.2) |
| 1274 | Oliguria | 6,126 | 356 | Norepinephrine Bitartrate (PRR 21.5) |
| 1275 | Blepharospasm | 6,125 | 321 | Botulinum Toxin Type A (PRR 268.9) |
| 1276 | Concomitant Disease Aggravated | 6,094 | 245 | Selexipag (PRR 23.9) |
| 1277 | Cholangitis | 6,084 | 270 | Durvalumab (PRR 43.4) |
| 1278 | Pigmentation Disorder | 6,080 | 195 | Minocycline (PRR 32.3) |
| 1279 | Meniscus Injury | 6,079 | 282 | Doxepin Hydrochloride (PRR 11.7) |
| 1280 | Infusion Site Swelling | 6,077 | 398 | Human Immunoglobulin G (PRR 97.5) |
| 1281 | Laryngeal Oedema | 6,072 | 126 | Iohexol (PRR 22.9) |
| 1282 | Inguinal Hernia | 6,025 | 241 | Palivizumab (PRR 22.8) |
| 1283 | Prescription Drug Used Without A Prescription | 6,025 | 104 | Fentanyl (PRR 24.5) |
| 1284 | Swelling Of Eyelid | 6,021 | 187 | Cenegermin-Bkbj (PRR 76.1) |
| 1285 | Tension | 6,021 | 153 | Divalproex Sodium (PRR 25.6) |
| 1286 | Vulvovaginal Burning Sensation | 6,016 | 41 | Miconazole Nitrate (PRR 1,070.2) |
| 1287 | Hearing Impaired | 6,002 | 108 | Teriparatide (PRR 9.5) |
| 1288 | Gangrene | 5,988 | 181 | Canagliflozin (PRR 153.9) |
| 1289 | Blood Pressure Inadequately Controlled | 5,985 | 139 | Valsartan And Hydrochlorothiazide (PRR 60.9) |
| 1290 | Hepatitis B | 5,985 | 159 | Entecavir (PRR 103.6) |
| 1291 | Dermatitis Acneiform | 5,972 | 163 | Panitumumab (PRR 282.6) |
| 1292 | Prothrombin Time Prolonged | 5,969 | 351 | Warfarin Sodium (PRR 34.4) |
| 1293 | Foetal Growth Restriction | 5,961 | 215 | Labetalol (PRR 35.6) |
| 1294 | Platelet Count Abnormal | 5,951 | 138 | Romiplostim (PRR 265.1) |
| 1295 | Squamous Cell Carcinoma Of Skin | 5,940 | 231 | Voriconazole Injection (PRR 52.2) |
| 1296 | Type 1 Diabetes Mellitus | 5,931 | 221 | Ziprasidone Mesylate (PRR 34.5) |
| 1297 | Product Administered To Patient Of Inappropriate Age | 5,930 | 127 | Propranolol Hydrochloride (PRR 70.7) |
| 1298 | Injection Site Vesicles | 5,926 | 70 | Fremanezumab-Vfrm (PRR 11.4) |
| 1299 | Hepatitis Cholestatic | 5,919 | 258 | Amoxicillin And Clavulanate Potassium (PRR 29.9) |
| 1300 | Endophthalmitis | 5,919 | 104 | Aflibercept (PRR 208.1) |
| 1301 | Sinus Headache | 5,902 | 253 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 9.2) |
| 1302 | Cardiac Pacemaker Insertion | 5,893 | 210 | Ranolazine (PRR 40.0) |
| 1303 | Pleurisy | 5,888 | 267 | Etonogestrel And Ethinyl Estradiol (PRR 14.7) |
| 1304 | Hyperchlorhydria | 5,866 | 73 | Dexlansoprazole (PRR 73.6) |
| 1305 | Energy Increased | 5,860 | 189 | Exenatide (PRR 20.5) |
| 1306 | Cataract Operation | 5,844 | 167 | Aflibercept (PRR 26.6) |
| 1307 | Odynophagia | 5,832 | 318 | Nystatin Ointment (PRR 13.1) |
| 1308 | Decreased Interest | 5,828 | 290 | Teriflunomide (PRR 23.4) |
| 1309 | Urine Odour Abnormal | 5,825 | 232 | Nitrofurantoin (Monohydrate/Macrocrystals) (PRR 16.2) |
| 1310 | Glucose Tolerance Impaired | 5,799 | 372 | Cimetidine (PRR 23.3) |
| 1311 | Feeling Of Body Temperature Change | 5,794 | 196 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 19.0) |
| 1312 | Symptom Recurrence | 5,790 | 116 | Nirmatrelvir And Ritonavir (PRR 79.5) |
| 1313 | Hypovolaemia | 5,771 | 478 | Quinine (PRR 19.1) |
| 1314 | Peripheral Sensory Neuropathy | 5,769 | 200 | Brentuximab Vedotin (PRR 52.3) |
| 1315 | Hypertriglyceridaemia | 5,758 | 291 | Pegaspargase (PRR 130.3) |
| 1316 | Bradykinesia | 5,755 | 204 | Rasagiline Mesylate (PRR 46.3) |
| 1317 | Product Preparation Issue | 5,752 | 93 | Botulinum Toxin Type A (PRR 40.3) |
| 1318 | Visual Disturbance | 5,745 | 121 | Calcium Gluconate (PRR 13.0) |
| 1319 | Skin Warm | 5,744 | 226 | Tretinoin (PRR 13.5) |
| 1320 | Product Label Confusion | 5,742 | 163 | Botulinum Toxin Type A (PRR 94.0) |
| 1321 | Rales | 5,732 | 516 | Ciclesonide (PRR 47.0) |
| 1322 | Social Avoidant Behaviour | 5,732 | 164 | Aripiprazole Oral (PRR 18.3) |
| 1323 | Metabolic Disorder | 5,729 | 218 | Asenapine Maleate (PRR 188.0) |
| 1324 | Hyperventilation | 5,724 | 243 | Sevoflurane (PRR 11.4) |
| 1325 | Stress Cardiomyopathy | 5,710 | 181 | Atropine (PRR 44.3) |
| 1326 | Coronary Artery Bypass | 5,704 | 104 | Ranolazine (PRR 34.1) |
| 1327 | Herpes Virus Infection | 5,700 | 214 | Valacyclovir Hydrochloride (PRR 26.2) |
| 1328 | Rheumatoid Factor Positive | 5,695 | 220 | Cortisone Acetate (PRR 1,636.5) |
| 1329 | Generalised Erythema | 5,694 | 119 | Iohexol (PRR 16.4) |
| 1330 | Blood Uric Acid Increased | 5,693 | 380 | Oseltamivir (PRR 66.8) |
| 1331 | Ventricular Septal Defect | 5,687 | 147 | Nevirapine (PRR 44.2) |
| 1332 | Hypertonia | 5,678 | 143 | Zidovudine (PRR 18.0) |
| 1333 | Cardiac Valve Disease | 5,674 | 241 | Octreotide Acetate (PRR 10.9) |
| 1334 | Mouth Swelling | 5,674 | 218 | Trimethoprim (PRR 12.2) |
| 1335 | Granulocytopenia | 5,668 | 158 | Clozapine (PRR 141.2) |
| 1336 | Skin Atrophy | 5,662 | 194 | Clobetasol Propionate Ointment Usp, 0.05% (PRR 40.8) |
| 1337 | Drug Diversion | 5,651 | 69 | Oxycodone (PRR 61.1) |
| 1338 | Enterocolitis | 5,636 | 307 | Ipilimumab (PRR 36.0) |
| 1339 | Exercise Tolerance Decreased | 5,635 | 309 | Eplerenone (PRR 29.6) |
| 1340 | Premature Labour | 5,631 | 140 | Methadone Hydrochloride (PRR 38.7) |
| 1341 | Intra-Uterine Contraceptive Device Expelled | 5,622 | 2 | Levonorgestrel (PRR 11,640.9) |
| 1342 | Peroneal Nerve Palsy | 5,611 | 162 | Dalfampridine (PRR 37.3) |
| 1343 | Neutrophilia | 5,602 | 104 | Clozapine (PRR 142.9) |
| 1344 | Neurological Symptom | 5,601 | 337 | Dutasteride (PRR 71.4) |
| 1345 | Cholecystitis Acute | 5,582 | 358 | Drospirenone And Ethinyl Estradiol (PRR 114.7) |
| 1346 | Angiopathy | 5,575 | 236 | Captopril (PRR 12.1) |
| 1347 | Intestinal Haemorrhage | 5,574 | 144 | Isotretinoin (PRR 61.0) |
| 1348 | Acute Pulmonary Oedema | 5,546 | 293 | Sevoflurane (PRR 15.9) |
| 1349 | Immune Effector Cell-Associated Neurotoxicity Syndrome | 5,544 | 147 | Axicabtagene Ciloleucel (PRR 1,255.2) |
| 1350 | Colectomy | 5,531 | 60 | Vedolizumab (PRR 29.3) |
| 1351 | Pulmonary Alveolar Haemorrhage | 5,528 | 306 | Dutasteride (PRR 72.8) |
| 1352 | Macular Oedema | 5,524 | 81 | Ranibizumab (PRR 91.5) |
| 1353 | Necrosis | 5,520 | 252 | Amphotericin B (PRR 14.9) |
| 1354 | Gastric Ulcer Haemorrhage | 5,512 | 190 | Rivaroxaban (PRR 18.5) |
| 1355 | Skin Toxicity | 5,506 | 128 | Panitumumab (PRR 261.5) |
| 1356 | Streptococcal Infection | 5,496 | 294 | Infliximab-Dyyb (PRR 15.5) |
| 1357 | Intracranial Pressure Increased | 5,496 | 187 | Tretinoin (PRR 24.5) |
| 1358 | Cystic Fibrosis | 5,491 | 132 | Dornase Alfa (PRR 500.7) |
| 1359 | Multiple Use Of Single-Use Product | 5,486 | 24 | Onabotulinumtoxina (PRR 292.0) |
| 1360 | Heart Rate Abnormal | 5,481 | 231 | Dofetilide (PRR 13.5) |
| 1361 | Hyperkeratosis | 5,462 | 243 | Vemurafenib (PRR 63.1) |
| 1362 | Prostatic Disorder | 5,458 | 78 | Ranitidine (PRR 18.8) |
| 1363 | Jaw Disorder | 5,453 | 130 | Alendronate Sodium (PRR 32.5) |
| 1364 | Deafness Unilateral | 5,430 | 128 | Agalsidase Beta (PRR 6.7) |
| 1365 | Drug Level Below Therapeutic | 5,425 | 184 | Infliximab-Dyyb (PRR 199.6) |
| 1366 | Choking Sensation | 5,425 | 175 | Levodopa (PRR 34.6) |
| 1367 | Periorbital Swelling | 5,415 | 154 | Avapritinib (PRR 140.7) |
| 1368 | Infective Pulmonary Exacerbation Of Cystic Fibrosis | 5,413 | 173 | Lumacaftor And Ivacaftor (PRR 898.3) |
| 1369 | Injection Site Injury | 5,412 | 49 | Tirzepatide (PRR 47.3) |
| 1370 | Intestinal Ischaemia | 5,408 | 303 | Norepinephrine Bitartrate (PRR 28.1) |
| 1371 | Autism Spectrum Disorder | 5,397 | 91 | Valproate Sodium (PRR 50.1) |
| 1372 | Product Physical Consistency Issue | 5,397 | 66 | Leuprolide Acetate (PRR 57.2) |
| 1373 | Tic | 5,391 | 84 | Atomoxetine Hydrochloride (PRR 67.4) |
| 1374 | Asthenopia | 5,369 | 133 | Cenegermin-Bkbj (PRR 40.7) |
| 1375 | Faecaloma | 5,367 | 256 | Lactulose (PRR 20.0) |
| 1376 | Hydrocephalus | 5,366 | 255 | Pyrazinamide (PRR 31.0) |
| 1377 | Normal Newborn | 5,363 | 260 | Oseltamivir (PRR 80.9) |
| 1378 | Stress Fracture | 5,361 | 112 | Alendronate Sodium (PRR 136.6) |
| 1379 | Cheilitis | 5,336 | 136 | Isotretinoin (PRR 42.2) |
| 1380 | Gingivitis | 5,330 | 259 | Chlorhexidine Gluconate (PRR 17.7) |
| 1381 | Bruxism | 5,327 | 201 | Lurasidone Hydrochloride (PRR 20.6) |
| 1382 | Virologic Failure | 5,326 | 34 | Lamivudine Oral (PRR 455.3) |
| 1383 | Learning Disability | 5,325 | 28 | Hydrocodone Bitartrate And Acetaminophen (PRR 303.9) |
| 1384 | Nonspecific Reaction | 5,320 | 107 | Pimavanserin Tartrate (PRR 104.2) |
| 1385 | Pharyngolaryngeal Pain | 5,317 | 125 | Salmeterol Xinafoate (PRR 39.7) |
| 1386 | Anal Abscess | 5,298 | 233 | Infliximab-Dyyb (PRR 41.8) |
| 1387 | Overweight | 5,290 | 209 | Risperidone (PRR 19.2) |
| 1388 | Anorectal Discomfort | 5,279 | 74 | Peginterferon Alfa-2A (PRR 206.3) |
| 1389 | Intestinal Resection | 5,278 | 27 | Infliximab (PRR 40.0) |
| 1390 | Erythema Of Eyelid | 5,276 | 55 | Bimatoprost (PRR 171.6) |
| 1391 | Anal Fissure | 5,268 | 158 | Infliximab-Dyyb (PRR 176.2) |
| 1392 | Anal Fistula | 5,265 | 113 | Infliximab-Dyyb (PRR 56.6) |
| 1393 | Product Leakage | 5,263 | 80 | Guselkumab (PRR 115.8) |
| 1394 | Food Poisoning | 5,254 | 236 | Human Immunoglobulin G (PRR 13.4) |
| 1395 | Hip Surgery | 5,247 | 135 | Upadacitinib (PRR 16.2) |
| 1396 | Product Size Issue | 5,247 | 61 | Loperamide Hydrochloride And Dimethicone (PRR 62.0) |
| 1397 | Behaviour Disorder | 5,237 | 175 | Brivaracetam (PRR 53.3) |
| 1398 | Nystagmus | 5,237 | 196 | Phenytoin (PRR 73.3) |
| 1399 | Gastrointestinal Motility Disorder | 5,233 | 207 | Linaclotide (PRR 26.2) |
| 1400 | Product Residue Present | 5,233 | 92 | Levodopa (PRR 207.1) |
| 1401 | On And Off Phenomenon | 5,197 | 61 | Levodopa (PRR 116.0) |
| 1402 | Polyarthritis | 5,184 | 192 | Anakinra (PRR 130.9) |
| 1403 | Serum Ferritin Increased | 5,182 | 165 | Deferasirox (PRR 230.9) |
| 1404 | Aplastic Anaemia | 5,175 | 313 | Micafungin Sodium (PRR 113.1) |
| 1405 | Blood Lactic Acid Increased | 5,173 | 280 | Zidovudine (PRR 87.7) |
| 1406 | Stomach Discomfort | 5,169 | 78 | Atomoxetine Hydrochloride (PRR 38.8) |
| 1407 | Sensitivity To Weather Change | 5,166 | 155 | Tofacitinib (PRR 46.7) |
| 1408 | Catatonia | 5,148 | 153 | Haloperidol Lactate (PRR 80.0) |
| 1409 | Failure To Thrive | 5,144 | 403 | Dronabinol (PRR 31.1) |
| 1410 | Tonsillitis | 5,143 | 119 | Canakinumab (PRR 15.5) |
| 1411 | Skin Necrosis | 5,139 | 253 | Febuxostat Tablets 40 Mg (PRR 60.7) |
| 1412 | Compression Fracture | 5,138 | 311 | Romosozumab-Aqqg (PRR 55.3) |
| 1413 | Varicose Vein | 5,124 | 227 | Ado-Trastuzumab Emtansine (PRR 20.9) |
| 1414 | Cerebral Ischaemia | 5,124 | 281 | Alteplase (PRR 13.1) |
| 1415 | Malabsorption | 5,124 | 155 | Olmesartan Medoxomil (PRR 89.9) |
| 1416 | Periorbital Oedema | 5,120 | 132 | Avapritinib (PRR 61.9) |
| 1417 | Peripheral Vascular Disorder | 5,119 | 299 | Nilotinib (PRR 31.5) |
| 1418 | Foetal Death | 5,117 | 202 | Dolutegravir Sodium (PRR 148.7) |
| 1419 | Benign Prostatic Hyperplasia | 5,113 | 436 | Acetylcysteine (PRR 56.7) |
| 1420 | Increased Upper Airway Secretion | 5,110 | 140 | Salmeterol Xinafoate (PRR 21.9) |
| 1421 | Trismus | 5,101 | 162 | Ziprasidone (PRR 16.9) |
| 1422 | Partial Seizures | 5,091 | 171 | Brivaracetam (PRR 94.1) |
| 1423 | Intermenstrual Bleeding | 5,085 | 40 | Copper (PRR 73.3) |
| 1424 | Femoral Neck Fracture | 5,065 | 188 | Romosozumab-Aqqg (PRR 35.9) |
| 1425 | Phlebitis | 5,059 | 186 | Iron Sucrose (PRR 18.3) |
| 1426 | Cachexia | 5,054 | 295 | Abacavir Sulfate (PRR 25.2) |
| 1427 | Endocarditis | 5,052 | 259 | Gentamicin (PRR 34.1) |
| 1428 | Electrocardiogram Qrs Complex Prolonged | 5,049 | 174 | Bupropion (PRR 45.2) |
| 1429 | Toe Amputation | 5,040 | 57 | Canagliflozin (PRR 535.9) |
| 1430 | Colorectal Cancer Stage Iii | 5,037 | 2 | Ranitidine Hydrochloride (PRR 19.0) |
| 1431 | Ammonia Increased | 5,035 | 151 | Rifaximin (PRR 202.2) |
| 1432 | Injection Site Discharge | 5,031 | 68 | Fremanezumab-Vfrm (PRR 46.5) |
| 1433 | Dysphoria | 5,021 | 116 | Duloxetine Hydrochloride (PRR 96.3) |
| 1434 | Petit Mal Epilepsy | 5,019 | 106 | Brivaracetam (PRR 72.7) |
| 1435 | Dyslipidaemia | 5,016 | 380 | Abacavir Sulfate (PRR 42.6) |
| 1436 | Activated Partial Thromboplastin Time Prolonged | 5,015 | 349 | Phytonadione (PRR 77.2) |
| 1437 | Drug Tolerance | 5,013 | 246 | Cortisone Acetate (PRR 78.4) |
| 1438 | Pathological Fracture | 5,013 | 247 | Risedronate Sodium (PRR 34.8) |
| 1439 | Product Colour Issue | 5,001 | 69 | Icosapent Ethyl (PRR 112.5) |
| 1440 | Coronary Arterial Stent Insertion | 4,995 | 103 | Ranolazine (PRR 37.8) |
| 1441 | Dermatitis Exfoliative | 4,992 | 194 | Rifampicin (PRR 24.2) |
| 1442 | Drug Delivery System Malfunction | 4,990 | 32 | Peginterferon Beta-1A (PRR 161.9) |
| 1443 | Erysipelas | 4,983 | 210 | Pemetrexed (PRR 14.2) |
| 1444 | Vulvovaginal Pruritus | 4,983 | 61 | Miconazole Nitrate (PRR 336.3) |
| 1445 | Vein Disorder | 4,981 | 124 | Natalizumab (PRR 16.1) |
| 1446 | Coronary Artery Stenosis | 4,980 | 254 | Ticagrelor (PRR 23.6) |
| 1447 | Multiple Drug Overdose | 4,969 | 114 | Derma Foam Excel Hand Sanitizer (PRR 86.0) |
| 1448 | Klebsiella Infection | 4,958 | 284 | Valganciclovir Hydrochloride Powder, (PRR 47.4) |
| 1449 | Post Transplant Lymphoproliferative Disorder | 4,955 | 99 | Tacrolimus Ointment 0.1% (PRR 233.7) |
| 1450 | Expired Drug Administered | 4,955 | 65 | Nicotine Polacrilex (PRR 13.8) |
| 1451 | Immune Reconstitution Inflammatory Syndrome | 4,941 | 130 | Efavirenz (PRR 155.0) |
| 1452 | Aneurysm | 4,937 | 155 | Valsartan And Hydrochlorothiazide (PRR 6.9) |
| 1453 | Hyperammonaemia | 4,930 | 180 | Valproic Acid (PRR 95.6) |
| 1454 | Application Site Swelling | 4,930 | 38 | Nicotine (PRR 79.2) |
| 1455 | Product Solubility Abnormal | 4,928 | 47 | Cholestyramine (PRR 64.8) |
| 1456 | Small For Dates Baby | 4,921 | 135 | Zidovudine (PRR 45.2) |
| 1457 | Hepatic Enzyme Abnormal | 4,916 | 191 | Desoximetasone (PRR 18.7) |
| 1458 | Diabetic Neuropathy | 4,914 | 309 | Ziprasidone Mesylate (PRR 49.7) |
| 1459 | Abdominal Tenderness | 4,903 | 352 | Bleomycin Sulfate (PRR 13.2) |
| 1460 | Protein Urine Present | 4,902 | 202 | Alemtuzumab (PRR 32.5) |
| 1461 | Hypernatraemia | 4,899 | 323 | Tolvaptan (PRR 114.9) |
| 1462 | Staphylococcal Sepsis | 4,894 | 328 | Anti-Thymocyte Globulin (Rabbit) (PRR 35.8) |
| 1463 | Sprue-Like Enteropathy | 4,894 | 31 | Olmesartan Medoxomil (PRR 1,419.6) |
| 1464 | Food Craving | 4,891 | 96 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 107.3) |
| 1465 | Application Site Burn | 4,888 | 37 | Buprenorphine (PRR 37.2) |
| 1466 | Heparin-Induced Thrombocytopenia | 4,884 | 118 | Heparin Sodium (PRR 533.2) |
| 1467 | Injection Site Inflammation | 4,878 | 76 | Interferon Beta-1B (PRR 15.6) |
| 1468 | Toxic Encephalopathy | 4,872 | 219 | Metronidazole Topical (PRR 64.8) |
| 1469 | Fluid Intake Reduced | 4,871 | 178 | Palivizumab (PRR 21.7) |
| 1470 | Breath Sounds Abnormal | 4,869 | 426 | Ciclesonide (PRR 126.3) |
| 1471 | Renal Cell Carcinoma | 4,869 | 92 | Sunitinib Malate (PRR 132.3) |
| 1472 | Mucous Stools | 4,860 | 119 | Vedolizumab (PRR 89.5) |
| 1473 | Haemorrhoidal Haemorrhage | 4,855 | 195 | Rivaroxaban (PRR 23.0) |
| 1474 | Foot Operation | 4,854 | 180 | Cortisone Acetate (PRR 34.7) |
| 1475 | Gastrointestinal Sounds Abnormal | 4,854 | 121 | Orlistat (PRR 15.2) |
| 1476 | Venoocclusive Liver Disease | 4,854 | 176 | Busulfan (PRR 290.7) |
| 1477 | Pancreatic Disorder | 4,854 | 123 | Pancrelipase (PRR 46.2) |
| 1478 | Incorrect Dosage Administered | 4,846 | 86 | Apalutamide (PRR 24.1) |
| 1479 | Organising Pneumonia | 4,843 | 200 | Valganciclovir Hydrochloride Powder, (PRR 18.2) |
| 1480 | Inflammatory Marker Increased | 4,840 | 247 | Anakinra (PRR 20.8) |
| 1481 | Aphagia | 4,820 | 76 | Sorafenib (PRR 24.9) |
| 1482 | Faecal Incontinence | 4,814 | 170 | Orlistat (PRR 44.9) |
| 1483 | Product Delivery Mechanism Issue | 4,800 | 41 | Alirocumab (PRR 105.5) |
| 1484 | Stillbirth | 4,796 | 90 | Lopinavir And Ritonavir (PRR 67.5) |
| 1485 | Finger Deformity | 4,786 | 157 | Chlorhexidine Gluconate (PRR 130.8) |
| 1486 | Enterococcal Infection | 4,779 | 296 | Basiliximab (PRR 59.7) |
| 1487 | Humerus Fracture | 4,779 | 209 | Alendronate Sodium (PRR 17.4) |
| 1488 | Medication Residue Present | 4,777 | 49 | Sitagliptin And Metformin Hydrochloride (PRR 14.3) |
| 1489 | Nasal Polyps | 4,762 | 155 | Ciclesonide (PRR 141.2) |
| 1490 | Guillain-Barre Syndrome | 4,760 | 180 | Busulfan (PRR 15.5) |
| 1491 | Kidney Transplant Rejection | 4,758 | 135 | Basiliximab (PRR 344.2) |
| 1492 | Rash Vesicular | 4,754 | 262 | Pseudoephedrine Hydrochloride (PRR 61.9) |
| 1493 | Tumour Marker Increased | 4,748 | 89 | Rucaparib (PRR 135.9) |
| 1494 | Hormone Level Abnormal | 4,747 | 95 | Octreotide Acetate (PRR 21.1) |
| 1495 | Subcutaneous Abscess | 4,736 | 182 | Minocycline (PRR 19.4) |
| 1496 | Hypervolaemia | 4,736 | 354 | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 94.0) |
| 1497 | Spinal Column Stenosis | 4,725 | 254 | Alendronate Sodium (PRR 22.7) |
| 1498 | Viral Upper Respiratory Tract Infection | 4,725 | 155 | Methylprednisolone Acetate (PRR 35.7) |
| 1499 | Vulvovaginal Pain | 4,719 | 40 | Miconazole Nitrate (PRR 641.8) |
| 1500 | Pulse Absent | 4,709 | 192 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 39.2) |
| 1501 | Endometriosis | 4,708 | 131 | Leuprolide Acetate (PRR 52.4) |
| 1502 | Suspected Suicide | 4,706 | 153 | Ethyl Alcohol (PRR 113.5) |
| 1503 | Chronic Lymphocytic Leukaemia | 4,706 | 79 | Venetoclax (PRR 65.9) |
| 1504 | Limb Operation | 4,703 | 106 | Upadacitinib (PRR 19.1) |
| 1505 | Cardiac Tamponade | 4,702 | 167 | Dabigatran Etexilate Mesylate (PRR 27.5) |
| 1506 | Hypovolaemic Shock | 4,700 | 238 | Fondaparinux Sodium (PRR 23.7) |
| 1507 | Sarcoidosis | 4,689 | 180 | Ciclesonide (PRR 62.0) |
| 1508 | Product Temperature Excursion Issue | 4,685 | 72 | Brentuximab Vedotin (PRR 41.6) |
| 1509 | Pre-Eclampsia | 4,676 | 136 | Labetalol (PRR 83.7) |
| 1510 | Multiple Myeloma | 4,669 | 101 | Thalidomide (PRR 127.0) |
| 1511 | Non-Small Cell Lung Cancer | 4,668 | 84 | Crizotinib (PRR 105.2) |
| 1512 | Blood Prolactin Increased | 4,664 | 64 | Paliperidone Palmitate (PRR 162.6) |
| 1513 | Vaginal Infection | 4,650 | 149 | Copper (PRR 33.5) |
| 1514 | Tibia Fracture | 4,648 | 126 | Emtricitabine And Tenofovir Alafenamide (PRR 24.8) |
| 1515 | Gastrointestinal Toxicity | 4,647 | 184 | Tofacitinib Citrate (PRR 39.9) |
| 1516 | Gestational Diabetes | 4,642 | 151 | Misoprostol (PRR 37.0) |
| 1517 | Colitis Microscopic | 4,632 | 143 | Dorzolamide Hydrochloride And Timolol Maleate (PRR 45.7) |
| 1518 | Yellow Skin | 4,629 | 84 | Sunitinib Malate (PRR 91.0) |
| 1519 | Skin Tightness | 4,628 | 83 | Epoetin Alfa (PRR 60.4) |
| 1520 | Umbilical Hernia | 4,624 | 142 | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 20.0) |
| 1521 | Intercepted Medication Error | 4,617 | 51 | Leuprolide Acetate (PRR 86.7) |
| 1522 | Colorectal Cancer Stage Iv | 4,617 | 3 | Ranitidine Hydrochloride (PRR 15.9) |
| 1523 | Nephrogenic Anaemia | 4,614 | 594 | Esomeprazole Magnesium (PRR 151.0) |
| 1524 | Skin Abrasion | 4,614 | 350 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 20.0) |
| 1525 | Performance Status Decreased | 4,613 | 171 | Ado-Trastuzumab Emtansine (PRR 16.2) |
| 1526 | Gastritis Erosive | 4,612 | 198 | Olmesartan Medoxomil (PRR 25.9) |
| 1527 | Pregnancy With Implant Contraceptive | 4,597 | 11 | Etonogestrel (PRR 1,155.0) |
| 1528 | Feeling Of Despair | 4,591 | 167 | Paroxetine Hydrochloride Hemihydrate (PRR 15.7) |
| 1529 | Synovial Cyst | 4,583 | 224 | Methylprednisolone Acetate (PRR 116.1) |
| 1530 | Arthritis Infective | 4,575 | 210 | Methylprednisolone Acetate (PRR 25.8) |
| 1531 | Blood Pressure Diastolic Increased | 4,575 | 265 | Infliximab-Dyyb (PRR 63.7) |
| 1532 | Rosacea | 4,573 | 143 | Brimonidine Tartrate (PRR 48.7) |
| 1533 | Localised Oedema | 4,571 | 140 | Riociguat (PRR 18.2) |
| 1534 | Chronic Myeloid Leukaemia | 4,568 | 47 | Nilotinib (PRR 155.8) |
| 1535 | Ischaemia | 4,566 | 176 | Testosterone Cypionate (PRR 66.6) |
| 1536 | Blood Cholesterol Abnormal | 4,561 | 159 | Olanzapine Pamoate (PRR 45.7) |
| 1537 | Acute Graft Versus Host Disease | 4,558 | 118 | Busulfan (PRR 292.1) |
| 1538 | Bundle Branch Block Right | 4,555 | 296 | Atropine (PRR 14.4) |
| 1539 | Ear Disorder | 4,544 | 157 | Valproate Sodium (PRR 15.5) |
| 1540 | Drug Effect Delayed | 4,538 | 56 | Loratadine And Pseudoephedrine Sulfate (PRR 48.1) |
| 1541 | Disease Complication | 4,538 | 123 | Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose (PRR 36.3) |
| 1542 | Renal Function Test Abnormal | 4,532 | 203 | Rucaparib (PRR 57.5) |
| 1543 | Dyspareunia | 4,530 | 25 | Copper (PRR 147.9) |
| 1544 | Weight Loss Poor | 4,507 | 30 | Liraglutide (PRR 49.2) |
| 1545 | Abdominal Hernia | 4,505 | 187 | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 20.5) |
| 1546 | Blood Thyroid Stimulating Hormone Decreased | 4,492 | 87 | Alemtuzumab (PRR 50.1) |
| 1547 | Drug Level Above Therapeutic | 4,488 | 188 | Infliximab-Dyyb (PRR 131.0) |
| 1548 | Lumbar Vertebral Fracture | 4,482 | 141 | Romosozumab-Aqqg (PRR 28.6) |
| 1549 | Papilloedema | 4,475 | 129 | Minocycline (PRR 21.8) |
| 1550 | Eye Operation | 4,467 | 99 | Carboxymethylcellulose Sodium (PRR 37.3) |
| 1551 | Blood Pressure Systolic Decreased | 4,464 | 215 | Riociguat (PRR 33.0) |
| 1552 | Injection Site Papule | 4,463 | 21 | Adalimumab (PRR 70.5) |
| 1553 | Vascular Device Infection | 4,457 | 318 | Teduglutide (PRR 553.3) |
| 1554 | Therapeutic Product Effect Delayed | 4,450 | 109 | Rimegepant Sulfate (PRR 49.8) |
| 1555 | Haemoglobin Increased | 4,445 | 214 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 45.2) |
| 1556 | Brain Neoplasm Malignant | 4,441 | 39 | Ranitidine (PRR 25.9) |
| 1557 | Urinary Tract Disorder | 4,440 | 178 | Dutasteride (PRR 118.2) |
| 1558 | Urine Abnormality | 4,427 | 153 | Dimenhydrinate (PRR 121.8) |
| 1559 | Immune Thrombocytopenia | 4,416 | 197 | Alemtuzumab (PRR 80.9) |
| 1560 | Meningitis Aseptic | 4,416 | 150 | Human Immunoglobulin G (PRR 49.3) |
| 1561 | Wheelchair User | 4,409 | 157 | Anakinra (PRR 57.4) |
| 1562 | Intentional Device Misuse | 4,402 | 36 | Budesonide And Formoterol Fumarate Dihydrate (PRR 89.9) |
| 1563 | Haemorrhagic Anaemia | 4,401 | 204 | Dabigatran Etexilate Mesylate (PRR 112.7) |
| 1564 | Physical Disability | 4,397 | 105 | Divalproex Sodium (PRR 62.9) |
| 1565 | Iron Deficiency | 4,389 | 361 | Phytonadione (PRR 74.9) |
| 1566 | Catheterisation Cardiac | 4,384 | 131 | Ranolazine (PRR 47.0) |
| 1567 | Rhinitis Allergic | 4,384 | 344 | Liothyronine Sodium (PRR 153.1) |
| 1568 | Blood Creatine Increased | 4,384 | 242 | Felodipine Extended-Release Tablets (PRR 20.6) |
| 1569 | Ileus Paralytic | 4,384 | 225 | Itraconazole (PRR 28.9) |
| 1570 | Ligament Rupture | 4,372 | 97 | Ciprofloxacin Hydrochloride And Hydrocortisone (PRR 7.4) |
| 1571 | Abdominal Abscess | 4,359 | 172 | Acetylcysteine (PRR 22.0) |
| 1572 | Gingival Swelling | 4,350 | 109 | Exemestane (PRR 16.6) |
| 1573 | Tongue Discolouration | 4,350 | 89 | Chlorhexidine Gluconate (PRR 22.2) |
| 1574 | Vulvovaginal Discomfort | 4,348 | 32 | Miconazole Nitrate (PRR 282.0) |
| 1575 | Pulmonary Function Test Decreased | 4,343 | 119 | Lumacaftor And Ivacaftor (PRR 244.2) |
| 1576 | Dysphemia | 4,329 | 169 | Cenobamate (PRR 11.6) |
| 1577 | Melanocytic Naevus | 4,328 | 127 | Vemurafenib (PRR 56.6) |
| 1578 | Onychomycosis | 4,323 | 271 | Pseudoephedrine Hydrochloride (PRR 229.4) |
| 1579 | Cytomegalovirus Viraemia | 4,319 | 184 | Valganciclovir Hydrochloride Powder, (PRR 278.4) |
| 1580 | Tooth Injury | 4,318 | 60 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate (PRR 1,942.4) |
| 1581 | Bone Cancer | 4,313 | 67 | Ribociclib (PRR 18.0) |
| 1582 | Rheumatic Fever | 4,312 | 202 | Desoximetasone (PRR 2,794.8) |
| 1583 | Monoplegia | 4,311 | 89 | Bleomycin Sulfate (PRR 15.1) |
| 1584 | Atrioventricular Block First Degree | 4,303 | 259 | Digoxin (PRR 23.6) |
| 1585 | Diverticulum Intestinal | 4,300 | 348 | Olmesartan Medoxomil (PRR 104.0) |
| 1586 | Immobile | 4,294 | 99 | Risedronate Sodium (PRR 17.4) |
| 1587 | Chapped Lips | 4,289 | 95 | Isotretinoin (PRR 55.9) |
| 1588 | Staphylococcal Bacteraemia | 4,278 | 287 | Daptomycin (PRR 60.6) |
| 1589 | Ocular Icterus | 4,274 | 110 | Atazanavir (PRR 34.7) |
| 1590 | Paronychia | 4,271 | 113 | Panitumumab (PRR 208.6) |
| 1591 | Tearfulness | 4,266 | 135 | Atazanavir (PRR 55.3) |
| 1592 | Hepatic Lesion | 4,264 | 208 | Octreotide Acetate (PRR 53.9) |
| 1593 | Alcoholism | 4,262 | 87 | Naltrexone (PRR 569.7) |
| 1594 | Metastatic Neoplasm | 4,256 | 127 | Ado-Trastuzumab Emtansine (PRR 15.8) |
| 1595 | Lung Neoplasm | 4,244 | 194 | Abacavir Sulfate (PRR 13.2) |
| 1596 | Intervertebral Disc Disorder | 4,241 | 211 | Bleomycin Sulfate (PRR 15.3) |
| 1597 | Tension Headache | 4,241 | 166 | Felodipine Extended-Release Tablets (PRR 187.1) |
| 1598 | Left Ventricular Hypertrophy | 4,230 | 385 | Captopril (PRR 26.9) |
| 1599 | Poor Peripheral Circulation | 4,222 | 103 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 14.2) |
| 1600 | Hepatic Pain | 4,221 | 120 | Octreotide Acetate (PRR 25.5) |
| 1601 | Purulent Discharge | 4,219 | 185 | Ketoprofen (PRR 24.8) |
| 1602 | Abnormal Sensation In Eye | 4,217 | 60 | Cenegermin-Bkbj (PRR 35.8) |
| 1603 | Bundle Branch Block Left | 4,214 | 275 | Digoxin (PRR 20.5) |
| 1604 | Cytomegalovirus Infection Reactivation | 4,213 | 149 | Thiotepa (PRR 243.8) |
| 1605 | Aortic Valve Incompetence | 4,212 | 292 | Captopril (PRR 21.3) |
| 1606 | Pulmonary Tuberculosis | 4,210 | 118 | Pyrazinamide (PRR 132.7) |
| 1607 | Abscess Limb | 4,210 | 239 | Canagliflozin (PRR 21.3) |
| 1608 | Uterine Haemorrhage | 4,204 | 35 | Misoprostol (PRR 38.3) |
| 1609 | Cardiac Failure Chronic | 4,200 | 177 | Eplerenone (PRR 112.5) |
| 1610 | Throat Cancer | 4,197 | 28 | Ranitidine Hydrochloride (PRR 32.5) |
| 1611 | Escherichia Urinary Tract Infection | 4,194 | 285 | Basiliximab (PRR 26.1) |
| 1612 | Lip Oedema | 4,190 | 73 | Amoxicillin (PRR 17.3) |
| 1613 | Erection Increased | 4,180 | 15 | Sildenafil Citrate (PRR 425.1) |
| 1614 | Incorrect Drug Administration Rate | 4,173 | 154 | Human Immunoglobulin G (PRR 94.3) |
| 1615 | Congestive Cardiomyopathy | 4,173 | 185 | Eplerenone (PRR 26.1) |
| 1616 | Muscle Fatigue | 4,172 | 112 | Ravulizumab (PRR 17.9) |
| 1617 | Device Operational Issue | 4,170 | 23 | Insulin Glargine (PRR 76.1) |
| 1618 | Accidental Exposure | 4,170 | 37 | Epinephrine (PRR 32.6) |
| 1619 | Shoulder Operation | 4,160 | 96 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 27.0) |
| 1620 | Therapeutic Response Unexpected With Drug Substitution | 4,158 | 39 | Extended Phenytoin Sodium (PRR 25.6) |
| 1621 | Hordeolum | 4,156 | 146 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 31.5) |
| 1622 | Hallucinations, Mixed | 4,155 | 175 | Pimavanserin Tartrate (PRR 34.9) |
| 1623 | Intestinal Stenosis | 4,154 | 33 | Vedolizumab (PRR 31.8) |
| 1624 | Tongue Discomfort | 4,154 | 114 | Cabozantinib (PRR 25.0) |
| 1625 | Sleep Terror | 4,152 | 132 | Felodipine Extended-Release Tablets (PRR 187.7) |
| 1626 | Febrile Bone Marrow Aplasia | 4,132 | 176 | Pegaspargase (PRR 332.9) |
| 1627 | Suicidal Behaviour | 4,128 | 113 | Varenicline Tartrate (PRR 23.2) |
| 1628 | Self-Injurious Ideation | 4,128 | 126 | Atomoxetine Hydrochloride (PRR 15.1) |
| 1629 | Thyroid Function Test Abnormal | 4,122 | 59 | Liothyronine Sodium (PRR 35.3) |
| 1630 | Pulseless Electrical Activity | 4,119 | 218 | Rocuronium Bromide (PRR 48.0) |
| 1631 | Aortic Dissection | 4,115 | 67 | Romosozumab-Aqqg (PRR 14.7) |
| 1632 | Red Cell Distribution Width Increased | 4,104 | 331 | Alemtuzumab (PRR 55.7) |
| 1633 | Onychomadesis | 4,101 | 201 | Pseudoephedrine Hydrochloride (PRR 323.5) |
| 1634 | Gastrointestinal Perforation | 4,099 | 97 | Bevacizumab (PRR 60.5) |
| 1635 | Attention Deficit Hyperactivity Disorder | 4,098 | 150 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 31.7) |
| 1636 | Hyperpyrexia | 4,092 | 139 | Bleomycin Sulfate (PRR 19.9) |
| 1637 | Application Site Exfoliation | 4,090 | 31 | Minoxidil Foam 5% (Womens) (PRR 94.8) |
| 1638 | Social Problem | 4,089 | 62 | Dalfampridine (PRR 58.4) |
| 1639 | Extravasation | 4,086 | 78 | Iohexol (PRR 84.4) |
| 1640 | Leg Amputation | 4,081 | 72 | Canagliflozin (PRR 167.3) |
| 1641 | Demyelination | 4,067 | 103 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 24.0) |
| 1642 | Goitre | 4,057 | 158 | Methimazole (PRR 33.1) |
| 1643 | Self-Medication | 4,055 | 84 | Testosterone (PRR 11.3) |
| 1644 | Peripheral Arterial Occlusive Disease | 4,050 | 143 | Nilotinib (PRR 79.4) |
| 1645 | Hyperuricaemia | 4,048 | 291 | Febuxostat Tablets 40 Mg (PRR 39.1) |
| 1646 | Anaphylactoid Reaction | 4,043 | 91 | Iron Sucrose (PRR 26.2) |
| 1647 | Peripheral Ischaemia | 4,041 | 144 | Norepinephrine Bitartrate (PRR 48.0) |
| 1648 | International Normalised Ratio Decreased | 4,034 | 117 | Warfarin Sodium (PRR 105.1) |
| 1649 | Spinal Stenosis | 4,030 | 232 | Methylprednisolone Acetate (PRR 59.4) |
| 1650 | Arthritis Bacterial | 4,028 | 152 | Methylprednisolone Acetate (PRR 46.6) |
| 1651 | Homicidal Ideation | 4,020 | 120 | Varenicline Tartrate (PRR 41.8) |
| 1652 | Candidiasis | 4,019 | 218 | Salmeterol Xinafoate (PRR 28.6) |
| 1653 | Application Site Discolouration | 4,019 | 44 | Glycerin, Lidocaine (PRR 30.6) |
| 1654 | Trigger Finger | 4,006 | 134 | Anastrozole (PRR 37.2) |
| 1655 | Recurrent Cancer | 4,000 | 104 | Niraparib (PRR 224.8) |
| 1656 | Low Turnover Osteopathy | 3,999 | 25 | Alendronate Sodium (PRR 3,302.6) |
| 1657 | Organ Failure | 3,998 | 87 | Drospirenone And Ethinyl Estradiol (PRR 19.7) |
| 1658 | Foreign Body | 3,994 | 49 | Loperamide Hydrochloride And Dimethicone (PRR 42.0) |
| 1659 | Enuresis | 3,987 | 146 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 100.3) |
| 1660 | Creatinine Renal Clearance Decreased | 3,977 | 183 | Quinapril Hydrochloride (PRR 394.1) |
| 1661 | Trigeminal Neuralgia | 3,973 | 93 | Carbamazepine (PRR 47.8) |
| 1662 | Cystitis Haemorrhagic | 3,967 | 140 | Busulfan (PRR 163.2) |
| 1663 | Vitamin B12 Deficiency | 3,966 | 186 | Methylprednisolone Acetate (PRR 22.5) |
| 1664 | Spinal Fusion Surgery | 3,965 | 199 | Diclofenac Potassium, Film Coated (PRR 75.8) |
| 1665 | Skin Papilloma | 3,964 | 107 | Vemurafenib (PRR 108.6) |
| 1666 | Intracranial Aneurysm | 3,959 | 84 | Dimenhydrinate (PRR 10.4) |
| 1667 | Azotaemia | 3,957 | 262 | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 24.0) |
| 1668 | Gallbladder Operation | 3,956 | 74 | Risankizumab-Rzaa (PRR 11.2) |
| 1669 | Muscle Haemorrhage | 3,955 | 47 | Fondaparinux Sodium (PRR 147.8) |
| 1670 | Fungal Skin Infection | 3,952 | 140 | Terbinafine Hydrochloride (PRR 23.3) |
| 1671 | Cerebral Atrophy | 3,948 | 243 | Valproic Acid (PRR 18.9) |
| 1672 | Obstruction | 3,945 | 144 | Teduglutide (PRR 82.4) |
| 1673 | Peripheral Venous Disease | 3,942 | 251 | Diclofenac Potassium, Film Coated (PRR 782.9) |
| 1674 | Patent Ductus Arteriosus | 3,939 | 122 | Paroxetine Hydrochloride (PRR 50.3) |
| 1675 | Euglycaemic Diabetic Ketoacidosis | 3,934 | 60 | Empagliflozin (PRR 330.9) |
| 1676 | Hyperphagia | 3,914 | 131 | Vortioxetine (PRR 54.8) |
| 1677 | Polydipsia | 3,908 | 130 | Tolvaptan (PRR 80.5) |
| 1678 | Testis Cancer | 3,907 | 3 | Ranitidine (PRR 28.1) |
| 1679 | Oesophageal Candidiasis | 3,902 | 232 | Pegaspargase (PRR 44.7) |
| 1680 | Blepharitis | 3,896 | 86 | Dorzolamide Hydrochloride And Timolol Maleate (PRR 33.5) |
| 1681 | Arteriospasm Coronary | 3,895 | 99 | Oxaliplatin (PRR 50.0) |
| 1682 | Oesophageal Pain | 3,894 | 117 | Dimenhydrinate (PRR 63.1) |
| 1683 | Suspected Counterfeit Product | 3,892 | 35 | Orlistat (PRR 23.6) |
| 1684 | Venous Thrombosis | 3,888 | 156 | Pegaspargase (PRR 44.9) |
| 1685 | Skin Odour Abnormal | 3,884 | 76 | Dapsone (PRR 11.1) |
| 1686 | Sensation Of Heaviness | 3,882 | 41 | Natalizumab (PRR 17.8) |
| 1687 | Cervix Carcinoma | 3,882 | 37 | Ranitidine Hydrochloride (PRR 22.6) |
| 1688 | Wound Secretion | 3,880 | 118 | Diltiazem Hydrochloride Extended-Release Tablets (PRR 15.2) |
| 1689 | Prostatomegaly | 3,876 | 156 | Finasteride (PRR 23.5) |
| 1690 | Vulvovaginal Mycotic Infection | 3,873 | 81 | Canagliflozin (PRR 23.2) |
| 1691 | Respiratory Acidosis | 3,872 | 199 | Sevoflurane (PRR 42.1) |
| 1692 | Epigastric Discomfort | 3,871 | 132 | Loperamide Hydrochloride Oral (PRR 32.6) |
| 1693 | Therapeutic Product Ineffective | 3,870 | 59 | Methylphenidate (PRR 24.8) |
| 1694 | Maternal Exposure During Breast Feeding | 3,869 | 88 | Certolizumab Pegol (PRR 45.4) |
| 1695 | Nail Discolouration | 3,865 | 88 | Hydroxyurea (PRR 14.2) |
| 1696 | Cardiopulmonary Failure | 3,864 | 146 | Sunitinib Malate (PRR 23.4) |
| 1697 | Exposure Via Breast Milk | 3,863 | 97 | Nicotine Polacrilex Mini (PRR 46.7) |
| 1698 | Oral Infection | 3,862 | 112 | Alendronate Sodium (PRR 35.1) |
| 1699 | Spinal Cord Compression | 3,859 | 141 | Bupivacaine (PRR 18.6) |
| 1700 | Procedural Haemorrhage | 3,858 | 49 | Copper (PRR 65.4) |
| 1701 | Viral Load Increased | 3,854 | 43 | Cabotegravir (PRR 327.0) |
| 1702 | Faeces Hard | 3,833 | 119 | Teduglutide (PRR 41.4) |
| 1703 | Idiopathic Pulmonary Fibrosis | 3,832 | 47 | Nintedanib (PRR 812.9) |
| 1704 | Pneumonia Fungal | 3,830 | 235 | Posaconazole Delayed-Release (PRR 79.9) |
| 1705 | Prostate Cancer Stage I | 3,827 | 2 | Ranitidine Hydrochloride (PRR 21.6) |
| 1706 | Muscle Rupture | 3,826 | 62 | Ciprofolxacin (PRR 15.8) |
| 1707 | Panic Disorder | 3,826 | 115 | Ziprasidone Mesylate (PRR 11.1) |
| 1708 | Gingival Disorder | 3,816 | 94 | Alendronate Sodium (PRR 25.3) |
| 1709 | Oesophageal Ulcer | 3,815 | 118 | Sucralfate Oral (PRR 20.2) |
| 1710 | Implant Site Pain | 3,812 | 6 | Etonogestrel (PRR 922.3) |
| 1711 | Rehabilitation Therapy | 3,808 | 85 | Carbidopa And Levodopa (PRR 31.5) |
| 1712 | Oesophageal Disorder | 3,808 | 84 | Esomeprazole Magnesium (PRR 11.9) |
| 1713 | Paranasal Sinus Hypersecretion | 3,794 | 122 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 33.6) |
| 1714 | Clavicle Fracture | 3,788 | 123 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate (PRR 20.9) |
| 1715 | Communication Disorder | 3,785 | 118 | Valproate Sodium (PRR 28.4) |
| 1716 | Tongue Oedema | 3,778 | 77 | Alteplase (PRR 27.3) |
| 1717 | Gastric Infection | 3,776 | 102 | Ado-Trastuzumab Emtansine (PRR 13.1) |
| 1718 | Loss Of Control Of Legs | 3,773 | 33 | Natalizumab (PRR 44.6) |
| 1719 | Conjunctival Haemorrhage | 3,769 | 86 | Ranibizumab (PRR 17.4) |
| 1720 | Therapeutic Product Effect Variable | 3,768 | 95 | Levodopa (PRR 163.6) |
| 1721 | Systemic Inflammatory Response Syndrome | 3,753 | 237 | Phenobarbital (PRR 26.5) |
| 1722 | Face Injury | 3,753 | 121 | Emicizumab (PRR 16.3) |
| 1723 | Rhinovirus Infection | 3,750 | 282 | Palivizumab (PRR 100.4) |
| 1724 | Thyroid Mass | 3,746 | 106 | Methimazole (PRR 17.1) |
| 1725 | Hepatic Necrosis | 3,734 | 167 | Icosapent Ethyl (PRR 25.8) |
| 1726 | Bone Density Abnormal | 3,725 | 52 | Romosozumab-Aqqg (PRR 216.9) |
| 1727 | Snoring | 3,724 | 255 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 58.5) |
| 1728 | Paranasal Sinus Discomfort | 3,718 | 206 | Mometasone (PRR 19.9) |
| 1729 | Protein Total Decreased | 3,716 | 221 | Dexamethasone Sodium Phosphate (PRR 14.4) |
| 1730 | Autoimmune Thyroiditis | 3,715 | 148 | Alemtuzumab (PRR 56.0) |
| 1731 | Impulsive Behaviour | 3,706 | 105 | Guanfacine (PRR 56.1) |
| 1732 | Chronic Sinusitis | 3,698 | 360 | Carboxymethylcellulose Sodium (PRR 140.0) |
| 1733 | Hepatic Cancer Stage Iv | 3,696 | 2 | Ranitidine Hydrochloride (PRR 11.8) |
| 1734 | Leukoencephalopathy | 3,693 | 139 | Cytarabine (PRR 38.3) |
| 1735 | Catheter Site Infection | 3,690 | 106 | Epoprostenol (PRR 155.0) |
| 1736 | Tendon Injury | 3,687 | 25 | Ciprofloxacin (PRR 22.1) |
| 1737 | Retinopathy | 3,687 | 73 | Encorafenib (PRR 26.5) |
| 1738 | Hyperacusis | 3,686 | 121 | Trimethoprim (PRR 15.5) |
| 1739 | Alcohol Use | 3,676 | 76 | Naltrexone (PRR 97.6) |
| 1740 | Maternal Exposure Timing Unspecified | 3,672 | 209 | Diclofenac Potassium, Film Coated (PRR 166.7) |
| 1741 | Throat Clearing | 3,671 | 83 | Sacubitril And Valsartan (PRR 130.2) |
| 1742 | Wound Haemorrhage | 3,664 | 61 | Fondaparinux Sodium (PRR 19.1) |
| 1743 | Viral Mutation Identified | 3,664 | 39 | Lamivudine Oral (PRR 674.7) |
| 1744 | Rectal Discharge | 3,662 | 11 | Orlistat (PRR 1,588.6) |
| 1745 | Chemotherapy | 3,657 | 73 | Pancrelipase (PRR 72.7) |
| 1746 | Hypomania | 3,640 | 132 | Abacavir Sulfate (PRR 106.6) |
| 1747 | Seborrhoea | 3,638 | 25 | Adapalene (PRR 86.5) |
| 1748 | Paradoxical Drug Reaction | 3,624 | 130 | Pyrazinamide (PRR 365.2) |
| 1749 | Amylase Increased | 3,616 | 149 | Sevoflurane (PRR 45.1) |
| 1750 | Carotid Artery Occlusion | 3,612 | 144 | Felodipine Extended-Release Tablets (PRR 224.9) |
| 1751 | Cardiac Dysfunction | 3,611 | 145 | Trastuzumab (PRR 37.4) |
| 1752 | Asthmatic Crisis | 3,609 | 52 | Mepolizumab (PRR 86.0) |
| 1753 | Ventricular Arrhythmia | 3,608 | 145 | Eplerenone (PRR 35.4) |
| 1754 | Food Intolerance | 3,606 | 109 | Avapritinib (PRR 14.4) |
| 1755 | Apparent Death | 3,605 | 58 | Canakinumab (PRR 189.9) |
| 1756 | Facial Bones Fracture | 3,605 | 107 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate (PRR 18.7) |
| 1757 | Thrombocytosis | 3,604 | 134 | Romiplostim (PRR 138.3) |
| 1758 | Scleroderma | 3,598 | 76 | Selexipag (PRR 36.5) |
| 1759 | Chronic Graft Versus Host Disease | 3,592 | 102 | Busulfan (PRR 289.3) |
| 1760 | Blood Phosphorus Decreased | 3,592 | 149 | Entecavir (PRR 25.1) |
| 1761 | Monocyte Count Increased | 3,591 | 199 | Clozapine (PRR 37.3) |
| 1762 | Frustration | 3,586 | 38 | Interferon Beta-1A (PRR 19.5) |
| 1763 | Spondylitis | 3,583 | 193 | Diclofenac Potassium, Film Coated (PRR 132.3) |
| 1764 | Liver Transplant | 3,575 | 78 | Rifaximin (PRR 47.7) |
| 1765 | Renal Transplant | 3,563 | 88 | Paricalcitol (PRR 72.9) |
| 1766 | Bone Lesion | 3,562 | 198 | Ribociclib (PRR 52.3) |
| 1767 | Freezing Phenomenon | 3,550 | 46 | Carbidopa And Levodopa (PRR 153.6) |
| 1768 | Prostate Cancer Stage Iv | 3,541 | 7 | Bicalutamide (PRR 15.2) |
| 1769 | Product Dispensing Issue | 3,531 | 54 | Brivaracetam (PRR 29.9) |
| 1770 | Haemorrhagic Diathesis | 3,527 | 113 | Ampicillin (PRR 21.6) |
| 1771 | Heart Disease Congenital | 3,525 | 72 | Paroxetine Hydrochloride (PRR 42.6) |
| 1772 | Maculopathy | 3,525 | 69 | Ranibizumab (PRR 29.0) |
| 1773 | Cutaneous Vasculitis | 3,524 | 143 | Anakinra (PRR 43.1) |
| 1774 | Pyoderma Gangrenosum | 3,521 | 66 | Adalimumab-Fkjp (PRR 59.4) |
| 1775 | Conjunctival Hyperaemia | 3,520 | 87 | Brinzolamide (PRR 33.8) |
| 1776 | Lung Transplant | 3,519 | 59 | Epoprostenol (PRR 122.6) |
| 1777 | Haemorrhage Subcutaneous | 3,515 | 77 | Fondaparinux Sodium (PRR 25.1) |
| 1778 | Fibrin D Dimer Increased | 3,515 | 131 | Baricitinib (PRR 22.3) |
| 1779 | Optic Ischaemic Neuropathy | 3,512 | 35 | Oral Semaglutide (PRR 61.9) |
| 1780 | Facial Paresis | 3,511 | 57 | Onabotulinumtoxina (PRR 97.7) |
| 1781 | Glossitis | 3,510 | 97 | Cabozantinib (PRR 24.3) |
| 1782 | Appendicectomy | 3,509 | 90 | Alendronate Sodium (PRR 23.5) |
| 1783 | Neonatal Respiratory Distress Syndrome | 3,506 | 107 | Ampicillin (PRR 52.7) |
| 1784 | Bronchiolitis | 3,499 | 64 | Palivizumab (PRR 775.2) |
| 1785 | Muscle Contractions Involuntary | 3,498 | 83 | Dimenhydrinate (PRR 11.2) |
| 1786 | Bone Erosion | 3,497 | 221 | Diclofenac Potassium, Film Coated (PRR 531.8) |
| 1787 | Jaundice Cholestatic | 3,495 | 181 | Abacavir Sulfate (PRR 100.4) |
| 1788 | Hangover | 3,492 | 92 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 47.3) |
| 1789 | Thrombophlebitis | 3,486 | 107 | Etonogestrel And Ethinyl Estradiol (PRR 24.3) |
| 1790 | Thrombotic Thrombocytopenic Purpura | 3,486 | 118 | Acetylcysteine (PRR 18.5) |
| 1791 | Logorrhoea | 3,484 | 112 | Lisdexamfetamine Dimesylate (PRR 26.6) |
| 1792 | Immune-Mediated Enterocolitis | 3,480 | 64 | Ipilimumab (PRR 228.7) |
| 1793 | Necrotising Fasciitis | 3,476 | 156 | Canagliflozin (PRR 25.5) |
| 1794 | Depressive Symptom | 3,468 | 180 | Atazanavir (PRR 66.8) |
| 1795 | Carotid Artery Stenosis | 3,464 | 196 | Nilotinib (PRR 36.6) |
| 1796 | Product Contamination | 3,464 | 43 | Methylprednisolone Acetate (PRR 25.8) |
| 1797 | Embolic Stroke | 3,463 | 70 | Dabigatran Etexilate (PRR 35.1) |
| 1798 | Erythema Nodosum | 3,456 | 91 | Infliximab-Dyyb (PRR 75.6) |
| 1799 | Hyperreflexia | 3,454 | 163 | Lithium (PRR 24.8) |
| 1800 | Viith Nerve Paralysis | 3,453 | 52 | Drospirenone And Ethinyl Estradiol (PRR 11.1) |
| 1801 | Reproductive Complication Associated With Device | 3,450 | 4 | Copper (PRR 830,735.0) |
| 1802 | Type I Hypersensitivity | 3,449 | 76 | Amoxicillin (PRR 34.8) |
| 1803 | Difficulty In Walking | 3,445 | 81 | Calcium Gluconate (PRR 26.5) |
| 1804 | Neurodermatitis | 3,439 | 29 | Nemolizumab-Ilto (PRR 140.6) |
| 1805 | Aortic Stenosis | 3,438 | 290 | Phytonadione (PRR 59.9) |
| 1806 | Ear Pruritus | 3,436 | 81 | Oseltamivir Phosphate (PRR 54.6) |
| 1807 | International Normalised Ratio Abnormal | 3,428 | 51 | Warfarin Sodium (PRR 111.4) |
| 1808 | Bronchopneumonia | 3,427 | 123 | Palivizumab (PRR 16.0) |
| 1809 | Priapism | 3,423 | 74 | Haloperidol (PRR 29.5) |
| 1810 | Functional Gastrointestinal Disorder | 3,421 | 157 | Diclofenac Potassium, Film Coated (PRR 65.3) |
| 1811 | Tachyphrenia | 3,419 | 113 | Lurasidone Hydrochloride (PRR 27.5) |
| 1812 | Depression Suicidal | 3,416 | 82 | Atazanavir (PRR 70.2) |
| 1813 | Hypopnoea | 3,415 | 196 | Felodipine Extended-Release Tablets (PRR 91.5) |
| 1814 | Granuloma | 3,414 | 140 | Dimenhydrinate (PRR 37.9) |
| 1815 | Micturition Disorder | 3,414 | 88 | Epoetin Alfa (PRR 12.4) |
| 1816 | Pustular Psoriasis | 3,404 | 162 | Pseudoephedrine Hydrochloride (PRR 88.8) |
| 1817 | Wound Complication | 3,397 | 122 | Drs. Clotrimazole (PRR 22.0) |
| 1818 | Aplasia Pure Red Cell | 3,396 | 123 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 155.6) |
| 1819 | Carbohydrate Antigen 125 Increased | 3,396 | 57 | Niraparib (PRR 1,118.4) |
| 1820 | Dermatitis Exfoliative Generalised | 3,392 | 159 | Apalutamide (PRR 31.3) |
| 1821 | Cervical Vertebral Fracture | 3,392 | 89 | Doxepin Hydrochloride (PRR 11.7) |
| 1822 | Blood Creatinine Abnormal | 3,389 | 146 | Eculizumab (PRR 28.5) |
| 1823 | Sudden Cardiac Death | 3,384 | 62 | Methadone Hydrochloride (PRR 13.2) |
| 1824 | Hepatic Fibrosis | 3,373 | 115 | Zidovudine (PRR 37.3) |
| 1825 | Regurgitation | 3,373 | 63 | Esomeprazole Magnesium (PRR 19.5) |
| 1826 | B-Cell Lymphoma | 3,372 | 104 | Axicabtagene Ciloleucel (PRR 27.9) |
| 1827 | Clostridial Infection | 3,370 | 147 | Piperacillin Sodium And Tazobactam Sodium (PRR 18.9) |
| 1828 | Left Ventricular Failure | 3,369 | 159 | Selexipag (PRR 22.1) |
| 1829 | Intercepted Product Storage Error | 3,369 | 39 | Alteplase (PRR 115.4) |
| 1830 | Application Site Dryness | 3,369 | 20 | Minoxidil Foam 5% (Womens) (PRR 176.7) |
| 1831 | Autoimmune Haemolytic Anaemia | 3,366 | 129 | Alemtuzumab (PRR 61.1) |
| 1832 | Diabetic Retinopathy | 3,355 | 90 | Insulin Human (PRR 57.2) |
| 1833 | Neoplasm Recurrence | 3,353 | 119 | Thiotepa (PRR 35.7) |
| 1834 | Hepatic Cyst | 3,348 | 151 | Amiodarone Hydrochloride (PRR 17.9) |
| 1835 | Lung Carcinoma Cell Type Unspecified Stage Iv | 3,347 | 13 | Ranitidine Hydrochloride (PRR 13.1) |
| 1836 | Wound Dehiscence | 3,346 | 116 | Basiliximab (PRR 18.2) |
| 1837 | Tongue Ulceration | 3,344 | 80 | Asenapine Maleate (PRR 22.5) |
| 1838 | Therapeutic Agent Toxicity | 3,337 | 121 | Lithium Carbonate (PRR 186.5) |
| 1839 | Supraventricular Extrasystoles | 3,334 | 150 | Dofetilide (PRR 16.2) |
| 1840 | Cytolytic Hepatitis | 3,326 | 115 | Rifampicin (PRR 39.7) |
| 1841 | Plantar Fasciitis | 3,322 | 122 | Mometasone (PRR 46.2) |
| 1842 | Exposure During Breast Feeding | 3,317 | 44 | Nevirapine (PRR 90.3) |
| 1843 | Nuclear Magnetic Resonance Imaging Abnormal | 3,317 | 23 | Natalizumab (PRR 35.4) |
| 1844 | Anxiety Disorder | 3,316 | 167 | Asenapine Maleate (PRR 28.6) |
| 1845 | Cerebral Haematoma | 3,311 | 90 | Alteplase (PRR 53.9) |
| 1846 | Metastases To Spine | 3,308 | 129 | Ribociclib (PRR 75.9) |
| 1847 | Prostate Cancer Metastatic | 3,308 | 49 | Abiraterone (PRR 142.9) |
| 1848 | Oligohydramnios | 3,308 | 89 | Indomethacin (PRR 56.5) |
| 1849 | Bk Virus Infection | 3,306 | 131 | Anti-Thymocyte Globulin (Rabbit) (PRR 179.4) |
| 1850 | High Density Lipoprotein Decreased | 3,296 | 96 | Inclisiran (PRR 40.0) |
| 1851 | Suspected Covid-19 | 3,289 | 79 | Ravulizumab (PRR 31.5) |
| 1852 | Skin Weeping | 3,283 | 59 | Dupilumab (PRR 61.4) |
| 1853 | Device Kink | 3,281 | 29 | Etonogestrel (PRR 676.8) |
| 1854 | Peptic Ulcer | 3,278 | 125 | Olmesartan Medoxomil (PRR 35.0) |
| 1855 | Lyme Disease | 3,276 | 119 | Meperidine Hydrochloride (PRR 72.6) |
| 1856 | Electrocardiogram St Segment Elevation | 3,276 | 102 | Sevoflurane (PRR 38.8) |
| 1857 | Otitis Media | 3,269 | 133 | Dimenhydrinate (PRR 33.4) |
| 1858 | Thrombosis In Device | 3,268 | 48 | Prasugrel Hydrochloride (PRR 194.9) |
| 1859 | Nephritis | 3,266 | 82 | Atezolizumab (PRR 34.2) |
| 1860 | Oedema Mouth | 3,259 | 43 | Nicotine Polacrilex (PRR 12.4) |
| 1861 | Skin Injury | 3,257 | 51 | Ciprofloxacin Hydrochloride And Hydrocortisone (PRR 23.9) |
| 1862 | Immunosuppressant Drug Level Increased | 3,251 | 132 | Tacrolimus (PRR 368.4) |
| 1863 | Drug Rash With Eosinophilia And Systemic Symptoms | 3,248 | 90 | Rifampicin (PRR 62.6) |
| 1864 | Listless | 3,245 | 75 | Captopril (PRR 20.2) |
| 1865 | Hypoventilation | 3,242 | 96 | Rocuronium Bromide (PRR 48.7) |
| 1866 | Breast Enlargement | 3,241 | 55 | Risperidone (PRR 25.9) |
| 1867 | Potentiating Drug Interaction | 3,239 | 187 | Pegaspargase (PRR 41.4) |
| 1868 | Deafness Neurosensory | 3,235 | 170 | Methimazole (PRR 46.7) |
| 1869 | Attention Deficit/Hyperactivity Disorder | 3,230 | 73 | Atomoxetine Hydrochloride (PRR 42.5) |
| 1870 | Injection Site Infection | 3,229 | 51 | Interferon Beta-1B (PRR 51.7) |
| 1871 | Plasma Cell Myeloma Recurrent | 3,227 | 37 | Bortezomib (PRR 149.4) |
| 1872 | Expired Device Used | 3,226 | 17 | Somatropin (PRR 229.9) |
| 1873 | Lymphocyte Count Increased | 3,225 | 81 | Clozapine (PRR 25.7) |
| 1874 | Bacterial Sepsis | 3,223 | 202 | Thiotepa (PRR 54.7) |
| 1875 | Near Death Experience | 3,223 | 59 | Niraparib (PRR 13.3) |
| 1876 | Antinuclear Antibody Positive | 3,221 | 112 | Methylprednisolone Acetate (PRR 62.8) |
| 1877 | Multiple Drug Overdose Intentional | 3,220 | 75 | Derma Foam Excel Hand Sanitizer (PRR 97.3) |
| 1878 | Hepatic Neoplasm | 3,219 | 79 | Octreotide Acetate (PRR 76.7) |
| 1879 | Posture Abnormal | 3,209 | 91 | Rotigotine (PRR 25.5) |
| 1880 | Liver Abscess | 3,200 | 122 | Gentamicin Sulfate (PRR 29.0) |
| 1881 | Infusion Site Haemorrhage | 3,199 | 220 | Treprostinil (PRR 128.6) |
| 1882 | Polymenorrhoea | 3,189 | 27 | Etonogestrel (PRR 53.1) |
| 1883 | Loose Tooth | 3,189 | 93 | Chlorhexidine Gluconate (PRR 30.4) |
| 1884 | Stupor | 3,189 | 137 | Lithium Carbonate (PRR 24.7) |
| 1885 | Cushingoid | 3,188 | 191 | Methylprednisolone Acetate (PRR 65.2) |
| 1886 | Exposure To Toxic Agent | 3,180 | 49 | Acetaminophen Tablet Extended Release (PRR 92.1) |
| 1887 | Ventricular Hypokinesia | 3,178 | 182 | Norepinephrine (PRR 34.3) |
| 1888 | Portal Vein Thrombosis | 3,178 | 103 | Nevirapine (PRR 40.6) |
| 1889 | Vulvovaginal Dryness | 3,174 | 54 | Anastrozole (PRR 32.2) |
| 1890 | Drug Effect Increased | 3,167 | 38 | Lisdexamfetamine Dimesylate (PRR 38.2) |
| 1891 | Incorrect Disposal Of Product | 3,163 | 9 | Evolocumab (PRR 144.8) |
| 1892 | Skin Erosion | 3,152 | 66 | Sulfur (PRR 12.6) |
| 1893 | Orthopnoea | 3,150 | 193 | Metolazone (PRR 39.0) |
| 1894 | Pancreatic Carcinoma Stage Iv | 3,150 | 5 | Ranitidine (PRR 8.9) |
| 1895 | Pneumonia Viral | 3,144 | 199 | Ciclesonide (PRR 90.0) |
| 1896 | Non-Cardiac Chest Pain | 3,140 | 152 | Prasugrel Hydrochloride (PRR 15.8) |
| 1897 | Hepatitis B Reactivation | 3,137 | 111 | Lamivudine Oral (PRR 118.0) |
| 1898 | Investigation | 3,136 | 29 | Darbepoetin Alfa (PRR 71.5) |
| 1899 | Abdominal Adhesions | 3,132 | 49 | Adalimumab (PRR 19.6) |
| 1900 | Testicular Pain | 3,126 | 41 | Finasteride (PRR 97.8) |
| 1901 | Bladder Pain | 3,115 | 80 | Vibegron (PRR 22.7) |
| 1902 | Bile Duct Stone | 3,115 | 71 | Drospirenone And Ethinyl Estradiol (PRR 44.4) |
| 1903 | Electroencephalogram Abnormal | 3,115 | 100 | Valproate Sodium (PRR 43.8) |
| 1904 | Facet Joint Syndrome | 3,112 | 222 | Diclofenac Potassium, Film Coated (PRR 1,748.2) |
| 1905 | Breast Cancer Recurrent | 3,111 | 56 | Anastrozole (PRR 76.4) |
| 1906 | Respiratory Rate Decreased | 3,108 | 87 | Fentanyl Citrate (PRR 17.1) |
| 1907 | Family Stress | 3,099 | 20 | Metoclopramide (PRR 615.8) |
| 1908 | Blood Blister | 3,093 | 69 | Ibrutinib (PRR 18.8) |
| 1909 | Blood Creatinine Decreased | 3,090 | 143 | Dimenhydrinate (PRR 42.6) |
| 1910 | Prostate Cancer Stage Ii | 3,089 | 2 | Ranitidine Hydrochloride (PRR 18.0) |
| 1911 | Iridocyclitis | 3,086 | 60 | Faricimab (PRR 207.7) |
| 1912 | Eosinophilic Pneumonia | 3,084 | 62 | Daptomycin (PRR 398.4) |
| 1913 | Swollen Joint Count Increased | 3,079 | 189 | Desoximetasone (PRR 2,866.8) |
| 1914 | Faecal Calprotectin Increased | 3,077 | 71 | Infliximab-Dyyb (PRR 179.1) |
| 1915 | Infusion Site Pruritus | 3,077 | 220 | Human Immunoglobulin G (PRR 121.9) |
| 1916 | Polymyalgia Rheumatica | 3,075 | 80 | Sarilumab (PRR 53.6) |
| 1917 | Intracardiac Thrombus | 3,075 | 48 | Pegaspargase (PRR 44.8) |
| 1918 | Device Placement Issue | 3,075 | 18 | Copper (PRR 352.9) |
| 1919 | Talipes | 3,068 | 71 | Paroxetine Hydrochloride (PRR 34.0) |
| 1920 | Brain Death | 3,063 | 101 | Norepinephrine (PRR 24.4) |
| 1921 | Diastolic Dysfunction | 3,062 | 243 | Theophylline Anhydrous (PRR 53.1) |
| 1922 | Chest X-Ray Abnormal | 3,059 | 125 | Oseltamivir Phosphate (PRR 64.3) |
| 1923 | Ischaemic Cardiomyopathy | 3,057 | 145 | Eplerenone (PRR 51.5) |
| 1924 | Self Injurious Behaviour | 3,054 | 50 | Paliperidone (PRR 38.4) |
| 1925 | Multiple-Drug Resistance | 3,054 | 178 | Phenobarbital (PRR 255.8) |
| 1926 | Ectopic Pregnancy | 3,048 | 37 | Misoprostol (PRR 31.3) |
| 1927 | Portal Hypertension | 3,047 | 129 | Nevirapine (PRR 70.2) |
| 1928 | Brain Natriuretic Peptide Increased | 3,042 | 168 | Selexipag (PRR 50.9) |
| 1929 | Thrombophlebitis Superficial | 3,040 | 104 | Drospirenone And Ethinyl Estradiol (PRR 203.6) |
| 1930 | Rectal Cancer | 3,040 | 49 | Regorafenib (PRR 59.7) |
| 1931 | Fibrosis | 3,036 | 158 | Epoetin Alfa (PRR 82.4) |
| 1932 | Substance Use Disorder | 3,036 | 50 | Ethyl Alcohol (PRR 122.2) |
| 1933 | Injection Site Hypersensitivity | 3,034 | 40 | Tirzepatide (PRR 28.2) |
| 1934 | Medical Device Discomfort | 3,030 | 16 | Levonorgestrel (PRR 235.8) |
| 1935 | Rebound Acid Hypersecretion | 3,027 | 366 | Esomeprazole Magnesium (PRR 422.0) |
| 1936 | Penile Pain | 3,027 | 13 | Levonorgestrel (PRR 62.1) |
| 1937 | Duodenitis | 3,026 | 150 | Cholestyramine (PRR 15.5) |
| 1938 | Diabetic Foot | 3,025 | 56 | Canagliflozin (PRR 244.7) |
| 1939 | Eyelids Pruritus | 3,022 | 33 | Bimatoprost (PRR 153.4) |
| 1940 | Nephrogenic Systemic Fibrosis | 3,021 | 86 | Epoetin Alfa (PRR 373.6) |
| 1941 | Mastication Disorder | 3,010 | 88 | Ravulizumab (PRR 43.1) |
| 1942 | Loss Of Employment | 3,008 | 106 | Iron Sucrose (PRR 70.4) |
| 1943 | Cerebrovascular Disorder | 3,004 | 55 | Paricalcitol (PRR 31.0) |
| 1944 | Atrioventricular Block Second Degree | 3,002 | 86 | Sevoflurane (PRR 21.9) |
| 1945 | Iritis | 3,000 | 57 | Faricimab (PRR 82.1) |
| 1946 | Foreign Body In Throat | 2,999 | 47 | Cholestyramine (PRR 20.9) |
| 1947 | Embolism Venous | 2,996 | 113 | Etonogestrel And Ethinyl Estradiol (PRR 38.4) |
| 1948 | Prostatitis | 2,996 | 67 | Finasteride (PRR 24.6) |
| 1949 | Blood Culture Positive | 2,990 | 170 | Pegaspargase (PRR 65.5) |
| 1950 | Myelofibrosis | 2,989 | 34 | Ruxolitinib (PRR 130.9) |
| 1951 | Dysaesthesia | 2,986 | 94 | Bleomycin Sulfate (PRR 23.9) |
| 1952 | Acne Cystic | 2,985 | 38 | Adapalene (PRR 106.6) |
| 1953 | Loss Of Therapeutic Response | 2,983 | 39 | Vedolizumab (PRR 125.6) |
| 1954 | Central Venous Catheterisation | 2,983 | 68 | Epoprostenol (PRR 109.3) |
| 1955 | Hiv Infection | 2,982 | 44 | Nevirapine (PRR 390.7) |
| 1956 | Lung Adenocarcinoma | 2,981 | 95 | Crizotinib (PRR 47.4) |
| 1957 | Keratitis | 2,980 | 88 | Prednisolone Acetate (PRR 31.5) |
| 1958 | Varices Oesophageal | 2,979 | 85 | Rifaximin (PRR 36.3) |
| 1959 | Dyschezia | 2,978 | 85 | Vedolizumab (PRR 24.4) |
| 1960 | Histiocytosis Haematophagic | 2,973 | 120 | Canakinumab (PRR 49.1) |
| 1961 | Bone Marrow Disorder | 2,972 | 107 | Romiplostim (PRR 25.6) |
| 1962 | Eye Injury | 2,971 | 159 | Pseudoephedrine Hydrochloride (PRR 90.4) |
| 1963 | Urine Analysis Abnormal | 2,970 | 62 | Alemtuzumab (PRR 97.1) |
| 1964 | Crepitations | 2,963 | 166 | Methylprednisolone Acetate (PRR 133.7) |
| 1965 | Normochromic Normocytic Anaemia | 2,963 | 170 | Dutasteride (PRR 273.4) |
| 1966 | Craniocerebral Injury | 2,961 | 82 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 13.1) |
| 1967 | Metabolic Encephalopathy | 2,960 | 219 | Cefepime Hydrochloride (PRR 22.6) |
| 1968 | Hypercapnia | 2,952 | 184 | Sevoflurane (PRR 61.7) |
| 1969 | Brain Herniation | 2,949 | 134 | Alteplase (PRR 50.6) |
| 1970 | Atypical Pneumonia | 2,942 | 116 | Posaconazole Delayed-Release (PRR 14.9) |
| 1971 | Thyroiditis | 2,941 | 60 | Ipilimumab (PRR 62.9) |
| 1972 | Emergency Care | 2,934 | 73 | Cannabidiol (PRR 104.2) |
| 1973 | Hepatitis Fulminant | 2,933 | 111 | Rifampicin (PRR 40.0) |
| 1974 | Tooth Discolouration | 2,924 | 18 | Chlorhexidine Gluconate (PRR 63.2) |
| 1975 | Growth Retardation | 2,922 | 64 | Canakinumab (PRR 58.3) |
| 1976 | Neck Injury | 2,908 | 98 | Oxymorphone Hydrochloride (PRR 21.7) |
| 1977 | Stridor | 2,907 | 85 | Sevoflurane (PRR 27.0) |
| 1978 | Thoracic Vertebral Fracture | 2,906 | 57 | Romosozumab-Aqqg (PRR 40.6) |
| 1979 | Strabismus | 2,906 | 65 | Valproate Sodium (PRR 43.3) |
| 1980 | Therapeutic Reaction Time Decreased | 2,904 | 34 | Vedolizumab (PRR 4,046.1) |
| 1981 | Negative Thoughts | 2,903 | 54 | Lurasidone Hydrochloride (PRR 17.8) |
| 1982 | Lymphoproliferative Disorder | 2,902 | 58 | Methotrexate Sodium (PRR 44.9) |
| 1983 | Abortion | 2,897 | 39 | Misoprostol (PRR 26.1) |
| 1984 | Lumbar Spinal Stenosis | 2,894 | 175 | Alendronate Sodium (PRR 40.4) |
| 1985 | Blood Parathyroid Hormone Increased | 2,885 | 37 | Cinacalcet Hydrochloride (PRR 103.6) |
| 1986 | Upper Respiratory Tract Congestion | 2,882 | 54 | Ciclesonide (PRR 20.4) |
| 1987 | Mixed Liver Injury | 2,873 | 128 | Amoxicillin And Clavulanate Potassium (PRR 41.5) |
| 1988 | Infusion Site Reaction | 2,869 | 235 | Cortisone Acetate (PRR 158.0) |
| 1989 | Haemothorax | 2,867 | 84 | Tranexamic Acid (PRR 38.1) |
| 1990 | Gastrointestinal Necrosis | 2,865 | 93 | Pegaspargase (PRR 16.2) |
| 1991 | Fibula Fracture | 2,863 | 76 | Emtricitabine And Tenofovir Alafenamide (PRR 28.0) |
| 1992 | Dyspnoea At Rest | 2,858 | 106 | Epoprostenol (PRR 52.3) |
| 1993 | Escherichia Sepsis | 2,855 | 180 | Pegaspargase (PRR 42.7) |
| 1994 | Hypoglycaemic Coma | 2,855 | 35 | Human Insulin (PRR 48.0) |
| 1995 | Vascular Graft | 2,851 | 34 | Ranolazine (PRR 69.5) |
| 1996 | Paraplegia | 2,848 | 78 | Bupivacaine (PRR 34.9) |
| 1997 | Pharyngeal Disorder | 2,848 | 32 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 13.2) |
| 1998 | Speech Disorder Developmental | 2,847 | 47 | Valproate Sodium (PRR 84.3) |
| 1999 | Fine Motor Skill Dysfunction | 2,844 | 85 | Anakinra (PRR 44.3) |
| 2000 | Hypertonic Bladder | 2,841 | 119 | Doxepin Hydrochloride (PRR 55.7) |
| 2001 | Autonomic Nervous System Imbalance | 2,841 | 131 | Haloperidol (PRR 24.8) |
| 2002 | Heart Valve Incompetence | 2,839 | 72 | Octreotide Acetate (PRR 13.7) |
| 2003 | Lung Cancer Metastatic | 2,839 | 52 | Erlotinib Hydrochloride (PRR 29.2) |
| 2004 | Vitamin B12 Decreased | 2,838 | 109 | Dimenhydrinate (PRR 33.6) |
| 2005 | Duodenal Ulcer Haemorrhage | 2,836 | 104 | Rivaroxaban (PRR 18.4) |
| 2006 | Biliary Colic | 2,836 | 68 | Drospirenone And Ethinyl Estradiol (PRR 109.3) |
| 2007 | Breast Cancer Stage Iv | 2,835 | 16 | Ranitidine Hydrochloride (PRR 13.5) |
| 2008 | Pulmonary Pain | 2,834 | 109 | Theophylline (PRR 50.5) |
| 2009 | Immune Thrombocytopenic Purpura | 2,832 | 55 | Alemtuzumab (PRR 179.9) |
| 2010 | Adenovirus Infection | 2,831 | 133 | Thiotepa (PRR 279.6) |
| 2011 | Lip Pain | 2,828 | 52 | Glycerin, Lidocaine (PRR 80.9) |
| 2012 | Coma Scale Abnormal | 2,825 | 137 | Diazepam Oral Solution (Concentrate) (PRR 23.7) |
| 2013 | Ejaculation Disorder | 2,825 | 14 | Finasteride (PRR 112.7) |
| 2014 | Device Power Source Issue | 2,824 | 39 | Somatropin (PRR 348.9) |
| 2015 | Wrong Patient Received Product | 2,823 | 68 | Oxazepam (PRR 44.1) |
| 2016 | Vomiting Projectile | 2,821 | 30 | Exenatide (PRR 9.3) |
| 2017 | Pancreatic Carcinoma Metastatic | 2,820 | 86 | Sitagliptin And Metformin Hydrochloride (PRR 78.4) |
| 2018 | Oesophageal Stenosis | 2,817 | 70 | Pegaspargase (PRR 13.4) |
| 2019 | Tumour Haemorrhage | 2,814 | 77 | Lenvatinib (PRR 43.3) |
| 2020 | Colorectal Cancer Stage Ii | 2,814 | 2 | Ranitidine Hydrochloride (PRR 19.1) |
| 2021 | Retinal Vein Occlusion | 2,814 | 46 | Ranibizumab (PRR 59.9) |
| 2022 | Joint Lock | 2,809 | 37 | Tofacitinib Citrate (PRR 10.8) |
| 2023 | Pneumatosis Intestinalis | 2,802 | 129 | Pegaspargase (PRR 90.7) |
| 2024 | Forced Expiratory Volume Decreased | 2,800 | 146 | Omalizumab (PRR 330.5) |
| 2025 | Atypical Femur Fracture | 2,800 | 22 | Alendronate Sodium Tablet (PRR 124.2) |
| 2026 | Haematological Malignancy | 2,798 | 15 | Ranitidine (PRR 34.9) |
| 2027 | Acute Lymphocytic Leukaemia | 2,796 | 88 | Blinatumomab (PRR 193.2) |
| 2028 | Renal Tubular Disorder | 2,795 | 106 | Tenofovir Disoproxil Fumarate Tablets (PRR 74.7) |
| 2029 | Neck Mass | 2,792 | 51 | Indomethacin (PRR 14.8) |
| 2030 | Cerebral Thrombosis | 2,792 | 49 | Pegaspargase (PRR 31.0) |
| 2031 | Diabetic Coma | 2,791 | 50 | Olanzapine Pamoate (PRR 136.9) |
| 2032 | Neutrophil Count Abnormal | 2,787 | 112 | Ribociclib (PRR 23.5) |
| 2033 | Eyelid Margin Crusting | 2,782 | 37 | Lifitegrast (PRR 62.4) |
| 2034 | Injection Site Scar | 2,781 | 41 | Interferon Beta-1B (PRR 59.7) |
| 2035 | Antipsychotic Drug Level Increased | 2,779 | 71 | Clozapine (PRR 228.6) |
| 2036 | Lung Consolidation | 2,776 | 224 | Ciclesonide (PRR 46.5) |
| 2037 | Proctitis | 2,768 | 196 | Carboxymethylcellulose Sodium (PRR 141.2) |
| 2038 | Respiratory Symptom | 2,765 | 200 | Dutasteride (PRR 156.1) |
| 2039 | Skin Hypertrophy | 2,765 | 86 | Epoetin Alfa (PRR 125.9) |
| 2040 | Oxygen Saturation Abnormal | 2,765 | 117 | Esketamine Hydrochloride (PRR 35.6) |
| 2041 | Anal Haemorrhage | 2,765 | 64 | Orlistat (PRR 27.9) |
| 2042 | Drug Tolerance Decreased | 2,764 | 247 | Pseudoephedrine Hydrochloride (PRR 295.5) |
| 2043 | Drug Screen False Positive | 2,760 | 57 | Desvenlafaxine Succinate (PRR 24.5) |
| 2044 | Endotracheal Intubation | 2,760 | 138 | Rocuronium Bromide (PRR 22.7) |
| 2045 | Thyroid Neoplasm | 2,757 | 48 | Tofacitinib Citrate (PRR 16.3) |
| 2046 | Trichorrhexis | 2,756 | 40 | Bimatoprost (PRR 81.9) |
| 2047 | Psychomotor Retardation | 2,754 | 91 | Valproate Sodium (PRR 72.4) |
| 2048 | Therapeutic Response Delayed | 2,753 | 38 | Eptinezumab-Jjmr (PRR 104.2) |
| 2049 | Rheumatoid Nodule | 2,749 | 120 | Methylprednisolone Acetate (PRR 138.4) |
| 2050 | Serum Sickness | 2,744 | 75 | Anti-Thymocyte Globulin (Rabbit) (PRR 221.5) |
| 2051 | Renal Cancer Stage Iv | 2,744 | 5 | Ranitidine Hydrochloride (PRR 12.5) |
| 2052 | Macule | 2,739 | 38 | Secukinumab (PRR 48.0) |
| 2053 | Vitreous Haemorrhage | 2,738 | 53 | Ranibizumab (PRR 155.7) |
| 2054 | Pleuritic Pain | 2,737 | 214 | Methylprednisolone Acetate (PRR 81.3) |
| 2055 | Rash Morbilliform | 2,737 | 106 | Vancomycin Hydrochloride (PRR 28.2) |
| 2056 | Red Blood Cell Count Increased | 2,736 | 54 | Dimenhydrinate (PRR 31.9) |
| 2057 | Cholecystitis Infective | 2,735 | 61 | Teduglutide (PRR 14.8) |
| 2058 | Wrong Patient Received Medication | 2,733 | 12 | Biotin (PRR 21.1) |
| 2059 | Tenosynovitis | 2,729 | 127 | Dimenhydrinate (PRR 161.9) |
| 2060 | Application Site Haemorrhage | 2,725 | 17 | Pegfilgrastim (PRR 220.8) |
| 2061 | Acute Graft Versus Host Disease In Skin | 2,724 | 109 | Thiotepa (PRR 428.8) |
| 2062 | Subdural Haemorrhage | 2,719 | 61 | Dabigatran Etexilate Mesylate (PRR 21.3) |
| 2063 | Clumsiness | 2,712 | 100 | Diroximel Fumarate (PRR 18.2) |
| 2064 | Oral Fungal Infection | 2,710 | 72 | Nystatin Ointment (PRR 18.6) |
| 2065 | Clonus | 2,707 | 138 | Propofol (PRR 24.5) |
| 2066 | Stoma Site Discharge | 2,706 | 33 | Carbidopa And Levodopa (PRR 128.2) |
| 2067 | Chondropathy | 2,697 | 35 | Captopril (PRR 16.2) |
| 2068 | Rhinalgia | 2,697 | 75 | Gentamicin (PRR 31.3) |
| 2069 | Ulcerative Keratitis | 2,694 | 65 | Prednisolone Acetate (PRR 46.6) |
| 2070 | Lip Blister | 2,693 | 41 | Glycerin, Lidocaine (PRR 51.4) |
| 2071 | Blood Phosphorus Increased | 2,690 | 179 | Oseltamivir (PRR 185.2) |
| 2072 | Type Iv Hypersensitivity Reaction | 2,688 | 82 | Ampicillin (PRR 97.1) |
| 2073 | Gastric Perforation | 2,688 | 74 | Lenvatinib (PRR 12.3) |
| 2074 | Invasive Ductal Breast Carcinoma | 2,687 | 74 | Letrozole Tablets (PRR 35.7) |
| 2075 | Anorgasmia | 2,685 | 62 | Finasteride (PRR 25.5) |
| 2076 | Gambling Disorder | 2,680 | 72 | Aripiprazole (PRR 553.3) |
| 2077 | Migraine With Aura | 2,678 | 61 | Rabeprazole (PRR 18.9) |
| 2078 | Skin Wrinkling | 2,677 | 35 | Onabotulinumtoxina (PRR 37.6) |
| 2079 | Temporomandibular Joint Syndrome | 2,676 | 59 | Alendronate Sodium (PRR 40.7) |
| 2080 | Gastrointestinal Injury | 2,676 | 24 | Isotretinoin (PRR 374.1) |
| 2081 | Blood Sodium Increased | 2,675 | 79 | Tolvaptan (PRR 92.3) |
| 2082 | Breast Swelling | 2,672 | 59 | Bicalutamide (PRR 13.9) |
| 2083 | Ear Congestion | 2,668 | 66 | Diltiazem Hydrochloride Extended-Release Tablets (PRR 22.2) |
| 2084 | Large Intestinal Ulcer | 2,667 | 83 | Encorafenib (PRR 29.6) |
| 2085 | Angioneurotic Oedema | 2,667 | 37 | Amlodipine Besylate And Benazepril Hydrochloride (PRR 60.7) |
| 2086 | Weight Bearing Difficulty | 2,667 | 47 | Sevoflurane (PRR 18.9) |
| 2087 | Abdominal Rigidity | 2,665 | 66 | Quinine (PRR 21.1) |
| 2088 | Alcohol Abuse | 2,660 | 82 | Ethyl Alcohol (PRR 182.4) |
| 2089 | Laryngospasm | 2,659 | 46 | Sevoflurane (PRR 65.7) |
| 2090 | Electric Shock Sensation | 2,654 | 86 | Ado-Trastuzumab Emtansine (PRR 25.4) |
| 2091 | Areflexia | 2,653 | 112 | Salmeterol Xinafoate (PRR 47.3) |
| 2092 | White Blood Cell Disorder | 2,650 | 66 | Brentuximab Vedotin (PRR 15.4) |
| 2093 | Bradypnoea | 2,650 | 82 | Methadone Hydrochloride (PRR 52.9) |
| 2094 | Gastrointestinal Stromal Tumour | 2,644 | 30 | Imatinib (PRR 174.6) |
| 2095 | Yawning | 2,642 | 40 | Rasagiline Mesylate (PRR 36.8) |
| 2096 | Steatorrhoea | 2,642 | 14 | Orlistat (PRR 1,332.6) |
| 2097 | Abdominal Mass | 2,639 | 80 | Vedolizumab (PRR 19.1) |
| 2098 | Anaesthetic Complication | 2,638 | 31 | Sevoflurane (PRR 148.8) |
| 2099 | Prostate Cancer Stage Iii | 2,636 | 2 | Ranitidine Hydrochloride (PRR 15.7) |
| 2100 | Nasal Disorder | 2,632 | 62 | Valproate Sodium (PRR 24.3) |
| 2101 | Product Cleaning Inadequate | 2,632 | 9 | Albuterol Sulfate (PRR 260.5) |
| 2102 | Mycobacterium Avium Complex Infection | 2,627 | 116 | Amikacin (PRR 208.1) |
| 2103 | Skin Discomfort | 2,624 | 24 | Adapalene (PRR 55.3) |
| 2104 | Blood Potassium Abnormal | 2,624 | 99 | Patiromer (PRR 47.9) |
| 2105 | Hypersensitivity Vasculitis | 2,622 | 72 | Colchicine (PRR 26.1) |
| 2106 | Renal Cancer Stage I | 2,620 | 2 | Ranitidine Hydrochloride (PRR 26.3) |
| 2107 | Shoulder Arthroplasty | 2,619 | 70 | Diclofenac Potassium, Film Coated (PRR 49.1) |
| 2108 | Alcohol Poisoning | 2,619 | 125 | Ethyl Alcohol (PRR 153.2) |
| 2109 | Protein Total Increased | 2,618 | 69 | Emtricitabine And Tenofovir Alafenamide (PRR 41.6) |
| 2110 | Pregnancy On Oral Contraceptive | 2,606 | 8 | Drospirenone And Ethinyl Estradiol (PRR 111.9) |
| 2111 | Hyperlactacidaemia | 2,604 | 113 | Norepinephrine (PRR 74.5) |
| 2112 | Radiculopathy | 2,603 | 247 | Carboxymethylcellulose Sodium (PRR 153.7) |
| 2113 | Animal Bite | 2,603 | 62 | Human Immunoglobulin G (PRR 15.3) |
| 2114 | Immune-Mediated Myositis | 2,603 | 39 | Atorvastatin Calcium, Film Coated (PRR 44.0) |
| 2115 | Personality Disorder | 2,602 | 163 | Methylprednisolone Acetate (PRR 161.2) |
| 2116 | Iucd Complication | 2,600 | 2 | Levonorgestrel (PRR 1,560.9) |
| 2117 | Psychomotor Skills Impaired | 2,594 | 85 | Atazanavir (PRR 85.1) |
| 2118 | Hypoxic-Ischaemic Encephalopathy | 2,594 | 108 | Sevoflurane (PRR 35.2) |
| 2119 | Urine Output Increased | 2,592 | 38 | Canagliflozin (PRR 70.6) |
| 2120 | Hepatitis Toxic | 2,591 | 80 | Pyrazinamide (PRR 67.8) |
| 2121 | Exfoliative Rash | 2,589 | 51 | Rifampicin (PRR 16.0) |
| 2122 | Medication Residue | 2,582 | 24 | Desvenlafaxine Succinate (PRR 200.3) |
| 2123 | Actinic Keratosis | 2,577 | 109 | Voriconazole Injection (PRR 107.0) |
| 2124 | Hypomenorrhoea | 2,576 | 8 | Levonorgestrel (PRR 84.0) |
| 2125 | Compartment Syndrome | 2,573 | 64 | Norepinephrine Bitartrate (PRR 35.7) |
| 2126 | Retinal Disorder | 2,572 | 35 | Ranibizumab (PRR 48.2) |
| 2127 | Blood Chloride Decreased | 2,566 | 173 | Metolazone (PRR 21.2) |
| 2128 | Ventricular Dysfunction | 2,564 | 76 | Isosorbide Mononitrate (PRR 24.0) |
| 2129 | Essential Hypertension | 2,556 | 268 | Alendronate Sodium (PRR 24.1) |
| 2130 | Lipoma | 2,554 | 48 | Tolterodine Tartrate (PRR 32.2) |
| 2131 | Eosinophilic Oesophagitis | 2,554 | 17 | Dupilumab (PRR 106.7) |
| 2132 | Drug Titration Error | 2,554 | 60 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 365.8) |
| 2133 | Hernia Repair | 2,553 | 49 | Niraparib (PRR 17.2) |
| 2134 | Acute Lymphocytic Leukaemia Recurrent | 2,549 | 60 | Blinatumomab (PRR 1,494.4) |
| 2135 | Aortic Arteriosclerosis | 2,547 | 237 | Chlorhexidine Gluconate (PRR 32.6) |
| 2136 | Hepatosplenomegaly | 2,546 | 143 | Amphotericin B (PRR 37.3) |
| 2137 | Postmenopausal Haemorrhage | 2,545 | 30 | Progesterone (PRR 44.2) |
| 2138 | Parkinson'S Disease | 2,545 | 28 | Carbidopa And Levodopa (PRR 57.8) |
| 2139 | Excoriation | 2,541 | 78 | Tolterodine Tartrate (PRR 21.2) |
| 2140 | Mucormycosis | 2,541 | 115 | Amphotericin B (PRR 182.8) |
| 2141 | Lactose Intolerance | 2,541 | 44 | Fluticasone Furoate (PRR 14.3) |
| 2142 | Lung Opacity | 2,541 | 242 | Standardized Senna Concentrate (PRR 60.0) |
| 2143 | Blood Pressure Diastolic Abnormal | 2,537 | 226 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 302.1) |
| 2144 | Hostility | 2,535 | 83 | Varenicline Tartrate (PRR 51.3) |
| 2145 | Cancer Pain | 2,534 | 143 | Trifluridine And Tipiracil (PRR 27.2) |
| 2146 | Mean Cell Volume Increased | 2,534 | 83 | Niraparib (PRR 34.5) |
| 2147 | Tuberculin Test Positive | 2,533 | 28 | Isoniazid (PRR 39.7) |
| 2148 | Increased Bronchial Secretion | 2,533 | 78 | Ciclesonide (PRR 58.2) |
| 2149 | Diabetic Complication | 2,531 | 52 | Ziprasidone Mesylate (PRR 47.0) |
| 2150 | Nocardiosis | 2,529 | 102 | Valganciclovir Hydrochloride Powder, (PRR 112.9) |
| 2151 | Angle Closure Glaucoma | 2,528 | 46 | Topiramate (PRR 68.7) |
| 2152 | Chemical Burn Of Skin | 2,524 | 10 | Adapalene (PRR 282.2) |
| 2153 | Exposure Via Ingestion | 2,519 | 38 | Derma Foam Excel Hand Sanitizer (PRR 274.1) |
| 2154 | Menopause | 2,517 | 63 | Copper (PRR 35.1) |
| 2155 | Labyrinthitis | 2,517 | 45 | Valsartan And Hydrochlorothiazide (PRR 18.5) |
| 2156 | Disseminated Tuberculosis | 2,513 | 71 | Pyrazinamide (PRR 171.9) |
| 2157 | Abdominal Infection | 2,513 | 85 | Ganciclovir Sodium (PRR 15.0) |
| 2158 | Endodontic Procedure | 2,510 | 44 | Alendronate Sodium (PRR 20.1) |
| 2159 | Osteitis | 2,510 | 50 | Chlorhexidine Gluconate (PRR 22.9) |
| 2160 | Catheter Site Pain | 2,508 | 83 | Epoprostenol (PRR 250.1) |
| 2161 | Haemorrhage Urinary Tract | 2,507 | 63 | Rivaroxaban (PRR 14.8) |
| 2162 | Dermatomyositis | 2,505 | 60 | Human Immunoglobulin G (PRR 24.7) |
| 2163 | Hyperparathyroidism Secondary | 2,499 | 478 | Calcitriol Capsules 0.25 Mcg (PRR 156.2) |
| 2164 | Ventricular Hypertrophy | 2,499 | 100 | Zidovudine (PRR 20.8) |
| 2165 | Platelet Disorder | 2,499 | 53 | Eltrombopag Olamine (PRR 55.9) |
| 2166 | Appendicitis Perforated | 2,499 | 41 | Sevoflurane (PRR 13.1) |
| 2167 | Brain Abscess | 2,494 | 110 | Voriconazole Injection (PRR 49.2) |
| 2168 | Ileostomy | 2,492 | 29 | Upadacitinib (PRR 33.2) |
| 2169 | Heart Injury | 2,490 | 24 | Testosterone Cypionate (PRR 13.2) |
| 2170 | Retinal Artery Occlusion | 2,489 | 36 | Aflibercept (PRR 46.1) |
| 2171 | Vasodilatation | 2,483 | 41 | Tranexamic Acid (PRR 30.5) |
| 2172 | Urinary Tract Infection Bacterial | 2,477 | 98 | Infliximab-Dyyb (PRR 39.7) |
| 2173 | Venoocclusive Disease | 2,474 | 87 | Busulfan (PRR 356.1) |
| 2174 | Physical Deconditioning | 2,472 | 91 | Tofacitinib Citrate (PRR 108.3) |
| 2175 | Metastases To Peritoneum | 2,472 | 85 | Regorafenib (PRR 40.0) |
| 2176 | Instillation Site Pain | 2,471 | 12 | Lifitegrast (PRR 1,374.7) |
| 2177 | Sedation Complication | 2,468 | 146 | Quinapril Hydrochloride (PRR 733.4) |
| 2178 | Tachyarrhythmia | 2,467 | 99 | Dutasteride (PRR 52.9) |
| 2179 | Gastrointestinal Tube Insertion | 2,466 | 59 | Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate (PRR 23.3) |
| 2180 | Intraventricular Haemorrhage | 2,463 | 71 | Ampicillin (PRR 46.8) |
| 2181 | Infrequent Bowel Movements | 2,463 | 50 | Orlistat (PRR 33.3) |
| 2182 | Abnormal Uterine Bleeding | 2,459 | 13 | Copper (PRR 1,684.3) |
| 2183 | Penis Disorder | 2,459 | 16 | Sildenafil Citrate (PRR 65.7) |
| 2184 | Blood Pressure Systolic Abnormal | 2,458 | 208 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 295.8) |
| 2185 | Injection Site Abscess | 2,450 | 28 | Naltrexone (PRR 73.2) |
| 2186 | Suffocation Feeling | 2,449 | 32 | Ciclesonide (PRR 17.7) |
| 2187 | Product Contamination Physical | 2,447 | 25 | Testosterone Cypionate (PRR 24.0) |
| 2188 | Cartilage Injury | 2,443 | 36 | Doxepin Hydrochloride (PRR 12.9) |
| 2189 | Stem Cell Transplant | 2,441 | 86 | Melphalan Hydrochloride (PRR 52.4) |
| 2190 | Retroperitoneal Haemorrhage | 2,439 | 40 | Enoxaparin Sodium (PRR 58.6) |
| 2191 | Product Packaging Difficult To Open | 2,439 | 50 | Voclosporin (PRR 160.3) |
| 2192 | Acute Psychosis | 2,437 | 68 | Pramipexole (PRR 22.6) |
| 2193 | Systemic Candida | 2,436 | 155 | Micafungin Sodium (PRR 95.2) |
| 2194 | Persecutory Delusion | 2,434 | 85 | Aripiprazole Oral (PRR 42.5) |
| 2195 | Eyelid Irritation | 2,429 | 35 | Bimatoprost (PRR 132.1) |
| 2196 | Catheter Site Haemorrhage | 2,428 | 80 | Epoprostenol (PRR 184.8) |
| 2197 | Bronchitis Chronic | 2,426 | 100 | Meperidine Hydrochloride (PRR 46.5) |
| 2198 | Eye Oedema | 2,424 | 44 | Ranibizumab (PRR 30.9) |
| 2199 | Dermal Cyst | 2,423 | 40 | Dimenhydrinate (PRR 17.1) |
| 2200 | Retinal Tear | 2,420 | 25 | Ranibizumab (PRR 45.9) |
| 2201 | Oral Intake Reduced | 2,420 | 60 | Gefitinib (PRR 21.1) |
| 2202 | Juvenile Idiopathic Arthritis | 2,418 | 61 | Anakinra (PRR 227.2) |
| 2203 | Device Infusion Issue | 2,418 | 131 | Human Immunoglobulin G (PRR 94.4) |
| 2204 | Glomerulonephritis | 2,413 | 80 | Basiliximab (PRR 53.6) |
| 2205 | Dental Operation | 2,412 | 30 | Upadacitinib (PRR 15.6) |
| 2206 | Skin Fragility | 2,412 | 10 | Adapalene (PRR 179.9) |
| 2207 | Breath Odour | 2,411 | 43 | Icosapent Ethyl (PRR 13.2) |
| 2208 | Self Esteem Decreased | 2,408 | 31 | Oxycodone Hydrochloride (PRR 47.7) |
| 2209 | Transplant Failure | 2,407 | 79 | Busulfan (PRR 137.0) |
| 2210 | Learning Disorder | 2,407 | 28 | Valproate Sodium (PRR 114.0) |
| 2211 | Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis | 2,406 | 60 | Tobramycin Solution (PRR 36.0) |
| 2212 | Blood Immunoglobulin E Increased | 2,405 | 86 | Ciclesonide (PRR 191.5) |
| 2213 | Blood Immunoglobulin G Decreased | 2,405 | 96 | Human Immunoglobulin G (PRR 117.4) |
| 2214 | Product Packaging Confusion | 2,402 | 32 | Umeclidinium Bromide And Vilanterol Trifenatate (PRR 122.4) |
| 2215 | Wrong Dose | 2,393 | 41 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 55.8) |
| 2216 | Premature Rupture Of Membranes | 2,390 | 47 | Zidovudine (PRR 73.6) |
| 2217 | Diabetes Insipidus | 2,390 | 105 | Sevoflurane (PRR 95.7) |
| 2218 | Pulse Abnormal | 2,389 | 35 | Iohexol (PRR 20.1) |
| 2219 | Lymphadenitis | 2,386 | 85 | Romiplostim (PRR 54.8) |
| 2220 | Radius Fracture | 2,385 | 39 | Romosozumab-Aqqg (PRR 39.5) |
| 2221 | Panniculitis | 2,380 | 116 | Febuxostat Tablets 40 Mg (PRR 131.7) |
| 2222 | Painful Respiration | 2,380 | 50 | Tobramycin Solution (PRR 18.4) |
| 2223 | Staring | 2,380 | 77 | Brivaracetam (PRR 16.6) |
| 2224 | Long Qt Syndrome | 2,378 | 95 | Lopinavir And Ritonavir (PRR 37.0) |
| 2225 | Slow Speech | 2,370 | 73 | Cenobamate (PRR 26.6) |
| 2226 | Varicella | 2,368 | 48 | Alemtuzumab (PRR 15.2) |
| 2227 | Urinary Hesitation | 2,368 | 47 | Atomoxetine Hydrochloride (PRR 64.1) |
| 2228 | Weight Abnormal | 2,364 | 48 | Cannabidiol (PRR 51.7) |
| 2229 | Lacunar Infarction | 2,362 | 62 | Prasugrel Hydrochloride (PRR 18.4) |
| 2230 | Intra-Abdominal Haemorrhage | 2,359 | 54 | Fondaparinux Sodium (PRR 39.8) |
| 2231 | Gastrointestinal Obstruction | 2,358 | 44 | Teduglutide (PRR 18.6) |
| 2232 | Pulmonary Infarction | 2,354 | 35 | Etonogestrel And Ethinyl Estradiol (PRR 157.2) |
| 2233 | Dysmorphism | 2,350 | 46 | Valproate Sodium (PRR 198.3) |
| 2234 | Urine Flow Decreased | 2,349 | 33 | Mirabegron (PRR 29.2) |
| 2235 | Sinus Operation | 2,346 | 56 | Dornase Alfa (PRR 55.7) |
| 2236 | Transplant | 2,345 | 44 | Darbepoetin Alfa (PRR 60.0) |
| 2237 | Myopia | 2,341 | 38 | Topiramate (PRR 33.1) |
| 2238 | Disturbance In Social Behaviour | 2,337 | 51 | Asenapine Maleate (PRR 515.4) |
| 2239 | Mycobacterium Tuberculosis Complex Test Positive | 2,336 | 38 | Isoniazid (PRR 33.8) |
| 2240 | Contrast Media Reaction | 2,332 | 1 | Iohexol (PRR 324.4) |
| 2241 | Oxygen Consumption Increased | 2,330 | 61 | 0Xygen (PRR 120.5) |
| 2242 | Ingrowing Nail | 2,328 | 62 | Lapatinib (PRR 16.9) |
| 2243 | Urinary Tract Obstruction | 2,328 | 61 | Bicalutamide (PRR 17.8) |
| 2244 | Circumstance Or Information Capable Of Leading To Device Use Error | 2,322 | 17 | Somatropin (PRR 139.2) |
| 2245 | Pancreatitis Chronic | 2,321 | 65 | Pancrelipase (PRR 77.8) |
| 2246 | Uterine Disorder | 2,315 | 25 | Tranexamic Acid (PRR 23.5) |
| 2247 | Haemolytic Uraemic Syndrome | 2,315 | 74 | Basiliximab (PRR 54.3) |
| 2248 | Aphthous Stomatitis | 2,311 | 29 | Sunitinib Malate (PRR 12.9) |
| 2249 | Ovarian Hyperstimulation Syndrome | 2,310 | 14 | Progesterone (PRR 161.3) |
| 2250 | Volvulus | 2,302 | 58 | Nevirapine (PRR 59.6) |
| 2251 | Breakthrough Pain | 2,300 | 27 | Buprenorphine (PRR 32.2) |
| 2252 | Pruritus Genital | 2,299 | 84 | Felodipine Extended-Release Tablets (PRR 375.5) |
| 2253 | Patella Fracture | 2,299 | 36 | Alendronate Sodium (PRR 17.0) |
| 2254 | Red Blood Cell Sedimentation Rate Abnormal | 2,297 | 95 | Abatacept (PRR 282.1) |
| 2255 | Polyomavirus-Associated Nephropathy | 2,295 | 60 | Tacrolimus (PRR 501.3) |
| 2256 | Eosinophil Count Decreased | 2,295 | 65 | Clozapine (PRR 141.4) |
| 2257 | Bilirubin Conjugated Increased | 2,294 | 93 | Atazanavir (PRR 34.9) |
| 2258 | Oral Surgery | 2,293 | 36 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 21.3) |
| 2259 | Haematological Infection | 2,293 | 123 | Teduglutide (PRR 37.9) |
| 2260 | Respiratory Tract Infection Viral | 2,289 | 98 | Palivizumab (PRR 34.6) |
| 2261 | Haemangioma | 2,289 | 49 | Propranolol Hydrochloride (PRR 51.6) |
| 2262 | Escherichia Bacteraemia | 2,283 | 171 | Pegaspargase (PRR 45.9) |
| 2263 | Discouragement | 2,283 | 44 | Tofacitinib (PRR 61.3) |
| 2264 | Weight Gain Poor | 2,283 | 36 | Teduglutide (PRR 42.4) |
| 2265 | Acute Febrile Neutrophilic Dermatosis | 2,283 | 65 | Azacitidine (PRR 29.7) |
| 2266 | Sinus Pain | 2,277 | 102 | Ciclesonide (PRR 72.4) |
| 2267 | Vitiligo | 2,275 | 47 | Ribociclib (PRR 42.2) |
| 2268 | Dengue Fever | 2,274 | 34 | Golimumab (PRR 20.2) |
| 2269 | Lichen Planus | 2,273 | 38 | Clobetasol Propionate Ointment Usp, 0.05% (PRR 17.9) |
| 2270 | Reaction To Excipient | 2,273 | 19 | Liothyronine Sodium (PRR 55.9) |
| 2271 | Eyelid Disorder | 2,272 | 38 | Bimatoprost (PRR 23.6) |
| 2272 | Pustule | 2,271 | 63 | Panitumumab (PRR 29.9) |
| 2273 | Methaemoglobinaemia | 2,271 | 89 | Daspone (PRR 566.4) |
| 2274 | Neck Surgery | 2,267 | 57 | Upadacitinib (PRR 20.7) |
| 2275 | Metastatic Malignant Melanoma | 2,265 | 28 | Dabrafenib (PRR 262.6) |
| 2276 | Oral Pruritus | 2,262 | 39 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 32.9) |
| 2277 | Reading Disorder | 2,260 | 36 | Valproate Sodium (PRR 16.3) |
| 2278 | Colorectal Cancer Metastatic | 2,258 | 19 | Panitumumab (PRR 684.4) |
| 2279 | Hepatocellular Damage | 2,257 | 22 | Rifampicin (PRR 18.4) |
| 2280 | Haematocrit Increased | 2,254 | 46 | Ruxolitinib (PRR 52.0) |
| 2281 | Computerised Tomogram Abnormal | 2,254 | 78 | Niraparib (PRR 81.3) |
| 2282 | Menopausal Symptoms | 2,252 | 50 | Estradiol (PRR 58.3) |
| 2283 | Flat Affect | 2,246 | 66 | Lurasidone Hydrochloride (PRR 21.7) |
| 2284 | Pregnancy After Post Coital Contraception | 2,245 | 8 | Levonorgestrel (PRR 712.5) |
| 2285 | Neurological Decompensation | 2,243 | 100 | Alteplase (PRR 132.6) |
| 2286 | Pancreatitis Necrotising | 2,242 | 41 | Pegaspargase (PRR 54.8) |
| 2287 | Renal Colic | 2,239 | 34 | Atazanavir (PRR 103.9) |
| 2288 | Infusion Site Infection | 2,237 | 80 | Treprostinil (PRR 348.1) |
| 2289 | Diverticulum Intestinal Haemorrhagic | 2,236 | 44 | Rivaroxaban (PRR 85.0) |
| 2290 | Cytomegalovirus Colitis | 2,235 | 112 | Ganciclovir Sodium (PRR 203.9) |
| 2291 | Application Site Urticaria | 2,235 | 18 | Nicotine (PRR 127.7) |
| 2292 | Gastric Polyps | 2,234 | 53 | Olmesartan Medoxomil (PRR 39.2) |
| 2293 | Kounis Syndrome | 2,231 | 98 | Rocuronium Bromide (PRR 74.2) |
| 2294 | Implant Site Infection | 2,231 | 13 | Etonogestrel (PRR 164.9) |
| 2295 | Pneumocystis Jiroveci Pneumonia | 2,228 | 80 | Prednisolone (PRR 33.9) |
| 2296 | Lichenoid Keratosis | 2,228 | 58 | Pembrolizumab (PRR 35.8) |
| 2297 | Large Intestinal Haemorrhage | 2,227 | 31 | Prasugrel Hydrochloride (PRR 16.7) |
| 2298 | Infectious Mononucleosis | 2,226 | 31 | Isotretinoin (PRR 18.3) |
| 2299 | Brain Operation | 2,226 | 55 | Brivaracetam (PRR 75.1) |
| 2300 | Small Intestine Carcinoma | 2,223 | 6 | Ranitidine Hydrochloride (PRR 49.3) |
| 2301 | Periarthritis | 2,222 | 41 | Dextrose (PRR 23.8) |
| 2302 | Adenocarcinoma | 2,220 | 71 | Erlotinib (PRR 20.5) |
| 2303 | Idiopathic Intracranial Hypertension | 2,218 | 37 | Minocycline (PRR 50.5) |
| 2304 | Corneal Oedema | 2,215 | 42 | Prednisolone Acetate (PRR 86.1) |
| 2305 | Pseudomembranous Colitis | 2,215 | 99 | Meropenem (PRR 41.0) |
| 2306 | Metastases To Meninges | 2,213 | 84 | Gefitinib (PRR 129.8) |
| 2307 | Tongue Blistering | 2,212 | 35 | Asenapine Maleate (PRR 35.2) |
| 2308 | Calcinosis | 2,209 | 36 | Asfotase Alfa (PRR 70.0) |
| 2309 | Paresis | 2,209 | 52 | Siponimod (PRR 22.4) |
| 2310 | Fear Of Death | 2,207 | 38 | Drospirenone And Ethinyl Estradiol (PRR 59.5) |
| 2311 | Chronic Gastritis | 2,207 | 68 | Olmesartan Medoxomil (PRR 19.8) |
| 2312 | Spinal Column Injury | 2,204 | 39 | Leflunomide (PRR 12.3) |
| 2313 | Blood Loss Anaemia | 2,202 | 85 | Rivaroxaban (PRR 25.4) |
| 2314 | Complications Of Transplanted Kidney | 2,202 | 93 | Basiliximab (PRR 333.1) |
| 2315 | Gastrointestinal Hypomotility | 2,202 | 65 | Oral Semaglutide (PRR 80.6) |
| 2316 | Bacterial Test Positive | 2,200 | 77 | Alemtuzumab (PRR 104.0) |
| 2317 | Dislocation Of Vertebra | 2,196 | 192 | Diclofenac Potassium, Film Coated (PRR 1,156.9) |
| 2318 | Electrocardiogram T Wave Inversion | 2,195 | 56 | Lithium Carbonate (PRR 16.4) |
| 2319 | Gastrointestinal Ulcer | 2,194 | 53 | Ganciclovir Sodium (PRR 13.5) |
| 2320 | Large Intestinal Obstruction | 2,190 | 41 | Dimenhydrinate (PRR 14.4) |
| 2321 | Product Package Associated Injury | 2,188 | 24 | Loperamide Hydrochloride And Dimethicone (PRR 45.3) |
| 2322 | Accident At Work | 2,186 | 24 | Infliximab-Dyyb (PRR 11.2) |
| 2323 | Faeces Pale | 2,186 | 34 | Lanreotide Acetate (PRR 41.9) |
| 2324 | Diabetic Nephropathy | 2,185 | 85 | Lansoprazole (PRR 50.3) |
| 2325 | Substance-Induced Psychotic Disorder | 2,183 | 68 | Methadone Hydrochloride (PRR 23.2) |
| 2326 | Cerebellar Syndrome | 2,183 | 69 | Metronidazole Topical (PRR 42.3) |
| 2327 | Distributive Shock | 2,181 | 95 | Norepinephrine (PRR 76.0) |
| 2328 | Electrocardiogram St Segment Depression | 2,181 | 59 | Sevoflurane (PRR 51.5) |
| 2329 | Nosocomial Infection | 2,180 | 52 | Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose (PRR 21.1) |
| 2330 | Dandruff | 2,177 | 19 | Minoxidil Foam 5% (Womens) (PRR 174.4) |
| 2331 | Endometrial Cancer | 2,177 | 33 | Raloxifene Hydrochloride (PRR 64.3) |
| 2332 | Colonoscopy | 2,175 | 48 | Tolvaptan (PRR 16.6) |
| 2333 | Reaction To Drug Excipients | 2,175 | 7 | Liothyronine Sodium (PRR 37.9) |
| 2334 | Graft Versus Host Disease In Skin | 2,173 | 103 | Thiotepa (PRR 292.2) |
| 2335 | Middle Ear Effusion | 2,169 | 58 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 14.1) |
| 2336 | Retroperitoneal Haematoma | 2,168 | 60 | Fondaparinux Sodium (PRR 90.8) |
| 2337 | Exposed Bone In Jaw | 2,162 | 72 | Zoledronic Acid (PRR 66.7) |
| 2338 | Pericardial Haemorrhage | 2,162 | 41 | Dabigatran Etexilate (PRR 38.8) |
| 2339 | Facial Palsy | 2,162 | 26 | Ziprasidone Mesylate (PRR 12.9) |
| 2340 | Bipolar I Disorder | 2,161 | 73 | Lithium (PRR 48.1) |
| 2341 | Limb Mass | 2,160 | 44 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 18.8) |
| 2342 | Renal Tubular Acidosis | 2,159 | 89 | Tenofovir Disoproxil Fumarate Tablets (PRR 46.6) |
| 2343 | Temperature Regulation Disorder | 2,157 | 132 | Methylprednisolone Acetate (PRR 580.7) |
| 2344 | Infection Susceptibility Increased | 2,157 | 45 | Cimetidine (PRR 58.6) |
| 2345 | Cervical Dysplasia | 2,155 | 33 | Etonogestrel And Ethinyl Estradiol (PRR 84.4) |
| 2346 | Clostridium Test Positive | 2,153 | 136 | Cefazolin (PRR 89.1) |
| 2347 | Gastric Cancer Stage Iv | 2,151 | 2 | Ranitidine Hydrochloride (PRR 9.5) |
| 2348 | Oligomenorrhoea | 2,150 | 14 | Etonogestrel (PRR 40.5) |
| 2349 | Product Lot Number Issue | 2,149 | 20 | Loperamide Hydrochloride And Dimethicone (PRR 17.7) |
| 2350 | Gastric Bypass | 2,149 | 50 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 26.1) |
| 2351 | Application Site Scab | 2,147 | 15 | Glycerin, Lidocaine (PRR 123.7) |
| 2352 | Oesophageal Varices Haemorrhage | 2,147 | 55 | Atezolizumab (PRR 61.4) |
| 2353 | Henoch-Schonlein Purpura | 2,143 | 38 | Adalimumab-Aaty (PRR 21.9) |
| 2354 | Corneal Disorder | 2,143 | 35 | Prednisolone Acetate (PRR 62.9) |
| 2355 | Jaw Fracture | 2,139 | 61 | Chlorhexidine Gluconate (PRR 30.2) |
| 2356 | Medical Device Pain | 2,132 | 10 | Levonorgestrel (PRR 244.6) |
| 2357 | Language Disorder | 2,132 | 39 | Valproate Sodium (PRR 103.0) |
| 2358 | Abscess Intestinal | 2,131 | 33 | Vedolizumab (PRR 23.3) |
| 2359 | Cd4 Lymphocytes Decreased | 2,131 | 54 | Ritonavir 100 Mg (PRR 133.1) |
| 2360 | Blood Testosterone Increased | 2,129 | 25 | Testosterone (PRR 111.9) |
| 2361 | Pharyngeal Erythema | 2,124 | 22 | Fosaprepitant Dimeglumine (PRR 12.2) |
| 2362 | Vitreous Detachment | 2,122 | 31 | Ranibizumab (PRR 52.8) |
| 2363 | Diffuse Large B-Cell Lymphoma Recurrent | 2,120 | 51 | Polatuzumab Vedotin (PRR 441.9) |
| 2364 | Lymphocytosis | 2,120 | 54 | Ibrutinib (PRR 39.9) |
| 2365 | Radiation Pneumonitis | 2,116 | 48 | Durvalumab (PRR 630.1) |
| 2366 | Cholestatic Liver Injury | 2,115 | 101 | Pyrazinamide (PRR 28.6) |
| 2367 | Periodontitis | 2,114 | 62 | Alendronate Sodium (PRR 30.2) |
| 2368 | Hepatic Neoplasm Malignant | 2,114 | 34 | Sorafenib (PRR 227.2) |
| 2369 | Derealisation | 2,111 | 57 | Paroxetine Hydrochloride Hemihydrate (PRR 30.0) |
| 2370 | Lipodystrophy Acquired | 2,106 | 26 | Zidovudine (PRR 406.1) |
| 2371 | Renal Neoplasm | 2,105 | 31 | Mometasone (PRR 22.5) |
| 2372 | Acute Myeloid Leukaemia Recurrent | 2,103 | 71 | Azacitidine For (PRR 314.8) |
| 2373 | Graft Versus Host Disease In Gastrointestinal Tract | 2,101 | 106 | Thiotepa (PRR 273.0) |
| 2374 | Exophthalmos | 2,101 | 33 | Methimazole (PRR 43.6) |
| 2375 | Amyotrophic Lateral Sclerosis | 2,100 | 7 | Ezetimibe And Simvastatin (PRR 11.2) |
| 2376 | Infusion Site Bruising | 2,099 | 163 | Human Immunoglobulin G (PRR 190.7) |
| 2377 | Dilatation Ventricular | 2,099 | 85 | Digoxin (PRR 26.8) |
| 2378 | Staphylococcus Test Positive | 2,097 | 87 | Epoprostenol (PRR 51.6) |
| 2379 | Colorectal Cancer Stage I | 2,095 | 2 | Ranitidine Hydrochloride (PRR 24.4) |
| 2380 | Foetal Distress Syndrome | 2,093 | 52 | Misoprostol (PRR 90.4) |
| 2381 | Hyperphosphataemia | 2,092 | 185 | Phytonadione (PRR 208.6) |
| 2382 | Neurogenic Bladder | 2,091 | 65 | Oxybutynin Chloride (PRR 27.6) |
| 2383 | Anaemia Macrocytic | 2,091 | 80 | Zidovudine (PRR 83.9) |
| 2384 | Sputum Increased | 2,088 | 104 | Amikacin (PRR 142.9) |
| 2385 | Urinary Bladder Haemorrhage | 2,085 | 42 | Prasugrel Hydrochloride (PRR 18.8) |
| 2386 | Vascular Occlusion | 2,084 | 24 | Ticagrelor (PRR 28.0) |
| 2387 | Atrial Tachycardia | 2,082 | 98 | Felodipine Extended-Release Tablets (PRR 427.7) |
| 2388 | Eye Contusion | 2,080 | 73 | Cenegermin-Bkbj (PRR 28.6) |
| 2389 | Ear Swelling | 2,078 | 37 | Omalizumab (PRR 10.6) |
| 2390 | Oculogyric Crisis | 2,078 | 62 | Aripiprazole Oral (PRR 86.1) |
| 2391 | Spina Bifida | 2,077 | 46 | Divalproex Sodium (PRR 115.8) |
| 2392 | Impaired Self-Care | 2,075 | 47 | Lithium Carbonate (PRR 21.6) |
| 2393 | Alanine Aminotransferase Abnormal | 2,071 | 142 | Febuxostat Tablets 40 Mg (PRR 140.4) |
| 2394 | Torticollis | 2,071 | 58 | Haloperidol Lactate (PRR 32.9) |
| 2395 | Optic Neuropathy | 2,070 | 47 | Linezolid (PRR 89.0) |
| 2396 | International Normalised Ratio Fluctuation | 2,069 | 43 | Meperidine Hydrochloride (PRR 185.4) |
| 2397 | Subileus | 2,069 | 63 | Rivastigmine (PRR 22.9) |
| 2398 | Walking Disability | 2,069 | 23 | Amlodipine Besylate And Valsartan (PRR 11.9) |
| 2399 | Venous Thrombosis Limb | 2,067 | 60 | Fondaparinux Sodium (PRR 28.9) |
| 2400 | Catheter Site Erythema | 2,067 | 51 | Epoprostenol (PRR 594.8) |
| 2401 | Microcytic Anaemia | 2,066 | 40 | Isoniazid (PRR 22.8) |
| 2402 | Physical Assault | 2,065 | 52 | Ethyl Alcohol (PRR 30.0) |
| 2403 | Hyperkinesia | 2,064 | 37 | Rivastigmine (PRR 66.9) |
| 2404 | Lung Abscess | 2,062 | 73 | Ganciclovir (PRR 19.9) |
| 2405 | Latent Tuberculosis | 2,061 | 36 | Isoniazid (PRR 53.2) |
| 2406 | Anal Pruritus | 2,061 | 11 | Peginterferon Alfa-2A (PRR 295.3) |
| 2407 | Livedo Reticularis | 2,059 | 50 | Iron Sucrose (PRR 34.5) |
| 2408 | Body Temperature Fluctuation | 2,056 | 55 | Infliximab-Dyyb (PRR 67.8) |
| 2409 | Intramedullary Rod Insertion | 2,053 | 12 | Alendronate Sodium (PRR 4,997.2) |
| 2410 | Atrial Thrombosis | 2,052 | 35 | Dabigatran Etexilate (PRR 52.5) |
| 2411 | Post Procedural Discomfort | 2,050 | 4 | Levonorgestrel (PRR 485.4) |
| 2412 | Diverticular Perforation | 2,048 | 49 | Baricitinib (PRR 19.1) |
| 2413 | Tongue Biting | 2,044 | 53 | Promethazine Hydrochloride (PRR 28.1) |
| 2414 | Compulsive Shopping | 2,043 | 40 | Aripiprazole (PRR 224.7) |
| 2415 | Akinesia | 2,042 | 51 | Levodopa (PRR 54.8) |
| 2416 | Rebound Eczema | 2,039 | 7 | Dupilumab (PRR 2,925.0) |
| 2417 | Varicella Zoster Virus Infection | 2,038 | 90 | Alemtuzumab (PRR 60.2) |
| 2418 | Skin Induration | 2,038 | 60 | Epoetin Alfa (PRR 195.3) |
| 2419 | Sleep Deficit | 2,038 | 58 | Brivaracetam (PRR 35.7) |
| 2420 | Hypospadias | 2,037 | 48 | Zidovudine (PRR 56.2) |
| 2421 | Cholangitis Sclerosing | 2,036 | 42 | Ursosiol (PRR 50.0) |
| 2422 | Renal Mass | 2,035 | 41 | Anakinra (PRR 16.9) |
| 2423 | Hyperparathyroidism | 2,034 | 65 | Lithium Carbonate (PRR 74.1) |
| 2424 | Neutropenic Colitis | 2,033 | 107 | Cytarabine (PRR 80.4) |
| 2425 | Impulse-Control Disorder | 2,033 | 53 | Pramipexole (PRR 144.0) |
| 2426 | Quadriplegia | 2,026 | 36 | Methylprednisolone Acetate (PRR 18.1) |
| 2427 | Capillary Leak Syndrome | 2,026 | 97 | Gemcitabine Hydrochloride (PRR 36.3) |
| 2428 | Device Connection Issue | 2,026 | 47 | Epoprostenol (PRR 57.7) |
| 2429 | Osteolysis | 2,024 | 117 | Chlorhexidine Gluconate (PRR 48.2) |
| 2430 | Insulin Resistance | 2,023 | 45 | Insulin Human (PRR 76.1) |
| 2431 | Change Of Bowel Habit | 2,022 | 37 | Orlistat (PRR 108.1) |
| 2432 | Injection Site Necrosis | 2,021 | 17 | Glatiramer Acetate (PRR 81.5) |
| 2433 | Chest Injury | 2,020 | 46 | Tobramycin Solution (PRR 18.2) |
| 2434 | Breast Disorder | 2,019 | 55 | Ado-Trastuzumab Emtansine (PRR 60.1) |
| 2435 | Muscle Contracture | 2,017 | 45 | Epoetin Alfa (PRR 32.8) |
| 2436 | Dermatitis Psoriasiform | 2,015 | 35 | Adalimumab-Aaty (PRR 19.6) |
| 2437 | Polycythaemia | 2,014 | 32 | Testosterone (PRR 153.2) |
| 2438 | Renal Haemorrhage | 2,013 | 31 | Rivaroxaban (PRR 27.5) |
| 2439 | Psychotic Symptom | 2,013 | 60 | Aripiprazole Oral (PRR 89.4) |
| 2440 | Rebound Atopic Dermatitis | 2,012 | 11 | Dupilumab (PRR 12,087.9) |
| 2441 | Injection Site Indentation | 2,012 | 22 | Erenumab-Aooe (PRR 36.3) |
| 2442 | Nipple Pain | 2,009 | 40 | Hydrocortisone Sodium Succinate (PRR 33.5) |
| 2443 | Vascular Stent Thrombosis | 2,007 | 24 | Ticagrelor (PRR 366.9) |
| 2444 | Device Related Sepsis | 2,006 | 112 | Teduglutide (PRR 218.8) |
| 2445 | Libido Increased | 2,004 | 72 | Botulinum Toxin Type A (PRR 35.0) |
| 2446 | Coronary Artery Thrombosis | 1,999 | 32 | Tranexamic Acid (PRR 28.4) |
| 2447 | Device Material Issue | 1,999 | 6 | Copper (PRR 301.9) |
| 2448 | Ear Haemorrhage | 1,995 | 24 | Emicizumab (PRR 27.4) |
| 2449 | Eosinophilic Granulomatosis With Polyangiitis | 1,993 | 105 | Ciclesonide (PRR 225.1) |
| 2450 | Adjustment Disorder With Depressed Mood | 1,990 | 192 | Diclofenac Potassium, Film Coated (PRR 1,294.9) |
| 2451 | Cardiac Discomfort | 1,988 | 34 | Telmisartan (PRR 17.2) |
| 2452 | Foaming At Mouth | 1,988 | 27 | Iohexol (PRR 20.4) |
| 2453 | Ejaculation Failure | 1,987 | 17 | Finasteride (PRR 125.4) |
| 2454 | Joint Crepitation | 1,986 | 16 | Ciprofloxacin (PRR 24.7) |
| 2455 | Hypophysitis | 1,986 | 41 | Ipilimumab (PRR 566.7) |
| 2456 | Sudden Hearing Loss | 1,985 | 16 | Adalimumab-Fkjp (PRR 13.5) |
| 2457 | Ultrafiltration Failure | 1,983 | 6 | Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose (PRR 278.5) |
| 2458 | Anorectal Disorder | 1,981 | 33 | Atropine (PRR 23.0) |
| 2459 | Small Intestinal Haemorrhage | 1,980 | 41 | Rivaroxaban (PRR 18.7) |
| 2460 | Lipids Increased | 1,979 | 35 | Inclisiran (PRR 25.1) |
| 2461 | Mucosal Dryness | 1,973 | 41 | Letrozole (PRR 19.5) |
| 2462 | Aplasia | 1,971 | 108 | Cytarabine (PRR 61.0) |
| 2463 | Empyema | 1,968 | 68 | Acetylcysteine (PRR 49.3) |
| 2464 | Occult Blood Positive | 1,968 | 40 | Warfarin Sodium (PRR 16.5) |
| 2465 | Device Deposit Issue | 1,964 | 8 | Albuterol Sulfate (PRR 835.9) |
| 2466 | Diplegia | 1,963 | 30 | Ampicillin (PRR 24.6) |
| 2467 | Hypoglycaemic Unconsciousness | 1,962 | 19 | Human Insulin (PRR 123.1) |
| 2468 | Cell Death | 1,962 | 69 | Fam-Trastuzumab Deruxtecan-Nxki (PRR 28.8) |
| 2469 | Gene Mutation | 1,961 | 122 | Imatinib (PRR 62.0) |
| 2470 | Multi-Organ Disorder | 1,960 | 38 | Salmeterol Xinafoate (PRR 84.1) |
| 2471 | Large Intestinal Stenosis | 1,952 | 25 | Vedolizumab (PRR 42.5) |
| 2472 | Vocal Cord Disorder | 1,952 | 31 | Salmeterol Xinafoate (PRR 13.7) |
| 2473 | Hyperaemia | 1,951 | 35 | Theophylline (PRR 12.1) |
| 2474 | Concomitant Disease Progression | 1,949 | 45 | Everolimus Tablets (PRR 20.0) |
| 2475 | Allergic Reaction To Excipient | 1,946 | 21 | Liothyronine Sodium (PRR 28.6) |
| 2476 | Pneumonia Staphylococcal | 1,945 | 71 | Remdesivir (PRR 31.9) |
| 2477 | Underweight | 1,938 | 32 | Teduglutide (PRR 19.4) |
| 2478 | Immune-Mediated Hepatitis | 1,938 | 46 | Ipilimumab (PRR 176.9) |
| 2479 | Reversible Cerebral Vasoconstriction Syndrome | 1,937 | 61 | Sumatriptan Succinate (PRR 51.9) |
| 2480 | Deep Vein Thrombosis Postoperative | 1,936 | 192 | Diclofenac Potassium, Film Coated (PRR 2,518.8) |
| 2481 | Hypogeusia | 1,935 | 29 | Vismodegib (PRR 59.5) |
| 2482 | Cutaneous Lupus Erythematosus | 1,935 | 32 | Terbinafine Hydrochloride (PRR 41.9) |
| 2483 | Purulence | 1,932 | 12 | Chlorhexidine Gluconate (PRR 10.7) |
| 2484 | Atrophy | 1,932 | 34 | Triamcinolone Acetonide (PRR 17.9) |
| 2485 | Nasal Septum Deviation | 1,931 | 62 | Ciclesonide (PRR 25.7) |
| 2486 | Colostomy | 1,929 | 22 | Niraparib (PRR 16.8) |
| 2487 | Pyelonephritis Acute | 1,927 | 66 | Basiliximab (PRR 24.2) |
| 2488 | Psychiatric Decompensation | 1,926 | 59 | Atazanavir (PRR 149.2) |
| 2489 | Alcohol Interaction | 1,925 | 32 | Ethyl Alcohol (PRR 325.1) |
| 2490 | Abdominal Wall Haematoma | 1,921 | 39 | Fondaparinux Sodium (PRR 82.9) |
| 2491 | Traumatic Lung Injury | 1,919 | 22 | Bleomycin Sulfate (PRR 45.1) |
| 2492 | Rheumatic Disorder | 1,918 | 32 | Icosapent Ethyl (PRR 54.7) |
| 2493 | Arterial Thrombosis | 1,918 | 51 | Heparin Sodium (PRR 25.7) |
| 2494 | Eyelid Pain | 1,915 | 79 | Cenegermin-Bkbj (PRR 1,006.6) |
| 2495 | Gallbladder Injury | 1,915 | 40 | Drospirenone And Ethinyl Estradiol (PRR 2,540.0) |
| 2496 | Joint Noise | 1,914 | 67 | Methylprednisolone Acetate (PRR 40.0) |
| 2497 | Intentional Misuse | 1,911 | 25 | Derma Foam Excel Hand Sanitizer (PRR 62.8) |
| 2498 | Bicytopenia | 1,911 | 76 | Linezolid (PRR 42.2) |
| 2499 | Cleft Palate | 1,910 | 68 | Drs. Clotrimazole (PRR 40.5) |
| 2500 | Conversion Disorder | 1,909 | 31 | Sevoflurane (PRR 21.2) |
| 2501 | Carcinoembryonic Antigen Increased | 1,906 | 52 | Regorafenib (PRR 100.3) |
| 2502 | Hyporeflexia | 1,906 | 28 | Lithium Carbonate (PRR 15.0) |
| 2503 | Cytomegalovirus Chorioretinitis | 1,904 | 131 | Ganciclovir Sodium (PRR 250.2) |
| 2504 | Osteoporotic Fracture | 1,901 | 60 | Raloxifene Hydrochloride (PRR 44.8) |
| 2505 | Bile Duct Obstruction | 1,899 | 52 | Octreotide Acetate (PRR 22.9) |
| 2506 | Hepatic Mass | 1,897 | 64 | Octreotide Acetate (PRR 29.9) |
| 2507 | Pneumonia Cytomegaloviral | 1,895 | 100 | Ganciclovir Sodium (PRR 224.2) |
| 2508 | Adrenal Disorder | 1,895 | 49 | Ipilimumab (PRR 25.7) |
| 2509 | Mechanical Ventilation | 1,893 | 63 | Bosentan (PRR 25.9) |
| 2510 | Adrenocortical Insufficiency Acute | 1,893 | 63 | Anti-Itch (PRR 86.6) |
| 2511 | Ocular Hypertension | 1,891 | 36 | Ranibizumab (PRR 61.6) |
| 2512 | Gingival Recession | 1,891 | 27 | Chlorhexidine Gluconate (PRR 23.1) |
| 2513 | Motion Sickness | 1,891 | 39 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 20.6) |
| 2514 | Hypercoagulation | 1,890 | 21 | Etonogestrel And Ethinyl Estradiol (PRR 191.8) |
| 2515 | Radiotherapy | 1,890 | 40 | Pembrolizumab (PRR 45.0) |
| 2516 | Arterial Disorder | 1,888 | 24 | Nilotinib (PRR 27.1) |
| 2517 | Immune-Mediated Hepatic Disorder | 1,887 | 36 | Pembrolizumab (PRR 232.6) |
| 2518 | Blood Bicarbonate Decreased | 1,884 | 79 | Magnesium Sulfate In Water For (PRR 44.4) |
| 2519 | Early Satiety | 1,882 | 42 | Exenatide (PRR 201.9) |
| 2520 | Human Herpesvirus 6 Infection | 1,881 | 95 | Thiotepa (PRR 421.6) |
| 2521 | Lip Disorder | 1,880 | 17 | Glycerin, Lidocaine (PRR 46.4) |
| 2522 | Myelopathy | 1,879 | 40 | Amphetamine (PRR 65.9) |
| 2523 | Lymphadenopathy Mediastinal | 1,876 | 86 | Exemestane (PRR 32.1) |
| 2524 | Gun Shot Wound | 1,875 | 39 | Ethyl Alcohol (PRR 22.7) |
| 2525 | Pancreatic Cyst | 1,874 | 29 | Pancrelipase (PRR 42.8) |
| 2526 | Jaundice Neonatal | 1,873 | 36 | Nicotine Polacrilex Mini (PRR 74.9) |
| 2527 | Sacroiliitis | 1,872 | 58 | Quinine (PRR 73.4) |
| 2528 | Secondary Progressive Multiple Sclerosis | 1,871 | 27 | Siponimod (PRR 89.3) |
| 2529 | Patient Dissatisfaction With Treatment | 1,870 | 29 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 550.0) |
| 2530 | Intervertebral Discitis | 1,868 | 71 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 52.1) |
| 2531 | Infected Skin Ulcer | 1,866 | 35 | Quinine (PRR 13.1) |
| 2532 | Bone Marrow Transplant | 1,863 | 52 | Venetoclax (PRR 57.6) |
| 2533 | Abortion Incomplete | 1,863 | 11 | Misoprostol (PRR 3,517.3) |
| 2534 | Narcolepsy | 1,862 | 59 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 65.3) |
| 2535 | Mastitis | 1,861 | 28 | Pertuzumab (PRR 22.0) |
| 2536 | Retinal Oedema | 1,860 | 19 | Ranibizumab (PRR 195.1) |
| 2537 | Living In Residential Institution | 1,858 | 28 | Cinacalcet Hydrochloride (PRR 58.0) |
| 2538 | Hypertensive Heart Disease | 1,858 | 61 | Amlodipine Besylate And Benazepril Hydrochloride (PRR 22.0) |
| 2539 | Drug Delivery System Issue | 1,857 | 19 | Budesonide, Glycopyrrolate, And Formoterol Fumarate (PRR 152.4) |
| 2540 | Blood Iron Increased | 1,857 | 37 | Deferasirox (PRR 217.3) |
| 2541 | Small Intestinal Perforation | 1,855 | 59 | Bevacizumab (PRR 27.1) |
| 2542 | Plasmacytoma | 1,854 | 33 | Bortezomib (PRR 83.9) |
| 2543 | Lobar Pneumonia | 1,853 | 67 | Theophylline (PRR 16.8) |
| 2544 | Impatience | 1,851 | 23 | Varenicline Tartrate (PRR 12.5) |
| 2545 | Adenocarcinoma Of Colon | 1,850 | 51 | Panitumumab (PRR 81.5) |
| 2546 | Diffuse Alopecia | 1,846 | 11 | Tofacitinib Citrate (PRR 20.0) |
| 2547 | Stoma Site Erythema | 1,846 | 30 | Carbidopa And Levodopa (PRR 123.4) |
| 2548 | White Blood Cells Urine Positive | 1,844 | 57 | Alemtuzumab (PRR 200.6) |
| 2549 | Hypertrichosis | 1,840 | 24 | Minoxidil Foam 5% (Womens) (PRR 115.9) |
| 2550 | Renal Cancer Stage Iii | 1,839 | 2 | Ranitidine Hydrochloride (PRR 24.3) |
| 2551 | Lymph Node Pain | 1,839 | 32 | Pyrazinamide (PRR 10.9) |
| 2552 | Blood Cholesterol Decreased | 1,838 | 34 | Inclisiran (PRR 119.6) |
| 2553 | Catheter Placement | 1,838 | 40 | Epoprostenol (PRR 257.1) |
| 2554 | Cystoid Macular Oedema | 1,837 | 45 | Ranibizumab (PRR 82.5) |
| 2555 | Tunnel Vision | 1,836 | 30 | Diltiazem Hydrochloride Extended-Release Tablets (PRR 31.4) |
| 2556 | Bladder Spasm | 1,836 | 48 | Fesoterodine Fumarate (PRR 39.5) |
| 2557 | Aura | 1,836 | 38 | Cenobamate (PRR 162.0) |
| 2558 | Stenosis | 1,832 | 45 | Eplerenone (PRR 26.1) |
| 2559 | Metastatic Renal Cell Carcinoma | 1,831 | 15 | Sunitinib Malate (PRR 378.3) |
| 2560 | Opportunistic Infection | 1,830 | 58 | Natalizumab (PRR 42.0) |
| 2561 | Ototoxicity | 1,830 | 72 | Amikacin (PRR 135.5) |
| 2562 | Dysentery | 1,830 | 35 | Epoprostenol (PRR 13.1) |
| 2563 | Accidental Death | 1,829 | 66 | Derma Foam Excel Hand Sanitizer (PRR 89.8) |
| 2564 | Hypoproteinaemia | 1,827 | 90 | Dexamethasone Sodium Phosphate (PRR 44.7) |
| 2565 | Dental Care | 1,826 | 21 | Denosumab (PRR 45.7) |
| 2566 | Nasal Obstruction | 1,824 | 35 | Ciclesonide (PRR 112.4) |
| 2567 | Cerebrospinal Fluid Leakage | 1,821 | 21 | Bupivacaine (PRR 37.3) |
| 2568 | Body Temperature Abnormal | 1,820 | 63 | Mupirocin Calcium (PRR 21.1) |
| 2569 | Oesophageal Spasm | 1,819 | 71 | Dimenhydrinate (PRR 145.3) |
| 2570 | Renal Cancer Stage Ii | 1,817 | 2 | Ranitidine Hydrochloride (PRR 24.4) |
| 2571 | Blood Thyroid Stimulating Hormone Abnormal | 1,816 | 14 | Levothyroxine Sodium (PRR 54.3) |
| 2572 | Injection Site Cellulitis | 1,816 | 20 | Interferon Beta-1B (PRR 68.6) |
| 2573 | Menometrorrhagia | 1,815 | 10 | Etonogestrel (PRR 157.3) |
| 2574 | Lupus Nephritis | 1,814 | 43 | Belimumab (PRR 191.1) |
| 2575 | Mean Cell Haemoglobin Decreased | 1,813 | 69 | Alemtuzumab (PRR 56.8) |
| 2576 | Tetany | 1,812 | 26 | Calcitriol Capsules 0.25 Mcg (PRR 37.4) |
| 2577 | Uterine Spasm | 1,812 | 8 | Levonorgestrel (PRR 111.3) |
| 2578 | Metamorphopsia | 1,812 | 24 | Ranibizumab (PRR 98.2) |
| 2579 | Hypersexuality | 1,811 | 39 | Rasagiline Mesylate (PRR 130.3) |
| 2580 | Traumatic Haemorrhage | 1,810 | 8 | Emicizumab (PRR 121.7) |
| 2581 | Pneumonia Klebsiella | 1,807 | 107 | Busulfan (PRR 33.8) |
| 2582 | Sinus Node Dysfunction | 1,807 | 56 | Amiodarone Hydrochloride (PRR 33.5) |
| 2583 | Venous Occlusion | 1,806 | 23 | Valsartan And Hydrochlorothiazide (PRR 29.4) |
| 2584 | Pneumoperitoneum | 1,806 | 65 | Erlotinib (PRR 21.6) |
| 2585 | Calciphylaxis | 1,806 | 40 | Warfarin (PRR 110.2) |
| 2586 | Conduction Disorder | 1,803 | 46 | Benzonatate (PRR 31.5) |
| 2587 | No Adverse Effect | 1,802 | 5 | Isotretinoin (PRR 509.6) |
| 2588 | Cerebral Venous Thrombosis | 1,800 | 31 | Pegaspargase (PRR 61.6) |
| 2589 | Vitritis | 1,798 | 25 | Faricimab (PRR 422.3) |
| 2590 | Pupillary Reflex Impaired | 1,798 | 37 | Doxepin (PRR 24.3) |
| 2591 | Monoparesis | 1,797 | 54 | Doxepin Hydrochloride (PRR 82.8) |
| 2592 | Vulvovaginal Swelling | 1,795 | 16 | Miconazole Nitrate (PRR 511.3) |
| 2593 | Soft Tissue Infection | 1,789 | 95 | Azacitidine For (PRR 33.5) |
| 2594 | Liver Transplant Rejection | 1,787 | 49 | Tacrolimus (PRR 211.2) |
| 2595 | Obsessive Thoughts | 1,787 | 45 | Atomoxetine Hydrochloride (PRR 15.4) |
| 2596 | Disorganised Speech | 1,785 | 47 | Voriconazole (PRR 46.7) |
| 2597 | Homicide | 1,782 | 34 | Ethyl Alcohol (PRR 60.7) |
| 2598 | Application Site Discomfort | 1,780 | 20 | Pegfilgrastim (PRR 64.2) |
| 2599 | Device Alarm Issue | 1,780 | 41 | Epoprostenol (PRR 299.1) |
| 2600 | Product Storage Issue | 1,779 | 14 | Insulin Glargine (PRR 43.6) |
| 2601 | Muscle Cramp | 1,777 | 20 | Teriparatide (PRR 82.7) |
| 2602 | Uterine Polyp | 1,775 | 14 | Copper (PRR 32.8) |
| 2603 | Vocal Cord Paralysis | 1,775 | 39 | Atovaquone (PRR 20.5) |
| 2604 | Fear Of Disease | 1,774 | 27 | Drospirenone And Ethinyl Estradiol (PRR 209.5) |
| 2605 | Product Tampering | 1,772 | 17 | Tirzepatide (PRR 45.5) |
| 2606 | Joint Arthroplasty | 1,771 | 47 | Anakinra (PRR 71.1) |
| 2607 | Nasal Oedema | 1,770 | 58 | Theophylline (PRR 274.4) |
| 2608 | Schizoaffective Disorder | 1,770 | 60 | Drs. Clotrimazole (PRR 246.2) |
| 2609 | Blood Hiv Rna Increased | 1,770 | 37 | Cabotegravir (PRR 257.8) |
| 2610 | Contrast Media Allergy | 1,769 | 19 | Iohexol (PRR 407.2) |
| 2611 | Imprisonment | 1,769 | 34 | Hydrocodone Bitartrate And Acetaminophen (PRR 48.8) |
| 2612 | Aortic Valve Stenosis | 1,766 | 67 | Theophylline Anhydrous (PRR 98.6) |
| 2613 | Paraparesis | 1,764 | 58 | Siponimod (PRR 22.7) |
| 2614 | Ophthalmic Herpes Zoster | 1,764 | 33 | Baricitinib (PRR 23.5) |
| 2615 | X-Ray Abnormal | 1,762 | 179 | Diclofenac Potassium, Film Coated (PRR 987.8) |
| 2616 | Drug Withdrawal Convulsions | 1,762 | 35 | Vigabatrin (PRR 528.2) |
| 2617 | Pneumomediastinum | 1,761 | 84 | Remdesivir (PRR 62.7) |
| 2618 | Induration | 1,759 | 28 | Fondaparinux Sodium (PRR 29.6) |
| 2619 | Granulocyte Count Decreased | 1,759 | 62 | Dextrose Monohydrate (PRR 109.9) |
| 2620 | Breast Cyst | 1,758 | 17 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 24.2) |
| 2621 | Drug Monitoring Procedure Not Performed | 1,757 | 19 | Niraparib (PRR 160.5) |
| 2622 | Ileal Stenosis | 1,755 | 18 | Azathioprine (PRR 43.1) |
| 2623 | Mitral Valve Disease | 1,755 | 32 | Mesna Injection (PRR 17.3) |
| 2624 | Histoplasmosis | 1,751 | 36 | Itraconazole (PRR 120.6) |
| 2625 | Kyphosis | 1,751 | 70 | Alendronate Sodium (PRR 54.8) |
| 2626 | Epstein-Barr Virus Associated Lymphoproliferative Disorder | 1,749 | 63 | Anti-Thymocyte Globulin (Rabbit) (PRR 184.9) |
| 2627 | Cytomegalovirus Test Positive | 1,748 | 106 | Anti-Thymocyte Globulin (Rabbit) (PRR 181.6) |
| 2628 | Intra-Abdominal Fluid Collection | 1,748 | 53 | Regorafenib (PRR 28.1) |
| 2629 | Suspected Product Quality Issue | 1,748 | 15 | Aflibercept (PRR 12.8) |
| 2630 | Cardiac Ablation | 1,747 | 38 | Dofetilide (PRR 74.1) |
| 2631 | Polymyositis | 1,744 | 25 | Posaconazole Delayed-Release (PRR 37.7) |
| 2632 | Gastrointestinal Oedema | 1,743 | 24 | Regorafenib (PRR 13.5) |
| 2633 | Jugular Vein Thrombosis | 1,742 | 77 | Drospirenone And Ethinyl Estradiol (PRR 43.6) |
| 2634 | Drug Screen Negative | 1,742 | 18 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 95.6) |
| 2635 | Subacute Cutaneous Lupus Erythematosus | 1,741 | 44 | Terbinafine Hydrochloride (PRR 106.9) |
| 2636 | Pseudomonal Sepsis | 1,739 | 146 | Pegaspargase (PRR 238.4) |
| 2637 | Transplant Dysfunction | 1,738 | 54 | Tacrolimus (PRR 335.9) |
| 2638 | Food Interaction | 1,738 | 27 | Nilotinib (PRR 19.6) |
| 2639 | Alopecia Areata | 1,733 | 35 | Baricitinib (PRR 62.8) |
| 2640 | Extremity Necrosis | 1,733 | 46 | Norepinephrine Bitartrate (PRR 51.8) |
| 2641 | Skin Hypopigmentation | 1,731 | 23 | Adapalene (PRR 61.6) |
| 2642 | Sensitivity Of Teeth | 1,731 | 15 | Chlorhexidine Gluconate (PRR 19.9) |
| 2643 | Emotional Poverty | 1,731 | 43 | Asenapine Maleate (PRR 83.2) |
| 2644 | Incorrect Storage Of Drug | 1,730 | 14 | Methylphenidate (PRR 52.5) |
| 2645 | Breast Discharge | 1,729 | 23 | Paliperidone Palmitate (PRR 43.0) |
| 2646 | Fanconi Syndrome Acquired | 1,728 | 46 | Tenofovir Disoproxil Fumarate (PRR 313.5) |
| 2647 | Burns Second Degree | 1,727 | 76 | Felodipine Extended-Release Tablets (PRR 178.8) |
| 2648 | Immune-Mediated Lung Disease | 1,725 | 40 | Nivolumab (PRR 148.5) |
| 2649 | Spinal Cord Injury | 1,725 | 24 | Oxymorphone Hydrochloride (PRR 34.8) |
| 2650 | Vertigo Positional | 1,725 | 44 | Meclizine Hcl 12.5Mg (PRR 24.3) |
| 2651 | Vascular Pseudoaneurysm | 1,723 | 37 | Prasugrel Hydrochloride (PRR 52.4) |
| 2652 | Mastectomy | 1,723 | 37 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 49.7) |
| 2653 | Pupil Fixed | 1,722 | 36 | Atropine (PRR 29.5) |
| 2654 | Otorrhoea | 1,721 | 13 | Desoximetasone (PRR 16.7) |
| 2655 | Spondylolisthesis | 1,720 | 51 | Alendronate Sodium (PRR 71.0) |
| 2656 | Hypopituitarism | 1,720 | 53 | Ipilimumab (PRR 160.4) |
| 2657 | Wound Infection Staphylococcal | 1,719 | 20 | Basiliximab (PRR 17.7) |
| 2658 | Recalled Product | 1,717 | 20 | Calcitriol Capsules 0.25 Mcg (PRR 394.5) |
| 2659 | Blood Amylase Increased | 1,715 | 41 | Sorafenib (PRR 71.3) |
| 2660 | Splenic Infarction | 1,714 | 43 | Hydroxyurea (PRR 26.5) |
| 2661 | Suspected Off Label Use | 1,713 | 65 | Infliximab-Dyyb (PRR 62.8) |
| 2662 | Terminal Insomnia | 1,713 | 54 | Sodium Oxybate (PRR 73.1) |
| 2663 | Rotator Cuff Repair | 1,711 | 22 | Methylprednisolone Acetate (PRR 49.5) |
| 2664 | Chorea | 1,708 | 50 | Metoclopramide (PRR 45.7) |
| 2665 | Meningitis Cryptococcal | 1,707 | 80 | Amphotericin B (PRR 138.0) |
| 2666 | Cervical Spinal Stenosis | 1,707 | 58 | Modafinil (PRR 15.4) |
| 2667 | Kidney Fibrosis | 1,707 | 57 | Basiliximab (PRR 106.6) |
| 2668 | Amyloidosis | 1,705 | 34 | Tafamidis (PRR 124.2) |
| 2669 | Papillary Thyroid Cancer | 1,704 | 30 | Bleomycin Sulfate (PRR 27.6) |
| 2670 | Medical Device Removal | 1,704 | 11 | Alendronate Sodium (PRR 75.4) |
| 2671 | Tongue Coated | 1,704 | 29 | Bimekizumab (PRR 17.5) |
| 2672 | Neuropathy | 1,703 | 19 | Thalidomide (PRR 55.1) |
| 2673 | Blood Chloride Increased | 1,701 | 59 | Tolvaptan (PRR 24.8) |
| 2674 | Lack Of Injection Site Rotation | 1,700 | 16 | Naltrexone (PRR 45.3) |
| 2675 | Mycobacterial Infection | 1,700 | 84 | Rifampin (PRR 90.9) |
| 2676 | Drug Dose Titration Not Performed | 1,700 | 29 | Siponimod (PRR 60.5) |
| 2677 | Female Genital Tract Fistula | 1,699 | 178 | Carboxymethylcellulose Sodium (PRR 241.3) |
| 2678 | Acute Sinusitis | 1,699 | 63 | Alendronate Sodium (PRR 23.7) |
| 2679 | Blood Ph Decreased | 1,698 | 43 | Magnesium Sulfate In Water For (PRR 55.6) |
| 2680 | Exposure To Sars-Cov-2 | 1,696 | 33 | Infliximab-Dyyb (PRR 67.0) |
| 2681 | Thyroidectomy | 1,694 | 12 | Thyroid, Porcine (PRR 26.9) |
| 2682 | Biliary Dyskinesia | 1,693 | 61 | Drospirenone And Ethinyl Estradiol (PRR 2,532.5) |
| 2683 | Serum Ferritin Decreased | 1,693 | 24 | Deferasirox (PRR 46.1) |
| 2684 | Bladder Neoplasm | 1,693 | 21 | Pioglitazone (PRR 23.8) |
| 2685 | Hyperammonaemic Encephalopathy | 1,691 | 61 | Valproic Acid (PRR 254.6) |
| 2686 | Laziness | 1,691 | 33 | Relugolix (PRR 21.4) |
| 2687 | Infusion Site Discharge | 1,688 | 178 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 204.4) |
| 2688 | Pancreatic Failure | 1,687 | 24 | Pancrelipase (PRR 324.9) |
| 2689 | Sleep Talking | 1,686 | 42 | Sodium Oxybate (PRR 38.8) |
| 2690 | Injection Site Oedema | 1,684 | 29 | Pegvaliase-Pqpz (PRR 25.8) |
| 2691 | Ectopic Pregnancy With Contraceptive Device | 1,682 | 4 | Levonorgestrel (PRR 310.5) |
| 2692 | Lower Respiratory Tract Congestion | 1,681 | 60 | Omalizumab (PRR 41.3) |
| 2693 | Erosive Oesophagitis | 1,680 | 15 | Mesna Injection (PRR 19.6) |
| 2694 | Enteritis Infectious | 1,680 | 34 | Azacitidine (PRR 12.3) |
| 2695 | Gaze Palsy | 1,679 | 57 | Phenobarbital (PRR 33.2) |
| 2696 | Spleen Disorder | 1,678 | 22 | Ruxolitinib (PRR 37.8) |
| 2697 | Post Procedural Haematoma | 1,675 | 25 | Fondaparinux Sodium (PRR 93.9) |
| 2698 | Bladder Cancer Stage Iv | 1,674 | 2 | Ranitidine Hydrochloride (PRR 15.9) |
| 2699 | Hepatorenal Syndrome | 1,674 | 64 | Quinine (PRR 56.3) |
| 2700 | Miliaria | 1,673 | 28 | Diclofenac Potassium, Film Coated (PRR 17.9) |
| 2701 | Spinal Deformity | 1,673 | 15 | Thiamine Hydrochloride (PRR 18.2) |
| 2702 | Dementia Alzheimer'S Type | 1,673 | 19 | Rivastigmine (PRR 116.7) |
| 2703 | Tympanic Membrane Perforation | 1,673 | 7 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 18.4) |
| 2704 | Fixed Eruption | 1,672 | 46 | Doxycycline Hyclate (PRR 27.4) |
| 2705 | Leukaemia Recurrent | 1,669 | 50 | Imatinib (PRR 88.1) |
| 2706 | Differential White Blood Cell Count Abnormal | 1,669 | 9 | Clozapine (PRR 1,462.4) |
| 2707 | Deafness Bilateral | 1,669 | 27 | Amikacin (PRR 26.1) |
| 2708 | Cerebellar Infarction | 1,667 | 33 | Febuxostat Tablets 40 Mg (PRR 17.3) |
| 2709 | Tongue Neoplasm Malignant Stage Unspecified | 1,667 | 4 | Ranitidine (PRR 18.8) |
| 2710 | Rectal Abscess | 1,661 | 32 | Infliximab-Dyyb (PRR 42.2) |
| 2711 | Malignant Pleural Effusion | 1,661 | 75 | Gefitinib (PRR 42.4) |
| 2712 | Pathological Gambling | 1,661 | 12 | Rasagiline Mesylate (PRR 71.3) |
| 2713 | Antibody Test Positive | 1,658 | 31 | Anakinra (PRR 207.0) |
| 2714 | Product Counterfeit | 1,658 | 14 | Fentanyl (PRR 40.6) |
| 2715 | Product Container Seal Issue | 1,658 | 24 | Travoprost (PRR 68.6) |
| 2716 | Enterobacter Infection | 1,657 | 101 | Pegaspargase (PRR 160.5) |
| 2717 | Educational Problem | 1,656 | 18 | Methylphenidate (PRR 88.6) |
| 2718 | Seizure Like Phenomena | 1,656 | 42 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 39.5) |
| 2719 | Colonic Polyp | 1,654 | 66 | Isotretinoin (PRR 35.5) |
| 2720 | Salmonellosis | 1,652 | 17 | Ampicillin (PRR 13.8) |
| 2721 | Glioblastoma | 1,651 | 21 | Temozolomide (PRR 192.1) |
| 2722 | Vein Rupture | 1,650 | 30 | Infliximab-Dyyb (PRR 53.3) |
| 2723 | Tonsillectomy | 1,650 | 29 | Alendronate Sodium (PRR 46.0) |
| 2724 | Vaccination Failure | 1,649 | 36 | Bendamustine Hcl (PRR 32.5) |
| 2725 | Illusion | 1,649 | 44 | Amantadine (PRR 24.9) |
| 2726 | Tonsillar Hypertrophy | 1,649 | 12 | Trimethoprim (PRR 16.2) |
| 2727 | Contraindicated Product Prescribed | 1,649 | 28 | Dutasteride (PRR 125.3) |
| 2728 | Retinitis | 1,648 | 194 | Diclofenac Potassium, Film Coated (PRR 1,321.4) |
| 2729 | Food Aversion | 1,647 | 26 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 71.7) |
| 2730 | Resuscitation | 1,647 | 29 | Iohexol (PRR 26.2) |
| 2731 | Mitral Valve Prolapse | 1,646 | 29 | Alendronate Sodium (PRR 34.4) |
| 2732 | Vena Cava Thrombosis | 1,645 | 57 | Drospirenone And Ethinyl Estradiol (PRR 55.9) |
| 2733 | Gastric Dilatation | 1,645 | 31 | Eplerenone (PRR 16.0) |
| 2734 | Skin Wound | 1,643 | 26 | Panitumumab (PRR 23.9) |
| 2735 | Linear Iga Disease | 1,643 | 53 | Vancomycin Hydrochloride (PRR 220.1) |
| 2736 | Systemic Infection | 1,642 | 90 | Torsemide (PRR 126.2) |
| 2737 | Mean Cell Haemoglobin Concentration Decreased | 1,642 | 51 | Clozapine (PRR 50.5) |
| 2738 | Troponin I Increased | 1,641 | 41 | Leucovorin Calcium (PRR 16.8) |
| 2739 | Mean Cell Haemoglobin Increased | 1,638 | 48 | Dimenhydrinate (PRR 52.6) |
| 2740 | Quadriparesis | 1,638 | 48 | Amphetamine (PRR 37.4) |
| 2741 | Intestinal Polyp | 1,636 | 15 | Teduglutide (PRR 17.2) |
| 2742 | Blood Calcium Abnormal | 1,634 | 38 | Calcitriol Capsules 0.25 Mcg (PRR 54.8) |
| 2743 | Spinal Cord Disorder | 1,630 | 23 | Daptomycin (PRR 19.5) |
| 2744 | Injection Site Atrophy | 1,629 | 15 | Asfotase Alfa (PRR 230.9) |
| 2745 | Leukocytoclastic Vasculitis | 1,629 | 14 | Rifampicin (PRR 23.0) |
| 2746 | Papilloma Viral Infection | 1,628 | 30 | Etonogestrel And Ethinyl Estradiol (PRR 54.2) |
| 2747 | Arthropod Sting | 1,625 | 24 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 22.0) |
| 2748 | Oropharyngeal Blistering | 1,624 | 18 | Asenapine Maleate (PRR 33.0) |
| 2749 | Metabolic Syndrome | 1,622 | 39 | Olanzapine Pamoate (PRR 83.0) |
| 2750 | Seborrhoeic Dermatitis | 1,621 | 42 | Ketoconazole (PRR 78.1) |
| 2751 | Splenic Rupture | 1,620 | 21 | Filgrastim (PRR 16.9) |
| 2752 | Bradyarrhythmia | 1,620 | 57 | Itraconazole (PRR 37.0) |
| 2753 | Pituitary Tumour Benign | 1,620 | 35 | Lanreotide Acetate (PRR 60.3) |
| 2754 | Optic Atrophy | 1,618 | 36 | Vigabatrin (PRR 48.3) |
| 2755 | Medical Procedure | 1,617 | 32 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 70.7) |
| 2756 | Pulmonary Arterial Pressure Increased | 1,614 | 30 | Selexipag (PRR 109.9) |
| 2757 | Bladder Cancer Stage Ii | 1,612 | 3 | Ranitidine Hydrochloride (PRR 22.3) |
| 2758 | Costochondritis | 1,611 | 23 | Etonogestrel And Ethinyl Estradiol (PRR 23.9) |
| 2759 | Dental Implantation | 1,610 | 10 | Denosumab (PRR 34.7) |
| 2760 | Skull Fracture | 1,609 | 20 | Cenobamate (PRR 23.5) |
| 2761 | Oxygen Therapy | 1,608 | 46 | Selexipag (PRR 49.4) |
| 2762 | Intra-Uterine Death | 1,607 | 26 | Lopinavir And Ritonavir (PRR 61.6) |
| 2763 | Anticonvulsant Drug Level Increased | 1,606 | 31 | Extended Phenytoin Sodium (PRR 303.3) |
| 2764 | Iga Nephropathy | 1,603 | 38 | Atovaquone (PRR 61.1) |
| 2765 | Myocardial Necrosis Marker Increased | 1,602 | 23 | Agalsidase Beta (PRR 25.6) |
| 2766 | Intercepted Product Dispensing Error | 1,601 | 11 | Tirzepatide (PRR 69.3) |
| 2767 | Cardiovascular Insufficiency | 1,601 | 36 | Calcium Gluconate (PRR 29.6) |
| 2768 | Strongyloidiasis | 1,600 | 88 | Basiliximab (PRR 131.9) |
| 2769 | Acute Leukaemia | 1,600 | 35 | Deferasirox (PRR 47.3) |
| 2770 | Aortic Valve Disease | 1,597 | 19 | Captopril (PRR 15.0) |
| 2771 | Analgesic Drug Level Increased | 1,596 | 20 | Acetaminophen Tablet Extended Release (PRR 46.6) |
| 2772 | Treatment Delayed | 1,596 | 20 | Cenegermin-Bkbj (PRR 101.6) |
| 2773 | Respiratory Alkalosis | 1,596 | 47 | Haloperidol Lactate (PRR 22.1) |
| 2774 | Vasoplegia Syndrome | 1,594 | 59 | Norepinephrine (PRR 154.2) |
| 2775 | Disinhibition | 1,591 | 56 | Asenapine Maleate (PRR 251.8) |
| 2776 | Cryptococcosis | 1,590 | 77 | Amphotericin B (PRR 117.4) |
| 2777 | Depersonalisation/Derealisation Disorder | 1,589 | 45 | Paroxetine Hydrochloride Hemihydrate (PRR 35.3) |
| 2778 | Night Blindness | 1,589 | 11 | Isotretinoin (PRR 32.4) |
| 2779 | Injection Related Reaction | 1,588 | 30 | Ofatumumab (PRR 42.9) |
| 2780 | Cystitis Interstitial | 1,585 | 27 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 15.3) |
| 2781 | Colon Cancer Metastatic | 1,585 | 23 | Regorafenib (PRR 92.7) |
| 2782 | Optic Nerve Disorder | 1,583 | 24 | Brinzolamide (PRR 19.8) |
| 2783 | Hypoglycaemia Neonatal | 1,582 | 32 | Ampicillin (PRR 24.0) |
| 2784 | Idiopathic Thrombocytopenic Purpura | 1,582 | 16 | Romiplostim (PRR 78.4) |
| 2785 | Total Lung Capacity Decreased | 1,581 | 110 | Phytonadione (PRR 110.2) |
| 2786 | Nasal Ulcer | 1,581 | 30 | Desloratadine (PRR 37.5) |
| 2787 | Ovarian Cancer Recurrent | 1,580 | 15 | Niraparib (PRR 427.4) |
| 2788 | Antiphospholipid Syndrome | 1,579 | 22 | Romiplostim (PRR 29.5) |
| 2789 | Focal Segmental Glomerulosclerosis | 1,578 | 47 | Basiliximab (PRR 149.5) |
| 2790 | Jc Virus Infection | 1,577 | 88 | Busulfan (PRR 81.9) |
| 2791 | Tinea Pedis | 1,577 | 32 | Terbinafine Hydrochloride (PRR 36.2) |
| 2792 | Inappropriate Affect | 1,577 | 36 | Aripiprazole Oral (PRR 16.1) |
| 2793 | Scleritis | 1,576 | 66 | Methylprednisolone Acetate (PRR 135.3) |
| 2794 | Limb Deformity | 1,575 | 34 | Leflunomide (PRR 36.3) |
| 2795 | Pneumonia Legionella | 1,575 | 27 | Alemtuzumab (PRR 23.7) |
| 2796 | Metabolic Alkalosis | 1,574 | 42 | Sodium Bicarbonate (PRR 46.0) |
| 2797 | Intermittent Claudication | 1,574 | 34 | Nilotinib (PRR 83.7) |
| 2798 | Neonatal Disorder | 1,574 | 26 | Zidovudine (PRR 113.5) |
| 2799 | Glycosylated Haemoglobin Decreased | 1,573 | 30 | Oral Semaglutide (PRR 29.6) |
| 2800 | Anticholinergic Syndrome | 1,573 | 69 | Loperamide Hydrochloride Oral (PRR 99.1) |
| 2801 | Respiratory Disorder Neonatal | 1,571 | 39 | Misoprostol (PRR 70.2) |
| 2802 | Inhibitory Drug Interaction | 1,570 | 59 | Cimetidine (PRR 79.9) |
| 2803 | Intestinal Ulcer | 1,561 | 17 | Infliximab-Dyyb (PRR 15.8) |
| 2804 | Urine Ketone Body Present | 1,560 | 28 | Dimenhydrinate (PRR 123.8) |
| 2805 | Enthesopathy | 1,557 | 93 | Dimenhydrinate (PRR 286.1) |
| 2806 | Osteosclerosis | 1,557 | 109 | Chlorhexidine Gluconate (PRR 83.4) |
| 2807 | Transcription Medication Error | 1,557 | 7 | Guanfacine (PRR 13.7) |
| 2808 | Keratopathy | 1,555 | 24 | Amiodarone Hydrochloride (PRR 37.8) |
| 2809 | Ophthalmoplegia | 1,552 | 43 | Zidovudine (PRR 79.0) |
| 2810 | Polycystic Ovaries | 1,551 | 62 | Liothyronine Sodium (PRR 487.8) |
| 2811 | Hepatitis E | 1,549 | 52 | Everolimus Tablets (PRR 61.3) |
| 2812 | Megacolon | 1,545 | 65 | Metronidazole Topical (PRR 33.4) |
| 2813 | Joint Destruction | 1,544 | 82 | Anakinra (PRR 246.9) |
| 2814 | Fungaemia | 1,544 | 111 | Micafungin Sodium (PRR 137.6) |
| 2815 | Pulmonary Function Test Abnormal | 1,542 | 71 | Oseltamivir Phosphate (PRR 111.8) |
| 2816 | Gastrointestinal Stoma Complication | 1,541 | 36 | Teduglutide (PRR 213.2) |
| 2817 | Pharyngeal Paraesthesia | 1,540 | 29 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 54.0) |
| 2818 | Coagulation Time Prolonged | 1,539 | 27 | Heparin Sodium (PRR 44.5) |
| 2819 | Bronchial Disorder | 1,539 | 53 | Ciclesonide (PRR 71.7) |
| 2820 | Violence-Related Symptom | 1,539 | 21 | Varenicline Tartrate (PRR 33.2) |
| 2821 | Osteomalacia | 1,539 | 30 | Tenofovir Disoproxil Fumarate (PRR 121.4) |
| 2822 | Histoplasmosis Disseminated | 1,538 | 50 | Itraconazole (PRR 102.9) |
| 2823 | Shoulder Fracture | 1,537 | 39 | Emtricitabine And Tenofovir Alafenamide (PRR 20.5) |
| 2824 | Vascular Rupture | 1,536 | 19 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 16.8) |
| 2825 | Neoplasm Skin | 1,535 | 56 | Quinine (PRR 36.9) |
| 2826 | Accidental Drug Intake By Child | 1,535 | 7 | Famotidine (PRR 11.8) |
| 2827 | Intestinal Operation | 1,534 | 11 | Risankizumab-Rzaa (PRR 26.7) |
| 2828 | Onycholysis | 1,533 | 35 | Docetaxel Anhydrous (PRR 32.2) |
| 2829 | Myelitis | 1,532 | 35 | Bleomycin Sulfate (PRR 29.3) |
| 2830 | Electrocardiogram T Wave Abnormal | 1,532 | 35 | Lithium Carbonate (PRR 28.6) |
| 2831 | Bacterial Vaginosis | 1,530 | 17 | Copper (PRR 101.4) |
| 2832 | Premature Separation Of Placenta | 1,530 | 38 | Misoprostol (PRR 58.8) |
| 2833 | Parainfluenzae Virus Infection | 1,528 | 105 | Pegaspargase (PRR 170.0) |
| 2834 | Mean Cell Volume Decreased | 1,526 | 47 | Alemtuzumab (PRR 47.8) |
| 2835 | Daydreaming | 1,526 | 27 | Rivastigmine (PRR 16.9) |
| 2836 | Sinus Arrest | 1,526 | 34 | Ticagrelor (PRR 51.6) |
| 2837 | Oral Mucosal Erythema | 1,526 | 13 | Rizatriptan Benzoate (PRR 14.8) |
| 2838 | Hypertrophic Cardiomyopathy | 1,524 | 23 | Agalsidase Beta (PRR 28.4) |
| 2839 | Anticoagulation Drug Level Above Therapeutic | 1,523 | 40 | Warfarin (PRR 287.3) |
| 2840 | Substance Use | 1,521 | 49 | Methadone Hydrochloride (PRR 84.5) |
| 2841 | Blood Pressure Immeasurable | 1,520 | 14 | Iohexol (PRR 54.0) |
| 2842 | Neuritis | 1,519 | 96 | Dutasteride (PRR 282.4) |
| 2843 | Immune-Mediated Myocarditis | 1,519 | 27 | Pembrolizumab (PRR 184.0) |
| 2844 | Eye Allergy | 1,518 | 25 | Travoprost (PRR 51.8) |
| 2845 | Genital Herpes | 1,517 | 28 | Valacyclovir Hydrochloride (PRR 30.2) |
| 2846 | Gastrostomy | 1,517 | 38 | Cenobamate (PRR 23.2) |
| 2847 | Calculus Urinary | 1,517 | 40 | Atazanavir (PRR 73.2) |
| 2848 | Product Deposit | 1,516 | 16 | Testosterone Cypionate (PRR 620.7) |
| 2849 | Myoglobin Blood Increased | 1,514 | 44 | Mometasone (PRR 101.1) |
| 2850 | Contraindication To Medical Treatment | 1,513 | 14 | Fondaparinux Sodium (PRR 24.0) |
| 2851 | Rubber Sensitivity | 1,512 | 28 | Omalizumab (PRR 25.0) |
| 2852 | Palliative Care | 1,512 | 25 | Lanreotide Acetate (PRR 39.2) |
| 2853 | Oral Mucosal Eruption | 1,510 | 22 | Acetylcysteine (PRR 20.7) |
| 2854 | Hypotonia Neonatal | 1,510 | 46 | Venlafaxine (PRR 32.2) |
| 2855 | Age-Related Macular Degeneration | 1,508 | 10 | Ranibizumab (PRR 327.8) |
| 2856 | Mouth Injury | 1,505 | 15 | Emicizumab (PRR 31.9) |
| 2857 | Fungal Peritonitis | 1,505 | 19 | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 140.8) |
| 2858 | Hypoaesthesia Facial | 1,503 | 16 | Lisinopril And Hydrochlorothiazide Tablets (PRR 12.4) |
| 2859 | Stoma Site Haemorrhage | 1,502 | 32 | Teduglutide (PRR 131.6) |
| 2860 | Coital Bleeding | 1,502 | 6 | Levonorgestrel (PRR 136.0) |
| 2861 | Adhesion | 1,501 | 16 | Adalimumab (PRR 11.7) |
| 2862 | Infertility Female | 1,500 | 8 | Copper (PRR 114.5) |
| 2863 | Pneumonia Pseudomonal | 1,500 | 94 | Tobramycin Solution (PRR 43.8) |
| 2864 | Incorrect Dose Administered By Product | 1,500 | 23 | Budesonide, Glycopyrrolate, And Formoterol Fumarate (PRR 60.2) |
| 2865 | Medical Device Implantation | 1,498 | 15 | Upadacitinib (PRR 28.3) |
| 2866 | Mantle Cell Lymphoma | 1,497 | 27 | Bendamustine Hcl (PRR 97.0) |
| 2867 | Oral Mucosal Exfoliation | 1,496 | 18 | Anakinra (PRR 92.7) |
| 2868 | Astigmatism | 1,492 | 26 | Valproate Sodium (PRR 54.7) |
| 2869 | Aspartate Aminotransferase Abnormal | 1,491 | 75 | Methylprednisolone Acetate (PRR 38.9) |
| 2870 | Infectious Pleural Effusion | 1,490 | 69 | Basiliximab (PRR 42.5) |
| 2871 | Injection Site Paraesthesia | 1,488 | 21 | Botulinum Toxin Type A (PRR 17.1) |
| 2872 | Epicondylitis | 1,488 | 20 | Phytonadione (PRR 19.9) |
| 2873 | Intercepted Drug Dispensing Error | 1,488 | 4 | Insulin Lispro (PRR 41.5) |
| 2874 | Gastritis Haemorrhagic | 1,485 | 16 | Rivaroxaban (PRR 27.1) |
| 2875 | Marasmus | 1,485 | 30 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 73.9) |
| 2876 | Haemorrhagic Transformation Stroke | 1,483 | 13 | Alteplase (PRR 571.3) |
| 2877 | Gingival Hypertrophy | 1,482 | 35 | Phenytoin (PRR 60.6) |
| 2878 | Superinfection | 1,482 | 42 | Ciclesonide (PRR 76.8) |
| 2879 | Infertility | 1,481 | 17 | Medroxyprogesterone Acetate (PRR 20.7) |
| 2880 | Tobacco User | 1,479 | 16 | Varenicline Tartrate (PRR 299.5) |
| 2881 | Pelvic Inflammatory Disease | 1,478 | 15 | Levonorgestrel (PRR 70.7) |
| 2882 | Pituitary Tumour | 1,478 | 12 | Octreotide Acetate (PRR 60.5) |
| 2883 | Angioplasty | 1,477 | 38 | Ranolazine (PRR 48.4) |
| 2884 | Secondary Adrenocortical Insufficiency | 1,477 | 68 | Ipilimumab (PRR 86.5) |
| 2885 | Blood Parathyroid Hormone Decreased | 1,472 | 92 | Febuxostat Tablets 40 Mg (PRR 221.8) |
| 2886 | Skin Striae | 1,471 | 30 | Ritonavir 100 Mg (PRR 30.0) |
| 2887 | Complex Regional Pain Syndrome | 1,468 | 35 | Rizatriptan Benzoate (PRR 26.8) |
| 2888 | Enterocolitis Haemorrhagic | 1,468 | 25 | Dasatinib (PRR 32.6) |
| 2889 | Gastrointestinal Wall Thickening | 1,466 | 41 | Mercaptopurine (PRR 33.6) |
| 2890 | Knee Deformity | 1,466 | 12 | Valproate Sodium (PRR 33.3) |
| 2891 | Apraxia | 1,465 | 45 | Blinatumomab (PRR 26.2) |
| 2892 | Cholangiocarcinoma | 1,465 | 31 | Durvalumab (PRR 30.2) |
| 2893 | Nephrectomy | 1,464 | 44 | Liothyronine Sodium (PRR 147.3) |
| 2894 | Impetigo | 1,463 | 26 | Terbinafine Hydrochloride (PRR 35.8) |
| 2895 | Axillary Pain | 1,462 | 27 | Ado-Trastuzumab Emtansine (PRR 37.7) |
| 2896 | Pneumonia Pneumococcal | 1,461 | 45 | Valganciclovir Hydrochloride Powder, (PRR 27.3) |
| 2897 | Excessive Eye Blinking | 1,459 | 69 | Metoclopramide (PRR 91.4) |
| 2898 | Genital Pain | 1,458 | 20 | Trimethoprim (PRR 53.6) |
| 2899 | Hyperthermia Malignant | 1,458 | 37 | Sevoflurane (PRR 613.5) |
| 2900 | Mental Fatigue | 1,458 | 25 | Cariprazine (PRR 10.8) |
| 2901 | Biliary Dilatation | 1,457 | 30 | Lapatinib (PRR 18.7) |
| 2902 | Precancerous Skin Lesion | 1,456 | 8 | Risankizumab-Rzaa (PRR 15.9) |
| 2903 | Gallbladder Cancer | 1,456 | 9 | Ranitidine Hydrochloride (PRR 39.4) |
| 2904 | Dark Circles Under Eyes | 1,454 | 20 | Bimatoprost (PRR 41.4) |
| 2905 | Diabetes Mellitus Non-Insulin-Dependent | 1,454 | 25 | Olanzapine Pamoate (PRR 330.1) |
| 2906 | Myoclonic Epilepsy | 1,454 | 40 | Clobazam (PRR 96.5) |
| 2907 | Pregnancy On Contraceptive | 1,453 | 16 | Copper (PRR 264.6) |
| 2908 | Nuclear Magnetic Resonance Imaging Brain Abnormal | 1,453 | 17 | Temozolomide (PRR 30.1) |
| 2909 | Heat Stroke | 1,452 | 10 | Topiramate (PRR 20.2) |
| 2910 | Cardiac Fibrillation | 1,452 | 10 | Dofetilide (PRR 17.9) |
| 2911 | Acute Abdomen | 1,450 | 25 | Dabigatran Etexilate Mesylate (PRR 14.3) |
| 2912 | Generalised Anxiety Disorder | 1,449 | 42 | Buspirone Hydrochloride (PRR 19.7) |
| 2913 | Nodal Rhythm | 1,449 | 30 | Diltiazem Hydrochloride Extended-Release Tablets (PRR 38.7) |
| 2914 | Coccydynia | 1,448 | 18 | Indomethacin (PRR 19.8) |
| 2915 | Heart Valve Replacement | 1,447 | 21 | Ranolazine (PRR 23.7) |
| 2916 | Seborrhoeic Keratosis | 1,447 | 41 | Mupirocin Calcium (PRR 29.9) |
| 2917 | Judgement Impaired | 1,445 | 32 | Atropine Sulfate (PRR 28.4) |
| 2918 | Sleep Paralysis | 1,445 | 31 | Suvorexant (PRR 306.9) |
| 2919 | Hyposmia | 1,444 | 10 | Fluticasone Furoate (PRR 21.7) |
| 2920 | Conjunctivitis Allergic | 1,444 | 109 | Dutasteride (PRR 662.5) |
| 2921 | Red Blood Cell Count Abnormal | 1,444 | 28 | Niraparib (PRR 35.0) |
| 2922 | Stoma Site Pain | 1,444 | 24 | Carbidopa And Levodopa (PRR 110.0) |
| 2923 | Ankle Operation | 1,443 | 22 | Anakinra (PRR 50.6) |
| 2924 | Small Cell Lung Cancer | 1,442 | 21 | Gefitinib (PRR 50.6) |
| 2925 | Immune-Mediated Adverse Reaction | 1,442 | 21 | Pembrolizumab (PRR 267.7) |
| 2926 | Foot Amputation | 1,441 | 17 | Canagliflozin (PRR 470.6) |
| 2927 | Steroid Diabetes | 1,440 | 66 | Methylprednisolone Sodium Succinate (PRR 46.3) |
| 2928 | Renal Infarct | 1,438 | 35 | Amphetamine (PRR 39.1) |
| 2929 | Multiple Congenital Abnormalities | 1,436 | 26 | Paroxetine Hydrochloride (PRR 39.7) |
| 2930 | Pancreatic Enzymes Increased | 1,435 | 23 | Sorafenib (PRR 23.6) |
| 2931 | Fat Tissue Increased | 1,433 | 31 | Nevirapine (PRR 37.6) |
| 2932 | Pulmonary Sepsis | 1,428 | 47 | Amphotericin B (PRR 28.4) |
| 2933 | Mutism | 1,426 | 43 | Haloperidol (PRR 40.9) |
| 2934 | Hypothalamo-Pituitary Disorder | 1,425 | 42 | Ipilimumab (PRR 62.6) |
| 2935 | Pelvic Venous Thrombosis | 1,423 | 26 | Drospirenone And Ethinyl Estradiol (PRR 223.0) |
| 2936 | Noninfective Gingivitis | 1,422 | 25 | Cetiirizine (PRR 22.7) |
| 2937 | Chorioretinopathy | 1,422 | 21 | Vemurafenib (PRR 54.0) |
| 2938 | Post Herpetic Neuralgia | 1,420 | 28 | Baricitinib (PRR 29.3) |
| 2939 | Haemorrhage In Pregnancy | 1,419 | 11 | Levonorgestrel (PRR 47.4) |
| 2940 | Normocytic Anaemia | 1,417 | 60 | Alemtuzumab (PRR 28.0) |
| 2941 | Product Monitoring Error | 1,416 | 66 | Torsemide (PRR 165.1) |
| 2942 | Bladder Transitional Cell Carcinoma | 1,415 | 29 | Pioglitazone (PRR 294.7) |
| 2943 | Myasthenia Gravis Crisis | 1,415 | 17 | Ravulizumab (PRR 159.7) |
| 2944 | Meningitis Bacterial | 1,414 | 38 | Cefepime Hydrochloride (PRR 21.3) |
| 2945 | Nail Infection | 1,414 | 35 | Lapatinib (PRR 36.0) |
| 2946 | Insulin-Like Growth Factor Increased | 1,414 | 13 | Lanreotide Acetate (PRR 201.9) |
| 2947 | Cerebellar Haemorrhage | 1,413 | 26 | Heparin Sodium (PRR 25.0) |
| 2948 | Uterine Rupture | 1,413 | 3 | Levonorgestrel (PRR 265.6) |
| 2949 | Vascular Injury | 1,413 | 10 | Quinine (PRR 24.3) |
| 2950 | Smear Cervix Abnormal | 1,412 | 20 | Etonogestrel And Ethinyl Estradiol (PRR 66.9) |
| 2951 | Pulmonary Valve Incompetence | 1,412 | 26 | Captopril (PRR 26.4) |
| 2952 | Precancerous Cells Present | 1,411 | 7 | Acetaminophen And Codeine (PRR 15.9) |
| 2953 | Cataplexy | 1,410 | 62 | Sodium Oxybate (PRR 606.0) |
| 2954 | Diabetic Foot Infection | 1,409 | 8 | Canagliflozin (PRR 1,007.5) |
| 2955 | Anticonvulsant Drug Level Decreased | 1,409 | 30 | Extended Phenytoin Sodium (PRR 442.6) |
| 2956 | Neuroendocrine Tumour | 1,407 | 11 | Octreotide Acetate (PRR 279.0) |
| 2957 | Tracheostomy | 1,407 | 21 | Bosentan (PRR 24.5) |
| 2958 | Alveolitis | 1,407 | 40 | Dimenhydrinate (PRR 66.0) |
| 2959 | Gluten Sensitivity | 1,406 | 12 | Liothyronine Sodium (PRR 32.7) |
| 2960 | Connective Tissue Disorder | 1,405 | 17 | Ciprofolxacin (PRR 22.2) |
| 2961 | Infusion Site Induration | 1,403 | 55 | Treprostinil (PRR 142.7) |
| 2962 | Genital Rash | 1,402 | 25 | Abacavir Sulfate (PRR 26.2) |
| 2963 | Blood Electrolytes Decreased | 1,400 | 23 | Teduglutide (PRR 17.8) |
| 2964 | Low Density Lipoprotein Decreased | 1,400 | 17 | Inclisiran (PRR 193.1) |
| 2965 | Chronic Inflammatory Demyelinating Polyradiculoneuropathy | 1,400 | 21 | Human Immunoglobulin G (PRR 98.8) |
| 2966 | Intellectual Disability | 1,399 | 38 | Valproate Sodium (PRR 119.0) |
| 2967 | Appendix Disorder | 1,398 | 16 | Alendronate Sodium (PRR 24.1) |
| 2968 | H1N1 Influenza | 1,396 | 31 | Oseltamivir (PRR 77.1) |
| 2969 | Culture Urine Positive | 1,395 | 36 | Dimenhydrinate (PRR 117.2) |
| 2970 | Intestinal Fistula | 1,393 | 16 | Azathioprine (PRR 25.5) |
| 2971 | Injection Site Hypoaesthesia | 1,392 | 24 | Epinephrine (PRR 19.1) |
| 2972 | Peripheral Artery Thrombosis | 1,392 | 29 | Heparin Sodium (PRR 28.8) |
| 2973 | Meniscus Lesion | 1,392 | 17 | Alendronate Sodium (PRR 25.2) |
| 2974 | Myelitis Transverse | 1,391 | 29 | Thiotepa (PRR 31.8) |
| 2975 | Auditory Disorder | 1,391 | 16 | Apixaban (PRR 17.4) |
| 2976 | Bronchial Obstruction | 1,389 | 41 | Mepolizumab (PRR 67.0) |
| 2977 | Periodontal Disease | 1,389 | 21 | Alendronate Sodium (PRR 56.5) |
| 2978 | Peritoneal Haemorrhage | 1,388 | 20 | Fondaparinux Sodium (PRR 54.9) |
| 2979 | Glomerular Filtration Rate Abnormal | 1,388 | 39 | Tenofovir Disoproxil Fumarate (PRR 108.3) |
| 2980 | Cardioversion | 1,387 | 31 | Dofetilide (PRR 81.8) |
| 2981 | Fanconi Syndrome | 1,387 | 49 | Tenofovir Disoproxil Fumarate Tablets (PRR 175.2) |
| 2982 | Labelled Drug-Drug Interaction Issue | 1,386 | 61 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 165.4) |
| 2983 | Acute Graft Versus Host Disease In Intestine | 1,385 | 75 | Thiotepa (PRR 494.0) |
| 2984 | Prothrombin Time Shortened | 1,385 | 13 | Warfarin Sodium (PRR 24.9) |
| 2985 | N-Terminal Prohormone Brain Natriuretic Peptide Increased | 1,384 | 58 | Eplerenone (PRR 140.3) |
| 2986 | Tonic Convulsion | 1,384 | 38 | Clobazam (PRR 101.2) |
| 2987 | Peripheral Artery Occlusion | 1,381 | 28 | Nilotinib (PRR 33.7) |
| 2988 | Product Ineffective For Unapproved Use | 1,380 | 122 | Oseltamivir (PRR 58.1) |
| 2989 | Obstructive Sleep Apnoea Syndrome | 1,378 | 167 | Mometasone (PRR 173.6) |
| 2990 | Peripheral Motor Neuropathy | 1,378 | 71 | Brentuximab Vedotin (PRR 95.6) |
| 2991 | Prerenal Failure | 1,378 | 31 | Tolvaptan (PRR 21.1) |
| 2992 | Echocardiogram Abnormal | 1,378 | 49 | Digoxin (PRR 26.8) |
| 2993 | Intensive Care | 1,377 | 38 | Ivacaftor (PRR 36.6) |
| 2994 | Norovirus Infection | 1,375 | 53 | Human Immunoglobulin G (PRR 42.0) |
| 2995 | Investigation Abnormal | 1,375 | 24 | Venetoclax (PRR 26.1) |
| 2996 | Atypical Mycobacterial Infection | 1,375 | 59 | Rifampin (PRR 59.4) |
| 2997 | Sudden Onset Of Sleep | 1,375 | 17 | Rasagiline Mesylate (PRR 61.8) |
| 2998 | Viraemia | 1,374 | 92 | Thiotepa (PRR 152.7) |
| 2999 | Mucous Membrane Disorder | 1,373 | 25 | Granisetron Hydrochloride (PRR 30.9) |
| 3000 | Vascular Purpura | 1,373 | 33 | Rifampin (PRR 52.7) |
| 3001 | Chronic Fatigue Syndrome | 1,371 | 28 | Acetylcysteine (PRR 24.4) |
| 3002 | Incisional Hernia | 1,370 | 14 | Teduglutide (PRR 15.9) |
| 3003 | Rhonchi | 1,368 | 73 | Ciclesonide (PRR 124.3) |
| 3004 | Lip And/Or Oral Cavity Cancer | 1,368 | 8 | Methylprednisolone Acetate (PRR 34.6) |
| 3005 | Renal Artery Stenosis | 1,368 | 49 | Valganciclovir (PRR 52.4) |
| 3006 | Diabetic Metabolic Decompensation | 1,367 | 36 | Insulin Glargine-Yfgn (PRR 112.8) |
| 3007 | Neovascular Age-Related Macular Degeneration | 1,366 | 10 | Aflibercept (PRR 162.6) |
| 3008 | Head Titubation | 1,365 | 35 | Asenapine Maleate (PRR 44.8) |
| 3009 | Nasal Discharge Discolouration | 1,364 | 53 | Levodopa (PRR 118.7) |
| 3010 | Thrombocytopenic Purpura | 1,364 | 14 | Quinine (PRR 36.1) |
| 3011 | Porphyria Acute | 1,363 | 160 | Diclofenac Potassium, Film Coated (PRR 580.0) |
| 3012 | Bezoar | 1,361 | 41 | Doxepin (PRR 63.8) |
| 3013 | Death Neonatal | 1,360 | 115 | Diclofenac Potassium, Film Coated (PRR 248.0) |
| 3014 | Meningitis Viral | 1,360 | 24 | Ganciclovir Sodium (PRR 35.3) |
| 3015 | Product Expiration Date Issue | 1,360 | 8 | Loperamide Hydrochloride And Dimethicone (PRR 12.1) |
| 3016 | Biliary Tract Disorder | 1,359 | 27 | Olanzapine Pamoate (PRR 19.8) |
| 3017 | Fracture Nonunion | 1,358 | 14 | Alendronate Sodium (PRR 418.3) |
| 3018 | Central Nervous System Lymphoma | 1,355 | 47 | Thiotepa (PRR 61.2) |
| 3019 | Therapeutic Procedure | 1,355 | 21 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 64.1) |
| 3020 | Application Site Inflammation | 1,354 | 18 | Crisaborole (PRR 45.8) |
| 3021 | Joint Instability | 1,354 | 16 | Methylprednisolone Acetate (PRR 19.3) |
| 3022 | Ureteric Obstruction | 1,352 | 32 | Trimethoprim (PRR 51.0) |
| 3023 | Agoraphobia | 1,351 | 27 | Paroxetine Hydrochloride Hemihydrate (PRR 27.5) |
| 3024 | Effusion | 1,351 | 22 | Bisacodyl Suppositories (PRR 21.7) |
| 3025 | Discharge | 1,349 | 25 | Infliximab-Dyyb (PRR 21.2) |
| 3026 | Immunoglobulins Decreased | 1,349 | 33 | Human Immunoglobulin G (PRR 106.6) |
| 3027 | Carbon Dioxide Increased | 1,348 | 51 | 0Xygen (PRR 25.9) |
| 3028 | Drug Specific Antibody | 1,347 | 43 | Anakinra (PRR 121.5) |
| 3029 | Corneal Abrasion | 1,347 | 23 | Carboxymethylcellulose Sodium (PRR 50.4) |
| 3030 | Premenstrual Syndrome | 1,347 | 10 | Drospirenone And Ethinyl Estradiol (PRR 38.1) |
| 3031 | Calculus Bladder | 1,346 | 17 | Salmeterol Xinafoate (PRR 18.1) |
| 3032 | Abscess Oral | 1,346 | 6 | Tranexamic Acid (PRR 21.0) |
| 3033 | Infusion Site Rash | 1,345 | 55 | Human Immunoglobulin G (PRR 65.4) |
| 3034 | Polytraumatism | 1,344 | 2 | Olanzapine Pamoate (PRR 16.4) |
| 3035 | Cluster Headache | 1,343 | 21 | Galcanezumab-Gnlm (PRR 72.5) |
| 3036 | Corneal Opacity | 1,342 | 26 | Brimonidine Tartrate (PRR 99.1) |
| 3037 | Skin Depigmentation | 1,341 | 17 | Pazopanib Hydrochloride (PRR 26.7) |
| 3038 | Intestinal Mass | 1,341 | 9 | Rucaparib (PRR 14.1) |
| 3039 | Sialoadenitis | 1,340 | 24 | Memantine (PRR 31.3) |
| 3040 | Brash Syndrome | 1,339 | 43 | Atropine (PRR 87.3) |
| 3041 | Tongue Dry | 1,337 | 16 | Bisacodyl Suppositories (PRR 15.8) |
| 3042 | Glycosuria | 1,335 | 48 | Tenofovir Disoproxil Fumarate Tablets (PRR 84.1) |
| 3043 | Ischaemic Hepatitis | 1,335 | 47 | Norepinephrine Bitartrate (PRR 44.6) |
| 3044 | Accidental Poisoning | 1,333 | 30 | Sotalol Hydrochloride (PRR 355.4) |
| 3045 | B-Lymphocyte Count Decreased | 1,330 | 29 | Ocrelizumab (PRR 198.4) |
| 3046 | Lymphocyte Percentage Decreased | 1,330 | 21 | Alemtuzumab (PRR 247.7) |
| 3047 | Anion Gap Increased | 1,324 | 34 | Norepinephrine (PRR 34.4) |
| 3048 | Packed Red Blood Cell Transfusion | 1,324 | 34 | Eculizumab (PRR 54.8) |
| 3049 | Cystitis Noninfective | 1,323 | 35 | Ocrelizumab (PRR 62.4) |
| 3050 | Device Misuse | 1,322 | 4 | Levonorgestrel (PRR 108.7) |
| 3051 | Stenotrophomonas Infection | 1,322 | 99 | Ganciclovir Sodium (PRR 66.1) |
| 3052 | Hirsutism | 1,320 | 26 | Valproate Sodium (PRR 32.2) |
| 3053 | Body Mass Index Increased | 1,320 | 36 | Ciclesonide (PRR 25.9) |
| 3054 | Macular Hole | 1,319 | 8 | Ranibizumab (PRR 82.0) |
| 3055 | Gastroenteritis Norovirus | 1,318 | 63 | Pegaspargase (PRR 69.8) |
| 3056 | Vulvovaginal Candidiasis | 1,317 | 44 | Drs. Clotrimazole (PRR 49.1) |
| 3057 | Peritoneal Cloudy Effluent | 1,315 | 10 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 575.4) |
| 3058 | Non-Hodgkin'S Lymphoma | 1,313 | 27 | Romiplostim (PRR 25.7) |
| 3059 | Extradural Haematoma | 1,312 | 31 | Bupivacaine (PRR 64.6) |
| 3060 | Cardioactive Drug Level Increased | 1,311 | 39 | Digoxin (PRR 982.6) |
| 3061 | Pharyngeal Ulceration | 1,311 | 13 | Thiotepa (PRR 25.2) |
| 3062 | Feeling Guilty | 1,310 | 25 | Vortioxetine (PRR 186.0) |
| 3063 | Obliterative Bronchiolitis | 1,309 | 70 | Meperidine Hydrochloride (PRR 152.9) |
| 3064 | Aspergillosis | 1,308 | 63 | Amphotericin B (PRR 108.2) |
| 3065 | Abnormal Sleep-Related Event | 1,308 | 27 | Sodium Oxybate (PRR 86.9) |
| 3066 | Mast Cell Activation Syndrome | 1,307 | 65 | Omalizumab (PRR 84.8) |
| 3067 | Oesophageal Haemorrhage | 1,307 | 22 | Granisetron (PRR 21.5) |
| 3068 | Intestinal Dilatation | 1,307 | 27 | Teduglutide (PRR 25.2) |
| 3069 | Foreign Body In Respiratory Tract | 1,307 | 16 | Ibuprofen Sodium (PRR 21.7) |
| 3070 | Tumour Pain | 1,306 | 57 | Loperamide Hydrochloride Oral (PRR 43.0) |
| 3071 | Exposure Via Father | 1,305 | 23 | Diazepam Oral Solution (Concentrate) (PRR 38.5) |
| 3072 | Lip Exfoliation | 1,304 | 12 | Glycerin, Lidocaine (PRR 56.8) |
| 3073 | Acquired Gene Mutation | 1,303 | 60 | Gefitinib (PRR 569.0) |
| 3074 | Acrochordon | 1,303 | 19 | Vemurafenib (PRR 66.2) |
| 3075 | Feelings Of Worthlessness | 1,300 | 17 | Sertraline Hydrochloride (PRR 31.2) |
| 3076 | Hypovitaminosis | 1,300 | 16 | Cefazolin (PRR 30.2) |
| 3077 | Implantable Defibrillator Insertion | 1,298 | 16 | Ranolazine (PRR 108.5) |
| 3078 | Anaemia Postoperative | 1,297 | 12 | Alendronate Sodium (PRR 363.6) |
| 3079 | Postpartum Haemorrhage | 1,295 | 23 | Misoprostol (PRR 114.7) |
| 3080 | Postural Orthostatic Tachycardia Syndrome | 1,294 | 55 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 125.7) |
| 3081 | Application Site Paraesthesia | 1,293 | 13 | Glycerin, Lidocaine (PRR 107.2) |
| 3082 | Lip Injury | 1,292 | 15 | Emicizumab (PRR 41.4) |
| 3083 | Immune Reconstitution Syndrome | 1,291 | 38 | Lamivudine (PRR 633.2) |
| 3084 | Protein Total Abnormal | 1,290 | 16 | Tenofovir Disoproxil Fumarate (PRR 332.2) |
| 3085 | Herpes Ophthalmic | 1,289 | 22 | Prednisolone Acetate (PRR 20.5) |
| 3086 | Adjustment Disorder | 1,288 | 73 | Methylprednisolone Acetate (PRR 327.1) |
| 3087 | Neuromyelitis Optica Spectrum Disorder | 1,287 | 8 | Ravulizumab (PRR 92.6) |
| 3088 | Sinus Arrhythmia | 1,287 | 15 | Guanfacine (PRR 35.4) |
| 3089 | Calcium Deficiency | 1,286 | 25 | Alendronate Sodium (PRR 75.9) |
| 3090 | Libido Disorder | 1,285 | 10 | Tadalafil (PRR 66.1) |
| 3091 | Iatrogenic Injury | 1,285 | 7 | Methylprednisolone Acetate (PRR 18.3) |
| 3092 | Blood Creatine Phosphokinase Mb Increased | 1,283 | 16 | Cefazolin (PRR 25.2) |
| 3093 | Wisdom Teeth Removal | 1,282 | 19 | Etonogestrel And Ethinyl Estradiol (PRR 34.9) |
| 3094 | Transitional Cell Carcinoma | 1,282 | 32 | Sirolimus (PRR 52.3) |
| 3095 | Dacryostenosis Acquired | 1,280 | 20 | Docetaxel Anhydrous (PRR 73.2) |
| 3096 | Plasma Cell Myeloma Refractory | 1,279 | 32 | Carfilzomib (PRR 411.4) |
| 3097 | Intercepted Product Prescribing Error | 1,279 | 16 | Cladribine (PRR 64.5) |
| 3098 | Tonic Clonic Movements | 1,278 | 30 | Ranolazine (PRR 31.7) |
| 3099 | Apgar Score Low | 1,277 | 29 | Magnesium Sulfate In Water For (PRR 74.7) |
| 3100 | Encephalitis Autoimmune | 1,276 | 48 | Atezolizumab (PRR 35.3) |
| 3101 | Stoma Site Infection | 1,276 | 17 | Carbidopa And Levodopa (PRR 132.8) |
| 3102 | Slow Response To Stimuli | 1,275 | 30 | Rasagiline Mesylate (PRR 23.8) |
| 3103 | Application Site Erosion | 1,275 | 11 | Buprenorphine (PRR 37.8) |
| 3104 | Off Label Use Of Device | 1,273 | 8 | Levonorgestrel (PRR 78.6) |
| 3105 | Adenocarcinoma Pancreas | 1,271 | 28 | Sitagliptin And Metformin Hydrochloride (PRR 85.9) |
| 3106 | Breast Cancer In Situ | 1,271 | 12 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 310.2) |
| 3107 | Left Atrial Dilatation | 1,268 | 75 | Digoxin (PRR 48.8) |
| 3108 | Subcutaneous Haematoma | 1,266 | 14 | Fondaparinux Sodium (PRR 62.4) |
| 3109 | Nephritis Interstitial | 1,266 | 28 | Piperacillin Sodium And Tazobactam Sodium (PRR 38.2) |
| 3110 | Ovarian Cyst Ruptured | 1,265 | 9 | Etonogestrel And Ethinyl Estradiol (PRR 27.5) |
| 3111 | Necrotising Colitis | 1,265 | 42 | Indomethacin (PRR 70.0) |
| 3112 | Application Site Warmth | 1,264 | 18 | Nicotine (PRR 75.5) |
| 3113 | Gestational Hypertension | 1,262 | 19 | Labetalol (PRR 41.9) |
| 3114 | Band Sensation | 1,261 | 22 | Alemtuzumab (PRR 66.1) |
| 3115 | Platelet Transfusion | 1,261 | 52 | Venetoclax (PRR 148.7) |
| 3116 | Endocrine Disorder | 1,261 | 22 | Olanzapine Pamoate (PRR 57.3) |
| 3117 | Postoperative Wound Complication | 1,261 | 7 | Fondaparinux Sodium (PRR 28.9) |
| 3118 | Adnexa Uteri Pain | 1,260 | 8 | Levonorgestrel (PRR 51.7) |
| 3119 | Abdominal Operation | 1,260 | 13 | Risankizumab-Rzaa (PRR 18.3) |
| 3120 | Carotid Artery Disease | 1,259 | 17 | Amlodipine Besylate And Benazepril Hydrochloride (PRR 16.2) |
| 3121 | Counterfeit Product Administered | 1,258 | 20 | Fentanyl (PRR 51.4) |
| 3122 | Abortion Missed | 1,257 | 23 | Misoprostol (PRR 24.1) |
| 3123 | Lip Haemorrhage | 1,257 | 23 | Glycerin, Lidocaine (PRR 110.5) |
| 3124 | Seroma | 1,257 | 25 | Amiodarone Hydrochloride (PRR 39.2) |
| 3125 | Benign Intracranial Hypertension | 1,256 | 10 | Tretinoin (PRR 71.3) |
| 3126 | Nocturnal Dyspnoea | 1,256 | 32 | Ciclesonide (PRR 31.0) |
| 3127 | Testicular Swelling | 1,256 | 17 | Umeclidinium (PRR 22.4) |
| 3128 | Troponin T Increased | 1,255 | 32 | Desloratadine (PRR 34.6) |
| 3129 | Mallory-Weiss Syndrome | 1,254 | 13 | Dimenhydrinate (PRR 20.5) |
| 3130 | Hepatic Infection | 1,254 | 28 | Nilotinib (PRR 31.7) |
| 3131 | Fistula Discharge | 1,253 | 22 | Infliximab-Dyyb (PRR 69.1) |
| 3132 | Gastric Ulcer Perforation | 1,252 | 25 | Diclofenac (PRR 24.3) |
| 3133 | Microcephaly | 1,252 | 44 | Misoprostol (PRR 63.3) |
| 3134 | Blood Bilirubin Abnormal | 1,252 | 52 | Fulvestrant (PRR 23.5) |
| 3135 | Neutrophil Percentage Increased | 1,251 | 18 | Alemtuzumab (PRR 215.7) |
| 3136 | Trisomy 21 | 1,251 | 28 | Lopinavir And Ritonavir (PRR 93.7) |
| 3137 | Glucose Urine Present | 1,250 | 24 | Empagliflozin (PRR 37.9) |
| 3138 | Epstein-Barr Virus Infection Reactivation | 1,249 | 73 | Busulfan (PRR 238.6) |
| 3139 | Obstruction Gastric | 1,249 | 19 | Leucovorin Calcium (PRR 15.9) |
| 3140 | Bronchial Secretion Retention | 1,248 | 73 | Ciclesonide (PRR 194.5) |
| 3141 | Cardiac Ventricular Thrombosis | 1,247 | 47 | Pegaspargase (PRR 41.9) |
| 3142 | Malignant Melanoma In Situ | 1,244 | 33 | Acetylcysteine (PRR 161.9) |
| 3143 | Drug Clearance Decreased | 1,243 | 57 | Sodium Bicarbonate (PRR 44.6) |
| 3144 | Vaginal Odour | 1,243 | 10 | Copper (PRR 64.1) |
| 3145 | Intraductal Proliferative Breast Lesion | 1,243 | 21 | Anastrozole Tablets (PRR 21.5) |
| 3146 | Breech Presentation | 1,242 | 22 | Nicotine Polacrilex Mini (PRR 56.9) |
| 3147 | Fractured Coccyx | 1,242 | 22 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate (PRR 20.6) |
| 3148 | Lip Discolouration | 1,241 | 19 | Glycerin, Lidocaine (PRR 45.7) |
| 3149 | Intercepted Product Selection Error | 1,240 | 8 | Tirzepatide (PRR 102.9) |
| 3150 | Beta Haemolytic Streptococcal Infection | 1,239 | 26 | Methocarbamol Tablets (PRR 26.6) |
| 3151 | Retinal Degeneration | 1,239 | 19 | Ranibizumab (PRR 62.8) |
| 3152 | Application Site Scar | 1,238 | 16 | Glycerin, Lidocaine (PRR 132.0) |
| 3153 | Amputation | 1,236 | 8 | Canagliflozin (PRR 247.8) |
| 3154 | Renal Atrophy | 1,235 | 36 | Pyrazinamide (PRR 23.6) |
| 3155 | Biliary Obstruction | 1,235 | 37 | Pancrelipase (PRR 37.8) |
| 3156 | Bradycardia Neonatal | 1,235 | 23 | Ampicillin (PRR 71.1) |
| 3157 | Blood Urea Decreased | 1,234 | 29 | Thiamine Hydrochloride (PRR 24.7) |
| 3158 | Helicobacter Gastritis | 1,232 | 12 | Olmesartan Medoxomil (PRR 41.2) |
| 3159 | Product Used For Unknown Indication | 1,231 | 36 | Miconazole Nitrate (PRR 135.0) |
| 3160 | Palatal Oedema | 1,230 | 8 | Ketoprofen (PRR 22.2) |
| 3161 | Allergy To Chemicals | 1,229 | 54 | Methylprednisolone Acetate (PRR 242.7) |
| 3162 | Expanded Disability Status Scale Score Increased | 1,229 | 13 | Fingolimod Hcl (PRR 289.1) |
| 3163 | Intra-Abdominal Haematoma | 1,227 | 22 | Fondaparinux Sodium (PRR 141.5) |
| 3164 | Infusion Site Irritation | 1,227 | 56 | Treprostinil (PRR 150.2) |
| 3165 | Eastern Cooperative Oncology Group Performance Status Worsened | 1,227 | 53 | Niraparib (PRR 108.2) |
| 3166 | Nasal Pruritus | 1,225 | 16 | Iohexol (PRR 39.5) |
| 3167 | White Matter Lesion | 1,225 | 38 | Amphotericin B (PRR 46.0) |
| 3168 | Bladder Prolapse | 1,224 | 15 | Estrogens, Conjugated (PRR 22.2) |
| 3169 | Peripheral Sensorimotor Neuropathy | 1,223 | 52 | Brentuximab Vedotin (PRR 75.7) |
| 3170 | Pharyngeal Haemorrhage | 1,222 | 12 | Norepinephrine (PRR 57.4) |
| 3171 | Aortic Valve Replacement | 1,222 | 14 | Tafamidis (PRR 24.9) |
| 3172 | Joint Warmth | 1,221 | 7 | Ciclesonide (PRR 28.0) |
| 3173 | Fractured Sacrum | 1,221 | 20 | Alendronate Sodium (PRR 33.7) |
| 3174 | Blast Crisis In Myelogenous Leukaemia | 1,221 | 9 | Imatinib (PRR 296.0) |
| 3175 | Post-Acute Covid-19 Syndrome | 1,220 | 35 | Human Immunoglobulin G (PRR 60.4) |
| 3176 | Staphylococcal Skin Infection | 1,220 | 14 | Atovaquone (PRR 23.5) |
| 3177 | Penile Swelling | 1,220 | 4 | Sildenafil Citrate (PRR 23.3) |
| 3178 | Pancreatic Neoplasm | 1,220 | 10 | Pancrelipase (PRR 46.0) |
| 3179 | Haematocrit Abnormal | 1,220 | 15 | Ruxolitinib (PRR 102.0) |
| 3180 | Blood Electrolytes Abnormal | 1,219 | 13 | Metolazone (PRR 16.9) |
| 3181 | Suspected Transmission Of An Infectious Agent Via Product | 1,218 | 12 | Bevacizumab (PRR 118.3) |
| 3182 | Sternal Fracture | 1,217 | 31 | Botulinum Toxin Type A (PRR 58.4) |
| 3183 | Rectal Tenesmus | 1,215 | 21 | Vedolizumab (PRR 46.6) |
| 3184 | Intervertebral Disc Operation | 1,215 | 9 | Upadacitinib (PRR 15.5) |
| 3185 | Hyperaesthesia Teeth | 1,214 | 17 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 18.9) |
| 3186 | Dysfunctional Uterine Bleeding | 1,214 | 7 | Copper (PRR 97.9) |
| 3187 | Retinal Thickening | 1,214 | 4 | Faricimab (PRR 13,498.1) |
| 3188 | Ejection Fraction Abnormal | 1,213 | 43 | Liothyronine Sodium (PRR 175.5) |
| 3189 | Bladder Discomfort | 1,213 | 16 | Vibegron (PRR 19.4) |
| 3190 | Oral Mucosa Erosion | 1,211 | 12 | Lamotrigine (PRR 39.6) |
| 3191 | Bladder Cancer Stage Iii | 1,210 | 2 | Ranitidine Hydrochloride (PRR 18.9) |
| 3192 | Vestibular Disorder | 1,210 | 33 | Gentamicin Sulfate (PRR 107.0) |
| 3193 | Cerebral Artery Embolism | 1,209 | 22 | Posaconazole Delayed-Release (PRR 23.8) |
| 3194 | Xerosis | 1,208 | 28 | Isotretinoin (PRR 164.4) |
| 3195 | Clostridium Colitis | 1,208 | 43 | Anti-Thymocyte Globulin (Rabbit) (PRR 25.9) |
| 3196 | Otitis Externa | 1,208 | 11 | Chlorhexidine Gluconate (PRR 17.1) |
| 3197 | Cardiac Death | 1,207 | 29 | Dronabinol (PRR 21.6) |
| 3198 | Blood Immunoglobulin G Increased | 1,205 | 27 | Icosapent Ethyl (PRR 66.7) |
| 3199 | Febrile Convulsion | 1,200 | 27 | Palivizumab (PRR 46.7) |
| 3200 | Mesothelioma | 1,197 | 4 | Miconazole Nitrate (PRR 16.0) |
| 3201 | Monocyte Count Decreased | 1,196 | 37 | Alemtuzumab (PRR 77.1) |
| 3202 | Bleeding Time Prolonged | 1,196 | 15 | Ticagrelor (PRR 28.4) |
| 3203 | Encephalitis Viral | 1,195 | 52 | Thiotepa (PRR 173.2) |
| 3204 | Pharyngeal Inflammation | 1,193 | 28 | Cetuximab (PRR 45.8) |
| 3205 | Application Site Hypersensitivity | 1,191 | 18 | Rivastigmine (PRR 62.7) |
| 3206 | Rectal Prolapse | 1,191 | 40 | Doxazosin Mesylate (PRR 43.7) |
| 3207 | Multimorbidity | 1,191 | 14 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 60.7) |
| 3208 | Upper Respiratory Tract Inflammation | 1,190 | 36 | Canakinumab (PRR 36.2) |
| 3209 | Bronchial Hyperreactivity | 1,188 | 48 | Ciclesonide (PRR 152.7) |
| 3210 | Large Intestine Infection | 1,188 | 29 | Piperacillin And Tazobactam (PRR 27.8) |
| 3211 | Bone Marrow Toxicity | 1,187 | 62 | Bleomycin Sulfate (PRR 34.5) |
| 3212 | Bile Duct Stenosis | 1,187 | 45 | Ursosiol (PRR 38.3) |
| 3213 | Infusion Site Warmth | 1,187 | 53 | Treprostinil (PRR 159.7) |
| 3214 | Embolism Arterial | 1,187 | 33 | Drospirenone And Ethinyl Estradiol (PRR 121.0) |
| 3215 | Infected Cyst | 1,185 | 9 | Infliximab-Dyyb (PRR 17.8) |
| 3216 | Escherichia Test Positive | 1,185 | 32 | Pegaspargase (PRR 62.4) |
| 3217 | Foetal Anticonvulsant Syndrome | 1,184 | 13 | Valproate Sodium (PRR 443.0) |
| 3218 | Full Blood Count Increased | 1,180 | 13 | Hydroxyurea (PRR 25.7) |
| 3219 | Pneumonia Influenzal | 1,180 | 51 | Oseltamivir Phosphate (PRR 43.2) |
| 3220 | Bile Duct Cancer | 1,180 | 13 | Pancrelipase (PRR 14.0) |
| 3221 | Secondary Immunodeficiency | 1,179 | 78 | Pegaspargase (PRR 409.6) |
| 3222 | Coccidioidomycosis | 1,179 | 19 | Amphotericin B (PRR 37.4) |
| 3223 | Acute Lung Injury | 1,179 | 34 | Norepinephrine (PRR 35.3) |
| 3224 | Streptococcal Sepsis | 1,178 | 56 | Ado-Trastuzumab Emtansine (PRR 114.0) |
| 3225 | Reflux Gastritis | 1,178 | 20 | Sucralfate Oral (PRR 36.9) |
| 3226 | Dysplasia | 1,176 | 29 | Vincristine Sulfate (PRR 26.3) |
| 3227 | Prostatic Operation | 1,176 | 15 | Relugolix (PRR 45.7) |
| 3228 | Preterm Premature Rupture Of Membranes | 1,176 | 12 | Ampicillin (PRR 25.9) |
| 3229 | Lupus Vulgaris | 1,175 | 183 | Diclofenac Potassium, Film Coated (PRR 2,790.4) |
| 3230 | Granulomatosis With Polyangiitis | 1,175 | 25 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 85.6) |
| 3231 | Immunosuppressant Drug Level Decreased | 1,175 | 49 | Tacrolimus (PRR 260.4) |
| 3232 | Chronic Respiratory Failure | 1,175 | 50 | 0Xygen (PRR 39.6) |
| 3233 | Labile Blood Pressure | 1,173 | 26 | Quinine (PRR 117.1) |
| 3234 | Cutaneous T-Cell Lymphoma | 1,172 | 26 | Brentuximab Vedotin (PRR 86.7) |
| 3235 | Retinal Vasculitis | 1,171 | 22 | Faricimab (PRR 141.1) |
| 3236 | Colon Operation | 1,170 | 11 | Risankizumab-Rzaa (PRR 21.4) |
| 3237 | Victim Of Crime | 1,169 | 27 | Ethyl Alcohol (PRR 287.1) |
| 3238 | Glycosylated Haemoglobin Abnormal | 1,168 | 22 | Empagliflozin (PRR 42.3) |
| 3239 | Nephrocalcinosis | 1,168 | 19 | Asfotase Alfa (PRR 92.9) |
| 3240 | Device Dispensing Error | 1,166 | 14 | Somatropin (PRR 38.5) |
| 3241 | Dilatation Atrial | 1,165 | 26 | Digoxin (PRR 32.6) |
| 3242 | Gambling | 1,164 | 11 | Aripiprazole (PRR 140.3) |
| 3243 | Morbid Thoughts | 1,164 | 9 | Esketamine Hydrochloride (PRR 24.6) |
| 3244 | Haematoma Muscle | 1,162 | 30 | Enoxaparin Sodium (PRR 57.2) |
| 3245 | Magnetic Resonance Imaging Abnormal | 1,162 | 22 | Ocrelizumab (PRR 82.6) |
| 3246 | Jc Polyomavirus Test Positive | 1,162 | 21 | Ocrelizumab (PRR 302.8) |
| 3247 | Tongue Haemorrhage | 1,162 | 5 | Alteplase (PRR 112.1) |
| 3248 | Incision Site Pain | 1,161 | 28 | Basiliximab (PRR 101.5) |
| 3249 | Rectal Ulcer | 1,160 | 13 | Sevelamer Carbonate (PRR 23.7) |
| 3250 | Product Contamination Microbial | 1,160 | 18 | Propofol (PRR 42.7) |
| 3251 | Sense Of Oppression | 1,159 | 12 | Fosaprepitant Dimeglumine (PRR 36.1) |
| 3252 | Hormone-Refractory Prostate Cancer | 1,158 | 15 | Lutetium Lu 177 Vipivotide Tetraxetan (PRR 234.9) |
| 3253 | Glomerulonephritis Membranous | 1,158 | 18 | Agalsidase Beta (PRR 25.6) |
| 3254 | Progressive Multiple Sclerosis | 1,156 | 19 | Interferon Beta-1B (PRR 39.9) |
| 3255 | Acute Prerenal Failure | 1,156 | 28 | Enalapril Maleate (PRR 27.0) |
| 3256 | Lip Ulceration | 1,156 | 15 | Thiotepa (PRR 42.3) |
| 3257 | Osteochondrosis | 1,155 | 30 | Torsemide (PRR 32.0) |
| 3258 | Epididymitis | 1,155 | 19 | Finasteride (PRR 23.5) |
| 3259 | Eyelid Skin Dryness | 1,154 | 15 | Dupilumab (PRR 53.1) |
| 3260 | Pruritus Allergic | 1,153 | 19 | Leflunomide (PRR 22.4) |
| 3261 | Restrictive Pulmonary Disease | 1,153 | 40 | Ciclesonide (PRR 239.0) |
| 3262 | Hypertensive Emergency | 1,153 | 31 | Labetalol (PRR 31.8) |
| 3263 | Lumbar Radiculopathy | 1,153 | 29 | Alendronate Sodium (PRR 62.5) |
| 3264 | Systemic Mycosis | 1,152 | 72 | Voriconazole Injection (PRR 155.6) |
| 3265 | Macrocytosis | 1,152 | 27 | Zidovudine (PRR 64.7) |
| 3266 | Groin Abscess | 1,151 | 19 | Clindamycin (PRR 23.0) |
| 3267 | Hypochloraemia | 1,151 | 15 | Indapamide (PRR 43.9) |
| 3268 | Peripheral Embolism | 1,150 | 9 | Dabigatran Etexilate Mesylate (PRR 25.1) |
| 3269 | Ischaemic Cerebral Infarction | 1,150 | 26 | Propofol (PRR 30.8) |
| 3270 | Sick Sinus Syndrome | 1,150 | 31 | Digoxin (PRR 46.0) |
| 3271 | Physical Product Label Issue | 1,150 | 3 | Guselkumab (PRR 12.4) |
| 3272 | Bladder Operation | 1,149 | 12 | Tolterodine Tartrate (PRR 16.3) |
| 3273 | Parotitis | 1,149 | 18 | Thiotepa (PRR 36.6) |
| 3274 | Splenectomy | 1,147 | 11 | Romiplostim (PRR 187.4) |
| 3275 | Radiation Skin Injury | 1,146 | 38 | Cetuximab (PRR 151.4) |
| 3276 | Aortic Thrombosis | 1,146 | 31 | Cisplatin (PRR 51.4) |
| 3277 | Open Reduction Of Fracture | 1,145 | 6 | Alendronate Sodium (PRR 1,645.3) |
| 3278 | Pupils Unequal | 1,145 | 10 | Fondaparinux Sodium (PRR 34.1) |
| 3279 | Surgical Failure | 1,144 | 8 | Adalimumab (PRR 28.4) |
| 3280 | Application Site Discharge | 1,144 | 8 | Buprenorphine (PRR 44.0) |
| 3281 | Cerebral Ventricle Dilatation | 1,144 | 34 | Darunavir (PRR 61.5) |
| 3282 | Po2 Decreased | 1,143 | 17 | Sevoflurane (PRR 49.1) |
| 3283 | Renal Tubular Injury | 1,142 | 56 | Basiliximab (PRR 92.9) |
| 3284 | Small Intestinal Resection | 1,140 | 12 | Risankizumab-Rzaa (PRR 33.5) |
| 3285 | Phobia | 1,139 | 5 | Interferon Beta-1A (PRR 18.2) |
| 3286 | Diffuse Alveolar Damage | 1,139 | 76 | Pegaspargase (PRR 114.6) |
| 3287 | Polydactyly | 1,139 | 33 | Nevirapine (PRR 119.2) |
| 3288 | Procalcitonin Increased | 1,139 | 47 | Meropenem (PRR 44.3) |
| 3289 | Pneumocystis Jirovecii Infection | 1,138 | 69 | Atovaquone (PRR 55.7) |
| 3290 | Mucosal Haemorrhage | 1,138 | 13 | Romiplostim (PRR 55.6) |
| 3291 | Distractibility | 1,138 | 23 | Guanfacine (PRR 40.1) |
| 3292 | Febrile Infection | 1,137 | 59 | Amphotericin B (PRR 32.8) |
| 3293 | Optic Nerve Injury | 1,137 | 21 | Brinzolamide (PRR 34.2) |
| 3294 | Pulmonary Granuloma | 1,137 | 17 | Pyrazinamide (PRR 31.6) |
| 3295 | Bloody Discharge | 1,136 | 34 | Meperidine Hydrochloride (PRR 232.4) |
| 3296 | Nephrogenic Diabetes Insipidus | 1,136 | 46 | Lithium (PRR 301.3) |
| 3297 | Arterial Haemorrhage | 1,134 | 35 | Amiodarone Hydrochloride (PRR 50.4) |
| 3298 | Hyporesponsive To Stimuli | 1,134 | 37 | Rasagiline Mesylate (PRR 42.1) |
| 3299 | Drug Effect Variable | 1,133 | 23 | Acetaminophen, Aspirin (Nsaid) And Caffeine (PRR 73.2) |
| 3300 | Oestrogen Receptor Assay Positive | 1,132 | 12 | Medroxyprogesterone Acetate (PRR 897.4) |
| 3301 | Palmar Erythema | 1,132 | 24 | Chlorhexidine Gluconate (PRR 45.1) |
| 3302 | Dyslexia | 1,132 | 9 | Valproate Sodium (PRR 46.5) |
| 3303 | Folate Deficiency | 1,131 | 33 | Ado-Trastuzumab Emtansine (PRR 42.2) |
| 3304 | Infection Reactivation | 1,130 | 71 | Valganciclovir Hydrochloride Powder, (PRR 88.9) |
| 3305 | Pelvic Abscess | 1,128 | 24 | Metronidazole (PRR 24.8) |
| 3306 | Subclavian Vein Thrombosis | 1,128 | 51 | Drospirenone And Ethinyl Estradiol (PRR 54.4) |
| 3307 | Central Nervous System Infection | 1,128 | 24 | Ado-Trastuzumab Emtansine (PRR 35.5) |
| 3308 | Focal Dyscognitive Seizures | 1,128 | 28 | Oxcarbazepine (PRR 243.3) |
| 3309 | Gastrointestinal Bacterial Infection | 1,128 | 17 | Ado-Trastuzumab Emtansine (PRR 22.1) |
| 3310 | T-Cell Lymphoma | 1,127 | 15 | Axicabtagene Ciloleucel (PRR 47.8) |
| 3311 | Vith Nerve Paralysis | 1,126 | 11 | Melphalan (PRR 19.1) |
| 3312 | Catheter Related Complication | 1,126 | 12 | Bupivacaine (PRR 38.2) |
| 3313 | Therapeutic Product Effect Increased | 1,126 | 10 | Linaclotide (PRR 27.2) |
| 3314 | Tooth Erosion | 1,125 | 15 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 306.3) |
| 3315 | Carbon Dioxide Decreased | 1,125 | 34 | Asfotase Alfa (PRR 39.5) |
| 3316 | Ligament Injury | 1,123 | 3 | Cefuroxime (PRR 18.0) |
| 3317 | Open Wound | 1,121 | 5 | Epoetin Alfa (PRR 19.0) |
| 3318 | Chemical Burn | 1,121 | 15 | Miconazole Nitrate (PRR 102.0) |
| 3319 | Cytogenetic Abnormality | 1,120 | 32 | Imatinib (PRR 50.5) |
| 3320 | Administration Site Pain | 1,120 | 27 | Epinephrine (PRR 26.4) |
| 3321 | Sarcoma | 1,118 | 12 | Pazopanib Hydrochloride (PRR 34.5) |
| 3322 | Halo Vision | 1,117 | 17 | Prednisolone Acetate (PRR 27.4) |
| 3323 | Hypersensitivity Pneumonitis | 1,117 | 32 | Daptomycin (PRR 112.3) |
| 3324 | Thyrotoxic Crisis | 1,116 | 21 | Methimazole (PRR 374.0) |
| 3325 | Tonsillar Disorder | 1,116 | 16 | Alendronate Sodium (PRR 36.4) |
| 3326 | Lymphocyte Count Abnormal | 1,115 | 44 | Gentamicin (PRR 73.1) |
| 3327 | Stress At Work | 1,115 | 8 | Vedolizumab (PRR 24.8) |
| 3328 | Klebsiella Sepsis | 1,114 | 82 | Fludarabine Phosphate (PRR 56.1) |
| 3329 | Intrusive Thoughts | 1,114 | 30 | Mirtazapine (PRR 25.5) |
| 3330 | Cleft Lip And Palate | 1,114 | 43 | Efavirenz (PRR 89.5) |
| 3331 | Complex Partial Seizures | 1,113 | 31 | Zonisamide (PRR 56.5) |
| 3332 | Benign Neoplasm | 1,113 | 2 | Methylprednisolone Acetate (PRR 18.8) |
| 3333 | Instillation Site Irritation | 1,113 | 8 | Lifitegrast (PRR 363.1) |
| 3334 | Allodynia | 1,110 | 21 | Ketoprofen (PRR 24.7) |
| 3335 | Cortisol Decreased | 1,109 | 36 | Pembrolizumab (PRR 34.2) |
| 3336 | Seronegative Arthritis | 1,108 | 137 | Diclofenac Potassium, Film Coated (PRR 781.1) |
| 3337 | Cryptorchism | 1,108 | 29 | Zidovudine (PRR 72.0) |
| 3338 | Haemoglobinuria | 1,108 | 4 | Eculizumab (PRR 706.2) |
| 3339 | Facial Spasm | 1,107 | 14 | Onabotulinumtoxina (PRR 20.1) |
| 3340 | Nephrosclerosis | 1,106 | 20 | Basiliximab (PRR 42.6) |
| 3341 | Gastrointestinal Ulcer Haemorrhage | 1,106 | 5 | Pegaspargase (PRR 17.1) |
| 3342 | Laryngeal Cancer | 1,106 | 3 | Ranitidine Hydrochloride (PRR 19.6) |
| 3343 | Blood Fibrinogen Decreased | 1,106 | 39 | Pegaspargase (PRR 139.6) |
| 3344 | Moaning | 1,105 | 18 | Sodium Oxybate (PRR 30.3) |
| 3345 | Rheumatoid Factor Increased | 1,104 | 22 | Methylprednisolone Acetate (PRR 55.3) |
| 3346 | Soft Tissue Disorder | 1,104 | 28 | Trimethoprim (PRR 181.6) |
| 3347 | Metabolic Surgery | 1,103 | 23 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 33.3) |
| 3348 | Blood Testosterone Abnormal | 1,103 | 9 | Leuprolide Acetate (PRR 143.4) |
| 3349 | Perirectal Abscess | 1,102 | 28 | Isotretinoin (PRR 59.6) |
| 3350 | Essential Tremor | 1,102 | 21 | Primidone (PRR 113.5) |
| 3351 | Drug Exposure Via Breast Milk | 1,097 | 7 | Nevirapine (PRR 29.8) |
| 3352 | Vanishing Bile Duct Syndrome | 1,096 | 54 | Nevirapine (PRR 94.2) |
| 3353 | Acarodermatitis | 1,094 | 9 | Clobetasol Propionate Ointment Usp, 0.05% (PRR 16.8) |
| 3354 | Cardiac Hypertrophy | 1,094 | 14 | Agalsidase Beta (PRR 50.5) |
| 3355 | Dry Age-Related Macular Degeneration | 1,093 | 17 | Aflibercept (PRR 71.5) |
| 3356 | Hyperglycaemic Hyperosmolar Nonketotic Syndrome | 1,092 | 31 | Alpelisib (PRR 62.8) |
| 3357 | Pulmonary Sarcoidosis | 1,092 | 10 | Adalimumab-Fkjp (PRR 22.4) |
| 3358 | Nail Growth Abnormal | 1,091 | 15 | Thyroid, Porcine (PRR 21.7) |
| 3359 | Streptococcus Test Positive | 1,091 | 13 | Pegaspargase (PRR 28.5) |
| 3360 | Immediate Post-Injection Reaction | 1,090 | 2 | Glatiramer Acetate (PRR 1,086.8) |
| 3361 | Tinea Infection | 1,089 | 11 | Terbinafine Hydrochloride (PRR 41.6) |
| 3362 | Instillation Site Reaction | 1,089 | 4 | Lifitegrast (PRR 18,530.4) |
| 3363 | Chronic Spontaneous Urticaria | 1,088 | 39 | Omalizumab (PRR 420.0) |
| 3364 | Product Selection Error | 1,088 | 4 | Nicotine (PRR 29.4) |
| 3365 | Listeriosis | 1,087 | 29 | Ampicillin (PRR 108.5) |
| 3366 | Arrhythmia Supraventricular | 1,087 | 23 | Dofetilide (PRR 18.4) |
| 3367 | Catheter Site Discharge | 1,086 | 26 | Epoprostenol (PRR 612.1) |
| 3368 | Amyloid Related Imaging Abnormality-Oedema/Effusion | 1,086 | 6 | Memantine (PRR 109.5) |
| 3369 | Pneumonia Streptococcal | 1,084 | 35 | Canakinumab (PRR 51.0) |
| 3370 | Haemorrhagic Disorder | 1,083 | 19 | Fondaparinux Sodium (PRR 31.2) |
| 3371 | Product Name Confusion | 1,082 | 7 | Ibuprofen And Diphenhydramine Citrate (PRR 39.7) |
| 3372 | Foetal Malformation | 1,081 | 26 | Zonisamide (PRR 52.6) |
| 3373 | Glomerulonephritis Rapidly Progressive | 1,078 | 12 | Atovaquone (PRR 16.9) |
| 3374 | Kidney Enlargement | 1,078 | 13 | Tolvaptan (PRR 21.6) |
| 3375 | Aortic Dilatation | 1,077 | 38 | Amphotericin B (PRR 36.2) |
| 3376 | Piloerection | 1,076 | 13 | Atomoxetine Hydrochloride (PRR 46.2) |
| 3377 | Toxic Anterior Segment Syndrome | 1,075 | 27 | Moxifloxacin Hydrochloride (PRR 196.7) |
| 3378 | Bladder Dilatation | 1,075 | 8 | Amphetamine (PRR 45.2) |
| 3379 | Post Procedural Swelling | 1,073 | 7 | Fondaparinux Sodium (PRR 14.5) |
| 3380 | Cardiac Amyloidosis | 1,073 | 32 | Tafamidis (PRR 434.9) |
| 3381 | Epstein-Barr Viraemia | 1,073 | 55 | Anti-Thymocyte Globulin (Rabbit) (PRR 256.3) |
| 3382 | Uterine Prolapse | 1,073 | 14 | Pramipexole (PRR 19.2) |
| 3383 | Claustrophobia | 1,072 | 20 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 20.5) |
| 3384 | Tumour Pseudoprogression | 1,072 | 21 | Temozolomide (PRR 207.2) |
| 3385 | Stress Urinary Incontinence | 1,072 | 15 | Alendronate Sodium (PRR 50.6) |
| 3386 | Intracranial Venous Sinus Thrombosis | 1,071 | 17 | Drospirenone And Ethinyl Estradiol (PRR 177.8) |
| 3387 | Bone Neoplasm | 1,070 | 21 | Ado-Trastuzumab Emtansine (PRR 20.9) |
| 3388 | Toxoplasmosis | 1,069 | 61 | Valganciclovir Hydrochloride Powder, (PRR 101.4) |
| 3389 | Acinetobacter Infection | 1,069 | 78 | Meropenem (PRR 82.7) |
| 3390 | Gastrointestinal Tract Irritation | 1,068 | 8 | Meperidine Hydrochloride (PRR 21.3) |
| 3391 | Somatic Symptom Disorder | 1,067 | 32 | Quinine (PRR 129.3) |
| 3392 | Iron Overload | 1,066 | 25 | Deferasirox (PRR 269.9) |
| 3393 | Hypertensive Nephropathy | 1,065 | 18 | Lansoprazole (PRR 197.3) |
| 3394 | Traumatic Haematoma | 1,065 | 8 | Fondaparinux Sodium (PRR 66.9) |
| 3395 | Congenital Central Nervous System Anomaly | 1,064 | 26 | Nevirapine (PRR 130.5) |
| 3396 | Right Ventricular Dysfunction | 1,063 | 27 | Sildenafil Powder, (PRR 49.4) |
| 3397 | Chronic Kidney Disease-Mineral And Bone Disorder | 1,062 | 312 | Esomeprazole Magnesium (PRR 187.6) |
| 3398 | Streptococcal Bacteraemia | 1,061 | 69 | Sirolimus (PRR 41.8) |
| 3399 | Immune-Mediated Hypothyroidism | 1,061 | 19 | Pembrolizumab (PRR 329.2) |
| 3400 | Binge Eating | 1,060 | 34 | Pramipexole (PRR 63.0) |
| 3401 | Vascular Calcification | 1,060 | 19 | Alendronate Sodium (PRR 36.0) |
| 3402 | Unmasking Of Previously Unidentified Disease | 1,060 | 36 | Pyrazinamide (PRR 38.3) |
| 3403 | Joint Contracture | 1,060 | 25 | Epoetin Alfa (PRR 178.9) |
| 3404 | Superficial Injury Of Eye | 1,057 | 20 | Cenegermin-Bkbj (PRR 87.2) |
| 3405 | Device Ineffective | 1,057 | 10 | Budesonide, Glycopyrrolate, And Formoterol Fumarate (PRR 50.2) |
| 3406 | Amaurosis Fugax | 1,056 | 74 | Dutasteride (PRR 688.9) |
| 3407 | Poor Feeding Infant | 1,055 | 21 | Nicotine Polacrilex Mini (PRR 97.0) |
| 3408 | Gastric Cancer Stage I | 1,054 | 2 | Ranitidine Hydrochloride (PRR 16.6) |
| 3409 | Infusion Site Mass | 1,054 | 55 | Human Immunoglobulin G (PRR 213.1) |
| 3410 | Cerebral Artery Occlusion | 1,054 | 13 | Alteplase (PRR 36.4) |
| 3411 | Hydrocele | 1,052 | 23 | Zidovudine (PRR 52.0) |
| 3412 | Neuromyopathy | 1,051 | 11 | Colchicine (PRR 63.3) |
| 3413 | Inner Ear Disorder | 1,051 | 6 | Meclizine (PRR 17.2) |
| 3414 | Small Intestinal Stenosis | 1,050 | 11 | Adalimumab (PRR 26.9) |
| 3415 | Dementia With Lewy Bodies | 1,050 | 22 | Pimavanserin Tartrate (PRR 243.4) |
| 3416 | Radiation Injury | 1,050 | 24 | Bicalutamide (PRR 21.1) |
| 3417 | Orchitis | 1,049 | 10 | Basiliximab (PRR 27.4) |
| 3418 | Non-Cardiogenic Pulmonary Oedema | 1,048 | 14 | Amlodipine (PRR 40.2) |
| 3419 | Gallbladder Enlargement | 1,048 | 16 | Pegaspargase (PRR 19.7) |
| 3420 | Bone Demineralisation | 1,048 | 69 | Emtricitabine And Tenofovir Disoproxil Fumarate (PRR 702.9) |
| 3421 | Feeding Disorder Neonatal | 1,047 | 19 | Ampicillin (PRR 31.6) |
| 3422 | Blood Sodium Abnormal | 1,047 | 15 | Tolvaptan (PRR 39.3) |
| 3423 | Sinusitis Bacterial | 1,046 | 16 | Infliximab-Dyyb (PRR 167.1) |
| 3424 | Joint Sprain | 1,046 | 19 | Amlodipine Besylate And Benazepril Hydrochloride (PRR 26.1) |
| 3425 | Asterixis | 1,046 | 32 | Valproate Sodium (PRR 40.0) |
| 3426 | Pancreatic Mass | 1,046 | 14 | Pancrelipase (PRR 34.5) |
| 3427 | Burns Third Degree | 1,044 | 4 | Rizatriptan Benzoate (PRR 17.8) |
| 3428 | Ocular Toxicity | 1,044 | 26 | Encorafenib (PRR 60.0) |
| 3429 | Factor Viii Inhibition | 1,043 | 2 | Emicizumab (PRR 48.1) |
| 3430 | Nasal Inflammation | 1,042 | 14 | Dornase Alfa (PRR 31.4) |
| 3431 | Enterococcal Bacteraemia | 1,042 | 71 | Busulfan (PRR 70.8) |
| 3432 | Subretinal Fluid | 1,042 | 14 | Ranibizumab (PRR 372.7) |
| 3433 | Application Site Papules | 1,041 | 13 | Nicotine (PRR 109.5) |
| 3434 | Teeth Brittle | 1,041 | 7 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate (PRR 106.8) |
| 3435 | Cogwheel Rigidity | 1,040 | 46 | Haloperidol (PRR 95.1) |
| 3436 | Systolic Dysfunction | 1,040 | 38 | Norepinephrine (PRR 61.8) |
| 3437 | Cytogenetic Analysis Abnormal | 1,040 | 9 | Nilotinib (PRR 640.1) |
| 3438 | Thyroid Hormones Increased | 1,039 | 17 | Cabozantinib (PRR 49.6) |
| 3439 | Abscess Jaw | 1,037 | 17 | Chlorhexidine Gluconate (PRR 35.7) |
| 3440 | Tumour Necrosis | 1,037 | 43 | Temozolomide (PRR 46.8) |
| 3441 | Blast Cell Count Increased | 1,037 | 31 | Blinatumomab (PRR 246.3) |
| 3442 | Allergy To Animal | 1,036 | 36 | Ciclesonide (PRR 92.2) |
| 3443 | Non-Alcoholic Steatohepatitis | 1,036 | 11 | Rifaximin (PRR 35.7) |
| 3444 | Pertussis | 1,035 | 8 | Palivizumab (PRR 37.6) |
| 3445 | Product Commingling | 1,034 | 6 | Fexofenadine Hcl (PRR 15.3) |
| 3446 | Oedema Mucosal | 1,034 | 4 | Meperidine Hydrochloride (PRR 26.5) |
| 3447 | Alveolitis Allergic | 1,033 | 8 | Daptomycin (PRR 33.2) |
| 3448 | Intervertebral Disc Compression | 1,033 | 3 | Golimumab (PRR 8.7) |
| 3449 | Heart Transplant Rejection | 1,032 | 32 | Anti-Thymocyte Globulin (Rabbit) (PRR 398.1) |
| 3450 | Prostatic Specific Antigen Abnormal | 1,032 | 16 | Leuprolide Acetate (PRR 204.3) |
| 3451 | Hypoperfusion | 1,032 | 29 | Norepinephrine Bitartrate (PRR 31.5) |
| 3452 | Ureterolithiasis | 1,032 | 10 | Febuxostat Tablets 40 Mg (PRR 20.0) |
| 3453 | Waist Circumference Increased | 1,031 | 16 | Inclisiran (PRR 40.9) |
| 3454 | Carpal Tunnel Decompression | 1,031 | 5 | Alendronate Sodium (PRR 26.8) |
| 3455 | Lymphangiosis Carcinomatosa | 1,029 | 56 | Gefitinib (PRR 100.5) |
| 3456 | Metastases To Pleura | 1,028 | 49 | Fulvestrant (PRR 121.1) |
| 3457 | Respiratory Tract Irritation | 1,028 | 27 | Tobramycin (PRR 41.4) |
| 3458 | Gastrointestinal Viral Infection | 1,028 | 16 | Human Immunoglobulin G (PRR 30.3) |
| 3459 | Post Lumbar Puncture Syndrome | 1,027 | 4 | Bupivacaine (PRR 57.8) |
| 3460 | Coronavirus Test Positive | 1,027 | 21 | Niraparib (PRR 94.4) |
| 3461 | Axillary Mass | 1,026 | 8 | Anastrozole Tablets (PRR 22.2) |
| 3462 | Genotype Drug Resistance Test Positive | 1,025 | 25 | Sofosbuvir (PRR 293.1) |
| 3463 | Bone Marrow Oedema | 1,024 | 16 | Imatinib (PRR 27.1) |
| 3464 | Skin Sensitisation | 1,023 | 12 | Methimazole (PRR 23.5) |
| 3465 | Local Anaesthetic Systemic Toxicity | 1,023 | 25 | Lidocaine Hydrochloride (PRR 913.6) |
| 3466 | Postictal State | 1,021 | 27 | Lacosamide (PRR 25.1) |
| 3467 | Uterine Contractions During Pregnancy | 1,021 | 1 | Iron Sucrose (PRR 12.9) |
| 3468 | Breast Discomfort | 1,018 | 8 | Levonorgestrel (PRR 17.7) |
| 3469 | Ketosis | 1,018 | 21 | Dapagliflozin (PRR 143.8) |
| 3470 | Pleural Fibrosis | 1,017 | 47 | Trazodone Hydrochloride (PRR 127.5) |
| 3471 | Breast Neoplasm | 1,017 | 20 | Ado-Trastuzumab Emtansine (PRR 88.0) |
| 3472 | Gastric Ph Decreased | 1,016 | 14 | Paroxetine Hydrochloride Hemihydrate (PRR 32.3) |
| 3473 | Autism | 1,016 | 10 | Divalproex Sodium (PRR 25.5) |
| 3474 | Demyelinating Polyneuropathy | 1,016 | 22 | Busulfan (PRR 44.4) |
| 3475 | Product Difficult To Swallow | 1,016 | 16 | Loperamide Hydrochloride And Dimethicone (PRR 190.7) |
| 3476 | Bladder Dysfunction | 1,015 | 22 | Tolterodine Tartrate (PRR 23.1) |
| 3477 | Product Blister Packaging Issue | 1,015 | 15 | Loperamide Hydrochloride And Dimethicone (PRR 72.4) |
| 3478 | Conjunctival Oedema | 1,015 | 22 | Bupivacaine (PRR 51.6) |
| 3479 | Light Chain Analysis Increased | 1,013 | 15 | Ixazomib (PRR 92.5) |
| 3480 | Benign Breast Neoplasm | 1,013 | 8 | Conjugated Estrogens (PRR 23.6) |
| 3481 | Catheter Related Infection | 1,012 | 30 | Epoetin Alfa (PRR 33.6) |
| 3482 | Brain Stem Infarction | 1,012 | 7 | Agalsidase Beta (PRR 15.7) |
| 3483 | Carotid Arteriosclerosis | 1,011 | 55 | Telmisartan (PRR 58.1) |
| 3484 | Metastases To Skin | 1,011 | 45 | Exemestane (PRR 135.7) |
| 3485 | Psychotic Behaviour | 1,010 | 16 | Oxazepam (PRR 21.5) |
| 3486 | Brugada Syndrome | 1,010 | 21 | Lithium Carbonate (PRR 47.9) |
| 3487 | Infusion Site Discomfort | 1,009 | 45 | Human Immunoglobulin G (PRR 112.1) |
| 3488 | Acute Promyelocytic Leukaemia | 1,008 | 33 | Tretinoin (PRR 100.4) |
| 3489 | Uterine Pain | 1,007 | 6 | Copper (PRR 87.7) |
| 3490 | Fulminant Type 1 Diabetes Mellitus | 1,007 | 19 | Nivolumab (PRR 312.0) |
| 3491 | Stoma Complication | 1,007 | 21 | Teduglutide (PRR 943.5) |
| 3492 | Breast Abscess | 1,006 | 5 | Clindamycin (PRR 16.4) |
| 3493 | Polyhydramnios | 1,006 | 26 | Ampicillin (PRR 64.0) |
| 3494 | Steroid Withdrawal Syndrome | 1,005 | 27 | Hydrocortisone Cream (PRR 95.5) |
| 3495 | Consciousness Fluctuating | 1,005 | 18 | Valproate Sodium (PRR 35.2) |
| 3496 | Retinal Toxicity | 1,005 | 30 | Hydroxychloroquine (PRR 90.0) |
| 3497 | Drug Exposure Before Pregnancy | 1,005 | 12 | Isotretinoin (PRR 63.5) |
| 3498 | Hypogonadism | 1,005 | 36 | Finasteride (PRR 154.1) |
| 3499 | Product Coating Issue | 1,005 | 7 | Icosapent Ethyl (PRR 125.3) |
| 3500 | Arthrodesis | 1,004 | 32 | Cefazolin (PRR 170.9) |
| 3501 | Testicular Disorder | 1,003 | 11 | Finasteride (PRR 64.8) |
| 3502 | Autonomic Neuropathy | 1,001 | 25 | Bortezomib (PRR 51.2) |
| 3503 | Hypochromic Anaemia | 1,001 | 16 | Bleomycin Sulfate (PRR 66.5) |
| 3504 | Gastrectomy | 1,000 | 11 | Imatinib Mesylate (PRR 22.3) |
| 3505 | Eye Colour Change | 998 | 17 | Bimatoprost (PRR 56.1) |
| 3506 | False Positive Investigation Result | 998 | 6 | Zonisamide (PRR 11.4) |
| 3507 | Product Measured Potency Issue | 998 | 3 | Heparin Sodium (PRR 42.1) |
| 3508 | Skin Oedema | 997 | 16 | Felodipine Extended-Release Tablets (PRR 26.0) |
| 3509 | Haemangioma Of Liver | 996 | 11 | Etonogestrel And Ethinyl Estradiol (PRR 27.1) |
| 3510 | Antisocial Behaviour | 995 | 17 | Amphetamine (PRR 20.4) |
| 3511 | Semen Volume Decreased | 995 | 4 | Finasteride (PRR 335.1) |
| 3512 | Brain Hypoxia | 995 | 12 | Midazolam (PRR 17.8) |
| 3513 | Mucosal Ulceration | 995 | 15 | Phenobarbital (PRR 26.4) |
| 3514 | Bloody Peritoneal Effluent | 994 | 4 | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 940.6) |
| 3515 | Ileal Ulcer | 993 | 24 | Adalimumab-Aaty (PRR 37.4) |
| 3516 | Spontaneous Haemorrhage | 993 | 7 | Emicizumab (PRR 161.7) |
| 3517 | Genital Hypoaesthesia | 992 | 11 | Finasteride (PRR 122.8) |
| 3518 | Drowning | 991 | 18 | Ethyl Alcohol (PRR 16.6) |
| 3519 | Reduced Facial Expression | 989 | 35 | Rotigotine (PRR 94.5) |
| 3520 | Butterfly Rash | 989 | 24 | Indapamide (PRR 83.0) |
| 3521 | Product Closure Removal Difficult | 989 | 12 | Latanoprost (PRR 82.0) |
| 3522 | Onychalgia | 988 | 20 | Lapatinib (PRR 47.8) |
| 3523 | Mesenteric Vein Thrombosis | 988 | 13 | Testosterone (PRR 42.4) |
| 3524 | Polyomavirus Viraemia | 987 | 37 | Tacrolimus Ointment 0.1% (PRR 349.5) |
| 3525 | Hemianopia | 986 | 30 | Ado-Trastuzumab Emtansine (PRR 66.8) |
| 3526 | Rectal Polyp | 986 | 12 | Olmesartan Medoxomil (PRR 87.8) |
| 3527 | Blood Immunoglobulin M Decreased | 985 | 16 | Ocrelizumab (PRR 70.8) |
| 3528 | Colon Adenoma | 985 | 10 | Olmesartan Medoxomil (PRR 36.2) |
| 3529 | Bladder Cancer Recurrent | 985 | 5 | Pioglitazone (PRR 84.3) |
| 3530 | Oropharyngeal Swelling | 983 | 2 | Amlodipine Besylate And Benazepril Hydrochloride (PRR 20.8) |
| 3531 | Prinzmetal Angina | 982 | 25 | Isosorbide Dinitrate (PRR 29.0) |
| 3532 | Lymphocytic Infiltration | 981 | 19 | Basiliximab (PRR 46.3) |
| 3533 | Myocardial Injury | 981 | 26 | Norepinephrine (PRR 38.4) |
| 3534 | Shoulder Pain | 981 | 7 | Calcium Gluconate (PRR 19.6) |
| 3535 | Ulna Fracture | 980 | 13 | Alendronate Sodium (PRR 51.0) |
| 3536 | Cardiac Aneurysm | 980 | 9 | Eplerenone (PRR 30.4) |
| 3537 | Mucosal Disorder | 980 | 24 | Thiotepa (PRR 43.1) |
| 3538 | Continuous Haemodiafiltration | 979 | 28 | Metformin Hcl (PRR 42.2) |
| 3539 | Intentional Medical Device Removal By Patient | 976 | 18 | Etonogestrel And Ethinyl Estradiol (PRR 202.0) |
| 3540 | Renal Transplant Failure | 976 | 34 | Tacrolimus (PRR 210.5) |
| 3541 | Acquired Haemophilia | 975 | 26 | Loperamide Hydrochloride Oral (PRR 29.7) |
| 3542 | Bone Marrow Depression | 975 | 18 | Epoetin Alfa (PRR 50.0) |
| 3543 | Pyuria | 974 | 16 | Basiliximab (PRR 22.1) |
| 3544 | High Density Lipoprotein Increased | 973 | 10 | Inclisiran (PRR 91.1) |
| 3545 | Idiopathic Urticaria | 972 | 2 | Omalizumab (PRR 333.4) |
| 3546 | Administration Site Extravasation | 972 | 24 | Fluorouracil Cream, 0.5% (PRR 16.9) |
| 3547 | Idiosyncratic Drug Reaction | 972 | 10 | Oseltamivir (PRR 38.2) |
| 3548 | Subcutaneous Emphysema | 970 | 25 | Remdesivir (PRR 55.0) |
| 3549 | Blood Iron Abnormal | 969 | 28 | Sulfasalazine (PRR 143.3) |
| 3550 | Dactylitis | 969 | 52 | Methylprednisolone Acetate (PRR 68.8) |
| 3551 | Epidermal Necrosis | 969 | 23 | Brinzolamide (PRR 81.8) |
| 3552 | Device Related Thrombosis | 968 | 51 | Teduglutide (PRR 66.5) |
| 3553 | Aortic Aneurysm Rupture | 967 | 8 | Alteplase (PRR 17.4) |
| 3554 | Hypocoagulable State | 967 | 14 | Amlodipine Besylate And Valsartan (PRR 27.6) |
| 3555 | Lymphadenectomy | 966 | 21 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 32.1) |
| 3556 | Sputum Retention | 965 | 26 | Amikacin (PRR 96.8) |
| 3557 | Spinal Laminectomy | 965 | 4 | Alendronate Sodium (PRR 32.8) |
| 3558 | Anal Cancer | 963 | 17 | Ritonavir 100 Mg (PRR 32.6) |
| 3559 | Neuroendocrine Carcinoma Of The Skin | 963 | 20 | Anti-Thymocyte Globulin (Rabbit) (PRR 43.6) |
| 3560 | Coarctation Of The Aorta | 962 | 17 | Paroxetine Hydrochloride (PRR 59.8) |
| 3561 | Bone Swelling | 961 | 20 | Chlorhexidine Gluconate (PRR 50.9) |
| 3562 | Oncologic Complication | 961 | 14 | Octreotide Acetate (PRR 21.9) |
| 3563 | Duodenal Perforation | 960 | 21 | Lenvatinib (PRR 26.8) |
| 3564 | Mastoiditis | 960 | 16 | Dimenhydrinate (PRR 102.7) |
| 3565 | Haemophilus Infection | 960 | 28 | Ciclesonide (PRR 49.3) |
| 3566 | Maternal Exposure During Delivery | 959 | 38 | Bupivacaine (PRR 793.7) |
| 3567 | Application Site Bruise | 958 | 7 | Pegfilgrastim (PRR 85.4) |
| 3568 | Hypofibrinogenaemia | 957 | 54 | Pegaspargase (PRR 775.8) |
| 3569 | Red Blood Cells Urine Positive | 957 | 29 | Alemtuzumab (PRR 350.0) |
| 3570 | Animal Scratch | 957 | 15 | Diltiazem Hydrochloride Extended-Release Tablets (PRR 61.2) |
| 3571 | Pco2 Decreased | 957 | 8 | Tranexamic Acid (PRR 19.7) |
| 3572 | Antinuclear Antibody Increased | 956 | 6 | Minocycline (PRR 17.0) |
| 3573 | Blood Urine | 955 | 4 | Naproxen Sodium Tablet (PRR 11.4) |
| 3574 | Neutropenic Infection | 954 | 63 | Bleomycin Sulfate (PRR 152.1) |
| 3575 | Partner Stress | 954 | 10 | Metoclopramide (PRR 30.9) |
| 3576 | Bladder Catheterisation | 954 | 20 | Alemtuzumab (PRR 26.6) |
| 3577 | Red Blood Cell Abnormality | 954 | 19 | Febuxostat Tablets 40 Mg (PRR 30.5) |
| 3578 | Actinomycosis | 953 | 18 | Chlorhexidine Gluconate (PRR 56.3) |
| 3579 | Prostate Infection | 953 | 7 | Testosterone Cypionate (PRR 17.2) |
| 3580 | Dust Allergy | 952 | 93 | Dutasteride (PRR 1,109.8) |
| 3581 | Lung Carcinoma Cell Type Unspecified Stage I | 952 | 2 | Ranitidine Hydrochloride (PRR 25.7) |
| 3582 | Cor Pulmonale | 952 | 20 | Bosentan (PRR 51.6) |
| 3583 | Rheumatoid Lung | 951 | 48 | Methylprednisolone Acetate (PRR 175.0) |
| 3584 | Cross Sensitivity Reaction | 951 | 23 | Ibuprofen Capsule (PRR 34.7) |
| 3585 | Colon Neoplasm | 951 | 3 | Axicabtagene Ciloleucel (PRR 22.4) |
| 3586 | Cerebellar Ataxia | 950 | 19 | Efavirenz (PRR 67.1) |
| 3587 | Hypervigilance | 950 | 8 | Suvorexant (PRR 15.3) |
| 3588 | Drug Administered In Wrong Device | 948 | 8 | Somatropin (PRR 161.5) |
| 3589 | Vaginal Disorder | 948 | 10 | Conjugated Estrogens (PRR 26.6) |
| 3590 | Hepatic Congestion | 948 | 21 | Bosentan (PRR 48.6) |
| 3591 | Arnold-Chiari Malformation | 948 | 23 | Misoprostol (PRR 77.1) |
| 3592 | Injection Site Scab | 947 | 18 | Fluticasone Furoate (PRR 50.4) |
| 3593 | Solar Lentigo | 946 | 14 | Voriconazole Injection (PRR 64.8) |
| 3594 | Implant Site Swelling | 946 | 4 | Etonogestrel (PRR 513.3) |
| 3595 | Penile Size Reduced | 946 | 11 | Finasteride (PRR 246.6) |
| 3596 | Cerebral Palsy | 945 | 16 | Ampicillin (PRR 62.7) |
| 3597 | Suspected Product Contamination | 945 | 5 | Methylprednisolone Acetate (PRR 36.2) |
| 3598 | Cancer Surgery | 944 | 17 | Panitumumab (PRR 27.3) |
| 3599 | Antibiotic Therapy | 943 | 11 | Ivacaftor (PRR 19.6) |
| 3600 | Exposure Via Direct Contact | 943 | 8 | Peginterferon Alfa-2A (PRR 118.2) |
| 3601 | Device Safety Feature Issue | 943 | 5 | Abatacept (PRR 364.5) |
| 3602 | Electrocardiogram Change | 943 | 8 | Benzonatate (PRR 27.3) |
| 3603 | Brain Stem Haemorrhage | 941 | 14 | Alteplase (PRR 76.1) |
| 3604 | Blood Alkaline Phosphatase Decreased | 941 | 16 | Asfotase Alfa (PRR 269.3) |
| 3605 | Agitation Neonatal | 941 | 22 | Misoprostol (PRR 37.0) |
| 3606 | Hypermetropia | 941 | 9 | Valproate Sodium (PRR 55.3) |
| 3607 | Telangiectasia | 940 | 11 | Ado-Trastuzumab Emtansine (PRR 45.5) |
| 3608 | Prothrombin Level Decreased | 940 | 6 | Fondaparinux Sodium (PRR 73.1) |
| 3609 | Placental Disorder | 939 | 20 | Lopinavir And Ritonavir (PRR 45.4) |
| 3610 | Facial Asymmetry | 939 | 6 | Botulinum Toxin Type A (PRR 126.7) |
| 3611 | Intussusception | 938 | 21 | Sirolimus (PRR 70.6) |
| 3612 | Amyloid Related Imaging Abnormality-Microhaemorrhages And Haemosiderin Deposits | 938 | 5 | Memantine (PRR 103.9) |
| 3613 | Bundle Branch Block | 937 | 9 | Benzonatate (PRR 17.7) |
| 3614 | Wrong Schedule | 937 | 9 | Glecaprevir And Pibrentasvir (PRR 43.4) |
| 3615 | Delayed Recovery From Anaesthesia | 936 | 14 | Sevoflurane (PRR 646.0) |
| 3616 | Vascular Pain | 936 | 8 | Aprepitant (PRR 30.9) |
| 3617 | Lipoatrophy | 936 | 24 | Zidovudine (PRR 149.4) |
| 3618 | Implant Site Erythema | 936 | 3 | Etonogestrel (PRR 984.0) |
| 3619 | Foreign Body In Eye | 934 | 16 | Carboxymethylcellulose Sodium (PRR 60.9) |
| 3620 | Ovarian Disorder | 934 | 15 | Goserelin (PRR 20.2) |
| 3621 | Discoloured Vomit | 934 | 13 | Brexpiprazole (PRR 64.9) |
| 3622 | Raynaud'S Phenomenon | 934 | 3 | Atomoxetine Hydrochloride (PRR 23.0) |
| 3623 | Haemorrhagic Arteriovenous Malformation | 933 | 7 | Rivaroxaban (PRR 690.4) |
| 3624 | Progesterone Receptor Assay Positive | 933 | 10 | Medroxyprogesterone Acetate (PRR 1,078.8) |
| 3625 | Eyelid Rash | 931 | 9 | Bimatoprost (PRR 48.8) |
| 3626 | Injection Site Ulcer | 931 | 10 | Interferon Beta-1B (PRR 106.2) |
| 3627 | Drug Dispensed To Wrong Patient | 931 | 9 | Dutasteride (PRR 139.1) |
| 3628 | Pelvic Discomfort | 930 | 6 | Copper (PRR 70.7) |
| 3629 | Skin Test Positive | 930 | 18 | Rocuronium Bromide (PRR 85.6) |
| 3630 | Intracranial Mass | 930 | 19 | Ganciclovir (PRR 26.6) |
| 3631 | Bone Graft | 929 | 6 | Alendronate Sodium (PRR 88.1) |
| 3632 | Urinary Tract Infection Enterococcal | 929 | 34 | Anti-Thymocyte Globulin (Rabbit) (PRR 51.0) |
| 3633 | Bone Cyst | 928 | 36 | Desoximetasone (PRR 111.5) |
| 3634 | Application Site Dermatitis | 928 | 12 | Nicotine (PRR 187.3) |
| 3635 | Skin Texture Abnormal | 927 | 14 | Nemolizumab-Ilto (PRR 23.3) |
| 3636 | Appendix Cancer | 927 | 3 | Ranitidine (PRR 38.3) |
| 3637 | Sleep-Related Eating Disorder | 927 | 36 | Sodium Oxybate (PRR 121.4) |
| 3638 | Oral Administration Complication | 927 | 5 | Buprenorphine (PRR 185.5) |
| 3639 | Temporal Arteritis | 927 | 5 | Terbinafine Hydrochloride (PRR 15.3) |
| 3640 | Tongue Injury | 926 | 9 | Emicizumab (PRR 35.3) |
| 3641 | Product After Taste | 925 | 19 | Lifitegrast (PRR 109.1) |
| 3642 | Stereotypy | 925 | 29 | Pramipexole (PRR 71.0) |
| 3643 | Product Shape Issue | 924 | 6 | Etonogestrel And Ethinyl Estradiol (PRR 53.6) |
| 3644 | Immune-Mediated Dermatitis | 924 | 15 | Ipilimumab (PRR 210.3) |
| 3645 | Retinal Exudates | 924 | 11 | Ranibizumab (PRR 146.9) |
| 3646 | Cerebral Toxoplasmosis | 923 | 74 | Busulfan (PRR 106.8) |
| 3647 | Microangiopathy | 923 | 27 | Ciclesonide (PRR 91.2) |
| 3648 | Venous Injury | 922 | 6 | Drospirenone And Ethinyl Estradiol (PRR 21.3) |
| 3649 | Pneumonia Cryptococcal | 922 | 33 | Amphotericin B (PRR 63.6) |
| 3650 | Therapeutic Response Increased | 922 | 10 | Suvorexant (PRR 26.5) |
| 3651 | Blood Urea Abnormal | 919 | 16 | Ribociclib (PRR 25.3) |
| 3652 | Pyelocaliectasis | 919 | 18 | Darunavir (PRR 43.2) |
| 3653 | Diffuse Large B-Cell Lymphoma Refractory | 918 | 45 | Polatuzumab Vedotin (PRR 290.2) |
| 3654 | Alpha Haemolytic Streptococcal Infection | 918 | 53 | Thiotepa (PRR 73.6) |
| 3655 | Klebsiella Bacteraemia | 918 | 64 | Posaconazole Delayed-Release (PRR 64.0) |
| 3656 | Enterocolitis Infectious | 918 | 47 | Pegaspargase (PRR 39.8) |
| 3657 | Pharyngeal Hypoaesthesia | 918 | 8 | Asenapine Maleate (PRR 53.5) |
| 3658 | Dilated Cardiomyopathy | 917 | 46 | Eplerenone (PRR 68.3) |
| 3659 | Fibroma | 917 | 12 | Levodopa (PRR 78.5) |
| 3660 | Extensor Plantar Response | 916 | 21 | Dimenhydrinate (PRR 39.1) |
| 3661 | Biopsy | 915 | 10 | Cholestyramine (PRR 19.0) |
| 3662 | Prurigo | 915 | 9 | Ritonavir (PRR 20.8) |
| 3663 | Premature Menopause | 914 | 21 | Busulfan (PRR 81.4) |
| 3664 | Foetal Heart Rate Abnormal | 914 | 21 | Misoprostol (PRR 100.3) |
| 3665 | Pulpitis Dental | 913 | 13 | Fondaparinux Sodium (PRR 42.9) |
| 3666 | Corrective Lens User | 913 | 4 | Oral Semaglutide (PRR 86.5) |
| 3667 | Skin Graft | 913 | 3 | Cefazolin (PRR 17.6) |
| 3668 | Adverse Food Reaction | 912 | 8 | Adalimumab (PRR 33.3) |
| 3669 | Muscle Swelling | 912 | 5 | Temozolomide (PRR 30.1) |
| 3670 | Wrist Surgery | 911 | 12 | Rocuronium Bromide (PRR 74.7) |
| 3671 | Nasal Cavity Cancer | 911 | 3 | Ranitidine Hydrochloride (PRR 87.6) |
| 3672 | Psychogenic Seizure | 911 | 34 | Clobazam (PRR 126.7) |
| 3673 | Colour Blindness | 911 | 13 | Rifampicin (PRR 20.5) |
| 3674 | Cerumen Impaction | 910 | 17 | Alendronate Sodium (PRR 54.9) |
| 3675 | Adenocarcinoma Gastric | 909 | 28 | Sucralfate Oral (PRR 38.0) |
| 3676 | Scrotal Swelling | 909 | 5 | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 26.2) |
| 3677 | Incision Site Infection | 908 | 6 | Cefazolin (PRR 116.1) |
| 3678 | Disturbance In Sexual Arousal | 908 | 17 | Finasteride (PRR 29.2) |
| 3679 | Catheter Site Swelling | 907 | 26 | Epoprostenol (PRR 299.9) |
| 3680 | Metastases To Adrenals | 907 | 44 | Gefitinib (PRR 62.6) |
| 3681 | Primary Sequestrum | 906 | 31 | Chlorhexidine Gluconate (PRR 107.9) |
| 3682 | Gastric Operation | 906 | 6 | Pancrelipase (PRR 21.0) |
| 3683 | Bronchopulmonary Aspergillosis Allergic | 905 | 122 | Bisacodyl Suppositories (PRR 201.9) |
| 3684 | Neuropsychiatric Symptoms | 905 | 27 | Montelukast Sodium (PRR 62.4) |
| 3685 | Arteriovenous Malformation | 904 | 10 | Ado-Trastuzumab Emtansine (PRR 58.7) |
| 3686 | Vasospasm | 904 | 7 | Sumatriptan Succinate (PRR 22.4) |
| 3687 | Haemochromatosis | 904 | 8 | Deferasirox (PRR 85.6) |
| 3688 | Hypoglycaemic Seizure | 902 | 10 | Human Insulin (PRR 69.2) |
| 3689 | Traumatic Intracranial Haemorrhage | 902 | 8 | Dabigatran Etexilate Mesylate (PRR 24.4) |
| 3690 | Ligament Disorder | 901 | 4 | Ciprofloxacin Hydrochloride And Hydrocortisone (PRR 27.4) |
| 3691 | Intestinal Infarction | 901 | 10 | Amphetamine (PRR 36.8) |
| 3692 | Pleurothotonus | 900 | 38 | Donepezil Hydrochloride (PRR 97.3) |
| 3693 | Anaesthetic Complication Neurological | 900 | 17 | Sevoflurane (PRR 3,410.0) |
| 3694 | Product Appearance Confusion | 900 | 4 | Tranexamic Acid (PRR 26.3) |
| 3695 | Aneurysm Ruptured | 900 | 8 | Iohexol (PRR 51.2) |
| 3696 | Chronic Graft Versus Host Disease In Skin | 899 | 39 | Thiotepa (PRR 260.4) |
| 3697 | Right Ventricular Hypertrophy | 899 | 25 | Theophylline Anhydrous (PRR 182.1) |
| 3698 | Selective Eating Disorder | 899 | 25 | Dalteparin Sodium (PRR 56.3) |
| 3699 | Abulia | 899 | 18 | Lithium Carbonate (PRR 35.0) |
| 3700 | Uterine Dilation And Curettage | 898 | 7 | Etonogestrel And Ethinyl Estradiol (PRR 64.7) |
| 3701 | Abnormal Withdrawal Bleeding | 897 | 4 | Etonogestrel And Ethinyl Estradiol (PRR 360.3) |
| 3702 | C-Reactive Protein | 896 | 164 | Diclofenac Potassium, Film Coated (PRR 2,777.1) |
| 3703 | Muscle Necrosis | 896 | 13 | Ticagrelor (PRR 23.4) |
| 3704 | Bone Contusion | 895 | 11 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 28.0) |
| 3705 | Mucosal Erosion | 895 | 24 | Micafungin Sodium (PRR 50.4) |
| 3706 | Nuchal Rigidity | 895 | 5 | Haloperidol Lactate (PRR 19.2) |
| 3707 | Protein Urine | 893 | 16 | Bevacizumab (PRR 34.0) |
| 3708 | Therapeutic Product Cross-Reactivity | 893 | 30 | Ampicillin (PRR 184.2) |
| 3709 | Hyperplasia | 893 | 14 | Basiliximab (PRR 30.2) |
| 3710 | Blood Magnesium Increased | 892 | 41 | Loperamide Hydrochloride Oral (PRR 115.9) |
| 3711 | Anaemia Of Chronic Disease | 892 | 32 | Alendronate Sodium (PRR 39.5) |
| 3712 | Catheter Management | 891 | 17 | Epoprostenol (PRR 2,268.8) |
| 3713 | Oropharyngeal Candidiasis | 890 | 19 | Theophylline (PRR 33.1) |
| 3714 | Infusion Site Nodule | 889 | 40 | Ketoprofen (PRR 112.7) |
| 3715 | Candida Sepsis | 888 | 50 | Amphotericin B (PRR 82.4) |
| 3716 | Cystic Fibrosis Respiratory Infection Suppression | 888 | 25 | Dornase Alfa (PRR 568.8) |
| 3717 | Heart Transplant | 887 | 30 | Tafamidis (PRR 85.6) |
| 3718 | Antipsychotic Drug Level Above Therapeutic | 886 | 24 | Lithium Carbonate (PRR 171.8) |
| 3719 | Saliva Altered | 886 | 7 | Rotigotine (PRR 19.7) |
| 3720 | Anogenital Warts | 885 | 31 | Lopinavir And Ritonavir (PRR 40.9) |
| 3721 | Blood Alkaline Phosphatase Abnormal | 885 | 29 | Asfotase Alfa (PRR 132.3) |
| 3722 | Sensation Of Pressure | 884 | 2 | Onabotulinumtoxina (PRR 6.9) |
| 3723 | Human Chorionic Gonadotropin Increased | 882 | 6 | Lenalidomide (PRR 92.2) |
| 3724 | Oophorectomy | 882 | 9 | Lanreotide Acetate (PRR 36.6) |
| 3725 | Blood Albumin Increased | 881 | 7 | Asfotase Alfa (PRR 28.7) |
| 3726 | Drug Detoxification | 880 | 17 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 357.5) |
| 3727 | Jaw Operation | 880 | 10 | Zoledronic Acid (PRR 24.6) |
| 3728 | Red Man Syndrome | 880 | 19 | Vancomycin Hydrochloride (PRR 311.9) |
| 3729 | Urine Protein/Creatinine Ratio Increased | 879 | 21 | Voclosporin (PRR 804.6) |
| 3730 | Abdominal Neoplasm | 879 | 13 | Octreotide Acetate (PRR 30.7) |
| 3731 | Catarrh | 878 | 75 | Felodipine Extended-Release Tablets (PRR 373.3) |
| 3732 | Upper Airway Obstruction | 878 | 13 | Midazolam Hydrochloride (PRR 47.6) |
| 3733 | Meningioma Benign | 877 | 1 | Medroxyprogesterone Acetate (PRR 856.8) |
| 3734 | Large For Dates Baby | 875 | 14 | Ampicillin (PRR 34.9) |
| 3735 | Injection Site Dryness | 873 | 12 | Peginterferon Beta-1A (PRR 39.1) |
| 3736 | Cerebellar Atrophy | 873 | 22 | Extended Phenytoin Sodium (PRR 205.8) |
| 3737 | Cleft Lip | 873 | 10 | Topiramate (PRR 30.7) |
| 3738 | Punctate Keratitis | 871 | 18 | Prednisolone Acetate (PRR 84.2) |
| 3739 | Parvovirus B19 Infection | 870 | 31 | Basiliximab (PRR 280.3) |
| 3740 | Thalamus Haemorrhage | 868 | 14 | Febuxostat Tablets 40 Mg (PRR 38.4) |
| 3741 | Drug Level Fluctuating | 868 | 17 | Extended Phenytoin Sodium (PRR 107.3) |
| 3742 | Gastrointestinal Fistula | 867 | 7 | Teduglutide (PRR 42.1) |
| 3743 | Arterial Stenosis | 867 | 5 | Nilotinib (PRR 31.4) |
| 3744 | Blood Triglycerides Abnormal | 866 | 11 | Icosapent Ethyl (PRR 84.7) |
| 3745 | Spinal Cord Neoplasm | 866 | 9 | Octreotide Acetate (PRR 22.7) |
| 3746 | Alcohol Withdrawal Syndrome | 866 | 18 | Naltrexone (PRR 103.2) |
| 3747 | Cardiac Output Decreased | 865 | 19 | Sevoflurane (PRR 47.2) |
| 3748 | Enterocutaneous Fistula | 865 | 26 | Teduglutide (PRR 96.7) |
| 3749 | Iud Migration | 864 | 2 | Levonorgestrel (PRR 1,143.2) |
| 3750 | Catheter Site Pruritus | 864 | 17 | Epoprostenol (PRR 1,475.5) |
| 3751 | Acute Chest Syndrome | 864 | 5 | Voxelotor (PRR 766.2) |
| 3752 | Transfusion Reaction | 864 | 12 | Deferasirox (PRR 32.1) |
| 3753 | Renal Tubular Atrophy | 863 | 23 | Basiliximab (PRR 165.9) |
| 3754 | Hyperleukocytosis | 863 | 30 | Hydroxyurea (PRR 70.8) |
| 3755 | Abdominal Sepsis | 863 | 25 | Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose (PRR 48.0) |
| 3756 | Peripheral Nerve Injury | 863 | 12 | Ciprofloxacin Hydrochloride And Hydrocortisone (PRR 41.0) |
| 3757 | Blood Prolactin Abnormal | 861 | 19 | Asenapine Maleate (PRR 2,234.1) |
| 3758 | Adrenocorticotropic Hormone Deficiency | 861 | 17 | Ipilimumab (PRR 129.0) |
| 3759 | Hilar Lymphadenopathy | 861 | 28 | Chlorhexidine Gluconate (PRR 29.5) |
| 3760 | Vascular Dementia | 861 | 12 | Asenapine Maleate (PRR 45.5) |
| 3761 | Detachment Of Retinal Pigment Epithelium | 860 | 10 | Ranibizumab (PRR 443.6) |
| 3762 | Craniosynostosis | 859 | 10 | Asfotase Alfa (PRR 104.1) |
| 3763 | Testicular Atrophy | 859 | 14 | Finasteride (PRR 128.8) |
| 3764 | Vasoconstriction | 859 | 7 | Norepinephrine Bitartrate (PRR 45.1) |
| 3765 | Product Outer Packaging Issue | 858 | 4 | Guselkumab (PRR 15.3) |
| 3766 | Neonatal Respiratory Distress | 856 | 22 | Ampicillin (PRR 57.0) |
| 3767 | Nodal Arrhythmia | 856 | 13 | Digoxin (PRR 36.9) |
| 3768 | Post-Injection Delirium Sedation Syndrome | 854 | 5 | Olanzapine Pamoate (PRR 148.2) |
| 3769 | Necrotising Myositis | 854 | 7 | Atorvastatin Calcium, Film Coated (PRR 36.1) |
| 3770 | Genital Burning Sensation | 854 | 4 | Miconazole Nitrate (PRR 51.3) |
| 3771 | Aptyalism | 854 | 9 | Thiamine Hydrochloride (PRR 31.9) |
| 3772 | Lung Hyperinflation | 853 | 32 | Ciclesonide (PRR 91.1) |
| 3773 | Cystocele | 853 | 11 | Alendronate Sodium (PRR 43.8) |
| 3774 | Product Reconstitution Quality Issue | 853 | 8 | Somatropin (PRR 68.2) |
| 3775 | Pulmonary Cavitation | 853 | 25 | Amikacin (PRR 56.8) |
| 3776 | Relapsing-Remitting Multiple Sclerosis | 852 | 28 | Doxepin Hydrochloride (PRR 184.9) |
| 3777 | Hepatic Cancer Metastatic | 852 | 13 | Sorafenib (PRR 39.1) |
| 3778 | Adenoma Benign | 852 | 12 | Mometasone (PRR 38.5) |
| 3779 | Gastrointestinal Neoplasm | 852 | 2 | Octreotide Acetate (PRR 36.9) |
| 3780 | Pouchitis | 851 | 28 | Vedolizumab (PRR 54.4) |
| 3781 | Eosinophilic Pneumonia Acute | 851 | 22 | Daptomycin (PRR 459.3) |
| 3782 | Infusion Site Discolouration | 850 | 33 | Ketoprofen (PRR 111.8) |
| 3783 | Intestinal Pseudo-Obstruction | 850 | 28 | Bisacodyl Suppositories (PRR 56.8) |
| 3784 | Abscess Drainage | 850 | 5 | Bimekizumab (PRR 43.2) |
| 3785 | Axonal Neuropathy | 850 | 17 | Rifampicin (PRR 27.0) |
| 3786 | Gingival Erythema | 850 | 8 | Chlorhexidine Gluconate (PRR 32.6) |
| 3787 | Allergic Sinusitis | 849 | 26 | Acetylcysteine (PRR 53.3) |
| 3788 | Non-Small Cell Lung Cancer Metastatic | 849 | 17 | Crizotinib (PRR 104.6) |
| 3789 | Malignant Hypertension | 849 | 12 | Cefazolin (PRR 27.2) |
| 3790 | Urge Incontinence | 849 | 11 | Tolterodine Tartrate (PRR 47.4) |
| 3791 | Soliloquy | 848 | 16 | Paliperidone Palmitate (PRR 34.5) |
| 3792 | Paternal Exposure During Pregnancy | 848 | 11 | Agalsidase Beta (PRR 21.4) |
| 3793 | Transmission Of An Infectious Agent Via A Medicinal Product | 848 | 2 | Propofol (PRR 49.6) |
| 3794 | Tongue Movement Disturbance | 847 | 14 | Lurasidone Hydrochloride (PRR 61.0) |
| 3795 | Abdominal Lymphadenopathy | 847 | 38 | Cabotegravir (PRR 81.6) |
| 3796 | Hepatic Haemorrhage | 847 | 12 | Sorafenib (PRR 21.7) |
| 3797 | Deafness Transitory | 846 | 25 | Diclofenac Potassium, Film Coated (PRR 305.4) |
| 3798 | Procedural Hypotension | 846 | 29 | Rocuronium Bromide (PRR 174.3) |
| 3799 | Enterovirus Infection | 844 | 43 | Mercaptopurine (PRR 70.7) |
| 3800 | Medication Overuse Headache | 844 | 18 | Acetaminophen, Aspirin (Nsaid) And Caffeine (PRR 362.5) |
| 3801 | Vital Functions Abnormal | 844 | 4 | Octreotide Acetate (PRR 30.2) |
| 3802 | Carotid Artery Thrombosis | 843 | 64 | Methylprednisolone Acetate (PRR 562.4) |
| 3803 | Lung Carcinoma Cell Type Unspecified Stage Iii | 843 | 2 | Ranitidine Hydrochloride (PRR 18.0) |
| 3804 | Congenital Cystic Kidney Disease | 843 | 17 | Misoprostol (PRR 38.7) |
| 3805 | Follicular Lymphoma | 842 | 28 | Obinutuzumab (PRR 334.1) |
| 3806 | Jc Virus Test Positive | 842 | 9 | Fingolimod Hcl (PRR 94.4) |
| 3807 | Fracture Delayed Union | 842 | 17 | Alendronate Sodium (PRR 223.6) |
| 3808 | Hepatitis A | 842 | 9 | Lamivudine Oral (PRR 29.3) |
| 3809 | Oesophageal Obstruction | 842 | 2 | Oxazepam (PRR 21.1) |
| 3810 | Non-Infectious Endophthalmitis | 840 | 9 | Aflibercept (PRR 814.2) |
| 3811 | Pyloric Stenosis | 840 | 15 | Oseltamivir (PRR 37.9) |
| 3812 | Steroid Dependence | 839 | 80 | Felodipine Extended-Release Tablets (PRR 384.8) |
| 3813 | Congenital Cardiovascular Anomaly | 839 | 16 | Divalproex Sodium (PRR 128.9) |
| 3814 | Electric Shock | 837 | 23 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 123.1) |
| 3815 | Glioblastoma Multiforme | 837 | 16 | Temozolomide (PRR 229.6) |
| 3816 | Choroidal Neovascularisation | 837 | 5 | Ranibizumab (PRR 585.2) |
| 3817 | Colonic Abscess | 837 | 8 | Vedolizumab (PRR 17.6) |
| 3818 | Device Loosening | 836 | 12 | Rotigotine (PRR 31.6) |
| 3819 | Covid-19 Immunisation | 835 | 10 | Certolizumab Pegol (PRR 205.4) |
| 3820 | Foetal Disorder | 834 | 19 | Labetalol (PRR 89.0) |
| 3821 | Depersonalisation | 834 | 2 | Paroxetine Hydrochloride (PRR 27.2) |
| 3822 | Culture Positive | 834 | 12 | Chlorhexidine Gluconate (PRR 36.1) |
| 3823 | Coronary Artery Dissection | 834 | 13 | Amphetamine (PRR 100.3) |
| 3824 | Twin Pregnancy | 833 | 15 | Atazanavir (PRR 48.5) |
| 3825 | Axial Spondyloarthritis | 833 | 14 | Certolizumab Pegol (PRR 178.7) |
| 3826 | Adrenal Suppression | 833 | 58 | Ritonavir 100 Mg (PRR 152.0) |
| 3827 | Tongue Pruritus | 833 | 6 | Iohexol (PRR 49.1) |
| 3828 | Food Refusal | 833 | 15 | Regorafenib (PRR 69.3) |
| 3829 | Enzyme Level Increased | 833 | 7 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 12.1) |
| 3830 | Mycotic Allergy | 832 | 91 | Dutasteride (PRR 1,333.1) |
| 3831 | Incision Site Complication | 831 | 4 | Eptinezumab-Jjmr (PRR 8.3) |
| 3832 | Incorrect Product Formulation Administered | 831 | 12 | Galcanezumab-Gnlm (PRR 86.2) |
| 3833 | Syncope Vasovagal | 830 | 2 | Cetuximab (PRR 8.1) |
| 3834 | Collapse Of Lung | 830 | 4 | Gefitinib (PRR 16.8) |
| 3835 | Ovarian Cancer Metastatic | 830 | 17 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 120.7) |
| 3836 | Myocardial Fibrosis | 830 | 20 | Methadone Hydrochloride (PRR 59.7) |
| 3837 | Vitreous Opacities | 830 | 11 | Aflibercept (PRR 184.5) |
| 3838 | Anaemia Haemolytic Autoimmune | 829 | 18 | Anti-Thymocyte Globulin (Rabbit) (PRR 86.8) |
| 3839 | Lip Pruritus | 828 | 17 | Dimenhydrinate (PRR 60.8) |
| 3840 | Pseudomonal Bacteraemia | 828 | 67 | Axicabtagene Ciloleucel (PRR 73.8) |
| 3841 | Accidental Needle Stick | 828 | 3 | Exenatide (PRR 105.0) |
| 3842 | Fungal Sepsis | 827 | 52 | Ganciclovir (PRR 79.2) |
| 3843 | Sciatic Nerve Injury | 827 | 10 | Octreotide Acetate (PRR 42.7) |
| 3844 | Lung Operation | 826 | 11 | Fluticasone Propionate And Salmeterol (PRR 27.4) |
| 3845 | Cardiac Stress Test Abnormal | 826 | 4 | Ezetimibe And Simvastatin (PRR 16.8) |
| 3846 | Recall Phenomenon | 825 | 25 | Gemcitabine Hydrochloride (PRR 79.3) |
| 3847 | Dental Discomfort | 825 | 4 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 11.6) |
| 3848 | Intentional Device Use Issue | 824 | 6 | Copper (PRR 496.1) |
| 3849 | Injection Site Coldness | 824 | 5 | Tirzepatide (PRR 74.3) |
| 3850 | Hydrothorax | 824 | 28 | Bosutinib (PRR 37.1) |
| 3851 | Developmental Hip Dysplasia | 823 | 29 | Lamotirigine (PRR 38.7) |
| 3852 | Campylobacter Infection | 823 | 22 | Bendamustine Hcl (PRR 59.6) |
| 3853 | Adrenal Mass | 823 | 12 | Ganciclovir (PRR 48.0) |
| 3854 | Septic Embolus | 823 | 31 | Posaconazole Delayed-Release (PRR 69.2) |
| 3855 | Mycosis Fungoides | 823 | 5 | Brentuximab Vedotin (PRR 55.7) |
| 3856 | Infected Bite | 822 | 13 | Human Immunoglobulin G (PRR 46.2) |
| 3857 | Circadian Rhythm Sleep Disorder | 822 | 13 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 26.7) |
| 3858 | Peritoneal Dialysis | 822 | 14 | Darbepoetin Alfa (PRR 103.4) |
| 3859 | Oesophageal Rupture | 822 | 2 | Asenapine Maleate (PRR 11.7) |
| 3860 | Allergic Granulomatous Angiitis | 821 | 9 | Montelukast Sodium (PRR 372.9) |
| 3861 | Csf Protein Increased | 821 | 16 | Efavirenz (PRR 25.3) |
| 3862 | Oesophageal Perforation | 821 | 18 | Eplerenone (PRR 70.2) |
| 3863 | Hypopyon | 821 | 19 | Moxifloxacin Hydrochloride (PRR 115.3) |
| 3864 | Peritonsillar Abscess | 821 | 1 | Trifluridine And Tipiracil (PRR 7.1) |
| 3865 | Mean Platelet Volume Decreased | 820 | 38 | Diclofenac Potassium, Film Coated (PRR 84.2) |
| 3866 | Vulvovaginal Erythema | 820 | 11 | Miconazole Nitrate (PRR 369.3) |
| 3867 | Ocular Vascular Disorder | 820 | 10 | Ranibizumab (PRR 37.0) |
| 3868 | Periorbital Haematoma | 819 | 2 | Cladribine (PRR 18.7) |
| 3869 | Product Use In Unapproved Therapeutic Environment | 819 | 7 | Cabotegravir (PRR 1,164.9) |
| 3870 | Granuloma Skin | 818 | 82 | Sulfasalazine (PRR 432.0) |
| 3871 | Vaccination Complication | 818 | 10 | Diroximel Fumarate (PRR 39.3) |
| 3872 | Infusion Site Oedema | 818 | 19 | Treprostinil (PRR 127.0) |
| 3873 | Syndactyly | 818 | 21 | Ampicillin (PRR 40.6) |
| 3874 | Gastric Cancer Stage Iii | 817 | 2 | Ranitidine Hydrochloride (PRR 15.6) |
| 3875 | Chemical Injury | 817 | 2 | Miconazole Nitrate (PRR 47.6) |
| 3876 | Vertebral Foraminal Stenosis | 816 | 26 | Chlorhexidine Gluconate (PRR 69.0) |
| 3877 | Endocrine Ophthalmopathy | 816 | 33 | Methimazole (PRR 292.1) |
| 3878 | Neonatal Hypoxia | 816 | 10 | Misoprostol (PRR 136.5) |
| 3879 | Genital Infection Fungal | 816 | 4 | Canagliflozin (PRR 364.8) |
| 3880 | Pneumonia Respiratory Syncytial Viral | 815 | 35 | Palivizumab (PRR 151.5) |
| 3881 | Leukocyturia | 815 | 7 | Alemtuzumab (PRR 128.5) |
| 3882 | Guttate Psoriasis | 814 | 9 | Triamcinolone Acetonide Ointment Usp, 0.05% (PRR 24.7) |
| 3883 | Sputum Culture Positive | 814 | 36 | Rabeprazole (PRR 122.5) |
| 3884 | Pseudomonas Test Positive | 814 | 30 | Pegaspargase (PRR 78.6) |
| 3885 | Gastroenteritis Salmonella | 813 | 5 | Travoprost (PRR 17.9) |
| 3886 | Amaurosis | 813 | 9 | Iohexol (PRR 40.8) |
| 3887 | Penile Haemorrhage | 812 | 7 | Sildenafil Citrate (PRR 21.3) |
| 3888 | Mitochondrial Toxicity | 812 | 24 | Zidovudine (PRR 652.7) |
| 3889 | Electrocardiogram St Segment Abnormal | 811 | 6 | Digoxin (PRR 30.8) |
| 3890 | Acne Pustular | 809 | 14 | Panitumumab (PRR 83.7) |
| 3891 | Resorption Bone Increased | 809 | 26 | Alendronate Sodium (PRR 85.6) |
| 3892 | Cerebral Venous Sinus Thrombosis | 809 | 22 | Pegaspargase (PRR 70.0) |
| 3893 | Documented Hypersensitivity To Administered Product | 809 | 5 | Iohexol (PRR 25.1) |
| 3894 | Bradycardia Foetal | 808 | 22 | Bupivacaine (PRR 91.8) |
| 3895 | Pulmonary Nocardiosis | 807 | 36 | Valganciclovir Hydrochloride Powder, (PRR 192.9) |
| 3896 | Erythrodermic Psoriasis | 807 | 17 | Adalimumab-Aaty (PRR 26.5) |
| 3897 | Compulsive Sexual Behaviour | 807 | 13 | Aripiprazole (PRR 493.0) |
| 3898 | Basal Ganglia Haemorrhage | 806 | 8 | Rivaroxaban (PRR 47.9) |
| 3899 | Enterococcal Sepsis | 806 | 67 | Micafungin Sodium (PRR 108.1) |
| 3900 | Simple Partial Seizures | 806 | 20 | Oxcarbazepine (PRR 258.4) |
| 3901 | Reaction To Preservatives | 806 | 11 | Travoprost (PRR 61.2) |
| 3902 | Incision Site Haemorrhage | 805 | 5 | Fondaparinux Sodium (PRR 113.4) |
| 3903 | Altered Visual Depth Perception | 805 | 12 | Trimethoprim (PRR 20.0) |
| 3904 | Anal Ulcer | 805 | 18 | Everolimus Tablets (PRR 34.8) |
| 3905 | Cartilage Atrophy | 804 | 5 | Adalimumab (PRR 69.2) |
| 3906 | Endometrial Hyperplasia | 803 | 9 | Raloxifene Hydrochloride (PRR 36.4) |
| 3907 | Breast Operation | 803 | 11 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 129.6) |
| 3908 | Dyschromatopsia | 803 | 13 | Voriconazole Injection (PRR 43.6) |
| 3909 | Infantile Apnoea | 803 | 17 | Ampicillin (PRR 47.8) |
| 3910 | Post-Traumatic Neck Syndrome | 803 | 17 | Botulinum Toxin Type A (PRR 97.1) |
| 3911 | Gingival Infection | 802 | 7 | Alendronate Sodium (PRR 37.5) |
| 3912 | Glomerular Filtration Rate Increased | 802 | 38 | Methylprednisolone Acetate (PRR 76.7) |
| 3913 | Polycythaemia Vera | 802 | 7 | Hydroxyurea (PRR 73.8) |
| 3914 | Tongue Erythema | 802 | 10 | Felodipine Extended-Release Tablets (PRR 30.1) |
| 3915 | Barrett'S Oesophagus | 801 | 2 | Esomeprazole Magnesium (PRR 38.7) |
| 3916 | Tonsil Cancer | 801 | 5 | Ciclesonide (PRR 33.1) |
| 3917 | Ketonuria | 801 | 11 | Empagliflozin (PRR 54.8) |
| 3918 | Lymphocyte Stimulation Test Positive | 801 | 11 | Carbamazepine (PRR 45.2) |
| 3919 | Reticulocyte Count Increased | 801 | 13 | Eculizumab (PRR 154.8) |
| 3920 | Pancreatitis Relapsing | 801 | 26 | Dimenhydrinate (PRR 55.1) |
| 3921 | Electromechanical Dissociation | 800 | 17 | Propofol (PRR 36.3) |
| 3922 | Vascular Access Complication | 799 | 35 | Diclofenac Potassium, Film Coated (PRR 89.8) |
| 3923 | Excessive Granulation Tissue | 799 | 14 | Chlorhexidine Gluconate (PRR 46.5) |
| 3924 | Device Damage | 798 | 11 | Epoprostenol (PRR 131.5) |
| 3925 | Craniofacial Fracture | 798 | 17 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 33.8) |
| 3926 | Chronic Hepatitis | 798 | 18 | Itraconazole (PRR 29.5) |
| 3927 | Superior Sagittal Sinus Thrombosis | 798 | 13 | Pegaspargase (PRR 133.2) |
| 3928 | Iiird Nerve Paralysis | 798 | 9 | Tretinoin (PRR 29.2) |
| 3929 | Renal Haemangioma | 797 | 5 | Dexlansoprazole (PRR 35,587.2) |
| 3930 | Hemianaesthesia | 797 | 13 | Dimethyl Fumarate (PRR 56.0) |
| 3931 | Orgasm Abnormal | 797 | 7 | Finasteride (PRR 61.0) |
| 3932 | Giant Cell Arteritis | 797 | 15 | Tocilizumab (PRR 48.8) |
| 3933 | Pelvic Mass | 797 | 13 | Nystatin Ointment (PRR 27.8) |
| 3934 | Placental Insufficiency | 797 | 11 | Atazanavir (PRR 52.7) |
| 3935 | Renal Abscess | 797 | 11 | Crizotinib (PRR 100.2) |
| 3936 | Parathyroid Disorder | 796 | 9 | Paricalcitol (PRR 45.8) |
| 3937 | Atypical Haemolytic Uraemic Syndrome | 796 | 23 | Eculizumab (PRR 114.9) |
| 3938 | Superficial Vein Thrombosis | 795 | 19 | Iron Sucrose (PRR 76.7) |
| 3939 | Hand-Foot-And-Mouth Disease | 794 | 10 | Palivizumab (PRR 24.3) |
| 3940 | Ureteric Stenosis | 794 | 16 | Basiliximab (PRR 129.1) |
| 3941 | Intervertebral Disc Space Narrowing | 794 | 38 | Chlorhexidine Gluconate (PRR 64.9) |
| 3942 | Seizure Cluster | 794 | 26 | Cannabidiol (PRR 238.4) |
| 3943 | Fear Of Falling | 794 | 11 | Carboxymethylcellulose Sodium (PRR 34.0) |
| 3944 | Pulmonary Valve Stenosis | 794 | 4 | Paroxetine Hydrochloride (PRR 80.8) |
| 3945 | Sepsis Neonatal | 794 | 26 | Ampicillin (PRR 168.8) |
| 3946 | Polypectomy | 793 | 7 | Epoprostenol (PRR 20.3) |
| 3947 | Systemic Lupus Erythematosus Rash | 792 | 25 | Diltiazem Hydrochloride Extended-Release Tablets (PRR 180.0) |
| 3948 | Periorbital Pain | 792 | 36 | Cenegermin-Bkbj (PRR 2,632.1) |
| 3949 | Breast Calcifications | 792 | 10 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 49.3) |
| 3950 | Limb Malformation | 792 | 13 | Valproate Sodium (PRR 93.0) |
| 3951 | Balanoposthitis | 792 | 8 | Canagliflozin (PRR 91.3) |
| 3952 | Bronchopulmonary Dysplasia | 792 | 23 | Palivizumab (PRR 147.9) |
| 3953 | Tumour Excision | 792 | 11 | Imatinib Mesylate (PRR 39.6) |
| 3954 | Opisthotonus | 791 | 13 | Oxycodone Hydrochloride And Acetaminophen (PRR 40.1) |
| 3955 | Starvation | 791 | 14 | Meperidine Hydrochloride (PRR 26.0) |
| 3956 | Embolia Cutis Medicamentosa | 791 | 10 | Diclofenac (PRR 186.1) |
| 3957 | Hepatitis Viral | 791 | 19 | Olanzapine Pamoate (PRR 59.5) |
| 3958 | Dysbiosis | 791 | 53 | Meropenem (PRR 91.6) |
| 3959 | Haptoglobin Decreased | 790 | 9 | Eculizumab (PRR 161.8) |
| 3960 | Lymphangitis | 790 | 10 | Iron Sucrose (PRR 25.1) |
| 3961 | Wound Drainage | 790 | 2 | Standardized Senna Concentrate (PRR 25.5) |
| 3962 | Choroidal Effusion | 789 | 28 | Guanfacine (PRR 75.8) |
| 3963 | Erosive Duodenitis | 788 | 18 | Olmesartan Medoxomil (PRR 45.1) |
| 3964 | Atonic Seizures | 787 | 26 | Clobazam (PRR 234.6) |
| 3965 | Product Dropper Issue | 787 | 12 | Travoprost (PRR 145.8) |
| 3966 | Mammoplasty | 787 | 5 | Etonogestrel And Ethinyl Estradiol (PRR 60.9) |
| 3967 | Blood Fibrinogen Increased | 787 | 12 | Phytonadione (PRR 28.4) |
| 3968 | Aortic Disorder | 787 | 5 | Cimetidine (PRR 25.0) |
| 3969 | Gouty Arthritis | 786 | 12 | Colchicine (PRR 58.2) |
| 3970 | Growth Of Eyelashes | 786 | 15 | Bimatoprost (PRR 438.0) |
| 3971 | Electrocardiogram Qt Corrected Interval Prolonged | 786 | 9 | Ziprasidone Mesylate (PRR 118.4) |
| 3972 | Uterine Enlargement | 785 | 10 | Bleomycin Sulfate (PRR 91.2) |
| 3973 | Perforation | 785 | 32 | Pseudoephedrine Hydrochloride (PRR 47.5) |
| 3974 | Thyroid Hormones Decreased | 785 | 13 | Thyroid, Porcine (PRR 56.3) |
| 3975 | Serous Retinal Detachment | 785 | 17 | Encorafenib (PRR 1,647.4) |
| 3976 | Pulmonary Hypoplasia | 785 | 17 | Nevirapine (PRR 54.1) |
| 3977 | Pneumonia Mycoplasmal | 785 | 15 | Cefuroxime (PRR 47.6) |
| 3978 | Eyelid Function Disorder | 784 | 6 | Cenegermin-Bkbj (PRR 26.7) |
| 3979 | Retinal Pigmentation | 784 | 8 | Minocycline (PRR 46.7) |
| 3980 | Placenta Praevia | 783 | 15 | Atazanavir (PRR 49.7) |
| 3981 | Abdominal Symptom | 783 | 6 | Voxelotor (PRR 63.2) |
| 3982 | Transposition Of The Great Vessels | 783 | 7 | Paroxetine Hydrochloride (PRR 50.9) |
| 3983 | Symmetrical Drug-Related Intertriginous And Flexural Exanthema | 783 | 31 | Itraconazole (PRR 118.9) |
| 3984 | Bronchial Carcinoma | 783 | 10 | Tolvaptan (PRR 24.2) |
| 3985 | Foetal Growth Retardation | 783 | 9 | Zidovudine (PRR 79.3) |
| 3986 | Reversible Posterior Leukoencephalopathy Syndrome | 782 | 20 | Vincristine Sulfate (PRR 39.2) |
| 3987 | Herpes Zoster Disseminated | 782 | 26 | Basiliximab (PRR 41.7) |
| 3988 | Exposure Via Body Fluid | 782 | 13 | Entecavir (PRR 103.7) |
| 3989 | Aseptic Necrosis Bone | 782 | 8 | Thalidomide (PRR 43.7) |
| 3990 | Procedural Nausea | 781 | 10 | Bupivacaine (PRR 70.6) |
| 3991 | Breast Feeding | 781 | 9 | Etonogestrel (PRR 35.6) |
| 3992 | Superinfection Bacterial | 781 | 45 | Valganciclovir Hydrochloride Powder, (PRR 42.5) |
| 3993 | Implant Site Extravasation | 781 | 5 | Bupivacaine (PRR 198.8) |
| 3994 | Vitamin B12 Increased | 781 | 20 | Methylprednisolone Acetate (PRR 82.4) |
| 3995 | Implant Site Pruritus | 781 | 1 | Etonogestrel (PRR 1,743.4) |
| 3996 | Injection Site Burning | 780 | 3 | Adalimumab (PRR 73.3) |
| 3997 | Pulmonary Mycosis | 780 | 19 | Voriconazole (PRR 55.0) |
| 3998 | Blood Alcohol Increased | 779 | 8 | Derma Foam Excel Hand Sanitizer (PRR 148.3) |
| 3999 | Endocarditis Bacterial | 779 | 23 | Gentamicin (PRR 57.1) |
| 4000 | Extradural Abscess | 779 | 9 | Methylprednisolone Acetate (PRR 51.0) |
| 4001 | Chronic Allograft Nephropathy | 778 | 29 | Tacrolimus (PRR 299.2) |
| 4002 | Sinusitis Fungal | 778 | 44 | Psyllium Husk (PRR 81.5) |
| 4003 | Electrocardiogram Repolarisation Abnormality | 777 | 16 | Polyethylene Glycol (PRR 32.7) |
| 4004 | Respiratory Syncytial Virus Bronchiolitis | 777 | 2 | Palivizumab (PRR 819.6) |
| 4005 | Eyelid Exfoliation | 776 | 12 | Bimatoprost (PRR 95.8) |
| 4006 | Laboratory Test Interference | 776 | 8 | Norepinephrine (PRR 28.0) |
| 4007 | Blister Infected | 776 | 7 | Instalax Polyethylene Glycol 3350 (PRR 17.5) |
| 4008 | Drug Tolerance Increased | 775 | 12 | Oxycodone Hydrochloride (PRR 35.0) |
| 4009 | Haemoperitoneum | 775 | 25 | Apixaban (PRR 38.2) |
| 4010 | Toe Operation | 775 | 5 | Rizatriptan Benzoate (PRR 21.3) |
| 4011 | Chondrocalcinosis Pyrophosphate | 773 | 5 | Colchicine (PRR 27.5) |
| 4012 | Skin Neoplasm Excision | 771 | 16 | Bendamustine Hydrochloride (PRR 36.8) |
| 4013 | Gallbladder Polyp | 771 | 8 | Rizatriptan Benzoate (PRR 62.9) |
| 4014 | Ruptured Ectopic Pregnancy | 770 | 4 | Levonorgestrel (PRR 124.1) |
| 4015 | Renal Cancer Metastatic | 770 | 7 | Sunitinib Malate (PRR 180.4) |
| 4016 | Blood Ketone Body Increased | 768 | 12 | Dapagliflozin (PRR 81.1) |
| 4017 | Grimacing | 768 | 13 | Metoclopramide (PRR 153.8) |
| 4018 | Pancreatic Pseudocyst | 768 | 10 | Pegaspargase (PRR 38.5) |
| 4019 | Diarrhoea Infectious | 768 | 11 | Chlorthalidone (PRR 35.7) |
| 4020 | Product Confusion | 767 | 10 | Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate (PRR 174.5) |
| 4021 | Skin Bacterial Infection | 766 | 5 | Clobetasol Propionate Ointment Usp, 0.05% (PRR 18.6) |
| 4022 | Microangiopathic Haemolytic Anaemia | 766 | 27 | Sirolimus (PRR 69.5) |
| 4023 | Vasculitic Rash | 766 | 8 | Anakinra (PRR 83.8) |
| 4024 | Mycoplasma Infection | 765 | 22 | Basiliximab (PRR 100.2) |
| 4025 | Croup Infectious | 764 | 14 | Palivizumab (PRR 86.7) |
| 4026 | Lip Erythema | 763 | 8 | Glycerin, Lidocaine (PRR 56.6) |
| 4027 | Aspiration Pleural Cavity | 763 | 16 | Epoprostenol (PRR 69.6) |
| 4028 | Cauda Equina Syndrome | 763 | 13 | Bupivacaine (PRR 119.9) |
| 4029 | Tracheobronchitis | 763 | 22 | Voriconazole Injection (PRR 43.3) |
| 4030 | Anosognosia | 762 | 25 | Asenapine Maleate (PRR 3,044.0) |
| 4031 | Muscle Discomfort | 762 | 9 | Inclisiran (PRR 48.6) |
| 4032 | Anticoagulation Drug Level Below Therapeutic | 762 | 17 | Warfarin (PRR 160.3) |
| 4033 | Pulmonary Artery Thrombosis | 762 | 17 | Panitumumab (PRR 30.3) |
| 4034 | Allergic Cough | 761 | 10 | Theophylline (PRR 33.9) |
| 4035 | Diaphragmatic Disorder | 761 | 17 | Ciclesonide (PRR 105.1) |
| 4036 | Qrs Axis Abnormal | 761 | 10 | Atropine (PRR 33.4) |
| 4037 | Critical Illness | 761 | 16 | Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose (PRR 16.8) |
| 4038 | Arterial Rupture | 761 | 7 | Basiliximab (PRR 28.3) |
| 4039 | Retinal Injury | 761 | 6 | Thiotepa (PRR 29.0) |
| 4040 | Limb Asymmetry | 760 | 5 | Alendronate Sodium (PRR 90.2) |
| 4041 | Retrograde Ejaculation | 760 | 6 | Tamsulosin Hydrochloride (PRR 44.8) |
| 4042 | Prescription Form Tampering | 759 | 7 | Zolpidem Tartrate (PRR 35.2) |
| 4043 | Heat Exhaustion | 759 | 8 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 16.0) |
| 4044 | Squamous Cell Carcinoma Of Lung | 759 | 8 | Baricitinib (PRR 46.5) |
| 4045 | Reflux Oesophagitis | 759 | 4 | Rizatriptan Benzoate (PRR 30.1) |
| 4046 | Corneal Transplant | 759 | 10 | Prednisolone Acetate (PRR 138.8) |
| 4047 | Complication Of Pregnancy | 757 | 7 | Cladribine (PRR 23.1) |
| 4048 | Malignant Ascites | 757 | 31 | Granisetron Hydrochloride (PRR 32.1) |
| 4049 | Debridement | 757 | 6 | Zoledronic Acid (PRR 46.2) |
| 4050 | Bronchitis Bacterial | 757 | 7 | Infliximab-Dyyb (PRR 103.3) |
| 4051 | Sensitisation | 756 | 40 | Liothyronine Sodium (PRR 1,252.3) |
| 4052 | Monoclonal Immunoglobulin Present | 755 | 26 | Fesoterodine Fumarate (PRR 90.5) |
| 4053 | Hypoparathyroidism | 755 | 25 | Calcitriol Capsules 0.25 Mcg (PRR 101.0) |
| 4054 | Ovarian Neoplasm | 755 | 2 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide (PRR 22.1) |
| 4055 | Carbohydrate Antigen 15-3 Increased | 752 | 29 | Fulvestrant (PRR 315.2) |
| 4056 | Cytomegalovirus Enterocolitis | 752 | 41 | Ganciclovir Sodium (PRR 149.1) |
| 4057 | Anticonvulsant Drug Level Below Therapeutic | 752 | 24 | Extended Phenytoin Sodium (PRR 344.0) |
| 4058 | Chromatopsia | 752 | 6 | Voriconazole (PRR 32.4) |
| 4059 | Coagulation Test Abnormal | 752 | 18 | Anti-Thymocyte Globulin (Rabbit) (PRR 45.4) |
| 4060 | Myasthenic Syndrome | 752 | 15 | Terazosin Hydrochloride (PRR 63.9) |
| 4061 | Negativism | 752 | 11 | Lisdexamfetamine Dimesylate (PRR 81.3) |
| 4062 | Suppressed Lactation | 751 | 9 | Levonorgestrel (PRR 38.9) |
| 4063 | Microalbuminuria | 751 | 13 | Nevirapine (PRR 31.1) |
| 4064 | Vein Collapse | 751 | 5 | Infliximab-Dyyb (PRR 50.7) |
| 4065 | Gastric Cancer Stage Ii | 750 | 2 | Ranitidine Hydrochloride (PRR 15.4) |
| 4066 | Limb Crushing Injury | 750 | 3 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 11.6) |
| 4067 | Tracheitis | 750 | 20 | Tobramycin Solution (PRR 54.8) |
| 4068 | Gingival Abscess | 749 | 7 | Fluticasone Furoate (PRR 44.7) |
| 4069 | Metapneumovirus Infection | 749 | 34 | Palivizumab (PRR 70.4) |
| 4070 | Procoagulant Therapy | 749 | 2 | Dabigatran Etexilate Mesylate (PRR 17,539.0) |
| 4071 | Gingival Ulceration | 749 | 4 | Nicotine Polacrilex (PRR 18.7) |
| 4072 | Perforated Ulcer | 749 | 1 | Eptinezumab-Jjmr (PRR 9.2) |
| 4073 | Chlamydial Infection | 748 | 10 | Etonogestrel And Ethinyl Estradiol (PRR 118.6) |
| 4074 | Soft Tissue Injury | 748 | 23 | Botulinum Toxin Type A (PRR 97.2) |
| 4075 | Gastrointestinal Surgery | 748 | 4 | Pancrelipase (PRR 14.8) |
| 4076 | Amphetamines Positive | 747 | 13 | Lisdexamfetamine Dimesylate (PRR 61.0) |
| 4077 | Genital Ulceration | 747 | 12 | Trimethoprim (PRR 102.5) |
| 4078 | Immune-Mediated Adrenal Insufficiency | 745 | 16 | Pembrolizumab (PRR 292.0) |
| 4079 | Tendon Discomfort | 745 | 9 | Ciprofolxacin (PRR 125.3) |
| 4080 | Enterovesical Fistula | 745 | 12 | Mesalamine (PRR 19.9) |
| 4081 | Increased Viscosity Of Upper Respiratory Secretion | 744 | 19 | Dornase Alfa (PRR 33.8) |
| 4082 | Carcinoid Tumour | 744 | 6 | Octreotide Acetate (PRR 400.1) |
| 4083 | Micturition Frequency Decreased | 744 | 3 | Eplerenone (PRR 33.4) |
| 4084 | Infection Parasitic | 743 | 2 | Benralizumab (PRR 11.3) |
| 4085 | Basophil Count Increased | 743 | 19 | Ribociclib (PRR 42.5) |
| 4086 | Creatinine Renal Clearance Increased | 742 | 42 | Quinapril Hydrochloride (PRR 219.5) |
| 4087 | Brain Stem Syndrome | 742 | 10 | Sevoflurane (PRR 37.7) |
| 4088 | Scotoma | 741 | 3 | Ranibizumab (PRR 83.0) |
| 4089 | Exposure To Communicable Disease | 741 | 4 | Cabotegravir (PRR 14.0) |
| 4090 | Electrocardiogram Pr Prolongation | 740 | 14 | Lacosamide (PRR 50.2) |
| 4091 | Foreign Body In Urogenital Tract | 740 | 1 | Copper (PRR 39,138.1) |
| 4092 | Coma Hepatic | 740 | 15 | Sorafenib (PRR 52.7) |
| 4093 | Heart Sounds Abnormal | 740 | 6 | Misoprostol (PRR 29.3) |
| 4094 | Self-Destructive Behaviour | 739 | 24 | Guanfacine (PRR 81.1) |
| 4095 | Oxygen Supplementation | 739 | 10 | 0Xygen (PRR 63.7) |
| 4096 | Delusional Disorder, Unspecified Type | 738 | 16 | Aripiprazole Oral (PRR 27.3) |
| 4097 | Cardiac Infection | 738 | 13 | Valganciclovir Hydrochloride Powder, (PRR 42.6) |
| 4098 | Eosinophil Count Abnormal | 736 | 21 | Ciclesonide (PRR 279.9) |
| 4099 | Fibrocystic Breast Disease | 736 | 10 | Alendronate Sodium (PRR 80.9) |
| 4100 | Parathyroid Tumour Benign | 735 | 10 | Lithium Carbonate (PRR 74.2) |
| 4101 | Lymph Node Tuberculosis | 734 | 14 | Pyrazinamide (PRR 144.7) |
| 4102 | Stoma Site Inflammation | 734 | 11 | Rotigotine (PRR 105.1) |
| 4103 | Dizziness Exertional | 734 | 22 | Riociguat (PRR 47.6) |
| 4104 | Spontaneous Haematoma | 734 | 6 | Fondaparinux Sodium (PRR 75.7) |
| 4105 | Thrombotic Stroke | 733 | 6 | Granisetron Hydrochloride (PRR 16.4) |
| 4106 | Arterial Injury | 733 | 4 | Goserelin (PRR 41.2) |
| 4107 | Oesophageal Discomfort | 732 | 2 | Crizotinib (PRR 13.5) |
| 4108 | Diet Refusal | 731 | 12 | Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose (PRR 31.6) |
| 4109 | Foreign Body Trauma | 731 | 5 | Naproxen Sodium Tablet (PRR 25.7) |
| 4110 | Serratia Infection | 731 | 25 | Thiotepa (PRR 67.6) |
| 4111 | Traumatic Fracture | 730 | 9 | Regorafenib (PRR 19.9) |
| 4112 | Osmotic Demyelination Syndrome | 730 | 17 | Tolvaptan (PRR 80.8) |
| 4113 | Cerebral Vasoconstriction | 730 | 5 | Sumatriptan Succinate (PRR 29.2) |
| 4114 | Dyspnoea Paroxysmal Nocturnal | 728 | 21 | Standardized Senna Concentrate (PRR 53.9) |
| 4115 | Eschar | 728 | 9 | Ampicillin (PRR 24.4) |
| 4116 | Mycobacterium Chelonae Infection | 727 | 58 | Pegaspargase (PRR 546.8) |
| 4117 | Ovarian Mass | 727 | 5 | Felodipine Extended-Release Tablets (PRR 30.7) |
| 4118 | Lip Erosion | 727 | 18 | Lamotrigine (PRR 70.4) |
| 4119 | Corneal Deposits | 727 | 20 | Cenegermin-Bkbj (PRR 186.2) |
| 4120 | Otitis Media Acute | 727 | 14 | Mercaptopurine (PRR 44.5) |
| 4121 | Hodgkin'S Disease | 726 | 11 | Bleomycin Sulfate (PRR 83.8) |
| 4122 | Disseminated Cryptococcosis | 726 | 44 | Amphotericin B (PRR 122.8) |
| 4123 | Pulmonary Artery Stenosis Congenital | 726 | 4 | Paroxetine Hydrochloride (PRR 82.5) |
| 4124 | Local Reaction | 726 | 11 | Cabotegravir (PRR 21.5) |
| 4125 | Legal Problem | 726 | 6 | Amphetamine (PRR 71.2) |
| 4126 | Blister Rupture | 726 | 10 | Salmeterol Xinafoate (PRR 26.9) |
| 4127 | Respiratory Tract Oedema | 726 | 4 | Ciclesonide (PRR 43.3) |
| 4128 | Obstructive Pancreatitis | 725 | 6 | Oral Semaglutide (PRR 25.9) |
| 4129 | Aortic Valve Sclerosis | 725 | 16 | Digoxin (PRR 32.9) |
| 4130 | Retinal Vascular Occlusion | 725 | 6 | Faricimab (PRR 50.6) |
| 4131 | Calculus Ureteric | 725 | 10 | Ceftriaxone (PRR 45.9) |
| 4132 | Vitamin B Complex Deficiency | 725 | 5 | Thiamine Hydrochloride (PRR 28.1) |
| 4133 | Graft Loss | 724 | 35 | Anti-Thymocyte Globulin (Rabbit) (PRR 380.1) |
| 4134 | Cholangitis Acute | 724 | 12 | Ursodiol (PRR 32.7) |
| 4135 | Benign Neoplasm Of Thyroid Gland | 724 | 4 | Baricitinib (PRR 15.0) |
| 4136 | Accommodation Disorder | 724 | 1 | Botulinum Toxin Type A (PRR 16.4) |
| 4137 | Brain Contusion | 723 | 8 | Pitavastatin Calcium (PRR 19.9) |
| 4138 | Central Obesity | 723 | 27 | Raltegravir (PRR 66.0) |
| 4139 | Clonic Convulsion | 722 | 18 | Phenobarbital (PRR 40.9) |
| 4140 | Venous Insufficiency | 722 | 11 | Alendronate Sodium (PRR 41.7) |
| 4141 | Finger Amputation | 722 | 5 | Bosentan (PRR 31.3) |
| 4142 | Hemianopia Homonymous | 722 | 7 | Ampicillin (PRR 24.6) |
| 4143 | Indifference | 722 | 5 | Zonisamide (PRR 17.7) |
| 4144 | Small Fibre Neuropathy | 721 | 10 | Levofloxacin (PRR 35.8) |
| 4145 | Eosinophilic Myocarditis | 721 | 26 | Goserelin (PRR 117.9) |
| 4146 | Granuloma Annulare | 721 | 2 | Baricitinib (PRR 24.2) |
| 4147 | Cardiac Enzymes Increased | 720 | 1 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 3.7) |
| 4148 | Apallic Syndrome | 720 | 16 | Sotalol Hydrochloride (PRR 41.3) |
| 4149 | Amino Acid Level Increased | 720 | 4 | Pegvaliase-Pqpz (PRR 589.8) |
| 4150 | Bunion | 719 | 5 | Alendronate Sodium (PRR 46.2) |
| 4151 | Antineutrophil Cytoplasmic Antibody Positive | 719 | 76 | Dutasteride (PRR 427.8) |
| 4152 | Withdrawal Bleed | 719 | 4 | Etonogestrel And Ethinyl Estradiol (PRR 249.2) |
| 4153 | Atrophic Vulvovaginitis | 719 | 19 | Alendronate Sodium (PRR 66.0) |
| 4154 | Bacterial Disease Carrier | 719 | 31 | Ciclesonide (PRR 258.2) |
| 4155 | Gastric Mucosal Lesion | 719 | 3 | Busulfan (PRR 20.5) |
| 4156 | Syphilis | 718 | 28 | Emtricitabine And Tenofovir Alafenamide (PRR 96.8) |
| 4157 | Transient Global Amnesia | 718 | 1 | Sumatriptan Succinate (PRR 18.7) |
| 4158 | West Nile Viral Infection | 717 | 14 | Anti-Thymocyte Globulin (Rabbit) (PRR 136.3) |
| 4159 | Dyslalia | 717 | 5 | Valacyclovir Hydrochloride (PRR 64.0) |
| 4160 | Foreign Body Aspiration | 717 | 4 | Lithium Carbonate (PRR 22.6) |
| 4161 | Symptom Masked | 717 | 9 | Norepinephrine (PRR 33.1) |
| 4162 | Bronchial Wall Thickening | 716 | 48 | Ciclesonide (PRR 408.1) |
| 4163 | Cervix Disorder | 716 | 9 | Etonogestrel And Ethinyl Estradiol (PRR 33.9) |
| 4164 | Toxic Leukoencephalopathy | 716 | 16 | Methadone Hydrochloride (PRR 38.3) |
| 4165 | Glomerulonephritis Minimal Lesion | 716 | 13 | Oseltamivir (PRR 40.8) |
| 4166 | Blood Folate Decreased | 715 | 19 | Baricitinib (PRR 141.5) |
| 4167 | Blunted Affect | 715 | 22 | Haloperidol (PRR 38.8) |
| 4168 | Cardiac Septal Defect | 715 | 26 | Misoprostol (PRR 119.9) |
| 4169 | Bite | 715 | 7 | Octreotide Acetate (PRR 34.9) |
| 4170 | Pubis Fracture | 714 | 2 | Alendronate Sodium (PRR 96.3) |
| 4171 | Neural Tube Defect | 714 | 19 | Divalproex Sodium (PRR 370.7) |
| 4172 | Vasculitis Necrotising | 714 | 3 | Minocycline (PRR 83.7) |
| 4173 | Foetal Exposure Timing Unspecified | 713 | 6 | Amphetamine (PRR 24.9) |
| 4174 | Proteus Infection | 713 | 20 | Valganciclovir Hydrochloride Powder, (PRR 82.8) |
| 4175 | Diabetic Ulcer | 713 | 6 | Canagliflozin (PRR 320.3) |
| 4176 | Amniotic Cavity Infection | 713 | 24 | Ampicillin (PRR 149.3) |
| 4177 | Dental Restoration Failure | 712 | 10 | Brinzolamide (PRR 65.7) |
| 4178 | Acute Graft Versus Host Disease In Liver | 712 | 42 | Busulfan (PRR 259.9) |
| 4179 | Oromandibular Dystonia | 712 | 31 | Haloperidol (PRR 63.2) |
| 4180 | Antibody Test Abnormal | 712 | 5 | Liothyronine Sodium (PRR 30.6) |
| 4181 | Palmoplantar Keratoderma | 711 | 61 | Felodipine Extended-Release Tablets (PRR 2,181.6) |
| 4182 | Alanine Aminotransferase Decreased | 711 | 15 | Tolvaptan (PRR 32.9) |
| 4183 | Anterior Chamber Cell | 711 | 11 | Aflibercept (PRR 225.8) |
| 4184 | Systemic Scleroderma | 710 | 20 | Selexipag (PRR 49.3) |
| 4185 | B-Cell Type Acute Leukaemia | 709 | 26 | Blinatumomab (PRR 464.7) |
| 4186 | Infection In An Immunocompromised Host | 709 | 30 | Amphotericin B (PRR 55.7) |
| 4187 | Congenital Hydronephrosis | 709 | 23 | Darunavir (PRR 77.9) |
| 4188 | Phimosis | 709 | 9 | Dapagliflozin (PRR 78.2) |
| 4189 | Cervical Radiculopathy | 709 | 13 | Tizanidine Hydrochloride (PRR 28.3) |
| 4190 | Lipids Abnormal | 708 | 14 | Efavirenz (PRR 29.4) |
| 4191 | Catheter Site Related Reaction | 708 | 16 | Epoprostenol (PRR 152.5) |
| 4192 | Pco2 Increased | 708 | 14 | Magnesium Sulfate Heptahydrate (PRR 121.3) |
| 4193 | Tongue Paralysis | 707 | 8 | Instalax Polyethylene Glycol 3350 (PRR 19.2) |
| 4194 | Pregnancy Of Partner | 707 | 8 | Thalidomide (PRR 43.1) |
| 4195 | Philadelphia Chromosome Positive | 707 | 8 | Imatinib (PRR 525.7) |
| 4196 | Dissociative Disorder | 707 | 13 | Esketamine Hydrochloride (PRR 168.0) |
| 4197 | Eye Rolling | 707 | 5 | Atomoxetine Hydrochloride (PRR 25.4) |
| 4198 | Visceral Leishmaniasis | 706 | 28 | Amphotericin B (PRR 115.7) |
| 4199 | Infantile Spasms | 706 | 15 | Vigabatrin (PRR 1,085.4) |
| 4200 | Noninfective Encephalitis | 706 | 8 | Dimenhydrinate (PRR 59.8) |
| 4201 | Laryngeal Disorder | 706 | 8 | Hydroxychloroquine (PRR 27.2) |
| 4202 | Immunisation Reaction | 706 | 13 | Human Immunoglobulin G (PRR 88.5) |
| 4203 | Differentiation Syndrome | 706 | 22 | Tretinoin (PRR 1,222.6) |
| 4204 | Alpha 1 Foetoprotein Increased | 705 | 19 | Sorafenib (PRR 257.0) |
| 4205 | Myofascial Pain Syndrome | 705 | 15 | Doxepin Hydrochloride (PRR 70.7) |
| 4206 | Jarisch-Herxheimer Reaction | 705 | 29 | Doxycycline Hyclate (PRR 244.0) |
| 4207 | Application Site Ulcer | 704 | 9 | Minoxidil Foam 5% (Womens) (PRR 144.0) |
| 4208 | Myopericarditis | 704 | 17 | Mesalamine (PRR 75.9) |
| 4209 | Blood Bilirubin Unconjugated Increased | 704 | 20 | Atazanavir (PRR 113.0) |
| 4210 | Orthostatic Intolerance | 704 | 21 | Captopril (PRR 50.3) |
| 4211 | Nasal Injury | 704 | 6 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 17.3) |
| 4212 | Graft Versus Host Disease In Liver | 703 | 42 | Thiotepa (PRR 225.7) |
| 4213 | Chylothorax | 703 | 21 | Dasatinib (PRR 171.4) |
| 4214 | Nodular Regenerative Hyperplasia | 702 | 32 | Ado-Trastuzumab Emtansine (PRR 197.4) |
| 4215 | Scrotal Oedema | 702 | 10 | Felodipine Extended-Release Tablets (PRR 42.6) |
| 4216 | Drug-Disease Interaction | 702 | 9 | Valproic Acid (PRR 26.4) |
| 4217 | Pancreatic Carcinoma Stage Iii | 700 | 2 | Ranitidine Hydrochloride (PRR 11.2) |
| 4218 | Borderline Personality Disorder | 700 | 20 | Ziprasidone Mesylate (PRR 29.8) |
| 4219 | Device Electrical Finding | 700 | 8 | Pegfilgrastim (PRR 291.6) |
| 4220 | Contraindicated Drug Administered | 700 | 6 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 97.9) |
| 4221 | Neonatal Asphyxia | 700 | 15 | Misoprostol (PRR 72.6) |
| 4222 | Malaria | 700 | 13 | Nevirapine (PRR 85.4) |
| 4223 | Urine Leukocyte Esterase Positive | 699 | 22 | Alemtuzumab (PRR 487.3) |
| 4224 | Alcohol Intolerance | 698 | 10 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 57.2) |
| 4225 | Monocyte Percentage Increased | 698 | 12 | Alemtuzumab (PRR 218.7) |
| 4226 | Delayed Graft Function | 698 | 58 | Basiliximab (PRR 671.2) |
| 4227 | Suture Related Complication | 698 | 4 | Epoprostenol (PRR 37.3) |
| 4228 | Vasogenic Cerebral Oedema | 698 | 29 | Temozolomide (PRR 74.5) |
| 4229 | Intraocular Pressure Test Abnormal | 698 | 15 | Dorzolamide Hydrochloride And Timolol Maleate (PRR 126.5) |
| 4230 | Renal Aplasia | 698 | 8 | Misoprostol (PRR 53.3) |
| 4231 | Retinal Vein Thrombosis | 697 | 7 | Raloxifene Hydrochloride (PRR 119.6) |
| 4232 | Puncture Site Haemorrhage | 697 | 10 | Prasugrel Hydrochloride (PRR 101.8) |
| 4233 | Viral Haemorrhagic Cystitis | 697 | 47 | Thiotepa (PRR 567.3) |
| 4234 | Propofol Infusion Syndrome | 697 | 27 | Propofol (PRR 4,449.0) |
| 4235 | Fluid Imbalance | 697 | 14 | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 128.1) |
| 4236 | Cryoglobulinaemia | 696 | 13 | Sofosbuvir (PRR 125.4) |
| 4237 | Haemorrhagic Cerebral Infarction | 696 | 10 | Alteplase (PRR 123.6) |
| 4238 | Mycobacterium Abscessus Infection | 696 | 40 | Amikacin (PRR 381.9) |
| 4239 | Respiratory Syncytial Virus Test Positive | 696 | 21 | Palivizumab (PRR 1,081.0) |
| 4240 | Thyroxine Increased | 696 | 6 | Thyroid, Porcine (PRR 34.3) |
| 4241 | Cushing'S Syndrome | 696 | 24 | Ritonavir 100 Mg (PRR 173.2) |
| 4242 | Tryptase Increased | 695 | 13 | Avapritinib (PRR 1,194.1) |
| 4243 | Painful Defaecation | 695 | 5 | Peginterferon Alfa-2A (PRR 51.4) |
| 4244 | Granulomatous Liver Disease | 695 | 16 | Rifampicin (PRR 79.9) |
| 4245 | Botulism | 694 | 8 | Botulinum Toxin Type A (PRR 535.1) |
| 4246 | Foetal Heart Rate Deceleration Abnormality | 694 | 17 | Bupivacaine (PRR 62.7) |
| 4247 | Gastrointestinal Scarring | 693 | 7 | Risankizumab-Rzaa (PRR 48.4) |
| 4248 | Glassy Eyes | 693 | 8 | Avapritinib (PRR 20.1) |
| 4249 | Parasomnia | 692 | 17 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 140.4) |
| 4250 | Electrocardiogram St-T Change | 692 | 5 | Digoxin (PRR 40.5) |
| 4251 | Gravitational Oedema | 692 | 4 | Indapamide (PRR 24.0) |
| 4252 | Dermatitis Diaper | 692 | 5 | Palivizumab (PRR 42.4) |
| 4253 | Multiple Drug Therapy | 689 | 83 | Quinapril Hydrochloride (PRR 322.2) |
| 4254 | Pelvic Fluid Collection | 688 | 9 | Basiliximab (PRR 34.1) |
| 4255 | Computerised Tomogram Thorax Abnormal | 688 | 33 | Aprepitant (PRR 119.5) |
| 4256 | Suspiciousness | 688 | 17 | Pramipexole (PRR 40.6) |
| 4257 | Haematospermia | 688 | 4 | Finasteride (PRR 34.7) |
| 4258 | Nutritional Condition Abnormal | 688 | 13 | Ampicillin (PRR 44.6) |
| 4259 | Perineal Pain | 687 | 17 | Copper (PRR 37.8) |
| 4260 | Pulmonary Veno-Occlusive Disease | 687 | 24 | Epoprostenol (PRR 141.0) |
| 4261 | Anastomotic Leak | 687 | 18 | Oxaliplatin (PRR 61.0) |
| 4262 | Neuroendocrine Carcinoma | 687 | 11 | Octreotide Acetate (PRR 55.6) |
| 4263 | Forearm Fracture | 687 | 11 | Ciclesonide (PRR 43.4) |
| 4264 | Cranial Nerve Disorder | 687 | 7 | Busulfan (PRR 27.5) |
| 4265 | Antipsychotic Drug Level Below Therapeutic | 686 | 24 | Asenapine Maleate (PRR 677.6) |
| 4266 | Painful Erection | 686 | 3 | Sildenafil Citrate (PRR 64.1) |
| 4267 | Leiomyoma | 686 | 3 | Goserelin (PRR 25.2) |
| 4268 | Chronic Lymphocytic Leukaemia Recurrent | 684 | 13 | Fludarabine Phosphate (PRR 280.1) |
| 4269 | Peptic Ulcer Haemorrhage | 684 | 11 | Cladribine (PRR 25.6) |
| 4270 | Scedosporium Infection | 684 | 48 | Voriconazole Injection (PRR 304.4) |
| 4271 | Brain Cancer Metastatic | 684 | 6 | Lapatinib (PRR 19.9) |
| 4272 | Injection Site Macule | 683 | 3 | Etanercept (PRR 74.5) |
| 4273 | Prothrombin Time Abnormal | 683 | 11 | Warfarin Sodium (PRR 52.8) |
| 4274 | Suture Rupture | 683 | 5 | Cortisone Acetate (PRR 43.0) |
| 4275 | Product Ineffective | 683 | 18 | Methylphenidate (PRR 99.3) |
| 4276 | Cerebral Cyst | 683 | 6 | Amphotericin B (PRR 19.7) |
| 4277 | Arachnoiditis | 683 | 11 | Methylprednisolone Acetate (PRR 264.0) |
| 4278 | Fungal Oesophagitis | 683 | 8 | Micafungin Sodium (PRR 43.9) |
| 4279 | Positron Emission Tomogram Abnormal | 682 | 9 | Niraparib (PRR 133.4) |
| 4280 | Soft Tissue Necrosis | 682 | 6 | Pegaspargase (PRR 20.2) |
| 4281 | Dyshidrotic Eczema | 681 | 5 | Doxepin Hydrochloride (PRR 24.5) |
| 4282 | Overlap Syndrome | 681 | 107 | Tretinoin (PRR 380.4) |
| 4283 | No Adverse Drug Effect | 681 | 6 | Isotretinoin (PRR 126.8) |
| 4284 | Foetal Hypokinesia | 681 | 2 | Entecavir (PRR 26.6) |
| 4285 | Feeling Of Relaxation | 680 | 8 | Atomoxetine Hydrochloride (PRR 26.5) |
| 4286 | Complications Of Maternal Exposure To Therapeutic Drugs | 680 | 6 | Zidovudine (PRR 54.5) |
| 4287 | Congenital Hand Malformation | 680 | 5 | Valproate Sodium (PRR 111.8) |
| 4288 | Scleral Hyperaemia | 679 | 6 | Bimatoprost (PRR 177.3) |
| 4289 | Episcleritis | 679 | 11 | Indomethacin (PRR 52.6) |
| 4290 | Marrow Hyperplasia | 679 | 28 | Epoetin Alfa (PRR 53.3) |
| 4291 | Arthroscopy | 678 | 3 | Alendronate Sodium (PRR 53.9) |
| 4292 | Infectious Peritonitis | 678 | 6 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 75.8) |
| 4293 | Surgical Procedure Repeated | 678 | 3 | Bupivacaine (PRR 30.0) |
| 4294 | Genital Swelling | 677 | 6 | Miconazole Nitrate (PRR 39.4) |
| 4295 | Choreoathetosis | 677 | 18 | Phenytoin (PRR 60.9) |
| 4296 | Stasis Dermatitis | 677 | 9 | Captopril (PRR 45.7) |
| 4297 | Oesophagitis Ulcerative | 677 | 13 | Meperidine Hydrochloride (PRR 33.9) |
| 4298 | Clear Cell Renal Cell Carcinoma | 676 | 20 | Testosterone (PRR 71.0) |
| 4299 | Foetal Exposure During Delivery | 676 | 27 | Misoprostol (PRR 943.0) |
| 4300 | Angular Cheilitis | 676 | 12 | Regorafenib (PRR 32.4) |
| 4301 | Fusarium Infection | 675 | 60 | Posaconazole Delayed-Release (PRR 337.2) |
| 4302 | Macular Fibrosis | 675 | 9 | Ranibizumab (PRR 114.3) |
| 4303 | Sars-Cov-2 Test Negative | 675 | 26 | Mesna Injection (PRR 158.6) |
| 4304 | Throat Lesion | 675 | 2 | Extended Phenytoin Sodium (PRR 22.5) |
| 4305 | Tumour Flare | 674 | 18 | Obinutuzumab (PRR 75.5) |
| 4306 | T-Lymphocyte Count Decreased | 674 | 22 | Alemtuzumab (PRR 60.7) |
| 4307 | Pleural Thickening | 673 | 37 | Trazodone Hydrochloride (PRR 159.3) |
| 4308 | Aortitis | 673 | 20 | Filgrastim (PRR 56.0) |
| 4309 | Abscess Neck | 673 | 7 | Cefuroxime (PRR 33.0) |
| 4310 | Blood Oestrogen Decreased | 672 | 11 | Estradiol (PRR 118.4) |
| 4311 | Ingrown Hair | 672 | 6 | Primidone (PRR 30.9) |
| 4312 | Retinal Pigment Epithelial Tear | 672 | 7 | Ranibizumab (PRR 716.1) |
| 4313 | Cytokine Storm | 672 | 26 | Axicabtagene Ciloleucel (PRR 154.9) |
| 4314 | Pneumothorax Spontaneous | 672 | 17 | Remdesivir (PRR 33.2) |
| 4315 | Post Procedural Discharge | 671 | 1 | Levonorgestrel (PRR 5.0) |
| 4316 | Keratoacanthoma | 671 | 13 | Vemurafenib (PRR 321.1) |
| 4317 | Product Design Issue | 671 | 6 | Travoprost (PRR 29.0) |
| 4318 | Radioisotope Scan Abnormal | 671 | 1 | Iohexol (PRR 26.5) |
| 4319 | Nasal Operation | 670 | 7 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 32.9) |
| 4320 | Neurodevelopmental Disorder | 670 | 13 | Lopinavir And Ritonavir (PRR 162.1) |
| 4321 | Bronchitis Viral | 670 | 6 | Gemfibrozil (PRR 25.0) |
| 4322 | Procedural Anxiety | 669 | 7 | Interferon Beta-1A (PRR 73.6) |
| 4323 | Inflammatory Pain | 669 | 14 | Atropine (PRR 57.6) |
| 4324 | Paraneoplastic Syndrome | 669 | 15 | Pemetrexed (PRR 25.3) |
| 4325 | Stoma Site Reaction | 669 | 12 | Rivastigmine (PRR 100.8) |
| 4326 | Cyst Rupture | 668 | 3 | Tolvaptan (PRR 58.0) |
| 4327 | Emergency Care Examination | 668 | 14 | Fluticasone Propionate And Salmeterol (PRR 72.6) |
| 4328 | Mitral Valve Stenosis | 668 | 3 | Digoxin (PRR 25.9) |
| 4329 | Head And Neck Cancer | 668 | 3 | Cetuximab (PRR 12.1) |
| 4330 | Acute Left Ventricular Failure | 668 | 14 | Tranexamic Acid (PRR 50.1) |
| 4331 | Urethral Stenosis | 667 | 3 | Bicalutamide (PRR 22.9) |
| 4332 | Infusion Site Inflammation | 666 | 19 | Ketoprofen (PRR 117.6) |
| 4333 | Hepatitis B Dna Increased | 666 | 16 | Entecavir (PRR 487.1) |
| 4334 | Mammogram Abnormal | 665 | 6 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 50.4) |
| 4335 | Postoperative Adhesion | 664 | 1 | Adalimumab (PRR 27.7) |
| 4336 | Sequestrectomy | 664 | 10 | Zoledronic Acid (PRR 63.9) |
| 4337 | Blood Lactate Dehydrogenase Abnormal | 664 | 11 | Eculizumab (PRR 137.8) |
| 4338 | Stoma Creation | 664 | 6 | Risankizumab-Rzaa (PRR 94.3) |
| 4339 | Hypoplastic Left Heart Syndrome | 664 | 3 | Paroxetine Hydrochloride (PRR 45.7) |
| 4340 | Bone Deformity | 664 | 8 | Asfotase Alfa (PRR 57.9) |
| 4341 | Personal Relationship Issue | 663 | 11 | Valproate Sodium (PRR 68.0) |
| 4342 | Lichen Sclerosus | 663 | 7 | Standardized Senna Concentrate (PRR 56.7) |
| 4343 | Substance Dependence | 661 | 22 | Ethyl Alcohol (PRR 109.9) |
| 4344 | Theft | 661 | 11 | Aripiprazole (PRR 96.3) |
| 4345 | Postoperative Abscess | 661 | 2 | Ustekinumab (PRR 16.9) |
| 4346 | Ophthalmic Migraine | 660 | 14 | Eptinezumab-Jjmr (PRR 24.5) |
| 4347 | Lymphocele | 660 | 26 | Basiliximab (PRR 206.5) |
| 4348 | Cutaneous Symptom | 660 | 17 | Methylprednisolone Acetate (PRR 44.0) |
| 4349 | Silent Myocardial Infarction | 660 | 2 | Isosorbide Dinitrate (PRR 33.3) |
| 4350 | Anti-Cyclic Citrullinated Peptide Antibody | 659 | 157 | Diclofenac Potassium, Film Coated (PRR 3,346.6) |
| 4351 | Drug Monitoring Procedure Incorrectly Performed | 659 | 12 | Tolvaptan (PRR 99.9) |
| 4352 | Hiv Test Positive | 659 | 13 | Nevirapine (PRR 193.4) |
| 4353 | Embolic Cerebral Infarction | 658 | 8 | Rivaroxaban (PRR 32.6) |
| 4354 | Endometritis | 658 | 10 | Misoprostol (PRR 669.5) |
| 4355 | Gallbladder Pain | 658 | 2 | Drospirenone And Ethinyl Estradiol (PRR 134.0) |
| 4356 | Lung Transplant Rejection | 657 | 41 | Valganciclovir (PRR 177.3) |
| 4357 | Ileal Perforation | 657 | 15 | Irinotecan Hydrochloride (PRR 37.8) |
| 4358 | Device Battery Issue | 657 | 4 | Bupivacaine (PRR 55.6) |
| 4359 | Defaecation Disorder | 657 | 11 | Doxepin (PRR 41.4) |
| 4360 | Phaeochromocytoma | 657 | 10 | Labetalol (PRR 46.5) |
| 4361 | Chronic Myelomonocytic Leukaemia | 657 | 18 | Azacitidine (PRR 111.2) |
| 4362 | Renal Vein Thrombosis | 656 | 17 | Basiliximab (PRR 67.2) |
| 4363 | Facial Discomfort | 655 | 10 | Botulinum Toxin Type A (PRR 80.4) |
| 4364 | Vulval Disorder | 655 | 12 | Miconazole Nitrate (PRR 44.5) |
| 4365 | Sputum Purulent | 654 | 27 | Ciclesonide (PRR 209.8) |
| 4366 | Delivery | 654 | 22 | Ampicillin (PRR 599.5) |
| 4367 | Single Functional Kidney | 654 | 7 | Atazanavir (PRR 45.7) |
| 4368 | Injection Site Exfoliation | 653 | 7 | Sarilumab (PRR 28.7) |
| 4369 | Medical Device Site Discomfort | 653 | 5 | Etonogestrel And Ethinyl Estradiol (PRR 289.4) |
| 4370 | Brow Ptosis | 652 | 2 | Onabotulinumtoxina (PRR 590.0) |
| 4371 | Oral Mucosal Discolouration | 652 | 4 | Nicotine Polacrilex (PRR 59.1) |
| 4372 | Senile Dementia | 652 | 4 | Rivastigmine (PRR 45.8) |
| 4373 | Hand Dermatitis | 651 | 11 | Ado-Trastuzumab Emtansine (PRR 94.5) |
| 4374 | Hallucination, Tactile | 651 | 12 | Cariprazine (PRR 49.1) |
| 4375 | Scleral Discolouration | 651 | 6 | Minocycline (PRR 95.3) |
| 4376 | Infusion Site Urticaria | 650 | 26 | Human Immunoglobulin G (PRR 119.7) |
| 4377 | Social Anxiety Disorder | 650 | 19 | Brexpiprazole (PRR 48.0) |
| 4378 | Internal Injury | 649 | 5 | Levonorgestrel (PRR 102.0) |
| 4379 | Patient-Device Incompatibility | 649 | 4 | Somatropin (PRR 25.1) |
| 4380 | Cataract Nuclear | 649 | 12 | Ranibizumab (PRR 149.4) |
| 4381 | Transformation To Acute Myeloid Leukaemia | 649 | 24 | Azacitidine (PRR 194.4) |
| 4382 | Bone Operation | 649 | 3 | Canagliflozin (PRR 19.8) |
| 4383 | Heat Illness | 649 | 9 | Apalutamide (PRR 24.9) |
| 4384 | Change In Seizure Presentation | 648 | 26 | Clobazam (PRR 181.8) |
| 4385 | Optical Coherence Tomography Abnormal | 648 | 4 | Faricimab (PRR 18,227.7) |
| 4386 | Fasciitis | 648 | 4 | Anastrozole Tablets (PRR 30.9) |
| 4387 | Spinal Cord Infection | 648 | 3 | Teduglutide (PRR 44.1) |
| 4388 | Urticaria Generalised | 647 | 3 | Agalsidase Beta (PRR 35.3) |
| 4389 | Intracranial Hypotension | 647 | 4 | Bupivacaine (PRR 20.8) |
| 4390 | Myeloproliferative Neoplasm | 646 | 16 | Hydroxyurea (PRR 82.5) |
| 4391 | Reflexes Abnormal | 646 | 3 | Trimethoprim (PRR 44.8) |
| 4392 | Precancerous Condition | 646 | 11 | Acalabrutinib (PRR 29.7) |
| 4393 | Gingival Discomfort | 646 | 11 | Quinapril Hydrochloride (PRR 24.7) |
| 4394 | Hypotrichosis | 645 | 9 | Vismodegib (PRR 29.4) |
| 4395 | Peritoneal Disorder | 645 | 22 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 86.7) |
| 4396 | Compulsions | 645 | 16 | Ropinirole (PRR 47.9) |
| 4397 | Sputum Abnormal | 645 | 13 | Amikacin (PRR 43.1) |
| 4398 | Cellulitis Staphylococcal | 645 | 8 | Canakinumab (PRR 74.3) |
| 4399 | Post Procedural Sepsis | 645 | 2 | Granisetron Hydrochloride (PRR 18.7) |
| 4400 | Anticonvulsant Drug Level Above Therapeutic | 644 | 20 | Phenytoin (PRR 281.9) |
| 4401 | Chronic Hepatic Failure | 644 | 14 | Rifaximin (PRR 165.4) |
| 4402 | Klebsiella Test Positive | 644 | 37 | Dimenhydrinate (PRR 43.4) |
| 4403 | Enterococcus Test Positive | 644 | 37 | Micafungin Sodium (PRR 115.7) |
| 4404 | Abdominal Wall Abscess | 644 | 6 | Basiliximab (PRR 86.4) |
| 4405 | Small Intestine Ulcer | 644 | 3 | Misoprostol (PRR 23.5) |
| 4406 | Blood Immunoglobulin A Decreased | 643 | 21 | Icosapent Ethyl (PRR 128.0) |
| 4407 | C-Reactive Protein Decreased | 643 | 24 | Methylprednisolone Acetate (PRR 118.3) |
| 4408 | Sickle Cell Anaemia | 643 | 10 | Deferasirox (PRR 208.3) |
| 4409 | Pneumococcal Sepsis | 643 | 34 | Cefuroxime (PRR 64.5) |
| 4410 | Short-Bowel Syndrome | 643 | 9 | Teduglutide (PRR 158.9) |
| 4411 | Skull Malformation | 643 | 21 | Valproate Sodium (PRR 88.5) |
| 4412 | Anoxic Encephalopathy | 643 | 7 | Salmeterol Xinafoate (PRR 42.0) |
| 4413 | Body Height Below Normal | 642 | 24 | Anakinra (PRR 1,178.0) |
| 4414 | Pressure Of Speech | 642 | 15 | Atropine Sulfate (PRR 61.9) |
| 4415 | Allergic Oedema | 642 | 6 | Cefazolin (PRR 62.0) |
| 4416 | Resting Tremor | 641 | 25 | Rasagiline Mesylate (PRR 95.0) |
| 4417 | Anisocytosis | 641 | 17 | Ribociclib (PRR 91.2) |
| 4418 | Parotid Gland Enlargement | 641 | 3 | Sevoflurane (PRR 43.7) |
| 4419 | Forced Vital Capacity Decreased | 640 | 25 | Ciclesonide (PRR 132.2) |
| 4420 | Sjs-Ten Overlap | 640 | 13 | Lamotirigine (PRR 38.4) |
| 4421 | Wrong Device Used | 640 | 4 | Somatropin (PRR 104.6) |
| 4422 | Blood Cortisol Decreased | 640 | 17 | Ritonavir 100 Mg (PRR 73.3) |
| 4423 | Pancreaticoduodenectomy | 640 | 4 | Pancrelipase (PRR 657.9) |
| 4424 | Pancreatic Carcinoma Stage Ii | 640 | 1 | Ranitidine Hydrochloride (PRR 8.5) |
| 4425 | Renal Surgery | 640 | 6 | Pazopanib Hydrochloride (PRR 18.4) |
| 4426 | Job Dissatisfaction | 640 | 5 | Lisdexamfetamine Dimesylate (PRR 25.6) |
| 4427 | Cerebral Small Vessel Ischaemic Disease | 640 | 1 | Miconazole Nitrate (PRR 18.8) |
| 4428 | Premature Ejaculation | 639 | 4 | Finasteride (PRR 54.9) |
| 4429 | Nasal Septum Perforation | 639 | 4 | Bevacizumab (PRR 32.8) |
| 4430 | Procedural Vomiting | 638 | 12 | Bupivacaine (PRR 57.3) |
| 4431 | Ruptured Cerebral Aneurysm | 638 | 2 | Romosozumab-Aqqg (PRR 19.5) |
| 4432 | Magnetic Resonance Imaging Head Abnormal | 637 | 13 | Vigabatrin (PRR 648.3) |
| 4433 | Mitral Valve Calcification | 637 | 15 | Eplerenone (PRR 60.8) |
| 4434 | Gastrointestinal Mucosal Disorder | 637 | 8 | Micafungin Sodium (PRR 47.1) |
| 4435 | Staphylococcal Abscess | 637 | 2 | Bupivacaine (PRR 21.2) |
| 4436 | Polysubstance Abuse | 636 | 10 | Oxycodone Hydrochloride (PRR 160.7) |
| 4437 | Thyroxine Free Increased | 636 | 6 | Alemtuzumab (PRR 114.1) |
| 4438 | Neuropathic Arthropathy | 635 | 10 | Canagliflozin (PRR 152.0) |
| 4439 | Autoimmune Colitis | 635 | 17 | Ipilimumab (PRR 386.9) |
| 4440 | Infective Exacerbation Of Chronic Obstructive Airways Disease | 635 | 15 | Ciclesonide (PRR 75.7) |
| 4441 | Chorioretinitis | 635 | 17 | Faricimab (PRR 154.3) |
| 4442 | Tracheo-Oesophageal Fistula | 634 | 13 | Epoetin Alfa (PRR 42.6) |
| 4443 | Cholinergic Syndrome | 634 | 12 | Donepezil Hydrochloride (PRR 93.7) |
| 4444 | Blood Urea Nitrogen/Creatinine Ratio Increased | 634 | 7 | Asfotase Alfa (PRR 74.7) |
| 4445 | Pneumonia Necrotising | 634 | 32 | Basiliximab (PRR 48.7) |
| 4446 | Implant Site Bruising | 634 | 2 | Etonogestrel (PRR 1,902.8) |
| 4447 | Vaginitis Bacterial | 633 | 4 | Etonogestrel And Ethinyl Estradiol (PRR 103.6) |
| 4448 | Urinary Sediment Present | 633 | 14 | Alemtuzumab (PRR 500.3) |
| 4449 | Glioma | 633 | 13 | Mercaptopurine (PRR 139.6) |
| 4450 | Extremity Contracture | 633 | 14 | Epoetin Alfa (PRR 187.3) |
| 4451 | Pancreatic Neuroendocrine Tumour | 633 | 12 | Octreotide Acetate (PRR 263.4) |
| 4452 | Intestinal Functional Disorder | 633 | 2 | Orlistat (PRR 39.9) |
| 4453 | Hypermagnesaemia | 633 | 16 | Magnesium Sulfate Heptahydrate (PRR 268.1) |
| 4454 | Oedema Genital | 633 | 5 | Miconazole Nitrate (PRR 50.0) |
| 4455 | Oesophageal Achalasia | 633 | 7 | Ivacaftor (PRR 42.0) |
| 4456 | Anion Gap | 632 | 16 | Norepinephrine (PRR 93.6) |
| 4457 | Spider Vein | 632 | 2 | Drospirenone And Ethinyl Estradiol (PRR 14.6) |
| 4458 | Blood Pressure Measurement | 632 | 7 | Sevoflurane (PRR 73.4) |
| 4459 | Hyperchloraemia | 632 | 11 | Sodium Bicarbonate (PRR 26.2) |
| 4460 | Blood Parathyroid Hormone Abnormal | 631 | 6 | Cinacalcet Hydrochloride (PRR 527.4) |
| 4461 | Injection Site Laceration | 631 | 5 | Epinephrine (PRR 37.6) |
| 4462 | Mucosal Discolouration | 631 | 6 | Levodopa (PRR 110.3) |
| 4463 | Inhalation Therapy | 630 | 7 | Fluticasone Propionate And Salmeterol (PRR 158.4) |
| 4464 | Mite Allergy | 630 | 81 | Dutasteride (PRR 2,113.7) |
| 4465 | Necrotising Retinitis | 630 | 31 | Ganciclovir (PRR 141.5) |
| 4466 | Nasal Crusting | 630 | 8 | Mometasone Furoate (PRR 52.5) |
| 4467 | Rectal Fissure | 629 | 6 | Isotretinoin (PRR 37.8) |
| 4468 | Laryngeal Discomfort | 629 | 5 | Iohexol (PRR 48.8) |
| 4469 | Arteritis | 628 | 10 | Basiliximab (PRR 34.5) |
| 4470 | Anal Inflammation | 627 | 19 | Mesna Injection (PRR 157.9) |
| 4471 | Drug Level Changed | 627 | 9 | Extended Phenytoin Sodium (PRR 100.7) |
| 4472 | Chalazion | 626 | 13 | Ivacaftor (PRR 59.9) |
| 4473 | Gastric Neoplasm | 626 | 2 | Ado-Trastuzumab Emtansine (PRR 23.9) |
| 4474 | Cyanosis Neonatal | 626 | 4 | Misoprostol (PRR 52.4) |
| 4475 | Endometrial Adenocarcinoma | 625 | 4 | Testosterone (PRR 41.7) |
| 4476 | Toxic Shock Syndrome | 625 | 15 | Drs. Clotrimazole (PRR 75.0) |
| 4477 | Dry Gangrene | 625 | 13 | Canagliflozin (PRR 155.0) |
| 4478 | Glomerulosclerosis | 624 | 21 | Basiliximab (PRR 111.5) |
| 4479 | Increased Viscosity Of Bronchial Secretion | 624 | 20 | Amikacin (PRR 106.2) |
| 4480 | Stoma Site Hypergranulation | 624 | 13 | Rotigotine (PRR 122.6) |
| 4481 | Bladder Irritation | 624 | 11 | Standardized Senna Concentrate (PRR 35.2) |
| 4482 | Blood Osmolarity Decreased | 624 | 4 | Valproate Sodium (PRR 26.5) |
| 4483 | Metastases To Pelvis | 623 | 34 | Ribociclib (PRR 97.0) |
| 4484 | Gastrointestinal Erosion | 623 | 6 | Basiliximab (PRR 28.9) |
| 4485 | Hepatobiliary Disease | 622 | 28 | Erlotinib (PRR 42.2) |
| 4486 | Prothrombin Time Ratio Decreased | 622 | 4 | Acetylcysteine (PRR 92.4) |
| 4487 | Chondrocalcinosis | 622 | 10 | Asfotase Alfa (PRR 44.3) |
| 4488 | Triple Negative Breast Cancer | 621 | 12 | Dexamethasone Sodium Phosphate (PRR 50.7) |
| 4489 | Intestinal Anastomosis | 620 | 14 | Cholestyramine (PRR 42.7) |
| 4490 | Monoclonal Gammopathy | 620 | 9 | Dexamethasone Sodium Phosphate (PRR 47.3) |
| 4491 | Dermatosis | 620 | 3 | Mometasone (PRR 30.0) |
| 4492 | Oesophageal Atresia | 619 | 15 | Darunavir (PRR 110.4) |
| 4493 | Foetal Heart Rate Decreased | 619 | 5 | Misoprostol (PRR 411.6) |
| 4494 | Lower Extremity Mass | 618 | 5 | Interferon Beta-1A (PRR 27.9) |
| 4495 | Pleural Disorder | 618 | 12 | Goserelin (PRR 33.3) |
| 4496 | Pernicious Anaemia | 618 | 2 | Cyanocobalamin (PRR 39.0) |
| 4497 | Aspirin-Exacerbated Respiratory Disease | 617 | 13 | Ibuprofen Capsule (PRR 48.1) |
| 4498 | Cyclic Vomiting Syndrome | 617 | 7 | Oral Semaglutide (PRR 382.7) |
| 4499 | Epstein-Barr Virus Test Positive | 617 | 15 | Anti-Thymocyte Globulin (Rabbit) (PRR 42.5) |
| 4500 | Bacillus Infection | 617 | 35 | Tofacitinib Citrate (PRR 72.6) |
| 4501 | Implant Site Scar | 617 | 2 | Etonogestrel (PRR 774.2) |
| 4502 | Inappropriate Prescribing | 616 | 3 | Polyethylene Glycol 3350 (PRR 673.4) |
| 4503 | Lipohypertrophy | 616 | 21 | Asfotase Alfa (PRR 106.3) |
| 4504 | Abdominal Compartment Syndrome | 615 | 34 | Bleomycin Sulfate (PRR 81.8) |
| 4505 | Muscle Abscess | 615 | 10 | Canakinumab (PRR 88.3) |
| 4506 | Parkinsonian Gait | 614 | 22 | Pramipexole (PRR 62.4) |
| 4507 | Spontaneous Penile Erection | 614 | 4 | Tadalafil (PRR 38.3) |
| 4508 | Osteomyelitis Chronic | 614 | 2 | Canagliflozin (PRR 158.4) |
| 4509 | Nipple Disorder | 613 | 8 | Phytonadione (PRR 36.5) |
| 4510 | Thyroxine Decreased | 613 | 6 | Liothyronine Sodium (PRR 84.7) |
| 4511 | Cervicobrachial Syndrome | 613 | 8 | Captopril (PRR 50.6) |
| 4512 | Corneal Perforation | 613 | 25 | Moxifloxacin Hydrochloride (PRR 91.1) |
| 4513 | Wrist Deformity | 612 | 33 | Diclofenac Potassium, Film Coated (PRR 136.4) |
| 4514 | Blood Bilirubin Decreased | 612 | 17 | Polatuzumab Vedotin (PRR 42.6) |
| 4515 | Remission Not Achieved | 612 | 9 | Sofosbuvir (PRR 200.9) |
| 4516 | Pitting Oedema | 612 | 2 | Lithium Carbonate (PRR 35.0) |
| 4517 | Thirst Decreased | 611 | 7 | Insulin Degludec (PRR 20.8) |
| 4518 | Monocytosis | 611 | 14 | Ampicillin (PRR 120.6) |
| 4519 | Diaphragmatic Hernia | 611 | 11 | Sirolimus (PRR 33.6) |
| 4520 | Psoas Abscess | 611 | 15 | Pyrazinamide (PRR 48.2) |
| 4521 | Nail Psoriasis | 610 | 5 | Secukinumab (PRR 53.2) |
| 4522 | Incorrect Drug Dosage Form Administered | 610 | 3 | Insulin Lispro (PRR 38.6) |
| 4523 | Persistent Foetal Circulation | 610 | 4 | Paroxetine Hydrochloride (PRR 110.3) |
| 4524 | Paracentesis | 610 | 19 | Epoprostenol (PRR 296.8) |
| 4525 | Hellp Syndrome | 610 | 10 | Magnesium Sulfate In Water For (PRR 63.8) |
| 4526 | Central Serous Chorioretinopathy | 610 | 18 | Triamcinolone Acetonide Ointment Usp, 0.05% (PRR 113.3) |
| 4527 | Arthritis Reactive | 610 | 5 | Anti-Thymocyte Globulin (Rabbit) (PRR 56.2) |
| 4528 | Low Density Lipoprotein Abnormal | 607 | 6 | Inclisiran (PRR 149.2) |
| 4529 | Vitamin D Increased | 607 | 6 | Asfotase Alfa (PRR 45.5) |
| 4530 | Lung Carcinoma Cell Type Unspecified Recurrent | 607 | 9 | Gefitinib (PRR 70.4) |
| 4531 | Hypergammaglobulinaemia Benign Monoclonal | 607 | 9 | Felodipine Extended-Release Tablets (PRR 24.4) |
| 4532 | Prolonged Labour | 606 | 4 | Peginterferon Beta-1A (PRR 51.4) |
| 4533 | Cerebral Aspergillosis | 606 | 45 | Voriconazole Injection (PRR 440.7) |
| 4534 | Prostate Cancer Recurrent | 606 | 12 | Bicalutamide (PRR 144.5) |
| 4535 | Open Angle Glaucoma | 606 | 13 | Brimonidine Tartrate (PRR 78.1) |
| 4536 | Atypical Fracture | 605 | 6 | Alendronate Sodium Tablet (PRR 110.0) |
| 4537 | Toxicologic Test Abnormal | 605 | 10 | Methadone Hydrochloride (PRR 59.0) |
| 4538 | Medical Device Site Infection | 605 | 7 | Baclofen (PRR 41.0) |
| 4539 | Excessive Cerumen Production | 605 | 3 | Octreotide Acetate (PRR 29.2) |
| 4540 | Perioral Dermatitis | 604 | 7 | Panitumumab (PRR 24.6) |
| 4541 | Blood Immunoglobulin M Increased | 604 | 14 | Icosapent Ethyl (PRR 136.7) |
| 4542 | Serum Sickness-Like Reaction | 604 | 2 | Amoxicillin (PRR 42.1) |
| 4543 | Hydrops Foetalis | 604 | 25 | Zidovudine (PRR 177.9) |
| 4544 | Cardiac Procedure Complication | 604 | 8 | Atropine (PRR 55.2) |
| 4545 | Biliary Tract Infection | 603 | 21 | Durvalumab (PRR 143.0) |
| 4546 | Pupillary Disorder | 603 | 4 | Prednisolone Acetate (PRR 30.5) |
| 4547 | Palatal Disorder | 602 | 2 | Botulinum Toxin Type A (PRR 19.7) |
| 4548 | Cortisol Increased | 601 | 7 | Ketoconazole Foam (PRR 73.9) |
| 4549 | Oxygen Consumption Decreased | 601 | 3 | Nintedanib (PRR 27.6) |
| 4550 | Neurodegenerative Disorder | 601 | 9 | Phenytoin (PRR 50.5) |
| 4551 | Gastrointestinal Bacterial Overgrowth | 601 | 7 | Rifaximin (PRR 232.4) |
| 4552 | Thyroid Operation | 601 | 2 | Paricalcitol (PRR 14.8) |
| 4553 | Cataract Subcapsular | 601 | 20 | Prednisolone Acetate (PRR 65.6) |
| 4554 | Human Herpesvirus 8 Infection | 600 | 26 | Basiliximab (PRR 196.5) |
| 4555 | Elbow Operation | 600 | 4 | Desoximetasone (PRR 22.3) |
| 4556 | Gingival Hyperplasia | 600 | 5 | Extended Phenytoin Sodium (PRR 72.3) |
| 4557 | Cyanopsia | 599 | 2 | Sildenafil Citrate (PRR 268.2) |
| 4558 | Meningomyelocele | 599 | 24 | Zidovudine (PRR 182.8) |
| 4559 | Superior Vena Cava Syndrome | 598 | 17 | Lapatinib (PRR 36.9) |
| 4560 | Auricular Swelling | 598 | 3 | Agalsidase Beta (PRR 19.0) |
| 4561 | Diaphragmatic Paralysis | 598 | 13 | Bupivacaine (PRR 49.5) |
| 4562 | Fat Necrosis | 598 | 6 | Busulfan (PRR 29.4) |
| 4563 | Blood Viscosity Increased | 598 | 3 | Testosterone Cypionate (PRR 23.6) |
| 4564 | Postoperative Thrombosis | 598 | 1 | Fondaparinux Sodium (PRR 21.7) |
| 4565 | Proctitis Ulcerative | 597 | 4 | Isotretinoin (PRR 197.5) |
| 4566 | Rectocele | 597 | 4 | Estrogens, Conjugated (PRR 29.2) |
| 4567 | Arteriovenous Fistula Site Complication | 597 | 10 | Darbepoetin Alfa (PRR 255.3) |
| 4568 | Hepatorenal Failure | 597 | 7 | Propofol (PRR 28.0) |
| 4569 | Sinoatrial Block | 596 | 6 | Posaconazole (PRR 33.0) |
| 4570 | Induced Labour | 596 | 6 | Misoprostol (PRR 32.8) |
| 4571 | Allergy To Metals | 595 | 7 | Copper (PRR 41.3) |
| 4572 | Terminal Ileitis | 595 | 23 | Adalimumab-Fkjp (PRR 109.7) |
| 4573 | Dysmetria | 595 | 24 | Siponimod (PRR 64.4) |
| 4574 | Grunting | 595 | 6 | Gentamicin (PRR 30.0) |
| 4575 | Gastrointestinal Polyp Haemorrhage | 594 | 5 | Rivaroxaban (PRR 42.4) |
| 4576 | Coronary Artery Restenosis | 594 | 5 | Prasugrel Hydrochloride (PRR 204.8) |
| 4577 | Post Procedural Inflammation | 594 | 1 | Risankizumab-Rzaa (PRR 13.5) |
| 4578 | Urethral Haemorrhage | 594 | 1 | Apalutamide (PRR 12.0) |
| 4579 | Agraphia | 593 | 8 | Natalizumab (PRR 56.9) |
| 4580 | Plasma Cell Leukaemia | 591 | 25 | Carfilzomib (PRR 185.3) |
| 4581 | Hypertensive Encephalopathy | 591 | 15 | Labetalol (PRR 46.2) |
| 4582 | Vitrectomy | 591 | 7 | Aflibercept (PRR 579.7) |
| 4583 | Retinal Ischaemia | 591 | 21 | Ranibizumab (PRR 95.1) |
| 4584 | Thyroid Cyst | 591 | 2 | Insulin Glulisine (PRR 31.6) |
| 4585 | Rectal Adenocarcinoma | 590 | 10 | Panitumumab (PRR 63.7) |
| 4586 | Respiratory Tract Haemorrhage | 590 | 15 | Febuxostat Tablets 40 Mg (PRR 121.2) |
| 4587 | Lymphatic Disorder | 590 | 4 | Sirolimus (PRR 40.3) |
| 4588 | Colon Cancer Stage Iv | 590 | 4 | Regorafenib (PRR 24.6) |
| 4589 | Eye Burns | 589 | 8 | Dorzolamide Hydrochloride And Timolol Maleate (PRR 161.3) |
| 4590 | Spondyloarthropathy | 589 | 18 | Desoximetasone (PRR 50.4) |
| 4591 | Adrenal Adenoma | 589 | 4 | Pitavastatin Calcium (PRR 20.9) |
| 4592 | Sitting Disability | 589 | 6 | Emtricitabine And Tenofovir Alafenamide (PRR 25.3) |
| 4593 | Myopathy Toxic | 589 | 13 | Bupivacaine (PRR 86.4) |
| 4594 | Unintentional Use For Unapproved Indication | 588 | 2 | Dupilumab (PRR 30.6) |
| 4595 | Mean Platelet Volume Increased | 588 | 11 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 46.0) |
| 4596 | Drop Attacks | 588 | 8 | Clobazam (PRR 52.3) |
| 4597 | Umbilical Cord Around Neck | 588 | 3 | Nicotine Polacrilex Mini (PRR 24.0) |
| 4598 | Bicuspid Aortic Valve | 587 | 4 | Paroxetine Hydrochloride (PRR 81.7) |
| 4599 | Gamma-Glutamyltransferase Abnormal | 587 | 8 | Brentuximab Vedotin (PRR 71.6) |
| 4600 | Malignant Peritoneal Neoplasm | 586 | 7 | Niraparib (PRR 74.2) |
| 4601 | Endoscopy | 586 | 3 | Sodium Oxybate (PRR 13.4) |
| 4602 | Thalamic Infarction | 586 | 9 | Pyrazinamide (PRR 54.2) |
| 4603 | Anterograde Amnesia | 586 | 6 | Cariprazine (PRR 38.8) |
| 4604 | Sacral Pain | 585 | 15 | Ketoprofen (PRR 53.2) |
| 4605 | Dermo-Hypodermitis | 585 | 8 | Ketoprofen (PRR 53.2) |
| 4606 | Graft Complication | 584 | 22 | Thiotepa (PRR 122.1) |
| 4607 | Hepatitis C Virus Test Positive | 584 | 9 | Ledipasvir And Sofosbuvir (PRR 237.1) |
| 4608 | Vulval Cancer | 584 | 3 | Baricitinib (PRR 22.4) |
| 4609 | Adenomyosis | 583 | 7 | Copper (PRR 33.6) |
| 4610 | Urinary Tract Infection Pseudomonal | 583 | 13 | Polyethylene Glycol (PRR 47.3) |
| 4611 | Epstein-Barr Virus Associated Lymphoma | 583 | 30 | Alemtuzumab (PRR 70.8) |
| 4612 | Aortic Calcification | 583 | 15 | Chlorhexidine Gluconate (PRR 60.1) |
| 4613 | Polyarteritis Nodosa | 583 | 7 | Minocycline (PRR 553.4) |
| 4614 | Labelled Drug-Disease Interaction Medication Error | 583 | 6 | Umeclidinium Bromide And Vilanterol Trifenatate (PRR 55.8) |
| 4615 | Amblyopia | 583 | 13 | Valproate Sodium (PRR 28.4) |
| 4616 | Trichotillomania | 582 | 11 | Aripiprazole (PRR 70.9) |
| 4617 | Campylobacter Gastroenteritis | 582 | 16 | Bendamustine Hcl (PRR 47.7) |
| 4618 | Eye Laser Surgery | 582 | 7 | Aflibercept (PRR 91.1) |
| 4619 | Osteogenesis Imperfecta | 581 | 7 | Risedronate Sodium (PRR 67.1) |
| 4620 | Acidosis Hyperchloraemic | 581 | 22 | Valproic Acid (PRR 58.0) |
| 4621 | Spirometry Abnormal | 580 | 82 | Dutasteride (PRR 2,421.3) |
| 4622 | Engraftment Syndrome | 580 | 41 | Thiotepa (PRR 509.9) |
| 4623 | Rebound Psoriasis | 580 | 3 | Secukinumab (PRR 260.7) |
| 4624 | Male Sexual Dysfunction | 580 | 5 | Finasteride (PRR 69.9) |
| 4625 | Dose Calculation Error | 580 | 4 | Tiotropium Bromide Inhalation Spray (PRR 83.6) |
| 4626 | Thought Blocking | 580 | 7 | Memantine (PRR 18.6) |
| 4627 | Anterior Chamber Inflammation | 580 | 9 | Faricimab (PRR 324.0) |
| 4628 | Peripheral T-Cell Lymphoma Unspecified | 579 | 15 | Brentuximab Vedotin (PRR 383.4) |
| 4629 | Crystal Nephropathy | 579 | 19 | Ascorbic Acid (PRR 55.8) |
| 4630 | Victim Of Chemical Submission | 579 | 16 | Ethyl Alcohol (PRR 50.7) |
| 4631 | Pneumococcal Infection | 579 | 22 | Bisacodyl Suppositories (PRR 69.5) |
| 4632 | Nerve Root Compression | 578 | 1 | Natalizumab (PRR 9.1) |
| 4633 | Alveolar Proteinosis | 578 | 25 | Sirolimus (PRR 90.5) |
| 4634 | Orthostatic Hypertension | 578 | 21 | Olanzapine Pamoate (PRR 98.6) |
| 4635 | Hypoaesthesia Eye | 578 | 14 | Salmeterol Xinafoate (PRR 82.0) |
| 4636 | Urethral Pain | 578 | 4 | Salmeterol Xinafoate (PRR 29.6) |
| 4637 | Endotracheal Intubation Complication | 578 | 8 | Rocuronium Bromide (PRR 113.8) |
| 4638 | Ejection Fraction | 577 | 40 | Liothyronine Sodium (PRR 1,377.3) |
| 4639 | Nasal Mucosal Disorder | 577 | 25 | Ado-Trastuzumab Emtansine (PRR 174.0) |
| 4640 | Irregular Breathing | 577 | 6 | Cefazolin (PRR 32.1) |
| 4641 | Cellulitis Orbital | 577 | 7 | Posaconazole Delayed-Release (PRR 26.6) |
| 4642 | Retroperitoneal Fibrosis | 577 | 3 | Imatinib (PRR 25.0) |
| 4643 | Lacrimal Disorder | 577 | 3 | Cladribine (PRR 26.6) |
| 4644 | Sleep Walking | 576 | 6 | Zolpidem Tartrate (PRR 244.0) |
| 4645 | Dermatillomania | 576 | 14 | Lisdexamfetamine Dimesylate (PRR 77.3) |
| 4646 | Lymphocyte Morphology Abnormal | 576 | 4 | Carbamazepine (PRR 45.6) |
| 4647 | Burn Oesophageal | 576 | 2 | Ribociclib (PRR 20.0) |
| 4648 | Metal Poisoning | 575 | 6 | Minocycline (PRR 61.0) |
| 4649 | Oesophageal Irritation | 575 | 2 | Terbinafine Hydrochloride (PRR 37.2) |
| 4650 | Mediastinitis | 574 | 18 | Basiliximab (PRR 87.3) |
| 4651 | Deep Brain Stimulation | 574 | 10 | Carbidopa And Levodopa (PRR 220.0) |
| 4652 | Hyperbilirubinaemia Neonatal | 574 | 19 | Ampicillin (PRR 58.2) |
| 4653 | Xerophthalmia | 573 | 4 | Panitumumab (PRR 30.8) |
| 4654 | Platelet Count | 573 | 2 | Romiplostim (PRR 50.0) |
| 4655 | Antiphospholipid Antibodies Positive | 573 | 5 | Etonogestrel And Ethinyl Estradiol (PRR 134.7) |
| 4656 | Haemorrhagic Ovarian Cyst | 572 | 2 | Copper (PRR 43.1) |
| 4657 | Blood Oestrogen Increased | 572 | 15 | Estradiol (PRR 46.0) |
| 4658 | Neuropsychological Symptoms | 572 | 17 | Montelukast Sodium (PRR 187.4) |
| 4659 | Transaminases Abnormal | 572 | 3 | Desoximetasone (PRR 56.2) |
| 4660 | Pleocytosis | 572 | 35 | Ampicillin (PRR 100.5) |
| 4661 | Suture Insertion | 572 | 3 | Pimavanserin Tartrate (PRR 17.2) |
| 4662 | Nerve Block | 572 | 4 | Bupivacaine (PRR 39.6) |
| 4663 | Protrusion Tongue | 571 | 17 | Haloperidol Lactate (PRR 48.2) |
| 4664 | Infusion Related Hypersensitivity Reaction | 571 | 6 | Oxaliplatin (PRR 26.2) |
| 4665 | Limb Reduction Defect | 571 | 4 | Misoprostol (PRR 73.5) |
| 4666 | Mental Disability | 571 | 7 | Theophylline (PRR 48.8) |
| 4667 | Laryngeal Stenosis | 570 | 20 | Ciclesonide (PRR 134.1) |
| 4668 | Enanthema | 570 | 13 | Iohexol (PRR 44.8) |
| 4669 | Flashback | 570 | 6 | Esketamine Hydrochloride (PRR 40.2) |
| 4670 | Eustachian Tube Dysfunction | 570 | 8 | Thiotepa (PRR 46.9) |
| 4671 | Sinus Polyp | 569 | 15 | Micafungin Sodium (PRR 66.4) |
| 4672 | Vaccination Site Pain | 569 | 4 | Cefuroxime (PRR 49.3) |
| 4673 | Colon Injury | 569 | 5 | Valganciclovir Hydrochloride Powder, (PRR 52.5) |
| 4674 | Motor Developmental Delay | 569 | 11 | Valproate Sodium (PRR 101.2) |
| 4675 | Burn Oral Cavity | 569 | 4 | Nicotine Polacrilex (PRR 15.7) |
| 4676 | Prostatectomy | 568 | 5 | Relugolix (PRR 96.4) |
| 4677 | Gallbladder Non-Functioning | 568 | 4 | Drospirenone And Ethinyl Estradiol (PRR 777.4) |
| 4678 | Urine Colour Abnormal | 568 | 3 | Fondaparinux Sodium (PRR 46.1) |
| 4679 | Renal Cell Carcinoma Stage Unspecified | 568 | 3 | Sorafenib (PRR 65.7) |
| 4680 | Retinal Vascular Disorder | 568 | 4 | Ranibizumab (PRR 111.9) |
| 4681 | Head Banging | 568 | 8 | Guanfacine (PRR 23.5) |
| 4682 | Corneal Epithelium Defect | 567 | 19 | Prednisolone Acetate (PRR 246.8) |
| 4683 | Joint Ankylosis | 566 | 19 | Desoximetasone (PRR 166.7) |
| 4684 | Jugular Vein Distension | 566 | 15 | Eplerenone (PRR 68.8) |
| 4685 | Ophthalmic Herpes Simplex | 566 | 13 | Ganciclovir (PRR 62.9) |
| 4686 | Internal Fixation Of Fracture | 566 | 5 | Alendronate Sodium (PRR 263.2) |
| 4687 | Collagen Disorder | 566 | 4 | Levofloxacin (PRR 25.5) |
| 4688 | Haematoma Infection | 566 | 4 | Fondaparinux Sodium (PRR 65.2) |
| 4689 | Salpingectomy | 565 | 6 | Copper (PRR 180.6) |
| 4690 | Right Ventricular Dilatation | 565 | 13 | Epoprostenol (PRR 61.3) |
| 4691 | Life Expectancy Shortened | 565 | 8 | Divalproex Sodium (PRR 237.0) |
| 4692 | Uterine Cyst | 564 | 4 | Levonorgestrel (PRR 12.2) |
| 4693 | Hepatitis C Virus | 564 | 1 | Nevirapine (PRR 33.2) |
| 4694 | Burnout Syndrome | 563 | 3 | Nebivolol (PRR 28.4) |
| 4695 | Cardiorenal Syndrome | 563 | 18 | Axicabtagene Ciloleucel (PRR 148.3) |
| 4696 | Precocious Puberty | 563 | 8 | Testosterone (PRR 86.7) |
| 4697 | Anencephaly | 563 | 19 | Misoprostol (PRR 70.6) |
| 4698 | Urinary Tract Infection Fungal | 563 | 4 | Canagliflozin (PRR 36.4) |
| 4699 | Nail Injury | 563 | 2 | Panitumumab (PRR 21.6) |
| 4700 | Eye Ulcer | 562 | 7 | Cenegermin-Bkbj (PRR 117.7) |
| 4701 | Radiation Necrosis | 562 | 23 | Ado-Trastuzumab Emtansine (PRR 199.3) |
| 4702 | Rotavirus Infection | 561 | 11 | Palivizumab (PRR 98.4) |
| 4703 | Suspected Suicide Attempt | 560 | 9 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 66.5) |
| 4704 | Encephalomalacia | 560 | 10 | Extended Phenytoin Sodium (PRR 46.0) |
| 4705 | Mechanical Ileus | 560 | 7 | Encorafenib (PRR 30.5) |
| 4706 | Intention Tremor | 560 | 10 | Zonisamide (PRR 36.1) |
| 4707 | Chikungunya Virus Infection | 559 | 4 | Losartan Potassium And Hydrochlorothiazide (PRR 29.3) |
| 4708 | Colonic Fistula | 559 | 2 | Isotretinoin (PRR 18.0) |
| 4709 | Apnoeic Attack | 559 | 7 | Palivizumab (PRR 58.1) |
| 4710 | Nail Bed Bleeding | 559 | 11 | Misoprostol (PRR 54.9) |
| 4711 | Victim Of Homicide | 558 | 11 | Fentanyl (PRR 66.5) |
| 4712 | Blood Growth Hormone Increased | 558 | 8 | Octreotide Acetate (PRR 848.1) |
| 4713 | Lung Infection Pseudomonal | 558 | 8 | Tobramycin (PRR 70.4) |
| 4714 | Legionella Infection | 558 | 4 | Alemtuzumab (PRR 40.0) |
| 4715 | Anti Factor Viii Antibody Positive | 558 | 1 | Emicizumab (PRR 109.2) |
| 4716 | Adrenal Haemorrhage | 557 | 7 | Fondaparinux Sodium (PRR 71.1) |
| 4717 | Spinal Epidural Haematoma | 557 | 12 | Clopidogrel Bisulfate (PRR 65.4) |
| 4718 | Body Tinea | 557 | 23 | Cimetidine (PRR 241.5) |
| 4719 | Device Maintenance Issue | 557 | 36 | Treprostinil (PRR 718.1) |
| 4720 | Intracranial Haematoma | 557 | 5 | Fondaparinux Sodium (PRR 61.4) |
| 4721 | Burning Mouth Syndrome | 557 | 3 | Indapamide (PRR 50.0) |
| 4722 | Postoperative Ileus | 557 | 2 | Bupivacaine (PRR 74.4) |
| 4723 | Meningitis Tuberculous | 556 | 31 | Pyrazinamide (PRR 427.8) |
| 4724 | Product Knowledge Deficit | 556 | 5 | Somatropin (PRR 70.4) |
| 4725 | Enteral Nutrition | 556 | 9 | Rivastigmine (PRR 41.2) |
| 4726 | Medical Device Site Pain | 555 | 5 | Bupivacaine (PRR 191.7) |
| 4727 | Life Support | 555 | 5 | Epoprostenol (PRR 41.1) |
| 4728 | Ejaculation Delayed | 555 | 5 | Finasteride (PRR 30.4) |
| 4729 | Occipital Neuralgia | 555 | 16 | Indomethacin (PRR 40.6) |
| 4730 | Bunion Operation | 554 | 17 | Cortisone Acetate (PRR 167.2) |
| 4731 | Soft Tissue Swelling | 554 | 11 | Anakinra (PRR 82.0) |
| 4732 | Mean Cell Haemoglobin Concentration Increased | 554 | 7 | Dimenhydrinate (PRR 131.7) |
| 4733 | Bone Fragmentation | 554 | 3 | Chlorhexidine Gluconate (PRR 67.7) |
| 4734 | Neurologic Neglect Syndrome | 553 | 55 | Methylprednisolone Acetate (PRR 976.0) |
| 4735 | Crystal Urine Present | 553 | 8 | Alemtuzumab (PRR 549.3) |
| 4736 | Brain Scan Abnormal | 553 | 14 | Salmeterol Xinafoate (PRR 219.0) |
| 4737 | Repetitive Speech | 553 | 11 | Rivastigmine (PRR 32.9) |
| 4738 | Pseudolymphoma | 553 | 1 | Vemurafenib (PRR 12.6) |
| 4739 | Colectomy Total | 552 | 4 | Infliximab (PRR 49.1) |
| 4740 | Tenosynovitis Stenosans | 552 | 47 | Methylprednisolone Acetate (PRR 434.0) |
| 4741 | Perfume Sensitivity | 552 | 15 | Omalizumab (PRR 213.4) |
| 4742 | Drug Effect Prolonged | 552 | 10 | Rocuronium Bromide (PRR 105.0) |
| 4743 | Thrombocythaemia | 552 | 6 | Fondaparinux Sodium (PRR 96.6) |
| 4744 | Blood Ph Increased | 552 | 2 | Bosutinib (PRR 25.5) |
| 4745 | Cardiospasm | 551 | 55 | Felodipine Extended-Release Tablets (PRR 4,708.6) |
| 4746 | Dyspraxia | 551 | 7 | Valproate Sodium (PRR 136.9) |
| 4747 | Postnasal Drip | 551 | 3 | Salmeterol Xinafoate (PRR 49.2) |
| 4748 | Renal Tubular Dysfunction | 551 | 19 | Tenofovir Disoproxil Fumarate Tablets (PRR 356.4) |
| 4749 | Oedematous Pancreatitis | 551 | 9 | Pyrazinamide (PRR 62.0) |
| 4750 | Helicobacter Test Positive | 551 | 9 | Olmesartan Medoxomil (PRR 62.8) |
| 4751 | Intravascular Haemolysis | 550 | 8 | Ravulizumab (PRR 70.2) |
| 4752 | Bacteriuria | 550 | 10 | Alemtuzumab (PRR 119.5) |
| 4753 | Portal Hypertensive Gastropathy | 549 | 21 | Nevirapine (PRR 100.8) |
| 4754 | Eye Infection Bacterial | 549 | 9 | Cenegermin-Bkbj (PRR 106.5) |
| 4755 | Type Iii Immune Complex Mediated Reaction | 549 | 7 | Sirolimus (PRR 46.3) |
| 4756 | Nail Dystrophy | 548 | 12 | Ado-Trastuzumab Emtansine (PRR 93.5) |
| 4757 | Thyroxine Free Decreased | 548 | 8 | Alemtuzumab (PRR 71.1) |
| 4758 | Genital Discomfort | 547 | 4 | Empagliflozin (PRR 24.3) |
| 4759 | Choroidal Detachment | 547 | 16 | Atropine Sulfate (PRR 80.7) |
| 4760 | Vulvovaginal Injury | 547 | 9 | Miconazole Nitrate (PRR 361.3) |
| 4761 | Tumour Rupture | 546 | 8 | Sorafenib (PRR 70.7) |
| 4762 | Metastases To Kidney | 546 | 10 | Pazopanib Hydrochloride (PRR 35.3) |
| 4763 | Urticaria Chronic | 546 | 6 | Omalizumab (PRR 54.5) |
| 4764 | Amniotic Fluid Volume Decreased | 546 | 3 | Mesna (PRR 46.1) |
| 4765 | Catheter Site Inflammation | 545 | 15 | Epoprostenol (PRR 420.3) |
| 4766 | Bronchostenosis | 545 | 12 | Valganciclovir Hydrochloride Powder, (PRR 48.3) |
| 4767 | Blood Magnesium Abnormal | 545 | 9 | Teduglutide (PRR 58.8) |
| 4768 | Blood Insulin Increased | 544 | 5 | Human Insulin (PRR 24.9) |
| 4769 | Haemorrhagic Infarction | 544 | 6 | Alteplase (PRR 225.0) |
| 4770 | Serositis | 544 | 16 | Calcitriol Capsules 0.25 Mcg (PRR 86.8) |
| 4771 | Retinopathy Of Prematurity | 543 | 12 | Indomethacin (PRR 209.7) |
| 4772 | Immune-Mediated Necrotising Myopathy | 541 | 2 | Atorvastatin Calcium, Film Coated (PRR 99.3) |
| 4773 | Chronic Myeloid Leukaemia Recurrent | 541 | 9 | Imatinib (PRR 423.7) |
| 4774 | Hyperamylasaemia | 541 | 6 | Basiliximab (PRR 33.3) |
| 4775 | Macroglossia | 541 | 13 | Phenobarbital (PRR 46.6) |
| 4776 | Presbyopia | 541 | 4 | Faricimab (PRR 23.9) |
| 4777 | Renal Stone Removal | 541 | 2 | Bimekizumab (PRR 39.4) |
| 4778 | Stoma Site Irritation | 540 | 12 | Carbidopa And Levodopa (PRR 145.9) |
| 4779 | Crystalluria | 540 | 13 | Amoxicillin (PRR 76.8) |
| 4780 | Enzyme Abnormality | 540 | 1 | Pancrelipase (PRR 26.1) |
| 4781 | Osteomyelitis Acute | 540 | 1 | Canagliflozin (PRR 764.9) |
| 4782 | Marital Problem | 539 | 5 | Testosterone Cypionate (PRR 26.2) |
| 4783 | Ephelides | 539 | 3 | Avapritinib (PRR 12.8) |
| 4784 | Hypertrophy | 539 | 5 | Chlorhexidine Gluconate (PRR 38.7) |
| 4785 | Subcutaneous Drug Absorption Impaired | 538 | 137 | Pseudoephedrine Hydrochloride (PRR 726.0) |
| 4786 | Endometrial Thickening | 538 | 6 | Progesterone (PRR 51.8) |
| 4787 | Product Closure Issue | 538 | 4 | Alteplase (PRR 183.7) |
| 4788 | Neurogenic Shock | 537 | 11 | Captopril (PRR 53.7) |
| 4789 | Bursitis Infective | 537 | 4 | Travoprost (PRR 55.0) |
| 4790 | Eosinophil Percentage Increased | 537 | 8 | Dimenhydrinate (PRR 178.6) |
| 4791 | Epiglottitis | 537 | 2 | Hydrocortisone Sodium Succinate (PRR 37.7) |
| 4792 | Renal Ischaemia | 536 | 26 | Magnesium Sulfate In Water For (PRR 103.4) |
| 4793 | Iris Disorder | 536 | 1 | Bimatoprost (PRR 58.2) |
| 4794 | B-Cell Lymphoma Recurrent | 535 | 27 | Bendamustine Hcl (PRR 201.9) |
| 4795 | Bleeding Varicose Vein | 535 | 10 | Atezolizumab (PRR 76.6) |
| 4796 | Exomphalos | 535 | 21 | Zidovudine (PRR 118.9) |
| 4797 | Urethritis | 535 | 2 | Obinutuzumab (PRR 14.3) |
| 4798 | Milk Allergy | 535 | 2 | Palivizumab (PRR 28.4) |
| 4799 | Suspected Product Tampering | 534 | 3 | Testosterone Cypionate (PRR 85.9) |
| 4800 | Sudden Unexplained Death In Epilepsy | 534 | 21 | Brivaracetam (PRR 157.3) |
| 4801 | Tobacco Abuse | 534 | 6 | Nicotine Polacrilex Mini (PRR 143.2) |
| 4802 | White Coat Hypertension | 534 | 8 | Infliximab-Dyyb (PRR 100.3) |
| 4803 | Morning Sickness | 534 | 11 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 38.3) |
| 4804 | Gingival Discolouration | 534 | 2 | Nicotine Polacrilex (PRR 20.0) |
| 4805 | Ovarian Failure | 533 | 17 | Ifosfamide (PRR 201.9) |
| 4806 | Rectal Perforation | 533 | 14 | Daptomycin (PRR 56.4) |
| 4807 | Manufacturing Product Shipping Issue | 533 | 6 | Iohexol (PRR 14.2) |
| 4808 | Scrotal Pain | 533 | 9 | Mesna Injection (PRR 48.1) |
| 4809 | Body Fat Disorder | 533 | 3 | Triamcinolone Acetonide Ointment Usp, 0.05% (PRR 22.2) |
| 4810 | Groin Infection | 533 | 3 | Cyclobenzaprine Hydrochloride (PRR 44.3) |
| 4811 | Stent Occlusion | 532 | 4 | Clopidogrel (PRR 47.6) |
| 4812 | Measles | 532 | 9 | Doxepin (PRR 51.4) |
| 4813 | Steatohepatitis | 531 | 8 | Pegaspargase (PRR 35.9) |
| 4814 | Pancreatectomy | 531 | 4 | Pancrelipase (PRR 440.6) |
| 4815 | Inadequate Diet | 531 | 1 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 5.1) |
| 4816 | Anal Stenosis | 530 | 12 | Vedolizumab (PRR 38.4) |
| 4817 | Anal Atresia | 530 | 15 | Zidovudine (PRR 120.1) |
| 4818 | Congenital Nose Malformation | 530 | 11 | Valproate Sodium (PRR 145.6) |
| 4819 | Blood Immunoglobulin A Increased | 529 | 22 | Methylprednisolone Acetate (PRR 112.7) |
| 4820 | Gastroenteritis Escherichia Coli | 529 | 11 | Basiliximab (PRR 58.7) |
| 4821 | Brain Midline Shift | 529 | 7 | Alteplase (PRR 77.4) |
| 4822 | Autoscopy | 529 | 10 | Promethazine Hydrochloride (PRR 57.8) |
| 4823 | Medical Device Change | 528 | 12 | Epoprostenol (PRR 196.1) |
| 4824 | Periorbital Cellulitis | 528 | 12 | Azacitidine For (PRR 45.0) |
| 4825 | Blood Gases Abnormal | 528 | 16 | Magnesium Sulfate In Water For (PRR 84.4) |
| 4826 | Convulsion Neonatal | 528 | 2 | Misoprostol (PRR 32.9) |
| 4827 | Molluscum Contagiosum | 527 | 9 | Mercaptopurine (PRR 44.9) |
| 4828 | Interleukin Level Increased | 527 | 23 | Canakinumab (PRR 247.0) |
| 4829 | Occult Blood | 527 | 12 | Telmisartan (PRR 50.8) |
| 4830 | Migration Of Implanted Drug | 527 | 1 | Etonogestrel (PRR 1,491.9) |
| 4831 | Hypertonia Neonatal | 527 | 4 | Methadone (PRR 33.5) |
| 4832 | Eczema Eyelids | 526 | 4 | Dupilumab (PRR 54.7) |
| 4833 | Corynebacterium Infection | 526 | 36 | Moxifloxacin (PRR 73.7) |
| 4834 | Left Atrial Enlargement | 526 | 10 | Eplerenone (PRR 84.5) |
| 4835 | Umbilical Cord Abnormality | 526 | 9 | Zidovudine (PRR 114.3) |
| 4836 | Coating In Mouth | 526 | 4 | Nitrofurantoin (PRR 32.0) |
| 4837 | Hypereosinophilic Syndrome | 525 | 4 | Mepolizumab (PRR 52.9) |
| 4838 | Uterine Infection | 525 | 3 | Levonorgestrel (PRR 32.3) |
| 4839 | Antipsychotic Drug Level Decreased | 525 | 15 | Clozapine (PRR 659.1) |
| 4840 | Neutrophil Percentage Decreased | 525 | 8 | Alemtuzumab (PRR 47.0) |
| 4841 | Insulin-Like Growth Factor Decreased | 525 | 7 | Somatropin (PRR 197.3) |
| 4842 | Intraocular Pressure Decreased | 525 | 13 | Travoprost (PRR 135.5) |
| 4843 | Instillation Site Erythema | 525 | 7 | Lifitegrast (PRR 848.6) |
| 4844 | Albuminuria | 525 | 13 | Voclosporin (PRR 41.8) |
| 4845 | Vestibular Neuronitis | 525 | 7 | Captopril (PRR 54.9) |
| 4846 | Uterine Cervix Stenosis | 524 | 3 | Levonorgestrel (PRR 576.5) |
| 4847 | Fracture Pain | 524 | 9 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 52.9) |
| 4848 | Respiratory Tract Infection Fungal | 524 | 21 | Basiliximab (PRR 55.7) |
| 4849 | Transverse Sinus Thrombosis | 524 | 8 | Drospirenone And Ethinyl Estradiol (PRR 193.8) |
| 4850 | Pharyngeal Mass | 524 | 2 | Pirfenidone (PRR 12.0) |
| 4851 | Corneal Erosion | 524 | 15 | Brinzolamide (PRR 56.1) |
| 4852 | Grief Reaction | 523 | 9 | Quinine (PRR 32.9) |
| 4853 | Infectious Colitis | 523 | 4 | Olmesartan Medoxomil (PRR 32.7) |
| 4854 | Urine Albumin/Creatinine Ratio Increased | 523 | 7 | Voclosporin (PRR 120.3) |
| 4855 | Faecal Vomiting | 523 | 3 | Oxazepam (PRR 58.8) |
| 4856 | Pulmonary Vasculitis | 522 | 79 | Dutasteride (PRR 1,012.5) |
| 4857 | Infected Fistula | 522 | 6 | Infliximab-Dyyb (PRR 44.9) |
| 4858 | Drug Level Abnormal | 522 | 7 | Infliximab-Dyyb (PRR 37.3) |
| 4859 | Oesophageal Food Impaction | 521 | 2 | Dupilumab (PRR 22.8) |
| 4860 | Milk-Alkali Syndrome | 521 | 9 | Calcium Carbonate (PRR 742.9) |
| 4861 | Bone Cancer Metastatic | 521 | 9 | Fulvestrant (PRR 41.2) |
| 4862 | Focal Nodular Hyperplasia | 520 | 16 | Thiotepa (PRR 110.0) |
| 4863 | Flight Of Ideas | 520 | 5 | Atropine Sulfate (PRR 45.5) |
| 4864 | Retroperitoneal Lymphadenopathy | 520 | 19 | Polatuzumab Vedotin (PRR 85.3) |
| 4865 | Intertrigo | 520 | 8 | Ketoconazole Foam (PRR 71.1) |
| 4866 | Myelodysplastic Syndrome Transformation | 519 | 10 | Azacitidine (PRR 231.7) |
| 4867 | Cryptosporidiosis Infection | 519 | 27 | Cabotegravir (PRR 135.9) |
| 4868 | Glomerulonephritis Membranoproliferative | 519 | 19 | Sofosbuvir (PRR 71.6) |
| 4869 | Aspartate Aminotransferase Decreased | 519 | 5 | Tolvaptan (PRR 33.9) |
| 4870 | Hypermetabolism | 519 | 12 | Fulvestrant (PRR 33.2) |
| 4871 | Nail Ridging | 519 | 3 | Abemaciclib (PRR 14.2) |
| 4872 | Hyphaema | 518 | 25 | Ranibizumab (PRR 65.5) |
| 4873 | Hyperlipasaemia | 518 | 8 | Sitagliptin And Metformin Hydrochloride (PRR 30.7) |
| 4874 | Faecal Volume Increased | 518 | 6 | Teduglutide (PRR 157.7) |
| 4875 | Acute Interstitial Pneumonitis | 517 | 16 | Daptomycin (PRR 76.7) |
| 4876 | Retinal Vascular Thrombosis | 517 | 4 | Raloxifene Hydrochloride (PRR 51.4) |
| 4877 | Infusion Site Vesicles | 516 | 12 | Treprostinil (PRR 102.7) |
| 4878 | Male Orgasmic Disorder | 516 | 2 | Finasteride (PRR 107.7) |
| 4879 | Myoglobinuria | 516 | 6 | Sevoflurane (PRR 49.5) |
| 4880 | Dyspnoea Exacerbated | 515 | 8 | Salmeterol Xinafoate (PRR 128.3) |
| 4881 | Tracheal Disorder | 515 | 1 | Palivizumab (PRR 18.7) |
| 4882 | Ligament Pain | 515 | 1 | Ciclesonide (PRR 36.4) |
| 4883 | Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome | 514 | 73 | Ciclesonide (PRR 2,140.9) |
| 4884 | Abdominal Injury | 514 | 4 | Goserelin (PRR 27.6) |
| 4885 | Tri-Iodothyronine Decreased | 514 | 2 | Liothyronine Sodium (PRR 196.2) |
| 4886 | Human Polyomavirus Infection | 513 | 34 | Tacrolimus Ointment 0.1% (PRR 209.3) |
| 4887 | Urticarial Vasculitis | 513 | 11 | Terbinafine Hydrochloride (PRR 65.7) |
| 4888 | Infantile Spitting Up | 513 | 4 | Vigabatrin (PRR 259.7) |
| 4889 | Gastric Antral Vascular Ectasia | 513 | 9 | Imatinib (PRR 127.3) |
| 4890 | Posturing | 513 | 10 | Haloperidol (PRR 36.5) |
| 4891 | Carbohydrate Antigen 19-9 Increased | 512 | 17 | Irinotecan Hydrochloride (PRR 55.6) |
| 4892 | Cyst Removal | 512 | 3 | Bimekizumab (PRR 21.4) |
| 4893 | Renal Haematoma | 511 | 5 | Basiliximab (PRR 72.0) |
| 4894 | Hepatic Adenoma | 511 | 6 | Testosterone (PRR 79.6) |
| 4895 | Victim Of Sexual Abuse | 511 | 10 | Ethyl Alcohol (PRR 103.7) |
| 4896 | Poor Personal Hygiene | 510 | 5 | Aripiprazole Oral (PRR 53.4) |
| 4897 | Skin Candida | 510 | 18 | Itraconazole (PRR 76.5) |
| 4898 | Cerebral Artery Thrombosis | 510 | 21 | Salmeterol Xinafoate (PRR 239.3) |
| 4899 | Plasmapheresis | 510 | 1 | Eculizumab (PRR 134.8) |
| 4900 | Injury Corneal | 510 | 7 | Prednisolone Acetate (PRR 56.7) |
| 4901 | Pulmonary Mucormycosis | 509 | 38 | Micafungin Sodium (PRR 232.2) |
| 4902 | Patellofemoral Pain Syndrome | 509 | 9 | Alendronate Sodium (PRR 86.6) |
| 4903 | Scapula Fracture | 509 | 7 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide (PRR 20.5) |
| 4904 | Pulse Pressure Decreased | 509 | 1 | Cetuximab (PRR 14.7) |
| 4905 | Reversible Airways Obstruction | 508 | 36 | Mepolizumab (PRR 334.9) |
| 4906 | Hypertensive Urgency | 508 | 11 | Guanfacine (PRR 58.5) |
| 4907 | Female Sterilisation | 508 | 9 | Etonogestrel And Ethinyl Estradiol (PRR 100.1) |
| 4908 | Acquired Immunodeficiency Syndrome | 508 | 20 | Lopinavir And Ritonavir (PRR 127.6) |
| 4909 | Executive Dysfunction | 508 | 6 | Valproate Sodium (PRR 67.6) |
| 4910 | Lower Respiratory Tract Infection Bacterial | 508 | 15 | Dornase Alfa (PRR 78.5) |
| 4911 | Orthopaedic Procedure | 508 | 1 | Esketamine Hydrochloride (PRR 6.9) |
| 4912 | Capillary Fragility | 506 | 4 | Abemaciclib (PRR 18.8) |
| 4913 | Aortic Valve Calcification | 506 | 9 | Hyoscyamine Sulfate (PRR 36.4) |
| 4914 | Invasive Lobular Breast Carcinoma | 506 | 16 | Exemestane (PRR 83.3) |
| 4915 | Application Site Infection | 506 | 6 | Glycerin, Lidocaine (PRR 103.6) |
| 4916 | Congenital Hydrocephalus | 506 | 20 | Efavirenz (PRR 92.9) |
| 4917 | Breast Cancer Male | 506 | 3 | Bicalutamide (PRR 79.9) |
| 4918 | Physiotherapy | 506 | 1 | Pimavanserin Tartrate (PRR 81.2) |
| 4919 | Blood Albumin Abnormal | 506 | 14 | Brentuximab Vedotin (PRR 53.5) |
| 4920 | Leukoplakia Oral | 506 | 1 | Bimekizumab (PRR 7.8) |
| 4921 | Meningitis Listeria | 505 | 11 | Alemtuzumab (PRR 87.5) |
| 4922 | Complications Of Transplant Surgery | 505 | 15 | Anti-Thymocyte Globulin (Rabbit) (PRR 100.8) |
| 4923 | Gastrointestinal Fungal Infection | 505 | 13 | Micafungin Sodium (PRR 106.5) |
| 4924 | Right Atrial Dilatation | 505 | 7 | Digoxin (PRR 36.1) |
| 4925 | Breast Conserving Surgery | 505 | 13 | Fluticasone Furoate (PRR 108.5) |
| 4926 | Keloid Scar | 505 | 2 | Etonogestrel (PRR 41.5) |
| 4927 | Metastatic Squamous Cell Carcinoma | 505 | 9 | Anti-Thymocyte Globulin (Rabbit) (PRR 36.3) |
| 4928 | Po2 Increased | 505 | 10 | Magnesium Sulfate In Water For (PRR 102.9) |
| 4929 | Pyoderma | 505 | 1 | Gefitinib (PRR 18.4) |
| 4930 | Injection Site Recall Reaction | 504 | 1 | Etanercept (PRR 911.8) |
| 4931 | Palmoplantar Pustulosis | 504 | 12 | Adalimumab-Aaty (PRR 82.8) |
| 4932 | Water Intoxication | 504 | 9 | Ado-Trastuzumab Emtansine (PRR 65.3) |
| 4933 | Transplant Evaluation | 504 | 15 | Epoprostenol (PRR 507.5) |
| 4934 | Inappropriate Schedule Of Product Discontinuation | 504 | 3 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 284.2) |
| 4935 | Cataract Operation Complication | 504 | 1 | Aflibercept (PRR 12.1) |
| 4936 | Suprapubic Pain | 503 | 2 | Copper (PRR 21.0) |
| 4937 | Diabetic Retinal Oedema | 503 | 10 | Ranibizumab (PRR 654.4) |
| 4938 | Kaposi'S Sarcoma | 503 | 23 | Lamivudine (PRR 154.6) |
| 4939 | Vertebral Lesion | 503 | 8 | Doxepin Hydrochloride (PRR 64.7) |
| 4940 | Cervical Incompetence | 503 | 3 | Ampicillin (PRR 45.8) |
| 4941 | Orbital Oedema | 503 | 2 | Avapritinib (PRR 93.6) |
| 4942 | Blepharal Pigmentation | 502 | 6 | Bimatoprost (PRR 902.3) |
| 4943 | Diabetes Mellitus Insulin-Dependent | 502 | 4 | Olanzapine Pamoate (PRR 224.6) |
| 4944 | Post Procedural Diarrhoea | 502 | 4 | Cholestyramine (PRR 49.4) |
| 4945 | Tracheal Stenosis | 502 | 4 | Sevoflurane (PRR 30.3) |
| 4946 | Neonatal Respiratory Failure | 502 | 3 | Ampicillin (PRR 126.1) |
| 4947 | Oesophageal Ulcer Haemorrhage | 501 | 4 | Bicalutamide (PRR 42.1) |
| 4948 | Glare | 501 | 7 | Ranibizumab (PRR 37.7) |
| 4949 | Splenic Haemorrhage | 500 | 5 | Fondaparinux Sodium (PRR 41.8) |
| 4950 | Shunt Occlusion | 500 | 16 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 133.2) |
| 4951 | Csf Test Abnormal | 500 | 6 | Ritonavir 100 Mg (PRR 34.2) |
| 4952 | Brain Neoplasm Benign | 500 | 3 | Lanreotide Acetate (PRR 32.2) |
| 4953 | Myeloid Leukaemia | 499 | 20 | Ifosfamide (PRR 82.0) |
| 4954 | Infusion Site Cellulitis | 499 | 16 | Treprostinil (PRR 147.9) |
| 4955 | Sepsis Syndrome | 499 | 9 | Gentamicin (PRR 52.7) |
| 4956 | Iris Adhesions | 499 | 16 | Adalimumab-Fkjp (PRR 63.6) |
| 4957 | Exposure Via Partner | 499 | 2 | Sofosbuvir (PRR 19.4) |
| 4958 | Abortion Threatened | 498 | 5 | Progesterone (PRR 34.1) |
| 4959 | Autoimmune Pancreatitis | 498 | 7 | Ipilimumab (PRR 44.3) |
| 4960 | Micrognathia | 498 | 9 | Misoprostol (PRR 151.6) |
| 4961 | Activities Of Daily Living Decreased | 497 | 8 | Sarilumab (PRR 92.0) |
| 4962 | Metastases To Bone Marrow | 497 | 34 | Blinatumomab (PRR 53.6) |
| 4963 | Labelled Drug-Food Interaction Medication Error | 497 | 11 | Nilotinib (PRR 139.3) |
| 4964 | Bladder Obstruction | 496 | 6 | Fesoterodine Fumarate (PRR 31.5) |
| 4965 | Herpes Zoster Oticus | 496 | 3 | Desoximetasone (PRR 27.1) |
| 4966 | Extranodal Marginal Zone B-Cell Lymphoma (Malt Type) | 496 | 1 | Bendamustine Hydrochloride (PRR 14.1) |
| 4967 | Plagiocephaly | 495 | 14 | Zidovudine (PRR 186.5) |
| 4968 | Left Ventricular Dilatation | 494 | 15 | Eplerenone (PRR 90.2) |
| 4969 | Intercepted Drug Prescribing Error | 494 | 4 | Polyethylene Glycol 3350 (PRR 52.3) |
| 4970 | Splenic Vein Thrombosis | 494 | 5 | Drospirenone And Ethinyl Estradiol (PRR 35.8) |
| 4971 | Respiratory Tract Infection Bacterial | 494 | 28 | Trimethoprim (PRR 94.1) |
| 4972 | Pharyngeal Abscess | 494 | 4 | Ganciclovir (PRR 42.0) |
| 4973 | Lower Respiratory Tract Infection Viral | 493 | 6 | Sulfur (PRR 56.3) |
| 4974 | Vocal Cord Dysfunction | 493 | 17 | Ciclesonide (PRR 195.7) |
| 4975 | Device Use Confusion | 493 | 8 | Budesonide, Glycopyrrolate, And Formoterol Fumarate (PRR 75.5) |
| 4976 | Tongue Eruption | 493 | 3 | Fluticasone Furoate (PRR 31.9) |
| 4977 | Dermatitis Infected | 493 | 1 | Panitumumab (PRR 50.3) |
| 4978 | Retrograde Amnesia | 493 | 2 | Indomethacin (PRR 39.2) |
| 4979 | Epstein Barr Virus Positive Mucocutaneous Ulcer | 492 | 6 | Methotrexate Sodium (PRR 80.7) |
| 4980 | Lentigo | 492 | 15 | Pegaspargase (PRR 87.1) |
| 4981 | Expulsion Of Medication | 492 | 6 | Goserelin (PRR 257.0) |
| 4982 | Hypercreatininaemia | 492 | 9 | Pemetrexed (PRR 47.6) |
| 4983 | Brain Damage | 492 | 1 | Ziprasidone Mesylate (PRR 21.1) |
| 4984 | Markedly Reduced Dietary Intake | 492 | 2 | Gefitinib (PRR 38.1) |
| 4985 | Salivary Gland Cancer | 491 | 6 | Ifosfamide (PRR 95.3) |
| 4986 | Angiocentric Lymphoma | 491 | 9 | Mercaptopurine (PRR 50.9) |
| 4987 | Transurethral Prostatectomy | 491 | 6 | Dutasteride (PRR 26.3) |
| 4988 | Sudden Infant Death Syndrome | 491 | 13 | Zidovudine (PRR 172.4) |
| 4989 | Sensorimotor Disorder | 491 | 5 | Bupivacaine (PRR 41.6) |
| 4990 | Brain Stem Stroke | 491 | 7 | Darunavir (PRR 76.9) |
| 4991 | Electrocardiogram Qt Interval Abnormal | 490 | 8 | Ribociclib (PRR 95.4) |
| 4992 | Vitreous Disorder | 490 | 4 | Aflibercept (PRR 154.0) |
| 4993 | Corneal Scar | 490 | 11 | Prednisolone Acetate (PRR 112.7) |
| 4994 | Artificial Crown Procedure | 489 | 2 | Denosumab (PRR 32.7) |
| 4995 | Hypermobility Syndrome | 489 | 11 | Valproate Sodium (PRR 112.0) |
| 4996 | Immune-Mediated Encephalitis | 489 | 13 | Pembrolizumab (PRR 139.7) |
| 4997 | Oral Cavity Fistula | 489 | 5 | Zoledronic Acid (PRR 89.4) |
| 4998 | Pilonidal Cyst | 489 | 1 | Isotretinoin (PRR 18.8) |
| 4999 | Tachycardia Foetal | 489 | 9 | Magnesium Sulfate In Water For (PRR 98.9) |
| 5000 | Intraocular Lens Implant | 489 | 6 | Carboxymethylcellulose Sodium (PRR 79.7) |
| 5001 | Urinary Tract Pain | 489 | 1 | Esketamine Hydrochloride (PRR 7.2) |
| 5002 | Visceral Congestion | 488 | 20 | Diazepam Oral Solution (Concentrate) (PRR 92.7) |
| 5003 | Hypohidrosis | 488 | 3 | Agalsidase Beta (PRR 37.5) |
| 5004 | Verbal Abuse | 488 | 8 | Haloperidol (PRR 36.6) |
| 5005 | Metastases To Abdominal Cavity | 488 | 19 | Lanreotide Acetate (PRR 66.9) |
| 5006 | Oral Lichen Planus | 487 | 2 | Bendamustine Hydrochloride (PRR 21.7) |
| 5007 | Pre-Existing Disease | 487 | 2 | Clozapine (PRR 43.1) |
| 5008 | Therapy Responder | 487 | 7 | Bendamustine Hydrochloride (PRR 55.2) |
| 5009 | Encephalitis Herpes | 487 | 11 | Micafungin Sodium (PRR 62.0) |
| 5010 | Hypercalciuria | 487 | 8 | Calcitriol Capsules 0.25 Mcg (PRR 151.3) |
| 5011 | Genital Erythema | 487 | 4 | Dapagliflozin (PRR 26.8) |
| 5012 | Tinea Cruris | 487 | 5 | Ketoconazole Foam (PRR 35.5) |
| 5013 | Electrolyte Depletion | 487 | 6 | Travoprost (PRR 35.1) |
| 5014 | Hypersplenism | 487 | 9 | Voxelotor (PRR 174.1) |
| 5015 | Wrong Patient | 486 | 6 | Oxazepam (PRR 216.8) |
| 5016 | Arteriovenous Fistula | 486 | 11 | Dimenhydrinate (PRR 62.2) |
| 5017 | Ear Injury | 486 | 3 | Tofacitinib Citrate (PRR 57.5) |
| 5018 | Necrotising Oesophagitis | 485 | 17 | Micafungin Sodium (PRR 72.9) |
| 5019 | Motor Neurone Disease | 485 | 10 | Dextrose (PRR 60.9) |
| 5020 | Body Height Increased | 485 | 2 | Teduglutide (PRR 101.8) |
| 5021 | Exostosis Of Jaw | 484 | 5 | Denosumab (PRR 150.8) |
| 5022 | Protein-Losing Gastroenteropathy | 484 | 4 | Amlodipine Besylate And Valsartan (PRR 43.7) |
| 5023 | Cerebral Artery Stenosis | 484 | 2 | Nilotinib (PRR 43.3) |
| 5024 | Anaemia Vitamin B12 Deficiency | 484 | 1 | Sitagliptin And Metformin Hydrochloride (PRR 41.6) |
| 5025 | Cell Marker Increased | 483 | 2 | Everolimus (PRR 30.9) |
| 5026 | Root Canal Infection | 483 | 1 | Infliximab-Dyyb (PRR 38.8) |
| 5027 | Lactation Disorder | 482 | 11 | Ursosiol (PRR 51.2) |
| 5028 | Infective Aneurysm | 482 | 32 | Basiliximab (PRR 113.2) |
| 5029 | Immunodeficiency Common Variable | 482 | 6 | Bendamustine Hydrochloride (PRR 33.1) |
| 5030 | Transmission Of Drug Via Semen | 482 | 4 | Isotretinoin (PRR 67.8) |
| 5031 | Bone Debridement | 482 | 8 | Melphalan (PRR 65.0) |
| 5032 | Blindness Cortical | 482 | 16 | Thiotepa (PRR 46.2) |
| 5033 | Central Nervous System Vasculitis | 482 | 7 | Pyrazinamide (PRR 61.4) |
| 5034 | Intraventricular Haemorrhage Neonatal | 482 | 14 | Ampicillin (PRR 208.9) |
| 5035 | Endocarditis Staphylococcal | 482 | 9 | Rifampicin (PRR 84.4) |
| 5036 | Pigmentary Maculopathy | 482 | 4 | Dicyclomine Hydrochloride (PRR 40.5) |
| 5037 | Pneumonia Haemophilus | 481 | 33 | Promethazine Hydrochloride (PRR 129.8) |
| 5038 | Blood Uric Acid Decreased | 481 | 12 | Ado-Trastuzumab Emtansine (PRR 152.5) |
| 5039 | Hoarseness | 481 | 2 | Salmeterol Xinafoate (PRR 189.4) |
| 5040 | Bladder Mass | 481 | 2 | Apalutamide (PRR 22.4) |
| 5041 | Blood Bicarbonate Increased | 480 | 1 | Paliperidone (PRR 13.2) |
| 5042 | Blood Corticotrophin Decreased | 479 | 12 | Ipilimumab (PRR 61.1) |
| 5043 | Exercise Lack Of | 479 | 1 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 31.0) |
| 5044 | Primary Progressive Multiple Sclerosis | 478 | 11 | Glatiramer Acetate (PRR 50.8) |
| 5045 | Opiates Positive | 478 | 11 | Ethyl Alcohol (PRR 60.4) |
| 5046 | Anaemia Neonatal | 478 | 15 | Zidovudine (PRR 298.7) |
| 5047 | Wound Necrosis | 478 | 2 | Bendamustine Hydrochloride (PRR 25.8) |
| 5048 | Tendon Operation | 478 | 1 | Rocuronium Bromide (PRR 57.2) |
| 5049 | Faecal Volume Decreased | 477 | 12 | Teduglutide (PRR 145.2) |
| 5050 | Open Fracture | 477 | 1 | Romosozumab-Aqqg (PRR 13.0) |
| 5051 | Infusion Site Abscess | 476 | 11 | Treprostinil (PRR 119.5) |
| 5052 | Skin Fibrosis | 476 | 12 | Epoetin Alfa (PRR 478.9) |
| 5053 | Product Dosage Form Issue | 476 | 3 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 87.8) |
| 5054 | Evans Syndrome | 475 | 8 | Romiplostim (PRR 151.7) |
| 5055 | Sars-Cov-2 Antibody Test Negative | 475 | 5 | Ocrelizumab (PRR 397.9) |
| 5056 | Cardiac Valve Vegetation | 475 | 26 | Rifampicin (PRR 119.1) |
| 5057 | Duodenal Stenosis | 475 | 7 | Erlotinib (PRR 32.1) |
| 5058 | Gastroschisis | 475 | 13 | Abacavir Sulfate (PRR 93.9) |
| 5059 | Postoperative Infection | 475 | 2 | Interferon Beta-1B (PRR 25.7) |
| 5060 | Pharmaceutical Nomadism | 474 | 4 | Zolpidem Tartrate (PRR 130.3) |
| 5061 | Dependence On Oxygen Therapy | 474 | 17 | Amikacin (PRR 100.2) |
| 5062 | Blood Creatine Abnormal | 474 | 4 | Avapritinib (PRR 29.5) |
| 5063 | Hypergammaglobulinaemia | 474 | 2 | Pemetrexed (PRR 18.8) |
| 5064 | Blastomycosis | 473 | 21 | Tacrolimus Ointment 0.1% (PRR 122.8) |
| 5065 | Amnestic Disorder | 473 | 6 | Fentanyl Citrate (PRR 48.7) |
| 5066 | Blast Cells Present | 473 | 15 | Blinatumomab (PRR 116.0) |
| 5067 | Status Asthmaticus | 472 | 11 | Salmeterol Xinafoate (PRR 205.3) |
| 5068 | Hepatic Haematoma | 472 | 5 | Isoniazid (PRR 90.2) |
| 5069 | Tumour Invasion | 472 | 7 | Polatuzumab Vedotin (PRR 32.1) |
| 5070 | Haemangioma Congenital | 472 | 7 | Misoprostol (PRR 99.5) |
| 5071 | Helplessness | 472 | 1 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 15.6) |
| 5072 | Application Site Acne | 471 | 7 | Minoxidil (PRR 197.5) |
| 5073 | Basedow'S Disease | 471 | 7 | Methimazole (PRR 51.6) |
| 5074 | Intestinal Angioedema | 470 | 3 | Lisinopril (PRR 86.6) |
| 5075 | Shock Hypoglycaemic | 470 | 7 | Insulin Human (PRR 93.0) |
| 5076 | Tuberculous Pleurisy | 470 | 5 | Pyrazinamide (PRR 103.6) |
| 5077 | Pulmonary Vascular Disorder | 470 | 8 | Thiotepa (PRR 175.3) |
| 5078 | Parathyroidectomy | 470 | 9 | Paricalcitol (PRR 171.4) |
| 5079 | Type V Hyperlipidaemia | 470 | 6 | Eplerenone (PRR 72.2) |
| 5080 | Morphoea | 470 | 5 | Inclisiran (PRR 91.4) |
| 5081 | Vaginal Burning Sensation | 470 | 2 | Etonogestrel And Ethinyl Estradiol (PRR 52.7) |
| 5082 | Graft Versus Host Disease In Lung | 469 | 30 | Busulfan (PRR 113.2) |
| 5083 | Atrioventricular Septal Defect | 469 | 14 | Nevirapine (PRR 108.1) |
| 5084 | Blood Cholesterol | 469 | 12 | Cortisone Acetate (PRR 63.4) |
| 5085 | Peripheral Artery Stenosis | 469 | 6 | Nilotinib (PRR 134.2) |
| 5086 | Oesophageal Adenocarcinoma | 469 | 2 | Lumacaftor And Ivacaftor (PRR 26.2) |
| 5087 | Chondrolysis | 469 | 1 | Bupivacaine (PRR 242.1) |
| 5088 | Ocular Neoplasm | 469 | 1 | Vismodegib (PRR 15.0) |
| 5089 | Sleep Attacks | 468 | 11 | Rotigotine (PRR 84.6) |
| 5090 | Zygomycosis | 468 | 16 | Voriconazole (PRR 126.4) |
| 5091 | Metaplasia | 468 | 4 | Testosterone Cypionate (PRR 182.5) |
| 5092 | Vein Discolouration | 468 | 1 | Bendamustine Hydrochloride (PRR 26.4) |
| 5093 | Air Embolism | 467 | 4 | Iohexol (PRR 112.3) |
| 5094 | Wolff-Parkinson-White Syndrome | 467 | 3 | Norepinephrine (PRR 29.6) |
| 5095 | Dysphasia | 467 | 1 | Temozolomide (PRR 23.8) |
| 5096 | Lacrimation Decreased | 467 | 5 | Carboxymethylcellulose Sodium (PRR 48.4) |
| 5097 | Drainage | 466 | 6 | Infliximab-Dyyb (PRR 38.6) |
| 5098 | Central Venous Catheter Removal | 466 | 9 | Epoprostenol (PRR 78.7) |
| 5099 | Pancreatic Carcinoma Stage I | 466 | 1 | Ranitidine Hydrochloride (PRR 11.0) |
| 5100 | Meningism | 465 | 2 | Ado-Trastuzumab Emtansine (PRR 26.8) |
| 5101 | Plicated Tongue | 464 | 8 | Bisacodyl Suppositories (PRR 42.7) |
| 5102 | Disseminated Aspergillosis | 463 | 45 | Micafungin Sodium (PRR 641.9) |
| 5103 | Skin Indentation | 463 | 5 | Botulinum Toxin Type A (PRR 44.6) |
| 5104 | Partial Seizures With Secondary Generalisation | 463 | 22 | Brivaracetam (PRR 200.9) |
| 5105 | Immune-Mediated Thyroiditis | 463 | 12 | Pembrolizumab (PRR 215.5) |
| 5106 | Minimal Residual Disease | 463 | 20 | Blinatumomab (PRR 542.3) |
| 5107 | Keratic Precipitates | 463 | 8 | Faricimab (PRR 602.5) |
| 5108 | Eczema Asteatotic | 462 | 4 | Gefitinib (PRR 30.3) |
| 5109 | Respiratory Tract Inflammation | 462 | 7 | Ciclesonide (PRR 113.6) |
| 5110 | Mean Cell Volume Abnormal | 462 | 5 | Niraparib (PRR 42.4) |
| 5111 | Ear Malformation | 462 | 10 | Valproate Sodium (PRR 60.0) |
| 5112 | Disseminated Bacillus Calmette-Guerin Infection | 462 | 10 | Isoniazid (PRR 108.5) |
| 5113 | Creatinine Renal Clearance Abnormal | 462 | 5 | Loperamide Hydrochloride Oral (PRR 35.9) |
| 5114 | Eating Disorder Symptom | 462 | 1 | Vigabatrin (PRR 9.3) |
| 5115 | Urethral Disorder | 462 | 1 | Vilazodone Hydrochloride (PRR 19.7) |
| 5116 | Biopsy Bone Marrow | 461 | 10 | Eculizumab (PRR 143.7) |
| 5117 | Central Nervous System Haemorrhage | 461 | 12 | Warfarin Sodium (PRR 63.2) |
| 5118 | Pancreatitis Haemorrhagic | 461 | 13 | Pyrazinamide (PRR 121.6) |
| 5119 | Anaphylactoid Shock | 461 | 5 | Iohexol (PRR 107.9) |
| 5120 | Pelvic Infection | 460 | 3 | Misoprostol (PRR 47.5) |
| 5121 | Lung Carcinoma Cell Type Unspecified Stage Ii | 460 | 2 | Ranitidine Hydrochloride (PRR 25.7) |
| 5122 | Magnesium Deficiency | 460 | 5 | Standardized Senna Concentrate (PRR 79.1) |
| 5123 | Tooth Impacted | 460 | 2 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 17.2) |
| 5124 | Angiosarcoma | 459 | 8 | Pazopanib Hydrochloride (PRR 75.3) |
| 5125 | Mechanical Urticaria | 459 | 7 | Omalizumab (PRR 59.3) |
| 5126 | Extraocular Muscle Paresis | 459 | 14 | Nevirapine (PRR 77.9) |
| 5127 | Patient Uncooperative | 459 | 9 | Oxazepam (PRR 60.4) |
| 5128 | Mononeuropathy Multiplex | 459 | 4 | Minocycline (PRR 98.4) |
| 5129 | Blood Phosphorus Abnormal | 459 | 8 | Paricalcitol (PRR 125.3) |
| 5130 | Immunoglobulins Increased | 459 | 3 | Human Immunoglobulin G (PRR 55.6) |
| 5131 | Eczema Nummular | 458 | 5 | Nemolizumab-Ilto (PRR 78.6) |
| 5132 | Adult T-Cell Lymphoma/Leukaemia | 458 | 5 | Brentuximab Vedotin (PRR 112.2) |
| 5133 | Multiple Drug Overdose Accidental | 458 | 16 | Nicotine Polacrilex Mini (PRR 104.1) |
| 5134 | Coombs Positive Haemolytic Anaemia | 458 | 12 | Romiplostim (PRR 333.2) |
| 5135 | Mastocytosis | 458 | 7 | Avapritinib (PRR 111.9) |
| 5136 | Gastric Varices | 458 | 15 | Tenofovir Disoproxil Fumarate Tablets (PRR 53.8) |
| 5137 | Pyogenic Granuloma | 458 | 8 | Panitumumab (PRR 38.8) |
| 5138 | Injury Asphyxiation | 458 | 1 | Atomoxetine Hydrochloride (PRR 46.2) |
| 5139 | Chloasma | 457 | 7 | Tretinoin (PRR 51.5) |
| 5140 | Infusion Site Haematoma | 457 | 2 | Natalizumab (PRR 48.6) |
| 5141 | Red Cell Distribution Width Decreased | 457 | 26 | Dimenhydrinate (PRR 202.8) |
| 5142 | Gastrointestinal Stoma Output Increased | 457 | 10 | Teduglutide (PRR 1,335.8) |
| 5143 | Necrosis Ischaemic | 457 | 27 | Phenobarbital (PRR 200.4) |
| 5144 | Ehlers-Danlos Syndrome | 457 | 12 | Asfotase Alfa (PRR 51.2) |
| 5145 | Retinal Scar | 457 | 9 | Ranibizumab (PRR 398.0) |
| 5146 | Anti-Thyroid Antibody Positive | 457 | 3 | Alemtuzumab (PRR 147.1) |
| 5147 | Biliary Sepsis | 456 | 16 | Chlorhexidine Gluconate (PRR 77.4) |
| 5148 | Soft Tissue Mass | 456 | 16 | Dextrose (PRR 127.3) |
| 5149 | Pulmonary Eosinophilia | 456 | 7 | Daptomycin (PRR 60.9) |
| 5150 | Primary Biliary Cholangitis | 456 | 8 | Ursosiol (PRR 83.5) |
| 5151 | Gallbladder Cholesterolosis | 455 | 6 | Drospirenone And Ethinyl Estradiol (PRR 1,757.5) |
| 5152 | Bone Infarction | 455 | 8 | Meperidine Hydrochloride (PRR 45.6) |
| 5153 | Sexually Inappropriate Behaviour | 454 | 15 | Haloperidol (PRR 43.6) |
| 5154 | Paroxysmal Nocturnal Haemoglobinuria | 454 | 6 | Eculizumab (PRR 214.0) |
| 5155 | Sickle Cell Disease | 454 | 9 | Voxelotor (PRR 576.0) |
| 5156 | Phaeohyphomycosis | 453 | 16 | Tacrolimus Ointment 0.1% (PRR 543.9) |
| 5157 | Locked-In Syndrome | 453 | 8 | Norepinephrine (PRR 53.0) |
| 5158 | Phonophobia | 453 | 8 | Ketoprofen (PRR 54.3) |
| 5159 | Therapeutic Product Ineffective For Unapproved Indication | 453 | 6 | Dalfampridine (PRR 29.5) |
| 5160 | Cerebral Hypoperfusion | 453 | 21 | Rasagiline Mesylate (PRR 330.1) |
| 5161 | Cirrhosis Alcoholic | 453 | 10 | Rifaximin (PRR 96.1) |
| 5162 | Biopsy Bone Marrow Abnormal | 453 | 5 | Romiplostim (PRR 342.5) |
| 5163 | Post-Traumatic Pain | 453 | 3 | Pertuzumab (PRR 20.8) |
| 5164 | Incision Site Erythema | 453 | 1 | Bupivacaine (PRR 24.9) |
| 5165 | Needle Fatigue | 452 | 20 | Doxepin Hydrochloride (PRR 381.5) |
| 5166 | Autoimmune Myositis | 452 | 10 | Nitrofurantoin (PRR 46.3) |
| 5167 | Anastomotic Ulcer | 452 | 5 | Cholestyramine (PRR 42.9) |
| 5168 | Infertility Male | 452 | 3 | Finasteride (PRR 68.4) |
| 5169 | Congenital Foot Malformation | 452 | 13 | Valproate Sodium (PRR 148.1) |
| 5170 | Epidermolysis | 452 | 6 | Gentamicin (PRR 47.1) |
| 5171 | Blood Creatine Phosphokinase Abnormal | 452 | 5 | Velpatasvir And Sofosbuvir (PRR 21.8) |
| 5172 | Heart Failure With Reduced Ejection Fraction | 451 | 10 | Linagliptin (PRR 33.8) |
| 5173 | Cholestasis Of Pregnancy | 451 | 23 | Miconazole Nitrate (PRR 145.8) |
| 5174 | Cardiac Pacemaker Replacement | 451 | 8 | Bosentan (PRR 21.1) |
| 5175 | Laparotomy | 451 | 3 | Copper (PRR 57.4) |
| 5176 | Vasculitis Cerebral | 451 | 3 | Rifampicin (PRR 41.9) |
| 5177 | Synovial Disorder | 450 | 34 | Methylprednisolone Acetate (PRR 192.2) |
| 5178 | Bankruptcy | 450 | 7 | Aripiprazole (PRR 1,038.0) |
| 5179 | Allergy To Plants | 450 | 13 | Diphenhydramine Hydrochloride Capsule, Liquid Filled (PRR 102.8) |
| 5180 | Caecitis | 450 | 12 | Cytarabine (PRR 131.4) |
| 5181 | Blood Chromogranin A Increased | 450 | 11 | Octreotide Acetate (PRR 439.9) |
| 5182 | Stress Symptoms | 450 | 2 | Atomoxetine Hydrochloride (PRR 36.4) |
| 5183 | Neurosis | 450 | 4 | Fexofenadine Hcl (PRR 66.9) |
| 5184 | Eczema Herpeticum | 449 | 7 | Baricitinib (PRR 64.3) |
| 5185 | Manufacturing Issue | 449 | 5 | Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate (PRR 33.3) |
| 5186 | Refusal Of Treatment By Relative | 449 | 4 | Vincristine Sulfate (PRR 27.9) |
| 5187 | Hernia Pain | 449 | 5 | Ciclesonide (PRR 49.1) |
| 5188 | Body Mass Index Decreased | 449 | 6 | Guanfacine (PRR 54.1) |
| 5189 | Cranial Nerve Paralysis | 449 | 1 | Axicabtagene Ciloleucel (PRR 18.9) |
| 5190 | Diabetic Eye Disease | 448 | 4 | Ziprasidone Mesylate (PRR 43.6) |
| 5191 | Meningoencephalitis Herpetic | 448 | 12 | Thiotepa (PRR 75.5) |
| 5192 | Coronary Angioplasty | 448 | 2 | Ranolazine (PRR 27.1) |
| 5193 | Fibroadenoma Of Breast | 447 | 6 | Brimonidine Tartrate (PRR 37.7) |
| 5194 | Immune-Mediated Nephritis | 447 | 14 | Ipilimumab (PRR 140.5) |
| 5195 | Urinary Tract Discomfort | 447 | 14 | Diltiazem Hydrochloride Extended-Release Tablets (PRR 136.2) |
| 5196 | Post Thrombotic Syndrome | 447 | 6 | Etonogestrel And Ethinyl Estradiol (PRR 126.1) |
| 5197 | Lymph Gland Infection | 447 | 2 | Valganciclovir Hydrochloride Powder, (PRR 31.1) |
| 5198 | Gastrointestinal Stenosis | 446 | 2 | Nevirapine (PRR 20.9) |
| 5199 | Hepatic Cancer Stage Iii | 446 | 1 | Ranitidine Hydrochloride (PRR 14.2) |
| 5200 | General Anaesthesia | 446 | 1 | Etonogestrel (PRR 497.9) |
| 5201 | Operative Haemorrhage | 446 | 8 | Sevoflurane (PRR 99.2) |
| 5202 | Herpes Simplex Encephalitis | 446 | 5 | Temozolomide (PRR 91.9) |
| 5203 | Vital Capacity Decreased | 445 | 29 | Mepolizumab (PRR 294.6) |
| 5204 | Catheter Site Rash | 445 | 15 | Epoprostenol (PRR 1,099.6) |
| 5205 | Gallbladder Rupture | 445 | 4 | Lenvatinib (PRR 29.8) |
| 5206 | Allergy To Arthropod Sting | 445 | 2 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 38.6) |
| 5207 | Cervicitis | 444 | 8 | Anti-Thymocyte Globulin (Rabbit) (PRR 90.2) |
| 5208 | Neck Deformity | 444 | 11 | Indomethacin (PRR 81.8) |
| 5209 | Post Inflammatory Pigmentation Change | 444 | 4 | Crisaborole (PRR 14.7) |
| 5210 | Hepatic Atrophy | 444 | 7 | Bevacizumab (PRR 53.0) |
| 5211 | Homeless | 444 | 6 | Aripiprazole (PRR 272.3) |
| 5212 | Tremor Neonatal | 444 | 5 | Nicotine Polacrilex Mini (PRR 107.7) |
| 5213 | Oesophageal Infection | 444 | 7 | Valganciclovir Hydrochloride Powder, (PRR 43.3) |
| 5214 | Malignant Transformation | 443 | 22 | Gefitinib (PRR 432.5) |
| 5215 | Delusion Of Grandeur | 442 | 33 | Gentamicin (PRR 254.6) |
| 5216 | Perineal Abscess | 442 | 8 | Piperacillin Sodium And Tazobactam Sodium (PRR 37.2) |
| 5217 | Therapeutic Product Effect Prolonged | 442 | 6 | Bupivacaine (PRR 94.5) |
| 5218 | Implant Site Reaction | 442 | 2 | Etonogestrel (PRR 259.2) |
| 5219 | Dopamine Dysregulation Syndrome | 442 | 8 | Levodopa (PRR 398.0) |
| 5220 | Haemorrhoid Operation | 442 | 1 | Selexipag (PRR 24.4) |
| 5221 | Pregnancy Test False Positive | 441 | 4 | Isotretinoin (PRR 303.4) |
| 5222 | Hepatic Enzyme Decreased | 441 | 9 | Methylprednisolone Acetate (PRR 78.9) |
| 5223 | Enlarged Uvula | 441 | 2 | Pegvaliase-Pqpz (PRR 17.3) |
| 5224 | Divorced | 440 | 5 | Aripiprazole (PRR 301.6) |
| 5225 | Vertebroplasty | 440 | 3 | Teriparatide (PRR 59.7) |
| 5226 | Perinatal Depression | 440 | 9 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 79.4) |
| 5227 | Congenital Musculoskeletal Anomaly | 440 | 13 | Zidovudine (PRR 58.7) |
| 5228 | Chronic Myeloid Leukaemia Transformation | 440 | 6 | Nilotinib (PRR 295.6) |
| 5229 | Mineral Supplementation | 439 | 7 | Selexipag (PRR 56.9) |
| 5230 | Intercepted Drug Administration Error | 439 | 6 | Fosaprepitant Dimeglumine (PRR 46.2) |
| 5231 | Pneumatosis | 439 | 18 | Phenobarbital (PRR 124.3) |
| 5232 | Congestive Hepatopathy | 439 | 23 | Amiodarone Hydrochloride (PRR 93.3) |
| 5233 | Mitochondrial Cytopathy | 439 | 14 | Abacavir Sulfate (PRR 129.0) |
| 5234 | Feeding Intolerance | 439 | 8 | Captopril (PRR 108.7) |
| 5235 | Electrocardiogram St-T Segment Abnormal | 439 | 6 | Atropine (PRR 46.6) |
| 5236 | Failure Of Child Resistant Mechanism For Pharmaceutical Product | 438 | 4 | Loratadine Tablet (PRR 62.6) |
| 5237 | Metastases To Pancreas | 438 | 12 | Octreotide Acetate (PRR 91.4) |
| 5238 | Postrenal Failure | 438 | 3 | Ceftriaxone (PRR 197.2) |
| 5239 | Gingival Blister | 438 | 1 | Nicotine Polacrilex (PRR 26.0) |
| 5240 | Elevated Mood | 437 | 4 | Lithium Carbonate (PRR 43.5) |
| 5241 | Allergy Test Positive | 437 | 6 | Amoxicillin (PRR 87.0) |
| 5242 | Degenerative Bone Disease | 437 | 10 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate (PRR 158.2) |
| 5243 | Lack Of Spontaneous Speech | 437 | 5 | Memantine (PRR 32.0) |
| 5244 | Gastric Fistula | 437 | 4 | Ganciclovir Sodium (PRR 36.7) |
| 5245 | Peak Expiratory Flow Rate Decreased | 436 | 15 | Ciclesonide (PRR 129.2) |
| 5246 | Pulmonary Valve Stenosis Congenital | 436 | 2 | Paroxetine Hydrochloride (PRR 57.6) |
| 5247 | Muscle Mass | 436 | 8 | Dronabinol (PRR 60.7) |
| 5248 | Bulimia Nervosa | 436 | 8 | Dimenhydrinate (PRR 60.0) |
| 5249 | Anaemia Megaloblastic | 436 | 7 | Atovaquone (PRR 48.3) |
| 5250 | Temporal Lobe Epilepsy | 435 | 15 | Mercaptopurine (PRR 101.7) |
| 5251 | Meibomian Gland Dysfunction | 435 | 13 | Carboxymethylcellulose Sodium (PRR 57.4) |
| 5252 | Facial Nerve Disorder | 435 | 2 | Quinine (PRR 51.3) |
| 5253 | Nitrite Urine Present | 434 | 5 | Alemtuzumab (PRR 378.5) |
| 5254 | Porphyria Non-Acute | 434 | 11 | Ribavirin (PRR 60.0) |
| 5255 | Vulvovaginal Inflammation | 434 | 5 | Miconazole Nitrate (PRR 255.4) |
| 5256 | Systolic Hypertension | 434 | 3 | Sevoflurane (PRR 23.3) |
| 5257 | Sinus Rhythm | 433 | 18 | Drs. Clotrimazole (PRR 203.6) |
| 5258 | Infusion Site Scar | 433 | 10 | Human Immunoglobulin G (PRR 178.0) |
| 5259 | Muscular Dystrophy | 433 | 3 | Oxybutynin Chloride (PRR 61.9) |
| 5260 | Spinal Cord Infarction | 433 | 9 | Bupivacaine (PRR 171.7) |
| 5261 | Bladder Hypertrophy | 433 | 9 | Ganciclovir (PRR 67.9) |
| 5262 | Autoimmune Thrombocytopenia | 433 | 3 | Cladribine (PRR 93.9) |
| 5263 | Haemangioma Of Skin | 432 | 2 | Fingolimod Hcl (PRR 41.7) |
| 5264 | Periostitis | 432 | 13 | Voriconazole Injection (PRR 1,050.5) |
| 5265 | Eyelid Infection | 432 | 3 | Bimatoprost (PRR 18.8) |
| 5266 | Hip Deformity | 432 | 3 | Asfotase Alfa (PRR 24.3) |
| 5267 | Sexually Transmitted Disease | 431 | 7 | Aripiprazole (PRR 69.0) |
| 5268 | Fracture Displacement | 431 | 4 | Risedronate Sodium (PRR 368.0) |
| 5269 | Reticulocyte Count Decreased | 431 | 9 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 121.0) |
| 5270 | Sexual Abuse | 431 | 5 | Ethyl Alcohol (PRR 45.1) |
| 5271 | Chronic Cutaneous Lupus Erythematosus | 431 | 8 | Adalimumab-Fkjp (PRR 44.6) |
| 5272 | Diabetic Hyperosmolar Coma | 431 | 8 | Olanzapine Pamoate (PRR 54.8) |
| 5273 | Oesophageal Dilatation | 431 | 7 | Theophylline Anhydrous (PRR 85.9) |
| 5274 | Peritoneal Tuberculosis | 430 | 4 | Pyrazinamide (PRR 148.4) |
| 5275 | Pelvic Haematoma | 430 | 5 | Enoxaparin Sodium (PRR 70.1) |
| 5276 | Corona Virus Infection | 430 | 33 | Pegaspargase (PRR 297.1) |
| 5277 | Pancreatic Atrophy | 430 | 3 | Pancrelipase (PRR 66.1) |
| 5278 | Retinal Pigment Epitheliopathy | 430 | 5 | Melphalan Hydrochloride (PRR 104.2) |
| 5279 | Stubbornness | 429 | 6 | Quetiapine Fumarate (PRR 176.6) |
| 5280 | Immunisation | 428 | 45 | Felodipine Extended-Release Tablets (PRR 2,718.5) |
| 5281 | Vaginal Prolapse | 428 | 1 | Pertuzumab (PRR 24.0) |
| 5282 | Threatened Labour | 428 | 4 | Dolutegravir Sodium (PRR 55.2) |
| 5283 | Joint Surgery | 428 | 2 | Tofacitinib Citrate (PRR 26.4) |
| 5284 | Encephalitis Cytomegalovirus | 427 | 26 | Ganciclovir Sodium (PRR 1,365.1) |
| 5285 | Belligerence | 427 | 5 | Atomoxetine Hydrochloride (PRR 38.4) |
| 5286 | Vulvovaginal Rash | 427 | 2 | Miconazole Nitrate (PRR 186.6) |
| 5287 | Creatine Kinase Increased | 427 | 8 | Inclisiran (PRR 101.0) |
| 5288 | Influenza A Virus Test Positive | 427 | 3 | Oseltamivir (PRR 95.1) |
| 5289 | Toxic Optic Neuropathy | 425 | 20 | Linezolid (PRR 229.1) |
| 5290 | Coronary Artery Atherosclerosis | 425 | 6 | Carisoprodol (PRR 37.1) |
| 5291 | Lenticular Opacities | 425 | 9 | Ranibizumab (PRR 55.2) |
| 5292 | Ostomy Bag Placement | 424 | 3 | Upadacitinib (PRR 112.5) |
| 5293 | Organic Erectile Dysfunction | 424 | 1 | Finasteride (PRR 453.0) |
| 5294 | Hallucination, Olfactory | 424 | 7 | Brivaracetam (PRR 44.5) |
| 5295 | Apparent Life Threatening Event | 424 | 2 | Misoprostol (PRR 67.6) |
| 5296 | Anal Sphincter Atony | 424 | 2 | Bupivacaine (PRR 32.0) |
| 5297 | Mantle Cell Lymphoma Recurrent | 423 | 24 | Bendamustine Hydrochloride (PRR 276.0) |
| 5298 | Immune-Mediated Hypophysitis | 423 | 10 | Ipilimumab (PRR 336.3) |
| 5299 | Phlebitis Superficial | 423 | 3 | Etonogestrel And Ethinyl Estradiol (PRR 51.4) |
| 5300 | Gliosis | 423 | 6 | Voriconazole Injection (PRR 40.1) |
| 5301 | Bone Scan Abnormal | 422 | 4 | Raloxifene Hydrochloride (PRR 52.5) |
| 5302 | Nail Bed Disorder | 422 | 3 | Rucaparib (PRR 16.9) |
| 5303 | Alveolar Osteitis | 421 | 15 | Diltiazem Hydrochloride Extended-Release Tablets (PRR 145.3) |
| 5304 | Fungal Foot Infection | 421 | 5 | Terbinafine Hydrochloride (PRR 45.4) |
| 5305 | Photodermatosis | 421 | 6 | Voriconazole Injection (PRR 231.6) |
| 5306 | Citrobacter Infection | 421 | 21 | Thiotepa (PRR 86.1) |
| 5307 | Intestinal Villi Atrophy | 421 | 1 | Olmesartan Medoxomil (PRR 141.9) |
| 5308 | Carotid Artery Dissection | 421 | 5 | Etonogestrel And Ethinyl Estradiol (PRR 34.6) |
| 5309 | Blood Homocysteine Increased | 421 | 1 | Phenytoin (PRR 34.3) |
| 5310 | Ductus Arteriosus Stenosis Foetal | 420 | 9 | Indomethacin (PRR 251.5) |
| 5311 | Rapid Eye Movements Sleep Abnormal | 420 | 4 | Vilazodone Hydrochloride (PRR 38.2) |
| 5312 | Gene Mutation Identification Test Positive | 420 | 13 | Imatinib (PRR 212.0) |
| 5313 | Frontotemporal Dementia | 420 | 4 | Memantine (PRR 44.7) |
| 5314 | Tissue Injury | 420 | 2 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 23.5) |
| 5315 | Carbon Monoxide Poisoning | 420 | 1 | Brivaracetam (PRR 16.6) |
| 5316 | Urinary Tract Infection Staphylococcal | 419 | 6 | Anti-Thymocyte Globulin (Rabbit) (PRR 37.5) |
| 5317 | Blood Product Transfusion Dependent | 419 | 10 | Eculizumab (PRR 115.1) |
| 5318 | Implant Site Fibrosis | 419 | 2 | Etonogestrel (PRR 978.2) |
| 5319 | Gastrointestinal Hypermotility | 419 | 2 | Rasagiline Mesylate (PRR 22.6) |
| 5320 | Oropharyngeal Spasm | 419 | 2 | Loperamide Hydrochloride Oral (PRR 34.6) |
| 5321 | Oculomucocutaneous Syndrome | 419 | 1 | Zonisamide (PRR 41.5) |
| 5322 | Vision Abnormal Neonatal | 418 | 14 | Methadone Hydrochloride (PRR 703.7) |
| 5323 | Delusional Disorder, Persecutory Type | 418 | 7 | Quetiapine Fumarate (PRR 125.0) |
| 5324 | Abdominal Cavity Drainage | 418 | 12 | Epoprostenol (PRR 145.2) |
| 5325 | Cutaneous Sarcoidosis | 418 | 4 | Dabrafenib (PRR 39.3) |
| 5326 | Hypertelorism Of Orbit | 418 | 5 | Misoprostol (PRR 101.7) |
| 5327 | Bone Neoplasm Malignant | 418 | 1 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 15.0) |
| 5328 | Volume Blood Decreased | 418 | 2 | Heparin Sodium (PRR 40.9) |
| 5329 | Genital Lesion | 418 | 4 | Nevirapine (PRR 62.3) |
| 5330 | Fistula Of Small Intestine | 417 | 3 | Vedolizumab (PRR 25.5) |
| 5331 | Chloroma | 417 | 17 | Bleomycin Sulfate (PRR 133.9) |
| 5332 | Paradoxical Psoriasis | 416 | 6 | Adalimumab-Aaty (PRR 324.9) |
| 5333 | Antepartum Haemorrhage | 416 | 4 | Misoprostol (PRR 79.9) |
| 5334 | Polyserositis | 416 | 10 | Thiotepa (PRR 48.2) |
| 5335 | Hearing Aid User | 416 | 4 | Oral Semaglutide (PRR 17.3) |
| 5336 | Polychondritis | 416 | 6 | Adalimumab-Aaty (PRR 64.1) |
| 5337 | Wound Debridement | 416 | 6 | Thalidomide (PRR 58.5) |
| 5338 | Medical Induction Of Coma | 416 | 3 | Senna Leaf (PRR 38.4) |
| 5339 | Ovarian Cancer Stage Iv | 416 | 3 | Niraparib (PRR 32.6) |
| 5340 | Activated Partial Thromboplastin Time Shortened | 416 | 4 | Heparin Sodium (PRR 52.7) |
| 5341 | Arterial Thrombosis Limb | 415 | 4 | Heparin Sodium (PRR 33.5) |
| 5342 | Mixed Connective Tissue Disease | 415 | 2 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 23.5) |
| 5343 | Vitamin B1 Deficiency | 415 | 3 | Thiamine Hydrochloride (PRR 149.1) |
| 5344 | Reflux Laryngitis | 415 | 1 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 35.4) |
| 5345 | Melanoma Recurrent | 414 | 7 | Dabrafenib (PRR 157.6) |
| 5346 | Extravascular Haemolysis | 414 | 3 | Ravulizumab (PRR 778.0) |
| 5347 | Gastroduodenal Ulcer | 414 | 10 | Fondaparinux Sodium (PRR 96.6) |
| 5348 | Candida Test Positive | 414 | 15 | Micafungin Sodium (PRR 85.9) |
| 5349 | Sarcopenia | 414 | 5 | Thiamine Hydrochloride (PRR 76.0) |
| 5350 | Vertebral Osteophyte | 414 | 3 | Baricitinib (PRR 26.4) |
| 5351 | Vaginal Ulceration | 414 | 1 | Miconazole Nitrate (PRR 47.0) |
| 5352 | Dental Fistula | 413 | 10 | Alendronate Sodium (PRR 75.4) |
| 5353 | Delusional Perception | 413 | 8 | Pseudoephedrine Hydrochloride (PRR 34.9) |
| 5354 | Hypotony Of Eye | 413 | 17 | Prednisolone Acetate (PRR 97.0) |
| 5355 | Hypocapnia | 413 | 4 | Rocuronium Bromide (PRR 66.5) |
| 5356 | Transferrin Saturation Decreased | 413 | 5 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 90.9) |
| 5357 | Drug Withdrawal Headache | 412 | 3 | Atomoxetine Hydrochloride (PRR 24.0) |
| 5358 | Visual Acuity Tests Abnormal | 412 | 3 | Faricimab (PRR 2,469.5) |
| 5359 | Corneal Dystrophy | 412 | 4 | Timolol Maleate (PRR 31.0) |
| 5360 | Gastrointestinal Candidiasis | 412 | 2 | Daptomycin (PRR 44.7) |
| 5361 | Intestinal Prolapse | 412 | 2 | Thiotepa (PRR 59.8) |
| 5362 | Vascular Stent Stenosis | 411 | 9 | Ticagrelor (PRR 169.9) |
| 5363 | Bone Fissure | 411 | 4 | Amlodipine Besylate And Valsartan (PRR 42.1) |
| 5364 | Metastases To Spleen | 411 | 18 | Blinatumomab (PRR 60.0) |
| 5365 | Transplantation Complication | 411 | 14 | Blinatumomab (PRR 203.1) |
| 5366 | Thrombocytopenia Neonatal | 411 | 9 | Ampicillin (PRR 108.4) |
| 5367 | Low Set Ears | 411 | 12 | Nevirapine (PRR 181.6) |
| 5368 | Muscle Strength Abnormal | 411 | 3 | Asfotase Alfa (PRR 36.0) |
| 5369 | Glucocorticoid Deficiency | 410 | 13 | Pembrolizumab (PRR 67.8) |
| 5370 | Metastases To The Mediastinum | 410 | 37 | Goserelin (PRR 87.8) |
| 5371 | Hypoxic Encephalopathy | 410 | 2 | Sevoflurane (PRR 56.2) |
| 5372 | Pulmonary Calcification | 410 | 2 | Meperidine Hydrochloride (PRR 44.9) |
| 5373 | Smooth Muscle Cell Neoplasm | 409 | 21 | Ganciclovir (PRR 729.3) |
| 5374 | Gastrointestinal Angiodysplasia | 409 | 4 | Dorzolamide Hydrochloride And Timolol Maleate (PRR 39.2) |
| 5375 | Biopsy Liver | 409 | 8 | Epoprostenol (PRR 60.5) |
| 5376 | Hyperferritinaemia | 409 | 14 | Anakinra (PRR 135.9) |
| 5377 | Pericarditis Constrictive | 409 | 9 | Valganciclovir Hydrochloride Powder, (PRR 56.0) |
| 5378 | Ureteral Disorder | 409 | 5 | Telmisartan (PRR 44.4) |
| 5379 | Cardiac Ventricular Disorder | 409 | 1 | Eplerenone (PRR 53.3) |
| 5380 | Uterine Mass | 408 | 2 | Copper (PRR 9.6) |
| 5381 | Invasive Breast Carcinoma | 408 | 8 | Ribociclib (PRR 71.6) |
| 5382 | Prostatic Pain | 408 | 8 | Finasteride (PRR 89.2) |
| 5383 | Artery Dissection | 408 | 6 | Alteplase (PRR 34.8) |
| 5384 | Conjunctivitis Infective | 407 | 1 | Natalizumab (PRR 12.7) |
| 5385 | Ductus Arteriosus Premature Closure | 407 | 3 | Indomethacin (PRR 219.9) |
| 5386 | Infusion | 407 | 4 | Venetoclax (PRR 36.7) |
| 5387 | Haemobilia | 407 | 6 | Sorafenib (PRR 35.7) |
| 5388 | Nail Operation | 406 | 23 | Pseudoephedrine Hydrochloride (PRR 310.6) |
| 5389 | Sphincter Of Oddi Dysfunction | 406 | 4 | Basiliximab (PRR 72.6) |
| 5390 | Masked Facies | 406 | 6 | Ziprasidone (PRR 39.1) |
| 5391 | Application Site Laceration | 406 | 5 | Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose (PRR 38.1) |
| 5392 | Wound Infection Bacterial | 406 | 1 | Atovaquone (PRR 45.3) |
| 5393 | Skin Laxity | 405 | 5 | Asfotase Alfa (PRR 47.2) |
| 5394 | Lagophthalmos | 405 | 15 | Bupivacaine (PRR 178.1) |
| 5395 | Clubbing | 405 | 8 | Canakinumab (PRR 170.6) |
| 5396 | Trichoglossia | 405 | 13 | Linezolid (PRR 133.5) |
| 5397 | Craniotomy | 405 | 5 | Temozolomide (PRR 40.6) |
| 5398 | Obstructive Uropathy | 405 | 3 | Bicalutamide (PRR 31.0) |
| 5399 | High Frequency Ablation | 404 | 2 | Rivaroxaban (PRR 31.7) |
| 5400 | Human Papilloma Virus Test Positive | 404 | 5 | Etonogestrel And Ethinyl Estradiol (PRR 69.8) |
| 5401 | Neutralising Antibodies Positive | 404 | 8 | Agalsidase Beta (PRR 377.3) |
| 5402 | Skin Chapped | 404 | 5 | Lapatinib (PRR 435.1) |
| 5403 | Peripheral Circulatory Failure | 404 | 16 | Vortioxetine (PRR 108.7) |
| 5404 | Vascular Stent Occlusion | 403 | 3 | Ticagrelor (PRR 390.4) |
| 5405 | Urethral Obstruction | 403 | 3 | Apalutamide (PRR 35.8) |
| 5406 | Delirium Tremens | 403 | 5 | Thiamine Hydrochloride (PRR 60.1) |
| 5407 | Death Of Relative | 403 | 4 | Human Immunoglobulin G (PRR 63.8) |
| 5408 | Squamous Cell Carcinoma Of The Oral Cavity | 403 | 1 | Axicabtagene Ciloleucel (PRR 42.7) |
| 5409 | Faecal Calprotectin Abnormal | 402 | 11 | Adalimumab-Adaz (PRR 84.4) |
| 5410 | Anhidrosis | 402 | 3 | Agalsidase Beta (PRR 63.3) |
| 5411 | Reproductive Tract Disorder | 402 | 2 | Finasteride (PRR 47.7) |
| 5412 | Ankyloglossia Congenital | 402 | 7 | Tenofovir Disoproxil Fumarate Tablets (PRR 61.5) |
| 5413 | Needle Track Marks | 402 | 4 | Nemolizumab-Ilto (PRR 85.7) |
| 5414 | Vulval Abscess | 402 | 2 | Tofacitinib Citrate (PRR 28.1) |
| 5415 | Vesicoureteric Reflux | 402 | 6 | Anti-Thymocyte Globulin (Rabbit) (PRR 79.4) |
| 5416 | Bone Abscess | 402 | 3 | Lithium Carbonate (PRR 44.2) |
| 5417 | Normal Pressure Hydrocephalus | 402 | 1 | Minocycline (PRR 40.9) |
| 5418 | Procedural Headache | 401 | 2 | Bupivacaine (PRR 39.6) |
| 5419 | Genital Abscess | 401 | 14 | Clindamycin (PRR 57.1) |
| 5420 | Neonatal Tachypnoea | 401 | 3 | Ampicillin (PRR 57.7) |
| 5421 | Acoustic Neuroma | 401 | 3 | Minocycline (PRR 36.3) |
| 5422 | Bronchitis Acute | 401 | 2 | Salmeterol Xinafoate (PRR 61.7) |
| 5423 | Endometrial Disorder | 400 | 13 | Epoetin Alfa (PRR 112.1) |
| 5424 | High Risk Pregnancy | 400 | 4 | Copper (PRR 75.2) |
| 5425 | Lymphocyte Percentage Increased | 400 | 4 | Letrozole Tablets (PRR 37.5) |
| 5426 | Granulocyte Count Increased | 400 | 18 | Methylprednisolone Acetate (PRR 151.2) |
| 5427 | Ureteric Cancer | 400 | 3 | Pioglitazone (PRR 59.4) |
| 5428 | Use Of Accessory Respiratory Muscles | 400 | 3 | Palivizumab (PRR 101.9) |
| 5429 | Scar Pain | 400 | 1 | Vemurafenib (PRR 21.9) |
| 5430 | Ureaplasma Infection | 399 | 29 | Basiliximab (PRR 259.2) |
| 5431 | Endometrial Hypertrophy | 399 | 4 | Raloxifene Hydrochloride (PRR 48.0) |
| 5432 | Vitamin D Abnormal | 399 | 3 | Asfotase Alfa (PRR 37.1) |
| 5433 | Spinal Cord Haemorrhage | 399 | 2 | Fondaparinux Sodium (PRR 72.9) |
| 5434 | Blood Uric Acid Abnormal | 399 | 7 | Amphotericin B (PRR 55.9) |
| 5435 | Ammonia Abnormal | 399 | 6 | Rifaximin (PRR 172.2) |
| 5436 | Viral Rash | 399 | 5 | Umeclidinium (PRR 29.5) |
| 5437 | Carditis | 399 | 1 | Meperidine Hydrochloride (PRR 52.1) |
| 5438 | Multiple Acyl-Coenzyme A Dehydrogenase Deficiency | 398 | 2 | Sertraline (PRR 473.7) |
| 5439 | Exposure Via Eye Contact | 398 | 5 | Crisaborole (PRR 50.2) |
| 5440 | Lymphocytic Leukaemia | 398 | 4 | Blinatumomab (PRR 30.5) |
| 5441 | Viral Pharyngitis | 398 | 2 | Palivizumab (PRR 13.7) |
| 5442 | Limb Amputation | 398 | 2 | Canagliflozin (PRR 1,448.5) |
| 5443 | Ecthyma | 398 | 16 | Posaconazole Delayed-Release (PRR 74.2) |
| 5444 | Brain Compression | 398 | 5 | Ganciclovir (PRR 41.7) |
| 5445 | Incorrect Product Dosage Form Administered | 397 | 5 | Galcanezumab-Gnlm (PRR 63.8) |
| 5446 | Sinonasal Obstruction | 397 | 2 | Mepolizumab (PRR 36.6) |
| 5447 | Pleuropericarditis | 397 | 6 | Colchicine (PRR 46.3) |
| 5448 | Splenic Abscess | 397 | 12 | Anti-Thymocyte Globulin (Rabbit) (PRR 94.3) |
| 5449 | Poor Sucking Reflex | 397 | 6 | Ursosiol (PRR 47.9) |
| 5450 | Necrotising Enterocolitis Neonatal | 397 | 12 | Zidovudine (PRR 174.3) |
| 5451 | Lichenification | 396 | 5 | Anti-Thymocyte Globulin (Rabbit) (PRR 46.4) |
| 5452 | Persistent Depressive Disorder | 396 | 9 | Fexofenadine Hcl (PRR 70.3) |
| 5453 | Cat Scratch Disease | 395 | 12 | Mycophenilic Acid (PRR 97.6) |
| 5454 | Bone Density Increased | 395 | 13 | Anakinra (PRR 177.5) |
| 5455 | Catheter Site Extravasation | 395 | 8 | Epoprostenol (PRR 98.2) |
| 5456 | Tumour Associated Fever | 395 | 18 | Pembrolizumab (PRR 47.7) |
| 5457 | Red Blood Cell Transfusion | 395 | 14 | Mesna Injection (PRR 106.3) |
| 5458 | Antibiotic Level Above Therapeutic | 395 | 18 | Vancomycin Hydrochloride (PRR 225.8) |
| 5459 | Device Colour Issue | 395 | 8 | Levodopa (PRR 101.5) |
| 5460 | Eye Infection Toxoplasmal | 395 | 13 | Triamcinolone Acetonide Ointment Usp, 0.05% (PRR 119.9) |
| 5461 | Sticky Skin | 394 | 7 | Loperamide Hydrochloride Oral (PRR 42.2) |
| 5462 | Rapid Eye Movement Sleep Behaviour Disorder | 394 | 15 | Amantadine (PRR 91.1) |
| 5463 | Oppositional Defiant Disorder | 394 | 14 | Guanfacine (PRR 163.9) |
| 5464 | Hepatic Cancer Stage Ii | 394 | 1 | Ranitidine Hydrochloride (PRR 14.1) |
| 5465 | Pancreas Infection | 394 | 5 | Oxazepam (PRR 46.3) |
| 5466 | Electrocardiogram T Wave Peaked | 394 | 5 | Desloratadine (PRR 55.7) |
| 5467 | Tri-Iodothyronine Increased | 394 | 3 | Liothyronine Sodium (PRR 247.6) |
| 5468 | Manufacturing Materials Issue | 394 | 1 | Guanfacine (PRR 27.1) |
| 5469 | Blighted Ovum | 393 | 6 | Lopinavir And Ritonavir (PRR 44.2) |
| 5470 | Factor V Leiden Mutation | 393 | 12 | Ciclesonide (PRR 140.0) |
| 5471 | Growth Hormone Deficiency | 393 | 7 | Lanreotide Acetate (PRR 219.3) |
| 5472 | Product Substitution | 393 | 3 | Adalimumab-Adaz (PRR 38.5) |
| 5473 | Asymptomatic Covid-19 | 393 | 6 | Nirmatrelvir And Ritonavir (PRR 83.1) |
| 5474 | Neutrophilic Dermatosis | 393 | 6 | Anti-Thymocyte Globulin (Rabbit) (PRR 53.6) |
| 5475 | Pancreatolithiasis | 393 | 1 | Pancrelipase (PRR 144.1) |
| 5476 | Vitamin K Deficiency | 393 | 13 | Cefazolin (PRR 216.0) |
| 5477 | Tricuspid Valve Disease | 392 | 1 | Tafamidis (PRR 22.8) |
| 5478 | Laryngeal Pain | 392 | 1 | Iohexol (PRR 25.9) |
| 5479 | Lung Diffusion Test Decreased | 391 | 19 | Nintedanib (PRR 129.7) |
| 5480 | Humidity Intolerance | 391 | 4 | Ciclesonide (PRR 117.8) |
| 5481 | Trichosporon Infection | 391 | 27 | Micafungin Sodium (PRR 271.9) |
| 5482 | Housebound | 391 | 4 | Methadone (PRR 40.3) |
| 5483 | Pulmonary Artery Stenosis | 391 | 4 | Ampicillin (PRR 65.9) |
| 5484 | Renal Salt-Wasting Syndrome | 390 | 4 | Cisplatin (PRR 184.7) |
| 5485 | Chronic Hepatitis C | 390 | 15 | Sofosbuvir (PRR 78.4) |
| 5486 | Mitral Valve Replacement | 390 | 1 | Bosentan (PRR 23.4) |
| 5487 | Product Label On Wrong Product | 390 | 3 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate (PRR 17.9) |
| 5488 | Dependence On Respirator | 390 | 3 | Palivizumab (PRR 39.3) |
| 5489 | Visual Brightness | 390 | 1 | Crizotinib (PRR 29.9) |
| 5490 | Nail Pitting | 389 | 3 | Terbinafine Hydrochloride (PRR 36.7) |
| 5491 | Blood Follicle Stimulating Hormone Increased | 389 | 9 | Quinapril Hydrochloride (PRR 173.4) |
| 5492 | Metastatic Lymphoma | 389 | 7 | Axicabtagene Ciloleucel (PRR 78.7) |
| 5493 | Convulsive Threshold Lowered | 389 | 1 | Tapentadol Hydrochloride (PRR 21.5) |
| 5494 | Congenital Diaphragmatic Hernia | 389 | 8 | Epoetin Alfa (PRR 75.3) |
| 5495 | Joint Hyperextension | 389 | 8 | Captopril (PRR 57.1) |
| 5496 | Gastrointestinal Anastomotic Leak | 388 | 8 | Oxaliplatin (PRR 74.9) |
| 5497 | Disease Risk Factor | 388 | 7 | Progesterone (PRR 34.0) |
| 5498 | Lower Respiratory Tract Infection Fungal | 388 | 21 | Voriconazole Injection (PRR 74.5) |
| 5499 | Lung Cyst | 388 | 8 | Docusate Sodium 100Mg (PRR 105.5) |
| 5500 | Temporomandibular Pain And Dysfunction Syndrome | 388 | 8 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 63.9) |
| 5501 | Poverty Of Speech | 388 | 3 | Memantine (PRR 32.0) |
| 5502 | Hearing Disability | 388 | 2 | Fentanyl Citrate (PRR 21.4) |
| 5503 | Nephritis Allergic | 388 | 4 | Cefepime (PRR 54.3) |
| 5504 | Ileitis | 387 | 2 | Isotretinoin (PRR 100.9) |
| 5505 | Malacoplakia | 387 | 17 | Tacrolimus Ointment 0.1% (PRR 1,047.0) |
| 5506 | Astrocytoma | 387 | 8 | Temozolomide (PRR 221.7) |
| 5507 | Toxic Neuropathy | 387 | 6 | Quinine (PRR 64.4) |
| 5508 | Ultrasound Scan Abnormal | 387 | 2 | Zidovudine (PRR 54.1) |
| 5509 | Transient Tachypnoea Of The Newborn | 387 | 3 | Oseltamivir (PRR 34.2) |
| 5510 | Gallbladder Perforation | 387 | 1 | Irinotecan Hydrochloride (PRR 21.2) |
| 5511 | Bladder Perforation | 386 | 3 | Abiraterone (PRR 20.1) |
| 5512 | Immune-Mediated Renal Disorder | 386 | 12 | Pembrolizumab (PRR 338.2) |
| 5513 | Stoma Site Extravasation | 386 | 8 | Rotigotine (PRR 147.9) |
| 5514 | Pregnancy Test Positive | 385 | 5 | Isotretinoin (PRR 52.8) |
| 5515 | Hypoglycaemic Encephalopathy | 385 | 5 | Glimepiride (PRR 85.1) |
| 5516 | B Precursor Type Acute Leukaemia | 384 | 10 | Blinatumomab (PRR 1,550.8) |
| 5517 | Bone Giant Cell Tumour | 384 | 1 | Denosumab (PRR 405.7) |
| 5518 | Haemorrhagic Cyst | 384 | 4 | Tolvaptan (PRR 46.2) |
| 5519 | Carotid Bruit | 384 | 5 | Alendronate Sodium (PRR 79.3) |
| 5520 | Diverticulitis Intestinal Haemorrhagic | 384 | 3 | Nintedanib (PRR 34.5) |
| 5521 | Dropped Head Syndrome | 384 | 13 | Rotigotine (PRR 135.2) |
| 5522 | Hepatic Cancer Stage I | 384 | 1 | Ranitidine Hydrochloride (PRR 18.8) |
| 5523 | Blue Toe Syndrome | 384 | 7 | Dalteparin Sodium (PRR 119.5) |
| 5524 | Skin Turgor Decreased | 384 | 2 | Acetaminophen And Codeine (PRR 41.0) |
| 5525 | Tracheomalacia | 384 | 5 | Sevoflurane (PRR 46.5) |
| 5526 | Urinary Casts | 384 | 1 | Alemtuzumab (PRR 164.7) |
| 5527 | Ovarian Enlargement | 383 | 3 | Progesterone (PRR 50.1) |
| 5528 | Disseminated Mucormycosis | 383 | 50 | Amphotericin B (PRR 296.3) |
| 5529 | Azoospermia | 383 | 6 | Bleomycin Sulfate (PRR 261.4) |
| 5530 | Adrenal Gland Cancer | 383 | 1 | Ranitidine Hydrochloride (PRR 23.3) |
| 5531 | Amyotrophy | 383 | 6 | Ketoprofen (PRR 42.5) |
| 5532 | Myocardial Oedema | 382 | 7 | Memantine (PRR 79.6) |
| 5533 | Suicide Threat | 382 | 2 | Lurasidone Hydrochloride (PRR 24.0) |
| 5534 | Walking Distance Test Abnormal | 381 | 16 | Selexipag (PRR 118.8) |
| 5535 | Hemiparaesthesia | 381 | 7 | Chlorthalidone (PRR 94.0) |
| 5536 | Bone Marrow Infiltration | 381 | 24 | Ribociclib (PRR 79.4) |
| 5537 | Leiomyosarcoma | 381 | 3 | Basiliximab (PRR 52.6) |
| 5538 | Aortic Rupture | 381 | 1 | Prochlorperazine Maleate (PRR 36.1) |
| 5539 | Osteosarcoma | 380 | 14 | Thiotepa (PRR 166.6) |
| 5540 | Adenoidectomy | 380 | 11 | Nicotine Polacrilex Mini (PRR 68.9) |
| 5541 | Metastases To Stomach | 380 | 14 | Dabrafenib (PRR 51.9) |
| 5542 | Administration Site Reaction | 380 | 1 | Guselkumab (PRR 7.7) |
| 5543 | Mesenteric Artery Thrombosis | 380 | 7 | Nevirapine (PRR 68.7) |
| 5544 | Impaired Reasoning | 380 | 1 | Valproate Sodium (PRR 52.9) |
| 5545 | Bovine Tuberculosis | 380 | 3 | Isoniazid (PRR 75.1) |
| 5546 | Hyperemesis Gravidarum | 380 | 1 | Brivaracetam (PRR 18.4) |
| 5547 | Cervical Polyp | 379 | 2 | Copper (PRR 38.4) |
| 5548 | Skin Ulcer Haemorrhage | 379 | 2 | Salicylic Acid (PRR 3.1) |
| 5549 | Intracranial Tumour Haemorrhage | 379 | 7 | Vemurafenib (PRR 66.4) |
| 5550 | Topical Steroid Withdrawal Reaction | 379 | 21 | Mometasone (PRR 585.0) |
| 5551 | Trisomy 18 | 379 | 22 | Efavirenz (PRR 251.4) |
| 5552 | Renal Dysplasia | 379 | 8 | Atazanavir (PRR 119.9) |
| 5553 | Sensation Of Blood Flow | 379 | 3 | Quinine (PRR 59.0) |
| 5554 | Reactive Gastropathy | 378 | 5 | Olmesartan Medoxomil (PRR 143.1) |
| 5555 | Hepatitis B Virus Test Positive | 378 | 2 | Entecavir (PRR 43.5) |
| 5556 | Bone Tuberculosis | 378 | 7 | Pyrazinamide (PRR 136.9) |
| 5557 | Intensive Care Unit Acquired Weakness | 377 | 27 | Midazolam Hydrochloride (PRR 149.0) |
| 5558 | Paternal Drugs Affecting Foetus | 377 | 1 | Isotretinoin (PRR 24.8) |
| 5559 | Macrocephaly | 377 | 12 | Nevirapine (PRR 213.9) |
| 5560 | Product Barcode Issue | 377 | 1 | Asenapine Maleate (PRR 19.3) |
| 5561 | Total Lung Capacity Abnormal | 376 | 74 | Dutasteride (PRR 914.5) |
| 5562 | Cystitis Viral | 376 | 42 | Busulfan (PRR 459.6) |
| 5563 | Breakthrough Haemolysis | 376 | 2 | Ravulizumab (PRR 1,190.7) |
| 5564 | Cardiovascular Symptom | 376 | 6 | Tramadol Hydrochloride (PRR 49.6) |
| 5565 | Fat Tissue Decreased | 376 | 3 | Lanreotide Acetate (PRR 65.1) |
| 5566 | Hypometabolism | 376 | 3 | Paliperidone (PRR 44.8) |
| 5567 | Appendicolith | 375 | 102 | Phytonadione (PRR 5,908.3) |
| 5568 | Pyroglutamic Acidosis | 375 | 17 | Acetaminophen Tablet Extended Release (PRR 262.8) |
| 5569 | Radiation Oesophagitis | 375 | 12 | Durvalumab (PRR 73.0) |
| 5570 | Prostatic Specific Antigen Decreased | 375 | 9 | Bicalutamide (PRR 81.0) |
| 5571 | Central Nervous System Leukaemia | 375 | 9 | Blinatumomab (PRR 2,069.7) |
| 5572 | Parvovirus Infection | 375 | 13 | Basiliximab (PRR 68.6) |
| 5573 | Lung Adenocarcinoma Stage Iv | 375 | 11 | Crizotinib (PRR 111.9) |
| 5574 | Instillation Site Pruritus | 375 | 3 | Lifitegrast (PRR 1,293.5) |
| 5575 | Electrocardiogram Qrs Complex Shortened | 375 | 3 | Norepinephrine (PRR 26.3) |
| 5576 | Injection Site Pustule | 374 | 5 | Cabotegravir (PRR 27.9) |
| 5577 | Bronchopleural Fistula | 374 | 11 | Remdesivir (PRR 131.2) |
| 5578 | Bile Duct Stent Insertion | 374 | 4 | Sitagliptin (PRR 184.3) |
| 5579 | Conjunctival Disorder | 374 | 3 | Ranibizumab (PRR 26.0) |
| 5580 | Eye Infection Fungal | 374 | 21 | Amphotericin B (PRR 160.7) |
| 5581 | Albumin Urine Present | 374 | 4 | Sorafenib (PRR 27.5) |
| 5582 | Alkalosis | 374 | 2 | Sodium Bicarbonate (PRR 45.2) |
| 5583 | Accelerated Hypertension | 374 | 4 | Pyrazinamide (PRR 54.6) |
| 5584 | Soft Tissue Haemorrhage | 374 | 1 | Emicizumab (PRR 90.1) |
| 5585 | Lacrimal Structure Injury | 373 | 5 | Docetaxel Anhydrous (PRR 755.4) |
| 5586 | Egfr Gene Mutation | 373 | 10 | Gefitinib (PRR 1,233.0) |
| 5587 | Stool Analysis Abnormal | 373 | 2 | Bupropion Hydrochloride (PRR 45.9) |
| 5588 | Neuroblastoma | 373 | 8 | Irinotecan Hydrochloride (PRR 116.2) |
| 5589 | Scrotal Abscess | 373 | 10 | Clindamycin Phosphate (PRR 58.4) |
| 5590 | Cardiac Assistance Device User | 373 | 2 | Ranolazine (PRR 77.7) |
| 5591 | Mediastinal Mass | 373 | 7 | Nicotine Polacrilex Mini (PRR 70.3) |
| 5592 | Hepatic Infarction | 373 | 6 | Ampicillin (PRR 83.5) |
| 5593 | Acetabulum Fracture | 373 | 4 | Cortisone Acetate (PRR 56.0) |
| 5594 | Periprosthetic Fracture | 373 | 3 | Alendronate Sodium Tablet (PRR 77.2) |
| 5595 | Lipoedema | 373 | 1 | Ivacaftor (PRR 50.1) |
| 5596 | Gastrointestinal Vascular Malformation Haemorrhagic | 372 | 2 | Rivaroxaban (PRR 200.4) |
| 5597 | Trichodysplasia Spinulosa | 372 | 15 | Tacrolimus Ointment 0.1% (PRR 626.2) |
| 5598 | Adenoidal Hypertrophy | 372 | 3 | Somatropin (PRR 73.7) |
| 5599 | Penile Erythema | 372 | 2 | Canagliflozin (PRR 33.3) |
| 5600 | Breast Reconstruction | 372 | 3 | Medroxyprogesterone Acetate (PRR 36.6) |
| 5601 | Implant Site Haemorrhage | 372 | 2 | Etonogestrel (PRR 403.6) |
| 5602 | Thrombotic Cerebral Infarction | 372 | 5 | Prasugrel Hydrochloride (PRR 260.6) |
| 5603 | Choroiditis | 371 | 31 | Dexamethasone Sodium Phosphate (PRR 451.4) |
| 5604 | Nasal Turbinate Hypertrophy | 371 | 21 | Ciclesonide (PRR 248.9) |
| 5605 | Hepatitis B Core Antibody Positive | 371 | 6 | Isoniazid (PRR 73.1) |
| 5606 | Congenital Umbilical Hernia | 371 | 14 | Dolutegravir Sodium (PRR 367.6) |
| 5607 | Corneal Reflex Decreased | 371 | 7 | Doxepin (PRR 98.6) |
| 5608 | Chemical Poisoning | 370 | 1 | Levonorgestrel (PRR 14.5) |
| 5609 | Central Line Infection | 370 | 4 | Agalsidase Beta (PRR 49.7) |
| 5610 | Hydroureter | 370 | 8 | Polatuzumab Vedotin (PRR 71.5) |
| 5611 | Herpes Simplex Reactivation | 370 | 16 | Thiotepa (PRR 124.5) |
| 5612 | Vascular Graft Occlusion | 370 | 4 | Heparin Sodium (PRR 37.7) |
| 5613 | Cerebellar Stroke | 370 | 13 | Rasagiline Mesylate (PRR 158.9) |
| 5614 | Viral Myocarditis | 370 | 2 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 15.4) |
| 5615 | Abscess Rupture | 370 | 1 | Ivacaftor (PRR 35.9) |
| 5616 | Keratoconjunctivitis Sicca | 369 | 2 | Isotretinoin (PRR 25.3) |
| 5617 | Acute Phase Reaction | 369 | 1 | Zoledronic Acid (PRR 278.2) |
| 5618 | Lumbar Puncture | 369 | 1 | Rocuronium Bromide (PRR 24.3) |
| 5619 | Hepatosplenic T-Cell Lymphoma | 368 | 11 | Mercaptopurine (PRR 286.7) |
| 5620 | Human Rhinovirus Test Positive | 368 | 23 | Promethazine Hydrochloride (PRR 200.9) |
| 5621 | Scleroderma Renal Crisis | 368 | 2 | Captopril (PRR 157.7) |
| 5622 | Single Umbilical Artery | 368 | 5 | Atazanavir (PRR 105.5) |
| 5623 | Nose Deformity | 368 | 3 | Valproate Sodium (PRR 54.8) |
| 5624 | Humoral Immune Defect | 367 | 7 | Bendamustine Hcl (PRR 221.4) |
| 5625 | Neuromuscular Block Prolonged | 367 | 13 | Rocuronium Bromide (PRR 1,206.7) |
| 5626 | Lid Sulcus Deepened | 367 | 6 | Bimatoprost (PRR 152.3) |
| 5627 | Body Dysmorphic Disorder | 367 | 9 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 81.0) |
| 5628 | Glasgow Coma Scale Abnormal | 367 | 4 | Felodipine Extended-Release Tablets (PRR 45.9) |
| 5629 | Floppy Iris Syndrome | 367 | 4 | Dutasteride (PRR 71.7) |
| 5630 | Pityriasis Rosea | 367 | 1 | Terbinafine Hydrochloride (PRR 45.5) |
| 5631 | Respiratory Gas Exchange Disorder | 366 | 21 | Ciclesonide (PRR 121.6) |
| 5632 | Biopsy Lung | 366 | 5 | Selexipag (PRR 29.6) |
| 5633 | Myosclerosis | 366 | 8 | Captopril (PRR 73.3) |
| 5634 | Mediastinal Disorder | 366 | 2 | Isosorbide Dinitrate (PRR 39.2) |
| 5635 | Malignant Neoplasm Of Unknown Primary Site | 366 | 1 | Velpatasvir And Sofosbuvir (PRR 13.4) |
| 5636 | Keratoconus | 365 | 4 | Progesterone (PRR 44.4) |
| 5637 | Immune-Mediated Arthritis | 365 | 9 | Pembrolizumab (PRR 191.5) |
| 5638 | Bronchopneumopathy | 365 | 4 | Human Insulin (PRR 37.3) |
| 5639 | Erythromelalgia | 365 | 3 | Hydroxyurea (PRR 57.0) |
| 5640 | Gastrointestinal Tract Adenoma | 365 | 1 | Teduglutide (PRR 61.6) |
| 5641 | Spinal Cord Oedema | 365 | 6 | Bupivacaine (PRR 75.7) |
| 5642 | Immune-Mediated Pancreatitis | 364 | 11 | Pembrolizumab (PRR 201.2) |
| 5643 | Her2 Positive Breast Cancer | 364 | 14 | Trastuzumab (PRR 512.7) |
| 5644 | Adhesive Tape Use | 364 | 5 | Methylphenidate (PRR 453.9) |
| 5645 | Urogenital Haemorrhage | 364 | 5 | Candesartan (PRR 60.0) |
| 5646 | Periodic Limb Movement Disorder | 364 | 11 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 140.5) |
| 5647 | Orgasmic Sensation Decreased | 364 | 2 | Finasteride (PRR 104.8) |
| 5648 | Enterobacter Sepsis | 364 | 11 | Busulfan (PRR 97.5) |
| 5649 | Axillary Vein Thrombosis | 364 | 4 | Drospirenone And Ethinyl Estradiol (PRR 98.4) |
| 5650 | Scan Abnormal | 364 | 9 | Niraparib (PRR 159.6) |
| 5651 | Vomiting In Pregnancy | 363 | 3 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate (PRR 19.3) |
| 5652 | Polycystic Ovarian Syndrome | 363 | 4 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 155.9) |
| 5653 | Alternaria Infection | 363 | 17 | Tacrolimus Ointment 0.1% (PRR 277.3) |
| 5654 | Obsessive-Compulsive Symptom | 363 | 5 | Cariprazine (PRR 56.8) |
| 5655 | Incision Site Impaired Healing | 363 | 2 | Upadacitinib (PRR 22.9) |
| 5656 | Product Administered By Wrong Person | 363 | 7 | Cabotegravir (PRR 118.8) |
| 5657 | Venous Pressure Jugular Increased | 363 | 13 | Ciclesonide (PRR 137.6) |
| 5658 | Trance | 363 | 1 | Pimavanserin Tartrate (PRR 15.1) |
| 5659 | Xanthopsia | 363 | 5 | Voriconazole (PRR 99.3) |
| 5660 | Splenic Lesion | 363 | 5 | Febuxostat Tablets 40 Mg (PRR 82.1) |
| 5661 | Product With Quality Issue Administered | 363 | 2 | Testosterone Cypionate (PRR 424.9) |
| 5662 | Anastomotic Stenosis | 362 | 6 | Adalimumab-Fkjp (PRR 65.3) |
| 5663 | Application Site Pustules | 362 | 5 | Minoxidil Foam 5% (Womens) (PRR 25.3) |
| 5664 | Diabetic Gastroparesis | 362 | 6 | Olanzapine Pamoate (PRR 47.5) |
| 5665 | Viral Test Positive | 362 | 15 | Insulin Glargine-Yfgn (PRR 131.6) |
| 5666 | Hyperparathyroidism Primary | 362 | 3 | Lithium Carbonate (PRR 131.1) |
| 5667 | Colour Blindness Acquired | 362 | 2 | Encorafenib (PRR 47.5) |
| 5668 | Salivary Gland Calculus | 362 | 6 | Meclizine Hcl 12.5Mg (PRR 61.4) |
| 5669 | Neonatal Hypotension | 362 | 4 | Ampicillin (PRR 71.4) |
| 5670 | Meningitis Pneumococcal | 362 | 1 | Bleomycin Sulfate (PRR 28.2) |
| 5671 | Skin Discharge | 361 | 4 | Nemolizumab-Ilto (PRR 27.7) |
| 5672 | Complications Of Bone Marrow Transplant | 361 | 17 | Busulfan (PRR 193.0) |
| 5673 | Cytomegalovirus Oesophagitis | 361 | 18 | Valganciclovir Hydrochloride Powder, (PRR 340.0) |
| 5674 | Generalised Bullous Fixed Drug Eruption | 361 | 6 | Ceftriaxone (PRR 39.1) |
| 5675 | Angiodysplasia | 361 | 6 | Thiotepa (PRR 62.1) |
| 5676 | Cervical Cord Compression | 361 | 1 | Fondaparinux Sodium (PRR 36.1) |
| 5677 | Complications Of Transplanted Liver | 360 | 16 | Basiliximab (PRR 115.1) |
| 5678 | Schizophrenia, Paranoid Type | 360 | 10 | Ziprasidone Mesylate (PRR 85.8) |
| 5679 | Essential Thrombocythaemia | 360 | 4 | Hydroxyurea (PRR 140.5) |
| 5680 | Feeding Tube User | 360 | 7 | Teduglutide (PRR 30.6) |
| 5681 | Shock Symptom | 360 | 1 | Nirmatrelvir And Ritonavir (PRR 8.7) |
| 5682 | Therapeutic Product Effective For Unapproved Indication | 360 | 4 | Vigabatrin (PRR 40.8) |
| 5683 | Pancreatic Insufficiency | 360 | 4 | Pancrelipase (PRR 63.5) |
| 5684 | Physical Examination Abnormal | 360 | 3 | Esketamine Hydrochloride (PRR 377.3) |
| 5685 | Lividity | 360 | 2 | Alteplase (PRR 43.7) |
| 5686 | Penis Injury | 359 | 6 | Finasteride (PRR 144.1) |
| 5687 | Grandiosity | 359 | 12 | Lithium (PRR 89.1) |
| 5688 | Non-Cirrhotic Portal Hypertension | 359 | 10 | Oxaliplatin (PRR 187.2) |
| 5689 | Stomal Hernia | 359 | 5 | Teduglutide (PRR 105.7) |
| 5690 | Vancomycin Infusion Reaction | 359 | 11 | Vancomycin Hydrochloride (PRR 1,152.8) |
| 5691 | Neurosarcoidosis | 359 | 4 | Adalimumab-Fkjp (PRR 59.4) |
| 5692 | Diet Noncompliance | 359 | 2 | Selexipag (PRR 27.8) |
| 5693 | Carcinoid Syndrome | 359 | 2 | Octreotide Acetate (PRR 371.4) |
| 5694 | Eclampsia | 359 | 5 | Labetalol (PRR 82.4) |
| 5695 | Coronary Artery Insufficiency | 359 | 1 | Acalabrutinib (PRR 24.2) |
| 5696 | Postmortem Blood Drug Level Increased | 358 | 15 | Bupropion (PRR 82.8) |
| 5697 | Nasopharyngeal Cancer | 358 | 2 | Tenofovir Disoproxil Fumarate Tablets (PRR 27.2) |
| 5698 | Breath Holding | 358 | 5 | Budesonide, Glycopyrrolate, And Formoterol Fumarate (PRR 63.1) |
| 5699 | Vaginal Fistula | 358 | 1 | Infliximab-Dyyb (PRR 51.1) |
| 5700 | Infected Dermal Cyst | 358 | 5 | Dimenhydrinate (PRR 85.4) |
| 5701 | Weaning Failure | 358 | 3 | Theophylline (PRR 62.8) |
| 5702 | Globulins Increased | 357 | 2 | Crizotinib (PRR 18.5) |
| 5703 | Lymphoma Transformation | 356 | 16 | Polatuzumab Vedotin (PRR 262.3) |
| 5704 | Globulins Decreased | 356 | 9 | Dexamethasone Sodium Phosphate (PRR 65.3) |
| 5705 | Anaesthesia | 356 | 2 | Bleomycin Sulfate (PRR 158.7) |
| 5706 | Time Perception Altered | 356 | 4 | Lurasidone Hydrochloride (PRR 43.7) |
| 5707 | Non-Small Cell Lung Cancer Stage Iv | 356 | 8 | Crizotinib (PRR 118.3) |
| 5708 | Heart Valve Stenosis | 356 | 3 | Ranolazine (PRR 28.4) |
| 5709 | Herpes Zoster Meningoencephalitis | 356 | 9 | Sirolimus (PRR 82.2) |
| 5710 | Vaginal Swelling | 356 | 1 | Miconazole Nitrate (PRR 119.5) |
| 5711 | Hypoglycaemia Unawareness | 355 | 8 | Insulin Human (PRR 126.1) |
| 5712 | Chronic Graft Versus Host Disease In Liver | 355 | 22 | Thiotepa (PRR 215.8) |
| 5713 | Diabetic Ketosis | 355 | 7 | Dapagliflozin (PRR 159.4) |
| 5714 | Pseudopolyp | 355 | 5 | Meperidine Hydrochloride (PRR 58.7) |
| 5715 | Lipid Metabolism Disorder | 355 | 2 | Cariprazine (PRR 31.9) |
| 5716 | Oesophageal Motility Disorder | 355 | 4 | Miconazole Nitrate (PRR 27.2) |
| 5717 | Eosinophilic Colitis | 355 | 1 | Teriflunomide (PRR 23.1) |
| 5718 | Bipolar Ii Disorder | 355 | 7 | Lithium (PRR 54.5) |
| 5719 | Liver Function Test Decreased | 355 | 1 | Bosutinib (PRR 26.4) |
| 5720 | Ankle Arthroplasty | 354 | 30 | Anakinra (PRR 459.9) |
| 5721 | Dysplastic Naevus | 354 | 6 | Voriconazole Injection (PRR 101.7) |
| 5722 | Brain Malformation | 354 | 10 | Amitriptyline Hydrochloride (PRR 56.1) |
| 5723 | Abscess Bacterial | 353 | 23 | Pegaspargase (PRR 420.3) |
| 5724 | Radial Nerve Palsy | 353 | 5 | Doxepin (PRR 84.8) |
| 5725 | Dialysis Related Complication | 353 | 9 | Paricalcitol (PRR 112.2) |
| 5726 | Urinary Tract Inflammation | 353 | 14 | Oseltamivir (PRR 92.0) |
| 5727 | Metastatic Carcinoma Of The Bladder | 353 | 1 | Pioglitazone (PRR 154.7) |
| 5728 | Kidney Malformation | 353 | 2 | Lopinavir And Ritonavir (PRR 63.4) |
| 5729 | Milia | 352 | 6 | Travoprost (PRR 48.8) |
| 5730 | Antidepressant Drug Level Increased | 352 | 4 | Fluoxetine (PRR 80.0) |
| 5731 | Plasmablastic Lymphoma | 352 | 15 | Sirolimus (PRR 73.5) |
| 5732 | Muscle Hypertrophy | 352 | 2 | Botulinum Toxin Type A (PRR 34.0) |
| 5733 | Cerebral Mass Effect | 352 | 4 | Alteplase (PRR 70.3) |
| 5734 | Mixed Anxiety And Depressive Disorder | 352 | 6 | Pegaspargase (PRR 39.5) |
| 5735 | Stab Wound | 352 | 4 | Amphetamine (PRR 36.2) |
| 5736 | Lymphoid Tissue Hyperplasia | 352 | 2 | Amiodarone Hydrochloride (PRR 54.3) |
| 5737 | Serum Serotonin Increased | 352 | 5 | Octreotide Acetate (PRR 202.8) |
| 5738 | Anisocoria | 352 | 9 | Diltiazem Hydrochloride Extended-Release Tablets (PRR 53.5) |
| 5739 | Thymoma | 352 | 2 | Ravulizumab (PRR 40.4) |
| 5740 | Microsporidia Infection | 351 | 30 | Posaconazole Delayed-Release (PRR 314.7) |
| 5741 | Catheter Removal | 351 | 9 | Epoprostenol (PRR 239.7) |
| 5742 | Fibrous Histiocytoma | 351 | 10 | Quinapril Hydrochloride (PRR 193.6) |
| 5743 | Inadequate Aseptic Technique In Use Of Product | 351 | 5 | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 427.5) |
| 5744 | Product Compounding Quality Issue | 351 | 2 | Voriconazole Injection (PRR 51.8) |
| 5745 | Meniscus Operation | 351 | 1 | Bimekizumab (PRR 14.1) |
| 5746 | Mental Retardation | 351 | 2 | Phenobarbital (PRR 46.4) |
| 5747 | Fat Embolism | 351 | 1 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 16.2) |
| 5748 | Nsaid Exacerbated Respiratory Disease | 350 | 12 | Umeclidinium (PRR 111.3) |
| 5749 | Endometrial Ablation | 350 | 19 | Ciclesonide (PRR 248.6) |
| 5750 | Pulmonary Malformation | 350 | 9 | Docusate Sodium 100Mg (PRR 194.6) |
| 5751 | Nasal Septal Operation | 350 | 5 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 56.5) |
| 5752 | Hypothalamic Pituitary Adrenal Axis Suppression | 350 | 10 | Triamcinolone Acetonide Ointment Usp, 0.05% (PRR 124.4) |
| 5753 | Tinea Versicolour | 350 | 5 | Terbinafine Hydrochloride (PRR 61.8) |
| 5754 | Chronic Left Ventricular Failure | 349 | 8 | Tafamidis (PRR 142.2) |
| 5755 | Androgen Deficiency | 349 | 4 | Finasteride (PRR 99.0) |
| 5756 | Breast Hyperplasia | 349 | 6 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 79.8) |
| 5757 | Cytomegalovirus Hepatitis | 349 | 19 | Ganciclovir Sodium (PRR 151.7) |
| 5758 | Fungal Test Positive | 349 | 6 | Voriconazole Injection (PRR 58.2) |
| 5759 | Burning Sensation Mucosal | 349 | 1 | Cyclobenzaprine Hydrochloride (PRR 47.4) |
| 5760 | Disseminated Varicella Zoster Virus Infection | 348 | 14 | Mycophenolate Mofetil Hydrochloride (PRR 79.0) |
| 5761 | Portal Venous Gas | 348 | 13 | Fluorouracil Cream, 0.5% (PRR 82.5) |
| 5762 | Multiple System Atrophy | 348 | 7 | Droxidopa (PRR 135.9) |
| 5763 | Implant Site Irritation | 348 | 1 | Etonogestrel (PRR 1,457.7) |
| 5764 | Pneumonitis Chemical | 348 | 6 | Bleomycin Sulfate (PRR 41.3) |
| 5765 | Lordosis | 348 | 8 | Valproate Sodium (PRR 81.2) |
| 5766 | Acquired Diaphragmatic Eventration | 348 | 4 | Brentuximab Vedotin (PRR 60.0) |
| 5767 | Gastroenteritis Clostridial | 348 | 2 | Thiotepa (PRR 38.2) |
| 5768 | Cytomegalovirus Enteritis | 347 | 16 | Valganciclovir Hydrochloride Powder, (PRR 254.1) |
| 5769 | Fallot'S Tetralogy | 347 | 4 | Paroxetine Hydrochloride (PRR 115.9) |
| 5770 | Intestinal Metastasis | 347 | 12 | Fulvestrant (PRR 68.3) |
| 5771 | Implant Site Discharge | 347 | 2 | Etonogestrel (PRR 230.0) |
| 5772 | Spine Malformation | 347 | 8 | Darunavir (PRR 139.7) |
| 5773 | Lower Urinary Tract Symptoms | 347 | 3 | Doxazosin (PRR 38.3) |
| 5774 | Ovarian Cancer Stage Iii | 347 | 2 | Niraparib (PRR 39.4) |
| 5775 | Atherosclerosis | 347 | 1 | Oxymorphone Hydrochloride (PRR 15.6) |
| 5776 | Pancreatic Necrosis | 347 | 1 | Brinzolamide (PRR 35.0) |
| 5777 | Tongue Exfoliation | 347 | 1 | Asenapine Maleate (PRR 35.1) |
| 5778 | Anastomotic Complication | 346 | 6 | Leucovorin Calcium (PRR 63.2) |
| 5779 | Injection Site Erosion | 346 | 4 | Interferon Beta-1B (PRR 45.7) |
| 5780 | Chronic Obstructive Airways Disease Exacerbated | 346 | 5 | Salmeterol Xinafoate (PRR 163.9) |
| 5781 | Tracheal Haemorrhage | 346 | 4 | Lenvatinib (PRR 47.2) |
| 5782 | Tachyphylaxis | 346 | 5 | Ranibizumab (PRR 63.6) |
| 5783 | Circumoral Oedema | 346 | 6 | Cefazolin (PRR 54.0) |
| 5784 | Wound Abscess | 346 | 1 | Cannabidiol (PRR 18.3) |
| 5785 | Acute Disseminated Encephalomyelitis | 346 | 2 | Alemtuzumab (PRR 69.5) |
| 5786 | Eye Symptom | 346 | 2 | Encorafenib (PRR 43.4) |
| 5787 | Radicular Pain | 346 | 1 | Bupivacaine (PRR 46.0) |
| 5788 | Activation Syndrome | 345 | 7 | Lurasidone Hydrochloride (PRR 105.1) |
| 5789 | Sperm Concentration Decreased | 345 | 3 | Finasteride (PRR 125.1) |
| 5790 | Colonic Stenosis | 345 | 7 | Diclofenac Sodium 1% (PRR 49.4) |
| 5791 | Left Ventricle Outflow Tract Obstruction | 345 | 7 | Norepinephrine Bitartrate (PRR 178.9) |
| 5792 | Chronic Respiratory Disease | 345 | 4 | Efavirenz (PRR 102.7) |
| 5793 | Soft Tissue Sarcoma | 345 | 4 | Pazopanib Hydrochloride (PRR 354.8) |
| 5794 | Social Phobia | 345 | 3 | Atomoxetine Hydrochloride (PRR 31.5) |
| 5795 | Biliary Cirrhosis Primary | 345 | 2 | Ursodiol (PRR 65.0) |
| 5796 | Mesothelioma Malignant | 345 | 1 | Miconazole Nitrate (PRR 28.0) |
| 5797 | Detoxification | 344 | 6 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 44.8) |
| 5798 | Elbow Deformity | 344 | 10 | Abatacept (PRR 93.0) |
| 5799 | Neutrophil Count Normal | 344 | 1 | Clozapine (PRR 6,133.0) |
| 5800 | Counterfeit Drug Administered | 344 | 1 | Tadalafil (PRR 31.1) |
| 5801 | Epidural Lipomatosis | 344 | 33 | Dimenhydrinate (PRR 379.6) |
| 5802 | Arteriovenous Fistula Thrombosis | 344 | 13 | Paricalcitol (PRR 120.4) |
| 5803 | Ureteral Stent Insertion | 344 | 3 | Niraparib (PRR 30.9) |
| 5804 | Pelvic Neoplasm | 344 | 6 | Lanreotide Acetate (PRR 121.0) |
| 5805 | Meconium In Amniotic Fluid | 344 | 5 | Misoprostol (PRR 153.1) |
| 5806 | Gait Spastic | 343 | 20 | Doxepin Hydrochloride (PRR 542.7) |
| 5807 | Blood Ketone Body | 343 | 3 | Empagliflozin (PRR 55.1) |
| 5808 | Asthma Exercise Induced | 343 | 10 | Ciclesonide (PRR 190.3) |
| 5809 | Heart Rate | 343 | 3 | Ciclesonide (PRR 65.0) |
| 5810 | Basal Ganglia Infarction | 343 | 9 | Sevoflurane (PRR 75.2) |
| 5811 | Human Herpesvirus 6 Infection Reactivation | 343 | 18 | Thiotepa (PRR 201.2) |
| 5812 | Joint Abscess | 343 | 2 | Insulin Degludec (PRR 26.6) |
| 5813 | Transferrin Saturation Increased | 343 | 3 | Iron Sucrose (PRR 72.3) |
| 5814 | Large Intestinal Ulcer Haemorrhage | 343 | 3 | Prasugrel Hydrochloride (PRR 24.2) |
| 5815 | Rectal Cancer Metastatic | 342 | 10 | Panitumumab (PRR 180.9) |
| 5816 | Metastases To Chest Wall | 342 | 21 | Exemestane (PRR 107.2) |
| 5817 | Neuromuscular Toxicity | 342 | 3 | Botulinum Toxin Type A (PRR 1,580.3) |
| 5818 | Growth Failure | 342 | 13 | Anakinra (PRR 120.5) |
| 5819 | Pulmonary Artery Dilatation | 342 | 7 | Theophylline Anhydrous (PRR 55.8) |
| 5820 | Herbal Interaction | 342 | 2 | Indapamide (PRR 45.8) |
| 5821 | Neonatal Infection | 342 | 12 | Ampicillin (PRR 99.3) |
| 5822 | Medial Tibial Stress Syndrome | 341 | 2 | Teriparatide (PRR 22.3) |
| 5823 | Gas Gangrene | 341 | 2 | Canagliflozin (PRR 362.8) |
| 5824 | Sports Injury | 341 | 3 | Emicizumab (PRR 35.3) |
| 5825 | Tooth Deposit | 341 | 1 | Lanreotide Acetate (PRR 39.5) |
| 5826 | Hepatitis C Rna Increased | 340 | 8 | Sofosbuvir (PRR 173.3) |
| 5827 | Hyperaldosteronism | 340 | 6 | Abiraterone (PRR 65.6) |
| 5828 | Idiopathic Interstitial Pneumonia | 340 | 7 | Nicotine Polacrilex Mini (PRR 77.5) |
| 5829 | Polymerase Chain Reaction Positive | 340 | 4 | Nilotinib (PRR 186.0) |
| 5830 | Non-Alcoholic Fatty Liver | 340 | 7 | Nevirapine (PRR 62.7) |
| 5831 | Ocular Myasthenia | 340 | 3 | Eplerenone (PRR 39.1) |
| 5832 | Electrocardiogram T Wave Amplitude Decreased | 340 | 7 | Calcium Gluconate (PRR 52.3) |
| 5833 | Insulin Autoimmune Syndrome | 339 | 9 | Methimazole (PRR 97.3) |
| 5834 | Vascular Stenosis | 339 | 3 | Canagliflozin (PRR 43.6) |
| 5835 | Small Cell Carcinoma | 339 | 6 | Erlotinib (PRR 45.3) |
| 5836 | Pterygium | 339 | 2 | Sirolimus (PRR 51.8) |
| 5837 | Soft Tissue Inflammation | 339 | 2 | Polatuzumab Vedotin (PRR 38.4) |
| 5838 | Anion Gap Decreased | 339 | 5 | Cimetidine (PRR 79.3) |
| 5839 | Choluria | 339 | 2 | Terbinafine Hydrochloride (PRR 42.2) |
| 5840 | Rhinocerebral Mucormycosis | 338 | 27 | Amphotericin B (PRR 274.8) |
| 5841 | Eosinophilic Fasciitis | 338 | 2 | Nivolumab (PRR 38.1) |
| 5842 | Patient Elopement | 338 | 7 | Pimavanserin Tartrate (PRR 166.8) |
| 5843 | Viral Diarrhoea | 338 | 6 | Thiotepa (PRR 108.3) |
| 5844 | Acquired Oesophageal Web | 338 | 2 | Olmesartan Medoxomil (PRR 79.8) |
| 5845 | Oxygen Saturation Increased | 338 | 2 | Nintedanib (PRR 71.7) |
| 5846 | Diaphragmalgia | 338 | 1 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 8.0) |
| 5847 | Cubital Tunnel Syndrome | 338 | 1 | Baricitinib (PRR 39.0) |
| 5848 | Boredom | 337 | 4 | Paliperidone Palmitate (PRR 45.1) |
| 5849 | Alcoholic Liver Disease | 337 | 9 | Thiamine Hydrochloride (PRR 94.3) |
| 5850 | Fluid Replacement | 337 | 6 | Niraparib (PRR 62.3) |
| 5851 | Blood Pressure Orthostatic Decreased | 337 | 1 | Droxidopa (PRR 367.3) |
| 5852 | Carotid Artery Aneurysm | 337 | 1 | Pseudoephedrine Hcl (PRR 17.0) |
| 5853 | Cystitis Bacterial | 336 | 29 | Pegaspargase (PRR 783.0) |
| 5854 | Chest Wall Pain | 336 | 2 | Calcium Gluconate (PRR 53.0) |
| 5855 | Immune-Mediated Cholangitis | 336 | 10 | Nivolumab (PRR 183.5) |
| 5856 | Distal Intestinal Obstruction Syndrome | 336 | 9 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 298.5) |
| 5857 | Pseudoporphyria | 336 | 9 | Imatinib (PRR 141.5) |
| 5858 | Pulmonary Necrosis | 336 | 7 | Ganciclovir Sodium (PRR 72.8) |
| 5859 | Conjunctivitis Bacterial | 336 | 2 | Panitumumab (PRR 24.1) |
| 5860 | Ligament Operation | 336 | 1 | Eptinezumab-Jjmr (PRR 20.6) |
| 5861 | Human Antichimeric Antibody Positive | 335 | 20 | Anakinra (PRR 11,473.4) |
| 5862 | Blood Triglycerides Decreased | 335 | 8 | Inclisiran (PRR 71.6) |
| 5863 | Stiff Person Syndrome | 335 | 4 | Human Immunoglobulin G (PRR 128.9) |
| 5864 | Product Dose Confusion | 335 | 5 | Oral Semaglutide (PRR 77.3) |
| 5865 | Post Concussion Syndrome | 335 | 5 | Vilazodone Hydrochloride (PRR 27.3) |
| 5866 | Benign Neoplasm Of Skin | 335 | 1 | Vemurafenib (PRR 36.9) |
| 5867 | Ileectomy | 334 | 3 | Ustekinumab (PRR 55.6) |
| 5868 | Decreased Vibratory Sense | 334 | 4 | Fingolimod Hcl (PRR 49.3) |
| 5869 | Graft Infection | 334 | 9 | Clindamycin (PRR 77.6) |
| 5870 | Laryngomalacia | 334 | 14 | Nevirapine (PRR 162.6) |
| 5871 | Oral Soft Tissue Disorder | 334 | 1 | Thalidomide (PRR 32.2) |
| 5872 | Neuromyelitis Optica | 333 | 3 | Interferon Beta-1A (PRR 51.9) |
| 5873 | Craniopharyngioma | 333 | 17 | Somatropin (PRR 352.9) |
| 5874 | Tenoplasty | 333 | 2 | Upadacitinib (PRR 28.9) |
| 5875 | Spinal Nerve Stimulator Implantation | 333 | 1 | Upadacitinib (PRR 32.8) |
| 5876 | Coagulation Time Shortened | 333 | 3 | Heparin Sodium (PRR 183.3) |
| 5877 | Administration Site Bruise | 333 | 2 | Alirocumab (PRR 44.6) |
| 5878 | Pneumonitis Aspiration | 333 | 3 | Cenobamate (PRR 265.1) |
| 5879 | Medullary Thyroid Cancer | 332 | 5 | Oral Semaglutide (PRR 63.6) |
| 5880 | Vascular Device Occlusion | 332 | 9 | Blinatumomab (PRR 87.8) |
| 5881 | Blood Viscosity Decreased | 332 | 2 | Ibrutinib (PRR 37.2) |
| 5882 | Blood Lactate Dehydrogenase Decreased | 332 | 8 | Eculizumab (PRR 89.5) |
| 5883 | Neonatal Respiratory Depression | 332 | 6 | Sevoflurane (PRR 93.9) |
| 5884 | Drug Effect Faster Than Expected | 331 | 5 | Diclofenac Sodium (PRR 56.1) |
| 5885 | Tumour Marker Abnormal | 331 | 15 | Ribociclib (PRR 137.0) |
| 5886 | Large Granular Lymphocytosis | 331 | 5 | Dasatinib (PRR 76.8) |
| 5887 | Acute Hepatitis B | 331 | 10 | Entecavir (PRR 96.5) |
| 5888 | Dysthymic Disorder | 331 | 2 | Etonogestrel And Ethinyl Estradiol (PRR 38.3) |
| 5889 | Gastrointestinal Polyp | 331 | 2 | Teduglutide (PRR 33.4) |
| 5890 | Inguinal Hernia Repair | 331 | 2 | Fluticasone Furoate (PRR 81.5) |
| 5891 | Hemihypoaesthesia | 330 | 5 | Diroximel Fumarate (PRR 106.6) |
| 5892 | Low Cardiac Output Syndrome | 330 | 8 | Tolvaptan (PRR 143.1) |
| 5893 | Blast Cell Crisis | 330 | 6 | Imatinib (PRR 135.4) |
| 5894 | Ectropion | 330 | 9 | Panitumumab (PRR 81.1) |
| 5895 | Acute Stress Disorder | 330 | 2 | Raltegravir (PRR 35.3) |
| 5896 | Blood Creatine Phosphokinase Decreased | 330 | 5 | Canakinumab (PRR 47.8) |
| 5897 | Benign Hydatidiform Mole | 329 | 6 | Tenofovir Disoproxil Fumarate Tablets (PRR 37.2) |
| 5898 | Immune Reconstitution Inflammatory Syndrome Associated Tuberculosis | 329 | 24 | Pyrazinamide (PRR 2,339.6) |
| 5899 | Posterior Capsule Opacification | 329 | 5 | Ranibizumab (PRR 111.5) |
| 5900 | Comminuted Fracture | 329 | 3 | Risedronate Sodium (PRR 117.0) |
| 5901 | Iodine Allergy | 329 | 6 | Meperidine Hydrochloride (PRR 70.8) |
| 5902 | Gastroenteritis Bacterial | 329 | 4 | Acalabrutinib (PRR 59.4) |
| 5903 | Ileocaecal Resection | 328 | 11 | Adalimumab-Fkjp (PRR 196.6) |
| 5904 | Alopecia Totalis | 328 | 6 | Docetaxel Anhydrous (PRR 54.1) |
| 5905 | Dermoid Cyst | 328 | 3 | Terbinafine Hydrochloride (PRR 51.1) |
| 5906 | Lung Lobectomy | 328 | 2 | Umeclidinium Bromide And Vilanterol Trifenatate (PRR 35.1) |
| 5907 | Urine Amphetamine Positive | 328 | 3 | Atomoxetine Hydrochloride (PRR 47.8) |
| 5908 | Juvenile Arthritis | 328 | 2 | Anakinra (PRR 81.4) |
| 5909 | Neonatal Aspiration | 328 | 5 | Zidovudine (PRR 79.8) |
| 5910 | Bacterial Pyelonephritis | 328 | 5 | Abacavir Sulfate (PRR 74.1) |
| 5911 | Lung Perforation | 328 | 1 | Rocuronium Bromide (PRR 27.3) |
| 5912 | Haemorrhagic Erosive Gastritis | 327 | 2 | Rivaroxaban (PRR 53.0) |
| 5913 | Blood Osmolarity Increased | 327 | 3 | Clozapine (PRR 24.3) |
| 5914 | Gastric Varices Haemorrhage | 327 | 8 | Sofosbuvir (PRR 40.2) |
| 5915 | Breast Haemorrhage | 327 | 4 | Ado-Trastuzumab Emtansine (PRR 61.9) |
| 5916 | Colostomy Closure | 327 | 1 | Niraparib (PRR 29.6) |
| 5917 | Multiple Sclerosis Pseudo Relapse | 326 | 8 | Ofatumumab (PRR 164.8) |
| 5918 | Gastroenteritis Radiation | 326 | 10 | Diphenoxylate Hydrochloride And Atropine Sulfate (PRR 73.2) |
| 5919 | Hemiplegic Migraine | 326 | 7 | Eptinezumab-Jjmr (PRR 102.6) |
| 5920 | Saliva Discolouration | 326 | 6 | Levodopa (PRR 676.8) |
| 5921 | Wrong Strength | 326 | 6 | Dofetilide (PRR 309.0) |
| 5922 | Coagulation Factor V Level Decreased | 326 | 4 | Gentamicin (PRR 45.2) |
| 5923 | Faecal Occult Blood Positive | 326 | 1 | Polatuzumab Vedotin (PRR 19.8) |
| 5924 | Diabetic Hyperglycaemic Coma | 325 | 5 | Human Insulin (PRR 63.9) |
| 5925 | Hypercreatinaemia | 325 | 5 | Selinexor (PRR 68.5) |
| 5926 | Genital Pruritus Female | 325 | 2 | Etonogestrel And Ethinyl Estradiol (PRR 109.5) |
| 5927 | Arrhythmic Storm | 325 | 6 | Amiodarone Hydrochloride (PRR 209.8) |
| 5928 | Allergic Respiratory Symptom | 325 | 1 | Remdesivir (PRR 19.4) |
| 5929 | Acanthosis | 325 | 4 | Piperacillin And Tazobactam (PRR 46.3) |
| 5930 | Pseudocirrhosis | 324 | 22 | Fulvestrant (PRR 202.8) |
| 5931 | Arthritis Enteropathic | 324 | 6 | Vedolizumab (PRR 59.2) |
| 5932 | Rectal Stenosis | 324 | 1 | Vedolizumab (PRR 39.8) |
| 5933 | Ileostomy Closure | 324 | 3 | Risankizumab-Rzaa (PRR 39.8) |
| 5934 | Genital Infection | 324 | 3 | Empagliflozin (PRR 72.9) |
| 5935 | Drug-Genetic Interaction | 324 | 14 | Doxepin (PRR 127.9) |
| 5936 | Secondary Hypogonadism | 324 | 9 | Testosterone (PRR 132.5) |
| 5937 | Penile Ulceration | 324 | 5 | Valganciclovir Hydrochloride Powder, (PRR 100.3) |
| 5938 | Unwanted Awareness During Anaesthesia | 324 | 5 | Sevoflurane (PRR 962.8) |
| 5939 | Hyponatraemic Syndrome | 324 | 2 | Dutasteride (PRR 48.3) |
| 5940 | Injection Site Thrombosis | 324 | 1 | Iron Sucrose (PRR 41.2) |
| 5941 | Abdominoplasty | 323 | 2 | Etonogestrel And Ethinyl Estradiol (PRR 45.7) |
| 5942 | Metastases To Breast | 323 | 14 | Ribociclib (PRR 126.3) |
| 5943 | Injection Site Anaesthesia | 323 | 1 | Epinephrine (PRR 50.0) |
| 5944 | Nephrostomy | 323 | 8 | Relugolix (PRR 39.9) |
| 5945 | Metabolic Function Test Abnormal | 323 | 1 | Pimavanserin Tartrate (PRR 59.2) |
| 5946 | Peripheral Nerve Lesion | 323 | 5 | Doxepin (PRR 93.0) |
| 5947 | Diverticulitis Intestinal Perforated | 323 | 7 | Baricitinib (PRR 165.4) |
| 5948 | Osteotomy | 323 | 1 | Zoledronic Acid (PRR 90.3) |
| 5949 | Hepatitis Alcoholic | 323 | 4 | Derma Foam Excel Hand Sanitizer (PRR 32.6) |
| 5950 | Thrombectomy | 323 | 5 | Etonogestrel And Ethinyl Estradiol (PRR 231.7) |
| 5951 | Cns Ventriculitis | 323 | 12 | Alteplase (PRR 96.3) |
| 5952 | Packaging Design Issue | 323 | 1 | Lifitegrast (PRR 24.1) |
| 5953 | Amino Acid Level Decreased | 323 | 1 | Pegvaliase-Pqpz (PRR 4,011.8) |
| 5954 | Pik3Ca-Activated Mutation | 322 | 24 | Fulvestrant (PRR 677.8) |
| 5955 | Implant Site Rash | 322 | 1 | Etonogestrel (PRR 1,071.5) |
| 5956 | Plastic Surgery | 322 | 1 | Etonogestrel (PRR 8.3) |
| 5957 | Asocial Behaviour | 322 | 2 | Valproic Acid (PRR 43.7) |
| 5958 | Central Nervous System Inflammation | 322 | 9 | Efavirenz (PRR 59.8) |
| 5959 | Pneumonia Escherichia | 322 | 4 | Polatuzumab Vedotin (PRR 54.3) |
| 5960 | Pneumocephalus | 322 | 2 | Sevoflurane (PRR 31.5) |
| 5961 | Electrocardiogram Qrs Complex Abnormal | 322 | 2 | Sevoflurane (PRR 31.5) |
| 5962 | Anticoagulation Drug Level Increased | 321 | 7 | Posaconazole (PRR 67.1) |
| 5963 | Rhythm Idioventricular | 321 | 8 | Atropine Sulfate (PRR 114.4) |
| 5964 | Loss Of Proprioception | 321 | 5 | Methimazole (PRR 50.5) |
| 5965 | Defect Conduction Intraventricular | 321 | 1 | Tolvaptan (PRR 65.3) |
| 5966 | Contraindicated Device Used | 320 | 2 | Levonorgestrel (PRR 737.5) |
| 5967 | Norovirus Test Positive | 320 | 27 | Pegaspargase (PRR 761.1) |
| 5968 | Compulsive Hoarding | 320 | 6 | Aripiprazole (PRR 552.0) |
| 5969 | Thrombophlebitis Migrans | 320 | 13 | Durvalumab (PRR 71.8) |
| 5970 | Administration Site Swelling | 320 | 3 | Diphenhydramine (PRR 77.3) |
| 5971 | Candida Pneumonia | 320 | 8 | Polatuzumab Vedotin (PRR 112.2) |
| 5972 | Discontinued Product Administered | 320 | 5 | Budesonide, Glycopyrrolate, And Formoterol Fumarate (PRR 44.5) |
| 5973 | Penile Oedema | 320 | 2 | Bicalutamide (PRR 39.5) |
| 5974 | Pseudocyst | 320 | 1 | Pancrelipase (PRR 35.9) |
| 5975 | Extraocular Muscle Disorder | 320 | 3 | Melphalan Hydrochloride (PRR 76.4) |
| 5976 | Cellulite | 320 | 4 | Crisaborole (PRR 41.4) |
| 5977 | Haematology Test Abnormal | 320 | 2 | Lutetium Lu 177 Vipivotide Tetraxetan (PRR 20.0) |
| 5978 | Cerebral Amyloid Angiopathy | 320 | 2 | Dolutegravir Sodium (PRR 51.6) |
| 5979 | Tonsillar Inflammation | 320 | 1 | Zonisamide (PRR 45.4) |
| 5980 | Pharyngeal Operation | 320 | 2 | Cariprazine (PRR 21.2) |
| 5981 | Diffuse Large B-Cell Lymphoma Stage Iv | 319 | 18 | Polatuzumab Vedotin (PRR 189.2) |
| 5982 | Oestradiol Decreased | 319 | 2 | Estradiol (PRR 260.3) |
| 5983 | Dreamy State | 319 | 4 | Tranexamic Acid (PRR 52.5) |
| 5984 | Red Blood Cell Schistocytes Present | 319 | 5 | Anti-Thymocyte Globulin (Rabbit) (PRR 66.3) |
| 5985 | Vulvitis | 319 | 3 | Pegaspargase (PRR 32.6) |
| 5986 | Ventricular Tachyarrhythmia | 319 | 2 | Sevoflurane (PRR 64.4) |
| 5987 | Conductive Deafness | 319 | 15 | Ampicillin (PRR 150.2) |
| 5988 | Aspergilloma | 319 | 4 | Voriconazole Injection (PRR 157.3) |
| 5989 | Salpingitis | 318 | 3 | Etonogestrel And Ethinyl Estradiol (PRR 36.8) |
| 5990 | Ankle Deformity | 318 | 4 | Desoximetasone (PRR 208.5) |
| 5991 | Bowel Sounds Abnormal | 318 | 1 | Exenatide (PRR 32.2) |
| 5992 | Varicose Vein Ruptured | 318 | 3 | Atezolizumab (PRR 70.4) |
| 5993 | Application Site Oedema | 318 | 2 | Methylphenidate (PRR 77.5) |
| 5994 | Liposarcoma | 318 | 1 | Pazopanib Hydrochloride (PRR 35.4) |
| 5995 | Parakeratosis | 318 | 2 | Brexpiprazole (PRR 32.3) |
| 5996 | Anorexia Nervosa | 318 | 1 | Valganciclovir Hydrochloride Powder, (PRR 44.0) |
| 5997 | Mitral Valve Repair | 318 | 1 | Dutasteride (PRR 40.9) |
| 5998 | Osteitis Deformans | 317 | 2 | Teriparatide (PRR 34.4) |
| 5999 | Post Procedural Contusion | 317 | 3 | Anakinra (PRR 45.1) |
| 6000 | Femoral Artery Occlusion | 317 | 1 | Nilotinib (PRR 30.1) |
| 6001 | Respiratory Muscle Weakness | 317 | 2 | Rocuronium Bromide (PRR 28.3) |
| 6002 | Eye Infection Viral | 317 | 4 | Cenegermin-Bkbj (PRR 103.5) |
| 6003 | Retrognathia | 317 | 1 | Misoprostol (PRR 84.1) |
| 6004 | Periorbital Irritation | 316 | 6 | Dupilumab (PRR 73.8) |
| 6005 | Procedural Dizziness | 316 | 2 | Levonorgestrel (PRR 63.5) |
| 6006 | Drug Therapy | 316 | 77 | Oseltamivir (PRR 1,474.7) |
| 6007 | Injection Site Pallor | 316 | 2 | Epinephrine (PRR 212.9) |
| 6008 | Colorectal Adenoma | 316 | 4 | Teduglutide (PRR 60.9) |
| 6009 | Seasonal Affective Disorder | 316 | 7 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 70.8) |
| 6010 | Echolalia | 316 | 13 | Memantine (PRR 165.3) |
| 6011 | Cold-Stimulus Headache | 316 | 1 | Bosutinib (PRR 22.2) |
| 6012 | Microtia | 315 | 5 | Epoetin Alfa (PRR 100.2) |
| 6013 | Catheter Site Irritation | 315 | 12 | Epoprostenol (PRR 876.7) |
| 6014 | Central Sleep Apnoea Syndrome | 315 | 8 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 235.7) |
| 6015 | Menstruation Normal | 315 | 3 | Etonogestrel (PRR 390.6) |
| 6016 | Product Reconstitution Issue | 315 | 3 | Naltrexone (PRR 53.1) |
| 6017 | Duplicate Therapy Error | 315 | 2 | Amantadine (PRR 48.6) |
| 6018 | Vena Cava Filter Insertion | 315 | 1 | Etonogestrel And Ethinyl Estradiol (PRR 721.6) |
| 6019 | Scarlet Fever | 315 | 1 | Canakinumab (PRR 50.1) |
| 6020 | Oesophageal Cancer Metastatic | 315 | 1 | Ado-Trastuzumab Emtansine (PRR 31.7) |
| 6021 | Contrast Media Deposition | 315 | 1 | Iohexol (PRR 24.1) |
| 6022 | Nail Bed Inflammation | 314 | 27 | Ado-Trastuzumab Emtansine (PRR 339.8) |
| 6023 | Oesophageal Fistula | 314 | 7 | Fluorouracil Cream, 0.5% (PRR 78.0) |
| 6024 | Acromegaly | 314 | 4 | Octreotide Acetate (PRR 163.6) |
| 6025 | Foetal Cardiac Disorder | 314 | 4 | Lopinavir And Ritonavir (PRR 55.7) |
| 6026 | Tumour Compression | 314 | 7 | Mesna Injection (PRR 100.0) |
| 6027 | Double Stranded Dna Antibody Positive | 314 | 2 | Voclosporin (PRR 225.4) |
| 6028 | Papilloma | 314 | 5 | Vemurafenib (PRR 111.5) |
| 6029 | Prostatic Haemorrhage | 314 | 2 | Terbinafine Hydrochloride (PRR 61.2) |
| 6030 | Adnexal Torsion | 313 | 5 | Tranexamic Acid (PRR 85.2) |
| 6031 | Euthanasia | 313 | 7 | Pramipexole (PRR 58.8) |
| 6032 | Bacterial Translocation | 313 | 14 | Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose (PRR 92.5) |
| 6033 | Metastases To Ovary | 313 | 12 | Goserelin (PRR 100.1) |
| 6034 | Refractory Anaemia With An Excess Of Blasts | 313 | 8 | Melphalan Hydrochloride (PRR 75.1) |
| 6035 | Primary Myelofibrosis | 313 | 6 | Ruxolitinib (PRR 120.5) |
| 6036 | Hepatic Vein Thrombosis | 313 | 2 | Eculizumab (PRR 42.0) |
| 6037 | Breast Cellulitis | 313 | 1 | Pertuzumab (PRR 27.9) |
| 6038 | Tuberculosis Gastrointestinal | 313 | 6 | Pyrazinamide (PRR 192.3) |
| 6039 | Typhoid Fever | 313 | 1 | Thiotepa (PRR 35.4) |
| 6040 | Tongue Spasm | 313 | 1 | Asenapine Maleate (PRR 23.2) |
| 6041 | Right Ventricular Enlargement | 312 | 3 | Selexipag (PRR 85.6) |
| 6042 | Meningococcal Infection | 312 | 2 | Ravulizumab (PRR 213.5) |
| 6043 | Bladder Injury | 312 | 1 | Copper (PRR 22.6) |
| 6044 | Renal Hypertension | 312 | 3 | Inclisiran (PRR 68.3) |
| 6045 | Ventricular Failure | 312 | 2 | Ciclesonide (PRR 257.4) |
| 6046 | Mental Disorder Due To A General Medical Condition | 312 | 2 | Tofacitinib Citrate (PRR 91.4) |
| 6047 | Caustic Injury | 312 | 1 | Chlorhexidine Gluconate (PRR 75.4) |
| 6048 | Nodal Osteoarthritis | 311 | 1 | Tofacitinib (PRR 31.3) |
| 6049 | Device Programming Error | 311 | 4 | Tiotropium Bromide Inhalation Spray (PRR 42.7) |
| 6050 | Urine Calcium Increased | 311 | 3 | Teriparatide (PRR 71.3) |
| 6051 | Bronchial Haemorrhage | 311 | 21 | Theophylline Anhydrous (PRR 313.8) |
| 6052 | Therapeutic Embolisation | 311 | 6 | Sofosbuvir (PRR 72.4) |
| 6053 | Biopsy Breast | 311 | 2 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 47.8) |
| 6054 | Anomaly Of External Ear Congenital | 311 | 5 | Misoprostol (PRR 108.3) |
| 6055 | Feeding Tube Complication | 311 | 1 | Cetuximab (PRR 24.3) |
| 6056 | Serum Ferritin Abnormal | 311 | 6 | Deferasirox (PRR 285.4) |
| 6057 | Muscle Tone Disorder | 311 | 4 | Rabeprazole (PRR 92.8) |
| 6058 | Lacunar Stroke | 311 | 2 | Avapritinib (PRR 28.1) |
| 6059 | Right Ventricular Systolic Pressure Increased | 310 | 10 | Tretinoin (PRR 59.2) |
| 6060 | Hormone Receptor Positive Her2 Negative Breast Cancer | 310 | 11 | Ribociclib (PRR 1,147.9) |
| 6061 | Post Procedural Bile Leak | 310 | 3 | Valganciclovir Hydrochloride Powder, (PRR 51.0) |
| 6062 | Carbon Dioxide Abnormal | 310 | 2 | Amitriptyline Hydrochloride (PRR 56.1) |
| 6063 | Chronic Hepatitis B | 310 | 10 | Tenofovir Disoproxil Fumarate Tablets (PRR 267.7) |
| 6064 | Pituitary Haemorrhage | 310 | 2 | Bicalutamide (PRR 55.0) |
| 6065 | Paraproteinaemia | 309 | 7 | Ixazomib (PRR 86.4) |
| 6066 | Borrelia Infection | 309 | 3 | Bendamustine Hcl (PRR 40.2) |
| 6067 | Allergy To Arthropod Bite | 309 | 3 | Quinapril Hydrochloride (PRR 70.1) |
| 6068 | Wound Infection Pseudomonas | 308 | 11 | Amiodarone Hydrochloride (PRR 171.2) |
| 6069 | Insulin-Requiring Type 2 Diabetes Mellitus | 308 | 7 | Ziprasidone Mesylate (PRR 79.9) |
| 6070 | Antimicrobial Susceptibility Test Resistant | 308 | 14 | Daptomycin (PRR 406.1) |
| 6071 | Mycobacterium Marinum Infection | 308 | 9 | Labetalol (PRR 96.9) |
| 6072 | Apoptosis | 308 | 12 | Mycophenilic Acid (PRR 149.8) |
| 6073 | Coronary Artery Surgery | 308 | 2 | Insulin Human (PRR 64.9) |
| 6074 | Hepatic Ischaemia | 308 | 9 | Quinine (PRR 223.7) |
| 6075 | Angioimmunoblastic T-Cell Lymphoma | 308 | 4 | Brentuximab Vedotin (PRR 260.2) |
| 6076 | Injection Site Hypertrophy | 308 | 4 | Asfotase Alfa (PRR 402.5) |
| 6077 | Retroperitoneal Abscess | 308 | 7 | Valganciclovir Hydrochloride Powder, (PRR 99.6) |
| 6078 | Presbyacusis | 307 | 25 | Trazodone Hydrochloride (PRR 534.4) |
| 6079 | Progesterone Decreased | 307 | 5 | Progesterone (PRR 120.8) |
| 6080 | Tumour Perforation | 307 | 11 | Oxaliplatin (PRR 117.8) |
| 6081 | Disability Assessment Scale Score Increased | 307 | 10 | Tocilizumab (PRR 1,246.7) |
| 6082 | Exposure To Allergen | 307 | 5 | Ciclesonide (PRR 123.7) |
| 6083 | Vascular Compression | 307 | 13 | Valganciclovir (PRR 85.1) |
| 6084 | Coombs Direct Test Positive | 307 | 3 | Human Immunoglobulin G (PRR 117.3) |
| 6085 | Polypoidal Choroidal Vasculopathy | 307 | 3 | Ranibizumab (PRR 1,442.8) |
| 6086 | Malabsorption From Injection Site | 307 | 3 | Naltrexone (PRR 47.0) |
| 6087 | Vaccine Interaction | 306 | 3 | Rituximab (PRR 280.0) |
| 6088 | Gastrointestinal Microorganism Overgrowth | 306 | 9 | Teduglutide (PRR 193.0) |
| 6089 | Skin Operation | 306 | 2 | Risankizumab-Rzaa (PRR 28.6) |
| 6090 | Visual Acuity Reduced Transiently | 306 | 5 | Aflibercept (PRR 239.8) |
| 6091 | Venous Haemorrhage | 306 | 4 | Posaconazole Delayed-Release (PRR 57.4) |
| 6092 | Allergy To Vaccine | 306 | 2 | Meperidine Hydrochloride (PRR 52.9) |
| 6093 | Central Hypothyroidism | 305 | 16 | Mercaptopurine (PRR 135.7) |
| 6094 | Nephritic Syndrome | 305 | 6 | Esomeprazole Magnesium Capsule, Delayed Release (PRR 79.4) |
| 6095 | Myocardial Rupture | 305 | 3 | Prasugrel Hydrochloride (PRR 83.9) |
| 6096 | Trichiasis | 305 | 4 | Bimatoprost (PRR 158.7) |
| 6097 | Corneal Infiltrates | 305 | 9 | Prednisolone Acetate (PRR 187.4) |
| 6098 | Anal Squamous Cell Carcinoma | 305 | 2 | Mycophenilic Acid (PRR 62.9) |
| 6099 | Respiratory Fume Inhalation Disorder | 305 | 3 | Umeclidinium Bromide And Vilanterol Trifenatate (PRR 25.0) |
| 6100 | Uraemic Encephalopathy | 305 | 6 | Cefepime Hydrochloride (PRR 71.5) |
| 6101 | Myxoedema Coma | 305 | 3 | Amiodarone Hydrochloride (PRR 217.6) |
| 6102 | Hypocholesterolaemia | 304 | 97 | Diclofenac Potassium, Film Coated (PRR 1,194.0) |
| 6103 | Incarcerated Hernia | 304 | 5 | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 47.3) |
| 6104 | Aspergillus Test Positive | 304 | 25 | Voriconazole Injection (PRR 140.9) |
| 6105 | Gastroenteritis Rotavirus | 304 | 4 | Palivizumab (PRR 90.3) |
| 6106 | Epidermolysis Bullosa | 304 | 1 | Apalutamide (PRR 23.6) |
| 6107 | Vaginal Lesion | 304 | 3 | Carboxymethylcellulose Sodium (PRR 75.3) |
| 6108 | Analgesic Therapy | 303 | 94 | Phytonadione (PRR 1,722.3) |
| 6109 | Pseudostroke | 303 | 6 | Lanreotide Acetate (PRR 35.5) |
| 6110 | Hyperinsulinaemia | 303 | 1 | Salicylic Acid (PRR 5.3) |
| 6111 | Congenital Choroid Plexus Cyst | 303 | 9 | Darunavir (PRR 102.4) |
| 6112 | Blood Beta-D-Glucan Increased | 303 | 11 | Micafungin Sodium (PRR 173.4) |
| 6113 | Corneal Lesion | 303 | 8 | Nevirapine (PRR 54.5) |
| 6114 | Vaginal Flatulence | 302 | 135 | Carboxymethylcellulose Sodium (PRR 2,666.2) |
| 6115 | Ectopic Pregnancy With Intrauterine Device | 302 | 2 | Levonorgestrel (PRR 2,707.7) |
| 6116 | Relapsing Multiple Sclerosis | 302 | 10 | Ocrelizumab (PRR 202.9) |
| 6117 | Smoke Sensitivity | 302 | 7 | Omalizumab (PRR 249.8) |
| 6118 | Eye Abscess | 302 | 7 | Triamcinolone Acetonide Ointment Usp, 0.05% (PRR 87.2) |
| 6119 | Cornea Verticillata | 302 | 4 | Brimonidine Tartrate (PRR 52.5) |
| 6120 | Retinal Depigmentation | 302 | 6 | Ranibizumab (PRR 186.1) |
| 6121 | Pupillary Light Reflex Tests Abnormal | 302 | 1 | Ranibizumab (PRR 18.6) |
| 6122 | Restrictive Cardiomyopathy | 302 | 15 | Phytonadione (PRR 92.7) |
| 6123 | Fear Of Eating | 302 | 3 | Trimethoprim (PRR 118.5) |
| 6124 | Complications Of Transplanted Lung | 301 | 15 | Basiliximab (PRR 378.0) |
| 6125 | Immune-Mediated Myasthenia Gravis | 301 | 5 | Pembrolizumab (PRR 168.9) |
| 6126 | Hepatectomy | 301 | 9 | Panitumumab (PRR 136.2) |
| 6127 | Scrotal Disorder | 301 | 4 | Finasteride (PRR 55.8) |
| 6128 | Erythropoiesis Abnormal | 301 | 7 | Bendamustine Hydrochloride (PRR 157.3) |
| 6129 | Breast Inflammation | 301 | 5 | Ado-Trastuzumab Emtansine (PRR 58.8) |
| 6130 | Peptic Ulcer Perforation | 301 | 1 | Pemetrexed (PRR 29.9) |
| 6131 | Haemorrhoids Thrombosed | 301 | 3 | Meperidine Hydrochloride (PRR 69.6) |
| 6132 | Lung Injury | 301 | 1 | Gefitinib (PRR 46.9) |
| 6133 | Defiant Behaviour | 300 | 8 | Guanfacine (PRR 110.2) |
| 6134 | Liver Operation | 300 | 4 | Panitumumab (PRR 69.9) |
| 6135 | Subdural Hygroma | 300 | 4 | Blinatumomab (PRR 54.6) |
| 6136 | Metastases To Heart | 300 | 5 | Gefitinib (PRR 47.0) |
| 6137 | Blood Creatine Decreased | 300 | 2 | Fosaprepitant Dimeglumine (PRR 68.5) |
| 6138 | Pericardial Disease | 300 | 2 | Telmisartan (PRR 119.9) |
| 6139 | Erythropenia | 300 | 2 | Mesna Injection (PRR 51.4) |
| 6140 | Joint Laxity | 299 | 15 | Naproxen Sodium Tablet, Coated (PRR 443.6) |
| 6141 | Gastric Hypomotility | 299 | 5 | Oral Semaglutide (PRR 114.0) |
| 6142 | Enterocolitis Viral | 299 | 13 | Thiotepa (PRR 225.1) |
| 6143 | Proctocolectomy | 299 | 6 | Adalimumab-Fkjp (PRR 75.3) |
| 6144 | Hypnagogic Hallucination | 299 | 5 | Sodium Oxybate (PRR 94.4) |
| 6145 | Decreased Eye Contact | 299 | 10 | Ziprasidone (PRR 141.5) |
| 6146 | Teratogenicity | 299 | 10 | Valganciclovir Hydrochloride Powder, (PRR 197.3) |
| 6147 | Pancreatic Injury | 299 | 2 | Pancrelipase (PRR 42.8) |
| 6148 | Retinopathy Hypertensive | 299 | 2 | Entecavir (PRR 55.3) |
| 6149 | Renal Artery Thrombosis | 299 | 5 | Anti-Thymocyte Globulin (Rabbit) (PRR 107.8) |
| 6150 | Hypoprothrombinaemia | 299 | 6 | Cefazolin (PRR 514.0) |
| 6151 | Stoma Closure | 298 | 12 | Cefuroxime (PRR 89.7) |
| 6152 | Semen Discolouration | 298 | 1 | Upadacitinib (PRR 94.9) |
| 6153 | Bladder Tamponade | 298 | 5 | Dalteparin Sodium (PRR 61.2) |
| 6154 | Enterobacter Bacteraemia | 298 | 17 | Posaconazole (PRR 112.1) |
| 6155 | Bone Metabolism Disorder | 298 | 12 | Abacavir Sulfate (PRR 97.4) |
| 6156 | Polychromasia | 298 | 4 | Ribociclib (PRR 68.3) |
| 6157 | Ear Infection Fungal | 298 | 1 | Fexofenadine (PRR 43.7) |
| 6158 | Device Computer Issue | 298 | 1 | Norepinephrine (PRR 33.2) |
| 6159 | Paternal Exposure Before Pregnancy | 297 | 5 | Cladribine (PRR 52.2) |
| 6160 | Eosinophilic Pneumonia Chronic | 297 | 6 | Ciclesonide (PRR 347.1) |
| 6161 | Device Related Bacteraemia | 297 | 12 | Teduglutide (PRR 261.3) |
| 6162 | Biopsy Liver Abnormal | 297 | 6 | Efavirenz (PRR 71.8) |
| 6163 | Transfusion-Related Acute Lung Injury | 297 | 2 | Human Immunoglobulin G (PRR 117.5) |
| 6164 | Bronchospasm Paradoxical | 297 | 2 | Umeclidinium Bromide And Vilanterol Trifenatate (PRR 66.2) |
| 6165 | Impaired Fasting Glucose | 297 | 1 | Ziprasidone Mesylate (PRR 40.4) |
| 6166 | Cytomegalovirus Gastrointestinal Infection | 296 | 15 | Valganciclovir Hydrochloride Powder, (PRR 631.7) |
| 6167 | Double Outlet Right Ventricle | 296 | 4 | Lopinavir And Ritonavir (PRR 81.9) |
| 6168 | Buttock Injury | 296 | 1 | Emicizumab (PRR 28.9) |
| 6169 | Electrocardiogram Qt Shortened | 296 | 2 | Guanfacine (PRR 45.4) |
| 6170 | Wrong Technique In Product Usage Process Performed In Error | 295 | 2 | Albuterol Sulfate (PRR 265.2) |
| 6171 | Retained Placenta Or Membranes | 295 | 2 | Misoprostol (PRR 197.8) |
| 6172 | Lack Of Administration Site Rotation | 295 | 5 | Naltrexone (PRR 172.1) |
| 6173 | Oestradiol Increased | 295 | 6 | Goserelin (PRR 71.4) |
| 6174 | Migraine Without Aura | 295 | 11 | Rizatriptan Benzoate (PRR 164.8) |
| 6175 | Epiphyses Premature Fusion | 295 | 4 | Isotretinoin (PRR 187.3) |
| 6176 | Duodenal Obstruction | 295 | 4 | Gemcitabine (PRR 32.2) |
| 6177 | Frostbite | 295 | 1 | Guselkumab (PRR 12.1) |
| 6178 | Eosinophilic Pleural Effusion | 295 | 5 | Valproic Acid (PRR 112.5) |
| 6179 | Bacterial Test | 295 | 2 | Alemtuzumab (PRR 648.6) |
| 6180 | Aspiration Bronchial | 295 | 1 | Rivastigmine (PRR 63.3) |
| 6181 | Teething | 295 | 1 | Palivizumab (PRR 77.6) |
| 6182 | Protein Deficiency | 295 | 1 | Teduglutide (PRR 37.5) |
| 6183 | Fallopian Tube Disorder | 294 | 6 | Tranexamic Acid (PRR 90.9) |
| 6184 | Idiopathic Pneumonia Syndrome | 294 | 27 | Thiotepa (PRR 404.1) |
| 6185 | Primary Adrenal Insufficiency | 294 | 11 | Posaconazole Delayed-Release (PRR 123.5) |
| 6186 | Joint Space Narrowing | 294 | 7 | Diroximel Fumarate (PRR 61.5) |
| 6187 | Nail Toxicity | 294 | 10 | Pertuzumab (PRR 113.5) |
| 6188 | Therapeutic Drug Monitoring Analysis Not Performed | 294 | 9 | Torsemide (PRR 207.2) |
| 6189 | Hair Injury | 294 | 2 | Minoxidil (PRR 131.2) |
| 6190 | Dental Necrosis | 294 | 1 | Emtricitabine And Tenofovir Alafenamide (PRR 31.7) |
| 6191 | Fibrin Degradation Products Increased | 294 | 2 | Tranexamic Acid (PRR 65.4) |
| 6192 | Lipoprotein (A) Increased | 293 | 8 | Inclisiran (PRR 329.3) |
| 6193 | Vagal Nerve Stimulator Implantation | 293 | 15 | Brivaracetam (PRR 293.7) |
| 6194 | Left-To-Right Cardiac Shunt | 293 | 7 | Ivacaftor (PRR 141.3) |
| 6195 | Implant Site Erosion | 293 | 3 | Baclofen (PRR 95.2) |
| 6196 | Pyomyositis | 293 | 3 | Pegaspargase (PRR 111.2) |
| 6197 | Change In Sustained Attention | 293 | 4 | Lisdexamfetamine Dimesylate (PRR 108.3) |
| 6198 | Feeling Hot And Cold | 293 | 1 | Atomoxetine Hydrochloride (PRR 57.2) |
| 6199 | Extrapulmonary Tuberculosis | 293 | 7 | Isoniazid (PRR 119.7) |
| 6200 | Mesenteric Panniculitis | 293 | 1 | Fremanezumab-Vfrm (PRR 18.7) |
| 6201 | Post Procedural Pneumonia | 293 | 1 | Ado-Trastuzumab Emtansine (PRR 34.2) |
| 6202 | Gastrointestinal Arteriovenous Malformation | 292 | 2 | Dabigatran Etexilate (PRR 25.0) |
| 6203 | Breast Engorgement | 292 | 2 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 33.9) |
| 6204 | Coronary Artery Embolism | 292 | 1 | Rocuronium Bromide (PRR 62.6) |
| 6205 | Vocal Cord Inflammation | 292 | 2 | Bleomycin Sulfate (PRR 64.0) |
| 6206 | Vulvovaginitis | 291 | 5 | Etonogestrel And Ethinyl Estradiol (PRR 40.3) |
| 6207 | Spasmodic Dysphonia | 291 | 9 | Haloperidol Lactate (PRR 157.7) |
| 6208 | Gastrointestinal Mucosa Hyperaemia | 291 | 2 | Vedolizumab (PRR 46.3) |
| 6209 | Poor Dental Condition | 291 | 4 | Glyburide (PRR 63.4) |
| 6210 | Regressive Behaviour | 291 | 4 | Atomoxetine Hydrochloride (PRR 40.8) |
| 6211 | Transient Acantholytic Dermatosis | 291 | 4 | Terbinafine Hydrochloride (PRR 66.2) |
| 6212 | Morganella Infection | 290 | 16 | Atovaquone (PRR 92.3) |
| 6213 | Fungal Endocarditis | 290 | 16 | Amphotericin B (PRR 313.0) |
| 6214 | Pleural Mesothelioma Malignant | 290 | 2 | Pemetrexed (PRR 41.9) |
| 6215 | Injection Site Cyst | 290 | 4 | Naltrexone (PRR 92.5) |
| 6216 | Abdominal Wall Disorder | 290 | 2 | Lanreotide Acetate (PRR 27.7) |
| 6217 | Gallbladder Oedema | 290 | 5 | Pegaspargase (PRR 132.6) |
| 6218 | Infective Exacerbation Of Bronchiectasis | 290 | 11 | Tobramycin (PRR 150.5) |
| 6219 | Hepatitis B Surface Antibody Positive | 290 | 2 | Polatuzumab Vedotin (PRR 22.3) |
| 6220 | Hepatic Artery Thrombosis | 289 | 10 | Tacrolimus (PRR 81.0) |
| 6221 | Psychosexual Disorder | 289 | 2 | Paliperidone Palmitate (PRR 109.8) |
| 6222 | Tissue Infiltration | 289 | 9 | Bleomycin Sulfate (PRR 268.5) |
| 6223 | Alopecia Universalis | 289 | 3 | Baricitinib (PRR 30.3) |
| 6224 | Catheter Site Haematoma | 289 | 2 | Dronedarone (PRR 43.2) |
| 6225 | Coagulation Time Abnormal | 289 | 2 | Heparin Sodium (PRR 88.6) |
| 6226 | Blood 25-Hydroxycholecalciferol Decreased | 288 | 9 | Valganciclovir (PRR 69.2) |
| 6227 | Creutzfeldt-Jakob Disease | 288 | 1 | Somatropin (PRR 21.1) |
| 6228 | Intraductal Papillary Mucinous Neoplasm | 288 | 11 | Amphotericin B (PRR 110.7) |
| 6229 | Autoimmune Neutropenia | 288 | 7 | Alemtuzumab (PRR 173.4) |
| 6230 | Neonatal Behavioural Syndrome | 288 | 3 | Vigabatrin (PRR 62.0) |
| 6231 | Hypouricaemia | 288 | 6 | Busulfan (PRR 77.8) |
| 6232 | Genital Erosion | 288 | 8 | Dalteparin Sodium (PRR 123.4) |
| 6233 | Premature Ageing | 288 | 2 | Bleomycin Sulfate (PRR 57.5) |
| 6234 | Leishmaniasis | 288 | 5 | Amphotericin B (PRR 137.3) |
| 6235 | Device Embolisation | 287 | 1 | Etonogestrel (PRR 922.3) |
| 6236 | Complication Of Delivery | 287 | 6 | Misoprostol (PRR 109.6) |
| 6237 | Bursa Disorder | 287 | 1 | Pirfenidone (PRR 10.9) |
| 6238 | Catheter Site Bruise | 287 | 5 | Epoprostenol (PRR 57.4) |
| 6239 | White Blood Cell Count | 287 | 1 | Acalabrutinib (PRR 30.4) |
| 6240 | Kidney Small | 287 | 1 | Captopril (PRR 78.1) |
| 6241 | Hyperosmolar State | 287 | 1 | Sevoflurane (PRR 62.6) |
| 6242 | Congenital Aplasia | 286 | 40 | Thiotepa (PRR 155.0) |
| 6243 | Graft Dysfunction | 286 | 11 | Anti-Thymocyte Globulin (Rabbit) (PRR 204.4) |
| 6244 | Hyperviscosity Syndrome | 286 | 3 | Bortezomib (PRR 66.8) |
| 6245 | Eye Infection Staphylococcal | 286 | 4 | Aflibercept (PRR 83.9) |
| 6246 | Dilatation Intrahepatic Duct Acquired | 286 | 6 | Voriconazole Injection (PRR 164.8) |
| 6247 | Burkholderia Cepacia Complex Infection | 286 | 13 | Chlorhexidine Gluconate (PRR 143.9) |
| 6248 | Salivary Gland Neoplasm | 286 | 1 | Emicizumab (PRR 23.9) |
| 6249 | Cervix Carcinoma Stage 0 | 285 | 1 | Levonorgestrel (PRR 9.0) |
| 6250 | Malocclusion | 285 | 1 | Somatropin (PRR 13.5) |
| 6251 | Postural Tremor | 285 | 5 | Lithium (PRR 86.3) |
| 6252 | Expressive Language Disorder | 285 | 1 | Valproic Acid (PRR 44.5) |
| 6253 | Ear Tube Insertion | 285 | 1 | Palivizumab (PRR 14.4) |
| 6254 | Agitated Depression | 285 | 3 | Quinine (PRR 125.3) |
| 6255 | Cardio-Respiratory Distress | 285 | 1 | Umeclidinium (PRR 33.1) |
| 6256 | Pulmonary Arterial Pressure Abnormal | 284 | 12 | Epoprostenol (PRR 107.5) |
| 6257 | Bone Development Abnormal | 284 | 3 | Asfotase Alfa (PRR 29.7) |
| 6258 | Diabetic Gangrene | 284 | 6 | Canagliflozin (PRR 148.4) |
| 6259 | Avulsion Fracture | 284 | 7 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate (PRR 49.9) |
| 6260 | Putamen Haemorrhage | 284 | 2 | Ledipasvir And Sofosbuvir (PRR 23.3) |
| 6261 | Enamel Anomaly | 284 | 5 | Anti-Thymocyte Globulin (Rabbit) (PRR 94.1) |
| 6262 | Androgenetic Alopecia | 283 | 2 | Minoxidil Foam 5% (Womens) (PRR 18.3) |
| 6263 | Vascular Encephalopathy | 283 | 4 | Rivastigmine (PRR 130.9) |
| 6264 | Red Blood Cells Urine | 283 | 5 | Alemtuzumab (PRR 161.7) |
| 6265 | Lens Disorder | 283 | 3 | Ranibizumab (PRR 62.8) |
| 6266 | Aversion | 283 | 3 | Lurasidone Hydrochloride (PRR 36.4) |
| 6267 | Systemic Mastocytosis | 283 | 2 | Avapritinib (PRR 282.8) |
| 6268 | Erythema Annulare | 283 | 3 | Terbinafine Hydrochloride (PRR 103.7) |
| 6269 | Bacterial Vulvovaginitis | 282 | 9 | Tofacitinib Citrate (PRR 181.9) |
| 6270 | Engraft Failure | 282 | 20 | Anti-Thymocyte Globulin (Rabbit) (PRR 377.4) |
| 6271 | Dermatophytosis | 282 | 12 | Valganciclovir Hydrochloride Powder, (PRR 144.3) |
| 6272 | Sle Arthritis | 282 | 7 | Belimumab (PRR 283.2) |
| 6273 | Shunt Malfunction | 282 | 6 | Primidone (PRR 114.7) |
| 6274 | Malignant Neoplasm Of Eye | 282 | 1 | Vismodegib (PRR 94.9) |
| 6275 | Percutaneous Coronary Intervention | 281 | 2 | Prasugrel Hydrochloride (PRR 52.3) |
| 6276 | Human Herpesvirus 6 Encephalitis | 281 | 16 | Axicabtagene Ciloleucel (PRR 280.5) |
| 6277 | Malignant Melanoma Stage Iv | 281 | 5 | Dabrafenib (PRR 251.1) |
| 6278 | Blood Corticotrophin Increased | 281 | 4 | Axitinib (PRR 35.3) |
| 6279 | Relapsing Fever | 281 | 3 | Nivolumab (PRR 53.3) |
| 6280 | Colon Dysplasia | 281 | 1 | Vedolizumab (PRR 54.6) |
| 6281 | Metastases To Bladder | 281 | 5 | Abiraterone (PRR 33.3) |
| 6282 | Hepatic Cancer Recurrent | 281 | 7 | Ledipasvir And Sofosbuvir (PRR 206.2) |
| 6283 | Jealous Delusion | 281 | 7 | Pramipexole (PRR 174.4) |
| 6284 | Postoperative Fever | 281 | 1 | Propofol (PRR 55.5) |
| 6285 | Periventricular Leukomalacia | 281 | 7 | Indomethacin (PRR 107.4) |
| 6286 | Chondromalacia | 281 | 2 | Fondaparinux Sodium (PRR 37.1) |
| 6287 | Secondary Hypertension | 281 | 1 | Pemetrexed (PRR 32.1) |
| 6288 | Thyroid Cancer Metastatic | 281 | 2 | Sorafenib (PRR 93.5) |
| 6289 | Cerebellar Haematoma | 281 | 2 | Fondaparinux Sodium (PRR 85.1) |
| 6290 | Burns First Degree | 280 | 2 | Salicylic Acid (PRR 5.7) |
| 6291 | Eyelid Thickening | 280 | 3 | Bimatoprost (PRR 134.5) |
| 6292 | Lymphomatoid Papulosis | 280 | 1 | Brentuximab Vedotin (PRR 44.4) |
| 6293 | Medical Device Site Haemorrhage | 280 | 1 | Dutasteride (PRR 46.5) |
| 6294 | Monoclonal Immunoglobulin Increased | 279 | 10 | Ixazomib (PRR 120.9) |
| 6295 | Carbuncle | 279 | 15 | Fesoterodine Fumarate (PRR 266.4) |
| 6296 | Eye Redness | 279 | 2 | Timolol Maleate (PRR 54.0) |
| 6297 | Colonic Pseudo-Obstruction | 279 | 7 | Dimenhydrinate (PRR 150.8) |
| 6298 | Omphalitis | 279 | 1 | Bimekizumab (PRR 17.8) |
| 6299 | Hypertensive Cardiomyopathy | 279 | 7 | Canakinumab (PRR 140.5) |
| 6300 | Haematoma Evacuation | 279 | 2 | Vilazodone Hydrochloride (PRR 32.8) |
| 6301 | Liver Tenderness | 279 | 2 | Nevirapine (PRR 42.1) |
| 6302 | Increased Dose Administered | 279 | 2 | Cenobamate (PRR 36.3) |
| 6303 | Haemorrhagic Ascites | 279 | 1 | Fondaparinux Sodium (PRR 46.9) |
| 6304 | Red Blood Cell Sedimentation Rate | 278 | 47 | Febuxostat Tablets 40 Mg (PRR 1,464.9) |
| 6305 | Post Cholecystectomy Syndrome | 278 | 15 | Drospirenone And Ethinyl Estradiol (PRR 1,067.1) |
| 6306 | Orthosis User | 278 | 1 | Dalfampridine (PRR 27.3) |
| 6307 | Biopsy Kidney | 278 | 3 | Voclosporin (PRR 117.5) |
| 6308 | Implant Site Inflammation | 278 | 1 | Etonogestrel (PRR 298.0) |
| 6309 | Pneumocystis Jiroveci Infection | 278 | 5 | Zidovudine (PRR 52.0) |
| 6310 | Shoplifting | 277 | 3 | Aripiprazole (PRR 334.3) |
| 6311 | Newborn Persistent Pulmonary Hypertension | 277 | 2 | Misoprostol (PRR 63.5) |
| 6312 | Babesiosis | 277 | 11 | Atovaquone (PRR 729.8) |
| 6313 | Shunt Stenosis | 277 | 10 | Darbepoetin Alfa (PRR 360.9) |
| 6314 | Dairy Intolerance | 277 | 8 | Nintedanib (PRR 40.6) |
| 6315 | Binocular Eye Movement Disorder | 277 | 9 | Rasagiline Mesylate (PRR 210.2) |
| 6316 | Acute Polyneuropathy | 277 | 9 | Brentuximab Vedotin (PRR 99.9) |
| 6317 | Gross Motor Delay | 277 | 3 | Valproate Sodium (PRR 82.5) |
| 6318 | White Blood Cells Urine | 277 | 1 | Alemtuzumab (PRR 92.8) |
| 6319 | Administration Site Erythema | 277 | 2 | Niacin (PRR 95.3) |
| 6320 | Adnexa Uteri Mass | 276 | 5 | Fulvestrant (PRR 71.0) |
| 6321 | Anaplastic Large Cell Lymphoma T- And Null-Cell Types | 276 | 6 | Brentuximab Vedotin (PRR 493.7) |
| 6322 | Genital Paraesthesia | 276 | 2 | Finasteride (PRR 93.5) |
| 6323 | Cerebral Fungal Infection | 276 | 10 | Voriconazole Injection (PRR 95.4) |
| 6324 | Merycism | 276 | 9 | Captopril (PRR 115.6) |
| 6325 | Cor Pulmonale Acute | 276 | 2 | Canakinumab (PRR 28.3) |
| 6326 | Limbic Encephalitis | 276 | 3 | Atezolizumab (PRR 39.6) |
| 6327 | Metastases To Neck | 276 | 6 | Ribociclib (PRR 105.1) |
| 6328 | Sudden Visual Loss | 276 | 2 | Aflibercept (PRR 54.9) |
| 6329 | Penile Discharge | 276 | 1 | Atomoxetine Hydrochloride (PRR 83.2) |
| 6330 | Catheter Site Cellulitis | 276 | 2 | Epoprostenol (PRR 201.1) |
| 6331 | Lymphocyte Adoptive Therapy | 276 | 1 | Axicabtagene Ciloleucel (PRR 1,334.7) |
| 6332 | Immature Granulocyte Count Increased | 275 | 3 | Alemtuzumab (PRR 84.3) |
| 6333 | Atopy | 275 | 14 | Ciclesonide (PRR 453.8) |
| 6334 | Platelet Dysfunction | 275 | 1 | Imatinib (PRR 63.2) |
| 6335 | Angiogram | 275 | 1 | Ranolazine (PRR 59.7) |
| 6336 | Iliac Artery Occlusion | 275 | 1 | Travoprost (PRR 26.5) |
| 6337 | Medical Device Monitoring Error | 274 | 1 | Levonorgestrel (PRR 1,233.1) |
| 6338 | Application Site Mass | 274 | 3 | Granisetron (PRR 52.0) |
| 6339 | Anticoagulant Therapy | 274 | 57 | Phytonadione (PRR 1,047.4) |
| 6340 | Non-Small Cell Lung Cancer Recurrent | 274 | 9 | Durvalumab (PRR 298.9) |
| 6341 | Mitral Valve Thickening | 274 | 8 | Eplerenone (PRR 134.8) |
| 6342 | Clinodactyly | 274 | 3 | Misoprostol (PRR 141.3) |
| 6343 | Gastrointestinal Ischaemia | 274 | 5 | Norepinephrine (PRR 51.0) |
| 6344 | Hypoaldosteronism | 274 | 2 | Heparin Sodium (PRR 125.5) |
| 6345 | Intestinal Diaphragm Disease | 273 | 9 | Diclofenac (PRR 114.5) |
| 6346 | Ventilation Perfusion Mismatch | 273 | 15 | Salmeterol Xinafoate (PRR 222.1) |
| 6347 | Lymphocytic Hypophysitis | 273 | 8 | Ipilimumab (PRR 521.6) |
| 6348 | Dermal Absorption Impaired | 273 | 5 | Methylphenidate (PRR 85.3) |
| 6349 | Product Impurity | 273 | 3 | Valsartan Oral (PRR 87.8) |
| 6350 | Enterocolitis Bacterial | 273 | 2 | Daratumumab (PRR 26.0) |
| 6351 | Poikilocytosis | 273 | 3 | Ribociclib (PRR 123.1) |
| 6352 | Central Nervous System Necrosis | 273 | 7 | Thiotepa (PRR 82.8) |
| 6353 | Cardiac Septal Hypertrophy | 273 | 2 | Paliperidone (PRR 26.9) |
| 6354 | Chronic Obstructive Airways Disease | 273 | 1 | Dofetilide (PRR 29.4) |
| 6355 | Anaemia Of Malignant Disease | 273 | 4 | Prochlorperazine Maleate (PRR 50.7) |
| 6356 | Oestrogen Deficiency | 272 | 1 | Denosumab (PRR 34.6) |
| 6357 | Inspiratory Capacity Decreased | 272 | 32 | Phenytoin (PRR 552.3) |
| 6358 | Ductal Adenocarcinoma Of Pancreas | 272 | 7 | Oxaliplatin (PRR 189.8) |
| 6359 | Genital Blister | 272 | 2 | Miconazole Nitrate (PRR 100.5) |
| 6360 | Parathyroid Tumour | 272 | 1 | Cinacalcet Hydrochloride (PRR 22.4) |
| 6361 | Asbestosis | 272 | 2 | Umeclidinium Bromide And Vilanterol Trifenatate (PRR 42.6) |
| 6362 | Hepatitis B Surface Antigen Positive | 272 | 5 | Entecavir (PRR 133.8) |
| 6363 | Atrial Enlargement | 272 | 5 | Eplerenone (PRR 296.6) |
| 6364 | Excitability | 272 | 1 | Atomoxetine Hydrochloride (PRR 226.5) |
| 6365 | Spinal Cord Abscess | 272 | 3 | Chlorthalidone (PRR 75.5) |
| 6366 | Blood Cholinesterase Decreased | 272 | 3 | Rivastigmine (PRR 121.6) |
| 6367 | Moraxella Infection | 272 | 9 | Amphotericin B (PRR 76.6) |
| 6368 | Microphthalmos | 272 | 2 | Misoprostol (PRR 48.2) |
| 6369 | Uterine Contractions Abnormal | 271 | 2 | Misoprostol (PRR 116.4) |
| 6370 | Syringomyelia | 271 | 2 | Raltegravir (PRR 48.3) |
| 6371 | Pancreatic Duct Dilatation | 271 | 3 | Dorzolamide Hydrochloride And Timolol Maleate (PRR 49.5) |
| 6372 | Renin Increased | 271 | 4 | Doxazosin (PRR 92.5) |
| 6373 | Onychophagia | 271 | 1 | Lisdexamfetamine Dimesylate (PRR 75.5) |
| 6374 | Loose Stools | 271 | 1 | Orlistat (PRR 15.1) |
| 6375 | Labile Hypertension | 271 | 4 | Captopril (PRR 126.8) |
| 6376 | Culture Stool Positive | 271 | 1 | Fosaprepitant Dimeglumine (PRR 40.1) |
| 6377 | Bulbar Palsy | 271 | 1 | Ravulizumab (PRR 59.0) |
| 6378 | Ureteric Dilatation | 271 | 1 | Basiliximab (PRR 60.8) |
| 6379 | Agonal Respiration | 271 | 2 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 252.4) |
| 6380 | Total Lung Capacity Increased | 270 | 55 | Ciclesonide (PRR 2,515.3) |
| 6381 | Malignant Melanoma Stage I | 270 | 2 | Tadalafil (PRR 116.0) |
| 6382 | Intestinal Anastomosis Complication | 270 | 2 | Vedolizumab (PRR 56.0) |
| 6383 | Bile Acid Malabsorption | 270 | 5 | Cholestyramine (PRR 160.2) |
| 6384 | American Trypanosomiasis | 270 | 7 | Axicabtagene Ciloleucel (PRR 81.1) |
| 6385 | Foetal Macrosomia | 270 | 3 | Ivacaftor (PRR 165.0) |
| 6386 | Palpable Purpura | 270 | 2 | Brimonidine Tartrate (PRR 68.7) |
| 6387 | Dental Plaque | 270 | 1 | Lifitegrast (PRR 14.3) |
| 6388 | Colon Cancer Recurrent | 270 | 3 | Regorafenib (PRR 135.6) |
| 6389 | Varicose Ulceration | 270 | 1 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 28.3) |
| 6390 | Arterial Stent Insertion | 270 | 1 | Ranolazine (PRR 45.3) |
| 6391 | Uterine Hypertonus | 270 | 1 | Misoprostol (PRR 189.5) |
| 6392 | Mucosal Toxicity | 269 | 10 | Thiotepa (PRR 119.6) |
| 6393 | Deja Vu | 269 | 7 | Cenobamate (PRR 86.3) |
| 6394 | Coombs Test Positive | 269 | 1 | Eculizumab (PRR 42.6) |
| 6395 | Carcinoma | 269 | 2 | Thalidomide (PRR 47.9) |
| 6396 | Retinal Operation | 269 | 1 | Aflibercept (PRR 44.9) |
| 6397 | Overgrowth Bacterial | 269 | 4 | Teduglutide (PRR 223.3) |
| 6398 | Cerebral Calcification | 269 | 2 | Raltegravir (PRR 48.6) |
| 6399 | Duodenogastric Reflux | 268 | 3 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 27.6) |
| 6400 | Cutis Laxa | 268 | 2 | Ranibizumab (PRR 91.4) |
| 6401 | Sars-Cov-2 Antibody Test Positive | 268 | 14 | Amphotericin B (PRR 126.7) |
| 6402 | Hypercalcaemia Of Malignancy | 268 | 3 | Gemcitabine (PRR 35.7) |
| 6403 | Solar Dermatitis | 268 | 3 | Vemurafenib (PRR 139.6) |
| 6404 | Scleral Disorder | 268 | 2 | Prednisolone Acetate (PRR 86.1) |
| 6405 | Ear Infection Bacterial | 268 | 1 | Infliximab-Dyyb (PRR 200.7) |
| 6406 | Foetal Arrhythmia | 268 | 4 | Zidovudine (PRR 54.1) |
| 6407 | Hyperadrenocorticism | 268 | 3 | Ritonavir 100 Mg (PRR 48.4) |
| 6408 | Infusion Site Thrombosis | 268 | 2 | Iron Sucrose (PRR 67.1) |
| 6409 | Gonorrhoea | 267 | 8 | Cabotegravir (PRR 69.4) |
| 6410 | Anticipatory Anxiety | 267 | 14 | Desoximetasone (PRR 632.9) |
| 6411 | Xeroderma | 267 | 9 | Panitumumab (PRR 254.9) |
| 6412 | Victim Of Abuse | 267 | 2 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 30.1) |
| 6413 | Arteriovenous Fistula Operation | 267 | 9 | Patiromer (PRR 95.8) |
| 6414 | Anion Gap Abnormal | 267 | 5 | Tenofovir Disoproxil Fumarate Tablets (PRR 64.9) |
| 6415 | Congenital Eye Disorder | 267 | 2 | Misoprostol (PRR 57.5) |
| 6416 | Chemical Burns Of Eye | 267 | 2 | Carboxymethylcellulose Sodium (PRR 42.2) |
| 6417 | Intra-Uterine Contraceptive Device Removal | 266 | 1 | Levonorgestrel (PRR 367.1) |
| 6418 | Catheterisation Cardiac Abnormal | 266 | 8 | Epoprostenol (PRR 88.3) |
| 6419 | Growth Disorder | 266 | 3 | Somatropin (PRR 33.2) |
| 6420 | Congenital Renal Disorder | 266 | 2 | Valsartan Oral (PRR 69.6) |
| 6421 | Spinal Muscular Atrophy | 266 | 12 | Gentamicin (PRR 136.3) |
| 6422 | Deposit Eye | 266 | 5 | Amiodarone Hydrochloride (PRR 201.1) |
| 6423 | Peritoneal Effluent Abnormal | 266 | 3 | Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose (PRR 310.7) |
| 6424 | Haemosiderosis | 266 | 4 | Deferasirox (PRR 159.6) |
| 6425 | Retinogram Abnormal | 266 | 4 | Vigabatrin (PRR 1,053.9) |
| 6426 | Catheter Site Thrombosis | 266 | 6 | Epoprostenol (PRR 95.0) |
| 6427 | Csf Pressure Increased | 266 | 5 | Prednisolone Acetate (PRR 70.4) |
| 6428 | Paternal Exposure Timing Unspecified | 266 | 1 | Bleomycin Sulfate (PRR 38.6) |
| 6429 | Capillaritis | 265 | 56 | Dutasteride (PRR 716.9) |
| 6430 | Genitourinary Tract Infection | 265 | 1 | Canagliflozin (PRR 21.6) |
| 6431 | Lentigo Maligna | 265 | 3 | Bendamustine Hcl (PRR 41.7) |
| 6432 | Body Temperature | 265 | 3 | Budesonide, Glycopyrrolate, And Formoterol Fumarate (PRR 46.1) |
| 6433 | Hepatitis C Antibody Positive | 265 | 1 | Methadone Hydrochloride (PRR 44.5) |
| 6434 | Eczema Infected | 265 | 1 | Crisaborole (PRR 33.2) |
| 6435 | Nasal Neoplasm | 265 | 1 | Vismodegib (PRR 35.8) |
| 6436 | Contrast Encephalopathy | 265 | 1 | Iohexol (PRR 703.0) |
| 6437 | Coagulation Factor Decreased | 265 | 1 | Fondaparinux Sodium (PRR 49.4) |
| 6438 | Basophil Count Decreased | 264 | 1 | Fingolimod Hcl (PRR 29.6) |
| 6439 | Genital Anaesthesia | 264 | 2 | Escitslopram (PRR 81.3) |
| 6440 | Antithrombin Iii Decreased | 264 | 12 | Pegaspargase (PRR 457.4) |
| 6441 | Crime | 264 | 3 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 48.3) |
| 6442 | Gastrointestinal Tract Mucosal Pigmentation | 264 | 6 | Atovaquone (PRR 101.7) |
| 6443 | Intestinal Malrotation | 264 | 3 | Indapamide (PRR 90.0) |
| 6444 | Confabulation | 264 | 4 | Ganciclovir (PRR 88.4) |
| 6445 | Thoracic Outlet Syndrome | 264 | 1 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 46.6) |
| 6446 | Loose Body In Joint | 263 | 13 | Naproxen Sodium Tablet, Coated (PRR 212.8) |
| 6447 | Exposure To Contaminated Device | 263 | 3 | Risperidone (PRR 156.7) |
| 6448 | Pulmonary Hypertensive Crisis | 263 | 12 | Sildenafil Powder, (PRR 211.8) |
| 6449 | Proctectomy | 263 | 2 | Panitumumab (PRR 36.3) |
| 6450 | Non-High-Density Lipoprotein Cholesterol Increased | 263 | 3 | Inclisiran (PRR 70.9) |
| 6451 | Pancreatic Steatosis | 263 | 9 | Amiodarone Hydrochloride (PRR 177.9) |
| 6452 | Respiratory Moniliasis | 263 | 2 | Azacitidine For (PRR 26.7) |
| 6453 | Listeria Sepsis | 263 | 9 | Alemtuzumab (PRR 108.0) |
| 6454 | Tuberculosis Of Central Nervous System | 263 | 10 | Pyrazinamide (PRR 445.0) |
| 6455 | Facial Wasting | 263 | 12 | Abacavir Sulfate (PRR 138.3) |
| 6456 | Hyperproteinaemia | 263 | 1 | Pertuzumab (PRR 33.4) |
| 6457 | Instillation Site Discharge | 263 | 2 | Lifitegrast (PRR 1,035.9) |
| 6458 | Oxygen Saturation | 263 | 3 | Sevoflurane (PRR 58.4) |
| 6459 | Growing Pains | 262 | 3 | Abaloparatide (PRR 84.5) |
| 6460 | Central Pain Syndrome | 262 | 8 | Ketoprofen (PRR 76.1) |
| 6461 | Retinitis Pigmentosa | 262 | 2 | Docetaxel Anhydrous (PRR 32.5) |
| 6462 | Varicocele | 262 | 2 | Finasteride (PRR 198.9) |
| 6463 | Spermatozoa Abnormal | 262 | 2 | Finasteride (PRR 85.2) |
| 6464 | Oedematous Kidney | 262 | 4 | Basiliximab (PRR 186.6) |
| 6465 | Cytotoxic Oedema | 262 | 5 | Dextrose (PRR 56.2) |
| 6466 | Ocular Surface Disease | 261 | 6 | Brimonidine Tartrate (PRR 243.2) |
| 6467 | Prolonged Expiration | 261 | 34 | Quinapril Hydrochloride (PRR 804.4) |
| 6468 | Scrotal Ulcer | 261 | 7 | Atovaquone (PRR 113.7) |
| 6469 | Graft Thrombosis | 261 | 8 | Basiliximab (PRR 179.1) |
| 6470 | Gastrointestinal Procedural Complication | 261 | 8 | Calcium Gluconate (PRR 120.3) |
| 6471 | Hyperhomocysteinaemia | 261 | 1 | Indapamide (PRR 65.8) |
| 6472 | Colonic Obstruction | 261 | 1 | Irinotecan Hydrochloride (PRR 31.6) |
| 6473 | Nasal Septum Disorder | 261 | 1 | Amphetamine (PRR 49.1) |
| 6474 | Hormone Receptor Positive Breast Cancer | 260 | 14 | Exemestane (PRR 131.4) |
| 6475 | Prostatic Abscess | 260 | 2 | Dapagliflozin (PRR 40.5) |
| 6476 | Bone Marrow Reticulin Fibrosis | 260 | 3 | Romiplostim (PRR 1,130.3) |
| 6477 | Red Blood Cell Sedimentation Rate Decreased | 260 | 7 | Methylprednisolone Acetate (PRR 170.4) |
| 6478 | Cholangitis Infective | 259 | 14 | Durvalumab (PRR 99.6) |
| 6479 | Hypophosphataemic Osteomalacia | 259 | 6 | Tenofovir Disoproxil Fumarate Tablets (PRR 223.7) |
| 6480 | Chillblains | 259 | 2 | Ixazomib (PRR 23.0) |
| 6481 | Apnoea Neonatal | 259 | 3 | Oseltamivir Phosphate (PRR 30.6) |
| 6482 | Symblepharon | 259 | 3 | Carboxymethylcellulose Sodium (PRR 107.6) |
| 6483 | Epiglottic Oedema | 259 | 1 | Sevoflurane (PRR 29.3) |
| 6484 | Short Stature | 258 | 21 | Canakinumab (PRR 462.2) |
| 6485 | Heart Failure With Preserved Ejection Fraction | 258 | 14 | Calcitriol Capsules 0.25 Mcg (PRR 371.3) |
| 6486 | Metastases To Soft Tissue | 258 | 14 | Febuxostat Tablets 40 Mg (PRR 108.6) |
| 6487 | Cholesterosis | 258 | 2 | Drospirenone And Ethinyl Estradiol (PRR 1,287.3) |
| 6488 | Beta 2 Microglobulin Increased | 258 | 10 | Brentuximab Vedotin (PRR 116.5) |
| 6489 | Immunoglobulins Abnormal | 258 | 2 | Human Immunoglobulin G (PRR 112.9) |
| 6490 | Narcotic Intoxication | 258 | 2 | Fentanyl Citrate (PRR 82.1) |
| 6491 | Drug Interaction Potentiation | 258 | 2 | Gefitinib (PRR 27.1) |
| 6492 | Mononucleosis Syndrome | 257 | 3 | Rifampicin (PRR 57.6) |
| 6493 | Dandy-Walker Syndrome | 257 | 10 | Nevirapine (PRR 642.5) |
| 6494 | Human Immunodeficiency Virus Transmission | 257 | 11 | Nevirapine (PRR 2,150.1) |
| 6495 | Oscillopsia | 257 | 7 | Gentamicin Sulfate (PRR 117.1) |
| 6496 | Infestation | 257 | 2 | Naltrexone (PRR 82.4) |
| 6497 | Pharyngitis Bacterial | 257 | 1 | Infliximab-Dyyb (PRR 73.2) |
| 6498 | Eyelid Operation | 257 | 2 | Carboxymethylcellulose Sodium (PRR 71.1) |
| 6499 | Pachymeningitis | 257 | 1 | Encorafenib (PRR 24.8) |
| 6500 | Aorta Hypoplasia | 257 | 1 | Dolutegravir Sodium (PRR 45.8) |
| 6501 | Bacteroides Infection | 256 | 41 | Phytonadione (PRR 440.8) |
| 6502 | Chest Wall Mass | 256 | 7 | Anastrozole Tablets (PRR 91.1) |
| 6503 | Airway Complication Of Anaesthesia | 256 | 7 | Rocuronium Bromide (PRR 279.6) |
| 6504 | Epiretinal Membrane | 256 | 4 | Faricimab (PRR 115.3) |
| 6505 | Eye Haematoma | 256 | 4 | Dutasteride (PRR 61.4) |
| 6506 | Erythema Infectiosum | 256 | 1 | Palivizumab (PRR 16.1) |
| 6507 | Congenital Hypothyroidism | 256 | 2 | Methimazole (PRR 63.6) |
| 6508 | Chronic Gastrointestinal Bleeding | 255 | 1 | Rivaroxaban (PRR 75.1) |
| 6509 | Postpartum Depression | 255 | 1 | Levonorgestrel (PRR 15.7) |
| 6510 | Generalised Pustular Psoriasis | 255 | 9 | Terbinafine Hydrochloride (PRR 95.6) |
| 6511 | Epileptic Aura | 255 | 4 | Extended Phenytoin Sodium (PRR 83.2) |
| 6512 | Malignant Catatonia | 255 | 8 | Haloperidol Lactate (PRR 241.8) |
| 6513 | Antidepressant Drug Level Above Therapeutic | 255 | 7 | Trazodone Hydrochloride (PRR 83.1) |
| 6514 | Abdominal Wall Haemorrhage | 255 | 15 | Amphotericin B (PRR 118.6) |
| 6515 | Herpes Zoster Reactivation | 255 | 7 | Mesna Injection (PRR 102.8) |
| 6516 | Chromosome Analysis Abnormal | 255 | 5 | Imatinib (PRR 273.4) |
| 6517 | Anal Infection | 255 | 2 | Azacitidine For (PRR 41.8) |
| 6518 | Eyelid Cyst | 255 | 1 | Bimatoprost (PRR 32.5) |
| 6519 | Dumping Syndrome | 255 | 2 | Teduglutide (PRR 117.2) |
| 6520 | Glomerulonephropathy | 255 | 4 | Basiliximab (PRR 79.7) |
| 6521 | Leukaemoid Reaction | 255 | 4 | Daspone (PRR 96.3) |
| 6522 | Tri-Iodothyronine Free Decreased | 254 | 5 | Alemtuzumab (PRR 91.9) |
| 6523 | Post 5-Alpha-Reductase Inhibitor Syndrome | 254 | 4 | Finasteride (PRR 21,498.5) |
| 6524 | Fistula Repair | 254 | 3 | Cinacalcet Hydrochloride (PRR 20.2) |
| 6525 | Fine Motor Delay | 254 | 2 | Valproate Sodium (PRR 109.8) |
| 6526 | Gastrointestinal Lymphoma | 254 | 3 | Cladribine (PRR 70.4) |
| 6527 | Uterine Atony | 254 | 2 | Misoprostol (PRR 297.0) |
| 6528 | Neovascularisation | 253 | 18 | Rizatriptan Benzoate (PRR 649.8) |
| 6529 | Adenoidal Disorder | 253 | 3 | Asfotase Alfa (PRR 24.9) |
| 6530 | Budd-Chiari Syndrome | 253 | 2 | Eculizumab (PRR 89.5) |
| 6531 | Rib Deformity | 253 | 4 | Ciclesonide (PRR 312.7) |
| 6532 | Venous Stenosis | 253 | 2 | Paricalcitol (PRR 48.1) |
| 6533 | Urticaria Papular | 253 | 1 | Iohexol (PRR 50.6) |
| 6534 | Peritoneal Adhesions | 252 | 3 | Levonorgestrel (PRR 29.9) |
| 6535 | Monkeypox | 252 | 11 | Valganciclovir Hydrochloride Powder, (PRR 131.2) |
| 6536 | Laparoscopy | 252 | 2 | Copper (PRR 90.9) |
| 6537 | Glaucoma Surgery | 252 | 8 | Dorzolamide Hydrochloride And Timolol Maleate (PRR 251.8) |
| 6538 | Microscopic Polyangiitis | 252 | 1 | Pirfenidone (PRR 14.6) |
| 6539 | Autophobia | 252 | 1 | Lurasidone Hydrochloride (PRR 28.4) |
| 6540 | Adamts13 Activity Decreased | 252 | 1 | Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate (PRR 23.2) |
| 6541 | Purpura Fulminans | 252 | 2 | Amphetamine (PRR 40.6) |
| 6542 | Mycobacterium Haemophilum Infection | 251 | 12 | Basiliximab (PRR 178.4) |
| 6543 | Bacterial Endophthalmitis | 251 | 6 | Aflibercept (PRR 178.3) |
| 6544 | Nipple Swelling | 251 | 8 | Hydrocortisone Sodium Succinate (PRR 289.1) |
| 6545 | Delayed Puberty | 251 | 3 | Ifosfamide (PRR 83.8) |
| 6546 | Hyponatraemic Seizure | 251 | 5 | Indapamide (PRR 151.6) |
| 6547 | Anti-Erythropoietin Antibody Positive | 251 | 12 | Epoetin Alfa (PRR 1,033.6) |
| 6548 | Metastases To Thorax | 251 | 13 | Fulvestrant (PRR 144.9) |
| 6549 | B-Cell Aplasia | 251 | 8 | Axicabtagene Ciloleucel (PRR 423.6) |
| 6550 | Mean Arterial Pressure Decreased | 251 | 6 | Norepinephrine Bitartrate (PRR 111.6) |
| 6551 | Anorectal Infection | 251 | 3 | Azacitidine For (PRR 52.4) |
| 6552 | Corneal Thinning | 251 | 6 | Prednisolone Acetate (PRR 127.8) |
| 6553 | Breast Disorder Female | 251 | 1 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 21.6) |
| 6554 | Rapid Correction Of Hyponatraemia | 251 | 1 | Tolvaptan (PRR 6,212.1) |
| 6555 | Superficial Spreading Melanoma Stage Unspecified | 251 | 1 | Vemurafenib (PRR 42.4) |
| 6556 | Inguinal Mass | 251 | 1 | Polatuzumab Vedotin (PRR 52.2) |
| 6557 | Device Allergy | 250 | 3 | Copper (PRR 44.2) |
| 6558 | Intestinal Sepsis | 250 | 11 | Canakinumab (PRR 468.7) |
| 6559 | Primary Amyloidosis | 250 | 7 | Bortezomib (PRR 259.2) |
| 6560 | Left Ventricular Enlargement | 250 | 6 | Eplerenone (PRR 133.6) |
| 6561 | Acute Myelomonocytic Leukaemia | 250 | 7 | Bleomycin Sulfate (PRR 137.7) |
| 6562 | Cavernous Sinus Thrombosis | 250 | 3 | Pegaspargase (PRR 41.8) |
| 6563 | Chronic Disease | 250 | 3 | Lamivudine Oral (PRR 75.4) |
| 6564 | Urinary Bladder Rupture | 250 | 2 | Carisoprodol (PRR 69.6) |
| 6565 | Thunderclap Headache | 250 | 5 | Dorzolamide Hydrochloride And Timolol Maleate (PRR 87.0) |
| 6566 | Spinal Cord Injury Cervical | 250 | 3 | Baricitinib (PRR 157.4) |
| 6567 | Ichthyosis | 250 | 3 | Acetylcysteine (PRR 82.4) |
| 6568 | Keratosis Pilaris | 249 | 4 | Vemurafenib (PRR 273.7) |
| 6569 | Injection Site Streaking | 249 | 2 | Teriparatide (PRR 40.5) |
| 6570 | Cutaneous Leishmaniasis | 249 | 3 | Adalimumab-Fkjp (PRR 148.6) |
| 6571 | Liver Carcinoma Ruptured | 249 | 6 | Sorafenib (PRR 214.9) |
| 6572 | Encephalocele | 249 | 6 | Nevirapine (PRR 137.4) |
| 6573 | Neonatal Seizure | 249 | 7 | Phenobarbital (PRR 79.1) |
| 6574 | Chest Wall Haematoma | 249 | 1 | Remdesivir (PRR 38.5) |
| 6575 | Intubation | 249 | 2 | Theophylline (PRR 175.4) |
| 6576 | Obsessive-Compulsive Personality Disorder | 249 | 2 | Rasagiline Mesylate (PRR 128.3) |
| 6577 | Meningorrhagia | 249 | 1 | Faricimab (PRR 63.4) |
| 6578 | Application Site Bleeding | 248 | 4 | Glycerin, Lidocaine (PRR 329.3) |
| 6579 | Escherichia Pyelonephritis | 248 | 3 | Pegaspargase (PRR 117.2) |
| 6580 | Fungal Pharyngitis | 248 | 4 | Atovaquone (PRR 53.2) |
| 6581 | Skull Fractured Base | 248 | 1 | Emicizumab (PRR 20.6) |
| 6582 | Rectal Ulcer Haemorrhage | 248 | 1 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 30.9) |
| 6583 | Device Wireless Communication Issue | 247 | 21 | Treprostinil (PRR 13,408.8) |
| 6584 | Myoglobin Urine Present | 247 | 13 | Sevoflurane (PRR 912.8) |
| 6585 | Child Abuse | 247 | 22 | Dimenhydrinate (PRR 434.9) |
| 6586 | Vitamin B1 Decreased | 247 | 10 | Norepinephrine (PRR 289.7) |
| 6587 | Cheyne-Stokes Respiration | 247 | 2 | Rocuronium Bromide (PRR 51.5) |
| 6588 | Retinal Neovascularisation | 247 | 3 | Ranibizumab (PRR 240.3) |
| 6589 | Keratomileusis | 247 | 3 | Carboxymethylcellulose Sodium (PRR 163.6) |
| 6590 | Injection Site Stinging | 246 | 1 | Teriparatide (PRR 134.5) |
| 6591 | Epiphysiolysis | 246 | 2 | Somatropin (PRR 160.0) |
| 6592 | Ventricular Hypoplasia | 246 | 6 | Darunavir (PRR 169.5) |
| 6593 | Somatic Delusion | 246 | 3 | Terbinafine Hydrochloride (PRR 276.8) |
| 6594 | Gastric Mucosal Hypertrophy | 246 | 1 | Teduglutide (PRR 51.9) |
| 6595 | Spinal Instability | 245 | 7 | Canakinumab (PRR 228.3) |
| 6596 | Thrombin Time Prolonged | 245 | 2 | Dabigatran Etexilate Mesylate (PRR 278.7) |
| 6597 | Acetonaemia | 245 | 5 | Olanzapine Pamoate (PRR 146.9) |
| 6598 | Withdrawal Bleeding Irregular | 245 | 2 | Drospirenone And Ethinyl Estradiol (PRR 2,819.8) |
| 6599 | Leukaemic Infiltration Extramedullary | 245 | 5 | Blinatumomab (PRR 6,147.7) |
| 6600 | Eye Complication Associated With Device | 245 | 3 | Aflibercept (PRR 79.1) |
| 6601 | Adenotonsillectomy | 245 | 3 | Etonogestrel And Ethinyl Estradiol (PRR 39.9) |
| 6602 | Dyscalculia | 245 | 2 | Valproate Sodium (PRR 124.6) |
| 6603 | Electrocardiogram P Wave Abnormal | 245 | 5 | Calcium Gluconate (PRR 73.5) |
| 6604 | Paranasal Sinus Hyposecretion | 245 | 4 | Loratadine And Pseudoephedrine Sulfate (PRR 32.4) |
| 6605 | Vessel Puncture Site Haemorrhage | 245 | 1 | Prasugrel Hydrochloride (PRR 243.1) |
| 6606 | Lack Of Satiety | 244 | 5 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 40.7) |
| 6607 | Oral Torus | 244 | 2 | Alendronate Sodium (PRR 1,464.2) |
| 6608 | Incision Site Discharge | 244 | 1 | Risankizumab-Rzaa (PRR 28.9) |
| 6609 | Cardiac Valve Replacement Complication | 244 | 2 | Dabigatran Etexilate (PRR 38.9) |
| 6610 | Victim Of Child Abuse | 244 | 19 | Dimenhydrinate (PRR 478.1) |
| 6611 | Blood Luteinising Hormone Increased | 244 | 2 | Busulfan (PRR 111.6) |
| 6612 | Self-Consciousness | 244 | 4 | Desoximetasone (PRR 51.5) |
| 6613 | Chemical Submission | 244 | 9 | Ethyl Alcohol (PRR 238.6) |
| 6614 | Diabetic Vascular Disorder | 244 | 3 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 104.6) |
| 6615 | Retinal Infarction | 244 | 2 | Cefuroxime (PRR 255.1) |
| 6616 | Hyperdynamic Left Ventricle | 244 | 8 | Norepinephrine Bitartrate (PRR 143.2) |
| 6617 | Anomalous Pulmonary Venous Connection | 244 | 2 | Atazanavir (PRR 42.7) |
| 6618 | Microcytosis | 244 | 1 | Asenapine Maleate (PRR 29.9) |
| 6619 | Swollen Joint Count | 243 | 106 | Diclofenac Potassium, Film Coated (PRR 1,977.9) |
| 6620 | Tubo-Ovarian Abscess | 243 | 3 | Rifampicin (PRR 88.3) |
| 6621 | Activated Partial Thromboplastin Time Abnormal | 243 | 6 | Febuxostat Tablets 40 Mg (PRR 115.6) |
| 6622 | Foreign Body Reaction | 243 | 1 | Etonogestrel (PRR 22.6) |
| 6623 | Acute Hiv Infection | 243 | 8 | Emtricitabine And Tenofovir Disoproxil Fumarate (PRR 272.6) |
| 6624 | Plantar Erythema | 243 | 3 | Regorafenib (PRR 196.4) |
| 6625 | Infected Neoplasm | 243 | 7 | Sirolimus (PRR 169.2) |
| 6626 | Cytomegalovirus Gastritis | 242 | 10 | Ganciclovir Sodium (PRR 354.8) |
| 6627 | Renal Amyloidosis | 242 | 4 | Basiliximab (PRR 84.2) |
| 6628 | Vascular Access Site Complication | 242 | 5 | Adrenalinum (PRR 323.5) |
| 6629 | Alcohol Problem | 242 | 3 | Ethyl Alcohol (PRR 54.2) |
| 6630 | Schizophreniform Disorder | 242 | 3 | Paliperidone (PRR 42.5) |
| 6631 | Neuroendocrine Carcinoma Metastatic | 242 | 2 | Octreotide Acetate (PRR 130.3) |
| 6632 | Myeloproliferative Disorder | 242 | 2 | Romiplostim (PRR 84.8) |
| 6633 | Post Viral Fatigue Syndrome | 242 | 2 | Cannabidiol (PRR 46.4) |
| 6634 | Oesophageal Squamous Cell Carcinoma | 242 | 1 | Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate (PRR 29.2) |
| 6635 | Instillation Site Lacrimation | 242 | 1 | Lifitegrast (PRR 3,616.8) |
| 6636 | Enterobacter Test Positive | 242 | 4 | Posaconazole (PRR 66.8) |
| 6637 | Renal Arteriosclerosis | 242 | 1 | Basiliximab (PRR 150.7) |
| 6638 | Neglect Of Personal Appearance | 241 | 7 | Thiamine Hydrochloride (PRR 159.5) |
| 6639 | Spontaneous Bacterial Peritonitis | 241 | 7 | Atovaquone (PRR 135.4) |
| 6640 | Dental Treatment | 241 | 1 | Thalidomide (PRR 54.0) |
| 6641 | Congenital Skin Dimples | 241 | 10 | Dolutegravir Sodium (PRR 131.5) |
| 6642 | Drain Placement | 241 | 1 | Infliximab-Dyyb (PRR 60.9) |
| 6643 | Corneal Degeneration | 241 | 6 | Brimonidine Tartrate (PRR 61.2) |
| 6644 | Gingival Injury | 241 | 1 | Emicizumab (PRR 35.7) |
| 6645 | Prostate Examination Abnormal | 241 | 1 | Dutasteride (PRR 99.3) |
| 6646 | Stoma Site Abscess | 240 | 3 | Teduglutide (PRR 60.1) |
| 6647 | Implant Site Haematoma | 240 | 3 | Etonogestrel (PRR 117.4) |
| 6648 | Calcium Ionised Decreased | 240 | 3 | Captopril (PRR 196.7) |
| 6649 | Aspartate Aminotransferase | 240 | 7 | Methylprednisolone Acetate (PRR 101.2) |
| 6650 | Noninfectious Peritonitis | 240 | 6 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 281.1) |
| 6651 | Pulmonary Resection | 240 | 5 | Amikacin (PRR 116.9) |
| 6652 | Dermatitis Herpetiformis | 240 | 3 | Daspone (PRR 132.3) |
| 6653 | Infective Spondylitis | 240 | 1 | Pitavastatin Calcium (PRR 52.1) |
| 6654 | Postictal Paralysis | 239 | 14 | Brivaracetam (PRR 222.9) |
| 6655 | Musculoskeletal Injury | 239 | 3 | Ciprofloxacin Hydrochloride And Hydrocortisone (PRR 389.4) |
| 6656 | Carcinoid Tumour Pulmonary | 239 | 6 | Everolimus Tablets (PRR 151.4) |
| 6657 | Renal Aneurysm | 239 | 5 | Nevirapine (PRR 111.3) |
| 6658 | Metastases To Gastrointestinal Tract | 239 | 2 | Octreotide Acetate (PRR 79.3) |
| 6659 | Nail Pigmentation | 239 | 3 | Hydroxyurea (PRR 104.7) |
| 6660 | Seminoma | 239 | 3 | Fosaprepitant Dimeglumine (PRR 87.0) |
| 6661 | Illness Anxiety Disorder | 239 | 1 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 28.4) |
| 6662 | Tubulointerstitial Nephritis And Uveitis Syndrome | 239 | 1 | Prednisolone Acetate (PRR 60.7) |
| 6663 | Metatarsalgia | 239 | 1 | Asfotase Alfa (PRR 35.3) |
| 6664 | Appendiceal Abscess | 239 | 1 | Baricitinib (PRR 55.6) |
| 6665 | Ophthalmic Vein Thrombosis | 239 | 1 | Micafungin Sodium (PRR 52.4) |
| 6666 | Congenital Heart Valve Disorder | 238 | 7 | Zidovudine (PRR 135.0) |
| 6667 | Intraocular Pressure Test | 238 | 4 | Micafungin Sodium (PRR 85.4) |
| 6668 | Ear Neoplasm Malignant | 238 | 1 | Vismodegib (PRR 29.8) |
| 6669 | Genital Discharge | 237 | 1 | Levonorgestrel (PRR 76.0) |
| 6670 | Chronic Graft Versus Host Disease Oral | 237 | 12 | Sirolimus (PRR 215.3) |
| 6671 | Buttock Pain | 237 | 1 | Teriparatide (PRR 31.8) |
| 6672 | Pain Exacerbated | 237 | 1 | Teriparatide (PRR 31.8) |
| 6673 | Paranasal Cyst | 237 | 6 | Dimenhydrinate (PRR 470.2) |
| 6674 | Pericardial Drainage | 237 | 2 | Selexipag (PRR 46.7) |
| 6675 | Complement Factor C3 Decreased | 237 | 3 | Voclosporin (PRR 232.9) |
| 6676 | Myocardial Depression | 237 | 9 | Phenobarbital (PRR 184.5) |
| 6677 | Macular Detachment | 237 | 7 | Guanfacine (PRR 217.3) |
| 6678 | Device Interaction | 237 | 3 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 630.7) |
| 6679 | Nail Bed Infection | 237 | 2 | Abiraterone (PRR 26.2) |
| 6680 | Breathing-Related Sleep Disorder | 237 | 3 | Testosterone (PRR 60.1) |
| 6681 | Granulomatous Dermatitis | 237 | 3 | Valganciclovir Hydrochloride Powder, (PRR 99.0) |
| 6682 | Clostridial Sepsis | 237 | 5 | Norepinephrine Bitartrate (PRR 70.3) |
| 6683 | Jejunal Perforation | 237 | 1 | Remdesivir (PRR 33.6) |
| 6684 | Tooth Socket Haemorrhage | 237 | 1 | Emicizumab (PRR 113.8) |
| 6685 | Neurogenic Bowel | 237 | 1 | Diroximel Fumarate (PRR 76.9) |
| 6686 | Arrested Labour | 237 | 1 | Misoprostol (PRR 74.6) |
| 6687 | Immune-Mediated Hyperthyroidism | 236 | 8 | Pembrolizumab (PRR 325.1) |
| 6688 | Camptocormia | 236 | 7 | Levodopa (PRR 185.9) |
| 6689 | Pancreatic Neuroendocrine Tumour Metastatic | 236 | 7 | Octreotide Acetate (PRR 361.3) |
| 6690 | Anaplastic Large-Cell Lymphoma | 236 | 3 | Brentuximab Vedotin (PRR 1,163.7) |
| 6691 | Ulnar Nerve Injury | 236 | 2 | Inclisiran (PRR 126.8) |
| 6692 | Post Procedural Fever | 236 | 2 | Palivizumab (PRR 17.4) |
| 6693 | Injection Site Nerve Damage | 236 | 2 | Naltrexone (PRR 87.1) |
| 6694 | Retinal Dystrophy | 236 | 1 | Vigabatrin (PRR 43.6) |
| 6695 | Vitamin B6 Decreased | 236 | 1 | Asfotase Alfa (PRR 3,689.4) |
| 6696 | Leukoplakia | 236 | 1 | Brivaracetam (PRR 81.2) |
| 6697 | Pelvic Adhesions | 235 | 2 | Copper (PRR 57.4) |
| 6698 | Device Intolerance | 235 | 3 | Levonorgestrel (PRR 48.9) |
| 6699 | Patient Dissatisfaction With Device | 235 | 10 | Levodopa (PRR 186.8) |
| 6700 | Cervical Cyst | 235 | 4 | Copper (PRR 111.0) |
| 6701 | Increased Insulin Requirement | 235 | 3 | Ranibizumab (PRR 110.2) |
| 6702 | Cardiac Failure High Output | 235 | 6 | Epoprostenol (PRR 223.7) |
| 6703 | Crest Syndrome | 235 | 5 | Epoprostenol (PRR 56.0) |
| 6704 | Toxic Erythema Of Chemotherapy | 235 | 6 | Thiotepa (PRR 271.0) |
| 6705 | Ovarian Haemorrhage | 235 | 1 | Etonogestrel (PRR 13.4) |
| 6706 | Pilonidal Disease | 235 | 4 | Infliximab-Dyyb (PRR 69.8) |
| 6707 | Infantile Apnoeic Attack | 235 | 2 | Zidovudine (PRR 69.1) |
| 6708 | Immune-Mediated Pneumonitis | 234 | 6 | Pembrolizumab (PRR 196.8) |
| 6709 | Pancreatic Carcinoma Recurrent | 234 | 5 | Pancrelipase (PRR 202.6) |
| 6710 | Parophthalmia | 234 | 3 | Bupivacaine (PRR 242.7) |
| 6711 | Bronchoscopy | 234 | 5 | Amikacin (PRR 139.3) |
| 6712 | Kidney Duplex | 234 | 6 | Misoprostol (PRR 221.7) |
| 6713 | Musculoskeletal Deformity | 233 | 26 | Sulfasalazine (PRR 385.0) |
| 6714 | Bone Marrow Necrosis | 233 | 9 | Tretinoin (PRR 214.6) |
| 6715 | Cd4 Lymphocytes Increased | 233 | 17 | Efavirenz (PRR 156.2) |
| 6716 | Penile Curvature | 233 | 1 | Finasteride (PRR 153.8) |
| 6717 | Accidental Exposure To Product Packaging | 233 | 5 | Everolimus Tablets (PRR 272.7) |
| 6718 | Lung Adenocarcinoma Metastatic | 233 | 5 | Erlotinib Hydrochloride (PRR 82.4) |
| 6719 | Herpes Simplex Hepatitis | 233 | 6 | Basiliximab (PRR 261.4) |
| 6720 | Transfusion-Related Circulatory Overload | 233 | 4 | Octreotide Acetate (PRR 132.2) |
| 6721 | Vaginal Mycosis | 233 | 1 | Etonogestrel And Ethinyl Estradiol (PRR 929.6) |
| 6722 | Craniofacial Deformity | 233 | 2 | Phenytoin (PRR 58.9) |
| 6723 | Coronary Artery Aneurysm | 233 | 1 | Human Immunoglobulin G (PRR 126.6) |
| 6724 | Injection Site Phlebitis | 233 | 3 | Fosaprepitant Dimeglumine (PRR 190.0) |
| 6725 | Labour Complication | 233 | 1 | Misoprostol (PRR 95.8) |
| 6726 | Cerebral Microangiopathy | 233 | 1 | Bosutinib (PRR 30.2) |
| 6727 | Neonatal Hypoacusis | 232 | 11 | Methadone Hydrochloride (PRR 412.7) |
| 6728 | High Density Lipoprotein Abnormal | 232 | 2 | Inclisiran (PRR 129.1) |
| 6729 | Tumour Hyperprogression | 232 | 4 | Pembrolizumab (PRR 203.7) |
| 6730 | Angina Bullosa Haemorrhagica | 232 | 5 | Temozolomide (PRR 130.0) |
| 6731 | Sweat Gland Tumour | 232 | 3 | Busulfan (PRR 78.5) |
| 6732 | Myocardial Necrosis | 232 | 3 | Ranolazine (PRR 43.9) |
| 6733 | Environmental Exposure | 232 | 4 | Derma Foam Excel Hand Sanitizer (PRR 286.4) |
| 6734 | Anterior Chamber Flare | 232 | 4 | Aflibercept (PRR 242.9) |
| 6735 | Agnosia | 232 | 4 | Rivastigmine (PRR 70.9) |
| 6736 | Extravasation Blood | 232 | 3 | Piperacillin And Tazobactam (PRR 65.6) |
| 6737 | Traumatic Liver Injury | 232 | 1 | Emicizumab (PRR 22.1) |
| 6738 | Tumour Ulceration | 232 | 3 | Polatuzumab Vedotin (PRR 56.6) |
| 6739 | Urogenital Fistula | 231 | 7 | Paclitaxel (Aibumin-Bound) (PRR 90.5) |
| 6740 | Continuous Positive Airway Pressure | 231 | 1 | Ambrisentan (PRR 31.6) |
| 6741 | Autoimmune Hypothyroidism | 231 | 7 | Alemtuzumab (PRR 118.9) |
| 6742 | Mucosal Infection | 231 | 6 | Pegaspargase (PRR 85.0) |
| 6743 | Vestibular Migraine | 231 | 6 | Zonisamide (PRR 83.8) |
| 6744 | Breast Lump Removal | 231 | 2 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 92.7) |
| 6745 | Sapho Syndrome | 231 | 5 | Isotretinoin (PRR 96.0) |
| 6746 | Application Site Hypoaesthesia | 231 | 4 | Glycerin, Lidocaine (PRR 133.1) |
| 6747 | Positive Airway Pressure Therapy | 231 | 10 | Cefuroxime (PRR 201.2) |
| 6748 | Anterior Chamber Disorder | 231 | 8 | Faricimab (PRR 128.4) |
| 6749 | Corneal Neovascularisation | 231 | 7 | Cenegermin-Bkbj (PRR 154.1) |
| 6750 | Fat Redistribution | 231 | 8 | Abacavir Sulfate (PRR 86.6) |
| 6751 | Neonatal Pneumonia | 231 | 2 | Oseltamivir (PRR 105.9) |
| 6752 | Amoebiasis | 231 | 2 | Basiliximab (PRR 71.7) |
| 6753 | Foetal Heart Rate Deceleration | 231 | 2 | Misoprostol (PRR 57.0) |
| 6754 | Larynx Irritation | 231 | 1 | Iohexol (PRR 78.4) |
| 6755 | Sleeve Gastrectomy | 230 | 4 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 53.7) |
| 6756 | Breakthrough Covid-19 | 230 | 3 | Bendamustine Hcl (PRR 80.3) |
| 6757 | Persistent Genital Arousal Disorder | 230 | 10 | Drs. Clotrimazole (PRR 367.5) |
| 6758 | Vitamin B6 Deficiency | 230 | 3 | Asfotase Alfa (PRR 176.3) |
| 6759 | Squamous Cell Carcinoma Of Head And Neck | 230 | 1 | Cetuximab (PRR 80.9) |
| 6760 | Pleural Infection | 230 | 2 | Erlotinib Hydrochloride (PRR 44.5) |
| 6761 | Meningitis Fungal | 230 | 5 | Methylprednisolone Acetate (PRR 274.8) |
| 6762 | Grip Strength | 229 | 103 | Diclofenac Potassium, Film Coated (PRR 3,487.4) |
| 6763 | Renal Graft Infection | 229 | 14 | Tacrolimus (PRR 756.4) |
| 6764 | Sarcoid-Like Reaction | 229 | 9 | Adalimumab-Fkjp (PRR 112.7) |
| 6765 | Self Mutilation | 229 | 1 | Paroxetine Hydrochloride (PRR 167.4) |
| 6766 | Hypogonadism Male | 229 | 2 | Finasteride (PRR 210.7) |
| 6767 | Adenoviral Hepatitis | 229 | 21 | Anti-Thymocyte Globulin (Rabbit) (PRR 260.4) |
| 6768 | Vascular Pseudoaneurysm Ruptured | 229 | 8 | Drs. Clotrimazole (PRR 440.2) |
| 6769 | Electrocardiogram Q Wave Abnormal | 229 | 5 | Telmisartan (PRR 136.4) |
| 6770 | Klebsiella Urinary Tract Infection | 229 | 3 | Thiotepa (PRR 89.1) |
| 6771 | Pseudarthrosis | 229 | 1 | Romosozumab-Aqqg (PRR 92.2) |
| 6772 | Cardiac Perforation | 229 | 2 | Prasugrel Hydrochloride (PRR 45.7) |
| 6773 | Incision Site Haematoma | 229 | 1 | Fondaparinux Sodium (PRR 315.0) |
| 6774 | Schizoaffective Disorder Bipolar Type | 228 | 7 | Lithium (PRR 110.8) |
| 6775 | Graft Versus Host Disease In Eye | 228 | 11 | Fludarabine Phosphate (PRR 144.6) |
| 6776 | Body Mass Index Abnormal | 228 | 9 | Calcitriol Capsules 0.25 Mcg (PRR 241.1) |
| 6777 | Herpes Zoster Cutaneous Disseminated | 228 | 3 | Febuxostat Tablets 40 Mg (PRR 55.3) |
| 6778 | Scleral Haemorrhage | 228 | 2 | Faricimab (PRR 34.2) |
| 6779 | Haemophilic Arthropathy | 228 | 5 | Emicizumab (PRR 188.9) |
| 6780 | Parenteral Nutrition | 228 | 9 | Micafungin Sodium (PRR 89.2) |
| 6781 | Glucose-6-Phosphate Dehydrogenase Deficiency | 228 | 3 | Zidovudine (PRR 125.3) |
| 6782 | Hairy Cell Leukaemia | 228 | 2 | Cladribine (PRR 196.8) |
| 6783 | Malabsorption From Administration Site | 228 | 1 | Rifampicin (PRR 55.6) |
| 6784 | Injection Site Granuloma | 227 | 3 | Lanreotide Acetate (PRR 96.9) |
| 6785 | Strangulated Hernia | 227 | 1 | Dabigatran Etexilate Mesylate (PRR 33.8) |
| 6786 | Tourette'S Disorder | 227 | 1 | Atomoxetine Hydrochloride (PRR 44.5) |
| 6787 | Oligodipsia | 227 | 2 | Palivizumab (PRR 109.6) |
| 6788 | Renal Cortical Necrosis | 227 | 6 | Tranexamic Acid (PRR 189.4) |
| 6789 | Albumin Globulin Ratio Decreased | 227 | 3 | Crizotinib (PRR 44.4) |
| 6790 | Endothelial Dysfunction | 227 | 1 | Ravulizumab (PRR 41.8) |
| 6791 | Breast Haematoma | 227 | 1 | Fondaparinux Sodium (PRR 118.5) |
| 6792 | Painful Ejaculation | 226 | 5 | Finasteride (PRR 249.4) |
| 6793 | Ecg Signs Of Myocardial Ischaemia | 226 | 5 | Brinzolamide (PRR 87.9) |
| 6794 | Necrotising Soft Tissue Infection | 226 | 5 | Rocuronium Bromide (PRR 73.2) |
| 6795 | Acute Motor-Sensory Axonal Neuropathy | 226 | 5 | Nebivolol (PRR 106.2) |
| 6796 | Shunt Infection | 226 | 3 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 34.0) |
| 6797 | Stoma Obstruction | 226 | 1 | Teduglutide (PRR 394.5) |
| 6798 | Infusion Site Phlebitis | 226 | 3 | Amiodarone Hydrochloride (PRR 262.5) |
| 6799 | Periorbital Inflammation | 225 | 5 | Zoledronic Acid (PRR 79.6) |
| 6800 | Nail Avulsion | 225 | 3 | Doxepin Hydrochloride (PRR 126.1) |
| 6801 | Carcinoid Crisis | 225 | 9 | Octreotide Acetate (PRR 1,384.5) |
| 6802 | Tumour Thrombosis | 225 | 2 | Atezolizumab (PRR 108.7) |
| 6803 | Breath Alcohol Test Positive | 225 | 4 | Ethyl Alcohol (PRR 46.9) |
| 6804 | Neuromuscular Blockade | 225 | 13 | Rocuronium Bromide (PRR 656.7) |
| 6805 | Platelet Function Test Abnormal | 225 | 2 | Prasugrel Hydrochloride (PRR 199.8) |
| 6806 | Intra-Ocular Injection Complication | 225 | 2 | Aflibercept (PRR 672.1) |
| 6807 | Laser Therapy | 225 | 1 | Aflibercept (PRR 44.2) |
| 6808 | Pharyngotonsillitis | 225 | 1 | Aflibercept (PRR 21.4) |
| 6809 | Nasal Abscess | 225 | 4 | Micafungin Sodium (PRR 126.1) |
| 6810 | Urinary Occult Blood Positive | 225 | 1 | Tafamidis (PRR 40.1) |
| 6811 | Uterine Scar | 224 | 2 | Copper (PRR 262.5) |
| 6812 | Type Iia Hyperlipidaemia | 224 | 6 | Lovastatin (PRR 269.9) |
| 6813 | Ivth Nerve Paralysis | 224 | 8 | Atovaquone (PRR 462.5) |
| 6814 | B-Cell Small Lymphocytic Lymphoma | 224 | 4 | Acalabrutinib (PRR 63.6) |
| 6815 | Iliotibial Band Syndrome | 224 | 5 | Doxepin Hydrochloride (PRR 126.7) |
| 6816 | Acid Base Balance Abnormal | 224 | 10 | Basiliximab (PRR 145.3) |
| 6817 | Optic Disc Haemorrhage | 224 | 5 | Acetaminophen, Aspirin (Nsaid) And Caffeine (PRR 45.3) |
| 6818 | Retinal Artery Thrombosis | 224 | 1 | Ranibizumab (PRR 40.4) |
| 6819 | Cancer Fatigue | 224 | 4 | Brentuximab Vedotin (PRR 156.1) |
| 6820 | Osteoradionecrosis | 223 | 4 | Chlorhexidine Gluconate (PRR 152.5) |
| 6821 | Endarterectomy | 223 | 5 | Riociguat (PRR 218.9) |
| 6822 | Renal-Limited Thrombotic Microangiopathy | 223 | 10 | Sirolimus (PRR 127.4) |
| 6823 | Neutropenia Neonatal | 223 | 18 | Zidovudine (PRR 461.2) |
| 6824 | Miller Fisher Syndrome | 223 | 1 | Durvalumab (PRR 23.4) |
| 6825 | Proteus Test Positive | 223 | 1 | Amikacin (PRR 51.3) |
| 6826 | Congenital Pulmonary Valve Atresia | 223 | 2 | Misoprostol (PRR 89.9) |
| 6827 | Staphylococcal Scalded Skin Syndrome | 223 | 1 | Dalteparin Sodium (PRR 102.0) |
| 6828 | Withdrawal Catatonia | 222 | 2 | Clozapine (PRR 114.5) |
| 6829 | Right-To-Left Cardiac Shunt | 222 | 2 | Selexipag (PRR 102.1) |
| 6830 | Stoma Site Odour | 222 | 7 | Rotigotine (PRR 142.4) |
| 6831 | Sick Leave | 222 | 3 | Sevoflurane (PRR 69.5) |
| 6832 | Lennox-Gastaut Syndrome | 222 | 10 | Vigabatrin (PRR 164.9) |
| 6833 | Placental Infarction | 222 | 4 | Atazanavir (PRR 90.0) |
| 6834 | Gouty Tophus | 222 | 2 | Colchicine (PRR 168.2) |
| 6835 | Monocyte Count Abnormal | 222 | 1 | Acetaminophen And Codeine (PRR 47.4) |
| 6836 | Rheumatoid Vasculitis | 222 | 2 | Pseudoephedrine Hydrochloride (PRR 37.2) |
| 6837 | Vaginal Mucosal Blistering | 222 | 1 | Miconazole Nitrate (PRR 461.4) |
| 6838 | Vaginal Inflammation | 221 | 2 | Etonogestrel (PRR 12.1) |
| 6839 | Tethered Cord Syndrome | 221 | 5 | Zidovudine (PRR 253.8) |
| 6840 | Hepatic Rupture | 221 | 3 | Sorafenib (PRR 72.9) |
| 6841 | Histology Abnormal | 221 | 3 | Mycophenolic Acid (PRR 68.2) |
| 6842 | Nonreassuring Foetal Heart Rate Pattern | 221 | 2 | Sodium Bicarbonate (PRR 79.3) |
| 6843 | Mucocutaneous Ulceration | 221 | 4 | Pegaspargase (PRR 80.5) |
| 6844 | Thrombolysis | 221 | 2 | Etonogestrel And Ethinyl Estradiol (PRR 239.7) |
| 6845 | Facial Dysmorphism | 221 | 4 | Valproate Sodium (PRR 146.0) |
| 6846 | Laryngeal Dyspnoea | 221 | 2 | Leucovorin Calcium (PRR 68.0) |
| 6847 | Colorectal Adenocarcinoma | 221 | 2 | Panitumumab (PRR 110.6) |
| 6848 | Articular Calcification | 221 | 2 | Sevoflurane (PRR 34.4) |
| 6849 | Myotonia | 221 | 2 | Sevoflurane (PRR 182.3) |
| 6850 | Drug Delivery Device Implantation | 220 | 2 | Natalizumab (PRR 138.7) |
| 6851 | Product Intolerance | 220 | 4 | Amlodipine Besylate And Valsartan (PRR 52.7) |
| 6852 | Stoma Site Discomfort | 220 | 6 | Teduglutide (PRR 121.1) |
| 6853 | Ultrasound Antenatal Screen Abnormal | 220 | 7 | Atazanavir (PRR 177.2) |
| 6854 | Bone Marrow Transplant Rejection | 220 | 9 | Fludarabine Phosphate (PRR 257.0) |
| 6855 | Blood Ethanol Increased | 220 | 5 | Derma Foam Excel Hand Sanitizer (PRR 348.8) |
| 6856 | Vertebral Artery Occlusion | 220 | 1 | Nilotinib (PRR 47.9) |
| 6857 | Hip Dysplasia | 220 | 2 | Clobazam (PRR 71.3) |
| 6858 | Maternal Condition Affecting Foetus | 220 | 5 | Zidovudine (PRR 164.2) |
| 6859 | Rectosigmoid Cancer | 220 | 1 | Regorafenib (PRR 76.4) |
| 6860 | Very Low Density Lipoprotein Increased | 220 | 1 | Inclisiran (PRR 72.7) |
| 6861 | Congenital Hiatus Hernia | 219 | 77 | Acetylcysteine (PRR 2,675.9) |
| 6862 | Upper Motor Neurone Lesion | 219 | 3 | Nevirapine (PRR 53.9) |
| 6863 | Human Herpes Virus 6 Serology Positive | 219 | 3 | Carbamazepine (PRR 178.2) |
| 6864 | Eyelash Discolouration | 219 | 3 | Bimatoprost (PRR 247.8) |
| 6865 | Superior Mesenteric Artery Syndrome | 219 | 2 | Darunavir (PRR 58.9) |
| 6866 | Stroke In Evolution | 219 | 1 | Alteplase (PRR 281.6) |
| 6867 | Brachial Plexopathy | 219 | 3 | Bupivacaine (PRR 106.5) |
| 6868 | Testicular Mass | 219 | 2 | Pyrazinamide (PRR 73.1) |
| 6869 | Alanine Aminotransferase | 219 | 1 | Axicabtagene Ciloleucel (PRR 39.2) |
| 6870 | Drug Clearance Increased | 219 | 4 | Brivaracetam (PRR 54.1) |
| 6871 | Vaginal Laceration | 219 | 1 | Miconazole Nitrate (PRR 150.4) |
| 6872 | Epileptic Encephalopathy | 218 | 14 | Vigabatrin (PRR 193.2) |
| 6873 | Metastases To Eye | 218 | 5 | Fulvestrant (PRR 137.1) |
| 6874 | Cold Urticaria | 218 | 3 | Omalizumab (PRR 90.3) |
| 6875 | Breast Atrophy | 218 | 1 | Etonogestrel (PRR 12.3) |
| 6876 | Tarsal Tunnel Syndrome | 218 | 15 | Quinine (PRR 116.6) |
| 6877 | Nodular Rash | 218 | 1 | Dabrafenib (PRR 37.6) |
| 6878 | Meningitis Chemical | 218 | 3 | Iohexol (PRR 239.6) |
| 6879 | Paralysis Flaccid | 218 | 1 | Bupivacaine (PRR 63.0) |
| 6880 | Mood Disorder Due To A General Medical Condition | 217 | 1 | Dupilumab (PRR 29.9) |
| 6881 | Iron Binding Capacity Total Decreased | 217 | 3 | Sodium Bicarbonate (PRR 121.7) |
| 6882 | Renal Cyst Haemorrhage | 217 | 15 | Amphotericin B (PRR 226.0) |
| 6883 | Systemic Sclerosis | 217 | 1 | Bosentan (PRR 87.4) |
| 6884 | Stoma Site Oedema | 217 | 5 | Teduglutide (PRR 524.1) |
| 6885 | Congenital Oral Malformation | 217 | 3 | Valproate Sodium (PRR 161.4) |
| 6886 | Perirenal Haematoma | 217 | 6 | Valganciclovir (PRR 130.8) |
| 6887 | Renal Hypoplasia | 217 | 1 | Tenofovir Disoproxil Fumarate Tablets (PRR 56.8) |
| 6888 | Autoimmune Myocarditis | 216 | 5 | Nivolumab (PRR 82.4) |
| 6889 | Bladder Cancer Stage I, With Cancer In Situ | 216 | 1 | Ranitidine Hydrochloride (PRR 61.6) |
| 6890 | Urethral Cancer | 216 | 1 | Ranitidine Hydrochloride (PRR 26.5) |
| 6891 | Oroantral Fistula | 216 | 1 | Zoledronic Acid (PRR 160.0) |
| 6892 | Automatism | 216 | 6 | Zonisamide (PRR 61.1) |
| 6893 | Cardiomyopathy Acute | 216 | 2 | Dalteparin Sodium (PRR 75.6) |
| 6894 | Mitochondrial Myopathy | 216 | 8 | Nevirapine (PRR 235.3) |
| 6895 | Increased Need For Sleep | 216 | 3 | Cenobamate (PRR 108.4) |
| 6896 | Disseminated Cytomegaloviral Infection | 216 | 7 | Ganciclovir Sodium (PRR 292.8) |
| 6897 | Glossoptosis | 216 | 3 | Sevoflurane (PRR 147.3) |
| 6898 | Renal Necrosis | 216 | 1 | Basiliximab (PRR 76.9) |
| 6899 | Prothrombin Time Ratio Increased | 216 | 2 | Pitavastatin Calcium (PRR 68.1) |
| 6900 | Scintillating Scotoma | 216 | 1 | Ado-Trastuzumab Emtansine (PRR 82.7) |
| 6901 | Uterine Inflammation | 215 | 3 | Copper (PRR 69.2) |
| 6902 | Autoimmune Nephritis | 215 | 8 | Ipilimumab (PRR 134.6) |
| 6903 | Patient Isolation | 215 | 2 | Mepolizumab (PRR 70.4) |
| 6904 | Renal Papillary Necrosis | 215 | 2 | Ceftriaxone (PRR 72.2) |
| 6905 | Cardiac Myxoma | 215 | 1 | Nebivolol (PRR 77.2) |
| 6906 | Pierre Robin Syndrome | 215 | 1 | Methadone Hydrochloride (PRR 74.3) |
| 6907 | Rash Scarlatiniform | 215 | 1 | Brentuximab Vedotin (PRR 78.4) |
| 6908 | Central Nervous System Lupus | 214 | 16 | Indapamide (PRR 540.4) |
| 6909 | Refractory Cancer | 214 | 18 | Polatuzumab Vedotin (PRR 184.0) |
| 6910 | Paranasal Sinus Inflammation | 214 | 4 | Doxepin (PRR 177.1) |
| 6911 | Pregnancy With Injectable Contraceptive | 214 | 1 | Medroxyprogesterone Acetate (PRR 1,175.9) |
| 6912 | Pubic Pain | 214 | 1 | Copper (PRR 9.2) |
| 6913 | Blood Human Chorionic Gonadotropin Increased | 214 | 2 | Thalidomide (PRR 633.2) |
| 6914 | Phrenic Nerve Paralysis | 214 | 5 | Sevoflurane (PRR 331.1) |
| 6915 | Moyamoya Disease | 214 | 1 | Deferasirox (PRR 76.4) |
| 6916 | Upper Respiratory Tract Infection Bacterial | 214 | 1 | Sarilumab (PRR 30.6) |
| 6917 | Toxic Cardiomyopathy | 214 | 1 | Testosterone (PRR 133.9) |
| 6918 | Cholelithotomy | 214 | 1 | Voxelotor (PRR 13.2) |
| 6919 | Dysbacteriosis | 214 | 1 | Droxidopa (PRR 13.7) |
| 6920 | Neuralgic Amyotrophy | 214 | 2 | Polatuzumab Vedotin (PRR 51.0) |
| 6921 | Crystal Deposit Intestine | 214 | 1 | Sevelamer Carbonate (PRR 537.7) |
| 6922 | Placenta Accreta | 213 | 2 | Progesterone (PRR 78.9) |
| 6923 | Pelvic Haemorrhage | 213 | 1 | Levonorgestrel (PRR 13.0) |
| 6924 | Blood Stem Cell Transplant Failure | 213 | 17 | Ifosfamide (PRR 216.9) |
| 6925 | Complications Of Transplanted Heart | 213 | 9 | Mycophenolate Mofetil (PRR 134.7) |
| 6926 | Brain Natriuretic Peptide Abnormal | 213 | 2 | Selexipag (PRR 56.6) |
| 6927 | Teratoma | 213 | 3 | Bleomycin Sulfate (PRR 554.7) |
| 6928 | Genital Disorder Male | 213 | 1 | Finasteride (PRR 151.1) |
| 6929 | Angiomyolipoma | 213 | 4 | Phenobarbital (PRR 101.0) |
| 6930 | Jaw Cyst | 213 | 1 | Pirfenidone (PRR 17.3) |
| 6931 | Disseminated Strongyloidiasis | 213 | 7 | Mycophenilic Acid (PRR 115.6) |
| 6932 | Central Vision Loss | 213 | 5 | Faricimab (PRR 153.3) |
| 6933 | Salivary Gland Pain | 213 | 1 | Botulinum Toxin Type A (PRR 32.1) |
| 6934 | Haemophilia | 213 | 3 | Tranexamic Acid (PRR 91.3) |
| 6935 | Corneal Infection | 213 | 1 | Brinzolamide (PRR 81.4) |
| 6936 | Vogt-Koyanagi-Harada Disease | 212 | 8 | Dabrafenib (PRR 131.9) |
| 6937 | Dihydropyrimidine Dehydrogenase Deficiency | 212 | 4 | Capecitabine (PRR 587.1) |
| 6938 | Central Nervous System Fungal Infection | 212 | 12 | Amphotericin B (PRR 252.6) |
| 6939 | Herpes Oesophagitis | 212 | 2 | Zonisamide (PRR 69.6) |
| 6940 | Vaccination Site Erythema | 212 | 1 | Ravulizumab (PRR 37.2) |
| 6941 | Melas Syndrome | 212 | 2 | Sirolimus (PRR 143.3) |
| 6942 | Atrioventricular Dissociation | 212 | 4 | Quinine (PRR 120.1) |
| 6943 | Renal Vessel Disorder | 212 | 1 | Basiliximab (PRR 96.8) |
| 6944 | Hyperinsulinaemic Hypoglycaemia | 212 | 2 | Insulin Glulisine (PRR 90.7) |
| 6945 | Arterial Repair | 212 | 1 | Ranolazine (PRR 38.3) |
| 6946 | Clostridium Bacteraemia | 212 | 2 | Brentuximab Vedotin (PRR 69.3) |
| 6947 | Meralgia Paraesthetica | 212 | 1 | Crisaborole (PRR 52.4) |
| 6948 | Penile Blister | 212 | 1 | Oseltamivir (PRR 50.3) |
| 6949 | Cerebral Nocardiosis | 211 | 10 | Valganciclovir Hydrochloride Powder, (PRR 386.7) |
| 6950 | Trichophytosis | 211 | 7 | Valganciclovir Hydrochloride Powder, (PRR 229.2) |
| 6951 | Kl-6 Increased | 211 | 4 | Fam-Trastuzumab Deruxtecan-Nxki (PRR 113.5) |
| 6952 | Growth Accelerated | 211 | 1 | Somatropin (PRR 27.9) |
| 6953 | Implant Site Cellulitis | 211 | 1 | Etonogestrel (PRR 757.3) |
| 6954 | Child Neglect | 211 | 6 | Dronabinol (PRR 156.0) |
| 6955 | Emphysematous Cystitis | 211 | 2 | Gefitinib (PRR 55.9) |
| 6956 | Retinal Occlusive Vasculitis | 211 | 6 | Faricimab (PRR 1,068.3) |
| 6957 | Meconium Aspiration Syndrome | 211 | 1 | Lurasidone Hydrochloride (PRR 39.2) |
| 6958 | Acute On Chronic Liver Failure | 211 | 4 | Ganciclovir (PRR 69.7) |
| 6959 | Extraskeletal Ossification | 211 | 2 | Romosozumab-Aqqg (PRR 44.8) |
| 6960 | Duodenal Polyp | 211 | 1 | Teduglutide (PRR 350.0) |
| 6961 | Histamine Level Increased | 211 | 2 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 96.2) |
| 6962 | Zinc Deficiency | 211 | 2 | Guanfacine (PRR 51.1) |
| 6963 | Product Contamination Chemical | 211 | 1 | Quinine (PRR 108.1) |
| 6964 | Rebound Psychosis | 210 | 7 | Atropine (PRR 264.3) |
| 6965 | Geotrichum Infection | 210 | 28 | Micafungin Sodium (PRR 409.0) |
| 6966 | Vascular Malformation | 210 | 7 | Dimenhydrinate (PRR 532.4) |
| 6967 | Disseminated Mycobacterium Avium Complex Infection | 210 | 16 | Cabotegravir (PRR 364.1) |
| 6968 | Pancreatic Operation | 210 | 1 | Pancrelipase (PRR 395.9) |
| 6969 | Optic Disc Disorder | 210 | 1 | Ranibizumab (PRR 31.0) |
| 6970 | Influenza Virus Test Positive | 210 | 3 | Oseltamivir (PRR 90.1) |
| 6971 | Spinal Cord Haematoma | 210 | 2 | Amantadine (PRR 88.7) |
| 6972 | Lip Infection | 210 | 2 | Glycerin, Lidocaine (PRR 90.0) |
| 6973 | Eosinophilic Cellulitis | 210 | 1 | Timolol Maleate (PRR 94.0) |
| 6974 | Cerebral Haemorrhage Neonatal | 210 | 1 | Misoprostol (PRR 62.8) |
| 6975 | Pseudocellulitis | 209 | 8 | Pemetrexed (PRR 467.7) |
| 6976 | Congenital Nystagmus | 209 | 4 | Methadone Hydrochloride (PRR 249.4) |
| 6977 | Catheter Site Injury | 209 | 5 | Ado-Trastuzumab Emtansine (PRR 85.5) |
| 6978 | Chronic Lymphocytic Leukaemia Transformation | 209 | 5 | Fludarabine Phosphate (PRR 202.9) |
| 6979 | Gastrointestinal Malformation | 209 | 5 | Zidovudine (PRR 201.8) |
| 6980 | Portal Fibrosis | 209 | 8 | Dolutegravir Sodium (PRR 165.6) |
| 6981 | Phaeochromocytoma Crisis | 209 | 4 | Labetalol (PRR 147.1) |
| 6982 | Splenic Cyst | 209 | 4 | Febuxostat Tablets 40 Mg (PRR 135.7) |
| 6983 | Marginal Zone Lymphoma | 209 | 3 | Bendamustine Hcl (PRR 74.5) |
| 6984 | Gingivitis Ulcerative | 209 | 6 | Amphotericin B (PRR 110.1) |
| 6985 | Severe Acute Respiratory Syndrome | 209 | 2 | Thiotepa (PRR 86.7) |
| 6986 | Female Reproductive Tract Disorder | 209 | 5 | Drs. Clotrimazole (PRR 81.0) |
| 6987 | Exposure Via Inhalation | 209 | 2 | Derma Foam Excel Hand Sanitizer (PRR 76.9) |
| 6988 | Anti-Insulin Antibody Positive | 208 | 5 | Human Insulin (PRR 527.1) |
| 6989 | Adult Failure To Thrive | 208 | 1 | Pimavanserin Tartrate (PRR 21.0) |
| 6990 | Reticulocytosis | 208 | 3 | Busulfan (PRR 80.9) |
| 6991 | Substance Abuser | 208 | 5 | Methadone Hydrochloride (PRR 204.5) |
| 6992 | Excessive Masturbation | 208 | 2 | Aripiprazole Oral (PRR 71.8) |
| 6993 | Adenoviral Haemorrhagic Cystitis | 208 | 10 | Fludarabine Phosphate (PRR 176.1) |
| 6994 | Birth Mark | 208 | 8 | Efavirenz (PRR 339.3) |
| 6995 | Electrocardiogram Pr Shortened | 208 | 5 | Posaconazole Delayed-Release (PRR 105.8) |
| 6996 | Rhegmatogenous Retinal Detachment | 208 | 8 | Prednisolone Acetate (PRR 134.0) |
| 6997 | Chorioretinal Atrophy | 208 | 4 | Melphalan Hydrochloride (PRR 394.0) |
| 6998 | Cd4 Lymphocytes Abnormal | 208 | 9 | Darunavir (PRR 250.0) |
| 6999 | Retinal Artery Embolism | 208 | 1 | Ranibizumab (PRR 31.3) |
| 7000 | Radiation Associated Pain | 208 | 5 | Standardized Senna Concentrate (PRR 101.2) |
| 7001 | Genital Herpes Simplex | 208 | 5 | Anti-Thymocyte Globulin (Rabbit) (PRR 171.9) |
| 7002 | Immobilisation Syndrome | 208 | 7 | Baricitinib (PRR 143.9) |
| 7003 | Peripheral Vein Thrombosis | 208 | 3 | Baricitinib (PRR 75.1) |
| 7004 | Lice Infestation | 208 | 1 | Tafamidis (PRR 25.8) |
| 7005 | Dissociative Identity Disorder | 208 | 1 | Asenapine Maleate (PRR 35.1) |
| 7006 | Acute Promyelocytic Leukaemia Differentiation Syndrome | 208 | 3 | Tretinoin (PRR 1,537.9) |
| 7007 | Inferior Vena Cava Dilatation | 207 | 3 | Eplerenone (PRR 173.7) |
| 7008 | Micrographic Skin Surgery | 207 | 1 | Ibrutinib (PRR 107.2) |
| 7009 | Neurofibromatosis | 207 | 1 | Somatropin (PRR 20.5) |
| 7010 | Conduct Disorder | 207 | 4 | Atomoxetine Hydrochloride (PRR 83.2) |
| 7011 | Lens Dislocation | 207 | 3 | Primidone (PRR 71.5) |
| 7012 | Sympathomimetic Effect | 207 | 1 | Abaloparatide (PRR 17.5) |
| 7013 | Microvascular Coronary Artery Disease | 207 | 4 | Ado-Trastuzumab Emtansine (PRR 151.9) |
| 7014 | Cytomegalovirus Gastroenteritis | 207 | 12 | Ganciclovir (PRR 279.2) |
| 7015 | Congenital Inguinal Hernia | 207 | 1 | Zonisamide (PRR 56.5) |
| 7016 | Bacterial Diarrhoea | 207 | 1 | Vemurafenib (PRR 51.7) |
| 7017 | Leprosy | 207 | 5 | Rifampicin (PRR 115.4) |
| 7018 | Pulse Pressure Increased | 207 | 1 | Axicabtagene Ciloleucel (PRR 31.0) |
| 7019 | Tooth Resorption | 206 | 2 | Romosozumab-Aqqg (PRR 78.2) |
| 7020 | Metabolic Dysfunction-Associated Steatohepatitis | 206 | 2 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 60.1) |
| 7021 | Contralateral Breast Cancer | 206 | 4 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 683.4) |
| 7022 | Anembryonic Gestation | 206 | 2 | Copper (PRR 17.0) |
| 7023 | Hiv Viraemia | 206 | 17 | Lamivudine Oral (PRR 1,038.5) |
| 7024 | Neutrophil Count | 206 | 3 | Sarilumab (PRR 53.0) |
| 7025 | Drug Specific Antibody Absent | 206 | 2 | Agalsidase Beta (PRR 228.7) |
| 7026 | Q Fever | 206 | 1 | Sirolimus (PRR 70.5) |
| 7027 | Kussmaul Respiration | 206 | 1 | Posaconazole Delayed-Release (PRR 66.6) |
| 7028 | Scrotal Infection | 206 | 1 | Dimenhydrinate (PRR 153.3) |
| 7029 | Bronchoalveolar Lavage Abnormal | 206 | 2 | Ganciclovir Sodium (PRR 100.3) |
| 7030 | Thyroxine Abnormal | 206 | 1 | Liothyronine Sodium (PRR 134.8) |
| 7031 | Ovulation Pain | 205 | 2 | Levonorgestrel (PRR 45.4) |
| 7032 | Bendopnoea | 205 | 8 | Treprostinil (PRR 339.6) |
| 7033 | Colony Stimulating Factor Therapy | 205 | 8 | Pegfilgrastim (PRR 116.1) |
| 7034 | Post Procedural Hypothyroidism | 205 | 5 | Efavirenz (PRR 179.6) |
| 7035 | Iris Hyperpigmentation | 205 | 5 | Bimatoprost (PRR 673.6) |
| 7036 | Pyelitis | 205 | 3 | Brinzolamide (PRR 97.3) |
| 7037 | Periorbital Disorder | 205 | 1 | Bimatoprost (PRR 40.9) |
| 7038 | Salt Craving | 205 | 1 | Orlistat (PRR 41.2) |
| 7039 | Iris Atrophy | 205 | 5 | Melphalan (PRR 214.7) |
| 7040 | Adrenomegaly | 205 | 3 | Blinatumomab (PRR 70.5) |
| 7041 | Desmoid Tumour | 205 | 2 | Imatinib (PRR 156.4) |
| 7042 | Mononeuropathy | 205 | 1 | Minocycline (PRR 81.9) |
| 7043 | Retained Products Of Conception | 204 | 3 | Misoprostol (PRR 521.1) |
| 7044 | Light Chain Analysis Abnormal | 204 | 5 | Dexamethasone Sodium Phosphate (PRR 72.8) |
| 7045 | Tracheostomy Malfunction | 204 | 2 | Bosentan (PRR 47.3) |
| 7046 | Quarantine | 204 | 4 | Mepolizumab (PRR 72.0) |
| 7047 | Injection Site Plaque | 204 | 3 | Cabotegravir (PRR 51.5) |
| 7048 | Congenital Multiplex Arthrogryposis | 204 | 8 | Ampicillin (PRR 258.0) |
| 7049 | Failure To Suspend Medication | 204 | 4 | Tizanidine (PRR 89.5) |
| 7050 | Autoinflammatory Disease | 204 | 13 | Canakinumab (PRR 544.2) |
| 7051 | Thermal Burns Of Eye | 204 | 2 | Asenapine Maleate (PRR 190.6) |
| 7052 | Vertebral Artery Dissection | 204 | 2 | Amphetamine (PRR 89.3) |
| 7053 | Absence Of Immediate Treatment Response | 204 | 2 | Voclosporin (PRR 1,891.3) |
| 7054 | Ventricular Dyskinesia | 204 | 2 | Eplerenone (PRR 83.7) |
| 7055 | Carotid Endarterectomy | 204 | 1 | Ranolazine (PRR 29.8) |
| 7056 | Anovulatory Cycle | 203 | 4 | Medroxyprogesterone Acetate (PRR 30.9) |
| 7057 | Post Transplant Distal Limb Syndrome | 203 | 10 | Tacrolimus (PRR 611.8) |
| 7058 | Primary Hypothyroidism | 203 | 4 | Lenvatinib (PRR 50.5) |
| 7059 | Congenital Aortic Stenosis | 203 | 1 | Paroxetine Hydrochloride (PRR 164.1) |
| 7060 | Treatment Related Secondary Malignancy | 203 | 6 | Bleomycin Sulfate (PRR 172.3) |
| 7061 | T-Cell Type Acute Leukaemia | 203 | 4 | Mercaptopurine (PRR 75.3) |
| 7062 | Product Information Content Complaint | 203 | 4 | Abaloparatide (PRR 85.8) |
| 7063 | Mycobacterium Test Positive | 203 | 8 | Calcitriol Capsules 0.25 Mcg (PRR 132.6) |
| 7064 | Product Contamination With Body Fluid | 203 | 2 | Liraglutide (PRR 36.0) |
| 7065 | Glomerulonephritis Acute | 203 | 2 | Minoxidil Foam 5% (Womens) (PRR 22.5) |
| 7066 | Eye Excision | 203 | 4 | Melphalan Hydrochloride (PRR 90.6) |
| 7067 | Pneumocystis Carinii Pneumonia | 203 | 6 | Lopinavir And Ritonavir (PRR 122.4) |
| 7068 | Pectus Excavatum | 203 | 1 | Valproate Sodium (PRR 231.7) |
| 7069 | Bullous Haemorrhagic Dermatosis | 203 | 3 | Fondaparinux Sodium (PRR 91.8) |
| 7070 | Corneal Graft Rejection | 203 | 2 | Prednisolone Acetate (PRR 219.7) |
| 7071 | Haemoglobin Urine Present | 202 | 8 | Alemtuzumab (PRR 705.0) |
| 7072 | Retinal Deposits | 202 | 3 | Aflibercept (PRR 42.1) |
| 7073 | Implantation Complication | 202 | 2 | Etonogestrel (PRR 97.6) |
| 7074 | Salpingo-Oophorectomy Bilateral | 202 | 2 | Tofacitinib Citrate (PRR 65.4) |
| 7075 | Genital Candidiasis | 202 | 2 | Bimekizumab (PRR 29.9) |
| 7076 | Ilium Fracture | 202 | 2 | Polatuzumab Vedotin (PRR 99.4) |
| 7077 | Subcapsular Renal Haematoma | 202 | 1 | Heparin Sodium (PRR 78.8) |
| 7078 | Gram Stain Positive | 202 | 1 | Pegaspargase (PRR 52.0) |
| 7079 | Transferrin Decreased | 202 | 1 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 509.7) |
| 7080 | Pancreas Transplant Rejection | 201 | 14 | Tacrolimus (PRR 377.9) |
| 7081 | Malignant Melanoma Stage Iii | 201 | 4 | Sildenafil Citrate (PRR 100.9) |
| 7082 | Blood Growth Hormone Decreased | 201 | 3 | Somatropin (PRR 150.8) |
| 7083 | Pituitary Enlargement | 201 | 1 | Ipilimumab (PRR 108.6) |
| 7084 | Keratitis Fungal | 201 | 16 | Moxifloxacin Hydrochloride (PRR 330.6) |
| 7085 | Cd4/Cd8 Ratio Decreased | 201 | 5 | Darunavir (PRR 1,282.6) |
| 7086 | Breast Necrosis | 201 | 2 | Abemaciclib (PRR 37.5) |
| 7087 | Biliary Cirrhosis | 201 | 2 | Ursosiol (PRR 124.8) |
| 7088 | Deafness Congenital | 201 | 4 | Valganciclovir Hydrochloride Powder, (PRR 242.3) |
| 7089 | Jejunal Ulcer | 201 | 1 | Thiotepa (PRR 55.6) |
| 7090 | Herpes Dermatitis | 201 | 2 | Cefazolin (PRR 82.3) |
| 7091 | Exposure To Fungus | 201 | 1 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 74.3) |
| 7092 | Premenstrual Dysphoric Disorder | 200 | 5 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 87.6) |
| 7093 | Eosinophilic Bronchitis | 200 | 10 | Rabeprazole (PRR 665.6) |
| 7094 | Nasal Herpes | 200 | 3 | Instalax Polyethylene Glycol 3350 (PRR 69.9) |
| 7095 | Benign Hepatic Neoplasm | 200 | 1 | Drospirenone And Ethinyl Estradiol (PRR 32.7) |
| 7096 | Brain Tumour Operation | 200 | 3 | Temozolomide (PRR 91.7) |
| 7097 | Cutaneous Lymphoma | 200 | 4 | Baricitinib (PRR 89.9) |
| 7098 | Cephalo-Pelvic Disproportion | 200 | 1 | Peginterferon Beta-1A (PRR 49.1) |
| 7099 | Nephrogenic Fibrosing Dermopathy | 200 | 1 | Epoetin Alfa (PRR 122.1) |
| 7100 | Sodium Retention | 200 | 1 | Sevoflurane (PRR 104.3) |
| 7101 | Truncus Arteriosus Persistent | 199 | 13 | Nicotine Polacrilex Mini (PRR 820.6) |
| 7102 | Cd8 Lymphocytes Decreased | 199 | 3 | Fingolimod Hcl (PRR 49.4) |
| 7103 | Neuroblastoma Recurrent | 199 | 15 | Temozolomide (PRR 232.9) |
| 7104 | C3 Glomerulopathy | 199 | 4 | Eculizumab (PRR 121.4) |
| 7105 | Withdrawal Hypertension | 199 | 4 | Clonidine (PRR 143.4) |
| 7106 | Systemic Toxicity | 199 | 1 | Bupivacaine (PRR 117.8) |
| 7107 | Hyponatraemic Encephalopathy | 199 | 1 | Bupivacaine (PRR 57.4) |
| 7108 | Nail Hypertrophy | 199 | 1 | Terbinafine Hydrochloride (PRR 72.8) |
| 7109 | Human Ehrlichiosis | 198 | 11 | Valganciclovir Hydrochloride Powder, (PRR 473.1) |
| 7110 | Perineal Infection | 198 | 5 | Dimenhydrinate (PRR 183.4) |
| 7111 | Alcoholic | 198 | 5 | Ethyl Alcohol (PRR 81.2) |
| 7112 | Progressive Supranuclear Palsy | 198 | 2 | Levodopa (PRR 91.6) |
| 7113 | Refractory Cytopenia With Unilineage Dysplasia | 198 | 4 | Epoetin Alfa (PRR 93.4) |
| 7114 | Product Quality Control Issue | 198 | 2 | Botulinum Toxin Type A (PRR 61.4) |
| 7115 | Retinal Aneurysm | 198 | 3 | Ranibizumab (PRR 168.1) |
| 7116 | Pleural Adhesion | 198 | 2 | Canakinumab (PRR 91.6) |
| 7117 | Abnormal Palmar/Plantar Creases | 198 | 4 | Ziprasidone (PRR 162.9) |
| 7118 | Severe Cutaneous Adverse Reaction | 198 | 1 | Bosutinib (PRR 110.3) |
| 7119 | Salmonella Bacteraemia | 198 | 1 | Dutasteride (PRR 66.3) |
| 7120 | Leukoderma | 197 | 5 | Nivolumab (PRR 234.8) |
| 7121 | Chemical Peritonitis | 197 | 3 | Sevoflurane (PRR 119.8) |
| 7122 | Antibody Test Negative | 197 | 2 | Agalsidase Beta (PRR 212.6) |
| 7123 | Pancreatic Abscess | 197 | 2 | Gemcitabine Hydrochloride (PRR 51.7) |
| 7124 | Menstrual Clots | 197 | 1 | Etonogestrel (PRR 33.3) |
| 7125 | Jaw Clicking | 197 | 8 | Esomeprazole Magnesium Capsule, Delayed Release (PRR 118.1) |
| 7126 | Shoulder Deformity | 197 | 1 | Paliperidone Palmitate (PRR 23.8) |
| 7127 | Haemoglobin | 197 | 2 | Temozolomide (PRR 36.4) |
| 7128 | Vitreal Cells | 197 | 4 | Aflibercept (PRR 465.1) |
| 7129 | Herpes Simplex Test Positive | 197 | 7 | Ganciclovir (PRR 86.0) |
| 7130 | Vessel Puncture Site Haematoma | 197 | 2 | Prasugrel Hydrochloride (PRR 181.0) |
| 7131 | Tongue Haematoma | 197 | 2 | Miconazole Nitrate (PRR 87.8) |
| 7132 | Nonalcoholic Fatty Liver Disease | 196 | 5 | Thiamine Hydrochloride (PRR 179.4) |
| 7133 | Prolactin-Producing Pituitary Tumour | 196 | 2 | Paliperidone Palmitate (PRR 38.4) |
| 7134 | Cellulitis Gangrenous | 196 | 7 | Eplerenone (PRR 105.9) |
| 7135 | Protein S Deficiency | 196 | 2 | Etonogestrel And Ethinyl Estradiol (PRR 203.8) |
| 7136 | Gastrointestinal Angiodysplasia Haemorrhagic | 195 | 1 | Rivaroxaban (PRR 145.4) |
| 7137 | Acne Fulminans | 195 | 3 | Isotretinoin (PRR 766.6) |
| 7138 | Chronic Graft Versus Host Disease In Eye | 195 | 11 | Busulfan (PRR 221.6) |
| 7139 | Exposure To Unspecified Agent | 195 | 4 | Instalax Polyethylene Glycol 3350 (PRR 517.6) |
| 7140 | Deafness Permanent | 195 | 9 | Methimazole (PRR 683.9) |
| 7141 | Medical Diet | 195 | 3 | Drospirenone And Ethinyl Estradiol (PRR 117.5) |
| 7142 | Alcoholic Pancreatitis | 195 | 2 | Ethyl Alcohol (PRR 41.4) |
| 7143 | Stent Malfunction | 195 | 3 | Prasugrel Hydrochloride (PRR 76.2) |
| 7144 | Retinopathy Proliferative | 195 | 2 | Ranibizumab (PRR 84.5) |
| 7145 | Hernia Obstructive | 195 | 1 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 17.6) |
| 7146 | Vessel Puncture Site Bruise | 195 | 3 | Ado-Trastuzumab Emtansine (PRR 176.3) |
| 7147 | Gingival Atrophy | 195 | 1 | Vigabatrin (PRR 53.1) |
| 7148 | Hypochromasia | 195 | 2 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 134.6) |
| 7149 | Device Extrusion | 194 | 2 | Etonogestrel (PRR 52.8) |
| 7150 | Factor V Inhibition | 194 | 11 | Ceftriaxone (PRR 290.5) |
| 7151 | Bronchial Fistula | 194 | 3 | Erlotinib Hydrochloride (PRR 90.3) |
| 7152 | Brachydactyly | 194 | 5 | Nevirapine (PRR 295.0) |
| 7153 | Oral Blood Blister | 194 | 3 | Eltrombopag Olamine (PRR 64.8) |
| 7154 | Encopresis | 194 | 2 | Valproate Sodium (PRR 135.3) |
| 7155 | Band Neutrophil Count Increased | 194 | 2 | Dimenhydrinate (PRR 199.7) |
| 7156 | Poor Weight Gain Neonatal | 194 | 2 | Misoprostol (PRR 91.9) |
| 7157 | Infantile Vomiting | 194 | 2 | Vigabatrin (PRR 22.4) |
| 7158 | Thrombophlebitis Septic | 194 | 1 | Thiotepa (PRR 69.5) |
| 7159 | Epidural Injection | 193 | 1 | Upadacitinib (PRR 48.7) |
| 7160 | Atonic Urinary Bladder | 193 | 1 | Ocrelizumab (PRR 52.1) |
| 7161 | Lymph Node Calcification | 193 | 6 | Ciclesonide (PRR 196.5) |
| 7162 | Wound Closure | 193 | 2 | Zoledronic Acid (PRR 143.9) |
| 7163 | Genital Tract Inflammation | 193 | 1 | Osimertinib (PRR 28.0) |
| 7164 | Ocular Procedural Complication | 193 | 2 | Losartan Potassium And Hydrochlorothiazide (PRR 161.9) |
| 7165 | Subretinal Fibrosis | 193 | 3 | Ranibizumab (PRR 566.3) |
| 7166 | Adenocarcinoma Metastatic | 193 | 4 | Panitumumab (PRR 103.8) |
| 7167 | Penile Infection | 193 | 1 | Canagliflozin (PRR 34.0) |
| 7168 | Weight Decrease Neonatal | 193 | 5 | Nicotine Polacrilex Mini (PRR 100.1) |
| 7169 | Antiphospholipid Antibodies | 193 | 14 | Chlorhexidine Gluconate (PRR 151.0) |
| 7170 | Pseudoaldosteronism | 193 | 4 | Posaconazole (PRR 1,266.8) |
| 7171 | Congenital Pulmonary Hypertension | 193 | 2 | Nicotine Polacrilex Mini (PRR 67.8) |
| 7172 | Oligoarthritis | 193 | 3 | Rifampin (PRR 155.6) |
| 7173 | Injection Site Hyperaesthesia | 193 | 1 | Peginterferon Beta-1A (PRR 42.2) |
| 7174 | In-Stent Coronary Artery Restenosis | 193 | 1 | Prasugrel Hydrochloride (PRR 715.9) |
| 7175 | Fracture Malunion | 193 | 1 | Nevirapine (PRR 48.8) |
| 7176 | Granulocytosis | 193 | 1 | Lumacaftor And Ivacaftor (PRR 38.3) |
| 7177 | Cryopyrin Associated Periodic Syndrome | 192 | 6 | Canakinumab (PRR 2,370.0) |
| 7178 | Eyelid Sensory Disorder | 192 | 2 | Onabotulinumtoxina (PRR 164.8) |
| 7179 | Metastases To Spinal Cord | 192 | 12 | Goserelin (PRR 210.8) |
| 7180 | Eosinophil Percentage Decreased | 192 | 5 | Alemtuzumab (PRR 153.6) |
| 7181 | Choroidal Haemorrhage | 192 | 4 | Faricimab (PRR 141.1) |
| 7182 | Familial Mediterranean Fever | 192 | 3 | Canakinumab (PRR 1,403.1) |
| 7183 | Bone Sarcoma | 192 | 2 | Thiotepa (PRR 198.1) |
| 7184 | Ocular Rosacea | 192 | 1 | Lifitegrast (PRR 34.0) |
| 7185 | Deformity Thorax | 192 | 4 | Lopinavir And Ritonavir (PRR 130.1) |
| 7186 | Metastatic Bronchial Carcinoma | 192 | 1 | Apalutamide (PRR 28.1) |
| 7187 | Congenital Megaureter | 192 | 2 | Misoprostol (PRR 142.4) |
| 7188 | Lipomatosis | 192 | 1 | Bleomycin Sulfate (PRR 76.2) |
| 7189 | Coombs Negative Haemolytic Anaemia | 192 | 1 | Polatuzumab Vedotin (PRR 33.8) |
| 7190 | Cryptogenic Organizing Pneumonia | 192 | 1 | Gefitinib (PRR 49.0) |
| 7191 | Semen Analysis Abnormal | 191 | 1 | Finasteride (PRR 411.2) |
| 7192 | Gastrostomy Tube Site Complication | 191 | 7 | Teduglutide (PRR 103.5) |
| 7193 | Gamma-Glutamyltransferase Decreased | 191 | 2 | Fulvestrant (PRR 90.4) |
| 7194 | Gastrostomy Tube Insertion | 191 | 1 | Cinacalcet Hydrochloride (PRR 32.5) |
| 7195 | Haemangioma Of Bone | 191 | 2 | Dabrafenib (PRR 48.8) |
| 7196 | Tonsillitis Bacterial | 191 | 1 | Azacitidine For (PRR 50.0) |
| 7197 | Failed Induction Of Labour | 191 | 1 | Rimegepant Sulfate (PRR 71.8) |
| 7198 | Right Atrial Enlargement | 191 | 2 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 137.7) |
| 7199 | Smoker | 190 | 1 | Varenicline Tartrate (PRR 128.5) |
| 7200 | Cystitis Radiation | 190 | 4 | Bicalutamide (PRR 83.9) |
| 7201 | Upper Respiratory Fungal Infection | 190 | 5 | Itraconazole (PRR 245.3) |
| 7202 | Metastases To Abdominal Wall | 190 | 3 | Letrozole Tablets (PRR 74.6) |
| 7203 | Adulterated Product | 190 | 11 | Theophylline Anhydrous (PRR 365.7) |
| 7204 | Plasmacytosis | 190 | 4 | Methimazole (PRR 101.4) |
| 7205 | Poriomania | 190 | 2 | Donepezil Hydrochloride (PRR 78.0) |
| 7206 | Chorioamnionitis | 190 | 5 | Cefazolin (PRR 140.1) |
| 7207 | Congenital Tricuspid Valve Incompetence | 190 | 3 | Cefuroxime (PRR 101.1) |
| 7208 | Dyssomnia | 190 | 1 | Suvorexant (PRR 34.5) |
| 7209 | General Physical Condition Decreased | 190 | 1 | Siponimod (PRR 50.2) |
| 7210 | Thymus Disorder | 190 | 2 | Ampicillin (PRR 139.6) |
| 7211 | Catheter Site Vesicles | 189 | 6 | Epoprostenol (PRR 1,000.0) |
| 7212 | Contraindication To Vaccination | 189 | 2 | Ustekinumab (PRR 57.8) |
| 7213 | Pelvic Floor Dysfunction | 189 | 5 | Vibegron (PRR 56.1) |
| 7214 | Pneumonia Adenoviral | 189 | 12 | Melphalan Hydrochloride (PRR 156.4) |
| 7215 | Macular Scar | 189 | 3 | Ranibizumab (PRR 492.8) |
| 7216 | Alveolar Lung Disease | 189 | 9 | Rifampicin (PRR 270.9) |
| 7217 | Parkinsonian Rest Tremor | 189 | 3 | Primidone (PRR 114.1) |
| 7218 | Rickets | 189 | 4 | Asfotase Alfa (PRR 179.0) |
| 7219 | Septic Pulmonary Embolism | 189 | 2 | Daptomycin (PRR 99.7) |
| 7220 | Vitamin B6 Increased | 189 | 1 | Asfotase Alfa (PRR 1,771.4) |
| 7221 | Sight Disability | 189 | 1 | Thiotepa (PRR 71.4) |
| 7222 | Chest Wall Abscess | 189 | 1 | Atovaquone (PRR 99.4) |
| 7223 | Cervix Haemorrhage Uterine | 188 | 2 | Levonorgestrel (PRR 21.0) |
| 7224 | Human Bocavirus Infection | 188 | 30 | Pegaspargase (PRR 4,004.8) |
| 7225 | Acanthamoeba Infection | 188 | 15 | Posaconazole Delayed-Release (PRR 264.1) |
| 7226 | Oesophageal Polyp | 188 | 2 | Ciclesonide (PRR 142.1) |
| 7227 | Meningococcal Sepsis | 188 | 3 | Eculizumab (PRR 322.1) |
| 7228 | Idiopathic Orbital Inflammation | 188 | 3 | Faricimab (PRR 288.6) |
| 7229 | Chorioretinal Disorder | 188 | 5 | Triamcinolone Acetonide Ointment Usp, 0.05% (PRR 117.7) |
| 7230 | Greater Trochanteric Pain Syndrome | 188 | 7 | Clobetasol Propionate Ointment Usp, 0.05% (PRR 101.6) |
| 7231 | Benign Pancreatic Neoplasm | 188 | 1 | Lanreotide Acetate (PRR 87.5) |
| 7232 | Uterine Cervical Pain | 187 | 2 | Copper (PRR 157.2) |
| 7233 | Starvation Ketoacidosis | 187 | 3 | Thiamine Hydrochloride (PRR 104.5) |
| 7234 | Intraocular Pressure Fluctuation | 187 | 10 | Travoprost (PRR 209.7) |
| 7235 | Dehiscence | 187 | 10 | Amphotericin B (PRR 176.8) |
| 7236 | Organic Brain Syndrome | 187 | 3 | Obinutuzumab (PRR 79.0) |
| 7237 | Rhabdomyosarcoma | 187 | 3 | Zidovudine (PRR 97.2) |
| 7238 | Total Cholesterol/Hdl Ratio Increased | 187 | 2 | Inclisiran (PRR 42.3) |
| 7239 | Supine Hypertension | 187 | 3 | Droxidopa (PRR 2,953.7) |
| 7240 | Developmental Coordination Disorder | 187 | 2 | Valproate Sodium (PRR 347.4) |
| 7241 | Neutrophil Pelger-Huet Anomaly Present | 187 | 7 | Ganciclovir Sodium (PRR 171.4) |
| 7242 | Malignant Polyp | 187 | 2 | Pramipexole (PRR 101.4) |
| 7243 | Coloboma | 187 | 1 | Darunavir (PRR 77.7) |
| 7244 | Procedural Hypertension | 187 | 2 | Sevoflurane (PRR 250.3) |
| 7245 | Interstitial Granulomatous Dermatitis | 187 | 3 | Diclofenac Potassium (PRR 42.1) |
| 7246 | Anastomotic Haemorrhage | 187 | 2 | Fondaparinux Sodium (PRR 70.6) |
| 7247 | Osteonecrosis Of External Auditory Canal | 186 | 3 | Imatinib (PRR 118.6) |
| 7248 | Genital Infection Female | 186 | 1 | Levonorgestrel (PRR 20.5) |
| 7249 | Haematopoietic Neoplasm | 186 | 2 | Tretinoin (PRR 308.8) |
| 7250 | Myelocyte Count Increased | 186 | 9 | Dimenhydrinate (PRR 209.2) |
| 7251 | High-Grade B-Cell Lymphoma | 186 | 9 | Axicabtagene Ciloleucel (PRR 184.9) |
| 7252 | Urinary Tract Candidiasis | 186 | 6 | Anti-Thymocyte Globulin (Rabbit) (PRR 193.8) |
| 7253 | Type 2 Lepra Reaction | 186 | 10 | Minocycline (PRR 892.2) |
| 7254 | Postoperative Delirium | 186 | 7 | Sevoflurane (PRR 335.8) |
| 7255 | Mycotic Endophthalmitis | 186 | 11 | Micafungin Sodium (PRR 312.3) |
| 7256 | Staphylococcal Osteomyelitis | 186 | 1 | Canagliflozin (PRR 52.2) |
| 7257 | Pyelonephritis Chronic | 186 | 3 | Pyrazinamide (PRR 61.2) |
| 7258 | Parasitic Gastroenteritis | 186 | 2 | Everolimus Tablets (PRR 78.0) |
| 7259 | Suspected Drug-Induced Liver Injury | 186 | 2 | Atovaquone (PRR 101.1) |
| 7260 | Foetal Heart Rate Disorder | 186 | 2 | Misoprostol (PRR 243.1) |
| 7261 | Hepatic Vascular Thrombosis | 186 | 1 | Glecaprevir And Pibrentasvir (PRR 31.0) |
| 7262 | Physical Abuse | 186 | 1 | Amphetamine (PRR 189.0) |
| 7263 | Injection Site Eczema | 185 | 1 | Dupilumab (PRR 33.6) |
| 7264 | Cor Pulmonale Chronic | 185 | 5 | Epoprostenol (PRR 62.5) |
| 7265 | Application Site Injury | 185 | 6 | Alirocumab (PRR 67.9) |
| 7266 | Radiation Proctitis | 185 | 3 | Bicalutamide (PRR 69.8) |
| 7267 | T-Lymphocyte Count Increased | 185 | 4 | Anti-Thymocyte Globulin (Rabbit) (PRR 86.5) |
| 7268 | Antidepressant Discontinuation Syndrome | 185 | 3 | Venlafaxine (PRR 142.5) |
| 7269 | Administration Site Discomfort | 185 | 2 | Etonogestrel (PRR 68.0) |
| 7270 | Haemofiltration | 185 | 2 | Vincristine Sulfate (PRR 62.6) |
| 7271 | Neurotransmitter Level Altered | 185 | 2 | Vigabatrin (PRR 23.5) |
| 7272 | Spider Naevus | 185 | 4 | Ado-Trastuzumab Emtansine (PRR 217.7) |
| 7273 | Kidney Rupture | 185 | 3 | Basiliximab (PRR 101.1) |
| 7274 | Laryngeal Inflammation | 185 | 2 | Cefepime Hydrochloride (PRR 66.0) |
| 7275 | Anaemia Folate Deficiency | 185 | 7 | Calcium Gluconate (PRR 119.7) |
| 7276 | Congenital Aortic Anomaly | 185 | 1 | Darunavir (PRR 70.3) |
| 7277 | Social Fear | 185 | 1 | Buspirone Hydrochloride (PRR 96.4) |
| 7278 | Hydrometra | 184 | 2 | Copper (PRR 75.8) |
| 7279 | Sleep Disorder Therapy | 184 | 78 | Phytonadione (PRR 5,904.1) |
| 7280 | Immune-Mediated Gastritis | 184 | 5 | Pembrolizumab (PRR 292.6) |
| 7281 | Chronic Graft Versus Host Disease In Intestine | 184 | 11 | Thiotepa (PRR 358.5) |
| 7282 | Hydrocholecystis | 184 | 4 | Doxepin (PRR 105.6) |
| 7283 | Blood Ketone Body Present | 184 | 2 | Zidovudine (PRR 128.1) |
| 7284 | Sclerosing Encapsulating Peritonitis | 184 | 1 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 356.9) |
| 7285 | Arterial Insufficiency | 184 | 1 | Nilotinib (PRR 53.6) |
| 7286 | Skin Pressure Mark | 184 | 1 | Alirocumab (PRR 696.2) |
| 7287 | Perseveration | 184 | 1 | Droxidopa (PRR 16.0) |
| 7288 | Tumour Embolism | 184 | 2 | Sorafenib (PRR 108.6) |
| 7289 | Refractory Anaemia | 184 | 1 | Erythropoietin (PRR 76.9) |
| 7290 | Arteriovenous Fistula Site Haemorrhage | 184 | 4 | Sevelamer Carbonate (PRR 115.1) |
| 7291 | Bifascicular Block | 184 | 3 | Memantine (PRR 78.2) |
| 7292 | Cerebral Ventricular Rupture | 184 | 2 | Febuxostat Tablets 40 Mg (PRR 80.9) |
| 7293 | Mouth Cyst | 184 | 1 | Loratadine And Pseudoephedrine Sulfate (PRR 43.4) |
| 7294 | Acute Cholecystitis Necrotic | 183 | 3 | Anti-Thymocyte Globulin (Rabbit) (PRR 149.1) |
| 7295 | Cytomegalovirus Antigen Positive | 183 | 7 | Ganciclovir (PRR 208.2) |
| 7296 | B-Lymphocyte Count Increased | 183 | 1 | Ocrelizumab (PRR 197.9) |
| 7297 | Lactation Insufficiency | 183 | 4 | Aripiprazole Oral (PRR 90.8) |
| 7298 | Mycobacterium Fortuitum Infection | 183 | 11 | Amikacin (PRR 239.1) |
| 7299 | Granulomatous Lymphadenitis | 183 | 4 | Pyrazinamide (PRR 101.3) |
| 7300 | Iris Transillumination Defect | 183 | 2 | Moxifloxacin Hydrochloride (PRR 1,694.5) |
| 7301 | Bone Decalcification | 183 | 1 | Paricalcitol (PRR 32.9) |
| 7302 | Intestinal Mucosal Hypertrophy | 183 | 1 | Teduglutide (PRR 61.4) |
| 7303 | Acinetobacter Bacteraemia | 183 | 1 | Remdesivir (PRR 43.8) |
| 7304 | Administration Related Reaction | 183 | 1 | Meperidine Hydrochloride (PRR 130.5) |
| 7305 | Application Site Haematoma | 182 | 1 | Pegfilgrastim (PRR 23.0) |
| 7306 | Emphysematous Pyelonephritis | 182 | 7 | Anti-Thymocyte Globulin (Rabbit) (PRR 265.7) |
| 7307 | Implant Site Abscess | 182 | 1 | Etonogestrel (PRR 381.3) |
| 7308 | Iiird Nerve Paresis | 182 | 4 | Sumatriptan Succinate (PRR 143.3) |
| 7309 | Musculoskeletal Toxicity | 182 | 11 | Anastrozole Tablets (PRR 133.2) |
| 7310 | Neurosurgery | 182 | 2 | Clobazam (PRR 60.1) |
| 7311 | Porokeratosis | 182 | 2 | Durvalumab (PRR 34.8) |
| 7312 | Intestinal Scarring | 182 | 1 | Aprepitant (PRR 79.5) |
| 7313 | Cutaneous Tuberculosis | 182 | 4 | Pyrazinamide (PRR 184.6) |
| 7314 | Cerebellar Ischaemia | 182 | 1 | Nebivolol (PRR 117.3) |
| 7315 | Chest Tube Insertion | 182 | 2 | Bupivacaine (PRR 75.9) |
| 7316 | Post Procedural Stroke | 182 | 2 | Sevoflurane (PRR 115.1) |
| 7317 | Hanging | 181 | 3 | Ethyl Alcohol (PRR 74.2) |
| 7318 | Transmission Of An Infectious Agent Via Product | 181 | 2 | Voriconazole Injection (PRR 105.7) |
| 7319 | Harvey-Bradshaw Index Increased | 181 | 1 | Infliximab-Dyyb (PRR 6,439.3) |
| 7320 | Anal Fissure Haemorrhage | 181 | 2 | Infliximab-Dyyb (PRR 83.4) |
| 7321 | Tuberculoma Of Central Nervous System | 181 | 10 | Pyrazinamide (PRR 2,446.8) |
| 7322 | Complement Factor C4 Decreased | 181 | 2 | Voclosporin (PRR 216.5) |
| 7323 | Monocyte Percentage Decreased | 181 | 2 | Alemtuzumab (PRR 164.4) |
| 7324 | Influenza B Virus Test Positive | 181 | 2 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 28.1) |
| 7325 | Magnetic Resonance Imaging Brain Abnormal | 181 | 1 | Vigabatrin (PRR 147.9) |
| 7326 | Cutaneous Calcification | 181 | 3 | Bleomycin Sulfate (PRR 130.3) |
| 7327 | Nikolsky'S Sign | 181 | 4 | Salmeterol Xinafoate (PRR 111.6) |
| 7328 | Blood Insulin Abnormal | 181 | 1 | Insulin Glulisine (PRR 58.1) |
| 7329 | Difficulty Removing Drug Implant | 180 | 1 | Etonogestrel (PRR 1,740.6) |
| 7330 | Hungry Bone Syndrome | 180 | 5 | Cinacalcet Hydrochloride (PRR 191.0) |
| 7331 | Abdominal Strangulated Hernia | 180 | 1 | Orlistat (PRR 22.9) |
| 7332 | Crystal Arthropathy | 180 | 2 | Methylprednisolone Acetate (PRR 120.8) |
| 7333 | Lung Squamous Cell Carcinoma Stage Unspecified | 180 | 1 | Erlotinib Hydrochloride (PRR 47.5) |
| 7334 | Laryngeal Obstruction | 180 | 3 | Sevoflurane (PRR 116.4) |
| 7335 | Myocarditis-Myositis-Myasthenia Gravis Overlap Syndrome | 179 | 6 | Pembrolizumab (PRR 148.6) |
| 7336 | Flat Anterior Chamber Of Eye | 179 | 6 | Topiramate (PRR 112.1) |
| 7337 | Malignant Melanoma Stage 0 | 179 | 52 | Oseltamivir (PRR 801.1) |
| 7338 | Acute Monocytic Leukaemia | 179 | 5 | Cytarabine (PRR 119.5) |
| 7339 | Parkinsonism Hyperpyrexia Syndrome | 179 | 7 | Pramipexole (PRR 455.8) |
| 7340 | Tumour Marker Decreased | 179 | 7 | Alpelisib (PRR 351.9) |
| 7341 | Herpes Simplex Oesophagitis | 179 | 2 | Micafungin Sodium (PRR 455.0) |
| 7342 | Osteoma | 179 | 4 | Febuxostat Tablets 40 Mg (PRR 160.2) |
| 7343 | Diabetic Ketoacidotic Hyperglycaemic Coma | 179 | 1 | Pemetrexed (PRR 51.3) |
| 7344 | Herpes Zoster Meningitis | 179 | 2 | Baricitinib (PRR 101.0) |
| 7345 | Malignant Neoplasm Of Spinal Cord | 179 | 1 | Peginterferon Beta-1A (PRR 36.3) |
| 7346 | Blood Test | 179 | 1 | Acalabrutinib (PRR 49.3) |
| 7347 | Drug Cross-Reactivity | 179 | 2 | Febuxostat Tablets 40 Mg (PRR 83.3) |
| 7348 | Immune-Mediated Uveitis | 178 | 3 | Nivolumab (PRR 505.4) |
| 7349 | Implant Site Hypoaesthesia | 178 | 1 | Etonogestrel (PRR 3,437.6) |
| 7350 | Acute Hepatitis C | 178 | 2 | Darunavir (PRR 73.2) |
| 7351 | Metastases To Nervous System | 178 | 5 | Goserelin (PRR 163.6) |
| 7352 | Encapsulating Peritoneal Sclerosis | 178 | 2 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 104.3) |
| 7353 | Ovarian Cystectomy | 178 | 1 | Etonogestrel And Ethinyl Estradiol (PRR 112.0) |
| 7354 | Penicillium Infection | 178 | 2 | Itraconazole (PRR 106.0) |
| 7355 | Floppy Infant | 178 | 1 | Palivizumab (PRR 31.1) |
| 7356 | Diaphragmatic Rupture | 178 | 1 | Botulinum Toxin Type A (PRR 110.4) |
| 7357 | Nerve Degeneration | 178 | 1 | Cholestyramine (PRR 91.6) |
| 7358 | Meningoencephalitis Viral | 178 | 2 | Efavirenz (PRR 134.9) |
| 7359 | Removal Of Internal Fixation | 177 | 3 | Alendronate Sodium (PRR 371.4) |
| 7360 | High Risk Sexual Behaviour | 177 | 3 | Sildenafil Powder, (PRR 181.6) |
| 7361 | Metastases To Muscle | 177 | 6 | Blinatumomab (PRR 145.0) |
| 7362 | Implant Site Mass | 177 | 2 | Etonogestrel (PRR 591.8) |
| 7363 | Gingival Oedema | 177 | 1 | Chlorhexidine Gluconate (PRR 136.3) |
| 7364 | Insulinoma | 176 | 3 | Everolimus Tablets (PRR 168.0) |
| 7365 | Melanoderma | 176 | 2 | Pemetrexed Disodium (PRR 66.0) |
| 7366 | Metabolic Dysfunction-Associated Liver Disease | 176 | 3 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 100.1) |
| 7367 | Cutaneous Mucormycosis | 176 | 14 | Atovaquone (PRR 350.1) |
| 7368 | Stoma Site Ulcer | 176 | 4 | Loperamide Hydrochloride Oral (PRR 109.8) |
| 7369 | Bacterial Colitis | 176 | 1 | Sirolimus (PRR 73.5) |
| 7370 | Brain Stem Ischaemia | 176 | 1 | Agalsidase Beta (PRR 39.0) |
| 7371 | Conjunctival Pallor | 176 | 1 | Fondaparinux Sodium (PRR 90.7) |
| 7372 | Fear Of Needles | 175 | 1 | Interferon Beta-1A (PRR 172.1) |
| 7373 | Rheumatoid Factor Negative | 175 | 9 | Leflunomide (PRR 1,245.1) |
| 7374 | Tobacco Withdrawal Symptoms | 175 | 3 | Varenicline Tartrate (PRR 427.9) |
| 7375 | Selective Abortion | 175 | 2 | Isotretinoin (PRR 177.5) |
| 7376 | Pancreatic Duct Obstruction | 175 | 2 | Pancrelipase (PRR 93.9) |
| 7377 | Ventricular Asystole | 175 | 4 | Labetalol (PRR 135.7) |
| 7378 | Dextrocardia | 175 | 3 | Nevirapine (PRR 81.9) |
| 7379 | Anticonvulsant Drug Level Abnormal | 175 | 4 | Extended Phenytoin Sodium (PRR 665.1) |
| 7380 | Oesophageal Hypomotility | 175 | 1 | Temozolomide (PRR 41.1) |
| 7381 | Pneumonectomy | 175 | 1 | Ranolazine (PRR 46.6) |
| 7382 | Globotriaosylsphingosine Increased | 175 | 1 | Agalsidase Beta (PRR 54,021.6) |
| 7383 | Ventricular Enlargement | 174 | 5 | Eplerenone (PRR 380.2) |
| 7384 | Arteriovenous Fistula Occlusion | 174 | 11 | Dimenhydrinate (PRR 297.4) |
| 7385 | May-Thurner Syndrome | 174 | 4 | Etonogestrel And Ethinyl Estradiol (PRR 279.9) |
| 7386 | Genitourinary Symptom | 174 | 2 | Polatuzumab Vedotin (PRR 63.1) |
| 7387 | Drug Resistance Mutation | 174 | 14 | Osimertinib (PRR 239.9) |
| 7388 | Panophthalmitis | 174 | 4 | Micafungin Sodium (PRR 72.6) |
| 7389 | Waxy Flexibility | 174 | 2 | Haloperidol Lactate (PRR 127.9) |
| 7390 | Bone Marrow Myelogram Abnormal | 174 | 2 | Romiplostim (PRR 49.3) |
| 7391 | Athetosis | 174 | 1 | Erythropoietin (PRR 102.4) |
| 7392 | Intestinal Tuberculosis | 174 | 2 | Isoniazid (PRR 121.1) |
| 7393 | Blood Prolactin Decreased | 174 | 3 | Liothyronine Sodium (PRR 85.3) |
| 7394 | Malignant Neoplasm Oligoprogression | 173 | 7 | Pemetrexed (PRR 141.3) |
| 7395 | Application Site Perspiration | 173 | 3 | Nicotine (PRR 107.7) |
| 7396 | Dysaesthesia Pharynx | 173 | 4 | Oxaliplatin (PRR 554.3) |
| 7397 | Blood Follicle Stimulating Hormone Decreased | 173 | 2 | Testosterone (PRR 84.4) |
| 7398 | Genitalia External Ambiguous | 173 | 9 | Zidovudine (PRR 530.6) |
| 7399 | Sicca Syndrome | 173 | 5 | Durvalumab (PRR 97.0) |
| 7400 | Aeromonas Infection | 173 | 13 | Selinexor (PRR 179.1) |
| 7401 | Ophthalmological Examination Abnormal | 173 | 3 | Vigabatrin (PRR 186.5) |
| 7402 | Tooth Malformation | 173 | 2 | Valproate Sodium (PRR 154.3) |
| 7403 | Anti-Platelet Antibody Positive | 173 | 2 | Romiplostim (PRR 84.8) |
| 7404 | Cystic Lymphangioma | 173 | 2 | Dolutegravir Sodium (PRR 68.6) |
| 7405 | Intestinal Haematoma | 173 | 1 | Emicizumab (PRR 29.7) |
| 7406 | Pituitary Tumour Recurrent | 172 | 1 | Somatropin (PRR 136.3) |
| 7407 | Glycosylated Haemoglobin | 172 | 2 | Inclisiran (PRR 126.6) |
| 7408 | Hepatitis C Rna Positive | 172 | 6 | Sofosbuvir (PRR 396.3) |
| 7409 | Viral Load | 172 | 10 | Glecaprevir And Pibrentasvir (PRR 142.0) |
| 7410 | Retinoic Acid Syndrome | 172 | 2 | Tretinoin (PRR 1,845.5) |
| 7411 | Enterovirus Test Positive | 172 | 4 | Mercaptopurine (PRR 213.6) |
| 7412 | Complement Factor Decreased | 172 | 3 | Voclosporin (PRR 212.3) |
| 7413 | Chondritis | 172 | 2 | Tobramycin Solution (PRR 62.6) |
| 7414 | Pericardial Effusion Malignant | 172 | 2 | Osimertinib (PRR 40.0) |
| 7415 | Hyperoxaluria | 172 | 5 | Daptomycin (PRR 154.1) |
| 7416 | Blood Luteinising Hormone Decreased | 172 | 1 | Testosterone (PRR 91.2) |
| 7417 | Tongue Fungal Infection | 172 | 1 | Bimekizumab (PRR 29.2) |
| 7418 | Hepatitis Chronic Active | 172 | 1 | Abemaciclib (PRR 31.1) |
| 7419 | Tri-Iodothyronine Free Increased | 172 | 1 | Alemtuzumab (PRR 191.5) |
| 7420 | Instillation Site Swelling | 172 | 1 | Lifitegrast (PRR 1,007.7) |
| 7421 | Procedural Failure | 172 | 1 | Tolvaptan (PRR 69.8) |
| 7422 | Eyelid Bleeding | 172 | 1 | Emicizumab (PRR 60.9) |
| 7423 | Eyelid Injury | 172 | 2 | Dorzolamide Hydrochloride And Timolol Maleate (PRR 78.8) |
| 7424 | Medical Device Site Swelling | 172 | 1 | Bupivacaine (PRR 108.6) |
| 7425 | Fractional Exhaled Nitric Oxide Increased | 171 | 22 | Mometasone (PRR 2,905.0) |
| 7426 | Cardioactive Drug Level Decreased | 171 | 2 | Digoxin (PRR 1,957.8) |
| 7427 | Abdominal Haematoma | 171 | 1 | Enoxaparin Sodium (PRR 136.7) |
| 7428 | Blood Aldosterone Increased | 171 | 1 | Drospirenone And Ethinyl Estradiol (PRR 32.3) |
| 7429 | Blood Copper Increased | 171 | 2 | Copper (PRR 86.4) |
| 7430 | Blood Lactic Acid Decreased | 171 | 7 | Norepinephrine (PRR 414.1) |
| 7431 | Anal Injury | 171 | 1 | Sunitinib Malate (PRR 47.1) |
| 7432 | Recurrence Of Neuromuscular Blockade | 171 | 5 | Rocuronium Bromide (PRR 2,674.2) |
| 7433 | School Refusal | 171 | 1 | Atomoxetine Hydrochloride (PRR 77.9) |
| 7434 | Speech Sound Disorder | 171 | 2 | Valproate Sodium (PRR 133.3) |
| 7435 | Tooth Hypoplasia | 171 | 4 | Busulfan (PRR 145.9) |
| 7436 | Hangnail | 171 | 1 | Gefitinib (PRR 41.2) |
| 7437 | Thymus Hypoplasia | 170 | 35 | Filgrastim (PRR 2,925.4) |
| 7438 | Pneumonia Parainfluenzae Viral | 170 | 2 | Carfilzomib (PRR 55.8) |
| 7439 | Pelvic Floor Muscle Weakness | 170 | 1 | Copper (PRR 23.8) |
| 7440 | Carbon Monoxide Diffusing Capacity Decreased | 170 | 2 | Pirfenidone (PRR 113.8) |
| 7441 | Polysubstance Dependence | 170 | 3 | Ethyl Alcohol (PRR 119.7) |
| 7442 | Basophil Percentage Increased | 170 | 1 | Ribociclib (PRR 78.0) |
| 7443 | Astrocytoma, Low Grade | 170 | 5 | Trametinib (PRR 127.9) |
| 7444 | Varicella Virus Test Positive | 170 | 3 | Amphotericin B (PRR 126.1) |
| 7445 | Chemotherapeutic Drug Level Increased | 170 | 2 | Pegaspargase (PRR 188.8) |
| 7446 | Thalassaemia | 170 | 1 | Isoniazid (PRR 97.5) |
| 7447 | Latent Autoimmune Diabetes In Adults | 170 | 2 | Anti-Thymocyte Globulin (Rabbit) (PRR 144.2) |
| 7448 | Septic Encephalopathy | 170 | 3 | Daptomycin (PRR 82.5) |
| 7449 | Uterine Injury | 169 | 2 | Copper (PRR 149.4) |
| 7450 | Acute Myopia | 169 | 4 | Aripiprazole Oral (PRR 136.0) |
| 7451 | Tumefactive Multiple Sclerosis | 169 | 1 | Fingolimod Hcl (PRR 338.9) |
| 7452 | Cryptococcal Cutaneous Infection | 169 | 3 | Amphotericin B (PRR 126.9) |
| 7453 | Atrial Septal Defect Repair | 169 | 7 | Bosentan (PRR 154.1) |
| 7454 | Cardiac Output Increased | 169 | 11 | Norepinephrine (PRR 386.5) |
| 7455 | Pulmonary Arterial Wedge Pressure Increased | 169 | 5 | Selexipag (PRR 120.4) |
| 7456 | Spermatozoa Progressive Motility Decreased | 169 | 1 | Salicylic Acid (PRR 12.0) |
| 7457 | High Arched Palate | 169 | 3 | Misoprostol (PRR 92.3) |
| 7458 | Subchorionic Haematoma | 169 | 1 | Copper (PRR 20.8) |
| 7459 | Hemivertebra | 169 | 5 | Darunavir (PRR 440.5) |
| 7460 | Ocular Vasculitis | 169 | 3 | Faricimab (PRR 694.9) |
| 7461 | Eyelash Changes | 169 | 5 | Bimatoprost (PRR 428.7) |
| 7462 | Ph Urine Increased | 169 | 2 | Dimenhydrinate (PRR 371.2) |
| 7463 | Viral Load Abnormal | 169 | 8 | Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate (PRR 367.6) |
| 7464 | Ultrasound Doppler Abnormal | 169 | 2 | Baricitinib (PRR 107.2) |
| 7465 | Pneumopericardium | 169 | 2 | Erlotinib (PRR 92.8) |
| 7466 | Acute Cardiac Event | 169 | 1 | Rocuronium Bromide (PRR 42.8) |
| 7467 | Bone Atrophy | 169 | 2 | Granisetron Hydrochloride (PRR 112.0) |
| 7468 | Cervix Carcinoma Recurrent | 168 | 5 | Paclitaxel (Aibumin-Bound) (PRR 92.3) |
| 7469 | Cerebellar Hypoplasia | 168 | 3 | Nevirapine (PRR 146.0) |
| 7470 | Multisystem Inflammatory Syndrome | 168 | 1 | Valacyclovir (PRR 79.0) |
| 7471 | Metastases To Retroperitoneum | 168 | 4 | Blinatumomab (PRR 153.4) |
| 7472 | Cataract Congenital | 168 | 1 | Lacosamide (PRR 79.8) |
| 7473 | Thyroglobulin Increased | 168 | 2 | Lenvatinib (PRR 90.5) |
| 7474 | Application Site Induration | 168 | 4 | Glycerin, Lidocaine (PRR 64.6) |
| 7475 | Anaemia Of Pregnancy | 168 | 1 | Misoprostol (PRR 79.1) |
| 7476 | New Onset Diabetes After Transplantation | 167 | 9 | Tacrolimus (PRR 5,374.4) |
| 7477 | Bronchiolitis Obliterans Syndrome | 167 | 16 | Busulfan (PRR 402.7) |
| 7478 | Chronic Graft Versus Host Disease In Lung | 167 | 9 | Thiotepa (PRR 246.9) |
| 7479 | Saccadic Eye Movement | 167 | 1 | Paliperidone Palmitate (PRR 63.7) |
| 7480 | Catheter Site Abscess | 167 | 7 | Carboxymethylcellulose Sodium (PRR 171.4) |
| 7481 | Foetal Chromosome Abnormality | 167 | 4 | Dalteparin Sodium (PRR 125.3) |
| 7482 | Vaccination Site Swelling | 167 | 3 | Felodipine Extended-Release Tablets (PRR 128.8) |
| 7483 | Foetal Monitoring Abnormal | 167 | 1 | Fremanezumab-Vfrm (PRR 44.5) |
| 7484 | Infusion Site Injury | 166 | 3 | Ketoprofen (PRR 255.0) |
| 7485 | Disseminated Blastomycosis | 166 | 6 | Amphotericin B (PRR 201.9) |
| 7486 | Nuclear Magnetic Resonance Imaging | 166 | 3 | Pegfilgrastim (PRR 104.0) |
| 7487 | Cardioactive Drug Level Above Therapeutic | 166 | 1 | Digoxin (PRR 1,007.8) |
| 7488 | Acute Myeloid Leukaemia Refractory | 166 | 8 | Azacitidine For (PRR 507.0) |
| 7489 | Blood Glucose | 166 | 1 | Exenatide (PRR 94.2) |
| 7490 | Alopecia Scarring | 166 | 12 | Sirolimus (PRR 142.2) |
| 7491 | Unevaluable Investigation | 166 | 1 | Cinacalcet Hydrochloride (PRR 181.3) |
| 7492 | Heterotaxia | 166 | 7 | Atazanavir (PRR 165.1) |
| 7493 | Carnitine Deficiency | 166 | 1 | Valproic Acid (PRR 189.1) |
| 7494 | Haemodialysis Complication | 166 | 4 | Iron Sucrose (PRR 139.9) |
| 7495 | Lip Squamous Cell Carcinoma | 166 | 4 | Itraconazole (PRR 151.3) |
| 7496 | Papillitis | 166 | 2 | Linezolid (PRR 79.7) |
| 7497 | Rabbit Syndrome | 166 | 1 | Valbenazine (PRR 15.2) |
| 7498 | Illiteracy | 166 | 1 | Paliperidone (PRR 63.3) |
| 7499 | Phlebolith | 166 | 1 | Desoximetasone (PRR 62.6) |
| 7500 | Hepatojugular Reflux | 166 | 5 | Esomeprazole Magnesium Capsule, Delayed Release (PRR 185.3) |
| 7501 | Pituitary Apoplexy | 166 | 2 | Imatinib (PRR 117.1) |
| 7502 | Congenital Coronary Artery Malformation | 166 | 3 | Tafamidis (PRR 188.4) |
| 7503 | Nodular Melanoma | 166 | 2 | Busulfan (PRR 84.7) |
| 7504 | Endometrial Cancer Stage I | 166 | 1 | Raloxifene Hydrochloride (PRR 101.1) |
| 7505 | Encephalitis Brain Stem | 166 | 3 | Ampicillin (PRR 213.4) |
| 7506 | Infective Myositis | 166 | 1 | Pegaspargase (PRR 74.8) |
| 7507 | Prostatic Obstruction | 166 | 1 | Apalutamide (PRR 32.6) |
| 7508 | Carcinoma In Situ | 166 | 1 | Rizatriptan Benzoate (PRR 90.0) |
| 7509 | In Vitro Fertilisation | 166 | 1 | Agalsidase Beta (PRR 55.6) |
| 7510 | Rhodococcus Infection | 165 | 9 | Tacrolimus Ointment 0.1% (PRR 298.5) |
| 7511 | Acute Right Ventricular Failure | 165 | 3 | Epoprostenol (PRR 158.9) |
| 7512 | Epidermodysplasia Verruciformis | 165 | 5 | Sirolimus (PRR 165.8) |
| 7513 | Meningitis Meningococcal | 165 | 3 | Eculizumab (PRR 196.3) |
| 7514 | Hyperbaric Oxygen Therapy | 165 | 1 | Zoledronic Acid (PRR 96.8) |
| 7515 | Psoriasis Area Severity Index Increased | 165 | 3 | Bimekizumab (PRR 49.7) |
| 7516 | Anaplastic Astrocytoma | 165 | 4 | Temozolomide (PRR 265.7) |
| 7517 | Dysdiadochokinesis | 165 | 5 | Efavirenz (PRR 133.3) |
| 7518 | Hand-Eye Coordination Impaired | 165 | 1 | Esketamine Hydrochloride (PRR 21.6) |
| 7519 | Oesophagogastric Fundoplasty | 165 | 1 | Vigabatrin (PRR 26.4) |
| 7520 | Eye Operation Complication | 165 | 1 | Prednisolone Acetate (PRR 102.4) |
| 7521 | Ovarian Adenoma | 165 | 1 | Baricitinib (PRR 110.0) |
| 7522 | Scrotal Erythema | 164 | 1 | Cabozantinib (PRR 34.1) |
| 7523 | Hypocomplementaemia | 164 | 1 | Belimumab (PRR 56.5) |
| 7524 | Peritoneal Perforation | 164 | 2 | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 89.3) |
| 7525 | Lactobacillus Infection | 164 | 4 | Busulfan (PRR 183.6) |
| 7526 | Mycobacterium Kansasii Infection | 164 | 5 | Alemtuzumab (PRR 132.6) |
| 7527 | Decreased Gait Velocity | 164 | 3 | Thiamine Hydrochloride (PRR 168.2) |
| 7528 | Pneumobilia | 163 | 2 | Sitagliptin And Metformin Hydrochloride (PRR 127.2) |
| 7529 | Pleural Neoplasm | 163 | 7 | Ado-Trastuzumab Emtansine (PRR 178.6) |
| 7530 | Retinal Cyst | 163 | 2 | Ranibizumab (PRR 387.9) |
| 7531 | Interferon Gamma Release Assay Positive | 163 | 2 | Isoniazid (PRR 338.3) |
| 7532 | Feeding Disorder Of Infancy Or Early Childhood | 163 | 1 | Palivizumab (PRR 137.2) |
| 7533 | Basilar Artery Occlusion | 163 | 1 | Alteplase (PRR 71.5) |
| 7534 | Enlarged Clitoris | 163 | 2 | Tenofovir Disoproxil Fumarate Tablets (PRR 124.4) |
| 7535 | Foetal Malposition | 163 | 1 | Peginterferon Beta-1A (PRR 29.8) |
| 7536 | Coagulation Factor Viii Level Decreased | 163 | 1 | Emicizumab (PRR 53.3) |
| 7537 | Interleukin-2 Receptor Increased | 163 | 2 | Anti-Thymocyte Globulin (Rabbit) (PRR 98.6) |
| 7538 | Acute Macular Neuroretinopathy | 163 | 2 | Bupivacaine (PRR 403.4) |
| 7539 | Adnexa Uteri Cyst | 162 | 3 | Etonogestrel And Ethinyl Estradiol (PRR 68.3) |
| 7540 | Cytomegalovirus Syndrome | 162 | 12 | Valganciclovir Hydrochloride Powder, (PRR 1,003.2) |
| 7541 | Leukaemia Plasmacytic | 162 | 2 | Thalidomide (PRR 217.7) |
| 7542 | Urine Ketone Body | 162 | 2 | Empagliflozin (PRR 129.7) |
| 7543 | Congenital Hearing Disorder | 162 | 2 | Lopinavir And Ritonavir (PRR 111.8) |
| 7544 | Diastolic Hypotension | 162 | 3 | Riociguat (PRR 156.9) |
| 7545 | Abscess Fungal | 162 | 9 | Amphotericin B (PRR 157.1) |
| 7546 | Manic Symptom | 162 | 6 | Cariprazine (PRR 211.4) |
| 7547 | Hepatic Calcification | 162 | 2 | Blinatumomab (PRR 90.0) |
| 7548 | Fibromuscular Dysplasia | 162 | 1 | Ciclesonide (PRR 190.9) |
| 7549 | Nasal Mucosal Discolouration | 162 | 1 | Levodopa (PRR 201.8) |
| 7550 | External Auditory Canal Atresia | 162 | 1 | Misoprostol (PRR 140.6) |
| 7551 | Urinary Retention Postoperative | 162 | 2 | Bupivacaine (PRR 131.0) |
| 7552 | Loss Of Bladder Sensation | 162 | 1 | Vibegron (PRR 49.0) |
| 7553 | Oxygen Consumption | 161 | 3 | Nintedanib (PRR 68.1) |
| 7554 | Corneal Epithelial Microcysts | 161 | 1 | Pomalidomide (PRR 42.4) |
| 7555 | Radiation Mucositis | 161 | 2 | Cetuximab (PRR 241.7) |
| 7556 | International Normalised Ratio | 161 | 2 | Dabigatran Etexilate Mesylate (PRR 114.2) |
| 7557 | Liver Scan Abnormal | 161 | 1 | Niraparib (PRR 148.3) |
| 7558 | Blood Immunoglobulin G Abnormal | 161 | 5 | Human Immunoglobulin G (PRR 379.0) |
| 7559 | Urobilinogen Urine Increased | 161 | 3 | Alemtuzumab (PRR 430.1) |
| 7560 | Intestinal Strangulation | 161 | 1 | Aprepitant (PRR 90.7) |
| 7561 | Holoprosencephaly | 161 | 2 | Methadone Hydrochloride (PRR 49.0) |
| 7562 | Hla Marker Study Positive | 161 | 1 | Canakinumab (PRR 49.0) |
| 7563 | Pyroglutamate Increased | 161 | 2 | Brinzolamide (PRR 125.2) |
| 7564 | Congenital Genitourinary Abnormality | 161 | 1 | Nevirapine (PRR 73.9) |
| 7565 | Fallopian Tube Cyst | 160 | 2 | Levonorgestrel (PRR 16.3) |
| 7566 | Fingerprint Loss | 160 | 1 | Capecitabine (PRR 194.8) |
| 7567 | Coagulation Factor Deficiency | 160 | 8 | Umeclidinium (PRR 276.2) |
| 7568 | Congenital Genital Malformation | 160 | 6 | Raltegravir (PRR 302.7) |
| 7569 | Alcohol Use Disorder | 160 | 3 | Ethyl Alcohol (PRR 67.7) |
| 7570 | Philadelphia Positive Acute Lymphocytic Leukaemia | 160 | 3 | Dasatinib (PRR 129.0) |
| 7571 | Central Nervous System Neoplasm | 160 | 2 | Imatinib (PRR 131.0) |
| 7572 | Extramedullary Haemopoiesis | 160 | 1 | Deferasirox (PRR 87.1) |
| 7573 | Brief Psychotic Disorder With Marked Stressors | 160 | 5 | Bupivacaine (PRR 132.7) |
| 7574 | Factor V Deficiency | 160 | 1 | Etonogestrel And Ethinyl Estradiol (PRR 62.5) |
| 7575 | Renal Artery Stent Placement | 160 | 1 | Ranolazine (PRR 51.1) |
| 7576 | Infantile Haemangioma | 160 | 1 | Misoprostol (PRR 173.2) |
| 7577 | Visual Pathway Disorder | 160 | 2 | Quinine (PRR 161.7) |
| 7578 | 5Q Minus Syndrome | 159 | 2 | Fludarabine Phosphate (PRR 84.8) |
| 7579 | Coronary Revascularisation | 159 | 2 | Clopidogrel Bisulfate (PRR 126.1) |
| 7580 | Autonomic Dysreflexia | 159 | 4 | Sevoflurane (PRR 150.2) |
| 7581 | Herpes Zoster Infection Neurological | 159 | 8 | Canakinumab (PRR 215.1) |
| 7582 | Retinal Drusen | 159 | 2 | Ranibizumab (PRR 146.1) |
| 7583 | Bile Acids Increased | 159 | 9 | Ursosiol (PRR 301.9) |
| 7584 | Brachial Plexus Injury | 159 | 2 | Bupivacaine (PRR 87.3) |
| 7585 | Orchidectomy | 159 | 1 | Bicalutamide (PRR 81.9) |
| 7586 | Crystal Urine | 159 | 2 | Abacavir Sulfate (PRR 128.1) |
| 7587 | Abnormal Menstrual Clots | 158 | 1 | Levonorgestrel (PRR 37.1) |
| 7588 | Labelled Drug-Food Interaction Issue | 158 | 4 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 237.2) |
| 7589 | Keratitis Bacterial | 158 | 7 | Prednisolone Acetate (PRR 195.5) |
| 7590 | Foetal Growth Abnormality | 158 | 3 | Abacavir Sulfate (PRR 224.0) |
| 7591 | Blood Pressure Orthostatic | 158 | 1 | Droxidopa (PRR 72.1) |
| 7592 | Coronavirus Pneumonia | 158 | 4 | Bendamustine Hydrochloride (PRR 155.7) |
| 7593 | Aminoaciduria | 158 | 3 | Gentamicin (PRR 154.6) |
| 7594 | Renal Cyst Infection | 158 | 3 | Tolvaptan (PRR 161.3) |
| 7595 | Antinuclear Antibody | 158 | 1 | Fosaprepitant Dimeglumine (PRR 70.1) |
| 7596 | Respiratory Paralysis | 158 | 1 | Rocuronium Bromide (PRR 69.7) |
| 7597 | Open Globe Injury | 158 | 1 | Bupivacaine (PRR 118.8) |
| 7598 | Acute Pulmonary Histoplasmosis | 158 | 1 | Atovaquone (PRR 84.5) |
| 7599 | Mineral Metabolism Disorder | 157 | 1 | Abatacept (PRR 76.1) |
| 7600 | Malignant Melanoma Stage Ii | 157 | 2 | Tadalafil (PRR 189.2) |
| 7601 | Confusional Arousal | 157 | 5 | Efavirenz (PRR 241.6) |
| 7602 | Pseudomeningocele | 157 | 2 | Triamcinolone Acetonide Ointment Usp, 0.05% (PRR 218.5) |
| 7603 | Gastrointestinal Mucormycosis | 157 | 18 | Micafungin Sodium (PRR 298.0) |
| 7604 | Enterobacter Pneumonia | 157 | 4 | Daptomycin (PRR 153.4) |
| 7605 | Diastasis Recti Abdominis | 157 | 4 | Efavirenz (PRR 113.5) |
| 7606 | Vascular Access Site Haemorrhage | 157 | 2 | Heparin Sodium (PRR 171.6) |
| 7607 | Adactyly | 157 | 2 | Misoprostol (PRR 176.8) |
| 7608 | Amniocentesis Abnormal | 157 | 1 | Misoprostol (PRR 259.4) |
| 7609 | Lung Diffusion Disorder | 156 | 10 | Ciclesonide (PRR 211.8) |
| 7610 | Catheter Site Nodule | 156 | 4 | Epoprostenol (PRR 156.7) |
| 7611 | Caudal Regression Syndrome | 156 | 5 | Raltegravir (PRR 449.1) |
| 7612 | Application Site Wound | 156 | 2 | Minoxidil Foam 5% (Womens) (PRR 29.6) |
| 7613 | Contact Lens Intolerance | 156 | 1 | Drospirenone And Ethinyl Estradiol (PRR 85.4) |
| 7614 | Attention-Seeking Behaviour | 156 | 2 | Atomoxetine Hydrochloride (PRR 72.8) |
| 7615 | Vertebral Artery Stenosis | 156 | 1 | Nilotinib (PRR 80.5) |
| 7616 | Corneal Decompensation | 156 | 7 | Moxifloxacin (PRR 112.0) |
| 7617 | Action Tremor | 156 | 2 | Lithium (PRR 157.4) |
| 7618 | Acid Fast Bacilli Infection | 156 | 5 | Rifampicin (PRR 202.7) |
| 7619 | Nephroangiosclerosis | 156 | 2 | Abacavir Sulfate (PRR 100.3) |
| 7620 | Medical Device Site Joint Infection | 156 | 1 | Tofacitinib Citrate (PRR 132.2) |
| 7621 | Combined Immunodeficiency | 156 | 3 | Bleomycin Sulfate (PRR 123.3) |
| 7622 | Meningocele | 156 | 3 | Misoprostol (PRR 130.8) |
| 7623 | Gastroenteritis Staphylococcal | 156 | 1 | Cladribine (PRR 71.7) |
| 7624 | Amniotic Fluid Volume Increased | 156 | 1 | Cariprazine (PRR 120.8) |
| 7625 | Vaginal Erosion | 156 | 1 | Miconazole Nitrate (PRR 689.5) |
| 7626 | Primary Hypogonadism | 155 | 2 | Busulfan (PRR 399.9) |
| 7627 | Osteopetrosis | 155 | 1 | Zoledronic Acid (PRR 211.7) |
| 7628 | Gastroenteritis Adenovirus | 155 | 9 | Thiotepa (PRR 419.0) |
| 7629 | Intra-Abdominal Pressure Increased | 155 | 9 | Phenobarbital (PRR 418.6) |
| 7630 | Renal Fusion Anomaly | 155 | 1 | Valproic Acid (PRR 92.1) |
| 7631 | Osteomyelitis Fungal | 155 | 6 | Amphotericin B (PRR 246.0) |
| 7632 | Aortic Valve Thickening | 155 | 2 | Cannabidiol (PRR 88.2) |
| 7633 | Chromosomal Deletion | 155 | 3 | Tretinoin (PRR 103.2) |
| 7634 | Cystoscopy | 155 | 1 | Etonogestrel And Ethinyl Estradiol (PRR 71.6) |
| 7635 | Diaphragm Muscle Weakness | 155 | 2 | Anakinra (PRR 114.8) |
| 7636 | Eye Paraesthesia | 155 | 3 | Terazosin Hydrochloride (PRR 127.3) |
| 7637 | Hepatic Vein Occlusion | 155 | 3 | Busulfan (PRR 152.2) |
| 7638 | Paraspinal Abscess | 155 | 3 | Amphotericin B (PRR 126.8) |
| 7639 | Lymphorrhoea | 155 | 1 | Basiliximab (PRR 122.0) |
| 7640 | Palindromic Rheumatism | 155 | 1 | Brivaracetam (PRR 93.2) |
| 7641 | Subclavian Artery Stenosis | 155 | 1 | Bosutinib (PRR 61.3) |
| 7642 | Naevus Flammeus | 155 | 1 | Alpelisib (PRR 47.1) |
| 7643 | Post-Tussive Vomiting | 154 | 9 | Amikacin (PRR 161.4) |
| 7644 | Blood Immunoglobulin E Decreased | 154 | 4 | Ciclesonide (PRR 268.1) |
| 7645 | Allogenic Stem Cell Transplantation | 154 | 10 | Azacitidine For (PRR 549.7) |
| 7646 | Meconium Stain | 154 | 5 | Zidovudine (PRR 509.6) |
| 7647 | Serum Amyloid A Protein Increased | 154 | 10 | Canakinumab (PRR 1,009.0) |
| 7648 | Scleroderma-Like Reaction | 154 | 3 | Pemetrexed (PRR 120.3) |
| 7649 | Allergy Test Negative | 154 | 5 | Ketoprofen (PRR 278.4) |
| 7650 | Histone Antibody Positive | 154 | 1 | Galcanezumab-Gnlm (PRR 17.6) |
| 7651 | Acoustic Stimulation Tests Abnormal | 154 | 4 | Atazanavir (PRR 335.8) |
| 7652 | Anal Discomfort | 154 | 1 | Orlistat (PRR 74.0) |
| 7653 | Blood Pressure Orthostatic Abnormal | 154 | 1 | Droxidopa (PRR 25.7) |
| 7654 | Narcotic Bowel Syndrome | 154 | 7 | Meclizine Hcl 12.5Mg (PRR 176.9) |
| 7655 | Rash Follicular | 154 | 2 | Vemurafenib (PRR 120.2) |
| 7656 | Oophorectomy Bilateral | 154 | 1 | Goserelin (PRR 130.9) |
| 7657 | Prothrombin Level Abnormal | 154 | 1 | Pegaspargase (PRR 80.9) |
| 7658 | Head Circumference Abnormal | 154 | 1 | Sevoflurane (PRR 49.7) |
| 7659 | Postictal Psychosis | 153 | 13 | Levetiracetam In Sodium Chloride (PRR 231.7) |
| 7660 | Autoimmune Arthritis | 153 | 3 | Ipilimumab (PRR 107.8) |
| 7661 | Secondary Hypothyroidism | 153 | 1 | Ipilimumab (PRR 60.2) |
| 7662 | Ovarian Abscess | 153 | 1 | Copper (PRR 16.3) |
| 7663 | Tracheal Fistula | 153 | 3 | Lenvatinib (PRR 216.7) |
| 7664 | Leukaemia Cutis | 153 | 7 | Blinatumomab (PRR 216.7) |
| 7665 | Mean Cell Haemoglobin Concentration Abnormal | 153 | 2 | Inclisiran (PRR 87.6) |
| 7666 | Skin Maceration | 153 | 2 | Posaconazole Delayed-Release (PRR 90.8) |
| 7667 | Mesangioproliferative Glomerulonephritis | 153 | 3 | Ganciclovir (PRR 157.5) |
| 7668 | Restless Arm Syndrome | 153 | 1 | Pramipexole (PRR 192.4) |
| 7669 | Urine Osmolarity Increased | 153 | 1 | Tolvaptan (PRR 100.1) |
| 7670 | Creatinine Urine Decreased | 153 | 3 | Dimenhydrinate (PRR 228.0) |
| 7671 | Sinusitis Aspergillus | 153 | 1 | Baricitinib (PRR 72.9) |
| 7672 | Medical Device Site Discharge | 153 | 1 | Bupivacaine (PRR 155.7) |
| 7673 | Oesophagobronchial Fistula | 152 | 1 | Cisplatin (PRR 82.4) |
| 7674 | Post-Traumatic Headache | 152 | 5 | Rizatriptan Benzoate (PRR 207.5) |
| 7675 | Pancreatic Fistula | 152 | 1 | Gemcitabine Hydrochloride (PRR 55.9) |
| 7676 | Fear-Related Avoidance Of Activities | 152 | 7 | Dolutegravir Sodium (PRR 145.2) |
| 7677 | Bone Sequestrum | 152 | 3 | Zoledronic Acid (PRR 191.1) |
| 7678 | Vitreous Haze | 152 | 4 | Aflibercept (PRR 316.9) |
| 7679 | Mycoplasma Test Positive | 152 | 1 | Palivizumab (PRR 46.0) |
| 7680 | Catheter Site Induration | 152 | 2 | Epoprostenol (PRR 148.6) |
| 7681 | Neurosyphilis | 152 | 2 | Efavirenz (PRR 103.7) |
| 7682 | Neonatal Respiratory Acidosis | 152 | 1 | Bupivacaine (PRR 91.5) |
| 7683 | Bladder Sphincter Atony | 152 | 1 | Daptomycin (PRR 60.9) |
| 7684 | Spinal Cord Ischaemia | 152 | 2 | Sevoflurane (PRR 67.7) |
| 7685 | Nasal Polypectomy | 151 | 2 | Mepolizumab (PRR 108.0) |
| 7686 | Perinephric Abscess | 151 | 4 | Anti-Thymocyte Globulin (Rabbit) (PRR 416.6) |
| 7687 | Vascular Fragility | 151 | 1 | Pertuzumab (PRR 66.0) |
| 7688 | Specific Gravity Urine Decreased | 151 | 4 | Alemtuzumab (PRR 954.2) |
| 7689 | Mesenteritis | 151 | 2 | Desoximetasone (PRR 196.1) |
| 7690 | Dacryocystitis | 151 | 1 | Lifitegrast (PRR 52.7) |
| 7691 | Abdominal Wall Wound | 151 | 2 | Cladribine (PRR 121.1) |
| 7692 | Platelet Aggregation Abnormal | 151 | 1 | Prasugrel Hydrochloride (PRR 114.5) |
| 7693 | Brucellosis | 151 | 1 | Rifampicin (PRR 130.3) |
| 7694 | Gastritis Atrophic | 151 | 1 | Nevirapine (PRR 62.8) |
| 7695 | Entropion | 151 | 1 | Vismodegib (PRR 80.0) |
| 7696 | Cytology Abnormal | 150 | 1 | Certolizumab Pegol (PRR 73.3) |
| 7697 | Status Migrainosus | 150 | 3 | Fremanezumab-Vfrm (PRR 129.4) |
| 7698 | Orbital Myositis | 150 | 1 | Ipilimumab (PRR 49.5) |
| 7699 | Airway Peak Pressure Increased | 150 | 13 | Rocuronium Bromide (PRR 1,082.1) |
| 7700 | Cardiac Asthma | 150 | 1 | Remdesivir (PRR 31.9) |
| 7701 | Limb Fracture | 150 | 2 | Polatuzumab Vedotin (PRR 58.4) |
| 7702 | Perineal Injury | 150 | 1 | Misoprostol (PRR 291.3) |
| 7703 | Rash Papulosquamous | 150 | 1 | Terbinafine Hydrochloride (PRR 114.6) |
| 7704 | Drug Therapeutic Incompatibility | 150 | 2 | Mesna (PRR 157.7) |
| 7705 | Immature Respiratory System | 150 | 1 | Ivacaftor (PRR 109.1) |
| 7706 | Device Component Issue | 149 | 1 | Levonorgestrel (PRR 83.6) |
| 7707 | Donor Specific Antibody Present | 149 | 11 | Anti-Thymocyte Globulin (Rabbit) (PRR 446.8) |
| 7708 | Catheter Site Warmth | 149 | 3 | Epoprostenol (PRR 417.5) |
| 7709 | Carbohydrate Antigen 27.29 Increased | 149 | 5 | Fulvestrant (PRR 215.4) |
| 7710 | Anticoagulation Drug Level Abnormal | 149 | 5 | Levetiracetam In Sodium Chloride (PRR 94.9) |
| 7711 | Sinobronchitis | 149 | 6 | Acetylcysteine (PRR 403.0) |
| 7712 | Brain Stem Glioma | 149 | 4 | Temozolomide (PRR 303.0) |
| 7713 | Liposuction | 149 | 2 | Etonogestrel And Ethinyl Estradiol (PRR 82.1) |
| 7714 | Ovarian Vein Thrombosis | 149 | 2 | Tranexamic Acid (PRR 132.7) |
| 7715 | Umbilical Haemorrhage | 149 | 3 | Brivaracetam (PRR 148.7) |
| 7716 | Anogenital Dysplasia | 149 | 4 | Darunavir (PRR 131.5) |
| 7717 | Colitis Erosive | 149 | 4 | Anti-Thymocyte Globulin (Rabbit) (PRR 185.5) |
| 7718 | Mucocutaneous Rash | 149 | 2 | Panitumumab (PRR 105.8) |
| 7719 | Vitamin A Decreased | 149 | 1 | Teduglutide (PRR 76.1) |
| 7720 | Congenital Tricuspid Valve Atresia | 149 | 2 | Misoprostol (PRR 137.3) |
| 7721 | Secondary Amyloidosis | 149 | 1 | Canakinumab (PRR 168.4) |
| 7722 | Thymus Enlargement | 149 | 2 | Bleomycin Sulfate (PRR 84.5) |
| 7723 | Lack Of Application Site Rotation | 149 | 1 | Lanreotide Acetate (PRR 73.2) |
| 7724 | Metamyelocyte Count Increased | 148 | 5 | Paliperidone (PRR 147.4) |
| 7725 | Medulloblastoma | 148 | 7 | Thiotepa (PRR 174.9) |
| 7726 | Benign Neoplasm Of Adrenal Gland | 148 | 2 | Rasagiline Mesylate (PRR 79.0) |
| 7727 | Mechanical Ventilation Complication | 148 | 8 | Rocuronium Bromide (PRR 609.9) |
| 7728 | Cataract Cortical | 148 | 1 | Ranibizumab (PRR 88.3) |
| 7729 | Peritoneal Haematoma | 148 | 2 | Fondaparinux Sodium (PRR 146.9) |
| 7730 | Blood Brain Barrier Defect | 148 | 1 | Alteplase (PRR 48.4) |
| 7731 | Refeeding Syndrome | 148 | 2 | Dextrose (PRR 102.3) |
| 7732 | Scabies | 148 | 1 | Crisaborole (PRR 44.9) |
| 7733 | Subacute Hepatic Failure | 148 | 1 | Pyrazinamide (PRR 143.4) |
| 7734 | Lymphoid Tissue Hypoplasia | 147 | 35 | Filgrastim (PRR 40,045.7) |
| 7735 | Autoimmune Dermatitis | 147 | 4 | Progesterone (PRR 151.5) |
| 7736 | Visual Perseveration | 147 | 2 | Topiramate (PRR 231.6) |
| 7737 | Blood Stem Cell Harvest Failure | 147 | 7 | Filgrastim (PRR 450.1) |
| 7738 | Parathyroid Gland Operation | 147 | 2 | Paricalcitol (PRR 62.7) |
| 7739 | Urinoma | 147 | 5 | Mycophenolic Acid (PRR 166.5) |
| 7740 | Vitreous Degeneration | 147 | 2 | Ranibizumab (PRR 76.0) |
| 7741 | Anal Fistula Infection | 147 | 1 | Infliximab-Dyyb (PRR 138.7) |
| 7742 | Macular Ischaemia | 147 | 3 | Ranibizumab (PRR 176.2) |
| 7743 | Protein S Decreased | 147 | 2 | Doxepin (PRR 133.9) |
| 7744 | Coagulation Factor Viii Level Increased | 147 | 2 | Etonogestrel And Ethinyl Estradiol (PRR 122.6) |
| 7745 | Neonatal Respiratory Arrest | 147 | 6 | Misoprostol (PRR 224.9) |
| 7746 | Pulmonary Air Leakage | 147 | 2 | Bupivacaine (PRR 162.5) |
| 7747 | Allergic Transfusion Reaction | 147 | 2 | Micafungin Sodium (PRR 86.4) |
| 7748 | Csf Cell Count Increased | 147 | 1 | Blinatumomab (PRR 260.7) |
| 7749 | Bandaemia | 147 | 1 | Lumacaftor And Ivacaftor (PRR 50.6) |
| 7750 | Subchorionic Haemorrhage | 146 | 3 | Rimegepant Sulfate (PRR 46.2) |
| 7751 | Pulmonary Endarterectomy | 146 | 3 | Riociguat (PRR 1,024.3) |
| 7752 | Viral Load Decreased | 146 | 8 | Peginterferon Alfa-2A (PRR 144.9) |
| 7753 | Hepatosplenic Candidiasis | 146 | 12 | Amphotericin B (PRR 359.7) |
| 7754 | No Adverse Reaction | 146 | 1 | Isotretinoin (PRR 169.5) |
| 7755 | Renal Cancer Recurrent | 146 | 3 | Pazopanib Hydrochloride (PRR 81.5) |
| 7756 | Conjunctival Scar | 146 | 7 | Timolol (PRR 168.3) |
| 7757 | Congenital Cytomegalovirus Infection | 146 | 6 | Valganciclovir Hydrochloride Powder, (PRR 239.8) |
| 7758 | Tonsillar Haemorrhage | 146 | 3 | Fosaprepitant Dimeglumine (PRR 123.3) |
| 7759 | Endocarditis Noninfective | 146 | 3 | Bleomycin Sulfate (PRR 230.6) |
| 7760 | Erythrosis | 146 | 1 | Obinutuzumab (PRR 63.7) |
| 7761 | Neurofibroma | 146 | 4 | Captopril (PRR 229.5) |
| 7762 | Tracheal Injury | 146 | 1 | Rocuronium Bromide (PRR 88.9) |
| 7763 | Bone Hypertrophy | 146 | 1 | Loperamide Hydrochloride Oral (PRR 102.6) |
| 7764 | Phobia Of Driving | 146 | 1 | Cariprazine (PRR 46.9) |
| 7765 | Blood Creatine Phosphokinase | 146 | 1 | Daptomycin (PRR 47.3) |
| 7766 | Total Bile Acids Increased | 146 | 1 | Dolutegravir Sodium (PRR 98.8) |
| 7767 | Light Chain Disease | 145 | 8 | Selinexor (PRR 159.1) |
| 7768 | Paraesthesia Ear | 145 | 2 | Desoximetasone (PRR 72.2) |
| 7769 | Postmortem Blood Drug Level Abnormal | 145 | 5 | Methadone Hydrochloride (PRR 272.5) |
| 7770 | Analgesic Drug Level Above Therapeutic | 145 | 8 | Tramadol Hydrochloride (PRR 150.1) |
| 7771 | Inflammatory Carcinoma Of The Breast | 145 | 2 | Ado-Trastuzumab Emtansine (PRR 88.1) |
| 7772 | Cervix Carcinoma Stage Iv | 145 | 1 | Testosterone (PRR 142.3) |
| 7773 | Ligament Laxity | 145 | 1 | Valproate Sodium (PRR 209.6) |
| 7774 | Instillation Site Foreign Body Sensation | 145 | 1 | Lifitegrast (PRR 468.3) |
| 7775 | Post Procedural Drainage | 145 | 1 | Fondaparinux Sodium (PRR 150.1) |
| 7776 | Endometrial Atrophy | 144 | 1 | Levonorgestrel (PRR 39.4) |
| 7777 | Immune-Mediated Neuropathy | 144 | 5 | Pembrolizumab (PRR 191.4) |
| 7778 | Application Site Odour | 144 | 1 | Buprenorphine (PRR 80.3) |
| 7779 | Forced Expiratory Volume Abnormal | 144 | 7 | Fluticasone Furoate (PRR 142.0) |
| 7780 | Drug Titration | 144 | 2 | Cenobamate (PRR 53.0) |
| 7781 | Ependymoma | 144 | 2 | Nevirapine (PRR 100.3) |
| 7782 | Heterophoria | 144 | 2 | Ketoprofen (PRR 131.1) |
| 7783 | Post Abortion Haemorrhage | 143 | 4 | Misoprostol (PRR 567.2) |
| 7784 | Germ Cell Cancer | 143 | 1 | Somatropin (PRR 78.1) |
| 7785 | Parathyroid Gland Enlargement | 143 | 6 | Itraconazole (PRR 341.4) |
| 7786 | Trichomoniasis | 143 | 2 | Etonogestrel And Ethinyl Estradiol (PRR 93.8) |
| 7787 | Strabismus Congenital | 143 | 2 | Methadone Hydrochloride (PRR 225.3) |
| 7788 | Cystic Fibrosis Related Diabetes | 143 | 8 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 1,205.7) |
| 7789 | Paralysis Recurrent Laryngeal Nerve | 143 | 1 | Lenvatinib (PRR 42.5) |
| 7790 | Inadequate Peritoneal Dialysis | 143 | 4 | Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose (PRR 618.2) |
| 7791 | Necrotising Scleritis | 143 | 6 | Triamcinolone Acetonide Ointment Usp, 0.05% (PRR 188.1) |
| 7792 | Dermatochalasis | 143 | 3 | Botulinum Toxin Type A (PRR 99.3) |
| 7793 | Oropharyngeal Oedema | 143 | 5 | Gentamicin (PRR 145.7) |
| 7794 | Reticulocytopenia | 143 | 6 | Anti-Thymocyte Globulin (Rabbit) (PRR 132.7) |
| 7795 | Bacterial Abdominal Infection | 143 | 1 | Durvalumab (PRR 76.9) |
| 7796 | Portal Vein Occlusion | 143 | 1 | Entecavir (PRR 105.6) |
| 7797 | Enterobiasis | 143 | 1 | Rasagiline Mesylate (PRR 67.7) |
| 7798 | Oropharyngeal Squamous Cell Carcinoma | 143 | 1 | Bleomycin Sulfate (PRR 88.2) |
| 7799 | Uterine Tachysystole | 143 | 1 | Misoprostol (PRR 5,697.2) |
| 7800 | Injected Limb Mobility Decreased | 143 | 1 | Cabotegravir (PRR 93.4) |
| 7801 | Tanning | 142 | 1 | Adapalene (PRR 3.3) |
| 7802 | Silent Thyroiditis | 142 | 5 | Pembrolizumab (PRR 94.3) |
| 7803 | Urticaria Thermal | 142 | 8 | Omalizumab (PRR 507.6) |
| 7804 | Gastrointestinal Mucosal Necrosis | 142 | 3 | Doxycycline Hyclate (PRR 200.1) |
| 7805 | Oophoritis | 142 | 2 | Bleomycin Sulfate (PRR 88.8) |
| 7806 | Myeloma Cast Nephropathy | 142 | 1 | Carfilzomib (PRR 142.0) |
| 7807 | Behcet'S Syndrome | 142 | 1 | Colchicine (PRR 160.5) |
| 7808 | Malignant Glioma | 142 | 2 | Temozolomide (PRR 200.7) |
| 7809 | Gastrointestinal Stoma Output Abnormal | 142 | 3 | Teduglutide (PRR 2,929.9) |
| 7810 | Testicular Torsion | 142 | 2 | Emicizumab (PRR 48.8) |
| 7811 | Mucosal Hypertrophy | 142 | 2 | Anti-Thymocyte Globulin (Rabbit) (PRR 174.5) |
| 7812 | Inclusion Body Myositis | 142 | 1 | Bleomycin Sulfate (PRR 73.5) |
| 7813 | Hair Growth Rate Abnormal | 142 | 1 | Rucaparib (PRR 50.9) |
| 7814 | Loop Electrosurgical Excision Procedure | 141 | 3 | Etonogestrel And Ethinyl Estradiol (PRR 155.0) |
| 7815 | Her-2 Positive Breast Cancer | 141 | 4 | Trastuzumab (PRR 289.6) |
| 7816 | Genital Atrophy | 141 | 3 | Finasteride (PRR 358.9) |
| 7817 | Pulmonary Interstitial Emphysema Syndrome | 141 | 9 | Rifampicin (PRR 380.2) |
| 7818 | Sarcoma Metastatic | 141 | 2 | Pazopanib Hydrochloride (PRR 149.7) |
| 7819 | Prominent Epicanthal Folds | 141 | 2 | Valproate Sodium (PRR 137.9) |
| 7820 | Disseminated Coccidioidomycosis | 141 | 3 | Amphotericin B (PRR 274.4) |
| 7821 | Crush Syndrome | 141 | 1 | Norepinephrine Bitartrate (PRR 86.9) |
| 7822 | Gastric Volvulus | 141 | 1 | Diroximel Fumarate (PRR 37.9) |
| 7823 | Collateral Circulation | 141 | 2 | Efavirenz (PRR 97.5) |
| 7824 | Selective Iga Immunodeficiency | 141 | 2 | Ganciclovir (PRR 138.6) |
| 7825 | Urine Protein/Creatinine Ratio Abnormal | 141 | 1 | Voclosporin (PRR 264.1) |
| 7826 | Semen Volume Increased | 140 | 1 | Sildenafil Citrate (PRR 436.2) |
| 7827 | Immune-Mediated Endocrinopathy | 140 | 3 | Pembrolizumab (PRR 240.6) |
| 7828 | Abscess Sterile | 140 | 1 | Leuprolide Acetate (PRR 173.0) |
| 7829 | B-Lymphocyte Abnormalities | 140 | 2 | Ocrelizumab (PRR 169.1) |
| 7830 | Beta 2 Microglobulin Urine Increased | 140 | 3 | Tenofovir Disoproxil Fumarate (PRR 98.7) |
| 7831 | Myomectomy | 140 | 1 | Copper (PRR 25.4) |
| 7832 | Metatarsal Excision | 140 | 1 | Canagliflozin (PRR 1,864.5) |
| 7833 | Sideroblastic Anaemia | 140 | 7 | Pyrazinamide (PRR 285.8) |
| 7834 | Mucocutaneous Haemorrhage | 140 | 2 | Romiplostim (PRR 285.8) |
| 7835 | Fallopian Tube Cancer | 140 | 2 | Niraparib (PRR 72.1) |
| 7836 | Vaginal Contraceptive Device Expelled | 140 | 1 | Etonogestrel And Ethinyl Estradiol (PRR ∞) |
| 7837 | Blood Urea Nitrogen/Creatinine Ratio Decreased | 140 | 1 | Tolvaptan (PRR 75.3) |
| 7838 | Gastrointestinal Stoma Output Decreased | 140 | 1 | Teduglutide (PRR 2,058.3) |
| 7839 | Biloma | 140 | 2 | Basiliximab (PRR 277.7) |
| 7840 | Tooth Development Disorder | 140 | 2 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate (PRR 50.6) |
| 7841 | Lesion Excision | 140 | 1 | Brivaracetam (PRR 68.0) |
| 7842 | Chronic Rhinosinusitis With Nasal Polyps | 139 | 2 | Benralizumab (PRR 38.8) |
| 7843 | Pineal Gland Cyst | 139 | 5 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 363.0) |
| 7844 | Normal Labour | 139 | 13 | Ampicillin (PRR 18,027.9) |
| 7845 | Osteoporosis Postmenopausal | 139 | 3 | Doxepin (PRR 229.9) |
| 7846 | Thoracotomy | 139 | 1 | Etonogestrel (PRR 23.1) |
| 7847 | Device Fastener Issue | 139 | 1 | Orlistat (PRR 36.2) |
| 7848 | Ear, Nose And Throat Disorder | 139 | 1 | Valproate Sodium (PRR 786.8) |
| 7849 | Delusion Of Reference | 139 | 2 | Pyrazinamide (PRR 82.6) |
| 7850 | Congenital Mitral Valve Incompetence | 139 | 3 | Zidovudine (PRR 147.0) |
| 7851 | Mycetoma Mycotic | 139 | 2 | Posaconazole Delayed-Release (PRR 131.1) |
| 7852 | Hypotensive Crisis | 139 | 3 | Ranolazine (PRR 154.5) |
| 7853 | Adenomatous Polyposis Coli | 139 | 1 | Busulfan (PRR 91.5) |
| 7854 | Inner Ear Inflammation | 139 | 1 | Palivizumab (PRR 29.9) |
| 7855 | Atypical Mycobacterial Pneumonia | 139 | 1 | Bendamustine Hydrochloride (PRR 51.5) |
| 7856 | Aplasia Cutis Congenita | 139 | 2 | Methimazole (PRR 205.4) |
| 7857 | Nocturnal Fear | 139 | 1 | Buspirone Hydrochloride (PRR 162.0) |
| 7858 | Diaphragmatic Spasm | 139 | 1 | Terbinafine Hydrochloride (PRR 221.3) |
| 7859 | Hepatopulmonary Syndrome | 139 | 1 | Ado-Trastuzumab Emtansine (PRR 541.2) |
| 7860 | Hepatic Enzyme | 138 | 60 | Diclofenac Potassium, Film Coated (PRR 3,214.2) |
| 7861 | Implant Site Warmth | 138 | 1 | Etonogestrel (PRR 503.1) |
| 7862 | Cryptitis | 138 | 5 | Cefuroxime (PRR 189.2) |
| 7863 | Csf Hiv Escape Syndrome | 138 | 13 | Lamivudine Oral (PRR 1,240.1) |
| 7864 | Chordee | 138 | 4 | Zidovudine (PRR 175.6) |
| 7865 | Perinephric Collection | 138 | 4 | Valganciclovir (PRR 144.7) |
| 7866 | Breast Ulceration | 138 | 1 | Anakinra (PRR 97.9) |
| 7867 | Leukaemic Infiltration | 138 | 5 | Acalabrutinib (PRR 134.1) |
| 7868 | Cell-Mediated Immune Deficiency | 138 | 4 | Axicabtagene Ciloleucel (PRR 112.6) |
| 7869 | Lymphangioma | 138 | 1 | Sirolimus (PRR 147.0) |
| 7870 | Thyroiditis Acute | 138 | 2 | Minocycline (PRR 234.0) |
| 7871 | Computerised Tomogram | 137 | 1 | Pegfilgrastim (PRR 77.7) |
| 7872 | Albumin Globulin Ratio Increased | 137 | 2 | Asfotase Alfa (PRR 62.5) |
| 7873 | Adenovirus Reactivation | 137 | 16 | Fludarabine Phosphate (PRR 1,376.4) |
| 7874 | Bladder Neoplasm Surgery | 137 | 1 | Relugolix (PRR 26.5) |
| 7875 | Cardiac Arrest Neonatal | 137 | 4 | Ampicillin (PRR 135.3) |
| 7876 | Platelet Morphology Abnormal | 137 | 1 | Romiplostim (PRR 74.4) |
| 7877 | Reperfusion Injury | 137 | 1 | Alteplase (PRR 183.2) |
| 7878 | Stoma Prolapse | 137 | 1 | Teduglutide (PRR 974.0) |
| 7879 | Spindle Cell Sarcoma | 137 | 1 | Bleomycin Sulfate (PRR 92.2) |
| 7880 | Haptoglobin Increased | 136 | 1 | Eculizumab (PRR 103.5) |
| 7881 | Implant Site Vesicles | 136 | 1 | Etonogestrel (PRR 973.9) |
| 7882 | Ovarian Germ Cell Teratoma Benign | 136 | 1 | Copper (PRR 30.1) |
| 7883 | Cervix Neoplasm | 136 | 1 | Dexlansoprazole (PRR 80.9) |
| 7884 | Bacillary Angiomatosis | 136 | 4 | Mycophenilic Acid (PRR 226.0) |
| 7885 | Hypermutation | 136 | 1 | Temozolomide (PRR 32,563.2) |
| 7886 | Perineal Ulceration | 136 | 1 | Alemtuzumab (PRR 254.1) |
| 7887 | Automatic Bladder | 136 | 1 | Interferon Beta-1B (PRR 67.8) |
| 7888 | Restless Leg Augmentation Syndrome | 136 | 4 | Pramipexole (PRR 1,439.5) |
| 7889 | Cystic Lung Disease | 136 | 2 | Erlotinib (PRR 65.1) |
| 7890 | Alkalosis Hypochloraemic | 136 | 3 | Rocuronium Bromide (PRR 95.8) |
| 7891 | Breath Sounds | 136 | 1 | Tiotropium Bromide Inhalation Spray (PRR 85.7) |
| 7892 | Labour Induction | 136 | 1 | Misoprostol (PRR 115.9) |
| 7893 | Bronchial Neoplasm | 135 | 16 | Ciclesonide (PRR 898.3) |
| 7894 | Unwanted Pregnancy | 135 | 2 | Etonogestrel (PRR 27.4) |
| 7895 | Visual Evoked Potentials Abnormal | 135 | 1 | Methadone (PRR 121.3) |
| 7896 | Pleuroperitoneal Communication | 135 | 2 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 137.4) |
| 7897 | Conjunctival Ulcer | 135 | 9 | Prednisolone Acetate (PRR 160.8) |
| 7898 | Congenital Naevus | 135 | 8 | Atazanavir (PRR 723.7) |
| 7899 | Accelerated Idioventricular Rhythm | 135 | 4 | Sevoflurane (PRR 178.8) |
| 7900 | Reaction To Food Additive | 135 | 1 | Rimegepant Sulfate (PRR 89.8) |
| 7901 | Circumcision | 135 | 1 | Emicizumab (PRR 51.4) |
| 7902 | Central Nervous System Viral Infection | 135 | 4 | Thiotepa (PRR 252.1) |
| 7903 | Papillary Renal Cell Carcinoma | 135 | 1 | Amlodipine Besylate And Valsartan (PRR 183.4) |
| 7904 | Hypotonic Urinary Bladder | 135 | 1 | Fesoterodine Fumarate (PRR 73.8) |
| 7905 | Skeletal Dysplasia | 135 | 1 | Misoprostol (PRR 116.8) |
| 7906 | Malignant Breast Lump Removal | 134 | 4 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 374.8) |
| 7907 | Arteriovenous Fistula Site Infection | 134 | 4 | Paricalcitol (PRR 171.8) |
| 7908 | Application Site Nodule | 134 | 1 | Minoxidil (PRR 25.5) |
| 7909 | Adrenogenital Syndrome | 134 | 3 | Lopinavir And Ritonavir (PRR 110.5) |
| 7910 | Retinoschisis | 134 | 3 | Ranibizumab (PRR 91.4) |
| 7911 | Phaehyphomycosis | 134 | 3 | Itraconazole (PRR 258.8) |
| 7912 | Stenotrophomonas Test Positive | 134 | 4 | Micafungin Sodium (PRR 115.0) |
| 7913 | Specific Gravity Urine Increased | 134 | 2 | Alemtuzumab (PRR 525.6) |
| 7914 | Aspiration Bone Marrow Abnormal | 134 | 3 | Blinatumomab (PRR 270.4) |
| 7915 | Instillation Site Discomfort | 134 | 1 | Lifitegrast (PRR 1,311.5) |
| 7916 | Malignant Fibrous Histiocytoma | 134 | 2 | Sirolimus (PRR 124.5) |
| 7917 | Asymptomatic Bacteriuria | 134 | 2 | Daptomycin (PRR 105.7) |
| 7918 | Atheroembolism | 134 | 1 | Tiotropium Bromide Inhalation Spray (PRR 117.9) |
| 7919 | Decompensated Hypothyroidism | 134 | 1 | Amiodarone Hydrochloride (PRR 149.7) |
| 7920 | Vascular Resistance Systemic Decreased | 134 | 2 | Bupivacaine (PRR 219.0) |
| 7921 | Retroperitoneal Mass | 134 | 3 | Polatuzumab Vedotin (PRR 99.9) |
| 7922 | Thyrotoxic Periodic Paralysis | 134 | 1 | Methimazole (PRR 732.0) |
| 7923 | Aspiration Bone Marrow | 133 | 4 | Venetoclax (PRR 125.1) |
| 7924 | Myocardial Stunning | 133 | 7 | Nicotine Polacrilex Mini (PRR 305.2) |
| 7925 | Delusion Of Parasitosis | 133 | 2 | Levodopa (PRR 67.2) |
| 7926 | Cough Decreased | 133 | 1 | Nintedanib (PRR 97.1) |
| 7927 | Intraocular Melanoma | 133 | 1 | Ranibizumab (PRR 50.1) |
| 7928 | Oculogyration | 133 | 2 | Ziprasidone Mesylate (PRR 273.5) |
| 7929 | Cryptococcal Fungaemia | 133 | 3 | Pegaspargase (PRR 94.4) |
| 7930 | Urinary Straining | 133 | 1 | Ranolazine (PRR 94.2) |
| 7931 | Acute Lymphocytic Leukaemia Refractory | 133 | 1 | Blinatumomab (PRR 3,418.0) |
| 7932 | Subarachnoid Haematoma | 133 | 1 | Dutasteride (PRR 277.2) |
| 7933 | Cervix Inflammation | 132 | 2 | Copper (PRR 167.2) |
| 7934 | Cervicogenic Headache | 132 | 6 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 385.3) |
| 7935 | Testicular Failure | 132 | 2 | Finasteride (PRR 452.6) |
| 7936 | Cytokine Increased | 132 | 4 | Axicabtagene Ciloleucel (PRR 2,861.0) |
| 7937 | Splenitis | 132 | 1 | Nilotinib (PRR 216.3) |
| 7938 | Congenital Anomaly In Offspring | 132 | 3 | Zidovudine (PRR 184.6) |
| 7939 | Coronary Artery Reocclusion | 132 | 1 | Prasugrel Hydrochloride (PRR 149.8) |
| 7940 | Fever Neonatal | 132 | 2 | Ampicillin (PRR 140.7) |
| 7941 | Splenic Neoplasm Malignancy Unspecified | 131 | 1 | Ranitidine Hydrochloride (PRR 31.6) |
| 7942 | Induced Abortion Failed | 131 | 2 | Misoprostol (PRR 2,689.0) |
| 7943 | Purple Glove Syndrome | 131 | 1 | Phenytoin (PRR 981.4) |
| 7944 | Congenital Bladder Anomaly | 131 | 2 | Indapamide (PRR 173.0) |
| 7945 | Corneal Defect | 131 | 3 | Prednisolone Acetate (PRR 96.5) |
| 7946 | Respiratory Syncytial Virus Bronchitis | 131 | 1 | Palivizumab (PRR 419.7) |
| 7947 | Bronchomalacia | 131 | 4 | Quinapril Hydrochloride (PRR 366.9) |
| 7948 | Norepinephrine Increased | 131 | 1 | Labetalol (PRR 115.1) |
| 7949 | Vasomotor Rhinitis | 131 | 1 | Acetylcysteine (PRR 222.6) |
| 7950 | Loss Of Dreaming | 131 | 1 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 57.2) |
| 7951 | Peripheral Artery Bypass | 131 | 1 | Inclisiran (PRR 214.4) |
| 7952 | Refusal Of Examination | 130 | 5 | Clozapine (PRR 291.0) |
| 7953 | Foetal Anaemia | 130 | 8 | Cefuroxime (PRR 433.2) |
| 7954 | Jaw Fistula | 130 | 1 | Zoledronic Acid (PRR 135.7) |
| 7955 | Immune Effector Cell-Associated Haematotoxicity | 130 | 4 | Axicabtagene Ciloleucel (PRR 971.2) |
| 7956 | Graft Versus Host Disease In Intestine | 130 | 9 | Anti-Thymocyte Globulin (Rabbit) (PRR 362.0) |
| 7957 | Confusion Postoperative | 130 | 4 | Cefazolin Sodium (PRR 143.8) |
| 7958 | Pneumonia Lipoid | 130 | 2 | Canakinumab (PRR 160.2) |
| 7959 | Sacroiliac Joint Dysfunction | 130 | 4 | Captopril (PRR 240.4) |
| 7960 | Paraphilia | 130 | 3 | Levodopa (PRR 224.5) |
| 7961 | Inflammatory Myofibroblastic Tumour | 130 | 1 | Crizotinib (PRR 79.2) |
| 7962 | Hepatic Artery Stenosis | 130 | 1 | Basiliximab (PRR 179.9) |
| 7963 | Gastritis Viral | 130 | 1 | Thiotepa (PRR 69.2) |
| 7964 | Respiratory Tract Malformation | 129 | 6 | Ursosiol (PRR 296.6) |
| 7965 | Implant Site Paraesthesia | 129 | 1 | Etonogestrel (PRR 1,810.2) |
| 7966 | Cystic Fibrosis Lung | 129 | 8 | Lumacaftor And Ivacaftor (PRR 554.9) |
| 7967 | Progressive External Ophthalmoplegia | 129 | 14 | Ritonavir 100 Mg (PRR 5,791.8) |
| 7968 | Anterior Chamber Fibrin | 129 | 5 | Prednisolone Acetate (PRR 169.0) |
| 7969 | Sarcoma Uterus | 129 | 1 | Pazopanib Hydrochloride (PRR 57.6) |
| 7970 | Developmental Regression | 129 | 2 | Clobazam (PRR 147.1) |
| 7971 | Neuroprosthesis Implantation | 129 | 5 | Rotigotine (PRR 248.4) |
| 7972 | Congenital Eyelid Malformation | 129 | 2 | Valproate Sodium (PRR 230.0) |
| 7973 | Pulmonary Valve Disease | 129 | 2 | Telmisartan (PRR 280.1) |
| 7974 | Cryptococcal Meningoencephalitis | 129 | 5 | Remdesivir (PRR 174.9) |
| 7975 | Instillation Site Dryness | 129 | 1 | Lifitegrast (PRR 729.6) |
| 7976 | Transient Aphasia | 129 | 1 | Panitumumab (PRR 148.8) |
| 7977 | Foetal Malnutrition | 129 | 1 | Darunavir (PRR 115.6) |
| 7978 | Renal Cyst Ruptured | 129 | 1 | Tolvaptan (PRR 361.3) |
| 7979 | Eczema Weeping | 129 | 1 | Nemolizumab-Ilto (PRR 79.8) |
| 7980 | Rhinoplasty | 129 | 1 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 97.4) |
| 7981 | Actinomyces Test Positive | 128 | 2 | Levonorgestrel (PRR 72.3) |
| 7982 | Body Surface Area Increased | 128 | 5 | Goserelin (PRR 117.2) |
| 7983 | Cd19 Lymphocytes Decreased | 128 | 3 | Ocrelizumab (PRR 314.4) |
| 7984 | Heart And Lung Transplant | 128 | 4 | Epoprostenol (PRR 486.4) |
| 7985 | Parathyroid Tumour Malignant | 128 | 4 | Cinacalcet Hydrochloride (PRR 174.4) |
| 7986 | Autoimmune Neuropathy | 128 | 1 | Ipilimumab (PRR 68.7) |
| 7987 | Delayed Engraftment | 128 | 8 | Melphalan Hydrochloride (PRR 172.1) |
| 7988 | Blood Lactic Acid | 128 | 4 | Sitagliptin And Metformin Hydrochloride (PRR 189.2) |
| 7989 | Hippocampal Sclerosis | 128 | 3 | Lacosamide (PRR 128.8) |
| 7990 | Blood Gastrin Increased | 128 | 2 | Everolimus Tablets (PRR 105.1) |
| 7991 | Eosinopenia | 128 | 1 | Benralizumab (PRR 42.2) |
| 7992 | Renal Replacement Therapy | 128 | 2 | Pegaspargase (PRR 128.5) |
| 7993 | Catheter Site Mass | 128 | 1 | Epoprostenol (PRR 120.2) |
| 7994 | Pseudohyponatraemia | 128 | 3 | Itraconazole (PRR 310.5) |
| 7995 | Urine Sodium Decreased | 128 | 2 | Lubiprostone (PRR 166.4) |
| 7996 | Abnormal Labour | 128 | 1 | Misoprostol (PRR 372.4) |
| 7997 | Self Esteem Inflated | 128 | 1 | Asenapine Maleate (PRR 57.6) |
| 7998 | Bacterial Toxaemia | 128 | 1 | Micafungin Sodium (PRR 99.8) |
| 7999 | Nephroblastoma | 127 | 5 | Etoposide (PRR 139.4) |
| 8000 | Medical Device Battery Replacement | 127 | 5 | Cannabidiol (PRR 92.7) |
| 8001 | Neisseria Infection | 127 | 2 | Ravulizumab (PRR 146.0) |
| 8002 | Implant Site Discolouration | 127 | 1 | Etonogestrel (PRR 1,239.5) |
| 8003 | Pelvic Deformity | 127 | 1 | Cinacalcet Hydrochloride (PRR 22.1) |
| 8004 | Hepatobiliary Scan Abnormal | 127 | 1 | Drospirenone And Ethinyl Estradiol (PRR 216.1) |
| 8005 | Enzyme Level Decreased | 127 | 1 | Pancrelipase (PRR 125.4) |
| 8006 | Chloropsia | 127 | 3 | Voriconazole (PRR 167.7) |
| 8007 | Leukostasis Syndrome | 127 | 4 | Azacitidine For (PRR 164.8) |
| 8008 | Diarrhoea Neonatal | 127 | 4 | Nicotine Polacrilex Mini (PRR 105.7) |
| 8009 | Early Morning Awakening | 127 | 1 | Atomoxetine Hydrochloride (PRR 135.0) |
| 8010 | Penile Discomfort | 127 | 1 | Relugolix (PRR 36.1) |
| 8011 | Protein C Deficiency | 127 | 1 | Etonogestrel And Ethinyl Estradiol (PRR 175.2) |
| 8012 | Cutaneous Nocardiosis | 127 | 4 | Valganciclovir Hydrochloride Powder, (PRR 281.6) |
| 8013 | Cytotoxic Lesions Of Corpus Callosum | 127 | 2 | Amphetamine (PRR 191.8) |
| 8014 | Colorectal Cancer Recurrent | 127 | 3 | Panitumumab (PRR 525.3) |
| 8015 | Drug Name Confusion | 127 | 1 | Bicalutamide (PRR 129.4) |
| 8016 | Epidural Haemorrhage | 127 | 2 | Ketoprofen (PRR 180.8) |
| 8017 | Haemophilus Test Positive | 127 | 1 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 54.2) |
| 8018 | Neurological Procedural Complication | 127 | 1 | Diroximel Fumarate (PRR 42.2) |
| 8019 | Epiploic Appendagitis | 127 | 1 | Bosutinib (PRR 56.0) |
| 8020 | Contrast Media Toxicity | 127 | 1 | Voclosporin (PRR 58.0) |
| 8021 | Term Birth | 127 | 1 | Amphetamine (PRR 124.7) |
| 8022 | Uterine Adhesions | 126 | 2 | Copper (PRR 125.3) |
| 8023 | Benign Ethnic Neutropenia | 126 | 1 | Clozapine (PRR 1,565.3) |
| 8024 | Herpes Simplex Pneumonia | 126 | 3 | Thiotepa (PRR 386.8) |
| 8025 | Hepatitis B Dna Assay Positive | 126 | 4 | Tenofovir Disoproxil Fumarate Tablets (PRR 185.4) |
| 8026 | Atrophy Of Globe | 126 | 3 | Melphalan (PRR 105.2) |
| 8027 | Pasteurella Infection | 126 | 1 | Dornase Alfa (PRR 43.8) |
| 8028 | Paraneoplastic Pemphigus | 126 | 2 | Bendamustine Hydrochloride (PRR 117.8) |
| 8029 | Nasal Flaring | 126 | 2 | Micafungin Sodium (PRR 166.4) |
| 8030 | Coronary Ostial Stenosis | 126 | 1 | Abacavir Sulfate (PRR 144.8) |
| 8031 | Optic Nerve Cupping | 126 | 2 | Brinzolamide (PRR 99.0) |
| 8032 | Superior Vena Cava Occlusion | 126 | 1 | Ivacaftor (PRR 63.9) |
| 8033 | Toxic Nodular Goitre | 126 | 1 | Methimazole (PRR 253.5) |
| 8034 | Infusion Site Pustule | 125 | 3 | Treprostinil (PRR 1,047.4) |
| 8035 | Hyperglycaemic Unconsciousness | 125 | 1 | Insulin Aspart (PRR 153.2) |
| 8036 | Enterocolonic Fistula | 125 | 1 | Isotretinoin (PRR 44.6) |
| 8037 | Exploratory Operation | 125 | 1 | Etonogestrel (PRR 29.8) |
| 8038 | Socioeconomic Precarity | 125 | 3 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate (PRR 96.3) |
| 8039 | Uterine Haematoma | 125 | 1 | Copper (PRR 28.6) |
| 8040 | Ergot Poisoning | 125 | 7 | Ritonavir 100 Mg (PRR 281.1) |
| 8041 | Injection Site Movement Impairment | 125 | 1 | Naltrexone (PRR 113.4) |
| 8042 | Breast Fibrosis | 125 | 2 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 68.3) |
| 8043 | Megakaryocytes Increased | 125 | 2 | Romiplostim (PRR 174.2) |
| 8044 | Oestrogen Receptor Positive Breast Cancer | 125 | 1 | Exemestane (PRR 122.4) |
| 8045 | Neutralising Antibodies | 125 | 3 | Interferon Beta-1B (PRR 74.2) |
| 8046 | Laryngitis Fungal | 125 | 1 | Busulfan (PRR 166.7) |
| 8047 | Blood Catecholamines Increased | 125 | 1 | Rocuronium Bromide (PRR 73.6) |
| 8048 | Cardiac Stress Test | 125 | 1 | Ranolazine (PRR 49.0) |
| 8049 | Uterine Hypotonus | 125 | 1 | Misoprostol (PRR 126.7) |
| 8050 | Medical Device Site Erythema | 125 | 1 | Bupivacaine (PRR 152.2) |
| 8051 | Mesenteric Neoplasm | 125 | 1 | Rucaparib (PRR 57.9) |
| 8052 | Magnetic Resonance Imaging | 124 | 1 | Pegfilgrastim (PRR 272.1) |
| 8053 | Personality Change Due To A General Medical Condition | 124 | 13 | Asenapine Maleate (PRR 606.3) |
| 8054 | Hepato-Lenticular Degeneration | 124 | 1 | Copper (PRR 11.9) |
| 8055 | Car T-Cell-Related Encephalopathy Syndrome | 124 | 2 | Axicabtagene Ciloleucel (PRR 26,937.2) |
| 8056 | Paraneoplastic Neurological Syndrome | 124 | 2 | Atezolizumab (PRR 210.4) |
| 8057 | Testicular Abscess | 124 | 1 | Dapagliflozin (PRR 97.9) |
| 8058 | Varicophlebitis | 124 | 1 | Ixazomib (PRR 56.5) |
| 8059 | Lymph Nodes Scan Abnormal | 124 | 4 | Niraparib (PRR 159.1) |
| 8060 | Sweat Gland Infection | 124 | 1 | Bimekizumab (PRR 58.4) |
| 8061 | Endometrial Cancer Recurrent | 124 | 1 | Durvalumab (PRR 42.9) |
| 8062 | Injection Site Calcification | 124 | 2 | Interferon Beta-1B (PRR 138.1) |
| 8063 | Calcification Of Muscle | 124 | 1 | Desoximetasone (PRR 95.7) |
| 8064 | Adenoiditis | 124 | 1 | Palivizumab (PRR 33.6) |
| 8065 | Lemierre Syndrome | 124 | 1 | Piperacillin And Tazobactam (PRR 112.1) |
| 8066 | Hypnopompic Hallucination | 124 | 2 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 144.5) |
| 8067 | Coronary Artery Perforation | 124 | 1 | Prasugrel Hydrochloride (PRR 104.1) |
| 8068 | Gallbladder Neoplasm | 124 | 1 | Lanreotide Acetate (PRR 88.5) |
| 8069 | Coagulation Factor V Level Abnormal | 123 | 6 | Umeclidinium (PRR 398.3) |
| 8070 | Airway Remodelling | 123 | 10 | Ciclesonide (PRR 5,429.9) |
| 8071 | Burkholderia Test Positive | 123 | 25 | Dextrose Monohydrate (PRR 458.7) |
| 8072 | Iris Neovascularisation | 123 | 5 | Melphalan Hydrochloride (PRR 115.2) |
| 8073 | Hysteroscopy | 123 | 1 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 53.2) |
| 8074 | Factor Ix Inhibition | 123 | 1 | Palivizumab (PRR 33.8) |
| 8075 | Haemorrhagic Cholecystitis | 123 | 1 | Remdesivir (PRR 52.5) |
| 8076 | Anti Factor Viii Antibody Increased | 123 | 1 | Emicizumab (PRR 408.1) |
| 8077 | Creatinine Urine Abnormal | 123 | 1 | Tafamidis (PRR 106.6) |
| 8078 | Administration Site Discolouration | 123 | 1 | Iron Sucrose (PRR 111.9) |
| 8079 | Plasmodium Falciparum Infection | 123 | 1 | Quinine (PRR 214.7) |
| 8080 | Progressive Relapsing Multiple Sclerosis | 122 | 2 | Interferon Beta-1B (PRR 76.1) |
| 8081 | Premenstrual Pain | 122 | 1 | Copper (PRR 62.5) |
| 8082 | Pancreatic Enzymes Decreased | 122 | 1 | Pancrelipase (PRR 160.3) |
| 8083 | Wrong Dosage Formulation | 122 | 1 | Galcanezumab-Gnlm (PRR 40.2) |
| 8084 | Balanitis Candida | 122 | 1 | Dapagliflozin (PRR 107.0) |
| 8085 | Tracheostomy Infection | 122 | 5 | Tobramycin Solution (PRR 121.5) |
| 8086 | Intentional Product Misuse To Child | 122 | 1 | Voxelotor (PRR 23.4) |
| 8087 | Incarcerated Inguinal Hernia | 122 | 1 | Azacitidine For (PRR 59.1) |
| 8088 | Neurosensory Hypoacusis | 122 | 1 | Ciclesonide (PRR 214.1) |
| 8089 | Hyperadrenalism | 122 | 1 | Abiraterone (PRR 65.3) |
| 8090 | Exposure To Radiation | 122 | 1 | Lutetium Lu 177 Vipivotide Tetraxetan (PRR 39.8) |
| 8091 | Stomatitis Haemorrhagic | 122 | 3 | Lanreotide Acetate (PRR 211.3) |
| 8092 | Congenital Nail Disorder | 122 | 2 | Epoetin Alfa (PRR 209.4) |
| 8093 | Roseolovirus Test Positive | 122 | 2 | Thiotepa (PRR 93.1) |
| 8094 | Malignant Neoplasm Of Pleura | 122 | 1 | Erlotinib (PRR 72.8) |
| 8095 | Solar Urticaria | 122 | 1 | Baricitinib (PRR 92.2) |
| 8096 | Fixed Drug Eruption | 122 | 1 | Iohexol (PRR 63.3) |
| 8097 | Lacrimation Disorder | 122 | 1 | Iohexol (PRR 63.3) |
| 8098 | Infusion Site Scab | 121 | 2 | Treprostinil (PRR 185.1) |
| 8099 | Rhesus Incompatibility | 121 | 9 | Nicotine Polacrilex Mini (PRR 1,778.4) |
| 8100 | Stomatococcal Infection | 121 | 5 | Cytarabine (PRR 177.0) |
| 8101 | Stenotrophomonas Sepsis | 121 | 3 | Fludarabine Phosphate (PRR 174.2) |
| 8102 | Csf Oligoclonal Band Present | 121 | 12 | Magnesium Sulfate In Water For (PRR 322.5) |
| 8103 | Intracranial Infection | 121 | 11 | Basiliximab (PRR 484.1) |
| 8104 | Angiosarcoma Metastatic | 121 | 3 | Anti-Thymocyte Globulin (Rabbit) (PRR 207.3) |
| 8105 | Anaplastic Thyroid Cancer | 121 | 2 | Dabrafenib (PRR 648.9) |
| 8106 | Genital Neoplasm Malignant Female | 121 | 1 | Paliperidone (PRR 54.7) |
| 8107 | Cystatin C Increased | 121 | 1 | Abemaciclib (PRR 54.3) |
| 8108 | Achromobacter Infection | 121 | 4 | Blinatumomab (PRR 104.0) |
| 8109 | Herpes Simplex Viraemia | 121 | 5 | Basiliximab (PRR 159.4) |
| 8110 | Perianal Erythema | 121 | 1 | Lapatinib (PRR 57.8) |
| 8111 | Anticoagulation Drug Level Decreased | 121 | 1 | Rifampin (PRR 232.9) |
| 8112 | Mucocutaneous Leishmaniasis | 121 | 4 | Daspone (PRR 151.2) |
| 8113 | Spinal Flattening | 121 | 1 | Acetaminophen And Codeine (PRR 137.2) |
| 8114 | Central Venous Pressure Increased | 121 | 1 | Rocuronium Bromide (PRR 76.1) |
| 8115 | Pharyngeal Haematoma | 121 | 1 | Miconazole Nitrate (PRR 124.4) |
| 8116 | Spinal Haematoma | 121 | 1 | Fondaparinux Sodium (PRR 134.1) |
| 8117 | Abortion Of Ectopic Pregnancy | 120 | 3 | Darunavir (PRR 98.2) |
| 8118 | Blood Growth Hormone Abnormal | 120 | 3 | Octreotide Acetate (PRR 268.2) |
| 8119 | Breast Microcalcification | 120 | 5 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 208.9) |
| 8120 | Eyelash Thickening | 120 | 4 | Travoprost (PRR 218.6) |
| 8121 | Genital Disorder | 120 | 2 | Minoxidil Foam 5% (Womens) (PRR 39.0) |
| 8122 | Hypersensitivity Myocarditis | 120 | 3 | Fondaparinux Sodium (PRR 259.4) |
| 8123 | Eastern Cooperative Oncology Group Performance Status Abnormal | 120 | 1 | Ribociclib (PRR 439.0) |
| 8124 | Abdominal Wall Cyst | 120 | 2 | Vigabatrin (PRR 129.7) |
| 8125 | Oligodendroglioma | 120 | 2 | Temozolomide (PRR 162.9) |
| 8126 | Congenital Cystic Lung | 120 | 4 | Ampicillin (PRR 305.2) |
| 8127 | Perineal Rash | 120 | 1 | Baricitinib (PRR 567.9) |
| 8128 | Candida Endophthalmitis | 120 | 2 | Daptomycin (PRR 118.7) |
| 8129 | Choanal Atresia | 120 | 1 | Methimazole (PRR 407.7) |
| 8130 | Antacid Therapy | 119 | 55 | Phytonadione (PRR 5,886.0) |
| 8131 | Fev1/Fvc Ratio Decreased | 119 | 7 | Ciclesonide (PRR 426.9) |
| 8132 | Renal Phospholipidosis | 119 | 3 | Eplerenone (PRR 328.2) |
| 8133 | Osteochondroma | 119 | 1 | Somatropin (PRR 64.0) |
| 8134 | Magnetic Resonance Imaging Spinal Abnormal | 119 | 2 | Ocrelizumab (PRR 351.9) |
| 8135 | Menstrual Discomfort | 119 | 1 | Copper (PRR 34.7) |
| 8136 | Malignant Urinary Tract Neoplasm | 119 | 2 | Axitinib (PRR 119.7) |
| 8137 | Arterial Restenosis | 119 | 2 | Prasugrel Hydrochloride (PRR 295.3) |
| 8138 | Choroidal Infarction | 119 | 4 | Melphalan (PRR 281.2) |
| 8139 | Hepatic Infection Fungal | 119 | 3 | Melphalan (PRR 112.1) |
| 8140 | Onychomalacia | 119 | 1 | Abemaciclib (PRR 65.0) |
| 8141 | Anal Erythema | 119 | 2 | Ado-Trastuzumab Emtansine (PRR 108.2) |
| 8142 | Urine Osmolarity Decreased | 119 | 1 | Tolvaptan (PRR 238.5) |
| 8143 | Neonatal Hyponatraemia | 119 | 2 | Zidovudine (PRR 142.7) |
| 8144 | Diverticulum Oesophageal | 119 | 1 | Sirolimus (PRR 173.2) |
| 8145 | Antibiotic Resistant Staphylococcus Test Positive | 119 | 2 | Prednisolone Acetate (PRR 106.8) |
| 8146 | Iron Metabolism Disorder | 119 | 1 | Avapritinib (PRR 75.3) |
| 8147 | Abdominal Wall Mass | 119 | 1 | Avapritinib (PRR 44.4) |
| 8148 | Urinary Fistula | 119 | 1 | Basiliximab (PRR 315.2) |
| 8149 | Product Gel Formation | 119 | 2 | Testosterone Cypionate (PRR 970.5) |
| 8150 | Separation Anxiety Disorder | 119 | 1 | Brivaracetam (PRR 101.5) |
| 8151 | Radial Pulse Abnormal | 119 | 1 | Iohexol (PRR 64.9) |
| 8152 | Uterine Malposition | 118 | 2 | Copper (PRR 75.6) |
| 8153 | Stoma Site Induration | 118 | 5 | Rotigotine (PRR 147.9) |
| 8154 | Insulin Resistant Diabetes | 118 | 1 | Insulin Human (PRR 119.8) |
| 8155 | Retinitis Viral | 118 | 10 | Ganciclovir (PRR 632.4) |
| 8156 | Ocular Pemphigoid | 118 | 2 | Brinzolamide (PRR 84.0) |
| 8157 | Anal Prolapse | 118 | 3 | Mometasone (PRR 177.8) |
| 8158 | Purpura Senile | 118 | 16 | Oseltamivir (PRR 241.9) |
| 8159 | Therapy Naive | 118 | 1 | Buprenorphine Hydrochloride, Naloxone Hydrochloride (PRR 175.9) |
| 8160 | Polyomavirus Test Positive | 118 | 1 | Everolimus Tablets (PRR 223.3) |
| 8161 | Gastrointestinal Angiectasia | 118 | 1 | Valsartan And Hydrochlorothiazide (PRR 111.4) |
| 8162 | Chemical Burn Of Genitalia | 118 | 1 | Miconazole Nitrate (PRR 4,157.7) |
| 8163 | Infusion Site Hypersensitivity | 117 | 1 | Treprostinil (PRR 82.4) |
| 8164 | Residual Urine Volume Increased | 117 | 4 | Mirabegron (PRR 110.7) |
| 8165 | Paranasal Sinus Mucosal Hypertrophy | 117 | 1 | Ocrelizumab (PRR 86.4) |
| 8166 | Lichen Planopilaris | 117 | 3 | Chlorthalidone (PRR 347.3) |
| 8167 | Neuropsychiatric Lupus | 117 | 2 | Clarithromycin (PRR 164.5) |
| 8168 | Hyperphosphaturia | 117 | 2 | Pemetrexed (PRR 90.6) |
| 8169 | Hypervitaminosis D | 117 | 3 | Calcitriol Capsules 0.25 Mcg (PRR 201.1) |
| 8170 | Primary Mediastinal Large B-Cell Lymphoma | 117 | 4 | Axicabtagene Ciloleucel (PRR 663.2) |
| 8171 | Human Metapneumovirus Test Positive | 117 | 2 | Palivizumab (PRR 140.5) |
| 8172 | Myoglobinaemia | 117 | 1 | Norepinephrine (PRR 123.8) |
| 8173 | Total Cholesterol/Hdl Ratio Decreased | 117 | 1 | Blinatumomab (PRR 70.6) |
| 8174 | Intermittent Explosive Disorder | 117 | 2 | Guanfacine (PRR 194.1) |
| 8175 | Tri-Iodothyronine Abnormal | 117 | 1 | Liothyronine Sodium (PRR 324.7) |
| 8176 | Type Ii Hypersensitivity | 116 | 1 | Oxaliplatin (PRR 260.9) |
| 8177 | Pulmonary Vein Stenosis | 116 | 2 | Palivizumab (PRR 113.9) |
| 8178 | Pancreatic Toxicity | 116 | 3 | Imatinib (PRR 136.1) |
| 8179 | Salpingo-Oophorectomy | 116 | 1 | Copper (PRR 30.9) |
| 8180 | Myelodysplastic Syndrome With Excess Blasts | 116 | 10 | Tretinoin (PRR 189.9) |
| 8181 | Hypoparathyroidism Secondary | 116 | 1 | Rabeprazole Sodium (PRR 140.0) |
| 8182 | Charles Bonnet Syndrome | 116 | 1 | Ranibizumab (PRR 90.4) |
| 8183 | Normal Tension Glaucoma | 116 | 2 | Brinzolamide (PRR 130.7) |
| 8184 | Psychiatric Evaluation | 116 | 1 | Valbenazine (PRR 53.1) |
| 8185 | Congenital Intestinal Malformation | 116 | 3 | Abacavir Sulfate (PRR 246.4) |
| 8186 | Undifferentiated Connective Tissue Disease | 116 | 1 | Diclofenac Potassium (PRR 68.8) |
| 8187 | Pulmonary Haematoma | 116 | 1 | Norepinephrine (PRR 106.2) |
| 8188 | Anti-Thyroid Antibody Increased | 116 | 3 | Methimazole (PRR 250.0) |
| 8189 | Spinal Claudication | 116 | 1 | Baricitinib (PRR 97.2) |
| 8190 | Blood Electrolytes Increased | 116 | 1 | Dutasteride (PRR 115.3) |
| 8191 | Superficial Siderosis Of Central Nervous System | 115 | 3 | Donepezil Hydrochloride (PRR 149.3) |
| 8192 | Abdominal Fat Apron | 115 | 2 | Asfotase Alfa (PRR 55.6) |
| 8193 | Myocardial Calcification | 115 | 5 | Norepinephrine Bitartrate (PRR 250.7) |
| 8194 | Heparin Resistance | 115 | 2 | Heparin Sodium (PRR 937.3) |
| 8195 | Catheter Site Discolouration | 115 | 1 | Epoprostenol (PRR 464.2) |
| 8196 | Post Embolisation Syndrome | 115 | 1 | Cefazolin (PRR 147.8) |
| 8197 | Autoimmune Lung Disease | 114 | 5 | Pemetrexed (PRR 135.8) |
| 8198 | Postnatal Growth Restriction | 114 | 5 | Rimegepant Sulfate (PRR 1,070.5) |
| 8199 | Copper Deficiency | 114 | 4 | Zinc Chloride (PRR 223.3) |
| 8200 | Disseminated Toxoplasmosis | 114 | 7 | Thiotepa (PRR 580.9) |
| 8201 | Xanthelasma | 114 | 1 | Nilotinib (PRR 115.1) |
| 8202 | Conjunctival Erosion | 114 | 1 | Ranibizumab (PRR 292.5) |
| 8203 | Dystrophic Calcification | 114 | 1 | Umeclidinium Bromide And Vilanterol Trifenatate (PRR 69.2) |
| 8204 | Fontanelle Bulging | 114 | 1 | Palivizumab (PRR 144.6) |
| 8205 | Congenital Pyelocaliectasis | 114 | 1 | Atazanavir (PRR 109.2) |
| 8206 | Vitello-Intestinal Duct Remnant | 114 | 1 | Misoprostol (PRR 139.8) |
| 8207 | Tendinous Contracture | 114 | 2 | Vibegron (PRR 144.2) |
| 8208 | Chlamydia Test Positive | 113 | 3 | Etonogestrel And Ethinyl Estradiol (PRR 111.4) |
| 8209 | Drug Delivery System Removal | 113 | 1 | Buprenorphine (PRR 1,583.6) |
| 8210 | Hyper Ige Syndrome | 113 | 9 | Ciclesonide (PRR 1,448.2) |
| 8211 | Medulloblastoma Recurrent | 113 | 5 | Thiotepa (PRR 283.2) |
| 8212 | Renal Cell Carcinoma Recurrent | 113 | 3 | Pazopanib Hydrochloride (PRR 82.8) |
| 8213 | Pseudomyopia | 113 | 2 | Daratumumab (PRR 171.3) |
| 8214 | Renal Cell Carcinoma Stage Iv | 113 | 4 | Sorafenib (PRR 165.1) |
| 8215 | Double Stranded Dna Antibody | 113 | 1 | Ixekizumab (PRR 48.6) |
| 8216 | Eosinophil Count | 113 | 3 | Ciclesonide (PRR 369.2) |
| 8217 | Vitreous Adhesions | 113 | 2 | Ranibizumab (PRR 138.7) |
| 8218 | Pelvic Kidney | 113 | 6 | Ivacaftor (PRR 226.7) |
| 8219 | Persistent Corneal Epithelial Defect | 113 | 5 | Cenegermin-Bkbj (PRR 283.7) |
| 8220 | Testicular Seminoma (Pure) | 113 | 2 | Baricitinib (PRR 256.4) |
| 8221 | Post-Depletion B-Cell Recovery | 113 | 1 | Blinatumomab (PRR 92.3) |
| 8222 | Ventriculo-Peritoneal Shunt | 113 | 1 | Brivaracetam (PRR 107.1) |
| 8223 | Nail Bed Tenderness | 113 | 1 | Ado-Trastuzumab Emtansine (PRR 188.0) |
| 8224 | Insulin-Like Growth Factor Abnormal | 113 | 1 | Lanreotide Acetate (PRR 315.3) |
| 8225 | Habitual Abortion | 112 | 1 | Levonorgestrel (PRR 44.6) |
| 8226 | Vogt-Koyanagi-Harada Syndrome | 112 | 1 | Ribavirin (PRR 165.7) |
| 8227 | Reticulocyte Count Abnormal | 112 | 2 | Eculizumab (PRR 146.2) |
| 8228 | Postmenopause | 112 | 1 | Copper (PRR 32.1) |
| 8229 | Vertical Infection Transmission | 112 | 4 | Zidovudine (PRR 470.3) |
| 8230 | Purulent Pericarditis | 112 | 1 | Sarilumab (PRR 68.8) |
| 8231 | Asteatosis | 112 | 3 | Clobazam (PRR 185.1) |
| 8232 | Megakaryocytes Abnormal | 112 | 2 | Romiplostim (PRR 92.1) |
| 8233 | Bilirubin Urine Present | 112 | 3 | Alemtuzumab (PRR 468.7) |
| 8234 | Peroneal Nerve Injury | 112 | 4 | Captopril (PRR 284.1) |
| 8235 | Laryngeal Dyskinesia | 112 | 1 | Ciclesonide (PRR 394.7) |
| 8236 | Immune Effector Cell-Associated Hlh-Like Syndrome | 112 | 1 | Axicabtagene Ciloleucel (PRR 403.7) |
| 8237 | Ureteric Injury | 112 | 1 | Brinzolamide (PRR 234.8) |
| 8238 | Catheter Thrombosis | 112 | 1 | Fondaparinux Sodium (PRR 197.8) |
| 8239 | Immunotoxicity | 111 | 3 | Durvalumab (PRR 252.7) |
| 8240 | Inadvertent Injection Air Bubble | 111 | 3 | Iohexol (PRR 168.9) |
| 8241 | Epididymal Cyst | 111 | 2 | Finasteride (PRR 271.9) |
| 8242 | Tobacco Interaction | 111 | 5 | Nicotine Polacrilex Mini (PRR 233.4) |
| 8243 | Hiv-Associated Neurocognitive Disorder | 111 | 16 | Efavirenz (PRR 1,010.7) |
| 8244 | Binge Drinking | 111 | 1 | Naltrexone (PRR 97.3) |
| 8245 | Gastroenteropancreatic Neuroendocrine Tumour Disease | 111 | 3 | Octreotide Acetate (PRR 1,413.5) |
| 8246 | Gastric Ph Increased | 111 | 2 | Telmisartan (PRR 240.6) |
| 8247 | Hair Follicle Tumour Benign | 111 | 1 | Anakinra (PRR 195.9) |
| 8248 | Nicotinic Acid Deficiency | 111 | 2 | Isoniazid (PRR 185.3) |
| 8249 | Splenic Embolism | 111 | 5 | Pyrazinamide (PRR 268.5) |
| 8250 | Nucleated Red Cells | 111 | 2 | Rucaparib (PRR 65.4) |
| 8251 | Melanosis | 111 | 1 | Vemurafenib (PRR 81.6) |
| 8252 | Congenital Cerebral Cyst | 111 | 2 | Dolutegravir Sodium (PRR 86.2) |
| 8253 | Joint Tuberculosis | 111 | 2 | Pyrazinamide (PRR 126.6) |
| 8254 | Hypoglobulinaemia | 111 | 2 | Polatuzumab Vedotin (PRR 79.7) |
| 8255 | Pulmonary Blastomycosis | 111 | 1 | Thiotepa (PRR 169.2) |
| 8256 | Tinea Capitis | 111 | 1 | Terbinafine Hydrochloride (PRR 157.6) |
| 8257 | Listeria Encephalitis | 111 | 2 | Ampicillin (PRR 169.1) |
| 8258 | Atlantoaxial Instability | 110 | 3 | Canakinumab (PRR 192.3) |
| 8259 | Right Atrial Hypertrophy | 110 | 11 | Theophylline Anhydrous (PRR 6,711.1) |
| 8260 | Transitional Cell Carcinoma Metastatic | 110 | 1 | Pembrolizumab (PRR 170.1) |
| 8261 | Acquired Factor V Deficiency | 110 | 14 | Umeclidinium (PRR 395.4) |
| 8262 | Chronic Recurrent Multifocal Osteomyelitis | 110 | 4 | Adalimumab-Fkjp (PRR 482.2) |
| 8263 | Cellulitis Of Male External Genital Organ | 110 | 2 | Canagliflozin (PRR 118.2) |
| 8264 | Failure To Anastomose | 110 | 2 | Thiamine Hydrochloride (PRR 224.0) |
| 8265 | Mesenteric Vascular Insufficiency | 110 | 2 | Tranexamic Acid (PRR 159.0) |
| 8266 | Blood Methaemoglobin Present | 110 | 3 | Daspone (PRR 446.0) |
| 8267 | Amniotic Band Syndrome | 110 | 1 | Misoprostol (PRR 190.4) |
| 8268 | Drug Half-Life Increased | 110 | 2 | Derma Foam Excel Hand Sanitizer (PRR 73.0) |
| 8269 | Human Chorionic Gonadotropin Decreased | 109 | 1 | Levonorgestrel (PRR 33.7) |
| 8270 | Salpingo-Oophorectomy Unilateral | 109 | 13 | Psyllium Husk (PRR 727.9) |
| 8271 | Pituitary Cyst | 109 | 1 | Somatropin (PRR 45.0) |
| 8272 | Wall Motion Score Index Abnormal | 109 | 9 | Goserelin (PRR 1,362.3) |
| 8273 | Neoplasm Of Appendix | 109 | 1 | Ranitidine Hydrochloride (PRR 61.0) |
| 8274 | Regurgitation Of Food | 109 | 1 | Exenatide (PRR 117.4) |
| 8275 | Congenital Uterine Anomaly | 109 | 1 | Copper (PRR 23.2) |
| 8276 | Lupus Pneumonitis | 109 | 1 | Belimumab (PRR 195.4) |
| 8277 | Bacillus Bacteraemia | 109 | 4 | Azacitidine For (PRR 211.3) |
| 8278 | Intestinal Barrier Dysfunction | 109 | 2 | Abemaciclib (PRR 60.6) |
| 8279 | Karyotype Analysis Abnormal | 109 | 2 | Darunavir (PRR 154.4) |
| 8280 | Electroconvulsive Therapy | 109 | 2 | Esketamine Hydrochloride (PRR 67.9) |
| 8281 | Fluid Intake Restriction | 109 | 1 | Tolvaptan (PRR 98.2) |
| 8282 | Skin Squamous Cell Carcinoma Recurrent | 109 | 1 | Sirolimus (PRR 246.4) |
| 8283 | Tracheal Inflammation | 109 | 1 | Crizotinib (PRR 112.3) |
| 8284 | Amimia | 109 | 1 | Rasagiline Mesylate (PRR 89.9) |
| 8285 | Glutamate Dehydrogenase Increased | 109 | 1 | Brentuximab Vedotin (PRR 77.3) |
| 8286 | Oxygen Saturation Immeasurable | 109 | 1 | Iohexol (PRR 95.6) |
| 8287 | Injection Site Abscess Sterile | 108 | 1 | Leuprolide Acetate (PRR 334.2) |
| 8288 | Meningoradiculitis | 108 | 2 | Ipilimumab (PRR 83.7) |
| 8289 | Tobacco Poisoning | 108 | 4 | Nicotine (PRR 595.8) |
| 8290 | Urine Phosphorus Increased | 108 | 2 | Lamivudine Oral (PRR 142.9) |
| 8291 | Tractional Retinal Detachment | 108 | 5 | Prednisolone Acetate (PRR 182.8) |
| 8292 | Retinoblastoma | 108 | 7 | Melphalan Hydrochloride (PRR 249.7) |
| 8293 | Lymphangioleiomyomatosis | 108 | 3 | Phenobarbital (PRR 179.4) |
| 8294 | Virilism | 108 | 1 | Testosterone (PRR 227.5) |
| 8295 | Poikiloderma | 108 | 2 | Busulfan (PRR 165.2) |
| 8296 | Autoimmune Thyroid Disorder | 108 | 1 | Alemtuzumab (PRR 290.9) |
| 8297 | Serratia Sepsis | 108 | 3 | Thiotepa (PRR 378.9) |
| 8298 | Trifascicular Block | 108 | 2 | Memantine (PRR 121.6) |
| 8299 | Catheter Site Oedema | 108 | 1 | Epoprostenol (PRR 127.1) |
| 8300 | Pharyngeal Cyst | 108 | 1 | Cortisone Acetate (PRR 81.8) |
| 8301 | Hypophosphatasia | 108 | 1 | Asfotase Alfa (PRR 1,127.4) |
| 8302 | Small Cell Lung Cancer Extensive Stage | 108 | 1 | Erlotinib (PRR 82.6) |
| 8303 | Atrophic Glossitis | 108 | 1 | Vismodegib (PRR 187.0) |
| 8304 | Atelectasis Neonatal | 108 | 2 | Ampicillin (PRR 201.0) |
| 8305 | Eye Naevus | 108 | 1 | Faricimab (PRR 73.4) |
| 8306 | Malignant Mediastinal Neoplasm | 107 | 7 | Travoprost (PRR 1,553.9) |
| 8307 | Neuroglycopenia | 107 | 12 | Vortioxetine (PRR 433.2) |
| 8308 | Hyperinsulinism | 107 | 1 | Olanzapine Pamoate (PRR 246.7) |
| 8309 | Pseudocholelithiasis | 107 | 2 | Ceftriaxone Sodium (PRR 13,949.6) |
| 8310 | Adrenal Cyst | 107 | 2 | Travoprost (PRR 303.8) |
| 8311 | Refractoriness To Platelet Transfusion | 107 | 2 | Busulfan (PRR 121.4) |
| 8312 | Medical Observation | 107 | 1 | Sotalol Hydrochloride (PRR 143.3) |
| 8313 | Propionibacterium Infection | 107 | 2 | Sirolimus (PRR 271.5) |
| 8314 | Rheumatoid Factor | 107 | 2 | Methylprednisolone Acetate (PRR 210.0) |
| 8315 | Muscle Contusion | 107 | 1 | Emicizumab (PRR 48.6) |
| 8316 | Investigation Noncompliance | 106 | 2 | Clozapine (PRR 191.7) |
| 8317 | Paradoxical Embolism | 106 | 1 | Drospirenone And Ethinyl Estradiol (PRR 71.5) |
| 8318 | Pelvic Congestion | 106 | 1 | Copper (PRR 18.9) |
| 8319 | Adhesiolysis | 106 | 1 | Copper (PRR 14.0) |
| 8320 | Genito-Pelvic Pain/Penetration Disorder | 106 | 2 | Ado-Trastuzumab Emtansine (PRR 174.5) |
| 8321 | Intestinal Atresia | 106 | 2 | Brivaracetam (PRR 352.1) |
| 8322 | Lupus Vasculitis | 106 | 1 | Belimumab (PRR 83.8) |
| 8323 | Hypercorticoidism | 106 | 3 | Ritonavir (PRR 280.8) |
| 8324 | Adjusted Calcium Decreased | 106 | 3 | Sirolimus (PRR 143.3) |
| 8325 | Polycystic Liver Disease | 106 | 5 | Febuxostat Tablets 40 Mg (PRR 286.0) |
| 8326 | Pinguecula | 106 | 1 | Ranibizumab (PRR 55.4) |
| 8327 | Corneal Toxicity | 106 | 2 | Thiotepa (PRR 85.4) |
| 8328 | Pericarditis Malignant | 106 | 1 | Durvalumab (PRR 50.6) |
| 8329 | Pigmentation Lip | 106 | 2 | Glycerin, Lidocaine (PRR 121.3) |
| 8330 | Focal Glomerulosclerosis | 106 | 1 | Sirolimus (PRR 404.4) |
| 8331 | Laryngitis Viral | 106 | 3 | Alpelisib (PRR 194.8) |
| 8332 | Corneal Abscess | 106 | 1 | Tobramycin Solution (PRR 103.9) |
| 8333 | Viral Vasculitis | 106 | 2 | Basiliximab (PRR 204.8) |
| 8334 | Implantable Cardiac Monitor Insertion | 106 | 1 | Ranolazine (PRR 78.2) |
| 8335 | Penile Necrosis | 106 | 1 | Dutasteride (PRR 208.9) |
| 8336 | Immune-Mediated Cystitis | 105 | 3 | Nivolumab (PRR 180.5) |
| 8337 | Adrenalitis | 105 | 3 | Ipilimumab (PRR 142.6) |
| 8338 | New Onset Refractory Status Epilepticus | 105 | 17 | Brivaracetam (PRR 1,060.4) |
| 8339 | Complement Factor Abnormal | 105 | 2 | Eculizumab (PRR 360.8) |
| 8340 | Dialysis Device Insertion | 105 | 3 | Patiromer (PRR 250.5) |
| 8341 | Gastrointestinal Disorder Congenital | 105 | 5 | Darunavir (PRR 576.1) |
| 8342 | Tumour Inflammation | 105 | 2 | Alpelisib (PRR 70.2) |
| 8343 | Illicit Prescription Attainment | 105 | 3 | Oxazepam (PRR 200.1) |
| 8344 | Drug-Device Interaction | 105 | 2 | Norepinephrine (PRR 97.3) |
| 8345 | Metastatic Carcinoid Tumour | 105 | 2 | Octreotide Acetate (PRR 529.0) |
| 8346 | Iris Hypopigmentation | 105 | 2 | Moxifloxacin Hydrochloride (PRR 337.5) |
| 8347 | Burkitt'S Lymphoma | 105 | 1 | Lopinavir And Ritonavir (PRR 126.6) |
| 8348 | Foreign Body Ingestion | 105 | 2 | Instalax Polyethylene Glycol 3350 (PRR 279.4) |
| 8349 | Synostosis | 105 | 2 | Nevirapine (PRR 216.2) |
| 8350 | Complement Factor C3 Increased | 105 | 1 | Agalsidase Beta (PRR 211.0) |
| 8351 | Peptostreptococcus Infection | 105 | 1 | Icosapent Ethyl (PRR 96.8) |
| 8352 | Ocular Stroke | 105 | 1 | Faricimab (PRR 75.5) |
| 8353 | Vulva Cyst | 104 | 1 | Copper (PRR 19.3) |
| 8354 | Viruria | 104 | 3 | Thiotepa (PRR 487.0) |
| 8355 | Pancreatic Stent Placement | 104 | 1 | Pancrelipase (PRR 461.4) |
| 8356 | Fundoscopy Abnormal | 104 | 2 | Ranibizumab (PRR 56.5) |
| 8357 | Poems Syndrome | 104 | 2 | Melphalan (PRR 178.6) |
| 8358 | Delirium Febrile | 104 | 1 | Oseltamivir Phosphate (PRR 90.6) |
| 8359 | Band Neutrophil Percentage Increased | 104 | 2 | Dimenhydrinate (PRR 408.6) |
| 8360 | Apgar Score Abnormal | 104 | 3 | Sevoflurane (PRR 180.6) |
| 8361 | Device Audio Issue | 104 | 1 | Fremanezumab-Vfrm (PRR 1,382.1) |
| 8362 | Scleral Thinning | 104 | 1 | Prednisolone Acetate (PRR 145.1) |
| 8363 | Nasal Turbinate Abnormality | 104 | 1 | Vilazodone Hydrochloride (PRR 113.9) |
| 8364 | Lymphoplasmacytoid Lymphoma/Immunocytoma | 104 | 1 | Siponimod (PRR 69.3) |
| 8365 | Psychogenic Pain Disorder | 103 | 1 | Levonorgestrel (PRR 36.4) |
| 8366 | Blood Immunoglobulin M Abnormal | 103 | 4 | Amphotericin B (PRR 239.8) |
| 8367 | Tuberous Sclerosis Complex | 103 | 6 | Zonisamide (PRR 499.5) |
| 8368 | Catheter Site Scab | 103 | 2 | Epoprostenol (PRR 1,138.8) |
| 8369 | Male Genital Atrophy | 103 | 2 | Finasteride (PRR 409.8) |
| 8370 | Pregnancy Test Negative | 103 | 2 | Isotretinoin (PRR 149.1) |
| 8371 | Anal Polyp | 103 | 2 | Peginterferon Beta-1A (PRR 81.0) |
| 8372 | Biochemical Pregnancy | 103 | 1 | Copper (PRR 29.8) |
| 8373 | Retinal Perivascular Sheathing | 103 | 1 | Aflibercept (PRR 79.6) |
| 8374 | Carcinoid Tumour Of The Small Bowel | 103 | 3 | Octreotide Acetate (PRR 292.1) |
| 8375 | Serous Retinopathy | 103 | 4 | Encorafenib (PRR 2,503.4) |
| 8376 | Pleuroparenchymal Fibroelastosis | 103 | 2 | Bleomycin Sulfate (PRR 370.4) |
| 8377 | Bilirubinuria | 103 | 1 | Pemetrexed (PRR 92.8) |
| 8378 | Suture Removal | 103 | 1 | Desoximetasone (PRR 117.4) |
| 8379 | Congenital Pulmonary Valve Disorder | 103 | 3 | Zidovudine (PRR 224.7) |
| 8380 | Swollen Tear Duct | 103 | 1 | Lifitegrast (PRR 51.4) |
| 8381 | Gastritis Fungal | 103 | 4 | Cefazolin (PRR 300.7) |
| 8382 | Myelomalacia | 103 | 1 | Tofacitinib Citrate (PRR 98.1) |
| 8383 | Perineal Fistula | 103 | 1 | Polatuzumab Vedotin (PRR 64.0) |
| 8384 | Mucous Membrane Pemphigoid | 103 | 2 | Daspone (PRR 155.8) |
| 8385 | Congenital Brain Damage | 103 | 1 | Misoprostol (PRR 155.8) |
| 8386 | Product Primary Packaging Issue | 103 | 1 | Travoprost (PRR 97.2) |
| 8387 | Purging | 102 | 2 | Isotretinoin (PRR 61.3) |
| 8388 | Proctocolitis | 102 | 1 | Isotretinoin (PRR 108.8) |
| 8389 | Allergy To Immunoglobulin Therapy | 102 | 3 | Human Immunoglobulin G (PRR 764.5) |
| 8390 | Refractory Cytopenia With Multilineage Dysplasia | 102 | 5 | Melphalan Hydrochloride (PRR 298.5) |
| 8391 | Clonal Evolution | 102 | 6 | Imatinib (PRR 235.8) |
| 8392 | Medical Device Site Thrombosis | 102 | 1 | Lenvatinib (PRR 61.3) |
| 8393 | Postoperative Respiratory Failure | 102 | 2 | Rocuronium Bromide (PRR 91.0) |
| 8394 | Urinary Casts Present | 102 | 2 | Rivastigmine (PRR 133.4) |
| 8395 | Overgrowth Fungal | 102 | 4 | Posaconazole Delayed-Release (PRR 183.3) |
| 8396 | Antibiotic Level Below Therapeutic | 102 | 1 | Posaconazole (PRR 508.5) |
| 8397 | Urinary Tract Infection Viral | 102 | 1 | Thiotepa (PRR 290.5) |
| 8398 | Transplantation Associated Food Allergy | 101 | 3 | Tacrolimus (PRR 2,532.2) |
| 8399 | B-Lymphocyte Count Abnormal | 101 | 1 | Ocrelizumab (PRR 82.6) |
| 8400 | Neurofibrosarcoma | 101 | 4 | Pazopanib Hydrochloride (PRR 155.5) |
| 8401 | Pancreatic Enzyme Abnormality | 101 | 1 | Pancrelipase (PRR 158.7) |
| 8402 | Enophthalmos | 101 | 1 | Bimatoprost (PRR 156.4) |
| 8403 | Compulsive Lip Biting | 101 | 1 | Valbenazine (PRR 25.3) |
| 8404 | Chordoma | 101 | 2 | Imatinib (PRR 522.2) |
| 8405 | Parkinsonian Crisis | 101 | 1 | Rotigotine (PRR 355.1) |
| 8406 | Prosthetic Cardiac Valve Thrombosis | 101 | 1 | Heparin Sodium (PRR 148.0) |
| 8407 | Vitamin A Deficiency | 101 | 1 | Teduglutide (PRR 269.2) |
| 8408 | Pulmonary Microemboli | 101 | 1 | Entecavir (PRR 112.5) |
| 8409 | Globotriaosylceramide Increased | 101 | 1 | Agalsidase Beta (PRR 54,584.3) |
| 8410 | Health Assessment Questionnaire Score Increased | 100 | 2 | Certolizumab Pegol (PRR 156.6) |
| 8411 | Biopsy Lung Abnormal | 100 | 3 | Docetaxel Anhydrous (PRR 188.7) |
| 8412 | Fungal Disease Carrier | 100 | 7 | Amphotericin B (PRR 316.2) |
| 8413 | Nasal Vestibulitis | 100 | 3 | Mupirocin (PRR 315.9) |
| 8414 | Alpha 1 Foetoprotein Abnormal | 100 | 7 | Zidovudine (PRR 341.5) |
| 8415 | Leukoerythroblastosis | 100 | 4 | Ifosfamide (PRR 273.0) |
| 8416 | Foetal Alcohol Syndrome | 100 | 5 | Ethyl Alcohol (PRR 168.0) |
| 8417 | Myeloma Recurrence | 100 | 1 | Thalidomide (PRR 178.7) |
| 8418 | C-Telopeptide Increased | 100 | 1 | Abaloparatide (PRR 87.3) |
| 8419 | Malignant Tumour Excision | 100 | 1 | Imatinib Mesylate (PRR 101.6) |
| 8420 | Foetal Valproate Syndrome | 100 | 2 | Valproate Sodium (PRR 857.0) |
| 8421 | Pericarditis Tuberculous | 100 | 3 | Pyrazinamide (PRR 219.1) |
| 8422 | Yersinia Infection | 100 | 1 | Sirolimus (PRR 152.7) |
| 8423 | Interstitial Lung Abnormality | 100 | 1 | Fam-Trastuzumab Deruxtecan-Nxki (PRR 86.0) |
| 8424 | Uterine Hyperstimulation | 100 | 1 | Misoprostol (PRR 264.1) |
| 8425 | Brachycephaly | 100 | 2 | Misoprostol (PRR 136.4) |
| 8426 | Lymph Node Abscess | 100 | 1 | Pyrazinamide (PRR 116.6) |
| 8427 | Sleep Disorder Due To General Medical Condition, Hypersomnia Type | 99 | 29 | Diclofenac Potassium, Film Coated (PRR 975.0) |
| 8428 | Endocrine Toxicity | 99 | 5 | Ipilimumab (PRR 229.8) |
| 8429 | Delusion Of Replacement | 99 | 4 | Pseudoephedrine Hydrochloride (PRR 107.7) |
| 8430 | Lymphatic Fistula | 99 | 7 | Amiodarone Hydrochloride (PRR 696.2) |
| 8431 | Implant Site Induration | 99 | 1 | Etonogestrel (PRR 761.5) |
| 8432 | Application Site Hyperaesthesia | 99 | 4 | Nicotine (PRR 202.5) |
| 8433 | Out Of Specification Test Results | 99 | 2 | Fludarabine Phosphate (PRR 151.0) |
| 8434 | Infusion Site Coldness | 99 | 2 | Fulvestrant (PRR 201.3) |
| 8435 | Urine Albumin/Creatinine Ratio Abnormal | 99 | 1 | Dapagliflozin (PRR 118.0) |
| 8436 | Pseudoendophthalmitis | 99 | 5 | Triamcinolone Acetonide (PRR 252.3) |
| 8437 | Bacillus Test Positive | 99 | 2 | Pegaspargase (PRR 256.8) |
| 8438 | Optic Glioma | 99 | 2 | Trametinib (PRR 130.1) |
| 8439 | Hypertelorism | 99 | 1 | Valproate Sodium (PRR 741.3) |
| 8440 | Anti-Interferon Antibody Positive | 99 | 1 | Interferon Beta-1B (PRR 292.1) |
| 8441 | Secondary Syphilis | 99 | 3 | Efavirenz (PRR 233.2) |
| 8442 | Shunt Thrombosis | 99 | 2 | Paricalcitol (PRR 263.0) |
| 8443 | Joint Prosthesis User | 99 | 1 | Emicizumab (PRR 52.6) |
| 8444 | Jaundice Hepatocellular | 99 | 1 | Pegaspargase (PRR 109.6) |
| 8445 | Foreign Body In Mouth | 99 | 1 | Cholestyramine (PRR 172.0) |
| 8446 | Oesophageal Intramural Haematoma | 99 | 1 | Rocuronium Bromide (PRR 155.2) |
| 8447 | Sporotrichosis | 99 | 1 | Itraconazole (PRR 245.7) |
| 8448 | Cerebral Salt-Wasting Syndrome | 98 | 4 | Cortisone Acetate (PRR 304.5) |
| 8449 | Radical Prostatectomy | 98 | 1 | Relugolix (PRR 37.5) |
| 8450 | Conjoined Twins | 98 | 3 | Indapamide (PRR 644.6) |
| 8451 | Haemodilution | 98 | 1 | Isoniazid (PRR 196.3) |
| 8452 | Congenital Musculoskeletal Disorder Of Limbs | 98 | 1 | Sirolimus (PRR 137.2) |
| 8453 | Biopsy Lymph Gland | 98 | 1 | Epoprostenol (PRR 122.2) |
| 8454 | Blood Erythropoietin Increased | 98 | 1 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 59.5) |
| 8455 | Subclavian Artery Occlusion | 98 | 2 | Granisetron Hydrochloride (PRR 129.9) |
| 8456 | Perichondritis | 98 | 2 | Mesna Injection (PRR 135.4) |
| 8457 | Hepatoblastoma | 97 | 2 | Somatropin (PRR 55.8) |
| 8458 | Blood Mercury Abnormal | 97 | 7 | Quinapril Hydrochloride (PRR 1,930.9) |
| 8459 | Probiotic Therapy | 97 | 5 | Cefuroxime (PRR 232.7) |
| 8460 | Penile Abscess | 97 | 2 | Ceftriaxone (PRR 208.2) |
| 8461 | Neuropathic Muscular Atrophy | 97 | 2 | Ofatumumab (PRR 88.3) |
| 8462 | Malacoplakia Gastrointestinal | 97 | 1 | Mycophenilic Acid (PRR 198.2) |
| 8463 | Bladder Transitional Cell Carcinoma Recurrent | 97 | 2 | Baricitinib (PRR 142.3) |
| 8464 | Postoperative Thoracic Procedure Complication | 97 | 1 | Erlotinib (PRR 92.4) |
| 8465 | Imaging Procedure Abnormal | 97 | 1 | Rucaparib (PRR 241.0) |
| 8466 | Prophylaxis Against Transplant Rejection | 96 | 1 | Tacrolimus (PRR ∞) |
| 8467 | Forced Expiratory Flow Decreased | 96 | 3 | Omalizumab (PRR 443.5) |
| 8468 | Heart Sounds | 96 | 30 | Quinapril Hydrochloride (PRR 4,395.6) |
| 8469 | Implant Site Hypersensitivity | 96 | 1 | Etonogestrel (PRR 693.9) |
| 8470 | Abortion Spontaneous Incomplete | 96 | 1 | Copper (PRR 32.1) |
| 8471 | Dialysis Hypotension | 96 | 2 | Sevelamer Carbonate (PRR 187.3) |
| 8472 | Tp53 Gene Mutation | 96 | 3 | Selinexor (PRR 104.5) |
| 8473 | Administration Site Wound | 96 | 1 | Alirocumab (PRR 45.5) |
| 8474 | Hepatitis Infectious Mononucleosis | 96 | 2 | Oseltamivir (PRR 373.3) |
| 8475 | Breast Prosthesis Implantation | 96 | 1 | Etonogestrel And Ethinyl Estradiol (PRR 121.3) |
| 8476 | Atypical Mycobacterium Test Positive | 96 | 4 | Rifampin (PRR 328.8) |
| 8477 | Aortic Bruit | 96 | 3 | Desoximetasone (PRR 155.9) |
| 8478 | Hepatic Cyst Infection | 96 | 1 | Tolvaptan (PRR 78.6) |
| 8479 | Cafe Au Lait Spots | 96 | 2 | Norepinephrine (PRR 153.1) |
| 8480 | Intestine Transplant Rejection | 96 | 3 | Basiliximab (PRR 728.3) |
| 8481 | Pulmonary Histoplasmosis | 96 | 1 | Itraconazole (PRR 254.5) |
| 8482 | Asplenia | 96 | 2 | Dronabinol (PRR 235.2) |
| 8483 | Anaphylactoid Syndrome Of Pregnancy | 96 | 1 | Misoprostol (PRR 427.3) |
| 8484 | Delayed Fontanelle Closure | 96 | 1 | Misoprostol (PRR 194.2) |
| 8485 | Atrioventricular Block Third Degree | 96 | 1 | Sevoflurane (PRR 108.8) |
| 8486 | Basal Ganglion Degeneration | 95 | 5 | Bleomycin Sulfate (PRR 1,071.9) |
| 8487 | Gastrointestinal Anastomotic Stenosis | 95 | 2 | Cholestyramine (PRR 180.0) |
| 8488 | Brca2 Gene Mutation | 95 | 4 | Olaparib (PRR 317.5) |
| 8489 | Blood Product Transfusion | 95 | 1 | Eculizumab (PRR 101.9) |
| 8490 | Secondary Hyperthyroidism | 95 | 3 | Sevelamer Carbonate (PRR 144.0) |
| 8491 | Mycobacterial Peritonitis | 95 | 8 | Cefazolin Sodium (PRR 349.6) |
| 8492 | Therapeutic Drug Monitoring Analysis Incorrectly Performed | 95 | 4 | Torsemide (PRR 318.7) |
| 8493 | Pulmonary Artery Occlusion | 95 | 1 | Riociguat (PRR 129.1) |
| 8494 | Corneal Endotheliitis | 95 | 3 | Faricimab (PRR 236.1) |
| 8495 | Scleral Pigmentation | 95 | 2 | Minocycline (PRR 745.7) |
| 8496 | Osteosarcoma Metastatic | 95 | 3 | Regorafenib (PRR 234.6) |
| 8497 | Synovial Sarcoma | 95 | 3 | Bleomycin Sulfate (PRR 236.9) |
| 8498 | Corneal Exfoliation | 95 | 3 | Brinzolamide (PRR 105.3) |
| 8499 | Mucoepidermoid Carcinoma | 95 | 1 | Melphalan (PRR 144.9) |
| 8500 | Astrocytoma Malignant | 95 | 4 | Nevirapine (PRR 576.5) |
| 8501 | Ventricular Internal Diameter Abnormal | 95 | 1 | Patiromer (PRR 101.3) |
| 8502 | Skin Squamous Cell Carcinoma Metastatic | 95 | 1 | Sirolimus (PRR 551.4) |
| 8503 | Benign Gastrointestinal Neoplasm | 95 | 1 | Peginterferon Beta-1A (PRR 51.7) |
| 8504 | Corneal Operation | 95 | 2 | Cenegermin-Bkbj (PRR 180.0) |
| 8505 | Ischaemic Enteritis | 95 | 1 | Sevelamer Carbonate (PRR 79.6) |
| 8506 | Eyelid Ptosis Congenital | 95 | 2 | Desloratadine (PRR 203.0) |
| 8507 | Cardiometabolic Syndrome | 95 | 1 | Asenapine Maleate (PRR 105.5) |
| 8508 | Amino Acid Level Abnormal | 95 | 1 | Pegvaliase-Pqpz (PRR 1,286.4) |
| 8509 | Pituitary Tumour Removal | 95 | 1 | Lanreotide Acetate (PRR 277.7) |
| 8510 | Aorto-Oesophageal Fistula | 94 | 2 | Cisplatin (PRR 130.6) |
| 8511 | Lung Diffusion Test Abnormal | 94 | 4 | Ciclesonide (PRR 1,287.6) |
| 8512 | Ultrasound Antenatal Screen | 94 | 15 | Nevirapine (PRR 2,406.4) |
| 8513 | Biopsy Breast Abnormal | 94 | 4 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 302.0) |
| 8514 | Meningococcal Bacteraemia | 94 | 2 | Eculizumab (PRR 350.9) |
| 8515 | Implant Site Oedema | 94 | 1 | Etonogestrel (PRR 366.9) |
| 8516 | Fat Intolerance | 94 | 1 | Drospirenone And Ethinyl Estradiol (PRR 242.6) |
| 8517 | Infantile Back Arching | 94 | 1 | Methadone (PRR 205.9) |
| 8518 | Prohormone Brain Natriuretic Peptide Increased | 94 | 2 | Brentuximab Vedotin (PRR 188.8) |
| 8519 | Vascular Stent Restenosis | 94 | 2 | Ticagrelor (PRR 276.4) |
| 8520 | Thalassaemia Beta | 94 | 1 | Deferasirox (PRR 148.9) |
| 8521 | Cold Flash | 94 | 2 | Relugolix (PRR 523.0) |
| 8522 | Thromboembolectomy | 94 | 1 | Etonogestrel And Ethinyl Estradiol (PRR 137.2) |
| 8523 | Encephalitis Enteroviral | 94 | 2 | Ifosfamide (PRR 198.5) |
| 8524 | Cyst Drainage | 94 | 1 | Bimekizumab (PRR 54.8) |
| 8525 | Lip Scab | 94 | 3 | Imatinib (PRR 140.4) |
| 8526 | Congenital Pneumonia | 94 | 3 | Cefuroxime (PRR 216.6) |
| 8527 | Anti-Insulin Antibody Increased | 94 | 2 | Human Insulin (PRR 539.5) |
| 8528 | Therapeutic Response Prolonged | 94 | 2 | Bupivacaine (PRR 151.8) |
| 8529 | Arthrofibrosis | 94 | 1 | Bupivacaine (PRR 265.1) |
| 8530 | Infusion Site Hypoaesthesia | 94 | 1 | Eptinezumab-Jjmr (PRR 155.9) |
| 8531 | Capnocytophaga Infection | 94 | 2 | Fondaparinux Sodium (PRR 144.4) |
| 8532 | Chronic Lymphocytic Leukaemia Refractory | 93 | 4 | Ibrutinib (PRR 169.6) |
| 8533 | Alpha Tumour Necrosis Factor Increased | 93 | 5 | Anakinra (PRR 597.0) |
| 8534 | Protothecosis | 93 | 13 | Anti-Thymocyte Globulin (Rabbit) (PRR 1,228.2) |
| 8535 | Lung Adenocarcinoma Recurrent | 93 | 3 | Pemetrexed (PRR 157.6) |
| 8536 | Pinealoblastoma | 93 | 4 | Zidovudine (PRR 8,777.7) |
| 8537 | Performance Enhancing Product Use | 93 | 2 | Testosterone (PRR 309.3) |
| 8538 | Eosinophilic Pustular Folliculitis | 93 | 2 | Daptomycin (PRR 101.4) |
| 8539 | Infant Irritability | 93 | 2 | Palivizumab (PRR 127.4) |
| 8540 | Adenovirus Test Positive | 93 | 2 | Thiotepa (PRR 123.8) |
| 8541 | Blood Antidiuretic Hormone Increased | 93 | 3 | Zidovudine (PRR 187.4) |
| 8542 | Leukodystrophy | 93 | 2 | Brentuximab Vedotin (PRR 115.3) |
| 8543 | Paraneoplastic Dermatomyositis | 93 | 1 | Abiraterone (PRR 86.8) |
| 8544 | Anorectal Polyp | 93 | 2 | Teduglutide (PRR 207.1) |
| 8545 | Optic Nerve Neoplasm | 93 | 1 | Zidovudine (PRR 208.7) |
| 8546 | Vocal Cord Operation | 93 | 2 | Atovaquone (PRR 178.2) |
| 8547 | Viral Uveitis | 93 | 3 | Valganciclovir Hydrochloride Powder, (PRR 182.7) |
| 8548 | Mucosal Atrophy | 93 | 1 | Meperidine Hydrochloride (PRR 241.9) |
| 8549 | Cardiac Valve Abscess | 93 | 4 | Ampicillin (PRR 236.4) |
| 8550 | Electrocardiogram T Wave Amplitude Increased | 93 | 1 | Guanfacine (PRR 118.8) |
| 8551 | T-Cell Prolymphocytic Leukaemia | 92 | 3 | Alemtuzumab (PRR 601.4) |
| 8552 | Central Nervous System Mass | 92 | 9 | Goserelin (PRR 1,927.1) |
| 8553 | Haptoglobin Abnormal | 92 | 2 | Eculizumab (PRR 416.8) |
| 8554 | Ileal Fistula | 92 | 1 | Isotretinoin (PRR 69.1) |
| 8555 | Peau D'Orange | 92 | 3 | Epoetin Alfa (PRR 691.8) |
| 8556 | Metapneumovirus Pneumonia | 92 | 3 | Anti-Thymocyte Globulin (Rabbit) (PRR 245.6) |
| 8557 | Philadelphia Positive Chronic Myeloid Leukaemia | 92 | 6 | Dasatinib (PRR 232.2) |
| 8558 | Negative Pressure Pulmonary Oedema | 92 | 9 | Rocuronium Bromide (PRR 2,011.8) |
| 8559 | Trichomegaly | 92 | 4 | Panitumumab (PRR 815.3) |
| 8560 | Ectopic Kidney | 92 | 8 | Raltegravir (PRR 419.9) |
| 8561 | Trabeculectomy | 92 | 5 | Timolol Maleate (PRR 256.1) |
| 8562 | Cerebrospinal Fistula | 92 | 1 | Triamcinolone Acetonide Ointment Usp, 0.05% (PRR 146.1) |
| 8563 | Eastern Cooperative Oncology Group Performance Status | 92 | 2 | Niraparib (PRR 602.2) |
| 8564 | Vitreoretinal Traction Syndrome | 92 | 1 | Anastrozole Tablets (PRR 188.8) |
| 8565 | Oral Lichenoid Reaction | 92 | 2 | Busulfan (PRR 161.2) |
| 8566 | Chanter Syndrome | 92 | 2 | Fentanyl Citrate (PRR 158.1) |
| 8567 | Mucocutaneous Toxicity | 92 | 1 | Panitumumab (PRR 92.6) |
| 8568 | Pigment Dispersion Syndrome | 92 | 1 | Moxifloxacin (PRR 221.5) |
| 8569 | Optic Nerve Hypoplasia | 92 | 1 | Methadone Hydrochloride (PRR 110.5) |
| 8570 | Axonal And Demyelinating Polyneuropathy | 92 | 1 | Brentuximab Vedotin (PRR 141.6) |
| 8571 | Visceral Pain | 92 | 1 | Pitavastatin Calcium (PRR 141.9) |
| 8572 | Stag Horn Calculus | 92 | 1 | Travoprost (PRR 109.3) |
| 8573 | Sleep Inertia | 91 | 3 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 637.5) |
| 8574 | Foramen Magnum Stenosis | 91 | 3 | Doxepin (PRR 253.4) |
| 8575 | Anti-Erythropoietin Antibody Negative | 91 | 4 | Epoetin Alfa (PRR 1,505.2) |
| 8576 | Platelet Toxicity | 91 | 2 | Gemcitabine (PRR 139.2) |
| 8577 | Blood 1,25-Dihydroxycholecalciferol Increased | 91 | 1 | Cinacalcet Hydrochloride (PRR 37.1) |
| 8578 | Hydrosalpinx | 91 | 1 | Copper (PRR 73.2) |
| 8579 | Disseminated Nocardiosis | 91 | 2 | Mycophenilic Acid (PRR 319.9) |
| 8580 | Platelet Aggregation Inhibition | 91 | 4 | Bupivacaine (PRR 439.5) |
| 8581 | Pancreatic Duct Stenosis | 91 | 1 | Umeclidinium Bromide And Vilanterol Trifenatate (PRR 87.9) |
| 8582 | Demodicidosis | 91 | 3 | Posaconazole Delayed-Release (PRR 499.9) |
| 8583 | Cerebral Hyperperfusion Syndrome | 91 | 1 | Alteplase (PRR 318.2) |
| 8584 | Amoebic Colitis | 91 | 1 | Remdesivir (PRR 71.8) |
| 8585 | Barotrauma | 91 | 1 | Remdesivir (PRR 53.2) |
| 8586 | Catheter Site Erosion | 91 | 1 | Epoprostenol (PRR 264.8) |
| 8587 | Lipids Decreased | 91 | 3 | Inclisiran (PRR 183.1) |
| 8588 | Pulmonary Amyloidosis | 91 | 1 | Tafamidis (PRR 102.7) |
| 8589 | Spinal Ligament Ossification | 91 | 1 | Asfotase Alfa (PRR 95.5) |
| 8590 | Labour Pain | 91 | 1 | Misoprostol (PRR 293.8) |
| 8591 | Metastases To Thyroid | 91 | 1 | Alpelisib (PRR 81.4) |
| 8592 | Hyperandrogenism | 91 | 1 | Tenofovir Disoproxil Fumarate Tablets (PRR 232.3) |
| 8593 | Fallopian Tube Perforation | 90 | 2 | Levonorgestrel (PRR 122.3) |
| 8594 | Uterine Cervical Laceration | 90 | 3 | Misoprostol (PRR 297.5) |
| 8595 | Dilated Pores | 90 | 2 | Adapalene (PRR 86.6) |
| 8596 | Device Monitoring Procedure Not Performed | 90 | 1 | Pegfilgrastim (PRR 139.9) |
| 8597 | Semen Viscosity Decreased | 90 | 1 | Finasteride (PRR 802.6) |
| 8598 | Calcification Metastatic | 90 | 2 | Alpelisib (PRR 170.5) |
| 8599 | Post Gastric Surgery Syndrome | 90 | 1 | Drospirenone And Ethinyl Estradiol (PRR 72.3) |
| 8600 | Labelled Drug-Disease Interaction Issue | 90 | 1 | Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate (PRR 77.1) |
| 8601 | Natural Killer Cell Count Decreased | 90 | 3 | Daratumumab (PRR 112.4) |
| 8602 | Infective Scleritis | 90 | 2 | Triamcinolone Acetonide Ointment Usp, 0.05% (PRR 304.8) |
| 8603 | Coma Blister | 90 | 3 | Vigabatrin (PRR 178.4) |
| 8604 | Panniculitis Lobular | 90 | 3 | Vemurafenib (PRR 123.6) |
| 8605 | Prognathism | 90 | 1 | Valproate Sodium (PRR 408.7) |
| 8606 | Prosthesis User | 90 | 1 | Desoximetasone (PRR 184.3) |
| 8607 | Megakaryocytes Decreased | 90 | 1 | Romiplostim (PRR 81.3) |
| 8608 | Pulmonary Haemorrhage Neonatal | 90 | 3 | Atazanavir (PRR 201.5) |
| 8609 | Bilevel Positive Airway Pressure | 90 | 1 | Remdesivir (PRR 111.5) |
| 8610 | Subdural Effusion | 90 | 1 | Rocuronium Bromide (PRR 103.9) |
| 8611 | Diabetic Wound | 90 | 1 | Methadone Hydrochloride (PRR 89.4) |
| 8612 | Neonatal Cardiac Failure | 90 | 2 | Ampicillin (PRR 245.1) |
| 8613 | Leriche Syndrome | 90 | 1 | Inclisiran (PRR 560.9) |
| 8614 | Chordae Tendinae Rupture | 90 | 1 | Oseltamivir (PRR 90.1) |
| 8615 | Calcineurin Inhibitor Induced Pain Syndrome | 89 | 2 | Tacrolimus Ointment 0.1% (PRR 2,791.2) |
| 8616 | Influenza Immunisation | 89 | 1 | Certolizumab Pegol (PRR 109.2) |
| 8617 | B-Cell Lymphoma Refractory | 89 | 6 | Doxorubicin (PRR 227.4) |
| 8618 | Intracranial Meningioma Malignant | 89 | 1 | Medroxyprogesterone Acetate (PRR 613.6) |
| 8619 | Acute Biphenotypic Leukaemia | 89 | 3 | Blinatumomab (PRR 404.2) |
| 8620 | Elliptocytosis | 89 | 3 | Ribociclib (PRR 673.4) |
| 8621 | Braf Gene Mutation | 89 | 6 | Dabrafenib (PRR 200.0) |
| 8622 | Abdominal Wall Anomaly | 89 | 1 | Ethyl Alcohol (PRR 86.1) |
| 8623 | Portopulmonary Hypertension | 89 | 2 | Epoprostenol (PRR 201.1) |
| 8624 | Pulmonary Septal Thickening | 89 | 3 | Fosaprepitant Dimeglumine (PRR 235.7) |
| 8625 | Vexas Syndrome | 89 | 4 | Canakinumab (PRR 189.9) |
| 8626 | Bk Polyomavirus Test Positive | 89 | 8 | Ganciclovir (PRR 228.7) |
| 8627 | Dosing Error | 89 | 3 | Memantine (PRR 109.9) |
| 8628 | Peri-Implantitis | 89 | 1 | Abiraterone (PRR 130.4) |
| 8629 | Parenteral Nutrition Associated Liver Disease | 89 | 1 | Teduglutide (PRR 131.8) |
| 8630 | Pericoronitis | 89 | 1 | Amphotericin B (PRR 210.2) |
| 8631 | Ventricular Hyperkinesia | 89 | 2 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 322.4) |
| 8632 | Diffuse Vasculitis | 89 | 1 | Liothyronine Sodium (PRR 268.8) |
| 8633 | Meibomianitis | 89 | 1 | Travoprost (PRR 83.9) |
| 8634 | Thyroid Atrophy | 89 | 1 | Methylprednisolone Acetate (PRR 328.9) |
| 8635 | Vena Cava Injury | 88 | 13 | Amphotericin B (PRR 587.5) |
| 8636 | Implant Site Necrosis | 88 | 1 | Etonogestrel (PRR 248.7) |
| 8637 | Application Site Fissure | 88 | 3 | Crisaborole (PRR 76.5) |
| 8638 | Chimerism | 88 | 11 | Thiotepa (PRR 447.6) |
| 8639 | Anaesthetic Complication Pulmonary | 88 | 3 | Sevoflurane (PRR 357.6) |
| 8640 | Tracheal Deviation | 88 | 2 | Sevoflurane (PRR 885.8) |
| 8641 | Peritoneal Fluid Analysis Abnormal | 88 | 2 | Alpelisib (PRR 113.7) |
| 8642 | Carcinoid Heart Disease | 88 | 2 | Octreotide Acetate (PRR 710.0) |
| 8643 | Tongue Thrust | 88 | 2 | Cariprazine (PRR 223.5) |
| 8644 | Gender Dysphoria | 88 | 1 | Paliperidone (PRR 77.0) |
| 8645 | Encephalitis Fungal | 88 | 6 | Posaconazole Delayed-Release (PRR 242.9) |
| 8646 | Meningitis Enteroviral | 88 | 1 | Obinutuzumab (PRR 180.6) |
| 8647 | Acquired Macroglossia | 88 | 2 | Busulfan (PRR 188.8) |
| 8648 | Accessory Spleen | 88 | 1 | Romiplostim (PRR 83.2) |
| 8649 | Bordetella Infection | 88 | 4 | Posaconazole Delayed-Release (PRR 163.7) |
| 8650 | Foetal Heart Rate Increased | 88 | 1 | Misoprostol (PRR 156.3) |
| 8651 | Eye Opacity | 88 | 1 | Travoprost (PRR 84.9) |
| 8652 | Long Qt Syndrome Congenital | 88 | 3 | Ampicillin (PRR 286.2) |
| 8653 | Eczema Infantile | 87 | 2 | Crisaborole (PRR 281.6) |
| 8654 | Immune-Mediated Encephalopathy | 87 | 2 | Nivolumab (PRR 209.4) |
| 8655 | Desmoplastic Small Round Cell Tumour | 87 | 10 | Temozolomide (PRR 1,159.4) |
| 8656 | Autologous Haematopoietic Stem Cell Transplant | 87 | 11 | Obinutuzumab (PRR 242.5) |
| 8657 | Brca1 Gene Mutation | 87 | 4 | Olaparib (PRR 224.0) |
| 8658 | Anotia | 87 | 1 | Isotretinoin (PRR 87.5) |
| 8659 | Orbital Infection | 87 | 2 | Triamcinolone Acetonide Ointment Usp, 0.05% (PRR 215.7) |
| 8660 | Ischaemic Skin Ulcer | 87 | 1 | Canagliflozin (PRR 194.1) |
| 8661 | Gastroenteritis Sapovirus | 87 | 2 | Mycophenilic Acid (PRR 176.3) |
| 8662 | Congenital Musculoskeletal Disorder | 87 | 3 | Zidovudine (PRR 202.0) |
| 8663 | Testicular Haemorrhage | 87 | 1 | Emicizumab (PRR 243.7) |
| 8664 | Osteorrhagia | 87 | 1 | Emicizumab (PRR 81.1) |
| 8665 | Antithrombin Iii Deficiency | 87 | 1 | Pegaspargase (PRR 354.0) |
| 8666 | Injection Site Deformation | 87 | 1 | Asfotase Alfa (PRR 364.8) |
| 8667 | X-Ray Limb Abnormal | 87 | 1 | Asfotase Alfa (PRR 126.6) |
| 8668 | Pharyngeal Polyp | 87 | 1 | Anti-Thymocyte Globulin (Rabbit) (PRR 297.6) |
| 8669 | Cervical Discharge | 86 | 3 | Copper (PRR 101.8) |
| 8670 | Synovial Fluid Analysis | 86 | 28 | Methylprednisolone Acetate (PRR 9,815.6) |
| 8671 | Intracardiac Pressure Increased | 86 | 2 | Treprostinil (PRR 143.4) |
| 8672 | Dystonic Tremor | 86 | 8 | Vortioxetine (PRR 654.8) |
| 8673 | Fluorosis | 86 | 7 | Voriconazole Injection (PRR 832.6) |
| 8674 | Infusion Site Streaking | 86 | 3 | Fosaprepitant Dimeglumine (PRR 319.6) |
| 8675 | Congenital Vesicoureteric Reflux | 86 | 1 | Raltegravir (PRR 147.2) |
| 8676 | Alpha-1 Antitrypsin Deficiency | 86 | 1 | Budesonide, Glycopyrrolate, And Formoterol Fumarate (PRR 72.0) |
| 8677 | Testicular Cancer Metastatic | 86 | 1 | Bleomycin Sulfate (PRR 235.4) |
| 8678 | Cerebrovascular Arteriovenous Malformation | 86 | 2 | Pyrazinamide (PRR 136.7) |
| 8679 | Single Component Of A Two-Component Product Administered | 86 | 1 | Cabotegravir (PRR 377.9) |
| 8680 | Ast/Alt Ratio Abnormal | 86 | 1 | Inclisiran (PRR 126.6) |
| 8681 | Device Implantation Error | 85 | 2 | Etonogestrel (PRR 191.8) |
| 8682 | Product Administered From Unauthorised Provider | 85 | 3 | Botulinum Toxin Type A (PRR 174.1) |
| 8683 | Cord Blood Transplant Therapy | 85 | 4 | Azacitidine For (PRR 285.8) |
| 8684 | Implant Site Dehiscence | 85 | 1 | Etonogestrel (PRR 39.1) |
| 8685 | Mitochondrial Dna Mutation | 85 | 10 | Magnesium Sulfate In Water For (PRR 888.5) |
| 8686 | Primary Effusion Lymphoma | 85 | 1 | Dasatinib (PRR 83.1) |
| 8687 | Congenital Teratoma | 85 | 6 | Zidovudine (PRR 280.9) |
| 8688 | Splenic Necrosis | 85 | 4 | Febuxostat Tablets 40 Mg (PRR 369.4) |
| 8689 | Angiodermatitis | 85 | 2 | Hydroxyurea (PRR 210.7) |
| 8690 | Tuberculosis Of Genitourinary System | 85 | 3 | Pyrazinamide (PRR 295.3) |
| 8691 | Scrotal Cyst | 85 | 4 | Tenofovir Disoproxil Fumarate Tablets (PRR 285.3) |
| 8692 | Idiopathic Generalised Epilepsy | 85 | 1 | Zonisamide (PRR 166.5) |
| 8693 | Pulmonary Vascular Resistance Abnormality | 85 | 1 | Epoprostenol (PRR 165.1) |
| 8694 | Tumour Obstruction | 85 | 3 | Trifluridine And Tipiracil (PRR 121.2) |
| 8695 | Tender Joint Count | 84 | 20 | Diclofenac Potassium, Film Coated (PRR 452.7) |
| 8696 | Haematotympanum | 84 | 2 | Ibrutinib (PRR 183.3) |
| 8697 | Application Site Eczema | 84 | 2 | Minoxidil (PRR 48.7) |
| 8698 | Autoimmune Pancytopenia | 84 | 5 | Alemtuzumab (PRR 272.8) |
| 8699 | Ocular Ischaemic Syndrome | 84 | 2 | Ranibizumab (PRR 71.2) |
| 8700 | Macular Pigmentation | 84 | 1 | Ranibizumab (PRR 143.4) |
| 8701 | Anterior Spinal Artery Syndrome | 84 | 4 | Bupivacaine (PRR 890.7) |
| 8702 | Ovarian Atrophy | 84 | 1 | Busulfan (PRR 626.1) |
| 8703 | Hyperintensity In Brain Deep Nuclei | 84 | 1 | Vigabatrin (PRR 52.9) |
| 8704 | Antidiuretic Hormone Abnormality | 84 | 1 | Rotigotine (PRR 130.7) |
| 8705 | Heparin-Induced Thrombocytopenia Test Positive | 84 | 1 | Heparin Sodium (PRR 276.9) |
| 8706 | Puncture Site Erythema | 84 | 2 | Teduglutide (PRR 162.5) |
| 8707 | Mesenteric Haemorrhage | 84 | 1 | Remdesivir (PRR 78.0) |
| 8708 | Post Procedural Hypotension | 84 | 4 | Tranexamic Acid (PRR 352.5) |
| 8709 | Spermatogenesis Abnormal | 84 | 1 | Bleomycin Sulfate (PRR 241.7) |
| 8710 | Device Pacing Issue | 84 | 1 | Dronedarone (PRR 102.0) |
| 8711 | Tongue Rough | 84 | 1 | Rucaparib (PRR 87.3) |
| 8712 | Pelvic Bone Injury | 84 | 1 | Alpelisib (PRR 119.3) |
| 8713 | Selective Mutism | 84 | 1 | Guanfacine (PRR 203.4) |
| 8714 | Uterine Tenderness | 83 | 3 | Misoprostol (PRR 259.8) |
| 8715 | Hepatitis D | 83 | 3 | Tenofovir Disoproxil Fumarate Tablets (PRR 293.1) |
| 8716 | Peritonitis Sclerosing | 83 | 2 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 398.9) |
| 8717 | Gilbert'S Syndrome | 83 | 1 | Atomoxetine Hydrochloride (PRR 119.7) |
| 8718 | Radiation Interaction | 83 | 2 | Thiotepa (PRR 332.8) |
| 8719 | Lymphocytic Lymphoma | 83 | 1 | Obinutuzumab (PRR 98.5) |
| 8720 | Nih Stroke Scale Score Increased | 83 | 1 | Alteplase (PRR 667.9) |
| 8721 | Systolic Anterior Motion Of Mitral Valve | 83 | 4 | Norepinephrine Bitartrate (PRR 345.1) |
| 8722 | Ultrasound Foetal Abnormal | 83 | 3 | Granisetron Hydrochloride (PRR 242.3) |
| 8723 | Child-Pugh-Turcotte Score Increased | 83 | 2 | Glecaprevir And Pibrentasvir (PRR 147.5) |
| 8724 | Chromoblastomycosis | 83 | 2 | Itraconazole (PRR 272.1) |
| 8725 | Rectal Cancer Recurrent | 83 | 1 | Regorafenib (PRR 139.6) |
| 8726 | Horner'S Syndrome | 83 | 1 | Bupivacaine (PRR 305.0) |
| 8727 | Spinal Cord Injury Thoracic | 83 | 1 | Siponimod (PRR 87.5) |
| 8728 | Incarcerated Umbilical Hernia | 83 | 1 | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 150.7) |
| 8729 | Immune-Mediated Neurological Disorder | 82 | 2 | Pembrolizumab (PRR 264.3) |
| 8730 | Complement Factor Increased | 82 | 3 | Eculizumab (PRR 198.1) |
| 8731 | Corynebacterium Bacteraemia | 82 | 7 | Micafungin Sodium (PRR 641.8) |
| 8732 | Sexual Relationship Change | 82 | 1 | Testosterone (PRR 250.1) |
| 8733 | Palate Injury | 82 | 1 | Desoximetasone (PRR 134.6) |
| 8734 | Angiokeratoma | 82 | 3 | Agalsidase Beta (PRR 1,105.0) |
| 8735 | Tuberculosis Skin Test Positive | 82 | 1 | Isoniazid (PRR 178.3) |
| 8736 | Acquired Hydrocele | 82 | 1 | Palivizumab (PRR 51.4) |
| 8737 | Pigment Nephropathy | 82 | 1 | Rifampin (PRR 220.7) |
| 8738 | Periorbital Infection | 82 | 3 | Thiotepa (PRR 268.6) |
| 8739 | Foetal Renal Impairment | 82 | 1 | Indomethacin (PRR 351.5) |
| 8740 | Benign Gastric Neoplasm | 82 | 1 | Peginterferon Beta-1A (PRR 60.3) |
| 8741 | Genitourinary Tract Neoplasm | 82 | 4 | Lanreotide Acetate (PRR 411.1) |
| 8742 | Alpha Hydroxybutyrate Dehydrogenase Increased | 82 | 1 | Crizotinib (PRR 62.1) |
| 8743 | Gastrointestinal Amyloidosis | 82 | 1 | Tafamidis (PRR 114.7) |
| 8744 | Graft Haemorrhage | 82 | 1 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 71.6) |
| 8745 | Post Infection Glomerulonephritis | 82 | 2 | Febuxostat Tablets 40 Mg (PRR 190.9) |
| 8746 | Polyneuropathy In Malignant Disease | 81 | 5 | Ketoprofen (PRR 453.0) |
| 8747 | Trigemino-Cardiac Reflex | 81 | 6 | Propofol (PRR 1,434.2) |
| 8748 | Hepatitis B Virus | 81 | 2 | Lamivudine (PRR 220.5) |
| 8749 | Macular Cyst | 81 | 1 | Ranibizumab (PRR 208.0) |
| 8750 | Liver Iron Concentration Increased | 81 | 1 | Deferasirox (PRR 257.0) |
| 8751 | Body Surface Area Decreased | 81 | 1 | Axitinib (PRR 185.7) |
| 8752 | Mini Mental Status Examination Abnormal | 81 | 1 | Rivastigmine (PRR 230.7) |
| 8753 | Apoptotic Colonopathy | 81 | 3 | Obinutuzumab (PRR 198.7) |
| 8754 | Hemianopia Heteronymous | 81 | 3 | Rifampicin (PRR 257.0) |
| 8755 | Roseola | 81 | 1 | Palivizumab (PRR 108.3) |
| 8756 | Noninfectious Myelitis | 81 | 1 | Peginterferon Beta-1A (PRR 127.0) |
| 8757 | Malignant Gastrointestinal Obstruction | 81 | 1 | Irinotecan Hydrochloride (PRR 129.4) |
| 8758 | Renal Graft Loss | 81 | 2 | Basiliximab (PRR 579.9) |
| 8759 | Bone Hyperpigmentation | 81 | 1 | Minocycline (PRR 3,997.0) |
| 8760 | Phyllodes Tumour | 81 | 1 | Methadone Hydrochloride (PRR 270.8) |
| 8761 | Stoma Site Rash | 81 | 1 | Trifluridine And Tipiracil (PRR 100.7) |
| 8762 | Myofascitis | 81 | 1 | Polatuzumab Vedotin (PRR 170.5) |
| 8763 | Transurethral Bladder Resection | 81 | 1 | Polatuzumab Vedotin (PRR 140.3) |
| 8764 | Drug Metabolite Level High | 81 | 1 | Cenobamate (PRR 95.9) |
| 8765 | Premature Baby Death | 81 | 2 | Ampicillin (PRR 275.3) |
| 8766 | Radiation Inflammation | 80 | 8 | Tamsulosin Hydrochloride (PRR 876.8) |
| 8767 | Ovarian Germ Cell Teratoma | 80 | 3 | Bleomycin Sulfate (PRR 1,342.6) |
| 8768 | Rhinitis Perennial | 80 | 4 | Theophylline Anhydrous (PRR 807.8) |
| 8769 | Pseudophakia | 80 | 3 | Faricimab (PRR 171.2) |
| 8770 | Withdrawal Of Life Support | 80 | 1 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 54.3) |
| 8771 | Uterine Leiomyosarcoma | 80 | 1 | Pazopanib Hydrochloride (PRR 207.3) |
| 8772 | Chorioretinal Scar | 80 | 1 | Ranibizumab (PRR 99.3) |
| 8773 | Hepatic Siderosis | 80 | 1 | Deferasirox (PRR 399.4) |
| 8774 | Right Atrial Pressure Increased | 80 | 1 | Selexipag (PRR 217.1) |
| 8775 | Encephalitis Toxic | 80 | 4 | Thiamine Hydrochloride (PRR 451.0) |
| 8776 | Arterial Intramural Haematoma | 80 | 1 | Durvalumab (PRR 162.9) |
| 8777 | Thyroxine Free Abnormal | 80 | 1 | Durvalumab (PRR 82.9) |
| 8778 | Septal Panniculitis | 80 | 5 | Anti-Thymocyte Globulin (Rabbit) (PRR 326.9) |
| 8779 | Inguinal Hernia, Obstructive | 80 | 2 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 73.4) |
| 8780 | Pulmonary Vein Occlusion | 80 | 1 | Tolvaptan (PRR 181.4) |
| 8781 | Congenital Bowing Of Long Bones | 80 | 2 | Atazanavir (PRR 183.5) |
| 8782 | Small Intestine Polyp | 80 | 1 | Teduglutide (PRR 272.4) |
| 8783 | Tularaemia | 80 | 1 | Sirolimus (PRR 299.6) |
| 8784 | Chronic Idiopathic Pain Syndrome | 80 | 1 | Indomethacin (PRR 558.8) |
| 8785 | Pyonephrosis | 80 | 1 | Eplerenone (PRR 205.9) |
| 8786 | Barbiturates Positive | 80 | 1 | Rimegepant Sulfate (PRR 64.0) |
| 8787 | Adrenergic Syndrome | 80 | 1 | Norepinephrine (PRR 157.8) |
| 8788 | Lepromatous Leprosy | 80 | 4 | Daspone (PRR 492.9) |
| 8789 | Cardiac Pacemaker Malfunction | 80 | 1 | Dofetilide (PRR 189.9) |
| 8790 | Bone Marrow Leukaemic Cell Infiltration | 80 | 2 | Blinatumomab (PRR 1,261.4) |
| 8791 | Oral Mucosal Roughening | 80 | 1 | Alpelisib (PRR 93.0) |
| 8792 | Vaccine Induced Antibody Absent | 80 | 2 | Mesna Injection (PRR 241.4) |
| 8793 | Hepatic Hydrothorax | 79 | 3 | Sofosbuvir (PRR 487.9) |
| 8794 | Acne Conglobata | 79 | 1 | Isotretinoin (PRR 106.6) |
| 8795 | Implant Site Urticaria | 79 | 1 | Etonogestrel (PRR 1,856.6) |
| 8796 | Pre-Engraftment Immune Reaction | 79 | 7 | Thiotepa (PRR 3,199.8) |
| 8797 | K-Ras Gene Mutation | 79 | 3 | Pemetrexed (PRR 109.3) |
| 8798 | Posterior Capsule Rupture | 79 | 2 | Ranibizumab (PRR 113.5) |
| 8799 | Supernumerary Nipple | 79 | 4 | Atazanavir (PRR 710.0) |
| 8800 | Portal Shunt | 79 | 1 | Rifaximin (PRR 127.6) |
| 8801 | Vascular Hyalinosis | 79 | 1 | Everolimus Tablets (PRR 200.6) |
| 8802 | Bacterial Tracheitis | 79 | 2 | Tofacitinib Citrate (PRR 130.4) |
| 8803 | Heparin-Induced Thrombocytopenia Test | 79 | 1 | Heparin Sodium (PRR 244.7) |
| 8804 | Spinal Epidural Haemorrhage | 79 | 1 | Ketoprofen (PRR 402.7) |
| 8805 | Primary Immunodeficiency Syndrome | 79 | 1 | Bleomycin Sulfate (PRR 226.9) |
| 8806 | Delayed Sleep Phase | 79 | 1 | Agalsidase Beta (PRR 88.9) |
| 8807 | Burkholderia Infection | 79 | 1 | Chlorhexidine Gluconate (PRR 292.7) |
| 8808 | Corneal Irritation | 79 | 1 | Travoprost (PRR 94.9) |
| 8809 | Polymenorrhagia | 78 | 2 | Levonorgestrel (PRR 51.2) |
| 8810 | Unevaluable Device Issue | 78 | 1 | Treprostinil (PRR 419.7) |
| 8811 | Aquagenic Pruritus | 78 | 1 | Ruxolitinib (PRR 463.1) |
| 8812 | Blastic Plasmacytoid Dendritic Cell Neoplasia | 78 | 3 | Azacitidine (PRR 210.2) |
| 8813 | Encapsulation Reaction | 78 | 1 | Etonogestrel (PRR 272.0) |
| 8814 | Ovarian Adhesion | 78 | 1 | Copper (PRR 47.5) |
| 8815 | Eye Infection Intraocular | 78 | 2 | Aflibercept (PRR 229.7) |
| 8816 | Protein C Increased | 78 | 1 | Ethyl Alcohol (PRR 87.4) |
| 8817 | Pharmacophobia | 78 | 1 | Voxelotor (PRR 63.5) |
| 8818 | Isosporiasis | 78 | 5 | Anti-Thymocyte Globulin (Rabbit) (PRR 336.4) |
| 8819 | Meningitis Enterococcal | 78 | 4 | Thiotepa (PRR 320.4) |
| 8820 | Blood Smear Test Abnormal | 78 | 1 | Romiplostim (PRR 157.9) |
| 8821 | Muscle Tension Dysphonia | 78 | 1 | Ciclesonide (PRR 954.5) |
| 8822 | Proctitis Haemorrhagic | 78 | 1 | Apalutamide (PRR 70.8) |
| 8823 | Cardiac Rehabilitation Therapy | 78 | 1 | Ranolazine (PRR 136.5) |
| 8824 | Keratosis Follicular | 78 | 1 | Encorafenib (PRR 143.9) |
| 8825 | Lumbosacral Plexopathy | 78 | 1 | Baricitinib (PRR 1,078.9) |
| 8826 | Diffuse Large B-Cell Lymphoma Stage Iii | 78 | 2 | Mesna Injection (PRR 136.1) |
| 8827 | Hepatic Embolisation | 78 | 1 | Lanreotide Acetate (PRR 221.1) |
| 8828 | Macular Thickening | 77 | 3 | Faricimab (PRR 900.8) |
| 8829 | Myeloblast Count Increased | 77 | 1 | Azacitidine (PRR 104.6) |
| 8830 | Ammonia Decreased | 77 | 1 | Rifaximin (PRR 99.3) |
| 8831 | Cells In Urine | 77 | 1 | Alemtuzumab (PRR 430.1) |
| 8832 | Product Administration Issue | 77 | 4 | Theophylline (PRR 552.2) |
| 8833 | Thymoma Malignant | 77 | 1 | Ravulizumab (PRR 106.9) |
| 8834 | Acquired Tracheo-Oesophageal Fistula | 77 | 1 | Irinotecan Hydrochloride (PRR 88.6) |
| 8835 | N-Terminal Prohormone Brain Natriuretic Peptide Abnormal | 77 | 1 | Eplerenone (PRR 361.0) |
| 8836 | Vascular Access Site Occlusion | 77 | 2 | Bleomycin Sulfate (PRR 266.5) |
| 8837 | Ischaemic Nephropathy | 77 | 1 | Inclisiran (PRR 479.0) |
| 8838 | Thyroid Stimulating Immunoglobulin Increased | 77 | 1 | Methimazole (PRR 929.9) |
| 8839 | Medical Device Entrapment | 76 | 1 | Levonorgestrel (PRR 140.7) |
| 8840 | Expanded Disability Status Scale | 76 | 3 | Fingolimod Hcl (PRR 347.9) |
| 8841 | Histiocytic Sarcoma | 76 | 2 | Axicabtagene Ciloleucel (PRR 117.1) |
| 8842 | Limbal Stem Cell Deficiency | 76 | 2 | Lapatinib (PRR 114.9) |
| 8843 | Kawasaki'S Disease | 76 | 1 | Palivizumab (PRR 75.2) |
| 8844 | Reocclusion | 76 | 1 | Alteplase (PRR 720.3) |
| 8845 | Oesophageal Carcinoma Recurrent | 76 | 1 | Romosozumab-Aqqg (PRR 85.1) |
| 8846 | Cardiac Malposition | 76 | 4 | Lopinavir And Ritonavir (PRR 666.0) |
| 8847 | Intestinal Transit Time Decreased | 76 | 1 | Apalutamide (PRR 179.5) |
| 8848 | Red Blood Cell Elliptocytes Present | 76 | 1 | Dimenhydrinate (PRR 480.1) |
| 8849 | Gastroenteritis Astroviral | 76 | 3 | Thiotepa (PRR 330.1) |
| 8850 | Computerised Tomogram Heart Abnormal | 75 | 3 | Eplerenone (PRR 194.0) |
| 8851 | Administration Site Odour | 75 | 1 | Treprostinil (PRR 221.5) |
| 8852 | Application Site Extravasation | 75 | 1 | Pegfilgrastim (PRR 239.9) |
| 8853 | Cytarabine Syndrome | 75 | 2 | Cytarabine (PRR 374.2) |
| 8854 | Hyperparathyroidism Tertiary | 75 | 2 | Cinacalcet Hydrochloride (PRR 151.2) |
| 8855 | Microvillous Inclusion Disease | 75 | 5 | Cholestyramine (PRR 360.7) |
| 8856 | Erythroleukaemia | 75 | 2 | Cladribine (PRR 222.8) |
| 8857 | Oxalosis | 75 | 1 | Orlistat (PRR 109.4) |
| 8858 | Malignant Mesenteric Neoplasm | 75 | 2 | Dabrafenib (PRR 151.8) |
| 8859 | Ureteric Compression | 75 | 4 | Fondaparinux Sodium (PRR 489.7) |
| 8860 | Camptodactyly Congenital | 75 | 1 | Valproate Sodium (PRR 341.3) |
| 8861 | Cerebral Ventricle Collapse | 75 | 5 | Micafungin Sodium (PRR 377.5) |
| 8862 | Splenic Marginal Zone Lymphoma | 75 | 1 | Bendamustine Hcl (PRR 230.5) |
| 8863 | Hypotonic-Hyporesponsive Episode | 75 | 1 | Palivizumab (PRR 56.4) |
| 8864 | Pneumonia Moraxella | 75 | 1 | Palivizumab (PRR 56.4) |
| 8865 | Purtscher Retinopathy | 75 | 2 | Bupivacaine (PRR 466.9) |
| 8866 | Spinal Anaesthesia | 75 | 1 | Bupivacaine (PRR 265.9) |
| 8867 | Atypical Fibroxanthoma | 75 | 1 | Bosutinib (PRR 96.5) |
| 8868 | Bone Marrow Oedema Syndrome | 75 | 1 | Bosutinib (PRR 96.5) |
| 8869 | Coeliac Artery Compression Syndrome | 75 | 1 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 136.1) |
| 8870 | Diffuse Idiopathic Skeletal Hyperostosis | 75 | 1 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 212.2) |
| 8871 | Device Inappropriate Shock Delivery | 74 | 1 | Sacubitril And Valsartan (PRR 168.9) |
| 8872 | Angiofibroma | 74 | 5 | Phenobarbital (PRR 428.1) |
| 8873 | Bladder Agenesis | 74 | 6 | Zidovudine (PRR 1,185.2) |
| 8874 | Pelvic Organ Injury | 74 | 1 | Copper (PRR 50.3) |
| 8875 | Coombs Indirect Test Positive | 74 | 1 | Daratumumab (PRR 466.7) |
| 8876 | Lipiduria | 74 | 1 | Orlistat (PRR 4,146.0) |
| 8877 | Fight In School | 74 | 1 | Atomoxetine Hydrochloride (PRR 241.0) |
| 8878 | Endocarditis Candida | 74 | 4 | Gentamicin (PRR 338.9) |
| 8879 | Feeding Problem In Newborn | 74 | 1 | Palivizumab (PRR 119.5) |
| 8880 | Duchenne Muscular Dystrophy | 74 | 1 | Eplerenone (PRR 224.9) |
| 8881 | Malignant Anorectal Neoplasm | 74 | 1 | Emtricitabine And Tenofovir Alafenamide (PRR 133.0) |
| 8882 | Necrotising Herpetic Retinopathy | 74 | 2 | Ganciclovir Sodium (PRR 307.2) |
| 8883 | Human Herpesvirus 7 Infection | 74 | 1 | Thiotepa (PRR 227.6) |
| 8884 | Non-Consummation | 74 | 1 | Iron Sucrose (PRR 264.5) |
| 8885 | Disruptive Mood Dysregulation Disorder | 74 | 2 | Brivaracetam (PRR 280.4) |
| 8886 | Drug Titration Issue | 73 | 1 | Tirzepatide (PRR 316.4) |
| 8887 | Clonal Haematopoiesis | 73 | 5 | Melphalan (PRR 236.4) |
| 8888 | Fibrinous Bronchitis | 73 | 2 | Pegaspargase (PRR 403.2) |
| 8889 | Hepatic Angiosarcoma | 73 | 1 | Everolimus Tablets (PRR 196.9) |
| 8890 | Antiacetylcholine Receptor Antibody Positive | 73 | 1 | Sotalol Hydrochloride (PRR 198.5) |
| 8891 | Diaphragmatic Injury | 73 | 4 | Pyrazinamide (PRR 435.7) |
| 8892 | Antibody Test | 73 | 2 | Agalsidase Beta (PRR 792.0) |
| 8893 | Choriocarcinoma | 73 | 1 | Bleomycin Sulfate (PRR 319.7) |
| 8894 | Urine Calcium Decreased | 73 | 1 | Asfotase Alfa (PRR 120.4) |
| 8895 | Paroxysmal Sympathetic Hyperactivity | 73 | 1 | Sevoflurane (PRR 265.5) |
| 8896 | Femoral Hernia Incarcerated | 72 | 4 | Amiodarone Hydrochloride (PRR 1,113.9) |
| 8897 | Diuretic Therapy | 72 | 2 | Epoprostenol (PRR 227.0) |
| 8898 | Haemorrhagic Occlusive Retinal Vasculitis | 72 | 3 | Faricimab (PRR 414.1) |
| 8899 | Plasma Cells Increased | 72 | 1 | Carfilzomib (PRR 177.4) |
| 8900 | Osteoarthropathy | 72 | 2 | Rizatriptan Benzoate (PRR 220.2) |
| 8901 | Urine Oxalate Increased | 72 | 1 | Orlistat (PRR 100.3) |
| 8902 | Protein Induced By Vitamin K Absence Or Antagonist Ii Increased | 72 | 3 | Sorafenib (PRR 309.5) |
| 8903 | Atypical Mycobacterial Lower Respiratory Tract Infection | 72 | 3 | Rifampin (PRR 285.0) |
| 8904 | Pyelonephritis Fungal | 72 | 8 | Anti-Thymocyte Globulin (Rabbit) (PRR 678.7) |
| 8905 | Harlequin Syndrome | 72 | 3 | Bupivacaine (PRR 239.8) |
| 8906 | Liver Ablation | 72 | 2 | Panitumumab (PRR 166.0) |
| 8907 | Oculoauriculovertebral Dysplasia | 72 | 1 | Remdesivir (PRR 116.5) |
| 8908 | Hepatic Vein Dilatation | 72 | 1 | Eplerenone (PRR 464.1) |
| 8909 | Glomerular Filtration Rate | 72 | 1 | Eplerenone (PRR 262.0) |
| 8910 | Chronic Papillomatous Dermatitis | 72 | 1 | Valganciclovir Hydrochloride Powder, (PRR 213.2) |
| 8911 | Oral Mucosa Haematoma | 72 | 1 | Acalabrutinib (PRR 128.1) |
| 8912 | Phlebitis Infective | 72 | 1 | Levodopa (PRR 245.9) |
| 8913 | Neutrophilic Panniculitis | 72 | 1 | Vemurafenib (PRR 535.0) |
| 8914 | Ventricular Remodelling | 72 | 1 | Basiliximab (PRR 1,125.6) |
| 8915 | Haemorrhage Coronary Artery | 72 | 1 | Prasugrel Hydrochloride (PRR 152.8) |
| 8916 | Sarcomatoid Mesothelioma | 72 | 1 | Axicabtagene Ciloleucel (PRR 124.0) |
| 8917 | Foetal Methotrexate Syndrome | 72 | 1 | Misoprostol (PRR 821.7) |
| 8918 | Tongue Necrosis | 72 | 1 | Miconazole Nitrate (PRR 256.7) |
| 8919 | Congenital Knee Deformity | 72 | 1 | Tenofovir Disoproxil Fumarate Tablets (PRR 141.7) |
| 8920 | Haemorrhagic Necrotic Pancreatitis | 72 | 1 | Micafungin Sodium (PRR 223.1) |
| 8921 | Spinal Shock | 72 | 1 | Amphetamine (PRR 314.3) |
| 8922 | Autophony | 72 | 1 | Methimazole (PRR 240.9) |
| 8923 | Gallbladder Adenocarcinoma | 71 | 2 | Durvalumab (PRR 77.4) |
| 8924 | Follicular Lymphoma Recurrent | 71 | 6 | Obinutuzumab (PRR 979.8) |
| 8925 | Blast Cell Count Decreased | 71 | 2 | Blinatumomab (PRR 151.1) |
| 8926 | Cardiac Steatosis | 71 | 1 | Cannabidiol (PRR 97.2) |
| 8927 | Phalangeal Hypoplasia | 71 | 2 | Atovaquone (PRR 525.6) |
| 8928 | Intercostal Retraction | 71 | 1 | Palivizumab (PRR 196.5) |
| 8929 | Multiple Drug Hypersensitivity | 71 | 1 | Rifampin (PRR 233.6) |
| 8930 | Mitochondrial Encephalomyopathy | 71 | 2 | Sevoflurane (PRR 149.4) |
| 8931 | Inferior Vena Cava Syndrome | 71 | 1 | Patiromer (PRR 138.7) |
| 8932 | Torus Fracture | 71 | 1 | Tofacitinib Citrate (PRR 173.5) |
| 8933 | Blood Culture Negative | 71 | 1 | Epoprostenol (PRR 1,460.2) |
| 8934 | Catheter Culture Positive | 71 | 1 | Epoprostenol (PRR 975.1) |
| 8935 | Cardiac Neoplasm Malignant | 71 | 1 | Vemurafenib (PRR 103.3) |
| 8936 | Ochronosis | 71 | 1 | Minocycline (PRR 1,549.6) |
| 8937 | Lung Adenocarcinoma Stage I | 71 | 1 | Polatuzumab Vedotin (PRR 94.1) |
| 8938 | Multisystem Inflammatory Syndrome In Children | 71 | 1 | Thiotepa (PRR 316.2) |
| 8939 | Arthritis Fungal | 71 | 1 | Daptomycin (PRR 170.8) |
| 8940 | Campylobacter Test Positive | 71 | 1 | Atovaquone (PRR 238.6) |
| 8941 | Stomal Varices | 70 | 2 | Oxaliplatin (PRR 698.9) |
| 8942 | Application Site Folliculitis | 70 | 2 | Minoxidil Foam 5% (Womens) (PRR 70.0) |
| 8943 | Fallopian Tube Obstruction | 70 | 1 | Copper (PRR 62.2) |
| 8944 | Acquired Porphyria | 70 | 17 | Diclofenac Potassium, Film Coated (PRR 563.9) |
| 8945 | Corneal Striae | 70 | 2 | Aflibercept (PRR 181.7) |
| 8946 | Infective Keratitis | 70 | 7 | Prednisolone Acetate (PRR 335.1) |
| 8947 | Cestode Infection | 70 | 2 | Standardized Senna Concentrate (PRR 615.9) |
| 8948 | Collagen-Vascular Disease | 70 | 1 | Brexpiprazole (PRR 161.6) |
| 8949 | Application Site Anaesthesia | 70 | 2 | Glycerin, Lidocaine (PRR 191.7) |
| 8950 | Liver Palpable | 70 | 3 | Eplerenone (PRR 649.8) |
| 8951 | Cytomegalovirus Duodenitis | 70 | 4 | Anti-Thymocyte Globulin (Rabbit) (PRR 286.6) |
| 8952 | Cardiac Resynchronisation Therapy | 70 | 1 | Tafamidis (PRR 107.0) |
| 8953 | Femoral Nerve Injury | 70 | 1 | Bupivacaine (PRR 247.4) |
| 8954 | Lymphangiectasia | 70 | 1 | Bosutinib (PRR 103.7) |
| 8955 | Hereditary Optic Atrophy | 69 | 6 | Tenofovir Disoproxil Fumarate Tablets (PRR 272.1) |
| 8956 | Perineal Cyst | 69 | 8 | Valganciclovir (PRR 419.1) |
| 8957 | Brain Radiation Necrosis | 69 | 2 | Pemetrexed (PRR 225.1) |
| 8958 | Csf Virus Identified | 69 | 3 | Tenofovir Disoproxil Fumarate Tablets (PRR 1,853.5) |
| 8959 | Retinal Fibrosis | 69 | 2 | Ranibizumab (PRR 276.4) |
| 8960 | Social (Pragmatic) Communication Disorder | 69 | 1 | Valproate Sodium (PRR 355.1) |
| 8961 | Procalcitonin Decreased | 69 | 3 | Fosaprepitant Dimeglumine (PRR 318.4) |
| 8962 | Ureteric Haemorrhage | 69 | 1 | Linagliptin (PRR 216.2) |
| 8963 | Oral Pigmentation | 69 | 1 | Imatinib (PRR 416.2) |
| 8964 | Tuberculosis Of Eye | 69 | 4 | Pyrazinamide (PRR 466.3) |
| 8965 | Coinfection | 69 | 1 | Remdesivir (PRR 234.1) |
| 8966 | Diffuse Axonal Injury | 69 | 2 | Ketoprofen (PRR 333.8) |
| 8967 | Anti-Insulin Antibody | 69 | 1 | Human Insulin (PRR 1,007.0) |
| 8968 | Anaesthetic Complication Cardiac | 69 | 3 | Sevoflurane (PRR 375.5) |
| 8969 | Potassium Wasting Nephropathy | 69 | 1 | Dolutegravir Sodium (PRR 219.7) |
| 8970 | Cervix Injury | 68 | 2 | Copper (PRR 186.8) |
| 8971 | Cardioactive Drug Level Below Therapeutic | 68 | 1 | Digoxin (PRR 2,987.0) |
| 8972 | Neonatal Hypocalcaemia | 68 | 2 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 182.4) |
| 8973 | Hysterotomy | 68 | 1 | Copper (PRR 30.1) |
| 8974 | Hormone-Dependent Prostate Cancer | 68 | 6 | Abiraterone (PRR 592.4) |
| 8975 | Hypertrophic Osteoarthropathy | 68 | 2 | Voriconazole Injection (PRR 427.8) |
| 8976 | Corneal Endothelial Cell Loss | 68 | 1 | Bimatoprost (PRR 204.1) |
| 8977 | Leiomyosarcoma Metastatic | 68 | 1 | Pazopanib Hydrochloride (PRR 199.1) |
| 8978 | Venous Stent Insertion | 68 | 1 | Etonogestrel And Ethinyl Estradiol (PRR 656.3) |
| 8979 | Portal Shunt Procedure | 68 | 1 | Rifaximin (PRR 541.4) |
| 8980 | Choriomeningitis Lymphocytic | 68 | 4 | Valganciclovir Hydrochloride Powder, (PRR 442.2) |
| 8981 | Stenotrophomonas Bacteraemia | 68 | 1 | Busulfan (PRR 201.6) |
| 8982 | Congenital Absence Of Bile Ducts | 68 | 1 | Darunavir (PRR 183.4) |
| 8983 | Fibrinolysis | 68 | 3 | Sevoflurane (PRR 198.7) |
| 8984 | Covid-19 Treatment | 68 | 5 | Remdesivir (PRR 697.4) |
| 8985 | Renal Osteodystrophy | 68 | 1 | Paricalcitol (PRR 116.9) |
| 8986 | Sars-Cov-2 Rna Increased | 68 | 1 | Remdesivir (PRR 301.2) |
| 8987 | Primary Stabbing Headache | 68 | 2 | Botulinum Toxin Type A (PRR 133.0) |
| 8988 | Joint Microhaemorrhage | 68 | 1 | Emicizumab (PRR 324.9) |
| 8989 | Inhibiting Antibodies | 68 | 1 | Emicizumab (PRR 256.8) |
| 8990 | Tryptase | 68 | 1 | Avapritinib (PRR 5,582.9) |
| 8991 | Renal Glycosuria | 68 | 1 | Entecavir (PRR 204.4) |
| 8992 | Respiratory Depth Decreased | 68 | 2 | Granisetron Hydrochloride (PRR 192.8) |
| 8993 | Procalcitonin Abnormal | 68 | 1 | Brentuximab Vedotin (PRR 196.4) |
| 8994 | Joint Deformity | 68 | 1 | Travoprost (PRR 111.0) |
| 8995 | Low Density Lipoprotein | 68 | 1 | Inclisiran (PRR 345.9) |
| 8996 | Mephisto Sign | 67 | 2 | Onabotulinumtoxina (PRR 731.4) |
| 8997 | Meningitis Candida | 67 | 5 | Ampicillin (PRR 604.8) |
| 8998 | Hyperfibrinogenaemia | 67 | 4 | Thiotepa (PRR 475.3) |
| 8999 | Haematuria Traumatic | 67 | 2 | Phenobarbital (PRR 222.7) |
| 9000 | Medical Device Site Abscess | 67 | 2 | Insulin Glulisine (PRR 238.7) |
| 9001 | Meningeal Neoplasm | 67 | 1 | Azacitidine For (PRR 133.4) |
| 9002 | Angiocardiogram | 67 | 1 | Umeclidinium Bromide And Vilanterol Trifenatate (PRR 168.8) |
| 9003 | Traumatic Ulcer | 67 | 1 | Panitumumab (PRR 130.6) |
| 9004 | Polyneuropathy Idiopathic Progressive | 67 | 2 | Cenobamate (PRR 290.9) |
| 9005 | Spur Cell Anaemia | 67 | 2 | Memantine (PRR 235.9) |
| 9006 | Polyglandular Disorder | 67 | 6 | Itraconazole (PRR 349.9) |
| 9007 | Hepatic Amoebiasis | 67 | 2 | Atovaquone (PRR 254.2) |
| 9008 | Computerised Tomogram Coronary Artery Abnormal | 67 | 1 | Eplerenone (PRR 643.0) |
| 9009 | Degenerative Aortic Valve Disease | 67 | 1 | Eplerenone (PRR 391.1) |
| 9010 | Abdominal Migraine | 67 | 1 | Rimegepant Sulfate (PRR 132.4) |
| 9011 | Anal Hypoaesthesia | 67 | 1 | Diroximel Fumarate (PRR 171.7) |
| 9012 | Fear Of Crowded Places | 67 | 1 | Buspirone Hydrochloride (PRR 292.5) |
| 9013 | Peripheral T-Cell Lymphoma Unspecified Recurrent | 67 | 1 | Brentuximab Vedotin (PRR 356.1) |
| 9014 | Hepatic Candidiasis | 67 | 2 | Micafungin Sodium (PRR 241.4) |
| 9015 | Catheter Site Discomfort | 67 | 1 | Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 110.2) |
| 9016 | Stenotrophomonas Maltophilia Pneumonia | 67 | 1 | Methimazole (PRR 359.4) |
| 9017 | Septo-Optic Dysplasia | 66 | 1 | Somatropin (PRR 105.9) |
| 9018 | Hair Transplant | 66 | 1 | Finasteride (PRR 991.5) |
| 9019 | Reticulocyte Percentage Increased | 66 | 1 | Eculizumab (PRR 166.1) |
| 9020 | Vaginitis Gardnerella | 66 | 1 | Copper (PRR 48.2) |
| 9021 | Gardnerella Infection | 66 | 1 | Copper (PRR 31.1) |
| 9022 | Disseminated Trichosporonosis | 66 | 5 | Amphotericin B (PRR 262.1) |
| 9023 | Pericarditis Fungal | 66 | 7 | Valganciclovir Hydrochloride Powder, (PRR 689.4) |
| 9024 | Factor Vii Deficiency | 66 | 5 | Captopril (PRR 582.5) |
| 9025 | Retinopathy Haemorrhagic | 66 | 3 | Thiotepa (PRR 534.4) |
| 9026 | Acantholysis | 66 | 1 | Vemurafenib (PRR 111.7) |
| 9027 | Musculoskeletal Procedural Complication | 66 | 1 | Diroximel Fumarate (PRR 143.1) |
| 9028 | Leukopenia Neonatal | 66 | 1 | Bleomycin Sulfate (PRR 165.1) |
| 9029 | Precipitate Labour | 66 | 1 | Misoprostol (PRR 628.4) |
| 9030 | Band Neutrophil Count Decreased | 66 | 1 | Daptomycin (PRR 267.6) |
| 9031 | Mediastinal Shift | 66 | 1 | Nevirapine (PRR 189.0) |
| 9032 | Nail Cuticle Fissure | 66 | 1 | Alpelisib (PRR 154.0) |
| 9033 | Obsessive Rumination | 66 | 1 | Amphetamine (PRR 162.2) |
| 9034 | Brown-Sequard Syndrome | 66 | 1 | Dutasteride (PRR 209.7) |
| 9035 | Aids Related Complication | 65 | 9 | Nevirapine (PRR 469.8) |
| 9036 | Juvenile Melanoma Benign | 65 | 2 | Thiotepa (PRR 598.0) |
| 9037 | Ganglioneuroma | 65 | 1 | Temozolomide (PRR 201.0) |
| 9038 | Oesophageal Variceal Ligation | 65 | 1 | Sofosbuvir (PRR 127.2) |
| 9039 | Developmental Glaucoma | 65 | 2 | Phenobarbital (PRR 637.9) |
| 9040 | Obstructive Defaecation | 65 | 2 | Dimenhydrinate (PRR 488.1) |
| 9041 | Tuberculoid Leprosy | 65 | 8 | Efavirenz (PRR 512.2) |
| 9042 | Anaplastic Lymphoma Kinase Gene Mutation | 65 | 1 | Crizotinib (PRR 166.4) |
| 9043 | Asthenospermia | 65 | 1 | Bleomycin Sulfate (PRR 243.1) |
| 9044 | Corynebacterium Sepsis | 65 | 1 | Polatuzumab Vedotin (PRR 216.8) |
| 9045 | Birth Trauma | 65 | 1 | Misoprostol (PRR 697.6) |
| 9046 | Moebius Ii Syndrome | 65 | 1 | Misoprostol (PRR 257.8) |
| 9047 | Abortion Infected | 65 | 1 | Misoprostol (PRR 217.3) |
| 9048 | Disseminated Herpes Simplex | 65 | 1 | Voclosporin (PRR 435.6) |
| 9049 | Anticholinergic Effect | 65 | 2 | Guanfacine (PRR 173.4) |
| 9050 | Amyloid Arthropathy | 64 | 17 | Theophylline (PRR 21,356.3) |
| 9051 | Device Chemical Property Issue | 64 | 2 | Somatropin (PRR 1,107.5) |
| 9052 | Implant Site Injury | 64 | 1 | Etonogestrel (PRR 1,885.6) |
| 9053 | Intestinal Intraepithelial Lymphocytes Increased | 64 | 5 | Cefuroxime (PRR 463.8) |
| 9054 | Negative Symptoms In Schizophrenia | 64 | 3 | Aripiprazole Oral (PRR 569.4) |
| 9055 | Neuroendocrine Carcinoma Of Prostate | 64 | 3 | Bicalutamide (PRR 315.0) |
| 9056 | Crossmatch Incompatible | 64 | 1 | Daratumumab (PRR 1,231.6) |
| 9057 | Mastitis Bacterial | 64 | 5 | Triamcinolone Acetonide Ointment Usp, 0.05% (PRR 607.6) |
| 9058 | Chest Wall Rigidity | 64 | 5 | Rocuronium Bromide (PRR 407.4) |
| 9059 | Pseudomonas Bronchitis | 64 | 1 | Tobramycin (PRR 160.1) |
| 9060 | Flagellate Dermatitis | 64 | 4 | Bleomycin Sulfate (PRR 1,668.6) |
| 9061 | Arachnodactyly | 64 | 1 | Valproate Sodium (PRR 564.4) |
| 9062 | Medical Device Site Dryness | 64 | 1 | Rivastigmine (PRR 204.4) |
| 9063 | Urethral Caruncle | 64 | 2 | Telmisartan (PRR 388.4) |
| 9064 | Infantile Colic | 64 | 1 | Palivizumab (PRR 66.6) |
| 9065 | Avian Influenza | 64 | 2 | Sirolimus (PRR 432.3) |
| 9066 | Pseudocholinesterase Deficiency | 64 | 1 | Rocuronium Bromide (PRR 326.9) |
| 9067 | Periumbilical Abscess | 64 | 4 | Carboxymethylcellulose Sodium (PRR 510.9) |
| 9068 | Haemolytic Transfusion Reaction | 64 | 1 | Blinatumomab (PRR 132.9) |
| 9069 | Anisometropia | 64 | 1 | Thiotepa (PRR 452.2) |
| 9070 | Conus Medullaris Syndrome | 64 | 2 | Bupivacaine (PRR 273.4) |
| 9071 | Reversible Splenial Lesion Syndrome | 64 | 1 | Cariprazine (PRR 149.0) |
| 9072 | Postoperative Respiratory Distress | 64 | 1 | Sevoflurane (PRR 307.4) |
| 9073 | Pelvic Operation | 64 | 1 | Vibegron (PRR 127.6) |
| 9074 | Scrotal Dermatitis | 63 | 1 | Cabozantinib (PRR 112.4) |
| 9075 | Pregnancy Test Urine Positive | 63 | 1 | Copper (PRR 32.7) |
| 9076 | Expiratory Reserve Volume Decreased | 63 | 1 | Fluticasone Furoate And Vilanterol Trifenatate (PRR 310.0) |
| 9077 | Faecal Calprotectin | 63 | 1 | Guselkumab (PRR 50.1) |
| 9078 | 5-Hydroxyindolacetic Acid Increased | 63 | 5 | Octreotide Acetate (PRR 1,571.2) |
| 9079 | Intentional Removal Of Drug Delivery System By Patient | 63 | 1 | Methylphenidate (PRR 205.1) |
| 9080 | Cardiothoracic Ratio Increased | 63 | 1 | Selexipag (PRR 170.2) |
| 9081 | Haematopoietic Stem Cell Mobilisation | 63 | 5 | Brentuximab Vedotin (PRR 691.0) |
| 9082 | Agitation Postoperative | 63 | 4 | Atropine (PRR 365.3) |
| 9083 | Sweat Test Abnormal | 63 | 4 | Ivacaftor (PRR 891.7) |
| 9084 | Mantle Cell Lymphoma Refractory | 63 | 1 | Obinutuzumab (PRR 328.7) |
| 9085 | Bacteroides Test Positive | 63 | 1 | Pegaspargase (PRR 146.5) |
| 9086 | Sigmoid Sinus Thrombosis | 63 | 1 | Norepinephrine (PRR 243.3) |
| 9087 | Cutaneous T-Cell Lymphoma Recurrent | 63 | 1 | Brentuximab Vedotin (PRR 383.0) |
| 9088 | Ovarian Necrosis | 63 | 1 | Polatuzumab Vedotin (PRR 183.8) |
| 9089 | Peritoneal Carcinoma Metastatic | 63 | 1 | Polatuzumab Vedotin (PRR 183.8) |
| 9090 | Femoral Nerve Palsy | 63 | 1 | Bupivacaine (PRR 323.9) |
| 9091 | Puncture Site Haematoma | 63 | 1 | Tranexamic Acid (PRR 246.2) |
| 9092 | Conjunctival Cyst | 63 | 1 | Travoprost (PRR 120.2) |
| 9093 | Medical Device Site Scab | 62 | 1 | Etonogestrel (PRR 178.0) |
| 9094 | Ectopic Pregnancy Termination | 62 | 2 | Etonogestrel (PRR 83.7) |
| 9095 | Median Nerve Injury | 62 | 1 | Etonogestrel (PRR 55.4) |
| 9096 | Behavioural Addiction | 62 | 3 | Ethyl Alcohol (PRR 223.2) |
| 9097 | Peritoneal Effluent Leukocyte Count Increased | 62 | 1 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 213.5) |
| 9098 | Meningitis Noninfective | 62 | 1 | Pemetrexed (PRR 143.7) |
| 9099 | Urine Calcium/Creatinine Ratio Increased | 62 | 3 | Telmisartan (PRR 440.2) |
| 9100 | Malassezia Infection | 62 | 3 | Mesna Injection (PRR 220.9) |
| 9101 | Skin Graft Infection | 62 | 1 | Anakinra (PRR 241.1) |
| 9102 | Haematological Neoplasm | 62 | 1 | Bicalutamide (PRR 231.8) |
| 9103 | Basilar Migraine | 62 | 1 | Vigabatrin (PRR 98.4) |
| 9104 | Electrocardiogram U Wave Present | 62 | 5 | Quinine (PRR 308.8) |
| 9105 | Mixed Dementia | 62 | 2 | Memantine (PRR 258.1) |
| 9106 | Gonococcal Infection | 62 | 1 | Ravulizumab (PRR 228.0) |
| 9107 | Administration Site Scar | 62 | 2 | Tobramycin Solution (PRR 220.4) |
| 9108 | Haemangioma Of Spleen | 62 | 1 | Cladribine (PRR 367.6) |
| 9109 | Angiolipoma | 62 | 1 | Nevirapine (PRR 159.0) |
| 9110 | Juvenile Myoclonic Epilepsy | 62 | 1 | Brivaracetam (PRR 247.9) |
| 9111 | Cytoreductive Surgery | 62 | 1 | Lanreotide Acetate (PRR 183.0) |
| 9112 | Basdai Score Increased | 61 | 2 | Certolizumab Pegol (PRR 390.4) |
| 9113 | Face Lift | 61 | 1 | Onabotulinumtoxina (PRR 131.1) |
| 9114 | No Device Malfunction | 61 | 1 | Epinephrine (PRR 19,013.4) |
| 9115 | Iliac Vein Occlusion | 61 | 1 | Drospirenone And Ethinyl Estradiol (PRR 92.1) |
| 9116 | Application Site Bruising | 61 | 1 | Nicotine (PRR 605.3) |
| 9117 | Aids Dementia Complex | 61 | 7 | Raltegravir (PRR 410.7) |
| 9118 | Cardiac Device Implantation | 61 | 1 | Relugolix (PRR 96.2) |
| 9119 | Immune-Mediated Oesophagitis | 61 | 1 | Pemetrexed (PRR 146.4) |
| 9120 | Acute Erythroid Leukaemia | 61 | 1 | Olaparib (PRR 296.1) |
| 9121 | Arteritis Infective | 61 | 2 | Basiliximab (PRR 479.1) |
| 9122 | Reperfusion Arrhythmia | 61 | 1 | Alteplase (PRR 1,255.4) |
| 9123 | Acinetobacter Sepsis | 61 | 1 | Acalabrutinib (PRR 153.2) |
| 9124 | T-Cell Lymphoma Recurrent | 61 | 1 | Trimethoprim (PRR 388.2) |
| 9125 | Ureteral Necrosis | 61 | 1 | Basiliximab (PRR 389.1) |
| 9126 | Anamnestic Reaction | 61 | 1 | Glecaprevir And Pibrentasvir (PRR 169.1) |
| 9127 | Csf Lymphocyte Count Increased | 61 | 1 | Blinatumomab (PRR 438.6) |
| 9128 | Enteropathy-Associated T-Cell Lymphoma | 61 | 1 | Brentuximab Vedotin (PRR 306.4) |
| 9129 | Acalculia | 61 | 1 | Axicabtagene Ciloleucel (PRR 109.0) |
| 9130 | Homosexuality | 61 | 1 | Cariprazine (PRR 115.6) |
| 9131 | Uterine Fibrosis | 60 | 1 | Levonorgestrel (PRR 89.6) |
| 9132 | Second Degree Chemical Burn Of Skin | 60 | 2 | Salicylic Acid (PRR 28.0) |
| 9133 | Computerised Tomogram Thorax | 60 | 10 | Aprepitant (PRR 2,091.9) |
| 9134 | Malignant Genitourinary Tract Neoplasm | 60 | 2 | Axicabtagene Ciloleucel (PRR 976.9) |
| 9135 | Tumour Fistulisation | 60 | 1 | Atezolizumab (PRR 133.7) |
| 9136 | Pharyngeal Enanthema | 60 | 1 | Tapentadol Hydrochloride (PRR 69.0) |
| 9137 | Thyroglobulin Decreased | 60 | 1 | Lenvatinib (PRR 111.8) |
| 9138 | Paroxysmal Perceptual Alteration | 60 | 5 | Haloperidol (PRR 700.2) |
| 9139 | Alcoholic Hangover | 60 | 1 | Naltrexone (PRR 205.2) |
| 9140 | Osteosarcoma Recurrent | 60 | 2 | Ifosfamide (PRR 414.8) |
| 9141 | Pulmonary Radiation Injury | 60 | 1 | Durvalumab (PRR 229.5) |
| 9142 | Umbilical Erythema | 60 | 4 | Ampicillin (PRR 764.5) |
| 9143 | Tumour Necrosis Factor Receptor-Associated Periodic Syndrome | 60 | 5 | Canakinumab (PRR 1,573.2) |
| 9144 | Cerebral Dysgenesis | 60 | 2 | Emtricitabine And Tenofovir Alafenamide (PRR 131.1) |
| 9145 | Cerebral Haemorrhage Foetal | 60 | 4 | Atropine Sulfate (PRR 481.4) |
| 9146 | Angiosclerosis | 60 | 1 | Paricalcitol (PRR 194.5) |
| 9147 | Apical Granuloma | 60 | 1 | Ravulizumab (PRR 109.9) |
| 9148 | Renal Hydrocele | 60 | 1 | Crizotinib (PRR 116.9) |
| 9149 | Anorectal Cellulitis | 60 | 1 | Pegaspargase (PRR 224.4) |
| 9150 | Passenger Lymphocyte Syndrome | 60 | 1 | Basiliximab (PRR 819.7) |
| 9151 | Hyperresponsive To Stimuli | 60 | 1 | Cariprazine (PRR 117.6) |
| 9152 | Testicular Infarction | 60 | 1 | Umeclidinium (PRR 642.6) |
| 9153 | Exposure To Contaminated Air | 59 | 1 | Varenicline Tartrate (PRR 123.1) |
| 9154 | Total Complement Activity Decreased | 59 | 2 | Eculizumab (PRR 1,872.1) |
| 9155 | High Turnover Osteopathy | 59 | 1 | Cinacalcet Hydrochloride (PRR 50.5) |
| 9156 | Cloacal Exstrophy | 59 | 5 | Zidovudine (PRR 1,722.2) |
| 9157 | Acquired Apparent Mineralocorticoid Excess | 59 | 4 | Abiraterone (PRR 1,289.1) |
| 9158 | Autoimmune Lymphoproliferative Syndrome | 59 | 4 | Thiotepa (PRR 1,295.4) |
| 9159 | Postmortem Blood Drug Level | 59 | 3 | Ethyl Alcohol (PRR 422.8) |
| 9160 | Lupus Enteritis | 59 | 1 | Belimumab (PRR 311.8) |
| 9161 | Lupus Endocarditis | 59 | 1 | Belimumab (PRR 150.4) |
| 9162 | Semenuria | 59 | 1 | Atomoxetine Hydrochloride (PRR 789.0) |
| 9163 | Delayed Haemolytic Transfusion Reaction | 59 | 1 | Voxelotor (PRR 85.8) |
| 9164 | Tonic Posturing | 59 | 1 | Ursosiol (PRR 332.8) |
| 9165 | Urine Leukocyte Esterase | 59 | 4 | Dimenhydrinate (PRR 790.2) |
| 9166 | Hyperkinetic Heart Syndrome | 59 | 3 | Febuxostat Tablets 40 Mg (PRR 368.2) |
| 9167 | Follicular Lymphoma Refractory | 59 | 3 | Obinutuzumab (PRR 996.1) |
| 9168 | Spleen Atrophy | 59 | 3 | Acalabrutinib (PRR 350.3) |
| 9169 | Transaminases | 59 | 1 | Lapatinib (PRR 273.6) |
| 9170 | Cortical Dysplasia | 59 | 3 | Cenobamate (PRR 133.6) |
| 9171 | Forced Expiratory Volume Increased | 59 | 1 | Fluticasone Furoate (PRR 309.1) |
| 9172 | Claudication Of Jaw Muscles | 59 | 1 | Fluticasone Furoate (PRR 269.4) |
| 9173 | Gastrointestinal Neuroendocrine Tumour | 59 | 1 | Axicabtagene Ciloleucel (PRR 195.2) |
| 9174 | Microgenia | 59 | 1 | Misoprostol (PRR 287.6) |
| 9175 | Circulatory Failure Neonatal | 59 | 1 | Cariprazine (PRR 253.0) |
| 9176 | Meningioma Malignant | 59 | 1 | Alpelisib (PRR 127.9) |
| 9177 | Rash Maculovesicular | 59 | 1 | Iohexol (PRR 284.0) |
| 9178 | Aids Encephalopathy | 58 | 15 | Ritonavir (PRR 1,007.7) |
| 9179 | Anti-Muellerian Hormone Level Decreased | 58 | 1 | Doxorubicin Hydrochloride (PRR 418.2) |
| 9180 | Rouleaux Formation | 58 | 2 | Ribociclib (PRR 498.8) |
| 9181 | Parainfluenza Virus Infection | 58 | 3 | Azacitidine For (PRR 298.3) |
| 9182 | Modified Radical Mastectomy | 58 | 1 | Conjugated Estrogens And Medroxyprogesterone Acetate (PRR 140.9) |
| 9183 | Scleroedema | 58 | 2 | Pemetrexed (PRR 253.0) |
| 9184 | Acrophobia | 58 | 1 | Paliperidone (PRR 102.9) |
| 9185 | Anti-Transglutaminase Antibody Increased | 58 | 1 | Rifaximin (PRR 136.2) |
| 9186 | Occupational Asthma | 58 | 4 | Theophylline Anhydrous (PRR 952.3) |
| 9187 | Leukonychia | 58 | 1 | Lapatinib (PRR 214.5) |
| 9188 | Inability To Crawl | 58 | 1 | Vigabatrin (PRR 77.8) |
| 9189 | Kaposi Sarcoma Inflammatory Cytokine Syndrome | 58 | 2 | Sirolimus (PRR 361.3) |
| 9190 | Sars-Cov-2 Viraemia | 58 | 1 | Remdesivir (PRR 407.2) |
| 9191 | Metastases To Salivary Gland | 58 | 2 | Valganciclovir Hydrochloride Powder, (PRR 313.3) |
| 9192 | Periorbital Discomfort | 58 | 1 | Cenegermin-Bkbj (PRR 358.3) |
| 9193 | Fibrillary Glomerulonephritis | 58 | 1 | Chlorthalidone (PRR 286.6) |
| 9194 | Castleman'S Disease | 58 | 2 | Nevirapine (PRR 266.1) |
| 9195 | Erythroblast Count Increased | 58 | 1 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 102.8) |
| 9196 | Pedal Pulse Abnormal | 58 | 1 | Captopril (PRR 1,138.8) |
| 9197 | Diabetes With Hyperosmolarity | 58 | 1 | Dolutegravir Sodium (PRR 170.8) |
| 9198 | Junctional Ectopic Tachycardia | 57 | 3 | Doxepin Hydrochloride (PRR 760.3) |
| 9199 | Anal Cyst | 57 | 3 | Siponimod (PRR 176.0) |
| 9200 | Administration Site Indentation | 57 | 2 | Alirocumab (PRR 221.0) |
| 9201 | Brain Lobectomy | 57 | 4 | Zonisamide (PRR 415.4) |
| 9202 | Blast Cell Proliferation | 57 | 1 | Dasatinib (PRR 182.0) |
| 9203 | Braf V600E Mutation Positive | 57 | 5 | Dabrafenib (PRR 888.2) |
| 9204 | Catheter Site Granuloma | 57 | 3 | Bupivacaine (PRR 417.5) |
| 9205 | Genetic Polymorphism | 57 | 5 | Abacavir Sulfate (PRR 1,154.4) |
| 9206 | Fatty Liver Alcoholic | 57 | 1 | Ethyl Alcohol (PRR 124.9) |
| 9207 | Mucoepidermoid Carcinoma Of Salivary Gland | 57 | 4 | Alemtuzumab (PRR 537.6) |
| 9208 | Medical Device Site Cellulitis | 57 | 2 | Insulin Glulisine (PRR 545.6) |
| 9209 | Mycobacterium Ulcerans Infection | 57 | 2 | Rifampicin (PRR 1,292.6) |
| 9210 | Injection Site Vasculitis | 57 | 1 | Fosaprepitant Dimeglumine (PRR 403.4) |
| 9211 | Clinical Trial Participant | 57 | 1 | Remdesivir (PRR 910.5) |
| 9212 | Scrotal Cellulitis | 57 | 1 | Emicizumab (PRR 93.5) |
| 9213 | Meningoencephalitis Amoebic | 57 | 3 | Atovaquone (PRR 304.0) |
| 9214 | T-Cell Lymphoma Stage Iv | 57 | 1 | Brentuximab Vedotin (PRR 331.4) |
| 9215 | Bacteroides Bacteraemia | 57 | 1 | Polatuzumab Vedotin (PRR 118.4) |
| 9216 | Aortoenteric Fistula | 57 | 1 | Daptomycin (PRR 666.3) |
| 9217 | Postpartum Sepsis | 57 | 1 | Nevirapine (PRR 681.4) |
| 9218 | Aortic Elongation | 57 | 1 | Bosutinib (PRR 128.7) |
| 9219 | Cerebral Microinfarction | 57 | 1 | Faricimab (PRR 302.0) |
| 9220 | Congenital Absence Of Cranial Vault | 57 | 1 | Ivacaftor (PRR 308.2) |
| 9221 | Colposcopy | 56 | 3 | Etonogestrel And Ethinyl Estradiol (PRR 283.5) |
| 9222 | Blood Erythropoietin Abnormal | 56 | 1 | Ruxolitinib (PRR 521.0) |
| 9223 | Parathyroid Hyperplasia | 56 | 1 | Cinacalcet Hydrochloride (PRR 194.3) |
| 9224 | Apparent Mineralocorticoid Excess | 56 | 5 | Abiraterone (PRR 916.7) |
| 9225 | Anorectal Malformation | 56 | 1 | Clobazam (PRR 371.2) |
| 9226 | Electroencephalogram | 56 | 3 | Cannabidiol (PRR 217.2) |
| 9227 | Autonomic Failure Syndrome | 56 | 1 | Droxidopa (PRR 74.1) |
| 9228 | Immune Recovery Uveitis | 56 | 7 | Ganciclovir (PRR 1,219.6) |
| 9229 | Cystostomy | 56 | 2 | Dolutegravir Sodium (PRR 441.6) |
| 9230 | Instillation Site Inflammation | 56 | 1 | Lifitegrast (PRR 1,826.4) |
| 9231 | Arteriovenous Graft Site Infection | 56 | 1 | Paricalcitol (PRR 144.4) |
| 9232 | Skin Graft Rejection | 56 | 2 | Anti-Thymocyte Globulin (Rabbit) (PRR 368.4) |
| 9233 | Lung Assist Device Therapy | 56 | 2 | Remdesivir (PRR 120.1) |
| 9234 | Tracheal Cancer | 56 | 1 | Crizotinib (PRR 125.9) |
| 9235 | Encephalitis Protozoal | 56 | 2 | Basiliximab (PRR 534.8) |
| 9236 | Rectal Cancer Stage Iv | 56 | 1 | Regorafenib (PRR 175.7) |
| 9237 | Oropharyngeal Discolouration | 56 | 2 | Felodipine Extended-Release Tablets (PRR 446.5) |
| 9238 | Viral Load Undetectable | 56 | 1 | Glecaprevir And Pibrentasvir (PRR 227.2) |
| 9239 | Glaucoma Drainage Device Placement | 56 | 1 | Travoprost (PRR 136.1) |
| 9240 | Pulmonary Function Test | 56 | 1 | Lumacaftor And Ivacaftor (PRR 186.7) |
| 9241 | Application Site Alopecia | 55 | 1 | Minoxidil (PRR 115.6) |
| 9242 | 5-Hydroxyindolacetic Acid In Urine Increased | 55 | 5 | Quinapril Hydrochloride (PRR 1,629.0) |
| 9243 | Acute Megakaryocytic Leukaemia | 55 | 1 | Olaparib (PRR 169.2) |
| 9244 | Small Cell Lung Cancer Recurrent | 55 | 1 | Durvalumab (PRR 125.2) |
| 9245 | Genital Prolapse | 55 | 2 | Efavirenz (PRR 272.1) |
| 9246 | Adverse Event Following Immunisation | 55 | 2 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 746.2) |
| 9247 | Blood Caffeine Increased | 55 | 1 | Acetaminophen, Aspirin (Nsaid) And Caffeine (PRR 122.3) |
| 9248 | Electrocardiogram T Wave Biphasic | 55 | 2 | Dofetilide (PRR 337.0) |
| 9249 | Postinfarction Angina | 55 | 1 | Alteplase (PRR 386.6) |
| 9250 | Cortical Visual Impairment | 55 | 2 | Vigabatrin (PRR 638.4) |
| 9251 | Pulmonary Capillary Haemangiomatosis | 55 | 1 | Epoprostenol (PRR 310.9) |
| 9252 | In-Stent Arterial Restenosis | 55 | 1 | Prasugrel Hydrochloride (PRR 633.8) |
| 9253 | Sarcomatoid Carcinoma | 55 | 2 | Gefitinib (PRR 282.2) |
| 9254 | Tooth Dislocation | 55 | 1 | Baricitinib (PRR 264.2) |
| 9255 | Vaccination Site Inflammation | 55 | 1 | Thiotepa (PRR 217.9) |
| 9256 | Pulmonary Sequestration | 55 | 1 | Pyrazinamide (PRR 271.2) |
| 9257 | Glioneuronal Tumour | 54 | 1 | Somatropin (PRR 153.2) |
| 9258 | Haemorrhage Foetal | 54 | 4 | Esomeprazole Magnesium Capsule, Delayed Release (PRR 551.3) |
| 9259 | Reactive Capillary Endothelial Proliferation | 54 | 1 | Atezolizumab (PRR 187.2) |
| 9260 | Jc Virus Csf Test Positive | 54 | 1 | Ixazomib (PRR 125.6) |
| 9261 | Exudative Retinopathy | 54 | 1 | Ranibizumab (PRR 274.1) |
| 9262 | Ovarian Epithelial Cancer Recurrent | 54 | 1 | Niraparib (PRR 239.6) |
| 9263 | Transdifferentiation Of Neoplasm | 54 | 1 | Imatinib (PRR 301.6) |
| 9264 | Prenatal Screening Test Abnormal | 54 | 1 | Atazanavir (PRR 251.7) |
| 9265 | Anti Factor X Activity Increased | 54 | 1 | Heparin Sodium (PRR 343.7) |
| 9266 | Congenital Toxoplasmosis | 54 | 1 | Zidovudine (PRR 311.1) |
| 9267 | Respiratory Papilloma | 54 | 2 | Erlotinib Hydrochloride (PRR 474.9) |
| 9268 | Hereditary Neuropathic Amyloidosis | 54 | 1 | Tafamidis (PRR 353.2) |
| 9269 | Lack Of Concomitant Drug Effect | 54 | 2 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 624.2) |
| 9270 | Tumour Cavitation | 54 | 1 | Regorafenib (PRR 182.8) |
| 9271 | Hyperkaliuria | 54 | 2 | Lisinopril And Hydrochlorothiazide Tablets (PRR 270.2) |
| 9272 | Teratoma Benign | 54 | 1 | Bleomycin Sulfate (PRR 1,093.2) |
| 9273 | Testicular Operation | 54 | 2 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate (PRR 184.9) |
| 9274 | Autoimmune Anaemia | 54 | 1 | Daptomycin (PRR 180.4) |
| 9275 | Epiphyses Delayed Fusion | 54 | 1 | Nevirapine (PRR 288.3) |
| 9276 | Gynaecological Chlamydia Infection | 53 | 1 | Levonorgestrel (PRR 144.2) |
| 9277 | Amphetamines Negative | 53 | 1 | Lisdexamfetamine Dimesylate (PRR 705.3) |
| 9278 | Erythema Dyschromicum Perstans | 53 | 3 | Erlotinib (PRR 1,409.3) |
| 9279 | Systemic Sclerosis Pulmonary | 53 | 1 | Nintedanib (PRR 194.0) |
| 9280 | Intra-Ocular Injection | 53 | 1 | Aflibercept (PRR 314.6) |
| 9281 | Fluoride Increased | 53 | 2 | Voriconazole (PRR 2,942.1) |
| 9282 | Retro-Orbital Neoplasm | 53 | 6 | Dexamethasone Sodium Phosphate (PRR 885.7) |
| 9283 | Conjunctival Bleb | 53 | 1 | Ranibizumab (PRR 648.0) |
| 9284 | Primitive Neuroectodermal Tumour | 53 | 1 | Ifosfamide (PRR 253.5) |
| 9285 | Intestinal Transit Time Abnormal | 53 | 2 | Panitumumab (PRR 202.0) |
| 9286 | Pseudoaneurysm Infection | 53 | 7 | Drs. Clotrimazole (PRR 6,149.2) |
| 9287 | Pacemaker Generated Rhythm | 53 | 1 | Sotalol Hydrochloride (PRR 327.6) |
| 9288 | Autoimmune Heparin-Induced Thrombocytopenia | 53 | 1 | Heparin Sodium (PRR 1,972.7) |
| 9289 | Tertiary Adrenal Insufficiency | 53 | 1 | Posaconazole Delayed-Release (PRR 336.8) |
| 9290 | Systemic Viral Infection | 53 | 1 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide (PRR 124.1) |
| 9291 | Oral Fibroma | 53 | 1 | Misoprostol (PRR 272.7) |
| 9292 | Skin Neoplasm Bleeding | 53 | 1 | Vismodegib (PRR 140.2) |
| 9293 | Prosthetic Valve Endocarditis | 53 | 1 | Anti-Thymocyte Globulin (Rabbit) (PRR 329.3) |
| 9294 | Toxic Goitre | 53 | 1 | Methimazole (PRR 616.3) |
| 9295 | Total Complement Activity Increased | 52 | 1 | Eculizumab (PRR 1,037.0) |
| 9296 | Detachment Of Macular Retinal Pigment Epithelium | 52 | 3 | Ranibizumab (PRR 261.0) |
| 9297 | Escherichia Peritonitis | 52 | 2 | Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose (PRR 331.2) |
| 9298 | Andropause | 52 | 1 | Relugolix (PRR 391.8) |
| 9299 | Ameloblastoma | 52 | 1 | Ifosfamide (PRR 230.4) |
| 9300 | Cytomegalovirus Nephritis | 52 | 6 | Valganciclovir Hydrochloride Powder, (PRR 902.9) |
| 9301 | Lower Motor Neurone Lesion | 52 | 1 | Azacitidine For (PRR 177.8) |
| 9302 | Blast Cells | 52 | 1 | Azacitidine For (PRR 149.1) |
| 9303 | Acanthoma | 52 | 2 | Everolimus Tablets (PRR 295.3) |
| 9304 | Heart Failure With Midrange Ejection Fraction | 52 | 4 | Thiotepa (PRR 518.7) |
| 9305 | Dopamine Agonist Withdrawal Syndrome | 52 | 3 | Pramipexole (PRR 1,163.3) |
| 9306 | Peritoneal Cyst | 52 | 3 | Tenofovir Disoproxil Fumarate Tablets (PRR 314.3) |
| 9307 | Lewis-Sumner Syndrome | 52 | 1 | Pegaspargase (PRR 308.9) |
| 9308 | Hiv Antibody Positive | 52 | 2 | Emtricitabine And Tenofovir Alafenamide (PRR 333.6) |
| 9309 | Neuroendocrine Tumour Of The Lung Metastatic | 52 | 1 | Rifampicin (PRR 430.4) |
| 9310 | Vaginal Exfoliation | 52 | 1 | Miconazole Nitrate (PRR 253.6) |
| 9311 | Urethral Spasm | 52 | 1 | Vibegron (PRR 216.2) |
| 9312 | Blood Luteinising Hormone Abnormal | 51 | 1 | Leuprolide Acetate (PRR 172.5) |
| 9313 | Device Calibration Failure | 51 | 1 | Somatropin (PRR 437.6) |
| 9314 | Implant Site Pustules | 51 | 1 | Etonogestrel (PRR 1,414.2) |
| 9315 | Adjusted Calcium Increased | 51 | 1 | Cinacalcet Hydrochloride (PRR 48.4) |
| 9316 | Uterine Abscess | 51 | 1 | Copper (PRR 64.2) |
| 9317 | Hypoprolactinaemia | 51 | 2 | Aripiprazole Oral (PRR 565.2) |
| 9318 | Systemic Immune Activation | 51 | 1 | Atezolizumab (PRR 556.4) |
| 9319 | Blood Hiv Rna | 51 | 5 | Dolutegravir Sodium (PRR 634.3) |
| 9320 | Gastric Ileus | 51 | 2 | Thiamine Hydrochloride (PRR 911.6) |
| 9321 | Myelodysplastic Syndrome With Multilineage Dysplasia | 51 | 3 | Atovaquone (PRR 884.1) |
| 9322 | Decompression Sickness | 51 | 1 | Vortioxetine (PRR 611.2) |
| 9323 | Type 1 Lepra Reaction | 51 | 5 | Daspone (PRR 1,068.0) |
| 9324 | Arteriovenous Shunt Operation | 51 | 1 | Paricalcitol (PRR 359.2) |
| 9325 | Vascular Resistance Systemic Increased | 51 | 3 | Misoprostol (PRR 521.1) |
| 9326 | Biopsy Cervix | 51 | 1 | Fluticasone Furoate (PRR 319.5) |
| 9327 | Postural Reflex Impairment | 51 | 1 | Levodopa (PRR 320.3) |
| 9328 | Renal Adenoma | 51 | 1 | Basiliximab (PRR 379.0) |
| 9329 | Vascular Access Malfunction | 51 | 1 | Sevelamer Carbonate (PRR 154.1) |
| 9330 | Drug Dependence, Antepartum | 51 | 1 | Methadone Hydrochloride (PRR 209.0) |
| 9331 | Lineage Switch Leukaemia | 51 | 1 | Blinatumomab (PRR 3,987.7) |
| 9332 | Traumatic Delivery | 51 | 1 | Misoprostol (PRR 657.4) |
| 9333 | Undifferentiated Sarcoma | 51 | 1 | Thiotepa (PRR 236.8) |
| 9334 | Vulvovaginal Exfoliation | 51 | 1 | Miconazole Nitrate (PRR 733.5) |
| 9335 | Fungating Wound | 51 | 1 | Alpelisib (PRR 149.2) |
| 9336 | Subcapsular Hepatic Haematoma | 51 | 1 | Ado-Trastuzumab Emtansine (PRR 210.0) |
| 9337 | Cutaneous Malacoplakia | 51 | 1 | Atovaquone (PRR 280.9) |
| 9338 | Disease Propensity | 50 | 1 | Ruxolitinib (PRR 4,534.9) |
| 9339 | Brown Tumour | 50 | 2 | Paricalcitol (PRR 128.0) |
| 9340 | Pancreatic Cystadenoma | 50 | 4 | Valganciclovir (PRR 387.5) |
| 9341 | Connective Tissue Disease-Associated Interstitial Lung Disease | 50 | 2 | Baricitinib (PRR 473.7) |
| 9342 | Hiv Associated Nephropathy | 50 | 15 | Abacavir Sulfate (PRR 915.2) |
| 9343 | Emphysematous Cholecystitis | 50 | 2 | Azacitidine For (PRR 401.7) |
| 9344 | Eyelash Hyperpigmentation | 50 | 2 | Bimatoprost (PRR 665.8) |
| 9345 | Rhabdoid Tumour | 50 | 4 | Ifosfamide (PRR 498.5) |
| 9346 | Hepatic Echinococciasis | 50 | 1 | Abemaciclib (PRR 228.4) |
| 9347 | Keratitis Interstitial | 50 | 1 | Brimonidine Tartrate (PRR 256.2) |
| 9348 | Adenovirus Interstitial Nephritis | 50 | 4 | Everolimus Tablets (PRR 482.3) |
| 9349 | Anticonvulsant Toxicity | 50 | 1 | Extended Phenytoin Sodium (PRR 761.8) |
| 9350 | Congenital Musculoskeletal Disorder Of Spine | 50 | 1 | Raltegravir (PRR 276.5) |
| 9351 | Left Atrial Hypertrophy | 50 | 2 | Posaconazole Delayed-Release (PRR 534.3) |
| 9352 | Cell-Mediated Cytotoxicity | 50 | 2 | Valganciclovir Hydrochloride Powder, (PRR 324.9) |
| 9353 | Encephalitis Bacterial | 50 | 1 | Ketoprofen (PRR 396.4) |
| 9354 | Vitamin A Increased | 50 | 2 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 470.4) |
| 9355 | Tryptase Decreased | 50 | 3 | Avapritinib (PRR 2,372.2) |
| 9356 | Atrial Appendage Closure | 50 | 1 | Tafamidis (PRR 112.7) |
| 9357 | Pericardial Calcification | 50 | 1 | Canakinumab (PRR 313.0) |
| 9358 | Implantable Defibrillator Malfunction | 50 | 1 | Dofetilide (PRR 270.0) |
| 9359 | Pulmonary Arteriopathy | 50 | 1 | Thiotepa (PRR 1,025.2) |
| 9360 | Prader-Willi Syndrome | 50 | 1 | Acetylcysteine (PRR 420.5) |
| 9361 | Compulsive Cheek Biting | 50 | 1 | Cariprazine (PRR 142.7) |
| 9362 | Tissue Rupture | 50 | 1 | Naltrexone Hydrochloride And Bupropion Hydrochloride (PRR 271.1) |
| 9363 | Vulval Cellulitis | 50 | 2 | Mesna Injection (PRR 279.8) |
| 9364 | Vulvovaginitis Trichomonal | 49 | 1 | Copper (PRR 67.2) |
| 9365 | Juvenile Chronic Myelomonocytic Leukaemia | 49 | 2 | Fludarabine Phosphate (PRR 364.4) |
| 9366 | Urinary Occult Blood | 49 | 1 | Atezolizumab (PRR 154.9) |
| 9367 | Alexithymia | 49 | 1 | Paliperidone Palmitate (PRR 90.1) |
| 9368 | Pericarditis Uraemic | 49 | 1 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 76.0) |
| 9369 | Genotype Drug Resistance Test | 49 | 3 | Entecavir (PRR 2,813.1) |
| 9370 | Eyelash Injury | 49 | 1 | Bimatoprost (PRR 162.3) |
| 9371 | Global Longitudinal Strain Abnormal | 49 | 1 | Carfilzomib (PRR 294.0) |
| 9372 | Granulomatous Rosacea | 49 | 8 | Itraconazole (PRR 712.5) |
| 9373 | Heliotrope Rash | 49 | 1 | Abemaciclib (PRR 145.2) |
| 9374 | Necrotising Panniculitis | 49 | 1 | Imatinib (PRR 571.7) |
| 9375 | Pelvic Misalignment | 49 | 4 | Felodipine Extended-Release Tablets (PRR 1,615.7) |
| 9376 | Tympanosclerosis | 49 | 1 | Ciclesonide (PRR 673.7) |
| 9377 | Platelet Distribution Width Increased | 49 | 1 | Eplerenone (PRR 586.6) |
| 9378 | Cervix Enlargement | 49 | 1 | Misoprostol (PRR 356.1) |
| 9379 | Haemophilus Bacteraemia | 49 | 1 | Atovaquone (PRR 360.6) |
| 9380 | Pancreatic Fibrosis | 49 | 2 | Derma Foam Excel Hand Sanitizer (PRR 169.7) |
| 9381 | Injection Site Joint Infection | 49 | 1 | Methylprednisolone Acetate (PRR 2,937.2) |
| 9382 | Balloon Atrial Septostomy | 48 | 1 | Bosentan (PRR 576.7) |
| 9383 | Blood Glucose False Positive | 48 | 1 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 790.8) |
| 9384 | Adiposis Dolorosa | 48 | 2 | Naltrexone (PRR 200.4) |
| 9385 | Choroidal Dystrophy | 48 | 1 | Melphalan Hydrochloride (PRR 1,265.6) |
| 9386 | Ganglioglioma | 48 | 2 | Dabrafenib (PRR 406.4) |
| 9387 | Aphantasia | 48 | 1 | Vortioxetine (PRR 244.5) |
| 9388 | Serpiginous Choroiditis | 48 | 4 | Pyrazinamide (PRR 2,215.0) |
| 9389 | Female Reproductive Neoplasm | 48 | 1 | Cortisone Acetate (PRR 240.7) |
| 9390 | Muckle-Wells Syndrome | 48 | 1 | Canakinumab (PRR 8,332.3) |
| 9391 | Electrocardiogram R On T Phenomenon | 48 | 1 | Dronedarone (PRR 237.1) |
| 9392 | Hyperglycaemic Crisis | 48 | 1 | Alpelisib (PRR 159.1) |
| 9393 | Mitochondrial Enzyme Deficiency | 48 | 1 | Sevoflurane (PRR 744.2) |
| 9394 | Alcohol Test Positive | 47 | 3 | Ethyl Alcohol (PRR 292.5) |
| 9395 | Erosive Pustular Dermatosis | 47 | 4 | Pemetrexed (PRR 658.0) |
| 9396 | Her2 Negative Breast Cancer | 47 | 1 | Ribociclib (PRR 487.8) |
| 9397 | Congenital Ectopic Bladder | 47 | 3 | Zidovudine (PRR 475.3) |
| 9398 | Marginal Zone Lymphoma Recurrent | 47 | 1 | Bendamustine Hcl (PRR 692.2) |
| 9399 | Dyskinesia Hyperpyrexia Syndrome | 47 | 1 | Amantadine (PRR 2,166.0) |
| 9400 | Spinocerebellar Disorder | 47 | 3 | Nevirapine (PRR 1,431.4) |
| 9401 | Blood Pyruvic Acid Increased | 47 | 1 | Zidovudine (PRR 802.9) |
| 9402 | Laryngeal Papilloma | 47 | 2 | Erlotinib Hydrochloride (PRR 569.9) |
| 9403 | Graft Ischaemia | 47 | 5 | Drs. Clotrimazole (PRR 426.3) |
| 9404 | Cockroach Allergy | 47 | 1 | Chlorthalidone (PRR 424.3) |
| 9405 | Pneumonia Salmonella | 47 | 1 | Bleomycin Sulfate (PRR 294.7) |
| 9406 | Abdominal Incarcerated Hernia | 47 | 1 | Polatuzumab Vedotin (PRR 145.4) |
| 9407 | Enzyme Induction | 47 | 1 | Pyrazinamide (PRR 324.1) |
| 9408 | Coronary Bypass Thrombosis | 47 | 1 | Testosterone Cypionate (PRR 890.6) |
| 9409 | Plasma Cells Decreased | 47 | 2 | Mesna Injection (PRR 440.6) |
| 9410 | Immune-Mediated Pancytopenia | 46 | 1 | Pembrolizumab (PRR 626.3) |
| 9411 | Patent Ductus Arteriosus Repair | 46 | 1 | Bosentan (PRR 377.6) |
| 9412 | Serous Cystadenocarcinoma Ovary | 46 | 1 | Letrozole Tablets (PRR 561.2) |
| 9413 | Pharyngeal Necrosis | 46 | 1 | Atezolizumab (PRR 210.8) |
| 9414 | Chronic Coronary Syndrome | 46 | 1 | Ticagrelor (PRR 230.0) |
| 9415 | Urea Cycle Disorder | 46 | 1 | Deferasirox (PRR 246.4) |
| 9416 | Jejunal Ulcer Perforation | 46 | 2 | Dabrafenib (PRR 207.8) |
| 9417 | Congenital Great Vessel Anomaly | 46 | 1 | Sitagliptin And Metformin Hydrochloride (PRR 303.0) |
| 9418 | Central Nervous System Abscess | 46 | 1 | Mycophenilic Acid (PRR 395.3) |
| 9419 | Hepatitis C Rna | 46 | 4 | Methadone Hydrochloride (PRR 234.5) |
| 9420 | Cerebral Hygroma | 46 | 1 | Ledipasvir And Sofosbuvir (PRR 162.2) |
| 9421 | Hyposomnia | 46 | 1 | Esketamine Hydrochloride (PRR 81.4) |
| 9422 | Sputum Decreased | 46 | 1 | Amikacin (PRR 338.7) |
| 9423 | Adult T-Cell Lymphoma/Leukaemia Recurrent | 46 | 4 | Febuxostat Tablets 40 Mg (PRR 497.6) |
| 9424 | Instillation Site Infection | 46 | 1 | Lifitegrast (PRR 309.6) |
| 9425 | Leukoerythroblastic Anaemia | 46 | 1 | Romiplostim (PRR 207.2) |
| 9426 | Erythema Elevatum Diutinum | 46 | 3 | Abacavir Sulfate (PRR 449.6) |
| 9427 | Lactate Pyruvate Ratio Increased | 46 | 1 | Zidovudine (PRR 1,697.0) |
| 9428 | Pneumonia Serratia | 46 | 1 | Remdesivir (PRR 148.7) |
| 9429 | Renal Lymphocele | 46 | 1 | Basiliximab (PRR 491.3) |
| 9430 | Prostatic Specific Antigen | 46 | 1 | Apalutamide (PRR 123.4) |
| 9431 | Cutaneous Sporotrichosis | 46 | 1 | Itraconazole (PRR 559.8) |
| 9432 | Urostomy Complication | 46 | 1 | Trifluridine And Tipiracil (PRR 135.3) |
| 9433 | Primary Mediastinal Large B-Cell Lymphoma Recurrent | 46 | 3 | Axicabtagene Ciloleucel (PRR 512.8) |
| 9434 | Radiation Myelopathy | 46 | 1 | Thiotepa (PRR 529.9) |
| 9435 | Brain Stem Haematoma | 46 | 2 | Fondaparinux Sodium (PRR 244.8) |
| 9436 | Radical Mastectomy | 46 | 1 | Ado-Trastuzumab Emtansine (PRR 300.9) |
| 9437 | Inappropriate Release Of Product For Distribution | 46 | 1 | Iohexol (PRR 450.3) |
| 9438 | Transplant Abscess | 46 | 1 | Atovaquone (PRR 387.6) |
| 9439 | Device Material Opacification | 45 | 1 | Somatropin (PRR 127.5) |
| 9440 | Occupational Therapy | 45 | 1 | Pimavanserin Tartrate (PRR 250.2) |
| 9441 | Uterine Polypectomy | 45 | 1 | Copper (PRR 74.1) |
| 9442 | Mixed Hepatocellular Cholangiocarcinoma | 45 | 1 | Atezolizumab (PRR 511.7) |
| 9443 | Subretinal Haematoma | 45 | 1 | Ranibizumab (PRR 284.7) |
| 9444 | Scopulariopsis Infection | 45 | 1 | Voriconazole Injection (PRR 389.0) |
| 9445 | Urachal Abnormality | 45 | 1 | Indapamide (PRR 580.1) |
| 9446 | Carotid Intima-Media Thickness Increased | 45 | 1 | Imatinib (PRR 428.8) |
| 9447 | Colloid Brain Cyst | 45 | 1 | Vortioxetine (PRR 188.1) |
| 9448 | Iatrogenic Kaposi Sarcoma | 45 | 1 | Busulfan (PRR 285.8) |
| 9449 | Cystic Fibrosis Pancreatic | 45 | 2 | Rifampin (PRR 356.2) |
| 9450 | Lissencephaly | 45 | 1 | Vigabatrin (PRR 262.9) |
| 9451 | Urticaria Pigmentosa | 45 | 1 | Avapritinib (PRR 371.4) |
| 9452 | Electrocardiogram J Wave | 45 | 1 | Levodopa (PRR 215.2) |
| 9453 | Therapeutic Agent-Diagnostic Test Interaction | 45 | 1 | Sevelamer Carbonate (PRR 278.5) |
| 9454 | Polymicrogyria | 45 | 1 | Emtricitabine And Tenofovir Alafenamide (PRR 179.0) |
| 9455 | Past-Pointing | 45 | 1 | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide (PRR 147.7) |
| 9456 | Cerebral Cavernous Malformation | 45 | 1 | Thiotepa (PRR 471.0) |
| 9457 | Abscess Sweat Gland | 45 | 1 | Terbinafine Hydrochloride (PRR 360.3) |
| 9458 | Gastrointestinal Submucosal Tumour | 45 | 1 | Ado-Trastuzumab Emtansine (PRR 240.8) |
| 9459 | Thrombin Time Abnormal | 44 | 1 | Dabigatran Etexilate Mesylate (PRR 285.6) |
| 9460 | Ectropion Of Cervix | 44 | 2 | Etonogestrel And Ethinyl Estradiol (PRR 275.8) |
| 9461 | Iris Discolouration | 44 | 1 | Bimatoprost (PRR 185.5) |
| 9462 | Ligamentum Flavum Hypertrophy | 44 | 2 | Rizatriptan Benzoate (PRR 386.9) |
| 9463 | Alveolar Rhabdomyosarcoma | 44 | 1 | Temozolomide (PRR 219.3) |
| 9464 | Infective Exacerbation Of Asthma | 44 | 1 | Benralizumab (PRR 164.1) |
| 9465 | Cd4 Lymphocyte Percentage Decreased | 44 | 2 | Cabotegravir (PRR 257.7) |
| 9466 | Meniscopathy | 44 | 4 | Captopril (PRR 811.4) |
| 9467 | Spastic Paralysis | 44 | 1 | Palivizumab (PRR 135.4) |
| 9468 | Schizencephaly | 44 | 4 | Atropine Sulfate (PRR 722.1) |
| 9469 | Flavobacterium Infection | 44 | 6 | Ganciclovir (PRR 522.7) |
| 9470 | Leptotrichia Infection | 44 | 1 | Crizotinib (PRR 163.6) |
| 9471 | Exposure Via Contaminated Device | 44 | 1 | Bendamustine Hydrochloride (PRR 222.7) |
| 9472 | End-Tidal Co2 Decreased | 44 | 2 | Sevoflurane (PRR 395.3) |
| 9473 | Coronary Vascular Graft Occlusion | 44 | 1 | Ranolazine (PRR 145.9) |
| 9474 | Diabetic Bullosis | 44 | 1 | Insulin Glulisine (PRR 323.0) |
| 9475 | Product Regimen Confusion | 44 | 1 | Cenobamate (PRR 249.3) |
| 9476 | Phenylketonuria | 44 | 1 | Pegvaliase-Pqpz (PRR 185.3) |
| 9477 | Occupational Exposure To Air Contaminants | 44 | 1 | Dutasteride (PRR 752.6) |
| 9478 | Rest Regimen | 44 | 1 | Lanreotide Acetate (PRR 419.0) |
| 9479 | Arrhythmia Induced Cardiomyopathy | 43 | 1 | Enzalutamide (PRR 369.9) |
| 9480 | Exposure Via Semen | 43 | 1 | Isotretinoin (PRR 202.7) |
| 9481 | Injection Site Alopecia | 43 | 2 | Minoxidil Foam 5% (Womens) (PRR 102.1) |
| 9482 | Neonatal Candida Infection | 43 | 6 | Ampicillin (PRR 1,808.7) |
| 9483 | Rhabdomyosarcoma Recurrent | 43 | 1 | Ifosfamide (PRR 841.5) |
| 9484 | Instillation Site Burn | 43 | 1 | Lifitegrast (PRR 1,607.9) |
| 9485 | Eczema Impetiginous | 43 | 1 | Panitumumab (PRR 215.3) |
| 9486 | Tonsillar Exudate | 43 | 1 | Zonisamide (PRR 426.1) |
| 9487 | Electrocardiogram T Wave Alternans | 43 | 4 | Norepinephrine (PRR 753.4) |
| 9488 | Congenital Hepatomegaly | 43 | 1 | Atazanavir (PRR 281.4) |
| 9489 | White Clot Syndrome | 43 | 1 | Heparin Sodium (PRR 655.4) |
| 9490 | Paravenous Drug Administration | 43 | 2 | Remdesivir (PRR 253.1) |
| 9491 | End-Tidal Co2 Increased | 43 | 2 | Sevoflurane (PRR 1,802.3) |
| 9492 | Oral Hyperaesthesia | 43 | 1 | Regorafenib (PRR 235.8) |
| 9493 | Thermohyperaesthesia | 43 | 1 | Regorafenib (PRR 235.8) |
| 9494 | Mucosal Excoriation | 43 | 1 | Asenapine Maleate (PRR 246.2) |
| 9495 | Paediatric Acute-Onset Neuropsychiatric Syndrome | 43 | 1 | Amphetamine (PRR 257.9) |
| 9496 | Lipoprotein Increased | 43 | 1 | Inclisiran (PRR 266.1) |
| 9497 | Antibiotic Prophylaxis | 43 | 1 | Ivacaftor (PRR 196.4) |
| 9498 | Bulbospinal Muscular Atrophy Congenital | 42 | 1 | Leuprolide Acetate (PRR 267.4) |
| 9499 | Malignant Spinal Cord Compression | 42 | 2 | Goserelin (PRR 1,704.2) |
| 9500 | Device Toxicity | 42 | 1 | Copper (PRR 361.4) |
| 9501 | Forced Vital Capacity Abnormal | 42 | 1 | Pirfenidone (PRR 283.4) |
| 9502 | Blood Ethanol | 42 | 5 | Ethyl Alcohol (PRR 573.8) |
| 9503 | Epilepsia Partialis Continua | 42 | 3 | Lacosamide (PRR 558.3) |
| 9504 | Cataract Traumatic | 42 | 1 | Ranibizumab (PRR 244.7) |
| 9505 | Biphasic Mesothelioma | 42 | 1 | Everolimus Tablets (PRR 440.1) |
| 9506 | Instillation Site Paraesthesia | 42 | 1 | Lifitegrast (PRR 397.8) |
| 9507 | Platelet Destruction Increased | 42 | 1 | Romiplostim (PRR 186.7) |
| 9508 | Hepatosplenomegaly Neonatal | 42 | 2 | Tobramycin Solution (PRR 346.4) |
| 9509 | Acral Lentiginous Melanoma | 42 | 1 | Pegaspargase (PRR 399.8) |
| 9510 | Hepatitis B E Antigen Positive | 42 | 2 | Entecavir (PRR 356.3) |
| 9511 | Gastrointestinal Stromal Cancer | 42 | 1 | Regorafenib (PRR 995.5) |
| 9512 | Metastases To Biliary Tract | 42 | 1 | Regorafenib (PRR 242.1) |
| 9513 | Central Nervous System Immune Reconstitution Inflammatory Response | 42 | 1 | Efavirenz (PRR 311.0) |
| 9514 | Taeniasis | 42 | 1 | Bleomycin Sulfate (PRR 402.8) |
| 9515 | Porto-Sinusoidal Vascular Disorder | 42 | 1 | Fam-Trastuzumab Deruxtecan-Nxki (PRR 217.3) |
| 9516 | Subacute Sclerosing Panencephalitis | 42 | 1 | Thiotepa (PRR 294.4) |
| 9517 | Oesophageal Mucosa Erythema | 42 | 1 | Meperidine Hydrochloride (PRR 531.3) |
| 9518 | Heart Rate Variability Increased | 42 | 1 | Eptinezumab-Jjmr (PRR 175.9) |
| 9519 | Uterine Stenosis | 41 | 1 | Levonorgestrel (PRR 159.9) |
| 9520 | Third Degree Chemical Burn Of Skin | 41 | 1 | Adapalene (PRR 8.9) |
| 9521 | Immune-Mediated Gastrointestinal Disorder | 41 | 1 | Ipilimumab (PRR 308.0) |
| 9522 | Periorbital Fat Atrophy | 41 | 2 | Bimatoprost (PRR 835.1) |
| 9523 | Hyalosis Asteroid | 41 | 2 | Faricimab (PRR 202.7) |
| 9524 | Selenium Deficiency | 41 | 1 | Abemaciclib (PRR 214.2) |
| 9525 | Portal Vein Cavernous Transformation | 41 | 1 | Azacitidine For (PRR 196.0) |
| 9526 | Hypotony Maculopathy | 41 | 2 | Brimonidine Tartrate (PRR 483.0) |
| 9527 | Follicular Lymphoma Stage Iv | 41 | 1 | Obinutuzumab (PRR 216.7) |
| 9528 | Vitamin B1 Increased | 41 | 4 | Dextrose (PRR 911.3) |
| 9529 | Non-Neutralising Antibodies Positive | 41 | 2 | Epoetin Alfa (PRR 1,013.1) |
| 9530 | Gastritis Hypertrophic | 41 | 1 | Epoprostenol (PRR 1,017.0) |
| 9531 | Portal Vein Flow Decreased | 41 | 1 | Velpatasvir And Sofosbuvir (PRR 175.2) |
| 9532 | Naevoid Melanoma | 41 | 2 | Erlotinib (PRR 368.2) |
| 9533 | Acquired Aminoaciduria | 41 | 1 | Entecavir (PRR 247.4) |
| 9534 | Subchondral Insufficiency Fracture | 41 | 1 | Dronedarone (PRR 747.7) |
| 9535 | Osteocalcin Increased | 41 | 1 | Asfotase Alfa (PRR 224.5) |
| 9536 | Kidney Malrotation | 41 | 1 | Polatuzumab Vedotin (PRR 365.5) |
| 9537 | Congenital Melanocytic Naevus | 41 | 1 | Dolutegravir Sodium (PRR 249.3) |
| 9538 | Glucose Tolerance Decreased | 41 | 1 | Testosterone Cypionate (PRR 251.8) |
| 9539 | Anorectal Varices | 41 | 1 | Anti-Thymocyte Globulin (Rabbit) (PRR 442.1) |
| 9540 | Aortic Wall Hypertrophy | 40 | 1 | Pegfilgrastim (PRR 126.0) |
| 9541 | Placental Hypertrophy | 40 | 1 | Buprenorphine (PRR 303.0) |
| 9542 | Alpha 1 Foetoprotein Decreased | 40 | 1 | Atezolizumab (PRR 202.9) |
| 9543 | Pulmonary Artery Therapeutic Procedure | 40 | 1 | Riociguat (PRR 637.4) |
| 9544 | Urine Copper Increased | 40 | 2 | Phenobarbital (PRR 691.1) |
| 9545 | Congenital Knee Dislocation | 40 | 3 | Tretinoin (PRR 744.1) |
| 9546 | Perineal Necrosis | 40 | 2 | Pegaspargase (PRR 1,537.2) |
| 9547 | Fibrinolysis Increased | 40 | 1 | Alteplase (PRR 293.8) |
| 9548 | Catheter Site Hypersensitivity | 40 | 1 | Epoprostenol (PRR 397.3) |
| 9549 | Hairy Cell Leukaemia Recurrent | 40 | 2 | Cladribine (PRR 1,443.1) |
| 9550 | Conjunctival Pigmentation | 40 | 1 | Minocycline (PRR 1,784.4) |
| 9551 | Trimethylaminuria | 40 | 1 | Cefuroxime (PRR 690.2) |
| 9552 | Urethral Polyp | 40 | 1 | Thiotepa (PRR 726.2) |
| 9553 | Csf Immunoglobulin Increased | 40 | 1 | Siponimod (PRR 189.1) |
| 9554 | Basfi Score Increased | 39 | 2 | Certolizumab Pegol (PRR 1,200.9) |
| 9555 | Oily Skin | 39 | 1 | Orlistat (PRR 118.0) |
| 9556 | Heteroplasia | 39 | 1 | Pemetrexed (PRR 250.2) |
| 9557 | Botryomycosis | 39 | 1 | Lapatinib (PRR 293.2) |
| 9558 | Mild Mental Retardation | 39 | 1 | Vigabatrin (PRR 118.9) |
| 9559 | Congenital Hiv Infection | 39 | 2 | Zidovudine (PRR 1,637.4) |
| 9560 | Scalp Haematoma | 39 | 1 | Emicizumab (PRR 140.3) |
| 9561 | Persistent Postural-Perceptual Dizziness | 39 | 1 | Avapritinib (PRR 252.6) |
| 9562 | Neutralising Antibodies Negative | 39 | 1 | Agalsidase Beta (PRR 409.3) |
| 9563 | Borderline Leprosy | 39 | 1 | Nevirapine (PRR 263.6) |
| 9564 | Cardiac Valve Fibroelastoma | 39 | 1 | Testosterone Cypionate (PRR 342.5) |
| 9565 | Gastric Ischaemia | 39 | 1 | Amphetamine (PRR 287.4) |
| 9566 | Uveitic Glaucoma | 39 | 1 | Faricimab (PRR 293.4) |
| 9567 | Trabeculoplasty | 39 | 1 | Dorzolamide Hydrochloride And Timolol Maleate (PRR 387.1) |
| 9568 | Migraine-Triggered Seizure | 38 | 2 | Erenumab-Aooe (PRR 100.5) |
| 9569 | Implant Site Thrombosis | 38 | 1 | Etonogestrel (PRR 116.0) |
| 9570 | Picornavirus Infection | 38 | 2 | Mercaptopurine (PRR 699.5) |
| 9571 | Brachial Artery Entrapment Syndrome | 38 | 3 | Amphetamine (PRR 381.0) |
| 9572 | Sexual Activity Decreased | 38 | 1 | Relugolix (PRR 359.2) |
| 9573 | Persistent Cloaca | 38 | 1 | Indapamide (PRR 939.3) |
| 9574 | Instillation Site Haemorrhage | 38 | 1 | Lifitegrast (PRR 238.7) |
| 9575 | Bartter'S Syndrome | 38 | 2 | Gentamicin Sulfate (PRR 767.9) |
| 9576 | Mucinous Breast Carcinoma | 38 | 1 | Goserelin (PRR 631.2) |
| 9577 | Pao2/Fio2 Ratio Decreased | 38 | 2 | Remdesivir (PRR 416.2) |
| 9578 | Catheter Site Dryness | 38 | 1 | Epoprostenol (PRR 733.4) |
| 9579 | Venous Pressure Jugular Decreased | 38 | 3 | Dalteparin Sodium (PRR 702.3) |
| 9580 | Decreased Bronchial Secretion | 38 | 3 | Doxepin Hydrochloride (PRR 1,333.5) |
| 9581 | Hypervitaminosis A | 38 | 1 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 196.2) |
| 9582 | Moraxella Test Positive | 38 | 1 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 143.0) |
| 9583 | Aberrant Aortic Arch | 38 | 1 | Botulinum Toxin Type A (PRR 253.9) |
| 9584 | Multiple Lentigines Syndrome | 38 | 4 | Insulin Glulisine (PRR 1,063.9) |
| 9585 | Isoimmune Haemolytic Disease | 38 | 2 | Abacavir Sulfate (PRR 482.2) |
| 9586 | Acquired Attr Amyloidosis | 38 | 1 | Tafamidis (PRR 719.5) |
| 9587 | Dedifferentiated Liposarcoma | 38 | 1 | Regorafenib (PRR 336.0) |
| 9588 | Premature Closure Of Cranial Sutures | 38 | 2 | Nevirapine (PRR 432.4) |
| 9589 | Periodontal Inflammation | 38 | 1 | Canakinumab (PRR 291.3) |
| 9590 | Bezold-Jarisch Reflex | 38 | 3 | Atropine (PRR 779.3) |
| 9591 | Hodgkin'S Disease Nodular Sclerosis Stage Unspecified | 38 | 1 | Bleomycin Sulfate (PRR 305.1) |
| 9592 | Maternal Use Of Illicit Drugs | 38 | 1 | Bupivacaine (PRR 337.4) |
| 9593 | Endometritis Decidual | 38 | 1 | Dolutegravir Sodium (PRR 432.4) |
| 9594 | Post Stroke Depression | 38 | 1 | Brivaracetam (PRR 272.2) |
| 9595 | Tidal Volume Decreased | 38 | 1 | Sevoflurane (PRR 469.4) |
| 9596 | Hiv Test False Positive | 38 | 1 | Cabotegravir (PRR 390.4) |
| 9597 | Middle Lobe Syndrome | 38 | 1 | Methylprednisolone Acetate (PRR 692.9) |
| 9598 | Bronchial Polyp | 37 | 2 | Docetaxel Anhydrous (PRR 568.3) |
| 9599 | Sputum Culture | 37 | 3 | Rabeprazole (PRR 1,541.4) |
| 9600 | Murphy'S Sign Positive | 37 | 1 | Drospirenone And Ethinyl Estradiol (PRR 445.2) |
| 9601 | Blood Stem Cell Harvest | 37 | 1 | Daratumumab (PRR 354.5) |
| 9602 | Antiviral Drug Level Below Therapeutic | 37 | 5 | Abacavir Sulfate (PRR 589.1) |
| 9603 | Pericarditis Lupus | 37 | 1 | Belimumab (PRR 243.1) |
| 9604 | Radiation Induced Fatigue | 37 | 1 | Relugolix (PRR 170.6) |
| 9605 | Infectious Crystalline Keratopathy | 37 | 3 | Prednisolone Acetate (PRR 1,089.0) |
| 9606 | Reticulin Increased | 37 | 1 | Romiplostim (PRR 1,174.2) |
| 9607 | First Bite Syndrome | 37 | 1 | Epoprostenol (PRR 438.4) |
| 9608 | Chronic Right Ventricular Failure | 37 | 1 | Epoprostenol (PRR 370.8) |
| 9609 | Fev1/Fvc Ratio Abnormal | 37 | 1 | Tiotropium Bromide Inhalation Spray (PRR 290.0) |
| 9610 | Acanthamoeba Keratitis | 37 | 2 | Prednisolone Acetate (PRR 554.6) |
| 9611 | Leukaemic Lymphoma | 37 | 1 | Polatuzumab Vedotin (PRR 497.4) |
| 9612 | Alveolar Soft Part Sarcoma | 37 | 1 | Thiotepa (PRR 508.3) |
| 9613 | Human Herpesvirus 6 Viraemia | 37 | 1 | Thiotepa (PRR 508.3) |
| 9614 | Vessel Puncture Site Inflammation | 37 | 1 | Iron Sucrose (PRR 701.4) |
| 9615 | Obstetric Procedure Complication | 37 | 1 | Bupivacaine (PRR 347.9) |
| 9616 | Encephalitic Infection | 37 | 1 | Miconazole Nitrate (PRR 288.9) |
| 9617 | Metastases To Fallopian Tube | 37 | 1 | Alpelisib (PRR 210.6) |
| 9618 | Hyposplenism | 37 | 1 | Dronabinol (PRR 713.8) |
| 9619 | Automatism Epileptic | 36 | 3 | Clobazam (PRR 762.0) |
| 9620 | Enteritis Necroticans | 36 | 1 | Paliperidone Palmitate (PRR 129.1) |
| 9621 | Macular Rupture | 36 | 1 | Aflibercept (PRR 133.2) |
| 9622 | Sars-Cov-2 Sepsis | 36 | 2 | Fluticasone Furoate (PRR 1,092.8) |
| 9623 | Urticaria Contact | 36 | 2 | Alirocumab (PRR 276.3) |
| 9624 | Congenital Diaphragmatic Anomaly | 36 | 6 | Febuxostat Tablets 40 Mg (PRR 786.8) |
| 9625 | Rectosigmoid Cancer Metastatic | 36 | 1 | Panitumumab (PRR 442.6) |
| 9626 | Hiv Wasting Syndrome | 36 | 4 | Lopinavir And Ritonavir (PRR 1,096.2) |
| 9627 | Catheter Site Dermatitis | 36 | 1 | Epoprostenol (PRR 1,135.0) |
| 9628 | Neonatal Intestinal Perforation | 36 | 3 | Magnesium Sulfate In Water For (PRR 814.4) |
| 9629 | Eccrine Squamous Syringometaplasia | 36 | 1 | Vemurafenib (PRR 216.3) |
| 9630 | Amyloidosis Senile | 36 | 1 | Tafamidis (PRR 998.2) |
| 9631 | Idiopathic Pancreatitis | 36 | 1 | Apalutamide (PRR 221.2) |
| 9632 | Blood Hiv Rna Decreased | 36 | 1 | Entecavir (PRR 2,799.7) |
| 9633 | Pachygyria | 36 | 1 | Efavirenz (PRR 1,332.8) |
| 9634 | Segmental Diverticular Colitis | 36 | 1 | Captopril (PRR 2,704.7) |
| 9635 | Anorectal Ulcer | 36 | 1 | Iron Sucrose (PRR 623.5) |
| 9636 | Eyelid Scar | 36 | 1 | Nevirapine (PRR 372.0) |
| 9637 | Non-Obstructive Cardiomyopathy | 36 | 1 | Sevoflurane (PRR 312.9) |
| 9638 | Keratouveitis | 36 | 1 | Faricimab (PRR 233.4) |
| 9639 | Monocyte Chemotactic Protein-1 Increased | 35 | 5 | Anakinra (PRR 7,522.3) |
| 9640 | Lichen Nitidus | 35 | 1 | Salicylic Acid (PRR 157.0) |
| 9641 | Antinuclear Antibody Negative | 35 | 1 | Belimumab (PRR 620.0) |
| 9642 | Pseudomonas Peritonitis | 35 | 2 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 794.6) |
| 9643 | Myelodysplastic Syndrome Unclassifiable | 35 | 2 | Baricitinib (PRR 539.5) |
| 9644 | T-Cell Lymphoma Refractory | 35 | 3 | Ifosfamide (PRR 2,419.4) |
| 9645 | Lung Squamous Cell Carcinoma Recurrent | 35 | 1 | Durvalumab (PRR 170.4) |
| 9646 | Transcatheter Arterial Chemoembolisation | 35 | 1 | Sofosbuvir (PRR 218.1) |
| 9647 | Traumatic Coma | 35 | 1 | Nebivolol (PRR 598.4) |
| 9648 | Floppy Eyelid Syndrome | 35 | 2 | Ritonavir 100 Mg (PRR 412.5) |
| 9649 | Ovarian Granulosa-Theca Cell Tumour | 35 | 1 | Zonisamide (PRR 486.7) |
| 9650 | Glycogen Storage Disorder | 35 | 1 | Vigabatrin (PRR 133.8) |
| 9651 | Forced Expiratory Volume | 35 | 2 | Itraconazole (PRR 1,499.9) |
| 9652 | Concomitant Drug Effect Decreased | 35 | 1 | Apalutamide (PRR 165.9) |
| 9653 | Abortion Induced Incomplete | 35 | 1 | Misoprostol (PRR 4,094.9) |
| 9654 | Cutaneous T-Cell Lymphoma Stage Iv | 35 | 1 | Baricitinib (PRR 278.4) |
| 9655 | Fabry'S Disease | 35 | 1 | Agalsidase Beta (PRR 4,314.2) |
| 9656 | Burkholderia Cepacia Infection | 35 | 1 | Chlorhexidine Gluconate (PRR 3,853.3) |
| 9657 | Hemisensory Neglect | 35 | 1 | Travoprost (PRR 225.5) |
| 9658 | Acth Stimulation Test Abnormal | 35 | 1 | Tenofovir Disoproxil Fumarate Tablets (PRR 310.9) |
| 9659 | Central Venous Pressure Decreased | 35 | 1 | Sevoflurane (PRR 417.2) |
| 9660 | Complications Of Transplanted Pancreas | 35 | 1 | Anti-Thymocyte Globulin (Rabbit) (PRR 764.2) |
| 9661 | Multifocal Micronodular Pneumocyte Hyperplasia | 34 | 2 | Docetaxel Anhydrous (PRR 738.8) |
| 9662 | Blood Human Chorionic Gonadotropin Abnormal | 34 | 1 | Thalidomide (PRR 503.0) |
| 9663 | Blood Amylase Abnormal | 34 | 1 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 89.2) |
| 9664 | Myocardial Reperfusion Injury | 34 | 3 | Dimenhydrinate (PRR 1,735.3) |
| 9665 | Contraceptive Device Complication | 34 | 1 | Etonogestrel And Ethinyl Estradiol (PRR 833.4) |
| 9666 | Gliosarcoma | 34 | 1 | Temozolomide (PRR 411.2) |
| 9667 | Eosinophilic Otitis Media | 34 | 1 | Benralizumab (PRR 497.0) |
| 9668 | Colostomy Bag User | 34 | 1 | Panitumumab (PRR 284.5) |
| 9669 | Congenital Hepatobiliary Anomaly | 34 | 1 | Lopinavir And Ritonavir (PRR 552.5) |
| 9670 | Superimposed Pre-Eclampsia | 34 | 1 | Labetalol (PRR 650.3) |
| 9671 | Procedure Aborted | 34 | 1 | Ketoprofen (PRR 660.6) |
| 9672 | Thiopurine Methyltransferase Decreased | 34 | 2 | Tofacitinib Citrate (PRR 1,784.9) |
| 9673 | Angiolymphoid Hyperplasia With Eosinophilia | 34 | 1 | Tofacitinib Citrate (PRR 758.8) |
| 9674 | Catecholamine Crisis | 34 | 1 | Rocuronium Bromide (PRR 304.4) |
| 9675 | Anastomotic Infection | 34 | 1 | Amiodarone Hydrochloride (PRR 481.3) |
| 9676 | Costal Cartilage Fracture | 34 | 1 | Blinatumomab (PRR 427.3) |
| 9677 | Herpes Simplex Colitis | 34 | 1 | Voclosporin (PRR 1,306.7) |
| 9678 | Urine Albumin/Creatinine Ratio Decreased | 34 | 1 | Icosapent Ethyl (PRR 633.6) |
| 9679 | Amniotic Fluid Index Decreased | 34 | 2 | Mesna Injection (PRR 434.1) |
| 9680 | Occupational Exposure To Drug | 34 | 1 | Sevoflurane (PRR 649.0) |
| 9681 | Apolipoprotein B Increased | 34 | 1 | Inclisiran (PRR 1,081.0) |
| 9682 | Device User Interface Issue | 33 | 1 | Somatropin (PRR 183.5) |
| 9683 | Diaphragmatic Operation | 33 | 3 | Trifluridine And Tipiracil (PRR 430.9) |
| 9684 | Minimum Inhibitory Concentration | 33 | 3 | Dutasteride (PRR 6,823.2) |
| 9685 | Iris Injury | 33 | 1 | Ranibizumab (PRR 293.6) |
| 9686 | X-Linked Lymphoproliferative Syndrome | 33 | 2 | Canakinumab (PRR 5,127.5) |
| 9687 | Vena Cava Filter Removal | 33 | 1 | Etonogestrel And Ethinyl Estradiol (PRR 781.3) |
| 9688 | Vital Dye Staining Cornea Present | 33 | 2 | Lifitegrast (PRR 282.9) |
| 9689 | Exanthema Subitum | 33 | 1 | Palivizumab (PRR 241.8) |
| 9690 | Stoma Site Dermatitis | 33 | 2 | Teduglutide (PRR 1,852.4) |
| 9691 | Acquired Plagiocephaly | 33 | 1 | Rimegepant Sulfate (PRR 364.8) |
| 9692 | Cytomegalovirus Myocarditis | 33 | 3 | Ganciclovir (PRR 1,016.3) |
| 9693 | Neuromuscular Blocking Therapy | 33 | 1 | Rocuronium Bromide (PRR 662.1) |
| 9694 | Vitamin B6 Abnormal | 33 | 1 | Asfotase Alfa (PRR 3,195.1) |
| 9695 | Generalised Onset Non-Motor Seizure | 33 | 1 | Brivaracetam (PRR 622.9) |
| 9696 | Serology Abnormal | 33 | 1 | Voclosporin (PRR 330.4) |
| 9697 | Placental Necrosis | 33 | 1 | Oseltamivir (PRR 360.4) |
| 9698 | Unintentional Medical Device Removal By Patient | 32 | 1 | Levonorgestrel (PRR 989.4) |
| 9699 | Multiple Sclerosis Plaque | 32 | 1 | Glatiramer Acetate (PRR 393.7) |
| 9700 | Implant Site Nerve Injury | 32 | 1 | Etonogestrel (PRR 725.2) |
| 9701 | Meningomyelitis Herpes | 32 | 4 | Fludarabine Phosphate (PRR 880.6) |
| 9702 | Diabetic Macroangiopathy | 32 | 5 | Basiliximab (PRR 1,560.7) |
| 9703 | Growth Hormone-Producing Pituitary Tumour | 32 | 2 | Primidone (PRR 1,802.0) |
| 9704 | Zoonotic Bacterial Infection | 32 | 4 | Labetalol (PRR 1,213.9) |
| 9705 | Chronic Eosinophilic Rhinosinusitis | 32 | 1 | Benralizumab (PRR 346.4) |
| 9706 | Progressive Bulbar Palsy | 32 | 1 | Abemaciclib (PRR 407.1) |
| 9707 | Acute Myeloid Leukaemia (In Remission) | 32 | 1 | Azacitidine For (PRR 263.8) |
| 9708 | Infiltration Anaesthesia | 32 | 1 | Anakinra (PRR 2,758.2) |
| 9709 | Benign Cardiac Neoplasm | 32 | 1 | Vigabatrin (PRR 399.6) |
| 9710 | Urine Output Fluctuation | 32 | 1 | Teduglutide (PRR 514.6) |
| 9711 | Epidural Analgesia | 32 | 1 | Ketoprofen (PRR 720.7) |
| 9712 | Oesophagopleural Fistula | 32 | 3 | Ganciclovir Sodium (PRR 1,029.7) |
| 9713 | Dopamine Transporter Scintigraphy Abnormal | 32 | 2 | Felodipine Extended-Release Tablets (PRR 714.7) |
| 9714 | Microsporum Infection | 32 | 1 | Posaconazole Delayed-Release (PRR 631.4) |
| 9715 | Eyeglasses Therapy | 32 | 1 | Budesonide, Glycopyrrolate, And Formoterol Fumarate (PRR 206.0) |
| 9716 | Necrotising Gastritis | 32 | 1 | Bleomycin Sulfate (PRR 1,208.3) |
| 9717 | Cinchonism | 32 | 1 | Quinine (PRR 3,545.7) |
| 9718 | Periproctitis | 32 | 1 | Oseltamivir (PRR 603.0) |
| 9719 | Broncholithiasis | 31 | 3 | Ciclesonide (PRR 3,733.0) |
| 9720 | Hair Metal Test Abnormal | 31 | 1 | Copper (PRR 51.6) |
| 9721 | Corrosive Oropharyngeal Injury | 31 | 1 | Tapentadol Hydrochloride (PRR 216.0) |
| 9722 | Blepharopachynsis | 31 | 1 | Bimatoprost (PRR 1,311.3) |
| 9723 | Foetal Biophysical Profile Score Abnormal | 31 | 2 | Sodium Bicarbonate (PRR 1,415.6) |
| 9724 | Cytomegalovirus Urinary Tract Infection | 31 | 3 | Busulfan (PRR 2,403.3) |
| 9725 | Thyroid Stimulating Immunoglobulin | 31 | 1 | Alemtuzumab (PRR 1,488.7) |
| 9726 | Pain Assessment | 31 | 1 | Desoximetasone (PRR 519.7) |
| 9727 | Conjunctival Follicles | 31 | 1 | Brimonidine Tartrate (PRR 642.0) |
| 9728 | Depilation | 31 | 1 | Panitumumab (PRR 730.3) |
| 9729 | Nih Stroke Scale Abnormal | 31 | 1 | Alteplase (PRR 659.6) |
| 9730 | Catheter Site Urticaria | 31 | 1 | Epoprostenol (PRR 552.7) |
| 9731 | Post Abortion Complication | 31 | 1 | Misoprostol (PRR 743.1) |
| 9732 | Maternal Death | 31 | 1 | Brivaracetam (PRR 804.7) |
| 9733 | Urine Protein/Creatinine Ratio Decreased | 31 | 1 | Voclosporin (PRR 460.7) |
| 9734 | Reaction To Sweetener | 31 | 1 | Calcium, Magnesium, Potassium, And Sodium Oxybates (PRR 464.6) |
| 9735 | Sleep-Related Breathing Disorder | 31 | 1 | Anti-Thymocyte Globulin (Rabbit) (PRR 897.1) |
| 9736 | Contraceptive Implant | 30 | 1 | Etonogestrel (PRR 652.7) |
| 9737 | Endometrial Thinning | 30 | 1 | Etonogestrel (PRR 108.8) |
| 9738 | Medical Device Site Calcification | 30 | 1 | Copper (PRR 96.4) |
| 9739 | Febrile Infection-Related Epilepsy Syndrome | 30 | 3 | Anakinra (PRR 725.8) |
| 9740 | Severe Myoclonic Epilepsy Of Infancy | 30 | 2 | Brivaracetam (PRR 578.4) |
| 9741 | Corpus Callosotomy | 30 | 2 | Brivaracetam (PRR 355.9) |
| 9742 | Carbohydrate Antigen 125 | 30 | 2 | Niraparib (PRR 468.4) |
| 9743 | Bone Metabolism Biochemical Marker Increased | 30 | 1 | Romosozumab-Aqqg (PRR 170.2) |
| 9744 | Ectopic Gastric Mucosa | 30 | 1 | Teduglutide (PRR 385.9) |
| 9745 | Biopsy Tongue | 30 | 1 | Fluticasone Furoate (PRR 624.4) |
| 9746 | Antineutrophil Cytoplasmic Antibody Decreased | 30 | 2 | Felodipine Extended-Release Tablets (PRR 782.8) |
| 9747 | Endometrial Sarcoma | 30 | 1 | Efavirenz (PRR 567.9) |
| 9748 | Herbal Toxicity | 30 | 1 | Pyrazinamide (PRR 443.0) |
| 9749 | Pseudohallucination | 30 | 1 | Cariprazine (PRR 447.0) |
| 9750 | Carbohydrate Antigen 15-3 | 30 | 1 | Alpelisib (PRR 265.2) |
| 9751 | False Negative Pregnancy Test | 29 | 1 | Etonogestrel (PRR 466.2) |
| 9752 | Implant Site Nodule | 29 | 1 | Etonogestrel (PRR 466.2) |
| 9753 | Implant Site Ulcer | 29 | 1 | Etonogestrel (PRR 165.8) |
| 9754 | Increased Intraperitoneal Volume | 29 | 2 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 472.3) |
| 9755 | Procollagen Type I C-Terminal Propeptide Increased | 29 | 2 | Timolol Maleate (PRR 668.2) |
| 9756 | Acute Postoperative Sialadenitis | 29 | 2 | Sevoflurane (PRR 1,529.8) |
| 9757 | Growing Teratoma Syndrome | 29 | 1 | Bleomycin Sulfate (PRR 12,586.7) |
| 9758 | Acute Graft Versus Host Disease Oral | 29 | 1 | Thiotepa (PRR 693.2) |
| 9759 | Dihydrotestosterone Increased | 29 | 1 | Dutasteride (PRR 533.1) |
| 9760 | Chemical Peel Of Skin | 28 | 2 | Adapalene (PRR 203.9) |
| 9761 | Cervical Friability | 28 | 1 | Copper (PRR 192.7) |
| 9762 | Inspiratory Capacity Abnormal | 28 | 3 | Ciclesonide (PRR 2,748.9) |
| 9763 | Vitreous Fibrin | 28 | 1 | Aflibercept (PRR 222.0) |
| 9764 | Gastrointestinal Examination Abnormal | 28 | 1 | Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride (PRR 182.5) |
| 9765 | N-Terminal Prohormone Brain Natriuretic Peptide Decreased | 28 | 1 | Ixazomib (PRR 342.1) |
| 9766 | Lymphodepletion | 28 | 1 | Carfilzomib (PRR 348.1) |
| 9767 | Angiogram Retina Abnormal | 28 | 1 | Ranibizumab (PRR 313.2) |
| 9768 | Epilepsy With Myoclonic-Atonic Seizures | 28 | 3 | Sevoflurane (PRR 1,619.8) |
| 9769 | Caput Succedaneum | 28 | 1 | Benralizumab (PRR 283.4) |
| 9770 | Pneumovirus Test Positive | 28 | 1 | Palivizumab (PRR 294.3) |
| 9771 | Bile Cast Nephropathy | 28 | 3 | Naproxen Sodium Tablet, Coated (PRR 512.0) |
| 9772 | Peritoneal Thickening | 28 | 4 | Nevirapine (PRR 1,281.2) |
| 9773 | Anaplastic Large Cell Lymphoma T- And Null-Cell Types Recurrent | 28 | 2 | Brentuximab Vedotin (PRR 2,341.9) |
| 9774 | Radioallergosorbent Test Positive | 28 | 1 | Fluticasone Furoate (PRR 954.0) |
| 9775 | Indolent Systemic Mastocytosis | 28 | 1 | Avapritinib (PRR 4,294.5) |
| 9776 | Exeresis | 28 | 1 | Tafamidis (PRR 211.9) |
| 9777 | Precursor B-Lymphoblastic Lymphoma Recurrent | 28 | 1 | Blinatumomab (PRR 2,300.6) |
| 9778 | Hepatitis G | 28 | 1 | Brentuximab Vedotin (PRR 553.6) |
| 9779 | Conjunctivalisation | 28 | 1 | Nevirapine (PRR 3,074.8) |
| 9780 | Stomach Scan Abnormal | 28 | 1 | Voclosporin (PRR 653.4) |
| 9781 | Hydromyelia | 28 | 1 | Tenofovir Disoproxil Fumarate Tablets (PRR 803.2) |
| 9782 | Patient-Device Interaction Issue | 27 | 1 | Somatropin (PRR 410.6) |
| 9783 | Ex-Drug Abuser | 27 | 3 | Ethyl Alcohol (PRR 710.5) |
| 9784 | Pulmonary Angioplasty | 27 | 1 | Riociguat (PRR 2,804.4) |
| 9785 | Retinal Laser Coagulation | 27 | 1 | Aflibercept (PRR 233.1) |
| 9786 | Congenital Neoplasm | 27 | 4 | Zidovudine (PRR 5,444.4) |
| 9787 | Eyelid Vascular Disorder | 27 | 1 | Bimatoprost (PRR 360.6) |
| 9788 | Cardiac Siderosis | 27 | 1 | Deferasirox (PRR 1,861.9) |
| 9789 | Abdominal Transposition | 27 | 2 | Prochlorperazine Maleate (PRR 2,096.7) |
| 9790 | Human Anti-Human Antibody Test | 27 | 5 | Anakinra (PRR 1,823.6) |
| 9791 | Bile Duct Cancer Recurrent | 27 | 1 | Durvalumab (PRR 292.0) |
| 9792 | Testicular Germ Cell Cancer Metastatic | 27 | 2 | Fosaprepitant Dimeglumine (PRR 1,404.6) |
| 9793 | Vascular Pseudoaneurysm Thrombosis | 27 | 1 | Amikacin (PRR 838.2) |
| 9794 | Pathergy Reaction | 27 | 1 | Fexofenadine (PRR 740.5) |
| 9795 | Involuntary Vocalisation | 27 | 2 | Fremanezumab-Vfrm (PRR 315.1) |
| 9796 | Cardiac Pacemaker Adjustment | 27 | 1 | Patiromer (PRR 187.8) |
| 9797 | Infective Corneal Ulcer | 27 | 3 | Tobramycin Solution (PRR 729.2) |
| 9798 | Chondrosarcoma Metastatic | 27 | 1 | Bendamustine Hydrochloride (PRR 302.1) |
| 9799 | Cd4 Lymphocytes | 27 | 1 | Efavirenz (PRR 533.1) |
| 9800 | Anti-Erythropoietin Antibody | 27 | 1 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 235.6) |
| 9801 | Chemokine Increased | 27 | 1 | Canakinumab (PRR 1,321.9) |
| 9802 | Adrenal Infarction | 27 | 1 | Brentuximab Vedotin (PRR 2,185.8) |
| 9803 | Paraneoplastic Rash | 27 | 1 | Brentuximab Vedotin (PRR 579.9) |
| 9804 | Serum Procollagen Type I N-Terminal Propeptide Increased | 27 | 1 | Timolol Maleate (PRR 600.0) |
| 9805 | Oropharyngeal Gonococcal Infection | 27 | 1 | Cabotegravir (PRR 736.2) |
| 9806 | Antithyroid Arthritis Syndrome | 27 | 1 | Methimazole (PRR 33,127.6) |
| 9807 | Vascular Anastomotic Haemorrhage | 26 | 11 | Valganciclovir (PRR 13,236.3) |
| 9808 | Plethysmography | 26 | 8 | Ciclesonide (PRR 38,178.8) |
| 9809 | Implant Site Cyst | 26 | 1 | Etonogestrel (PRR 373.0) |
| 9810 | Uterine Cervical Metaplasia | 26 | 1 | Copper (PRR 87.6) |
| 9811 | Subretinal Hyperreflective Exudation | 26 | 2 | Faricimab (PRR 611.3) |
| 9812 | Peritoneal Dialysate Leakage | 26 | 3 | Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose (PRR 331.2) |
| 9813 | Malignant Cranial Nerve Neoplasm | 26 | 5 | Dexamethasone Sodium Phosphate (PRR 3,277.1) |
| 9814 | Functional Endoscopic Sinus Surgery | 26 | 2 | Alpelisib (PRR 1,060.8) |
| 9815 | Unevaluable Therapy | 26 | 1 | Esketamine Hydrochloride (PRR 277.7) |
| 9816 | Ankle Brachial Index Decreased | 26 | 1 | Imatinib (PRR 737.0) |
| 9817 | Lenticulostriatal Vasculopathy | 26 | 1 | Raltegravir (PRR 666.8) |
| 9818 | Subglottic Laryngitis | 26 | 1 | Palivizumab (PRR 498.8) |
| 9819 | Ascending Flaccid Paralysis | 26 | 2 | Bendamustine Hydrochloride (PRR 413.6) |
| 9820 | Diaphragmatic Aplasia | 26 | 4 | Lopinavir And Ritonavir (PRR 2,898.8) |
| 9821 | Parvovirus B19 Infection Reactivation | 26 | 1 | Basiliximab (PRR 936.4) |
| 9822 | Gastrointestinal Protozoal Infection | 26 | 1 | Cladribine (PRR 1,352.9) |
| 9823 | Lipoprotein (A) Decreased | 26 | 1 | Inclisiran (PRR 471.7) |
| 9824 | Actinomyces Bacteraemia | 25 | 1 | Copper (PRR 65.7) |
| 9825 | Actinomycotic Sepsis | 25 | 6 | Canakinumab (PRR 4,086.0) |
| 9826 | Paroxysmal Extreme Pain Disorder | 25 | 2 | Efavirenz (PRR 3,965.0) |
| 9827 | Diabetic Neuropathic Ulcer | 25 | 1 | Canagliflozin (PRR 545.8) |
| 9828 | Liver Iron Concentration Abnormal | 25 | 3 | Tolterodine Tartrate (PRR 1,304.0) |
| 9829 | Optic Nerve Operation | 25 | 2 | Dimenhydrinate (PRR 2,484.7) |
| 9830 | Pilonidal Sinus Repair | 25 | 1 | Bimekizumab (PRR 185.9) |
| 9831 | Cardiopulmonary Exercise Test Abnormal | 25 | 4 | Captopril (PRR 2,344.0) |
| 9832 | Donor Leukocyte Infusion | 25 | 1 | Busulfan (PRR 622.0) |
| 9833 | Haemophilic Pseudotumour | 25 | 1 | Emicizumab (PRR 792.2) |
| 9834 | Congenital Pharyngeal Anomaly | 25 | 1 | Fluticasone Furoate (PRR 965.9) |
| 9835 | Immunodeficiency Congenital | 25 | 2 | Abacavir Sulfate (PRR 1,423.7) |
| 9836 | Cerebral Malaria | 25 | 1 | Nevirapine (PRR 576.5) |
| 9837 | Epilepsy Surgery | 25 | 2 | Brivaracetam (PRR 2,135.6) |
| 9838 | Excessive Dynamic Airway Collapse | 25 | 1 | Sevoflurane (PRR 341.4) |
| 9839 | Hypophenylalaninaemia | 25 | 1 | Pegvaliase-Pqpz (PRR ∞) |
| 9840 | Apolipoprotein A-I Decreased | 25 | 1 | Inclisiran (PRR 353.8) |
| 9841 | First Degree Chemical Burn Of Skin | 24 | 1 | Adapalene (PRR 95.9) |
| 9842 | Cellulitis Enterococcal | 24 | 3 | Trimethoprim (PRR 3,529.5) |
| 9843 | Synovial Sarcoma Metastatic | 24 | 1 | Pazopanib Hydrochloride (PRR 650.0) |
| 9844 | Cftr Gene Mutation | 24 | 6 | Dimenhydrinate (PRR 9,761.2) |
| 9845 | Critical Illness Myopathy | 24 | 1 | Raltegravir (PRR 755.8) |
| 9846 | Cerebral Reperfusion Injury | 24 | 1 | Alteplase (PRR 570.4) |
| 9847 | Diffusion-Weighted Brain Mri Abnormal | 24 | 1 | Vigabatrin (PRR 285.4) |
| 9848 | Left Ventricular False Tendon | 24 | 1 | Patiromer (PRR 500.9) |
| 9849 | Hepatic Displacement | 24 | 4 | Lopinavir And Ritonavir (PRR 3,069.3) |
| 9850 | Bronchial Anastomosis Complication | 24 | 1 | Amphotericin B (PRR 996.2) |
| 9851 | Antasthmatic Drug Level Above Therapeutic | 24 | 2 | Theophylline Anhydrous (PRR 4,074.6) |
| 9852 | Ischaemic Contracture Of The Left Ventricle | 24 | 1 | Calcium Gluconate (PRR 1,726.3) |
| 9853 | Hydranencephaly | 24 | 2 | Efavirenz (PRR 1,332.8) |
| 9854 | Leukaemic Infiltration Renal | 24 | 1 | Blinatumomab (PRR 1,687.1) |
| 9855 | Hodgkin'S Disease Recurrent | 24 | 1 | Bleomycin Sulfate (PRR 1,006.9) |
| 9856 | Post Abortion Infection | 24 | 1 | Misoprostol (PRR 3,560.8) |
| 9857 | Induced Abortion Haemorrhage | 24 | 1 | Misoprostol (PRR 1,281.9) |
| 9858 | Kwashiorkor | 24 | 1 | Nevirapine (PRR 606.9) |
| 9859 | Choanal Stenosis | 24 | 1 | Dolutegravir Sodium (PRR 461.3) |
| 9860 | Pseudofolliculitis Barbae | 24 | 1 | Loratadine And Pseudoephedrine Sulfate (PRR 373.8) |
| 9861 | Poor School Attendance | 24 | 1 | Guanfacine (PRR 528.8) |
| 9862 | Neonatal Thyrotoxicosis | 24 | 1 | Methimazole (PRR 1,590.1) |
| 9863 | Non-Renal Cell Carcinoma Of Kidney | 23 | 1 | Gemcitabine (PRR 988.8) |
| 9864 | Csf Hiv Virus Identified | 23 | 5 | Tenofovir Disoproxil Fumarate Tablets (PRR 3,748.3) |
| 9865 | Noninfective Retinitis | 23 | 1 | Aflibercept (PRR 355.3) |
| 9866 | Cardiac Iron Overload | 23 | 1 | Deferasirox (PRR 603.1) |
| 9867 | Hypokinetic Dysarthria | 23 | 6 | Bisacodyl Suppositories (PRR 3,674.5) |
| 9868 | Cardiac Pacemaker Evaluation | 23 | 1 | Droxidopa (PRR 340.1) |
| 9869 | Dna Mismatch Repair Protein Gene Mutation | 23 | 1 | Temozolomide (PRR 904.5) |
| 9870 | Cystic Fibrosis Hepatic Disease | 23 | 4 | Dornase Alfa (PRR 972.2) |
| 9871 | Lymphatic Duct Injury | 23 | 1 | Bendamustine Hcl (PRR 586.8) |
| 9872 | Ultrasound Ovary Abnormal | 23 | 1 | Phenobarbital (PRR 1,315.7) |
| 9873 | Pulmonary Trichosporonosis | 23 | 2 | Micafungin Sodium (PRR 1,308.8) |
| 9874 | Primary Progressive Aphasia | 23 | 1 | Avapritinib (PRR 751.5) |
| 9875 | Urine Chloride Decreased | 23 | 2 | Lubiprostone (PRR 1,414.1) |
| 9876 | Genital Infection Viral | 23 | 1 | Tiotropium Bromide Inhalation Spray (PRR 1,701.5) |
| 9877 | Retroviral Rebound Syndrome | 23 | 1 | Efavirenz (PRR 995.1) |
| 9878 | Foveal Degeneration | 23 | 1 | Dutasteride (PRR 903.1) |
| 9879 | Radiation Retinopathy | 23 | 1 | Faricimab (PRR 385.1) |
| 9880 | Olfactory Groove Meningioma | 22 | 1 | Medroxyprogesterone Acetate (PRR 8,752.0) |
| 9881 | Application Site Plaque | 22 | 2 | Minoxidil Foam 5% (Womens) (PRR 236.2) |
| 9882 | Cervix Scarring | 22 | 1 | Copper (PRR 4,818.6) |
| 9883 | Colposcopy Abnormal | 22 | 1 | Copper (PRR 76.1) |
| 9884 | Anti Factor V Antibody | 22 | 4 | Micafungin Sodium (PRR 4,294.4) |
| 9885 | Duodenal Varices | 22 | 1 | Ixazomib (PRR 412.7) |
| 9886 | Cerebellar Haemangioma | 22 | 1 | Carfilzomib (PRR 508.8) |
| 9887 | Malignant Connective Tissue Neoplasm | 22 | 1 | Pazopanib Hydrochloride (PRR 640.1) |
| 9888 | Instillation Site Hypersensitivity | 22 | 1 | Lifitegrast (PRR 1,838.7) |
| 9889 | Infantile Asthma | 22 | 1 | Palivizumab (PRR 773.6) |
| 9890 | Haemodialysis-Induced Symptom | 22 | 1 | Paricalcitol (PRR 327.2) |
| 9891 | Staphylococcal Mediastinitis | 22 | 1 | Sirolimus (PRR 1,286.6) |
| 9892 | B-Cell Small Lymphocytic Lymphoma Recurrent | 22 | 1 | Bendamustine Hydrochloride (PRR 651.4) |
| 9893 | Nocturnal Hypertension | 22 | 1 | Tafamidis (PRR 1,222.7) |
| 9894 | Familial Amyloidosis | 22 | 2 | Tafamidis (PRR 662.3) |
| 9895 | Schizotypal Personality Disorder | 22 | 1 | Pseudoephedrine Hcl (PRR 298.1) |
| 9896 | Endobronchial Valve Implantation | 22 | 1 | Budesonide, Glycopyrrolate, And Formoterol Fumarate (PRR 314.4) |
| 9897 | Microvascular Cranial Nerve Palsy | 22 | 1 | Bosutinib (PRR 365.7) |
| 9898 | Basal Cell Naevus Syndrome | 22 | 1 | Vismodegib (PRR 369.0) |
| 9899 | Activated Pi3 Kinase Delta Syndrome | 22 | 1 | Alpelisib (PRR 1,652.4) |
| 9900 | Epithelitis | 21 | 1 | Durvalumab (PRR 3,270.8) |
| 9901 | Cystic Fibrosis Gastrointestinal Disease | 21 | 2 | Dornase Alfa (PRR 652.6) |
| 9902 | Hcov-Hku1 Infection | 21 | 2 | Mercaptopurine (PRR 1,319.1) |
| 9903 | Instillation Site Complication | 21 | 1 | Lifitegrast (PRR 299.5) |
| 9904 | Disseminated Gonococcal Infection | 21 | 1 | Ravulizumab (PRR 615.7) |
| 9905 | Blood Pyruvic Acid Decreased | 21 | 1 | Zidovudine (PRR 6,611.1) |
| 9906 | Retroperitoneal Disorder | 21 | 4 | Nevirapine (PRR 2,096.5) |
| 9907 | Infrapatellar Fat Pad Inflammation | 21 | 1 | Botulinum Toxin Type A (PRR 523.6) |
| 9908 | Blood Bromide Increased | 21 | 1 | Rocuronium Bromide (PRR 551.7) |
| 9909 | Clear Cell Sarcoma Of Soft Tissue | 21 | 1 | Regorafenib (PRR 559.9) |
| 9910 | Vascular Cognitive Impairment | 21 | 1 | Canakinumab (PRR 600.9) |
| 9911 | Germ Cell Neoplasm | 21 | 1 | Blinatumomab (PRR 469.1) |
| 9912 | Cutaneous T-Cell Lymphoma Refractory | 21 | 1 | Brentuximab Vedotin (PRR 634.3) |
| 9913 | Uveal Prolapse | 21 | 1 | Nevirapine (PRR 1,153.1) |
| 9914 | Opiates Negative | 20 | 1 | Tapentadol Hydrochloride (PRR 334.3) |
| 9915 | Retinal Pallor | 20 | 1 | Ranibizumab (PRR 421.6) |
| 9916 | Chronic Infantile Neurological Cutaneous And Articular Syndrome | 20 | 2 | Canakinumab (PRR 3,571.0) |
| 9917 | Glucocorticoids Increased | 20 | 2 | Ritonavir 100 Mg (PRR 1,701.7) |
| 9918 | Aquagenic Wrinkling Of Palms | 20 | 1 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 417.0) |
| 9919 | Enzyme Activity Decreased | 20 | 1 | Pegaspargase (PRR 728.2) |
| 9920 | Hereditary Alpha Tryptasaemia | 20 | 1 | Avapritinib (PRR 429.5) |
| 9921 | Postpartum Stress Disorder | 20 | 1 | Misoprostol (PRR 1,748.0) |
| 9922 | Manipulation | 20 | 1 | Bupivacaine (PRR 954.3) |
| 9923 | Opsoclonus | 20 | 1 | Cenobamate (PRR 440.0) |
| 9924 | Aspergillosis Oral | 20 | 1 | Anti-Thymocyte Globulin (Rabbit) (PRR 859.7) |
| 9925 | Serum Procollagen Type I N-Terminal Propeptide Decreased | 19 | 2 | Romosozumab-Aqqg (PRR 547.2) |
| 9926 | Uterine Myoma Expulsion | 19 | 1 | Relugolix (PRR 514.3) |
| 9927 | Computerised Tomogram Pelvis Abnormal | 19 | 1 | Niraparib (PRR 1,040.9) |
| 9928 | Anaplastic Oligodendroglioma | 19 | 1 | Temozolomide (PRR 575.6) |
| 9929 | Transgender Operation | 19 | 1 | Esketamine Hydrochloride (PRR 218.7) |
| 9930 | Bronchial Dysplasia | 19 | 1 | Palivizumab (PRR 253.8) |
| 9931 | Lactobacillus Bacteraemia | 19 | 1 | Remdesivir (PRR 416.2) |
| 9932 | Sleep Disorder Due To General Medical Condition, Mixed Type | 19 | 8 | Diclofenac Potassium, Film Coated (PRR 1,442.2) |
| 9933 | Factor Viii Activity Increased | 19 | 1 | Emicizumab (PRR 448.9) |
| 9934 | Mastocytic Leukaemia | 19 | 1 | Avapritinib (PRR 458.1) |
| 9935 | Lymphoplasmacytoid Lymphoma/Immunocytoma Recurrent | 19 | 1 | Bendamustine Hydrochloride (PRR 620.4) |
| 9936 | Device Priming | 19 | 1 | Budesonide, Glycopyrrolate, And Formoterol Fumarate (PRR 1,161.6) |
| 9937 | Pseudofracture | 19 | 1 | Asfotase Alfa (PRR 958.5) |
| 9938 | Bcg Related Cystitis | 19 | 1 | Axicabtagene Ciloleucel (PRR 1,897.3) |
| 9939 | Renal Pseudoaneurysm | 19 | 1 | Polatuzumab Vedotin (PRR 399.7) |
| 9940 | Hepatic Iron Overload | 19 | 1 | Thiotepa (PRR 778.1) |
| 9941 | Infusion Site Fibrosis | 19 | 1 | Bupivacaine (PRR 795.2) |
| 9942 | Pancreatic Pseudoaneurysm | 19 | 1 | Anti-Thymocyte Globulin (Rabbit) (PRR 1,190.4) |
| 9943 | Spleen Ischaemia | 19 | 1 | Inclisiran (PRR 3,567.2) |
| 9944 | Acute Macular Outer Retinopathy | 19 | 1 | Oseltamivir (PRR 489.9) |
| 9945 | Gaming Disorder | 19 | 1 | Guanfacine (PRR 705.1) |
| 9946 | Implant Site Papules | 18 | 1 | Etonogestrel (PRR 1,523.0) |
| 9947 | Fallopian Tube Adhesion | 18 | 1 | Copper (PRR 602.3) |
| 9948 | Fallopian Tube Enlargement | 18 | 1 | Copper (PRR 185.3) |
| 9949 | Prostaglandin Analogue Periorbitopathy | 18 | 1 | Bimatoprost (PRR 1,442.5) |
| 9950 | Vertebral Lateral Recess Stenosis | 18 | 2 | Rizatriptan Benzoate (PRR 1,301.5) |
| 9951 | Retinopathy Sickle Cell | 18 | 1 | Voxelotor (PRR 185.4) |
| 9952 | Diffuse Uveal Melanocytic Proliferation | 18 | 1 | Durvalumab (PRR 511.1) |
| 9953 | Oesophagomediastinal Fistula | 18 | 1 | Durvalumab (PRR 511.1) |
| 9954 | Amniotic Fluid Index Increased | 18 | 3 | Ivacaftor (PRR 13,096.6) |
| 9955 | Ketogenic Diet | 18 | 1 | Vigabatrin (PRR 407.7) |
| 9956 | Porphyrins Stool Increased | 18 | 1 | Phenobarbital (PRR 2,870.6) |
| 9957 | Urine Delta Aminolevulinate Increased | 18 | 1 | Phenobarbital (PRR 1,435.3) |
| 9958 | Stoma Site Complication | 18 | 1 | Teduglutide (PRR 982.3) |
| 9959 | Faecal Elastase Concentration Abnormal | 18 | 1 | Elexacaftor, Tezacaftor, And Ivacaftor (PRR 333.6) |
| 9960 | Factor Viii Activity Decreased | 18 | 1 | Emicizumab (PRR 841.8) |
| 9961 | Mastocytoma | 18 | 1 | Avapritinib (PRR 1,717.8) |
| 9962 | Ivth Nerve Disorder | 18 | 1 | Methadone Hydrochloride (PRR 961.3) |
| 9963 | Familial Cold Autoinflammatory Syndrome | 18 | 1 | Canakinumab (PRR 15,382.6) |
| 9964 | Vertebral End Plate Inflammation | 18 | 2 | Travoprost (PRR 6,252.6) |
| 9965 | Pride Syndrome | 18 | 1 | Gefitinib (PRR 1,843.9) |
| 9966 | Encephalitis Japanese B | 18 | 1 | Micafungin Sodium (PRR 943.8) |
| 9967 | Perceptual Disturbance | 18 | 1 | Amphetamine (PRR 718.4) |
| 9968 | Non-Secretory Adenoma Of Pituitary | 17 | 1 | Somatropin (PRR 917.5) |
| 9969 | Perinatal Hbv Infection | 17 | 2 | Tenofovir Disoproxil Fumarate Tablets (PRR 2,710.8) |
| 9970 | Alcoholic Coma | 17 | 1 | Ethyl Alcohol (PRR 860.8) |
| 9971 | Foveal Reflex Abnormal | 17 | 1 | Ranibizumab (PRR 1,435.6) |
| 9972 | Flour Sensitivity | 17 | 1 | Sitagliptin And Metformin Hydrochloride (PRR 1,767.4) |
| 9973 | High Grade B-Cell Lymphoma Burkitt-Like Lymphoma Recurrent | 17 | 1 | Olaparib (PRR 1,822.2) |
| 9974 | Mycoplasma Genitalium Infection | 17 | 2 | Dolutegravir Sodium (PRR 2,594.7) |
| 9975 | Splenosis | 17 | 1 | Romiplostim (PRR 1,228.0) |
| 9976 | Iliac Artery Perforation | 17 | 1 | Romosozumab-Aqqg (PRR 328.3) |
| 9977 | Tracheobronchitis Viral | 17 | 1 | Crizotinib (PRR 503.5) |
| 9978 | Laryngeal Leukoplakia | 17 | 1 | Granisetron (PRR 826.4) |
| 9979 | Electrocardiogram High Voltage | 17 | 1 | Brentuximab Vedotin (PRR 624.5) |
| 9980 | Stent Embolisation | 17 | 1 | Prasugrel Hydrochloride (PRR 2,303.5) |
| 9981 | Hypogonadism Female | 17 | 1 | Thiotepa (PRR 1,936.5) |
| 9982 | Lysosomal Storage Disorder | 17 | 1 | Agalsidase Beta (PRR 1,575.6) |
| 9983 | Hiv Peripheral Neuropathy | 17 | 1 | Tenofovir Disoproxil Fumarate Tablets (PRR 741.4) |
| 9984 | Muscle Relaxant Therapy | 17 | 1 | Quinine (PRR 2,729.3) |
| 9985 | Scan With Contrast Abnormal | 17 | 1 | Iohexol (PRR 537.6) |
| 9986 | Congenital Lymphoedema | 17 | 2 | Ampicillin (PRR 1,758.5) |
| 9987 | Rotator Cuff Tear Arthropathy | 17 | 1 | Vibegron (PRR 1,415.5) |
| 9988 | Speech-Language Therapy | 16 | 1 | Pimavanserin Tartrate (PRR 825.8) |
| 9989 | Implant Site Dermatitis | 16 | 1 | Etonogestrel (PRR 435.1) |
| 9990 | Hysterosalpingectomy | 16 | 1 | Copper (PRR 619.5) |
| 9991 | Risk Of Future Pregnancy Miscarriage | 16 | 1 | Copper (PRR 481.9) |
| 9992 | Cervix Erythema | 16 | 1 | Copper (PRR 111.2) |
| 9993 | Testosterone Deficiency Syndrome | 16 | 1 | Relugolix (PRR 685.7) |
| 9994 | Exchange Blood Transfusion | 16 | 1 | Voxelotor (PRR 309.0) |
| 9995 | Peripheral Blood Stem Cell Apheresis | 16 | 2 | Brentuximab Vedotin (PRR 3,382.8) |
| 9996 | Intracranial Venous Sinus Stenosis | 16 | 2 | Acetaminophen, Aspirin (Nsaid) And Caffeine (PRR 951.0) |
| 9997 | Fractional Exhaled Nitric Oxide Abnormal | 16 | 1 | Benralizumab (PRR 472.4) |
| 9998 | Autoimmune Vasculitis | 16 | 1 | Esketamine Hydrochloride (PRR 530.1) |
| 9999 | Disseminated Enteroviral Infection | 16 | 1 | Obinutuzumab (PRR 1,264.2) |
| 10000 | Instillation Site Vesicles | 16 | 1 | Lifitegrast (PRR 424.3) |
| 10001 | Tartrate-Resistant Acid Phosphatase Increased | 16 | 1 | Romosozumab-Aqqg (PRR 919.3) |
| 10002 | Mitral Perforation | 16 | 1 | Remdesivir (PRR 520.3) |
| 10003 | Medically Induced Preterm Birth | 16 | 2 | Instalax Polyethylene Glycol 3350 (PRR 1,304.0) |
| 10004 | Antithrombin Iii | 16 | 1 | Pegaspargase (PRR 7,362.4) |
| 10005 | Melanaemia | 16 | 1 | Prasugrel Hydrochloride (PRR 682.5) |
| 10006 | Oculocardiac Reflex | 16 | 2 | Sevoflurane (PRR 3,218.5) |
| 10007 | Proctitis Bacterial | 16 | 2 | Mesna Injection (PRR 1,144.5) |
| 10008 | Ictal Bradycardia Syndrome | 16 | 1 | Sevoflurane (PRR 834.4) |
| 10009 | Acne Infantile | 16 | 1 | Oseltamivir (PRR 603.0) |
| 10010 | Her2 Gene Amplification | 15 | 2 | Osimertinib (PRR 972.5) |
| 10011 | Flt3 Gene Mutation | 15 | 2 | Azacitidine For (PRR 4,573.3) |
| 10012 | Conjunctival Retraction | 15 | 1 | Ranibizumab (PRR 2,153.4) |
| 10013 | Rhizobium Radiobacter Bacteraemia | 15 | 1 | Busulfan (PRR 8,591.8) |
| 10014 | Sertoli-Cell-Only Syndrome | 15 | 1 | Busulfan (PRR 1,982.7) |
| 10015 | Pituitary Stalk Interruption Syndrome | 15 | 1 | Fluticasone Furoate (PRR 4,722.4) |
| 10016 | Anaemia Heinz Body | 15 | 3 | Daspone (PRR 1,869.0) |
| 10017 | Apheresis Related Complication | 15 | 1 | Axicabtagene Ciloleucel (PRR 527.0) |
| 10018 | Orthostatic Headache | 15 | 1 | Polatuzumab Vedotin (PRR 775.2) |
| 10019 | Lung Disease Infective Exacerbation | 15 | 2 | Thiotepa (PRR 1,906.2) |
| 10020 | Jc Polyomavirus Test | 15 | 1 | Brivaracetam (PRR 2,644.1) |
| 10021 | Basal Cell Carcinoma Metastatic | 15 | 1 | Vismodegib (PRR 849.9) |
| 10022 | Blood Hiv Rna Below Assay Limit | 15 | 1 | Cabotegravir (PRR 644.1) |
| 10023 | Iris Vascular Disorder | 14 | 1 | Aflibercept (PRR 499.6) |
| 10024 | Red Blood Cell Hyperchromic Morphology | 14 | 2 | Gentamicin Sulfate (PRR ∞) |
| 10025 | Intramyelinic Oedema | 14 | 1 | Vigabatrin (PRR 3,567.4) |
| 10026 | Intermittent Positive Pressure Breathing | 14 | 2 | Cefuroxime (PRR 4,548.9) |
| 10027 | Clenched Hand | 14 | 1 | Fluticasone Furoate (PRR 2,289.6) |
| 10028 | Blepharorrhaphy | 14 | 1 | Cenegermin-Bkbj (PRR 10,319.7) |
| 10029 | Hyper Igd Syndrome | 14 | 1 | Canakinumab (PRR 2,563.8) |
| 10030 | Arachnoid Web | 14 | 1 | Bupivacaine (PRR 1,670.0) |
| 10031 | Pik3Ca Related Overgrowth Spectrum | 14 | 1 | Alpelisib (PRR 2,386.8) |
| 10032 | Her2 Positive Salivary Gland Cancer | 14 | 1 | Ado-Trastuzumab Emtansine (PRR 1,850.8) |
| 10033 | Plasmablast Count Increased | 14 | 2 | Mesna Injection (PRR 2,517.9) |
| 10034 | Congenital Intestinal Obstruction | 14 | 1 | Oseltamivir (PRR 712.6) |
| 10035 | Uterine Leiomyoma Calcification | 13 | 1 | Copper (PRR 214.2) |
| 10036 | Rhesus Antigen Positive | 13 | 1 | Belimumab (PRR ∞) |
| 10037 | Lens Capsulotomy | 13 | 1 | Aflibercept (PRR 777.2) |
| 10038 | Disease Activity Score | 13 | 1 | Bimekizumab (PRR 433.9) |
| 10039 | Instillation Site Rash | 13 | 1 | Lifitegrast (PRR 1,091.1) |
| 10040 | Npm1 Gene Mutation | 13 | 5 | Thiotepa (PRR 11,982.0) |
| 10041 | Pseudocroup | 13 | 1 | Palivizumab (PRR 1,160.4) |
| 10042 | Masked Fever | 13 | 1 | Remdesivir (PRR 975.5) |
| 10043 | Fryns Syndrome | 13 | 1 | Epoetin Alfa (PRR ∞) |
| 10044 | Parotid Gland Haemorrhage | 13 | 1 | Entecavir (PRR 1,527.1) |
| 10045 | Antemortem Blood Drug Level Abnormal | 13 | 1 | Methadone Hydrochloride (PRR 854.5) |
| 10046 | Cd19 Antigen Loss | 13 | 1 | Blinatumomab (PRR 1,246.2) |
| 10047 | Mitochondrial Aspartate Aminotransferase Increased | 13 | 1 | Gefitinib (PRR 5,185.9) |
| 10048 | Trisomy 17 | 13 | 1 | Nevirapine (PRR 7,687.1) |
| 10049 | Autoimmune Aplastic Anaemia | 13 | 1 | Brivaracetam (PRR 1,028.3) |
| 10050 | Hbv-Dna Polymerase Increased | 13 | 1 | Tenofovir Disoproxil Fumarate Tablets (PRR 1,506.0) |
| 10051 | Bladder Telangiectasia | 13 | 2 | Mesna Injection (PRR 2,158.2) |
| 10052 | Hyperphenylalaninaemia | 13 | 1 | Pegvaliase-Pqpz (PRR 8,442.3) |
| 10053 | Apolipoprotein B Decreased | 13 | 1 | Inclisiran (PRR 8,647.8) |
| 10054 | Thyrotoxic Myopathy | 13 | 1 | Methimazole (PRR 14,576.2) |
| 10055 | Aids Cholangiopathy | 12 | 2 | Zidovudine (PRR 3,111.1) |
| 10056 | Ovarian Germ Cell Cancer Stage Ii | 12 | 1 | Paliperidone (PRR 4,457.3) |
| 10057 | Pulmonary Valve Sclerosis | 12 | 3 | Raltegravir (PRR 6,298.0) |
| 10058 | Rhinolaryngitis | 12 | 1 | Palivizumab (PRR 451.3) |
| 10059 | Early Infantile Epileptic Encephalopathy With Burst-Suppression | 12 | 1 | Vigabatrin (PRR 1,019.3) |
| 10060 | Cyp3A4 Polymorphism | 12 | 1 | Goserelin (PRR 7,746.2) |
| 10061 | Cronobacter Infection | 12 | 2 | Tobramycin Solution (PRR 2,424.5) |
| 10062 | Gangrene Neonatal | 12 | 1 | Acetaminophen And Codeine (PRR 2,390.4) |
| 10063 | Dermatoporosis | 12 | 1 | Acalabrutinib (PRR 858.2) |
| 10064 | Bispectral Index Decreased | 12 | 2 | Rocuronium Bromide (PRR 882.7) |
| 10065 | Anaplastic Large Cell Lymphoma T- And Null-Cell Types Refractory | 12 | 1 | Brentuximab Vedotin (PRR 4,059.4) |
| 10066 | Myeloblast Percentage Decreased | 12 | 1 | Cladribine (PRR 3,030.5) |
| 10067 | Bacille Calmette-Guerin Scar Reactivation | 12 | 2 | Thiotepa (PRR 2,178.6) |
| 10068 | Congenital Clavicular Agenesis | 12 | 3 | Ampicillin (PRR 5,024.2) |
| 10069 | Aorto-Cardiac Fistula | 12 | 1 | Amphetamine (PRR 1,796.1) |
| 10070 | Skin Implant Removal | 11 | 1 | Etonogestrel (PRR 1,160.4) |
| 10071 | Genital Scarring | 11 | 1 | Copper (PRR 180.7) |
| 10072 | Prosthetic Cardiac Valve Obstruction | 11 | 1 | Lenvatinib (PRR 2,850.6) |
| 10073 | Hepatic Venous Pressure Gradient Abnormal | 11 | 2 | Cetuximab (PRR ∞) |
| 10074 | Clang Associations | 11 | 1 | Paliperidone (PRR 2,377.2) |
| 10075 | Retinal Function Test Abnormal | 11 | 1 | Vigabatrin (PRR 1,189.1) |
| 10076 | Cow Pox | 11 | 1 | Sirolimus (PRR 6,947.7) |
| 10077 | Leser-Trelat Sign | 11 | 1 | Encorafenib (PRR 787.9) |
| 10078 | High Grade B-Cell Lymphoma Recurrent | 11 | 1 | Axicabtagene Ciloleucel (PRR 790.5) |
| 10079 | Adenoviral Encephalitis | 11 | 1 | Polatuzumab Vedotin (PRR 1,218.2) |
| 10080 | Endometritis Bacterial | 11 | 1 | Misoprostol (PRR 2,563.7) |
| 10081 | Mitochondrial Neurogastrointestinal Encephalopathy | 11 | 1 | Pyrazinamide (PRR 1,845.8) |
| 10082 | Congenital Tuberculosis | 11 | 2 | Tenofovir Disoproxil Fumarate Tablets (PRR 1,376.9) |
| 10083 | Subependymal Cyst | 11 | 1 | Dolutegravir Sodium (PRR 4,036.2) |
| 10084 | Weissella Infection | 11 | 1 | Micafungin Sodium (PRR 4,294.4) |
| 10085 | Light Anaesthesia | 11 | 1 | Sevoflurane (PRR 2,086.0) |
| 10086 | 5-Alpha-Reductase Deficiency | 11 | 1 | Dutasteride (PRR 4,477.7) |
| 10087 | Optical Coherence Tomography | 11 | 1 | Faricimab (PRR 11,552.8) |
| 10088 | Medical Device Site Movement Impairment | 10 | 1 | Etonogestrel (PRR 1,740.6) |
| 10089 | Instillation Site Exfoliation | 10 | 1 | Lifitegrast (PRR 545.5) |
| 10090 | Acinic Cell Carcinoma Of Salivary Gland | 10 | 2 | Baricitinib (PRR 2,157.9) |
| 10091 | Parasympathetic Nerve Injury | 10 | 1 | Peginterferon Beta-1A (PRR 6,347.8) |
| 10092 | Epidermal Naevus Syndrome | 10 | 1 | Vemurafenib (PRR 1,153.8) |
| 10093 | Labour Augmentation | 10 | 1 | Misoprostol (PRR 8,545.8) |
| 10094 | Bromoderma | 10 | 1 | Brivaracetam (PRR 1,542.4) |
| 10095 | Congenital Methaemoglobinaemia | 10 | 1 | Umeclidinium (PRR 2,323.2) |
| 10096 | Intravascular Gas | 10 | 1 | Iohexol (PRR 3,763.5) |
| 10097 | Proctitis Gonococcal | 10 | 1 | Cabotegravir (PRR 1,104.2) |
| 10098 | Implant Site Coldness | 9 | 1 | Etonogestrel (PRR 1,523.0) |
| 10099 | Eosinophilic Cholangitis | 9 | 1 | Abemaciclib (PRR 1,300.5) |
| 10100 | Abiotrophia Defectiva Endocarditis | 9 | 2 | Daptomycin (PRR 1,804.1) |
| 10101 | Benign Recurrent Intrahepatic Cholestasis | 9 | 2 | Micafungin Sodium (PRR 19,631.5) |
| 10102 | Bile Acids | 9 | 1 | Fluticasone Furoate (PRR 13,737.9) |
| 10103 | Breast Milk Odour Abnormal | 9 | 1 | Fluticasone Furoate (PRR 13,737.9) |
| 10104 | Argentine Haemorrhagic Fever | 9 | 1 | Basiliximab (PRR ∞) |
| 10105 | Cardiac Valve Discolouration | 9 | 1 | Minocycline (PRR 6,245.4) |
| 10106 | Affective Ambivalence | 9 | 1 | Cariprazine (PRR 1,117.5) |
| 10107 | Blood Hiv Rna Fluctuation | 9 | 1 | Dolutegravir Sodium (PRR 1,845.1) |
| 10108 | Pythium Insidiosum Infection | 9 | 1 | Terbinafine Hydrochloride (PRR 4,683.8) |
| 10109 | Non-Hodgkin'S Lymphoma Unspecified Histology Aggressive | 9 | 2 | Mesna Injection (PRR 3,147.4) |
| 10110 | Blood Chromogranin A | 9 | 1 | Lanreotide Acetate (PRR 2,122.9) |
| 10111 | Implant Site Hyperaesthesia | 8 | 1 | Etonogestrel (PRR 3,046.0) |
| 10112 | Double Heterozygous Sickling Disorders | 8 | 1 | Voxelotor (PRR 556.2) |
| 10113 | Barth Syndrome | 8 | 1 | Palivizumab (PRR 812.3) |
| 10114 | Parathyroid Scan Abnormal | 8 | 1 | Sevelamer Carbonate (PRR 5,431.5) |
| 10115 | Abnormal Dna Methylation | 8 | 1 | Bleomycin Sulfate (PRR 3,356.4) |
| 10116 | Antiplatelet Therapy | 8 | 1 | Baricitinib (PRR 2,157.9) |
| 10117 | Cerebellar Mutism | 8 | 1 | Selinexor (PRR 1,442.1) |
| 10118 | Instillation Site Odour | 7 | 1 | Lifitegrast (PRR 954.7) |
| 10119 | Respiratory Syncytial Virus Test Negative | 7 | 1 | Palivizumab (PRR 3,384.6) |
| 10120 | Tetralogy Of Fallot Repair | 7 | 1 | Palivizumab (PRR 1,805.1) |
| 10121 | Talipes Correction | 7 | 1 | Vigabatrin (PRR 1,902.6) |
| 10122 | Toxic Cataract | 7 | 1 | Abiraterone (PRR 3,819.6) |
| 10123 | Radiosensitisation Therapy | 7 | 1 | Vemurafenib (PRR 2,307.7) |
| 10124 | Migraine Postdrome | 7 | 1 | Fremanezumab-Vfrm (PRR 1,359.1) |
| 10125 | Pharyngeal Chlamydia Infection | 7 | 1 | Emtricitabine And Tenofovir Alafenamide (PRR 1,376.1) |
| 10126 | Mevalonate Kinase Deficiency | 7 | 1 | Canakinumab (PRR 11,537.0) |
| 10127 | Bronchial Atresia | 7 | 1 | Canakinumab (PRR 4,807.1) |
| 10128 | Eyelid Calcification | 7 | 1 | Asfotase Alfa (PRR 5,192.0) |
| 10129 | Bone Cement Implantation Syndrome | 7 | 1 | Sevoflurane (PRR 3,337.7) |
| 10130 | Fiducial Marker Placement | 6 | 1 | Relugolix (PRR 1,763.3) |
| 10131 | Electrodesiccation | 6 | 1 | Bendamustine Hydrochloride (PRR 3,474.0) |
| 10132 | External Counterpulsation | 6 | 1 | Ranolazine (PRR 1,993.3) |
| 10133 | Cerebral Artery Stent Insertion | 6 | 1 | Iohexol (PRR 12,545.2) |
| 10134 | Blood Copper | 5 | 1 | Copper (PRR 722.8) |
| 10135 | Enlarged Foetal Cisterna Magna | 5 | 1 | Vigabatrin (PRR 2,140.5) |
| 10136 | Reticulocyte Haemoglobin Increased | 5 | 1 | Methoxy Polyethylene Glycol-Epoetin Beta (PRR 2,827.2) |
| 10137 | Globotriaosylceramide | 5 | 1 | Agalsidase Beta (PRR ∞) |
| 10138 | Congenital Epiblepharon | 4 | 1 | Cariprazine (PRR 6,705.2) |
| 10139 | Globotriaosylsphingosine | 4 | 1 | Agalsidase Beta (PRR ∞) |
| 10140 | Delftia Acidovorans Infection | 4 | 1 | Sevoflurane (PRR 7,509.8) |
| 10141 | Mesenteric Traction Syndrome | 4 | 1 | Sevoflurane (PRR 7,509.8) |
| 10142 | Apolipoprotein E Increased | 4 | 1 | Inclisiran (PRR 7,783.0) |
| 10143 | Door Syndrome | 3 | 4 | Pseudoephedrine Hcl (PRR ∞) |
Top drugs by signal strength (max PRR)